0001829126-23-002816.txt : 20230419 0001829126-23-002816.hdr.sgml : 20230419 20230418203933 ACCESSION NUMBER: 0001829126-23-002816 CONFORMED SUBMISSION TYPE: 10-K/A PUBLIC DOCUMENT COUNT: 102 CONFORMED PERIOD OF REPORT: 20221231 FILED AS OF DATE: 20230419 DATE AS OF CHANGE: 20230418 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Celsius Holdings, Inc. CENTRAL INDEX KEY: 0001341766 STANDARD INDUSTRIAL CLASSIFICATION: BOTTLED & CANNED SOFT DRINKS CARBONATED WATERS [2086] IRS NUMBER: 202745790 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-34611 FILM NUMBER: 23828303 BUSINESS ADDRESS: STREET 1: 2424 N. FEDERAL HWY STREET 2: SUITE 208 CITY: BOCA RATON STATE: FL ZIP: 33431 BUSINESS PHONE: 561-276-2239 MAIL ADDRESS: STREET 1: 2424 N. FEDERAL HWY STREET 2: SUITE 208 CITY: BOCA RATON STATE: FL ZIP: 33431 FORMER COMPANY: FORMER CONFORMED NAME: VECTOR VENTURES CORP. DATE OF NAME CHANGE: 20051018 10-K/A 1 celsiusholdings_10ka.htm 10-K/A
0001341766 true FY 2022 Yes No Yes Yes 0001341766 2022-01-01 2022-12-31 0001341766 2022-06-30 0001341766 2023-02-14 0001341766 2022-12-31 0001341766 2021-12-31 0001341766 us-gaap:SeriesAPreferredStockMember 2022-12-31 0001341766 us-gaap:SeriesAPreferredStockMember 2021-12-31 0001341766 2021-01-01 2021-12-31 0001341766 2020-01-01 2020-12-31 0001341766 us-gaap:CommonStockMember 2019-12-31 0001341766 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001341766 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0001341766 us-gaap:RetainedEarningsMember 2019-12-31 0001341766 2019-12-31 0001341766 us-gaap:PreferredStockMember 2019-12-31 0001341766 us-gaap:CommonStockMember 2020-12-31 0001341766 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001341766 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001341766 us-gaap:RetainedEarningsMember 2020-12-31 0001341766 2020-12-31 0001341766 us-gaap:PreferredStockMember 2020-12-31 0001341766 us-gaap:CommonStockMember 2021-12-31 0001341766 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001341766 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001341766 us-gaap:RetainedEarningsMember 2021-12-31 0001341766 us-gaap:PreferredStockMember 2021-12-31 0001341766 us-gaap:CommonStockMember 2020-01-01 2020-12-31 0001341766 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-12-31 0001341766 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-12-31 0001341766 us-gaap:RetainedEarningsMember 2020-01-01 2020-12-31 0001341766 us-gaap:PreferredStockMember 2020-01-01 2020-12-31 0001341766 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0001341766 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0001341766 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-12-31 0001341766 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0001341766 us-gaap:PreferredStockMember 2021-01-01 2021-12-31 0001341766 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001341766 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001341766 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-12-31 0001341766 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001341766 us-gaap:PreferredStockMember 2022-01-01 2022-12-31 0001341766 us-gaap:CommonStockMember 2022-12-31 0001341766 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001341766 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001341766 us-gaap:RetainedEarningsMember 2022-12-31 0001341766 us-gaap:PreferredStockMember 2022-12-31 0001341766 celh:FuncFoodGroupMember 2022-01-01 2022-12-31 0001341766 celh:FuncFoodGroupMember 2022-12-31 0001341766 celh:TransitionAgreementMember us-gaap:ConvertiblePreferredStockMember 2022-07-29 2022-08-01 0001341766 celh:TransitionAgreementMember 2022-01-01 2022-12-31 0001341766 us-gaap:SalesRevenueNetMember celh:CustomerConcentrationRiskTotalMember celh:PepsicoIncMember 2022-01-01 2022-12-31 0001341766 us-gaap:SalesRevenueNetMember celh:CustomerConcentrationRiskTotalMember celh:PepsicoIncMember 2021-01-01 2021-12-31 0001341766 us-gaap:SalesRevenueNetMember celh:CustomerConcentrationRiskTotalMember celh:PepsicoIncMember 2020-01-01 2020-12-31 0001341766 us-gaap:SalesRevenueNetMember celh:CustomerConcentrationRiskTotalMember celh:CostcoMember 2022-01-01 2022-12-31 0001341766 us-gaap:SalesRevenueNetMember celh:CustomerConcentrationRiskTotalMember celh:CostcoMember 2021-01-01 2021-12-31 0001341766 us-gaap:SalesRevenueNetMember celh:CustomerConcentrationRiskTotalMember celh:CostcoMember 2020-01-01 2020-12-31 0001341766 us-gaap:SalesRevenueNetMember celh:CustomerConcentrationRiskTotalMember celh:AmazonMember 2022-01-01 2022-12-31 0001341766 us-gaap:SalesRevenueNetMember celh:CustomerConcentrationRiskTotalMember celh:AmazonMember 2021-01-01 2021-12-31 0001341766 us-gaap:SalesRevenueNetMember celh:CustomerConcentrationRiskTotalMember celh:AmazonMember 2020-01-01 2020-12-31 0001341766 us-gaap:SalesRevenueNetMember celh:CustomerConcentrationRiskTotalMember celh:AllOtherMember 2022-01-01 2022-12-31 0001341766 us-gaap:SalesRevenueNetMember celh:CustomerConcentrationRiskTotalMember celh:AllOtherMember 2021-01-01 2021-12-31 0001341766 us-gaap:SalesRevenueNetMember celh:CustomerConcentrationRiskTotalMember celh:AllOtherMember 2020-01-01 2020-12-31 0001341766 us-gaap:SalesRevenueNetMember celh:CustomerConcentrationRiskTotalMember 2022-01-01 2022-12-31 0001341766 us-gaap:SalesRevenueNetMember celh:CustomerConcentrationRiskTotalMember 2021-01-01 2021-12-31 0001341766 us-gaap:SalesRevenueNetMember celh:CustomerConcentrationRiskTotalMember 2020-01-01 2020-12-31 0001341766 us-gaap:AccountsReceivableMember celh:CustomerConcentrationRiskTotalMember celh:PepsicoIncMember 2022-01-01 2022-12-31 0001341766 us-gaap:AccountsReceivableMember celh:CustomerConcentrationRiskTotalMember celh:PepsicoIncMember 2021-01-01 2021-12-31 0001341766 us-gaap:AccountsReceivableMember celh:CustomerConcentrationRiskTotalMember celh:AmazonMember 2022-01-01 2022-12-31 0001341766 us-gaap:AccountsReceivableMember celh:CustomerConcentrationRiskTotalMember celh:AmazonMember 2021-01-01 2021-12-31 0001341766 us-gaap:AccountsReceivableMember celh:CustomerConcentrationRiskTotalMember celh:PublixMember 2022-01-01 2022-12-31 0001341766 us-gaap:AccountsReceivableMember celh:CustomerConcentrationRiskTotalMember celh:PublixMember 2021-01-01 2021-12-31 0001341766 us-gaap:AccountsReceivableMember celh:CustomerConcentrationRiskTotalMember celh:AllOtherMember 2022-01-01 2022-12-31 0001341766 us-gaap:AccountsReceivableMember celh:CustomerConcentrationRiskTotalMember celh:AllOtherMember 2021-01-01 2021-12-31 0001341766 us-gaap:AccountsReceivableMember celh:CustomerConcentrationRiskTotalMember 2022-01-01 2022-12-31 0001341766 us-gaap:AccountsReceivableMember celh:CustomerConcentrationRiskTotalMember 2021-01-01 2021-12-31 0001341766 srt:MinimumMember 2022-01-01 2022-12-31 0001341766 srt:MaximumMember 2022-01-01 2022-12-31 0001341766 country:US 2022-12-31 0001341766 country:US 2021-12-31 0001341766 country:SE 2022-12-31 0001341766 country:SE 2021-12-31 0001341766 country:FI 2022-12-31 0001341766 country:FI 2021-12-31 0001341766 celh:OtherMember 2022-12-31 0001341766 celh:OtherMember 2021-12-31 0001341766 celh:ForeignRevenuesMember 2022-01-01 2022-12-31 0001341766 celh:ForeignRevenuesMember 2021-01-01 2021-12-31 0001341766 celh:ForeignRevenuesMember 2020-01-01 2020-12-31 0001341766 country:SE 2022-01-01 2022-12-31 0001341766 country:SE 2021-01-01 2021-12-31 0001341766 country:SE 2020-01-01 2020-12-31 0001341766 celh:PepsicoIncMember 2022-07-29 2022-08-01 0001341766 celh:PepsicoIncMember 2022-12-31 0001341766 celh:PepsicoIncMember 2022-01-01 2022-12-31 0001341766 celh:LicenseAgreementMember 2022-01-01 2022-12-31 0001341766 celh:LicenseAgreementMember 2021-01-01 2021-12-31 0001341766 celh:LicenseAgreementMember 2020-01-01 2020-12-31 0001341766 srt:NorthAmericaMember 2022-01-01 2022-12-31 0001341766 srt:NorthAmericaMember 2021-01-01 2021-12-31 0001341766 srt:NorthAmericaMember 2020-01-01 2020-12-31 0001341766 srt:EuropeMember 2022-01-01 2022-12-31 0001341766 srt:EuropeMember 2021-01-01 2021-12-31 0001341766 srt:EuropeMember 2020-01-01 2020-12-31 0001341766 srt:AsiaMember 2022-01-01 2022-12-31 0001341766 srt:AsiaMember 2021-01-01 2021-12-31 0001341766 srt:AsiaMember 2020-01-01 2020-12-31 0001341766 celh:OtherMember 2022-01-01 2022-12-31 0001341766 celh:OtherMember 2021-01-01 2021-12-31 0001341766 celh:OtherMember 2020-01-01 2020-12-31 0001341766 srt:MaximumMember 2022-12-31 0001341766 srt:MinimumMember 2022-12-31 0001341766 srt:MinimumMember celh:MerchandisingEquipmentCoolersMember 2022-01-01 2022-12-31 0001341766 srt:MaximumMember celh:MerchandisingEquipmentCoolersMember 2022-01-01 2022-12-31 0001341766 celh:MerchandisingEquipmentCoolersMember 2022-12-31 0001341766 celh:MerchandisingEquipmentCoolersMember 2021-12-31 0001341766 srt:MinimumMember us-gaap:OfficeEquipmentMember 2022-01-01 2022-12-31 0001341766 srt:MaximumMember us-gaap:OfficeEquipmentMember 2022-01-01 2022-12-31 0001341766 us-gaap:OfficeEquipmentMember 2022-12-31 0001341766 us-gaap:OfficeEquipmentMember 2021-12-31 0001341766 us-gaap:VehiclesMember 2022-01-01 2022-12-31 0001341766 us-gaap:VehiclesMember 2022-12-31 0001341766 us-gaap:VehiclesMember 2021-12-31 0001341766 celh:PepsicoIncMember us-gaap:SeriesAPreferredStockMember 2022-08-01 0001341766 celh:PepsicoIncMember 2022-01-01 2022-12-31 0001341766 celh:PepsicoIncMember 2022-12-31 0001341766 celh:PepsicoIncMember us-gaap:SeriesAPreferredStockMember 2022-01-01 2022-12-31 0001341766 celh:PepsicoIncMember 2022-07-29 2022-08-01 0001341766 celh:PepsicoIncMember us-gaap:SeriesAPreferredStockMember 2022-07-29 2022-08-01 0001341766 celh:ContractAssetsCurrentMember celh:PepsicoIncMember 2022-01-01 2022-12-31 0001341766 celh:ContractAssetsNonCurrentMember celh:PepsicoIncMember 2022-01-01 2022-12-31 0001341766 us-gaap:BuildingMember us-gaap:MajorityShareholderMember celh:CDFinancialLLCMember 2022-01-01 2022-12-31 0001341766 celh:SeriesAConvertiblePreferredStockMember 2022-12-31 0001341766 celh:SecuritiesPurchaseAgreementMember us-gaap:SeriesAPreferredStockMember 2022-12-31 0001341766 celh:SecuritiesPurchaseAgreementMember us-gaap:SeriesAPreferredStockMember 2022-01-01 2022-12-31 0001341766 us-gaap:SeriesAPreferredStockMember 2022-01-01 2022-12-31 0001341766 celh:EightPercentageMember 2022-01-01 2022-12-31 0001341766 celh:TenPercentageMember 2022-01-01 2022-12-31 0001341766 celh:TwelvePercentageMember 2022-01-01 2022-12-31 0001341766 srt:MinimumMember us-gaap:SeriesAPreferredStockMember 2022-12-31 0001341766 srt:MaximumMember us-gaap:SeriesAPreferredStockMember 2022-12-31 0001341766 celh:StockIncentivePlan2015Member 2022-01-01 2022-12-31 0001341766 celh:StockIncentivePlan2015Member 2021-01-01 2021-12-31 0001341766 celh:StockIncentivePlan2015Member 2020-01-01 2020-12-31 0001341766 2021-06-01 2021-06-09 0001341766 2021-06-09 0001341766 2021-06-01 2021-06-14 0001341766 celh:CompanyMember 2021-06-01 2021-06-14 0001341766 celh:SellingStockholdersMember 2021-06-01 2021-06-11 0001341766 celh:SellingStockholdersMember 2021-06-01 2021-06-14 0001341766 us-gaap:SeriesAPreferredStockMember 2022-08-01 0001341766 us-gaap:SeriesAPreferredStockMember 2022-07-29 2022-08-01 0001341766 us-gaap:FairValueInputsLevel1Member us-gaap:SeriesAPreferredStockMember 2022-12-31 0001341766 us-gaap:FairValueInputsLevel2Member us-gaap:SeriesAPreferredStockMember 2022-12-31 0001341766 us-gaap:FairValueInputsLevel3Member us-gaap:SeriesAPreferredStockMember 2022-12-31 0001341766 us-gaap:FairValueInputsLevel1Member us-gaap:IndefinitelivedIntangibleAssetsMember 2022-12-31 0001341766 us-gaap:FairValueInputsLevel2Member us-gaap:IndefinitelivedIntangibleAssetsMember 2022-12-31 0001341766 us-gaap:FairValueInputsLevel3Member us-gaap:IndefinitelivedIntangibleAssetsMember 2022-12-31 0001341766 us-gaap:FairValueInputsLevel1Member 2022-12-31 0001341766 us-gaap:FairValueInputsLevel2Member 2022-12-31 0001341766 us-gaap:FairValueInputsLevel3Member 2022-12-31 0001341766 us-gaap:DomesticCountryMember 2022-01-01 2022-12-31 0001341766 us-gaap:DomesticCountryMember 2021-01-01 2021-12-31 0001341766 us-gaap:DomesticCountryMember 2020-01-01 2020-12-31 0001341766 us-gaap:ForeignCountryMember 2022-01-01 2022-12-31 0001341766 us-gaap:ForeignCountryMember 2021-01-01 2021-12-31 0001341766 us-gaap:ForeignCountryMember 2020-01-01 2020-12-31 0001341766 srt:MinimumMember us-gaap:NonUsMember 2022-01-01 2022-12-31 0001341766 srt:MaximumMember us-gaap:NonUsMember 2022-01-01 2022-12-31 0001341766 srt:MinimumMember celh:USFederalMember 2022-01-01 2022-12-31 0001341766 srt:MinimumMember celh:USStateAndLocalMember 2022-01-01 2022-12-31 0001341766 srt:MaximumMember celh:USFederalMember 2022-01-01 2022-12-31 0001341766 srt:MaximumMember celh:USStateAndLocalMember 2022-01-01 2022-12-31 0001341766 celh:StockIncentivePlanMember 2007-01-01 2007-01-18 0001341766 2015-04-30 0001341766 celh:StockIncentivePlan2015Member 2015-04-01 2015-04-30 0001341766 us-gaap:GeneralAndAdministrativeExpenseMember 2022-01-01 2022-12-31 0001341766 us-gaap:GeneralAndAdministrativeExpenseMember 2021-01-01 2021-12-31 0001341766 us-gaap:GeneralAndAdministrativeExpenseMember 2020-01-01 2020-12-31 0001341766 celh:VestedMember 2022-01-01 2022-12-31 0001341766 us-gaap:RestrictedStockUnitsRSUMember 2022-12-31 0001341766 us-gaap:PerformanceSharesMember 2022-01-01 2022-12-31 0001341766 us-gaap:PerformanceSharesMember 2022-12-31 0001341766 srt:MinimumMember 2021-01-01 2021-12-31 0001341766 srt:MaximumMember 2021-01-01 2021-12-31 0001341766 srt:MinimumMember 2020-01-01 2020-12-31 0001341766 srt:MaximumMember 2020-01-01 2020-12-31 0001341766 celh:RangeOfExercisePrice1Member 2022-12-31 0001341766 celh:RangeOfExercisePrice1Member 2022-01-01 2022-12-31 0001341766 celh:RangeOfExercisePrice2Member 2022-12-31 0001341766 celh:RangeOfExercisePrice2Member 2022-01-01 2022-12-31 0001341766 celh:RangeOfExercisePrice3Member 2022-12-31 0001341766 celh:RangeOfExercisePrice3Member 2022-01-01 2022-12-31 0001341766 celh:RangeOfExercisePrice4Member 2022-12-31 0001341766 celh:RangeOfExercisePrice4Member 2022-01-01 2022-12-31 0001341766 celh:RangeOfExercisePrice5Member 2022-12-31 0001341766 celh:RangeOfExercisePrice5Member 2022-01-01 2022-12-31 0001341766 celh:RangeOfExercisePrice6Member 2022-12-31 0001341766 celh:RangeOfExercisePrice6Member 2022-01-01 2022-12-31 0001341766 celh:RangeOfExercisePrice7Member 2022-12-31 0001341766 celh:RangeOfExercisePrice7Member 2022-01-01 2022-12-31 0001341766 us-gaap:RestrictedStockMember 2021-12-31 0001341766 us-gaap:RestrictedStockMember 2020-12-31 0001341766 us-gaap:RestrictedStockMember 2022-01-01 2022-12-31 0001341766 us-gaap:RestrictedStockMember 2021-01-01 2021-12-31 0001341766 us-gaap:RestrictedStockMember 2022-12-31 0001341766 us-gaap:RestrictedStockUnitsRSUMember 2021-12-31 0001341766 us-gaap:RestrictedStockUnitsRSUMember 2020-12-31 0001341766 us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-12-31 0001341766 us-gaap:RestrictedStockUnitsRSUMember 2021-01-01 2021-12-31 0001341766 us-gaap:PerformanceSharesMember 2021-12-31 0001341766 us-gaap:PerformanceSharesMember 2020-12-31 0001341766 us-gaap:PerformanceSharesMember 2021-01-01 2021-12-31 0001341766 2020-11-01 2020-11-30 0001341766 stpr:NY celh:NovemberTwentyThreeTwoThousensTwentyOneMember 2022-10-01 2022-10-12 0001341766 2022-10-01 2022-10-12 0001341766 stpr:NY celh:NovemberTwentyThreeTwoThousensTwentyOneMember 2022-01-01 2022-12-31 0001341766 stpr:FL celh:DthreemLicensingGroupMember 2021-05-01 2021-05-04 0001341766 us-gaap:SubsequentEventMember 2023-01-01 2023-01-18 0001341766 us-gaap:SubsequentEventMember 2023-02-01 2023-02-13 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 10-K/A

(Amendment No. 1)

 

 

 

(Mark One)

☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the fiscal year ended December 31, 2022

 

OR

 

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

FOR THE TRANSITION PERIOD FROM __________ TO __________

 

Commission File Number 001-38149

 

 

 

CELSIUS HOLDINGS, INC.

(Exact name of Registrant as specified in its Charter)

 

 

 

Nevada   20-2745790

(State or other jurisdiction of

incorporation or organization)

   (I.R.S. Employer
Identification No.)
     
2424 N. Federal Highway,
Suite 208,
Boca Raton, Florida		   33431
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (561) 276-2239

 

 

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of exchange on which registered
Common Stock, $0.001 par value   CELH   Nasdaq Capital Market  

 

Securities registered pursuant to Section 12(g) of the Act: None

 

Indicate by check mark if the Registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. YES ☒   NO ☐

 

Indicate by check mark if the Registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act. YES ☐   NO ☒

 

Indicate by check mark whether the Registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. YES ☒   NO ☐

 

Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit such files). YES ☒   NO ☐

 

 

 

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☒ Accelerated filer ☐
Non-accelerated filer ☐ Smaller reporting company ☐
Emerging growth company ☐    

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report ☒

 

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the fi ling reflect the correction of an error to previously issued financial statements. ☐

 

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐

 

Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). YES ☐   NO ☒

 

The aggregate market value of the common stock held by non-affiliates of the Registrant was approximately 4,935,115,169 as of June 30, 2022, for the Company’s common stock on such date on the Nasdaq Capital Market. For purposes of the foregoing computation, all executive officers, directors, and 10% beneficial owners of the Registrant are deemed to be affiliates.

 

There were 76,706,874 shares of common stock outstanding as of February 14, 2023.

 

DOCUMENTS INCORPORATED BY REFERENCE

 

Portions of the registrant’s Definitive Proxy Statement to be filed subsequent to the date hereof with the Securities and Exchange Commission (the “SEC”) pursuant to Regulation 14A in connection with the registrant’s 2023 Annual Meeting of Stockholders are incorporated by reference into Part III of this Report. Such Definitive Proxy Statement will be filed with the SEC no later than 120 days after the conclusion of the registrant’s fiscal year ended December 31, 2022.

 

 

 

 

 

 

EXPLANATORY NOTE

 

This Amendment No. 1 on Form 10-K/A (“Amendment No. 1”) is being filed to amend Celsius Holdings, Inc.’s (together with its consolidated subsidiaries, the “Company”) Annual Report on Form 10-K for the fiscal year ended December 31, 2022 (“Original Filing”), filed with the U.S. Securities and Exchange Commission (“SEC”) on March 1, 2023 (“Original Filing Date”). The sole purpose of this Amendment No. 1 is to amend Exhibits 31.2 and 32.2 to reflect that Jarrod Langhans was the Chief Financial Officer at the time of the Original Filing and to correct paragraph 4(c) of the certifications of its Chief Executive Officer filed as Exhibit 31.1 and Chief Financial Officer filed as Exhibit 31.2 to the Original Form 10-K. The corrected certifications are filed as Exhibits 31.1, 31.2 and 32.2 to this Amendment No. 1.

 

In addition, the Company is including in this Amendment No. 1 a currently dated consents of Ernst & Young LLP and Assurance Dimensions, Inc., its auditors, attached hereto as Exhibit 23.1 and 23.2, and as required by Rule 12b-15 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), the Company’s principal executive officer and principal financial officer are providing new currently dated certifications required pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant Section 302 of the Sarbanes-Oxley Act of 2002, which are filed hereto as Exhibits 31.1 and 31.2.

 

Except as described above, this Amendment No. 1 does not amend, update or change any other items or disclosures in the Original Filing. This Amendment No. 1 speaks only as of the Original Filing Date, and the Company has not undertaken herein to amend, supplement or update any information contained in the Original Filing to give effect to any subsequent events. Accordingly, this Amendment No. 1 should be read in conjunction with the Company’s filings made with the SEC subsequent to the filing of the Original Filing, including any amendment to those filings.

 

i

 

 

TABLE OF CONTENTS

 

        Page
Part I       1
         
Item 1.   Business   1
Item 1A.   Risk Factors   10
Item 1B.   Unresolved Staff Comments   28
Item 2.   Properties   28
Item 3.   Legal Proceedings   28
Item 4.   Mine Safety Disclosures   28
         
Part II       29
         
Item 5.   Market For Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities   29
Item 6.   [Reserved]   30
Item 7.   Management’s Discussion and Analysis of Financial Condition and Results of Operations   31
Item 7A.   Quantitative and Qualitative Disclosures about Market Risk   36
Item 8.   Financial Statements and Supplementary Data   36
Item 9.   Changes in and Disagreements with Accountants on Accounting and Financial Disclosure   37
Item 9A.   Controls and Procedures   37
Item 9B.   Other Information   38
Item 9C.   Disclosure Regarding Foreign Jurisdictions that Prevent Inspections   38
         
Part III       39
         
Item 10.   Directors, Executive Officers and Corporate Governance   39
Item 11.   Executive Compensation   39
Item 12.   Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters   39
Item 13.   Certain Relationships and Related Transactions, and Director Independence   39
Item 14.   Principal Accountant Fees and Services   39
         
Part IV       40
         
Item 15.   Exhibits and Financial Statement Schedules   40
Item 16.   Form 10-K Summary   41
         
Signatures       43

 

 

When used in this Annual Report on Form 10-K (this “Report”), unless otherwise indicated, the terms “the Company,” “Celsius,” “we,” “us” and “our” refers to Celsius Holdings, Inc. and its subsidiaries.

 

We have proprietary rights to trademarks used in this Report that are important to our business, many of which are registered under applicable intellectual property laws. Solely for convenience, the trademarks, service marks, logos and trade names referred to in this Report may sometimes appear without the ® and TM symbols, but such references are not intended to indicate, in any way, that we will not assert, to the fullest extent under applicable law, our rights or the rights of the applicable licensors to these trademarks, service marks and trade names.

 

ii

 

 

NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

This Report contains statements that are based on the current expectations of our Company and management about future events within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). You are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results, levels of activity, performance or achievements expressed or implied may differ materially from those projected in the forward-looking statements as a result of various factors.

 

Our forward-looking statements may include, but are not limited to, statements about:

 

  ● our ability to implement and/or maintain price increases, including through reductions in promotional allowances;

 

  ● our expectations relating to expansion into additional geographic markets and product lines;

 

  ● our expectations relating to revenue, operating costs and profitability;

 

  ● our expectations regarding our strategy and investments;

 

  ● our expectations regarding our business, including market opportunity, consumer demand and our competitive advantage;

 

  ● our expectations regarding supply chains and distribution networks;

 

  ● the impact of future and existing food and drug laws and regulations on our business;

 

  ● our expectations regarding cost and availability of materials and ingredients;

 

  ● our expectations regarding our future growth prospects and our ability to manage our growth and hire capable personnel to support our growth;

 

  ● the potential ongoing impact of new COVID-19 variants on us directly, or on our distributors or suppliers;

 

  ● expected competition from the beverage industry including the subcategories of functional energy and supplements;

 

  ● our expectations relating to marketing and advertising expense;

 

  ● the timing of our receipt and recognition of revenues and other payments;

 

  ● our expectations about our trademarks and trade secrets;

 

  ● our expectations relating to macroeconomic conditions;

 

  ● general economic and business conditions in particular industries, markets or geographic regions, as well as the potential for a significant economic slowdown, stagflation or economic recession;

 

  ● political unrest and military actions in foreign countries, particularly the armed conflict in Ukraine and associated geopolitical tensions and responses, including on inflation, supply chains, commodities, energy, and cyber-security, as well as the impact on world markets and energy supplies resulting therefrom;

 

  ● our critical accounting policies and related estimates or changes in accounting practices;

 

iii

 

 

  ● liquidity and capital needs;

 

  ● political, legislative, regulatory and legal challenges;

 

  ● the merits or potential impact of any lawsuits filed against us or disputes we may be party to;

 

  ● other statements regarding our future operations, financial condition, prospects and business strategies; and

 

  ● our ability to respond to anticipated inflationary pressures, including reduction in consumer discretionary income and our ability to pass along rising costs through increased selling prices, and unfavorable global or regional economic conditions, including economic slowdown or recession.

 

These forward-looking statements and any others within this Report are subject to a number of risks, uncertainties and assumptions, including but not limited to: our ability to successfully make and integrate acquisitions; the impact on our operations of public health crises, new COVID-19 variants; and the performance, reliability and availability of our ecommerce platform and underlying network infrastructure.

 

The foregoing list of important factors and other risks detailed from time to time in our reports filed with the Securities and Exchange Commission is not exhaustive. See “Part I, Item 1A - Risk Factors,” for a more complete discussion of these risks and uncertainties and for other risks and uncertainties. Those factors and the other risk factors described therein are not necessarily all of the important factors that could cause actual results or developments to differ materially from those expressed in any of our forward-looking statements. Other unknown or unpredictable factors also could harm our results.

 

The words “anticipate,” “assume,” “believe,” “could,” “designed,” “estimate,” “expect,” “forecast,” “goal,” “hope,” “intend,” “may,” “might,” “objective,” “plan,” “potential,” “project,” “seek,” “should,” “target,” or the negatives and variations of such words and similar expressions are intended to identify forward-looking statements, but are not the exclusive means of identifying such statements. Those statements appear in this Report, particularly in “Item 1. Business,” “Item 1A. Risk Factors” and “Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations” and include statements regarding the intent, belief or current expectations of the Company and management that are subject to known and unknown risks, uncertainties and assumptions.

 

iv

 

 

PART I

 

Item 1. Business

 

Overview

 

Celsius is a fast-growing company in the functional energy drink and liquid supplement categories in the United States and internationally. We engage in the development, processing, marketing, sale, and distribution of functional drinks and liquid supplements to a broad range of consumers. We believe that we provide differentiated products that offer clinically proven and innovative formulas meant to change the lives of our consumers for the better. We also believe that our brand is attractive to a broad range of customers including fitness enthusiasts.

 

Our core offerings include pre- and post-workout functional energy drinks, as well as protein bars. Our flagship functional energy drink and liquid supplement brands are backed by science, being clinically proven to deliver health benefits by six self-funded studies published in various journals including the Journal of the International Society of Sports Nutrition, the Journal of the American College of Nutrition, and the Journal of Strength and Conditioning Research. These studies have concluded that a single serving of CELSIUS® burns 100-140 calories (by increasing a consumer’s resting metabolism an average of 12%, while providing sustained energy for up to three hours.

 

Our flagship functional energy drink and liquid supplement brands are backed by science, being clinically proven to deliver health benefits by six self-funded studies published in various journals including the Journal of the International Society of Sports Nutrition, the Journal of the American College of Nutrition, and the Journal of Strength and Conditioning Research. These studies have concluded that a single serving of CELSIUS® burns 100-140 calories (by increasing a consumer’s resting metabolism an average of 12%, while providing sustained energy for up to three hours.

 

Our flagship asset, CELSIUS®, is an energy drink which accelerates metabolism and burns calories and body fat while providing energy. This product line comes in two versions, a ready-to-drink supplement format and an on-the-go powder form. We also offer a CELSIUS HEAT and a BRANCH CHAIN AMINO ACIDS line, catered to both pre- and post-workout consumer needs. Our products are currently offered in major retail channels in the US including conventional grocery, natural, convenience, fitness, mass market, vitamin specialty and e-commerce.

 

On August 1, 2022, the Company and PepsiCo Inc. (“Pepsi”), entered into multiple agreements, including a Securities Purchase Agreement (“Purchase Agreement”), Lock-Up Agreements, Registration Rights Agreement, a distribution agreement (“Distribution Agreement”), and a Channel Transition Agreement (“Transition Agreement”). The Purchase Agreement, Lock-Up Agreements and Registration Rights Agreement pertain to the Company’s issuance of 1,466,666 shares of Series A Convertible Preferred Stock (“Series A” or “Series A Preferred Stock”) in exchange for cash proceeds of $550 million, excluding transaction costs. The Transition Agreement specifies payments to be made by Pepsi to Celsius for transitioning certain existing distribution rights to Pepsi. The Distribution Agreement resulted in Pepsi becoming the Company’s primary distribution supplier for the Company’s products in the United States.

 

Potential Effects of new COVID-19 Variants on the Company’s Business

 

The COVID-19 pandemic has presented and continues to present a substantial public health and economic challenge around the world and is affecting our employees, communities and business operations, as well as the global economy and financial markets. The human and economic consequences of the COVID-19 pandemic as well as the measures taken or that may be taken in the future by governments, businesses (including the Company and our suppliers, distributors, co-packers and other service providers) and the public at large to limit new variants could directly and indirectly impact our business and results of operations, including, without limitation, the following:

 

●Decreases in sales of our products in various distribution channels that are affected by COVID-19 variants. A resurgence of COVID-19 variants could cause reinstituted lockdowns and other restrictions, which could further impact customer demand. If COVID-19 variants and related unfavorable economic conditions continued to intensify, the negative impact on our sales, including our new product innovation launches, could be prolonged and may become more severe.

 

●Deteriorating economic conditions and continued financial uncertainties in many of our major markets due to the COVID-19 pandemic, such as increased and prolonged unemployment, decreases in per capita income and the level of disposable income, declines in consumer confidence, or economic slowdowns or recessions, could affect consumer purchasing power and consumers’ ability to purchase our products, thereby reducing demand for our products. In addition, public concern among consumers regarding the risk of contracting COVID-19 may also reduce demand for our products.

 

1

 

 

●The closures of, and restrictions on, on-premise retailers and other establishments that sell our products as a result of new COVID-19 variants could adversely impact our sales and results of operations.

 

●Our advertising, marketing, promotional, sponsorship and endorsement activities have been, and will continue to be, disrupted by reduced opportunities for such activities due to measures taken to limit the spread of new COVID-19 variants and cancellations of or reduced capacity at sporting events, concerts and other events could result in decreased demand for our products. Our product sampling programs, which are part of our strategy to develop brand awareness, have been, and could be, disrupted by new COVID-19 variants. If we are unable to successfully adapt to the changing landscape of advertising, marketing, promotional, sponsorship and endorsement opportunities created by the COVID-19 pandemic, our sales, market share, volume growth and overall financial results could be negatively affected.

 

●Our innovation activities, including our ability to introduce new products in certain markets, have been delayed and/or adversely impacted by the COVID-19 pandemic. If such innovation activities are disrupted delay the launch of new products and/or we are unable to secure sufficient distribution levels for such new products, our business and results of operations could be adversely affected.

 

●Some of our suppliers, distributors and co-packers may experience plant closures, production slowdowns and disruptions in operations as a result of the impact of new COVID-19 variants. This could result in a disruption to our operations.

 

●We may experience delays in receiving certain raw materials as a result of shipping delays due to, among other things, additional safety requirements imposed by port authorities, closures of, or congestion at ports, reduced availability of commercial transportation, border restrictions and capacity constraints.

 

●Due to increased demand in at-home consumption, the beverage category has experienced some shortages of aluminum cans. However, we have been able to secure adequate supply and have not experienced significant adverse effects on our business, operations and financial condition from such shortage, however we are unable to accurately predict how this might change in the future.

 

●Governmental authorities at the U.S. federal, state and/or municipal level and in certain foreign jurisdictions may increase or impose new income taxes, indirect taxes or other taxes or revise interpretations of existing tax rules and regulations as a means of financing the costs of stimulus or may take other measures to protect populations and economies from the impact of the COVID-19 pandemic. Increases in direct and indirect tax rates could affect our net income and increases in consumer taxes could affect our products’ affordability and reduce our sales.

 

●We may be required to record significant impairment charges with respect to goodwill or intangible assets whose fair values may be negatively affected by the effects of the COVID-19 pandemic or new COVID-19 variants in the future.

 

●The continued financial impact of the COVID-19 pandemic may cause one or more of the financial institutions we do business with to fail or default in their obligations to us or to become insolvent or file for bankruptcy, which could cause us to incur significant losses and negatively impact our results of operations and financial condition.

 

●Actions we have taken or may take, or decisions we have made or may make, as a consequence of the COVID-19 pandemic may result in negative publicity and the Company becoming a party to litigation claims and/or legal proceedings, which could consume significant financial and managerial resources, result in decreased demand for our products and injury to our reputation.

 

Any of the negative impacts of the COVID-19 pandemic, including those described above, alone or in combination with others, may have a material adverse effect on our business, reputation, operating results and/or financial condition. Any of these negative impacts, alone or in combination with others, could exacerbate many of the risk factors discussed herein, any of which could materially affect our business, reputation, operating results and/or financial condition.

 

Corporate Information

 

We were incorporated in the State of Nevada on April 26, 2005. The Company’s annual report on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, and all amendments to those reports are made available free of charge through the Company’s website as soon as practicable after such material is electronically filed with, or furnished to, the SEC. Our website is www.celsiusholdingsinc.com. Information contained on, or that can be accessed through our website is not incorporated by reference into this Report.

 

2

 

 

Our Products

 

We seek to combine nutritional science with mainstream beverages by using our proprietary thermogenic (calorie-burning) MetaPlus® formulation, while fostering the goal of healthier everyday refreshment by being as natural as possible without the artificial preservatives often found in many energy drinks or sodas. CELSIUS® has no chemical preservatives, aspartame or high fructose corn syrup and is very low in sodium. CELSIUS® uses good-for-you ingredients and supplements such as green tea (EGCG), ginger, calcium, chromium, B vitamins and vitamin C. CELSIUS® is sweetened with sucralose, a sugar-derived sweetener that is found in Splenda®, which makes our functional energy drinks low-calorie and suitable for consumers whose sugar intake is restricted. Each 12 ounce can of CELSIUS® contains 200 milligrams of caffeine which is comparable to one 12-ounce cup of coffee from the leading coffeehouse.

 

CELSIUS® calorie-burning functional energy drinks were first introduced to the marketplace in 2005.

 

According to multiple clinical studies we funded, a single serving (12 ounce can) of CELSIUS® burns 100 to 140 calories by increasing a consumer’s metabolism an average of 12% for up to a three-hour period. In addition, these studies have indicated that drinking a single serving of CELSIUS® prior to exercising may improve cardiovascular health and fitness and enhance the loss of fat and gain of muscle from exercise.

 

We currently have five functional energy drink lines:

 

●CELSIUS® Originals and Vibe our initial product line, is currently offered in various flavors which are carbonated and non-carbonated.

 

●CELSIUS HEAT™, introduced in 2018 is a trainer’s grade functional energy drink. CELSIUS HEAT™ is also a dietary supplement that uses the same proprietary thermogenic MetaPlus® formula as CELSIUS®, Originals, which is proven to accelerate metabolism, boost energy and accelerate calorie and fat burn when combined with exercise. CELSIUS HEAT™, which is packed with 2,000mg of L-citrulline and 300mg of caffeine, comes in eight carbonated flavors: Apple Jack’d, Orangesicle, Inferno Punch, Cherry Lime, Blueberry Pomegranate, Strawberry Dragonfruit, Tangerine Grapefruit and Jackfruit.

 

●CELSIUS® BCCA+ENERGY, introduced in 2019, is an innovative branched-chain amino acids (BCAA) functional energy drink that fuels muscle recovery. The CELSIUS® BCCA+ENERGY product line was initially launched in the fitness channel.

 

●CELSIUS® On-the-Go is a powdered form of the active ingredients in our functional energy drinks in individual On-The-Go packets as well as multiple serving canisters.

 

●CELSIUS® Sweetened with Stevia is a natural line extension introduced in 2018, targeting the natural products channel. CELSIUS® Sweetened with Stevia is available in six refreshing flavors: three sparkling - grapefruit, cucumber lime, orange pomegranate and three non-carbonated - pineapple coconut, watermelon berry and strawberries & cream. This product line boasts a clean ingredient panel featuring 100% natural caffeine-from-green-coffee bean extract and Stevia an all-natural sweetener.

 

CELSIUS® ready-to drink products are packaged in a distinctive 12 ounce sleek can that uses vivid colors in abstract patterns to create a strong on-shelf impact. The cans are sold in various packaging units are designed to provide a clean, crisp and more modern look. In addition to being sugar free, our original ready-to-drink product line is non-GMO, kosher and vegan certified and soy and gluten free.

 

Func Food Group Oyj, a company incorporated under the laws of Finland (“Func Food”) was acquired in October 2019, as a result we acquired the beverages, protein bars, supplements and superfoods marketed and distributed in Finland, Sweden, and Norway. These products are distributed under the FAST, FitFarm and CocoVi brands and which are owned by Func Food.

 

3

 

 

Clinical Studies

 

It is our belief that clinical studies substantiating product claims will become more important as more and more “alternative” beverages are marketed with health claims. CELSIUS® was one of the first functional energy drinks to be launched along with a clinical study. CELSIUS® is also one of very few functional energy drinks that has clinical research on the actual product itself. Some functional energy drink and supplement companies that do mention studies backing their claims are referencing independent studies conducted on one or more of the ingredients in the product. We believe that it is important and will become more important over time, to have studies on the actual product.

 

We have funded seven U.S. based clinical studies for CELSIUS®. Each was conducted by a research organization and each studied the total CELSIUS® formula. The first study was conducted by the Ohio Research Group of Exercise Science & Sports Nutrition. The remaining studies were conducted by the Applied Biochemistry & Molecular Physiology Laboratory of the University of Oklahoma. We funded all of the studies and provided CELSIUS® functional energy drinks for the studies. However, none of our directors, executive officers or principal stockholders is in any way affiliated with either of the two research organizations which conducted the studies.

 

The first study was conducted in 2005 by the Ohio Research Group of Exercise Science & Sports Nutrition www.ohioresearchgroup.com. The Ohio Research Group of Exercise Science & Sports Nutrition is a multidisciplinary clinical research team dedicated to exploring the relationship between exercise, nutrition, dietary supplements and health. This placebo-controlled, double-blind cross-over study compared the effects of CELSIUS® and the placebo on metabolic rate. Twenty-two participants were randomly assigned to ingest a 12-ounce serving of CELSIUS® and on a separate day a serving of twelve ounces of Diet Coke®. All subjects completed both trials using a randomized, counterbalanced design. Randomized means that subjects were selected for each group randomly to ensure that the different treatments were statistically equivalent. Counterbalancing means that individuals in one group drank the placebo on the first day and drank CELSIUS® on the second day. The other group did the opposite. Counterbalancing is a design method that is used to control “order effects.” In other words, this was done to make sure that the order that subjects were served does not impact the results and analysis.

 

Metabolic rate (via indirect calorimetry, measurements taken from breaths into and out of calorimeter) and substrate oxidation (via respiratory exchange ratios) were measured at baseline (pre-ingestion) and for ten minutes at the end of each hour for three hours post-ingestion. The results showed an average increase of metabolism of twelve percent over the three-hour period, compared to a statistically insignificant change for the control group. Metabolic rate, or metabolism, is the rate at which the body expends energy. This is also referred to as the “caloric burn rate.” Indirect calorimetry calculates heat that living organisms produce from their production of carbon dioxide. It is called “indirect” because the caloric burn rate is calculated from a measurement of oxygen uptake. Direct calorimetry would involve the subject being placed inside the calorimeter for the measurement to determine the heat being produced. Respiratory Exchange Ratio is the ratio oxygen taken in a breath compared to the carbon dioxide breathed out in one breath or exchange. Measuring this ratio can be used for estimating which substrate (fuel such as carbohydrate or fat) is being metabolized or ‘oxidized’ to supply the body with energy.

 

The second study was conducted by the Applied Biochemistry & Molecular Physiology Laboratory of University of Oklahoma in 2007. This blinded, placebo-controlled study was conducted on a total of 60 men and women of normal weight. An equal number of participants were separated into two groups to compare one serving (a single 12 ounce can) of CELSIUS® to a placebo of the same amount. According to the study, those subjects consuming CELSIUS® burned significantly more calories versus those consuming the placebo, over a three-hour period. The study confirmed that over the three-hour period, subjects consuming a single serving of CELSIUS® burned 65% more calories than those consuming the placebo drink and burned an average of more than 100 to 140 calories compared to the placebo. These results were statistically significant.

 

The third study, conducted by the Applied Biochemistry & Molecular Physiology Laboratory of University of Oklahoma in 2007, extended our second study with the same group of 60 individuals and protocol for 28 days and showed the same statistical significance of increased calorie burn (minimal attenuation). While the University of Oklahoma study did extend for 28 days, more testing would be needed for long term analysis of the CELSIUS® calorie-burning effects. Also, although these studies were on relatively small numbers of subjects, they have statistically significant results. Additional studies on a larger number and wider range of body compositions can be considered to further the analysis.

 

4

 

 

The fourth study, conducted by the Applied Biochemistry & Molecular Physiology Laboratory of University of Oklahoma in 2009, combined CELSIUS® use with exercise. This ten-week placebo-controlled, randomized and blinded study was conducted on a total of 37 subjects. Participants were randomly assigned into one of two groups: Group 1 consumed one serving of CELSIUS® per day, and Group 2 consumed one serving of an identically flavored and labeled placebo beverage. Both groups participated in ten weeks of combined aerobic and weight training, following the American College of Sports Medicine guidelines of training for previously sedentary adults. The results showed that consuming a single serving of CELSIUS® prior to exercising may enhance the positive adaptations of exercise on body composition, cardio-respiratory fitness and endurance performance. According to the preliminary findings, subjects consuming a single serving of CELSIUS® lost significantly more fat mass and gained significantly more muscle mass than those subjects consuming the placebo — a 93.75% greater loss in fat and 50% greater gain in muscle mass, respectively. The study also confirmed that subjects consuming CELSIUS® significantly improved measures of cardio-respiratory fitness and the ability to delay the onset of fatigue when exercising to exhaustion.

 

The fifth study was conducted by the Applied Biochemistry & Molecular Physiology Laboratory of University of Oklahoma in 2009. This ten-week placebo-controlled, randomized and blinded study was conducted on a total of 27 previously sedentary overweight and obese female subjects. Participants were randomly assigned into groups that consumed identically tasting treatment drinks with exercise or without exercise. All participants consumed one drink, either placebo or CELSIUS®, per day for 10 weeks. The exercise groups participated in ten weeks of combined aerobic and weight training, following the American College of Sports Medicine guidelines of training for previously sedentary adults. No changes were made to their diet. The results showed that consuming a single serving of CELSIUS® prior to exercising may improve cardiovascular health and fitness and enhance the positive adaptations of exercise on body composition. According to the preliminary findings, subjects consuming a single serving of CELSIUS® lost significantly more fat mass and gained significantly more muscle mass when compared to exercise alone — a 46% greater loss in fat, 27% greater gain in muscle mass, respectively. The study also confirmed that subjects consuming CELSIUS® significantly improved measures of cardio-respiratory fitness — 35% greater endurance performance with significant improvements to lipid profiles — total cholesterol decreases of 5 to 13% and bad LDL cholesterol 12 to 18%. Exercise alone had no effect on blood lipid levels.

 

The sixth study was conducted by the Applied Biochemistry & Molecular Physiology Laboratory of University of Oklahoma in 2009. This ten-week placebo-controlled, randomized and blinded study was conducted on a total of 37 previously sedentary male subjects. Participants were randomly assigned into groups that consumed identically tasting treatment drinks with exercise or without exercise. All participants consumed one drink, either placebo or CELSIUS®, per day for 10 weeks. The exercise groups participated in ten weeks of combined aerobic and weight training, following the American College of Sports Medicine guidelines of training for previously sedentary adults. No changes were made to their diet. The results showed that consuming a single serving of CELSIUS® prior to exercising may improve cardiovascular health and fitness and enhance the positive adaptations of exercise on body composition. Significantly greater decreases in fat mass and percentage body fat and increases in VO2 were observed in the subjects that consumed CELSIUS® before exercise versus those that consumed the placebo before exercise. Mood was not affected. Clinical markers for hepatic, renal, cardiovascular and immune function, as determined by pre-and post-blood work revealed no adverse effects.

 

Our seventh study was conducted by Miami Research Institute in 2010 and demonstrated the efficacy and safety of the powders and the shots. This study allows the Company to make the same structure/function claims as its ready to drink products.

 

Manufacture and Supply of Our Products

 

Our functional energy drinks and supplements are produced by established third party beverage co-packers. A co-packer is a manufacturing plant that provides the service of filling bottles or cans for the brand owner. Utilizing co-packers allows us produce in multiple locations strategically placed throughout the country. We purchase most of the ingredients and all packaging materials. The co-pack facility assembles our products and charges us a fee by the case. The shelf life of CELSIUS® products is specified as 15 to 18 months.

 

5

 

 

Substantially all of the raw materials used in the preparation, bottling and packaging of our products are purchased by us or by our co-packers in accordance with our specifications. Generally, we obtain the ingredients used in our products from domestic suppliers and some ingredients have several reliable suppliers. The ingredients in CELSIUS® include green tea (EGCG), ginger (from the root), caffeine, B vitamins, vitamin C, taurine, guarana, chromium, calcium, glucuronolactone, sucralose, natural flavors and natural colorings. We have no major supply contracts with any of our suppliers. For certain ingredients, there are limited suppliers. In case of a supply restriction or interruption from any of the flavor and coloring suppliers, we would have to test and qualify other suppliers, which may disrupt our production schedules.

 

Packaging materials are available from multiple sources in the United States. While the beverage industry has experienced some shortages of cans as a result of the COVID-19 pandemic, we have been able to secure adequate supply and have not experienced significant adverse effects from such shortages.

 

We believe that our co-packing arrangements and supply sources are adequate for our present needs.

 

Func Food similarly has its FAST and other products manufactured by independent third parties in the Nordic countries.

 

Distribution

 

Domestic

 

In the United States and elsewhere in North America, CELSIUS® is sold across many retail segments. They include supermarkets, convenience stores, drug stores, nutritional stores, and mass merchants. We also sell to health clubs, gyms, the military, and e-commerce websites.

 

We distribute our products domestically through direct-store delivery (DSD), distributors as well as sales direct to retailers (DTR).

 

Our products are also sold online through e-commerce platforms such as Amazon and Walmart.com.

 

Pepsi. Distribution Agreement

 

On August 1, 2022, we entered into the Distribution Agreement relating to the sale and distribution of certain of the Company’s beverage products in existing channels and distribution methods in the United States, excluding certain existing customer accounts, sales channels, Puerto Rico and the US Virgin Islands (the “Territory”). Under the Distribution Agreement, the Company granted Pepsi the right to sell and distribute its existing beverage products in existing channels and distribution methods and future beverage products that are added from time to time as licensed products under the Distribution Agreement in defined territories. The Distribution Agreement represents a master service agreement and can be cancelled by either party in accordance with the terms of the Distribution Agreement without cause in the nineteenth year of the term (i.e., 2041), the twenty-ninth year of the term (i.e., 2051) and each ten (10) year period thereafter (i.e., 2061, 2071, etc.) by providing twelve (12) months’ written notice on August 1st of each such year to the other party. Except for a termination by the Company “with cause” or a termination by Pepsi “without cause”, the Company is required to pay Pepsi certain compensation upon a termination as specified in the Distribution Agreement.

 

The Company agreed to provide Pepsi a right of first offer in the event the Company intends to (i) manufacture, distribute or sell products in certain additional countries as specified in the Distribution Agreement or (ii) distribute or sell products in any future channels and distribution methods during the term of the Distribution Agreement. Additionally, pursuant to the Distribution Agreement, the Company and Pepsi agreed to use commercially reasonable efforts to negotiate and execute with Pepsi a distribution agreement reasonably consistent with the Distribution Agreement for the sale and distribution of the products in Canada, and Pepsi agreed to meet and confer in good faith with the Company regarding the terms and conditions upon which Pepsi may be willing to sell or distribute products, either directly or through local sub-distributors in certain other additional countries. The Distribution Agreement includes other customary provisions, including non-competition covenants in favor of the Company, representations and warranties, indemnification provisions, insurance provisions and confidentiality provisions.

 

In connection with the Distribution Agreement the Company and Pepsi also executed a Channel Transition Agreement, providing for the Company’s transition of certain existing distribution rights in the Territory to Pepsi.

 

6

 

 

International

 

We distribute our products in various foreign regions through regional and country-specific distribution partners. In October 2019, we acquired Func Food, our Nordic distribution partner, who markets both our products as well as other products under its own brands.

 

We market our products in the Asian market through local distributors in Hong Kong and a license agreement with our partner in China, Qifeng Food Technology (Beijing) Co., Ltd. (“Qifeng”). While we initially began both local production and preliminary distribution of the CELSIUS® brand in 2018 through our partnership with Qifeng, effective January 1, 2019, we restructured our China distribution efforts by entering into two separate agreements as it relates to the commercialization of our CELSIUS® products and a repayment of an investment agreement with Qifeng. Under the license agreement, Qifeng was granted the exclusive license rights to manufacture, market and commercialize CELSIUS® brand products in China. Qifeng will pay a minimum royalty fee of approximately $6.9 million for the first five years of the term of the agreement, transitioning to a volume-based royalty fee, thereafter and until the licensing agreement is terminated or canceled. Under a separate economic agreement, Qifeng will repay the marketing investments made by CELSIUS® into the China market through 2018. The repayment, which was formalized via a note receivable from Qifeng, will need to be serviced even if the licensing agreement is cancelled or terminated.

 

With our new partnership with Pepsi, we would expect to utilize the Pepsi system as we develop international expansion plans in future periods.

 

Customer Concentration

 

The following table shows the revenue concentration of our customers accounting for more than 10% of revenue, for the years ended December 31, 2022, 2021 and 2020:

 

   2022   2021   2020 
Pepsi   22.2%   -    - 
Costco   16.7%   12.7%   2.9%
Amazon   8.8%   10.1%   15.1%
All other   52.3%   77.2%   82.0%
Total   100.0%   100.0%   100.0%

 

The following table shows the accounts receivable concentration accounting for more than 10% of accounts receivables, for the years ended December 31, 2022 and 2021:

 

   2022   2021 
Pepsi   47.6%   - 
Amazon   11.8%   22.7%
Publix   1.4%   10.3%
All other   39.2%   67.0%
Total   100.0%   100.0%

 

Sales and Marketing

 

We believe that one of the keys to success in the beverage industry is differentiation, by making our brands and products visually appealing and distinctive from other beverages on the shelves of retailers. We review our products and packaging on an ongoing basis and, where practical, endeavor to make them different and unique. The labels and graphics for many of our products are refreshed from time to time to maximize their visibility and identification, wherever they may be placed in stores, which we continue to reevaluate from time to time.

 

Where appropriate, we partner with our distributors, or retailers to assist our marketing efforts.

 

7

 

 

Seasonality of Sales

 

As is typical in the functional energy drink and supplement industries, sales of products are seasonal, with the highest sales volumes generally occurring in the second and third fiscal quarters, which correspond to the warmer months of the year in our major markets, albeit with our recent significant growth, we have seen ongoing quarter over quarter growth regardless of the season.

 

Competition

 

We believe that our CELSIUS® brand products are one of the few functional energy drink and supplement lines whose effectiveness is supported by clinical studies, which gives us a unique position. However, our products do compete broadly with not only functional energy drinks and supplements, but all categories of liquid refreshments. The functional energy drink, supplement and liquid refreshment markets are highly competitive, and include international, national, regional and local producers and distributors, most of whom have greater financial, management and other resources than us. Our direct competitors in the functional energy drink and supplement markets include, but are not limited to The Coca-Cola Company, Dr. Pepper Snapple Group, Nestlé, Waters North America, Inc., Hansen Natural Corp., Vital Pharmaceuticals, Inc, Monster Energy, and Red Bull.

 

Proprietary Rights

 

We have registered the CELSIUS® and MetaPlus® trademarks with the United States Patent and Trademark Office, as well as a number of additional trademarks.

 

We have and will continue to take appropriate measures, such as entering into confidentiality agreements with our contract packers and ingredient suppliers, to maintain the secrecy and proprietary nature of our MetaPlus® formulation and product formulas.

 

We maintain our MetaPlus® formulation and product formulas as trade secrets. We believe that trade secrecy is a preferable method of protection for our formulas as patenting them might require their disclosure. Other than a company that is our outsourced production manager, no single member of the raw material supply chain or our co-packers has access to the complete formula.

 

We consider our trademarks and trade secrets to be of considerable value and importance to our business. No successful challenges to our registered trademarks have arisen and we have no reason to believe that any such challenges will arise in the future.

 

Government Regulation

 

The production, distribution and sale of our products in the United States is subject to the Federal Food, Drug and Cosmetic Act, the Dietary Supplement Health and Education Act of 1994, the Occupational Safety and Health Act, various environmental statutes and various other federal, state and local statutes and regulations applicable to the production, transportation, sale, safety, advertising, labeling and ingredients of such products. California law requires that a specific warning appear on any product that contains a component listed by California as having been found to cause cancer or birth defects. The law exposes all food and beverage producers to the possibility of having to provide warnings on their products because the law recognizes no generally applicable quantitative thresholds below which a warning is not required. Consequently, even trace amounts of listed components can expose affected products to the prospect of warning labels. Products containing listed substances that occur naturally in the product or that are contributed to the product solely by a municipal water supply are generally exempt from the warning requirement. While none of our products are required to display warnings under this law, we cannot predict whether an important component of any of our products might be added to the California list in the future. We also are unable to predict whether or to what extent a warning under this law would have an impact on costs or sales of our products.

 

The marketing and sale of our products internationally is similarly subject to compliance with applicable laws, rules and regulations in those foreign countries where our products are sold.

 

8

 

 

Compliance with Environmental Laws

 

The facilities of our co-packers in the United States are subject to federal, state and local environmental laws and regulations, including those relating to air emissions, the use of water resources and recycling. Our operations in other countries are subject to similar federal, state, local and supranational laws and regulations that may be applicable in such countries. Changes in environmental compliance mandates, and any expenditures necessary to comply with such requirements, could adversely affect our financial performance and future growth. Compliance with these provisions has not had, nor do we expect such compliance to have, any material adverse effect upon our capital expenditures, net income or competitive position.

 

Container Deposits

 

Measures have been enacted in various localities and states that require that a deposit be charged for certain non-refillable beverage containers. The precise requirements imposed by these measures vary. We are required to collect deposits from our customers and to remit such deposits to the respective jurisdictions based upon the number of cans and bottles of certain carbonated and non-carbonated products sold in such states.

 

Other deposit, recycling or product stewardship proposals have been introduced in certain states and localities and in Congress, and we anticipate that similar legislation or regulations may be proposed in the future at the local, state and federal levels, both in the United States and elsewhere.

 

Human Capital Resources

 

As of December 31, 2022, the Company employs 378 people including its executive officers, in five different countries. This includes 324 employees in the US, 49 in countries within Europe, and 5 in Hong Kong.

 

Employees

 

We believe people are our most important asset, and we strive to attract and retain high-performing talents. Through comprehensive and competitive compensation and benefits, ongoing employee learning and development, and a focus on health and well-being, we strive to support our employees in all aspects of their lives.

 

We believe we have a talented, motivated and dedicated team, and work to create an inclusive, safe and supportive environment for all team members.

 

Diversity, Equity, and Inclusion

 

We believe a culture that celebrates diverse talent, individual identity, and different points of view, empowers employees to contribute new ideas that support our continued and growing success. Women, racial and ethnic minorities collectively constitute a meaningful part of our overall workforce across all levels of our global organization.

 

Culture and Engagement

 

We believe open and honest communication among team members, managers and leaders helps create an open, collaborative work environment where everyone can contribute, grow, and succeed. Team members are encouraged to come to their managers with questions, feedback or concerns. We also encourage regular, live communication across the organization and host quarterly global town halls with our senior leadership.

 

Leadership, Training and Development

 

We focus on investing in inspirational leadership, learning opportunities and capabilities to equip our global workforce with the skills they need while improving engagement and retention. We provide formal and informal learning programs, which are designed to help our employees continuously grow and strengthen their skills throughout their careers. We offer a variety of programs that contribute to our leadership, training and development goals, and comprehensive coaching and mentoring programs that support leadership and employee development.

 

9

 

 

Compensation and Benefits

 

We believe that compensation should be competitive and equitable and should enable employees to share in the Company’s success. The Company recognizes its people are most likely to thrive when they have the resources to meet their needs and the time and support to succeed in their professional and personal lives. In support of this, we offer a wide variety of benefits for employees around the world and invest in tools and resources that are designed to support employees’ individual growth and development.

 

Our compensation programs are designed to reinforce our growth agenda and our talent strategy as well as to drive a strong connection between the contributions of our employees and their pay. We conduct annual pay equity analyses to help ensure our base pay structures are fair and to identify and address potential issues or disparities and we adjust base pay, where appropriate. Also, as permitted by local law, annually, we perform an adverse impact analysis on base pay, annual incentives, and long-term incentives to help ensure fairness. We provide compensation packages designed to attract and retain talent while maintaining alignment with the market. We believe the structure of our compensation packages provides the appropriate incentives to attract, retain and motivate our employees.

 

Our base pay aligns with employee positions, skill levels, experience, and geographic location. Additionally, we provide competitive employee benefits packages, which vary by country and region. These employee benefits packages may include: employee assistance programs, medical and dental insurance, vision insurance, well-being rewards programs, core and supplemental life insurance, long and short-term disability, accident insurance, critical illness insurance, retirement savings plans, prepaid legal services, healthy rewards programs, identity theft assistance, financial courses and advisors, vacation pay, holiday pay, annual incentive awards, recognition programs, and equity awards for eligible employees.

 

Our Compensation Committee provides oversight of the our policies and strategies relating to talent, leadership, and culture, including diversity, equity and inclusion, as well as the Company’s compensation philosophy and programs. The Compensation Committee also evaluates and approves our compensation plans, policies and programs applicable to our senior executives. In addition, the Compensation Committee oversees succession planning and talent development for our senior executives.

 

We believe that our approach to human capital resources has been instrumental in our growth, and has made us a desirable destination for employees.

 

Information about our Executive Officers

 

The following is a description of the business experience and background of Jarrod Langhans, our Chief Financial Officer, who is our only executive officer who is not a member of our board of directors.

 

Jarrod Langhans, 42, became our Chief Financial Officer in April 2022. Mr. Langhans served as Chief Financial Officer of the European and Israel operating segments of Primo Water Corporation. From July 2012 through May 2020, he has held various executive positions within Primo Water Corporation across the accounting, finance and investor relations areas. Mr. Langhans’ prior experience also includes working for major accounting firms such as CBIZ Mayer Hoffman McCann (MHM) and Cherry Bekaert. He is a Certified Public Accountant in Florida and has an extensive and diversified financial and leadership background across areas such as financial reporting.

 

Item 1A. Risk Factors

 

In addition to the other information contained in this Report, including in “Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations” and the consolidated financial statement and notes, you should carefully consider the following risks. The risks and uncertainties discussed below and elsewhere in this Report may not be the only risks we face. Additional risks and uncertainties not presently known to us, or that we currently see as immaterial, may also materially adversely affect our business, financial condition, operating results and prospects.

 

10

 

 

Risk Factors Relating to Our Business

 

Our business and results of operations may be adversely affected by new COVID-19 variants

 

COVID-19 has presented and continues to present a substantial public health and economic challenge around the world and is affecting our employees, communities and business operations, as well as the global economy and financial markets. The human and economic consequences of new COVID-19 variants as well as the measures taken or that may be taken in the future by governments, businesses (including the Company and our suppliers, distributors, co-packers and other service providers) and the public at large to limit the spread of new COVID-19 variants, may directly and indirectly impact our business and results of operations, including, without limitation, the following:

 

●Decreases in sales of our products in various distribution channels that are affected by COVID-19 variants. A resurgence of COVID-19 variants could cause reinstituted lockdowns and other restrictions, which could further impact customer demand. If COVID-19 variants and related unfavorable economic conditions continued to intensify, the negative impact on our sales, including our new product innovation launches, could be prolonged and may become more severe.

 

●Deteriorating economic conditions and continued financial uncertainties in many of our major markets due to the COVID-19 pandemic, such as increased and prolonged unemployment, decreases in per capita income and the level of disposable income, declines in consumer confidence, or economic slowdowns or recessions, could affect consumer purchasing power and consumers’ ability to purchase our products, thereby reducing demand for our products. In addition, public concern among consumers regarding the risk of contracting COVID-19 may also reduce demand for our products.

 

●The closures of, and restrictions on, on-premise retailers and other establishments that sell our products as a result of new COVID-19 variants could adversely impact our sales and results of operations.

 

●Our advertising, marketing, promotional, sponsorship and endorsement activities have been, and will continue to be, disrupted by reduced opportunities for such activities due to measures taken to limit the spread of new COVID-19 variants and cancellations of/or reduced capacity at sporting events, concerts and other events could result in decreased demand for our products. Our product sampling programs, which are part of our strategy to develop brand awareness, have been, and could be, disrupted by new COVID-19 variants. If we are unable to successfully adapt to the changing landscape of advertising, marketing, promotional, sponsorship and endorsement opportunities created by the COVID-19 pandemic, our sales, market share, volume growth and overall financial results could be negatively affected.

 

●Our innovation activities, including our ability to introduce new products in certain markets, have been delayed and/or adversely impacted by the COVID-19 pandemic. If such innovation activities are disrupted, delay the launch of new products and/or we are unable to secure sufficient distribution levels for such new products, our business and results of operations could be adversely affected.

 

●Some of our suppliers, distributors and co-packers may experience plant closures, production slowdowns and disruptions in operations as a result of the impact of new COVID-19 variants. This could result in a disruption to our operations.

 

●We may experience delays in receiving certain raw materials as a result of shipping delays due to, among other things, additional safety requirements imposed by port authorities, closures of, or congestion at ports, reduced availability of commercial transportation, border restrictions and capacity constraints.

 

●Due to increased demand in at-home consumption, the beverage category has experienced some shortages of aluminum cans. However, we have been able to secure adequate supply and have not experienced significant adverse effects on our business, operations and financial condition from such shortage, however we are unable to accurately predict how this might change in the future.

 

●Governmental authorities at the U.S. federal, state and/or municipal level and in certain foreign jurisdictions may increase or impose new income taxes, indirect taxes or other taxes or revise interpretations of existing tax rules and regulations as a means of financing the costs of stimulus or may take other measures to protect populations and economies from the impact of the COVID-19 pandemic. Increases in direct and indirect tax rates could affect our net income and increases in consumer taxes could affect our products’ affordability and reduce our sales.

 

11

 

 

●We may be required to record significant impairment charges with respect to goodwill or intangible assets whose fair values may be negatively affected by the effects of the COVID-19 pandemic or new COVID-19 variants in the future.

 

●The continued financial impact of new COVID-19 variants may cause one or more of the financial institutions we do business with to fail or default in their obligations to us or to become insolvent or file for bankruptcy, which could cause us to incur significant losses and negatively impact our results of operations and financial condition.

 

●Actions we have taken or may take, or decisions we have made or may make, as a consequence of the COVID-19 pandemic may result in negative publicity and the Company becoming a party to litigation claims and/or legal proceedings, which could consume significant financial and managerial resources, result in decreased demand for our products and injury to our reputation.

 

Any of the negative impacts of the COVID-19 pandemic, including those described above, alone or in combination with others, may have a material adverse effect on our business, reputation, operating results and/or financial condition. Any of these negative impacts, alone or in combination with others, could exacerbate many of the risk factors discussed herein, any of which could materially affect our business, reputation, operating results and/or financial condition.

 

Consolidation of retailers, wholesalers and distributors in the industry may result in downward pressure on sales prices.

 

Consolidation can cause significant downward pricing pressure and can impose additional costs on us. If we are unable to successfully manage the potential impact of these commercial changes, our financial results may be materially and adversely affected.

 

We rely on third party co-packers to manufacture our products. If we are unable to maintain good relationships with our co-packers and/or their ability to manufacture our products becomes constrained or unavailable to us, our business could suffer.

 

We do not directly manufacture our products, but instead outsource such manufacturing to established third party co-packers. These third-party co-packers may not be able to fulfill our demand as it arises, could begin to charge rates that make using their services cost inefficient or may simply not be able to or willing to provide their services to us on a timely basis or at all. In the event of any disruption or delay, whether caused by a rift in our relationship or the inability of our co-packers to manufacture our products as required, we would need to secure the services of alternative co-packers. We may be unable to procure alternative packing facilities at commercially reasonable rates and/or within a reasonably short time period and any such transition could be costly. In such case, our business, financial condition and results of operations would be adversely affected.

 

We rely on distributors to distribute our products in the DSD sales channel and in international markets. If we are unable to maintain good relationships with our existing distributors, our business could suffer.

 

We distribute CELSIUS® in the DSD sales channel by entering into agreements with direct-to-store delivery distributors having established sales, marketing and distribution organizations. We similarly are seeking to expand our international distribution, by entering into agreements with large established distributors who service those markets. Many of our distributors are affiliated with and manufacture and/or distribute other beverage products. In many cases, such products compete directly with our products. The marketing efforts of our distributors are important for our success. If CELSIUS® proves to be less attractive to our distributors and/or if we fail to attract distributors, and/or our distributors do not market and promote our products with greater focus in preference to the products of our competitors, our business, financial condition and results of operations could be adversely affected.

 

Our customers are material to our success. If we are unable to maintain good relationships with our existing customers, our business could suffer.

 

Unilateral decisions could be taken by our distributors, grocery chains, convenience chains, drug stores, nutrition stores, mass merchants, club warehouses and other customers to discontinue carrying all or any of our products that they are carrying at any time, which could cause our business to suffer.

 

12

 

 

Increases in cost or shortages of raw materials or increases in costs of co-packing could harm our business.

 

The principal raw materials used by us are flavors and ingredient blends as well as aluminum cans, the prices of which are subject to fluctuations. We are uncertain whether the prices of any of the above or any other raw materials or ingredients we utilize will rise in the future and whether we will be able to pass any of such increases on to our customers. We do not use hedging agreements or alternative instruments to manage the risks associated with securing sufficient ingredients or raw materials. In addition, some of these raw materials, such as our sleek 12 ounce can, are available from a limited number of suppliers. As alternative sources of supply may not be available, any interruption in the supply of such raw materials might materially harm us.

 

While the functional energy drink and supplement industries have experienced some shortages of cans as a result of the COVID-19 pandemic, Celsius has been able to secure adequate supply, though potentially at higher cost. To address the industry-wide shortage of aluminum cans, we have imported cans manufactured abroad which affected our margins in 2021 and 2022. We are unable to accurately predict how these cost trends might evolve prospectively. Such industry-wide shortages of raw materials, including aluminum cans, could from time to time in the future be encountered, which could interfere with and/or delay production of certain of our products and negatively impact our financial performance.

 

Our failure to accurately estimate demand for our products could adversely affect our business and financial results.

 

We may not correctly estimate demand for our existing products and/or new products. Our ability to estimate demand for our products is imprecise, particularly with regard to new products, and may be less precise during periods of rapid growth, including in new markets. If we materially underestimate demand for our products or are unable to secure sufficient ingredients, flavors, aluminum cans and other raw materials for our supplements or experience difficulties with our co-packing arrangements, including production shortages or quality issues, we might not be able to satisfy demand on a short-term basis. Moreover, industry-wide shortages of certain ingredients have occurred and could occur, from time to time in the future, resulting in production fluctuations and/or product shortages. We generally do not use hedging agreements or alternative instruments to manage this risk. Such shortages could interfere with and/or delay production of certain of our products and could have a material adverse effect on our business and financial results.

 

If we do not accurately anticipate the future demand for a particular product or the time it will take to obtain new inventory, our inventory levels may be inadequate and our results of operations may be negatively impacted. If we fail to meet our shipping schedules, we could damage our relationships with distributors and/or retailers, increase our distribution costs and/or cause sales opportunities to be delayed or lost. In order to be able to deliver our products on a timely basis, we need to maintain adequate inventory levels of the desired products. If the inventory of our products held by our distributors and/or retailers is too high, they will not place orders for additional products, which could unfavorably impact our future sales and adversely affect our operating results.

 

Changes in the retail landscape or the loss of key retail or food service customers could adversely affect our financial results.

 

Our industry is being affected by the trend toward consolidation in and blurring of the lines between retail channels, particularly in Europe and the United States. Larger retailers may seek lower prices from us, may demand increased marketing or promotional expenditures, and may be more likely to use their distribution networks to introduce and develop private-label brands, any of which could negatively affect our profitability. In addition, discounters and value stores are growing at a rapid pace. Our industry is also being affected by the rapid growth in sales through e-commerce retailers, e-commerce websites, mobile commerce applications and subscription services, which may result in a shift away from physical retail operations to digital channels. As we build our e-commerce capabilities, we may not be able to develop and maintain successful relationships with existing and new e-commerce retailers without experiencing a deterioration of our relationships with key customers operating physical retail channels. If we are unable to successfully adapt to the rapidly changing retail landscape, including the rapid growth in digital commerce, our share of sales, volume growth and overall financial results could be negatively affected. In addition, our success depends in part on our ability to maintain good relationships with key retail customers. The loss of one or more of our key retail customers could have an adverse effect on our financial performance.

 

13

 

 

Significant additional labeling or warning requirements or limitations on the marketing or sale of our products may inhibit sales of affected products.

 

Various jurisdictions may seek to adopt significant additional product labeling or warning requirements or limitations on the marketing or sale of our products as a result of what our products contain or allegations that our products cause adverse health effects. If these types of requirements become applicable to one or more of our products under current or future environmental or health laws or regulations, they may inhibit sales of such products.

 

For example, under one such law in California, known as Proposition 65, if the state has determined that a substance causes cancer or harms human reproduction, a warning must be provided for any product sold in the state that exposes consumers to that substance, unless the exposure falls under an established safe harbor level or another exemption is applicable. If we were required to add Proposition 65 warnings on the labels of one or more of our supplement products produced for sale in California, the resulting consumer reaction to the warnings and possible adverse publicity could negatively affect our sales both in California and in other markets.

 

Our continued expansion outside of the United States exposes us to uncertain conditions and other risks in international markets.

 

We have sales of products internationally in a variety of markets and are currently seeking to expand our international distribution. As our growth strategy includes further expanding our international business, if we are unable to continue to expand distribution of our products outside the United States, our growth rate could be adversely affected. Although we intend to sell through established distributors in international markets, we have limited or no operating experience in many of such markets and it may be costly to promote our brands in international markets. We face and will continue to face substantial risks associated with foreign distribution and sale of our products, including economic and/or political instability in various international markets; fluctuations in foreign currency exchange rates; restrictions on or costs relating to the repatriation of foreign profits to the United States, including possible taxes and/or withholding obligations on any repatriations; and tariffs and/or trade restrictions. These risks could have a significant impact on our ability to distribute and sell our products on a competitive basis in international markets and could have a material adverse effect on our business, financial condition and results of operations. Also, distribution and sale of products outside of the United States are subject to risks relating to appropriate compliance with legal and regulatory requirements in local jurisdictions, potentially higher product damage rates if our products are shipped long distances, potentially higher incidence of fraud and/or corruption, credit risk of distributors and potentially adverse tax consequences.

 

Numerous U.S. and International laws including export and import controls affect our ability to compete in international markets.

 

U.S. export control laws and economic and trade sanctions prohibit the provision of certain products and services to U.S. embargoed or sanctioned countries, governments and persons. Even though we take precautions to prevent our products from being shipped or provided to embargoed countries and U.S. sanctions targets, they could be shipped, or provided by our distributors, to those countries and targets despite such precautions. The provision of goods in violation of U.S. export controls and/or sanctions could have negative consequences for our business, including government investigations, penalties and reputational harm. We must also comply with U.S. import laws.

 

U.S. laws such as the Foreign Corrupt Practices Act (the “FCPA”) also impact our international activities. We are subject to the FCPA and other laws that prohibit improper payments and offers to foreign officials and political parties for the purpose of obtaining or retaining business. Selling products into international markets, including through distributors, creates the risk of unauthorized payments or offers, for which we may be held responsible. Violations of the FCPA or other applicable anti-corruption and anti-bribery laws may result in severe criminal or civil sanctions, or other liabilities, which could negatively affect our business, operating results and financial condition.

 

Changes in export and import regulations, economic sanctions and related laws, shifts in the enforcement or scope of existing regulations, changes in the countries, governments or persons targeted by such regulations and the imposition of tariffs may create delays in the introduction and sale of our products in international markets, result in decreased ability to export or sell our products to existing or potential customers with international operations or in some cases, prevent the export or import of our products to certain countries, governments or persons.

 

Actions taken with respect to tariffs or trade relations between the United States and other countries, the products subject to such actions, and actions taken by other countries in retaliation may also have an adverse impact on us. The failure to comply with applicable current or future U.S. import, export control, sanctions and anti-corruption laws, including U.S. Customs regulations, could expose us and our employees to substantial civil or criminal penalties, fines and in extreme cases, incarceration. In addition, if our distributors fail to obtain appropriate import, export or re-export licenses or authorizations, or otherwise act in accordance with applicable laws, we may be adversely affected through reputational harm and penalties.

 

14

 

 

Failure to successfully complete or manage strategic transactions can adversely affect our business

 

We regularly review our portfolio of businesses and evaluate potential acquisitions, joint ventures, distribution agreements, divestitures, and other strategic transactions. The success of these transactions, including the recent completion of the strategic transaction with Pepsi, is dependent upon, among other things, our ability to realize the full extent of the expected returns, benefits, cost savings or synergies as a result of a transaction, within the anticipated time frame, or at all; and receipt of necessary consents, clearances and approvals. Risks associated with strategic transactions include integrating manufacturing, distribution, sales, accounting, financial reporting and administrative support activities and information technology systems with our company or difficulties separating such personnel, activities and systems in connection with divestitures; operating through new business models or in new categories or territories; motivating, recruiting and retaining executives and key employees; conforming controls (including internal control over financial reporting and disclosure controls and procedures) and policies (including with respect to environmental compliance, health and safety compliance and compliance with anti-bribery laws); retaining existing customers and consumers and attracting new customers and consumers; managing tax costs or inefficiencies; maintaining good relations with divested or refranchised businesses in our supply or sales chain; inability to offset loss of revenue associated with divested brands or businesses; managing the impact of business decisions or other actions or omissions of our joint venture partners that may have different interests than we do; and other unanticipated problems or liabilities, such as contingent liabilities and litigation. Strategic transactions that are not successfully completed or managed effectively, or our failure to effectively manage the risks associated with such transactions, could continue to result in adverse effects on our business.

 

If we fail to realize a significant portion of the anticipated benefits of our strategic arrangement with Pepsi, our financial results could be adversely affected.

 

We have a long-term strategic distribution arrangement with Pepsi. If we are unable to successfully manage our relationship with Pepsi, or if for any other reason we fail to realize all or a significant part of the benefits we expect from this strategic relationship, our financial performance could be adversely affected.

 

Global or regional catastrophic events could impact our operations and affect our ability to grow our business.

 

Because of our increasingly global presence, our business could be affected by unstable political conditions, civil unrest, protests and demonstrations, large-scale terrorist acts, especially those directed against the United States or other major industrialized countries where our products are distributed, the outbreak or escalation of armed hostilities, such as the Russian conflict in the Ukraine, major natural disasters and extreme weather conditions, such as hurricanes, wildfires, tornadoes, earthquakes or floods, or widespread outbreaks of infectious diseases (such as the COVID-19 pandemic). Such catastrophic events could impact our operations and our supply chain, including the production and/or distribution of our products. Materials and/or personnel may need to mobilize to other locations. Our headquarters and a large part of our operations are located in Florida, a state at greater risk of hurricanes. Some of the raw materials we use, including certain sizes of cans, are available from limited suppliers, and a regional catastrophic event impacting such suppliers could adversely impact our operations. In addition, such events could disrupt global or regional economic activity, which could affect consumer purchasing power and consumers’ ability to purchase our products, thereby reducing demand for our products. If our operations are disrupted or we are unable to grow our business as a result of these factors, our growth rate could decline and our business, financial condition and results of operations could be adversely affected.

 

Climate change and natural disasters may affect our business.

 

There is concern that a gradual increase in global average temperatures due to increased carbon dioxide and other greenhouse gases in the atmosphere could cause significant changes in weather patterns around the globe and an increase in the frequency and severity of natural disasters. Changing weather patterns could result in decreased agricultural productivity in certain regions, and/or outbreaks of diseases or other health issues, which may limit availability and/or increase the cost of certain ingredients used in our products and could impact the food security of communities around the world. Increased frequency or duration of extreme weather conditions could also impair production capabilities, disrupt our supply chain and/or impact demand for our products.

 

15

 

 

Natural disasters and extreme weather conditions, such as hurricanes, wildfires, earthquakes or floods, and outbreaks of diseases (such as the COVID-19 pandemic) or other health issues may affect our operations and the operation of our supply chain, impact the operations of our distributors and unfavorably impact our consumers’ ability to purchase our products. In addition, public expectations for reductions in greenhouse gas emissions could result in increased energy, transportation and raw material costs, and may require us to make additional investments in facilities and equipment. Changes in applicable laws, regulations, standards or practices related to greenhouse gas emissions, packaging and water scarcity, as well as initiatives by advocacy groups in favor of certain climate change-related laws, regulations, standards or practices, may result in increased compliance costs, capital expenditures and other financial obligations, which could affect our business, financial condition and results of operations. Sales of our products may also be influenced to some extent by weather conditions in the markets in which we operate. Our third-party co-packers use a number of key ingredients in the manufacture of our liquid supplement products and powder packets that are derived from agricultural commodities. Increased demand for food products and decreased agricultural productivity in certain regions of the world as a result of changing weather patterns and other factors may limit the availability or increase the cost of such agricultural commodities and could impact the food security of communities around the world. Weather conditions may influence consumer demand for certain of our supplements, which could have an effect on our operations, either positively or negatively.

 

We depend upon our trademarks and proprietary rights, and any failure to protect our intellectual property rights or any claims that we are infringing upon the rights of others may adversely affect our competitive position.

 

Our success depends, in large part, on our ability to protect our current and future brands and products and to defend our intellectual property rights. We cannot be sure that trademarks will be issued with respect to any future trademark applications or that our competitors will not challenge, invalidate or circumvent any existing or future trademarks issued to, or licensed by, us.

 

Our products are manufactured using our proprietary blends of ingredients. These blends are created by third-party suppliers to our specifications and then supplied to our co-packers. Although all of the third parties in our supply and manufacture chain execute confidentiality agreements, there can be no assurance that our trade secrets, including our proprietary ingredient blends will not become known to competitors.

 

We believe that our competitors, many of whom are more established and have greater financial and personnel resources than we do, may be able to replicate or reverse engineer our processes, brands, flavors, or our products in a manner that could circumvent our protective safeguards. Therefore, we cannot give you any assurance that our confidential business information will remain proprietary. Any such loss of confidentiality could diminish or eliminate any competitive advantage provided by our proprietary information.

 

We must continually maintain, protect and/or upgrade our information technology systems, including protecting us from internal and external cyber-security threats.

 

Information technology enables us to operate efficiently, interface with customers, maintain financial accuracy and efficiency and accurately produce our financial statements. If we do not appropriately allocate and effectively manage the resources necessary to build and sustain the proper technology infrastructure, we could be subject to transaction errors, processing inefficiencies, the loss of customers, business disruptions, and/or the loss of and/or damage to intellectual property through security breaches, including internal and external cyber-security threats. Cyber-security attacks by hackers, criminal groups or nation-state organizations are evolving and include, but are not limited to, malicious software (malware, ransomware and viruses), phishing and social engineering, cyber extortion, attempts to gain unauthorized access to networks, computer systems and data, malicious or negligent actions of employees (including misuse of information they are entitled to access) and other forms of electronic security breaches that could lead to disruptions in business systems, an inability to process customer orders and/or lost customer orders, unauthorized access, destruction, loss, alteration, falsification, unavailability or release of material confidential or otherwise protected information and corruption of data. Such cyberattacks could result in violations of data protection laws and regulations, damage to the reputation and credibility of the Company, loss of opportunities to acquire or divest of businesses, and loss of ability to commercialize products developed through research and development efforts and, therefore, could have a negative impact on net operating revenues.

 

16

 

 

We rely on relationships with third parties, including suppliers, distributors, co-packers, contractors, cloud data storage and other information technology service providers and other external business partners, for certain functions or for services in support of our operations. These third-party service providers, and partners, with whom we may share data including without limitation, for data hosting, back-office support, and other functions, are subject to similar risks as we are relating to cyber-security, privacy violations, business interruption, and systems, as well as employee failures. While we have procedures in place for selecting and managing our relationships with third-party service providers and other business partners, we do not have control over their business operations or governance and compliance systems, practices and procedures, which increases our financial, legal, reputational and operational risk. These third parties may experience cyber-security incidents that may involve data we share with them or rely on them to provide to us, and the need to coordinate with such third-parties, including with respect to timely notification and access to personnel and information concerning an incident, may complicate our efforts to resolve any issues that arise.

 

We believe that we have adopted appropriate measures including but not limited to ongoing cyber-security risk assessments and business continuity measures to mitigate potential risks to our technology and our operations from these information technology-related disruptions. However, given the unpredictability of the timing, nature and scope of such disruptions, we could potentially be subject to operational interruption, damage to our brand image and private data exposure. We could also be required to spend significant financial and other resources to remedy the damage caused by a cyber-security attack or to repair or replace networks and information systems.

 

Moreover, if our data management systems do not effectively collect, store, process and report relevant data for the operation of our business (whether due to network or equipment malfunction or constraints, software deficiencies, cyber-security attack and/or human error), our ability to effectively plan, forecast and execute our business plan and comply with applicable laws and regulations will be impaired, perhaps materially. Any such impairment could materially and adversely affect our financial condition, results of operations, cash flows and the timeliness with which we report our internal and external operating results. While we have purchased cyber-security insurance, there are no assurances that the coverage would be adequate in relation to any incurred losses. Moreover, as cyber-security attacks and increase in frequency and magnitude, we may be unable to obtain cyber-security insurance in amounts and on terms we view as appropriate for our operations.

 

If we fail to comply with data privacy and personal data protection laws, we could be subject to adverse publicity, government enforcement actions and/or private litigation, which may negatively impact our business and operating results.

 

We receive, process, transmit and store information relating to certain identified or identifiable individuals (“personal data”), including current and former employees, in the ordinary course of business. As a result, we are subject to various U.S. federal and state and foreign laws and regulations relating to personal data. These laws are subject to change, and new personal data legislation may be enacted in other jurisdictions at any time. In the European Union, the General Data Protection Regulation (the “GDPR”) became effective in May 2018 for all member states. The GDPR includes operational requirements for companies receiving or processing personal data of residents of the European Union different from those that were previously in place and also includes significant penalties for noncompliance. Additionally, the California Consumer Privacy Act of 2018 (the “CCPA”), which was enacted in June 2018 and came into effect on January 1, 2020, provides a new private right of action and statutory damages for certain data breaches and imposes operational requirements on companies that process personal data of California residents, including making new disclosures to consumers, employees and B2B contacts about data collection, processing and sharing practices and allowing consumers to opt out of certain data sharing with third parties. Other states have, or may, adopt similar such requirements and regulations.

 

Changes introduced by the GDPR and the CCPA, as well as other changes to existing personal data protection laws and the introduction of such laws in other jurisdictions, and changes to regulation, industry standards and contractual obligations, subject the Company to, among other things, additional costs and expenses and may require costly changes to our business practices and security systems, policies, procedures and practices. The interpretation and application of these laws and regulations are often uncertain and evolving; as a result, there can be no assurance that our data protection measures will be deemed adequate by a regulator or court. There can be no assurances that our security controls over personal data, training of personnel on data privacy and data security, vendor management processes, and the policies, procedures and practices we implement will prevent the improper processing or breaches of personal data. Data breaches or improper processing, or breaches of personal data in violation of the GDPR, the CCPA and/or of other personal data protection or privacy laws and regulations, could harm our reputation, cause loss of consumer confidence, subject us to government enforcement actions (including fines), and mandatory corrective action, or result in private litigation against us, which may result in potential loss of revenue, increased costs, liability for monetary damages or fines and/or criminal prosecution, thereby negatively impacting our business and operating results.

 

17

 

 

If we fail to manage future growth effectively, our business could be materially adversely affected.

 

We have experienced rapid growth and anticipate such growth may continue. During the year ended December 31, 2022, we grew from 225 to 378 employees, and expect to continue expanding our hiring and marketing efforts with no assurance that our business or revenue will continue to grow. This growth may place significant demands on management and our operational infrastructure. As we continue to grow, we must manage such growth effectively by successfully integrating, developing and motivating a large number of new employees, while maintaining the beneficial aspects of our company culture. If we do not manage the growth of our business and operations effectively, the quality of our products and efficiency of our operations could suffer and we may not be able to execute on our business plan, which could harm our brand, results of operations and overall business. Accordingly, we cannot guarantee that we will achieve our planned growth, or even if we are able to grow as planned, that we will continue to sustain such growth or performance.

 

We may incur material losses as a result of product recall and product liability.

 

We may be liable if the consumption of any of our products causes injury, illness or death. We also may be required to recall some of our products if they become contaminated or are damaged or mislabeled. A significant product liability judgment against us, or a widespread product recall, could have a material adverse effect on our business, financial condition and results of operations. The amount of the insurance we carry is limited, and that insurance is subject to certain exclusions and may or may not be adequate.

 

We rely on our management team and other key personnel.

 

We depend on the skills, experience, relationships, and continued services of key personnel, including our experienced management team. In addition, our ability to achieve our operating goals also depends on our ability to recruit, train, and retain qualified individuals. We compete with other companies both within and outside of our industry for talented personnel, and we may lose key personnel or fail to attract and retain additional talented personnel. Any such loss or failure could adversely affect our product sales, financial condition, and operating results.

 

In particular, our continued success will depend in part, on our ability to retain the talents and dedication of key employees. Our business may be adversely affected, and our management team may be distracted as a result of new COVID-19 variants. Furthermore, we may not be able to locate suitable replacements for any of our key employees who leave or be able to offer employment to potential replacements on reasonable terms, all of which could adversely affect our procurement and distribution processes, sales and marketing activities, financial processes & condition and results of operations.

 

The U.S. Food and Drug Administration (the “FDA”) has not passed on the efficacy of our products or the accuracy of any claim we make related to our products.

 

Although seven independent clinical studies have been conducted relating to the calorie-burning and related effects of our products, the results of these studies have not been submitted to or reviewed by the FDA.

 

Further, the FDA has not passed on the efficacy of any of our products nor has it reviewed or passed on any claims we make related to our products, including the claim that our products aid consumers in burning calories or enhancing their metabolism.

 

The Federal Trade Commission (the “FTC”) regulates advertising and may review the truthfulness of and substantiation for any claim we make related to our products.

 

Our advertising activities are subject to regulation by the FTC under the Federal Trade Commission Act. In recent years, the FTC and state attorneys general have initiated numerous investigations of dietary and nutritional supplement companies and products. Any actions or investigations initiated against the Company by governmental authorities or private litigants could have a material adverse effect on our business, financial condition and results of operations.

 

The shifting regulatory environment through the various jurisdictions in which are products are sold necessitates building and maintaining robust systems to achieve and maintain compliance in multiple jurisdictions and increases the possibility that we may violate one or more of the legal requirements. If our operations are found to be in violation of any applicable laws or regulations, we may be subject to, without limitation, civil and criminal penalties, damages, fines, the curtailment or restructuring of our operations, injunctions, or product withdrawals, recalls or seizures, any of which could adversely affect our ability to operate our business, our financial condition and results of operations.

 

18

 

 

Risk Factors Relating to Our Industry

 

We are subject to significant competition in the functional energy drink and supplement industries.

 

The functional energy drink and supplement industries are highly competitive. The principal areas of competition are pricing, packaging, distribution channel penetration, development of new products and flavors and marketing campaigns. Our products compete with a wide range of drinks produced by a relatively large number of manufacturers, most of which have substantially greater financial, marketing and distribution resources and name recognition than we do.

 

Important factors affecting our ability to compete successfully include the taste and flavor of our products, trade and consumer promotions, rapid and effective development of new, unique cutting-edge products, attractive and different packaging, branded product advertising and pricing. Our products compete with all liquid refreshments and with products of much larger and substantially better financed competitors, including the products of numerous nationally and internationally known producers, such as The Coca Cola Company, Dr. Pepper Snapple Group, Nestlé, Waters North America, Inc., Hansen Natural Corp., Vital Pharmaceuticals, Inc., Monster Energy and Red Bull. We also compete with companies that are smaller or primarily local in operation. Our products also compete with private label brands such as those carried by supermarket chains, convenience store chains, drug store chains, mass merchants and club warehouses. New competitors continue to emerge, some of which target specific markets of ours as well as the health and wellness space. This may require additional marketing expenditures on our part to remain competitive.

 

The rapid growth in sales through e-commerce retailers, e-commerce websites, mobile commerce applications and subscription services, may result in a shift away from physical retail operations to digital channels and a reduction in impulse purchases. Further, the ability of consumers to compare prices on a real-time basis using digital technology puts additional pressure on us to maintain competitive prices. Sales in gas chains may also be affected by improvements in fuel efficiency and increased consumer preferences for electric or alternative fuel-powered vehicles, which may result in fewer trips by consumers to gas stations and a corresponding reduction in purchases by consumers in convenience gas retailers. We have been growing our e-commerce sales by using Amazon and leveraging our retail partners e-commerce platforms, rather than building our own internal platform. However, if we are unable to successfully adapt to the rapidly changing retail landscape, our share of sales, volume growth and overall financial results could be negatively affected.

 

Due to competition in the functional energy drink and supplement industries, there can be no assurance that we will not encounter difficulties in maintaining our current revenues, market share or position in the functional energy drink and supplement industries. If our revenues decline, our business, financial condition and results of operations could be adversely affected.

 

Our inability to innovate successfully and to provide new cutting-edge products could adversely affect our business and financial results.

 

Our ability to compete in the highly competitive functional energy drink and supplement industries and to achieve our business growth objectives depends, in part, on our ability to develop new flavors, products and packaging. The success of our innovation, in turn, depends on our ability to identify consumer trends and cater to consumer preferences. If we are not successful in our innovation activities, our business, financial condition and results of operation could be adversely affected.

 

Changes in consumer product and shopping preferences may reduce demand for some of our products.

 

The functional energy drink and supplement categories are subject to changing consumer preferences and shifts in consumer preferences may adversely affect us. There is increasing awareness of and concern for health, wellness and nutrition considerations, including concerns regarding caloric intake associated with sugar-sweetened drinks and the perceived undesirability of artificial ingredients. Our products do not contain the artificial preservatives often found in many energy drinks and sodas. CELSIUS® has no aspartame or high fructose corn syrup and is very low in sodium. The main CELSIUS® line of products are sweetened with sucralose, a sugar-derived sweetener that is found in Splenda®, which makes our liquid supplements low-calorie. However, consumer preferences may shift away from the trend towards healthier options that we have observed, and as such, there can be no assurance that our current products and product lines will maintain their current levels of demand. There are also changes in demand for different packages, sizes and configurations. This may reduce demand for our functional energy drinks and liquid supplements, which could reduce our revenues and adversely affect our results of operations.

 

19

 

 

Consumers are seeking greater variety in their functional energy drinks and supplements. Our future success will depend, in part, upon our continued ability to develop and introduce different and innovative drinks and supplements that appeal to consumers. In order to retain and expand our market share, we must continue to develop and introduce different and innovative supplements and be competitive in the areas of efficacy, taste, quality and price, although there can be no assurance of our ability to do so. There is no assurance that consumers will continue to purchase our products in the future. Product lifecycles for some functional energy drink and supplement brands, products and/or packages may be limited to a few years before consumers’ preferences change. The functional energy drink and supplements we currently market are in varying stages of their product lifecycles, and there can be no assurance that such products will become or remain profitable for us. We may be unable to achieve volume growth through product and packaging initiatives. We may also be unable to penetrate new markets. Additionally, as shopping patterns are being affected by the digital evolution, with consumers embracing shopping by way of mobile device applications, e-commerce retailers and e-commerce websites or platforms, we may be unable to address or anticipate changes in consumer shopping preferences or engage with our consumers on their preferred platforms. If our revenues decline, our business, financial condition and results of operations could be adversely affected.

 

We derive virtually all of our revenues from functional energy drinks and supplements, and competitive pressure in the functional energy drink and supplement category could adversely affect our business and operating results.

 

Our focus is in the functional energy drink and supplement categories, and our business is vulnerable to adverse changes impacting the fitness supplement category and business, which could adversely impact our business and the trading price of our common stock.

 

Virtually all of our sales are derived from our functional energy drink and supplements, including our CELSIUS® Originals and Vibe, CELSIUS HEAT, CELSIUS BCCA+ENERGY, CELSIUS® On-the-Go and CELSIUS® product lines. Any decrease in the sales of our functional energy drinks and supplements could significantly adversely affect our future revenues and net income. Historically, we have experienced substantial competition from new entrants in the functional energy drink and supplement categories.

 

The increasing number of competitive products and limited amount of shelf space, including in coolers, in retail stores may adversely impact our ability to gain or maintain our share of sales in the marketplace. In addition, certain actions of our competitors, including unsubstantiated and/or misleading claims, false advertising claims and tortious interference in our business, as well as competitors selling misbranded products, could impact our sales. Competitive pressures in the functional energy drink and supplement categories could impact our revenues, cause price erosion and/or lower market share, any of which could have a material adverse effect on our business and results of operations.

 

We compete in an industry that is brand-conscious, so brand name recognition and acceptance of our products are critical to our success and significant marketing and advertising could be needed to achieve and sustain brand recognition.

 

Our business is substantially dependent upon awareness and market acceptance of our products and brands by our targeted consumers. Our business depends on acceptance by our independent distributors of our brand as one that has the potential to provide incremental sales growth rather than reduce distributors’ existing beverage sales. The development of brand awareness and market acceptance is likely to require significant marketing and advertising expenditures. There can be no assurance that CELSIUS® will achieve and maintain satisfactory levels of acceptance by independent distributors and retail consumers. Any failure of the CELSIUS® brand to maintain or increase acceptance or market penetration would likely have a material adverse effect on business, financial condition and results of operations.

 

If we are unable to successfully manage new product launches, our business and financial results could be adversely affected.

 

Due to the highly competitive nature of the global functional energy drink and supplement sectors, we expect and intend to continue to introduce new products and evolve existing products to better match consumer demand. The success of new and evolved products depends on a number of factors, including timely and successful development and consumer acceptance. Such endeavors may also involve significant risks and uncertainties, including distraction of management from current operations, greater than expected liabilities and expenses, inadequate return on capital, exposure to additional regulations and reliance on the performance of third parties.

 

Our sales are affected by seasonality.

 

As is typical in the “alternative” beverage category, our sales are seasonal, albeit with our recent significant growth, we have seen ongoing quarter over quarter growth regardless of the season. Our highest sales volumes generally occur in the second and third quarters, which correspond to the warmer months of the year in our major markets. Consumer demand for our products is also affected by weather conditions. Cool, wet spring or summer weather could result in decreased sales of our products and could have an adverse effect on our results of operations.

 

20

 

 

Our business is subject to many regulations and noncompliance is costly.

 

The production, marketing and sale of our functional energy drinks and supplements are subject to the rules and regulations of various federal, state and local health agencies. The marketing and sale of our products internationally is similarly subject to compliance with applicable laws, rules and regulations in those foreign countries where our products are sold. If a regulatory authority finds that a current or future product or production run is not in compliance with any of these regulations, we may be fined, or production may be stopped, thus adversely affecting our business, financial condition and results of operations. Similarly, any adverse publicity associated with any noncompliance may damage our reputation and our ability to successfully market our products. Furthermore, the rules and regulations are subject to change from time to time and while we closely monitor developments in this area, we have no way of anticipating whether changes in these rules and regulations will impact our business adversely. Additional or revised regulatory requirements, whether labeling, environmental, tax or otherwise, could have an adverse effect on our business, financial condition and results of operations.

 

Product safety and quality concerns, or other negative publicity (whether or not warranted) could damage our brand image and corporate reputation and may cause our business to suffer.

 

Our success depends in large part on our ability to maintain consumer confidence in the safety and quality of all of our products. We have rigorous product safety and quality standards, which we expect our operations as well as our suppliers to meet. However, despite our strong commitment to product safety and quality, we or our suppliers may not always meet these standards, particularly as we expand our product offerings through innovation or acquisitions into product categories that are beyond our traditional range of functional energy drinks and supplements. If we or our suppliers fail to comply with applicable product safety and quality standards, or if our supplement products taken to the market are or become contaminated or adulterated by any means, we may be required to conduct costly product recalls and may become subject to product liability claims and negative publicity, which could cause our business to suffer.

 

Our success also depends on our ability to build and maintain the brand image for our existing products, new products and brand extensions and maintain our corporate reputation. There can be no assurance that our advertising, marketing and promotional programs and our commitment to product safety and quality, human rights and environmental sustainability will have the desired impact on our products’ brand image and on consumer preferences and demand. Claims regarding product safety, quality and/or ingredient content issues, efficacy or lack thereof (real or imagined), our culture and our workforce, our environmental impact and the sustainability of our operations, or allegations of product contamination, even if false or unfounded, could tarnish the image of our brands and may cause consumers to choose other products. Consumer demand for our products could diminish significantly if we, our employees, distributors, suppliers or business partners fail to preserve the quality of our products, act or are perceived to act in an unethical, illegal, discriminatory, unequal or socially irresponsible manner, including with respect to the sourcing, content or sale of our products, service and treatment of our customers, or the use of customer data. Furthermore, our brand image or perceived product quality could be adversely affected by litigation, unfavorable reports in the media (internet or elsewhere), studies in general and regulatory or other governmental inquiries (in each case whether involving our products or those of our competitors) and proposed or new legislation affecting our industry. Negative postings or comments on social media or networking websites about the Company or any one of our brands, even if inaccurate or malicious, could generate adverse publicity that could damage the reputation of our brands or the Company. Business incidents, whether isolated or recurring and whether originating from us, our distributors, suppliers or business partners, that erode consumer trust can significantly reduce brand value or potentially trigger boycotts of our products and can have a negative impact on consumer demand for our products as well as our reputation and financial results. The impact of such incidents may be exacerbated if they receive considerable publicity, including rapidly through social or digital media (including for malicious reasons) or result in litigation.

 

In addition, from time to time, there are public policy endeavors that are either directly related to our products and packaging or to our business. These public policy debates can occasionally be the subject of backlash from advocacy groups that have a differing point of view and could result in adverse media and consumer reaction, including product boycotts. Similarly, our sponsorship relationships could subject us to negative publicity as a result of actual or alleged misconduct by individuals or entities associated with organizations we sponsor or support. Likewise, campaigns by activists connecting us, or our supply chain, with human and workplace rights, environmental or animal rights issues could adversely impact our corporate image and reputation. Allegations, even if untrue, that we are not respecting the human rights found in the United Nations Universal Declaration of Human Rights; actual or perceived failure by our suppliers or other business partners to comply with applicable labor and workplace rights laws, including child labor laws, or their actual or perceived abuse or misuse of migrant workers; adverse publicity surrounding obesity and health concerns related to our products, our environmental impact and the sustainability of our operations, labor relations, our culture and our workforce or the like could negatively affect our Company’s overall reputation and brand image, which in turn could have a negative impact on our products’ acceptance by consumers.

 

21

 

 

Litigation could expose us to significant liabilities and reduce demand for our products.

 

We have been and are a party, from time to time, to various litigation claims and legal proceedings, including, but not limited to, intellectual property, false advertising, product liability, breach of contract claims and others. Other lawsuits have been filed against us claiming that certain statements made in our advertisements and/or on the labels of our products were false and/or misleading or otherwise not in compliance with food standards under local law. Putative class action lawsuits have also been filed against us, alleging that certain claims in our marketing promotional amount to false advertising. We do not believe any statements made by us in our promotional materials or set forth on our product labels are false or misleading or noncompliant with local law, and we have been defending, and will continue to vigorously defend such lawsuits. At times, even if the Company believes that it is acting in compliance with the law, management may choose to settle claims in order to avoid lengthy trials or disruptions to its business.

 

Any of the foregoing matters or other litigation, the threat thereof, or unfavorable media attention arising from pending or threatened litigation could consume significant financial and managerial resources and result in diminished operational efficiency of the Company, significant monetary awards against us, an injunction barring the sale of any of our products and injury to our reputation. Our failure to successfully defend or settle any litigation or legal proceedings could result in liabilities that, to the extent not covered by our insurance, could have a material adverse effect on our financial condition, revenue and profitability, and could cause the market value of our common stock to decline.

 

If we do not maintain an effective internal control environment as well as adequate control procedures over our financial reporting, investor confidence may be adversely affected thereby affecting the value of our stock price. The Company has identified material weaknesses in its internal control over financial reporting that, if not remediated, could result in additional material misstatements in its consolidated financial statements.

 

We are required to maintain proper internal control over our financial reporting and adequate controls related to our disclosures. As defined in Rule 13a-15(f) under the Exchange Act, internal control over financial reporting is a process designed by, or under the supervision of, the principal executive and principal financial officers and effected by the board of directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. If we fail to maintain adequate controls, our business, the results of operations, financial condition and/or the value of our stock may be adversely impacted.

 

As described in Part II, Item 9A — Controls and Procedures, management identified material weaknesses in the Company’s internal control over financial reporting in 2021 and 2022. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Company’s annual or interim financial statements will not be prevented or detected on a timely basis.

 

The Company is in the process of remediating the material weaknesses. If the Company’s remediation efforts are insufficient or if additional material weaknesses in internal control over financial reporting are discovered or occur in the future, the Company’s consolidated financial statements may contain material misstatements and it could be required to revise or restate its financial results, which could materially and adversely affect the Company’s business, results of operations and financial condition, restrict its ability to access the capital markets, require it to expend significant resources to correct the material weakness, subject it to fines, penalties or judgments, harm its reputation or otherwise cause a decline in investor confidence.

 

We face investigation from the SEC, the timeline for which and the results of which are currently unknown.

 

On January 8, 2021, we received a letter from the SEC Division of Enforcement seeking the production of documents in connection with a non-public fact-finding inquiry by the SEC to determine whether violations of the federal securities laws have occurred. On August 20, 2021, the SEC issued a subpoena for production of documents in connection with the matter. Neither the January 8, 2021 SEC letter nor the August 20, 2021 subpoena means that the SEC has concluded that the Company or anyone else has violated the federal securities laws. We have cooperated and will continue to cooperate with the SEC staff in its investigation. At this time, however, we cannot predict the length, scope, or results of the investigation or the impact, if any, of the investigation on our results of operations.

 

We may also be subject to further or other examinations, investigations, proceedings and orders by the SEC or other regulators. Any such further or other actions could be expensive and damaging to our business, results of operations and financial condition.

 

22

 

 

Risk Factors Related to Financial Risks

 

Fluctuations in our effective tax rate could adversely affect our financial condition and results of operations.

 

We are subject to income and other taxes in both the U.S. and certain foreign jurisdictions. Therefore, we are subject to audits for multiple tax years in various jurisdictions at once.

 

Our 2019 through 2021 U.S. federal income tax returns are subject to examination by the IRS. Our state income tax returns are subject to examination for the 2018 through 2021 tax years.

 

At any given time, events may occur which change our expectation about how any such tax audits will be resolved and thus, there could be significant variability in our quarterly and/or annual tax rates, because these events may change our plans for uncertain tax positions.

 

Changes in U.S. tax laws as a result of any legislation proposed by the new U.S. Presidential Administration or U.S. Congress, which may include efforts to change or repeal the 2017 Tax Cuts and Jobs Act and the federal corporate income tax rate reduction, could adversely affect our provision for income taxes, resulting in an adverse impact on our financial condition or results of operations. In addition, changes in the manner in which U.S. multinational corporations are taxed on foreign earnings, including changes in how existing tax laws are interpreted or enforced, could adversely affect our financial condition or results of operations. For example, the Organization for Economic Cooperation and Development (“OECD”) has recommended changes to numerous long-standing international tax principles through its base erosion and profit shifting (“BEPS”) project. These changes, to the extent adopted, may increase tax uncertainty, result in higher compliance costs and adversely affect our provision for income taxes, results of operations and/or cash flow. In connection with the OECD’s BEPS project, companies are required to disclose more information to tax authorities on operations around the world, which may lead to greater audit scrutiny of profits earned in various countries. Economic and political pressures to increase tax revenues in jurisdictions in which we operate, or the adoption of new or reformed tax legislation or regulation, may make resolving tax disputes more difficult and the final resolution of tax audits and any related litigation could differ from our historical provisions and accruals, resulting in an adverse impact on our financial condition or results of operations.

 

We may be required in the future to record a significant charge to earnings if our goodwill or intangible assets become impaired.

 

Under United States Generally Accepted Accounting Principles (“U.S. GAAP”), we are required to review our intangible assets for impairment when events or changes in circumstances indicate the carrying value may not be recoverable. Factors that may be considered a change in circumstances indicating that the carrying value of our intangible assets may not be recoverable include, declining or slower than anticipated growth rates for certain of our existing products, a decline in stock price and market capitalization, and slower growth rates in our industry.

 

We may be required in the future to record a significant charge to earnings during the period in which we determine that our intangible assets have been impaired. Any such charge would adversely impact our results of operations. As of December 31, 2022, our goodwill totaled approximately $13.7 million and intangible assets totaled approximately $12.3 million.

 

Fluctuations in foreign currency exchange rates may adversely affect our operating results.

 

We are exposed to foreign currency exchange rate risk with respect to our sales, expenses, profits, assets and liabilities denominated in currencies other than the U.S. dollar. As a result, our reported earnings may be affected by changes in foreign currency exchange rates. Moreover, any favorable impacts to profit margins or financial results from fluctuations in foreign currency exchange rates are likely to be unsustainable over time. For the years ended December 31, 2022, 2021 and 2020, aggregate foreign currency transaction (losses) gains, resulted in a loss of $2.5 million, and gains of $0.8 million and $0.6 million, respectively.

 

23

 

 

Potential changes in accounting standards or practices and/or taxation may adversely affect our financial results.

 

We cannot predict the impact that future changes in accounting standards or practices may have on our financial results. New accounting standards could be issued that change the way we record revenues, expenses, assets and liabilities. These changes in accounting standards could adversely affect our reported earnings. Increases in direct and indirect income tax rates could affect after-tax income. Equally, increases in indirect taxes (including environmental taxes pertaining to the disposal of beverage containers and/or indirect taxes on beverages generally or energy drinks in particular) could affect our products’ affordability and reduce our sales.

 

If we fail to maintain effective disclosure controls and procedures and internal control over financial reporting on a consolidated basis, our stock price and investor confidence in the Company could be materially and adversely affected.

 

We are required to maintain both disclosure controls and procedures as well as internal control over financial reporting that are effective for the purposes described in “Part II, Item 9A – Controls and Procedures.” If we fail to maintain such controls and procedures, our business, results of operations, financial condition and/or the value of our stock could be materially harmed.

 

Uncertainty in the financial markets and other adverse changes in general economic or political conditions in any of the major countries in which we do business could adversely affect our industry, business and results of operations.

 

Global economic uncertainties, including highly inflationary economies and foreign currency exchange rates, affect businesses such as ours in a number of ways, making it difficult to accurately forecast and plan our future business activities. There can be no assurance that economic improvements will occur, or that they would be sustainable, or that they would enhance conditions in markets relevant to us. In addition, we cannot predict the duration and severity of disruptions in any of our markets or the impact they may have on our customers or business, as our expansion outside of the United States has increased our exposure to any developments or crises in African, Asian, European and other international markets. Unfavorable economic conditions and financial uncertainties in our major international markets and unstable political conditions, including civil unrest and governmental changes, in certain of our other international markets could undermine global consumer confidence and reduce consumers’ purchasing power, thereby reducing demand for our products. Included in the foregoing are long-term uncertainties surrounding the United Kingdom’s withdrawal from the European Union on January 31, 2020 (commonly referred to as “Brexit”) and any resulting increases in tariffs, importation restrictions, out of stocks, volatility in currency exchange rates, including the valuation of the euro and the British pound in particular, changes in the laws and regulations applied in the United Kingdom or impacts on economic and market conditions in the United Kingdom, the European Union and its member states and elsewhere.

 

Volatility of stock price may restrict sale opportunities.

 

Our stock price is affected by a number of factors, including stockholder expectations, financial results, the introduction of new products by us and our competitors, general economic and market conditions such as inflation, estimates and projections by the investment community and public comments by other parties as well as many other factors including litigation, many of which are beyond our control. We do not provide guidance on our future performance, including, but not limited to, our revenues, margins, product mix, operating expenses or net income. We may be unable to achieve analysts’ net revenue and/or earnings forecasts, which are based on their own projected revenues, sales volumes and sales mix of many product types and/or new products, certain of which are more profitable than others, as well as their own estimates of gross margin and operating expenses. There can be no assurance that we will achieve any such projected levels or mix of product sales, revenues, gross margins, operating profits and/or net income. As a result, our stock price is subject to significant volatility, and stockholders may not be able to sell our stock at attractive prices. In addition, periods of volatility in the market price of our stock could result in the initiation of securities class action litigation against us. During the fiscal year ended December 31, 2022, the high of our stock price was $122.24 and the low was $38.31.

 

Our investments are subject to risks which may cause losses and affect the liquidity of these investments.

 

On December 31, 2022, we had $652.9 million in cash and cash equivalents. Certain of these investments are subject to general credit, liquidity, market and interest rate risks. These risks associated with our investment portfolio may have an adverse effect on our future results of operations, liquidity and financial condition.

 

24

 

 

Risk Factors Related to our Common Stock

 

We cannot guarantee the continued existence of an active established public trading market for our common stock.

 

Our common stock currently is listed for trading on the Nasdaq Capital Market. Trading in stock quoted on the Nasdaq Capital Market may often experience wide fluctuations in trading prices, due to many factors that may have little to do with our operations or business prospects. This volatility could depress the market price of our common stock for reasons unrelated to operating performance.

 

Market prices for our common stock may also be influenced by a number of other factors, including:

 

●the issuance of new equity securities pursuant to a public or private offering;

 

●changes in interest rates;

 

●competitive developments, including announcements by competitors of new products or services or significant contracts, acquisitions, strategic partnerships, joint ventures or capital commitments;

 

●variations in quarterly operating results;

 

●change in financial estimates by securities analysts;

 

●the depth and liquidity of the market for our common stock;

 

●investor perceptions of CELSIUS® and the functional energy drink and supplement industries generally; and

 

●general economic and other national conditions.

 

Our board of directors has the authority, without stockholder approval, to issue preferred stock with terms that may not be beneficial to common stockholders and with the ability to affect adversely stockholder voting power and perpetuate their control over us. We have outstanding shares of preferred stock with rights and preferences superior to those of our common stock.

 

Our Articles of Incorporation allows our board of directors to issue shares of preferred stock without any vote or further action by our stockholders. Our board of directors has the authority to fix and determine the relative rights and preferences of preferred stock. As a result, our board of directors could authorize the issuance of a series of preferred stock that would grant to holders the preferred right to our assets upon liquidation, the right to receive dividend payments before dividends are distributed to the holders of common stock and the right to the redemption of the shares, together with a premium, prior to the redemption of our common stock.

 

On August 1, 2022, the Company filed the Series A Certificate with the Secretary of the State of Nevada (the “Series A Certificate”). The Series A Certificate authorizes 1,466,666 shares of Series A Preferred Stock (the “Series A Preferred Stock”), all of which were issued and sold to Pepsi, and are initially convertible at the rate of five shares of the Company’s common stock, par value $0.001 per share, for each share of Series A Preferred Stock. The Series A Preferred Stock ranks, with respect to distribution rights and rights on liquidation, winding-up and dissolution, (i) senior and in priority of payment to the Company’s common stock, (ii) on parity with any class or series of capital stock of the Company expressly designated as ranking on parity with the Series A Preferred Stock, and (iii) junior to any class or series of capital stock of the Company expressly designated as ranking senior to the Series A Preferred Stock. Upon any voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Company (but excluding any change of control), each holder of Series A Preferred Stock will be entitled to receive an amount per share of Series A Preferred Stock equal to the Liquidation Preference, as defined in the Series A Certificate. Holders of shares of Series A Preferred Stock will be entitled to cumulative dividends, which will be payable quarterly in arrears either in cash, in-kind, or a combination thereof. Dividends will accrue on each share of Series A Preferred Stock at the rate of 5.00% per annum, subject to adjustment as set forth in the Series A Certificate. In addition to such quarterly regular dividends, such shares of Series A Preferred Stock are entitled to participate in dividends paid to holders of common stock.

 

25

 

 

Our principal stockholders can exert significant influence on the Company’s corporate affairs.

 

Our principal stockholder owns approximately 24% of our issued and outstanding common stock. Accordingly, they will be able to effectively influence the election of directors, as well as all other matters requiring stockholder approval. The interests of our principal stockholders may differ from the interests of other stockholders with respect to the issuance of shares, business transactions with or sales to other companies, selection of other directors and other business decisions.

 

We do not expect to pay cash dividends on our common stock in the foreseeable future.

 

We have never paid cash dividends on our common stock. We do not expect to pay cash dividends on our common stock at any time in the foreseeable future. The future payment of dividends directly depends upon our future earnings, capital requirements, financial requirements and other factors that our board of directors will consider. Since we do not anticipate paying cash dividends on our common stock, return on your investment, if any, will depend solely on an increase, if any, in the market value of our common stock.

 

26

 

 

General Risk Factors

 

We are subject to the periodic reporting requirements of the Exchange Act that require us to incur audit fees and legal fees in connection with the preparation of such reports. These additional costs could reduce or eliminate our ability to earn a profit.

 

We are subject to the periodic reporting requirements of the Exchange Act and as a result, we are now required to file periodic reports with the Securities and Exchange Commission (the “SEC”) pursuant to the Exchange Act and the rules and regulations promulgated thereunder. In order to comply with these requirements, our independent registered public accounting firm has to review our financial statements on a quarterly basis and audit our financial statements on an annual basis. Moreover, our legal counsel has to review and assist in the preparation of such reports. The costs charged by these professionals for such services cannot be accurately predicted at this time because factors such as the number and type of transactions that we engage in and the complexity of our reports cannot be determined at this time and will have a major effect on the amount of time to be spent by our auditors and attorneys. However, the incurrence of such costs will obviously be an expense to our operations and thus have a negative effect on our ability to meet our overhead requirements and earn a profit. If we cannot provide reliable financial reports or prevent fraud, our business and operating results could be harmed, investors could lose confidence in our reported financial information, and the trading price of our common stock, if a market ever develops, could drop significantly.

 

Our periodic filings as required under the Exchange Act may be subject to review and comment by the SEC, which may result in changes to our public disclosure.

 

Our periodic filings with the SEC in compliance with the reporting requirements of the Exchange Act, may be subject to review and comment by the SEC. Should the SEC conduct such review and comment, we may be required to revise such periodic filings, including but not limited to the financial statements contained therein.

 

27

 

 

Item 1B. Unresolved Staff Comments.

 

Not applicable.

 

Item 2. Properties.

 

We do not own any real property. We lease our principal executive offices located at 2424 North Federal Highway, Boca Raton, Florida 33431. Our premises are leased for a monthly cost of $37.6 thousand. These leases have different periods and extend until the end of 2024. We have no warehouses or other facilities in the United States as we store our product at third party contract warehouse facilities.

 

We also have leased office space in Europe which have an aggregate monthly cost of approximately $11.6 thousand. These leases have different periods and extend until August 2023.

 

Item 3. Legal Proceedings.

 

We are occasionally subject to litigation or other legal proceedings relating to our business. Refer to Note 19 of the Notes to our Consolidated Financial Statements related to commitments and contingencies, which is incorporated herein by reference. In addition, from time to time, we may become party to litigation or other legal proceedings that we consider to be a part of the ordinary course of our business.

 

Item 4. Mine Safety Disclosures

 

Not applicable.

 

28

 

 

PART II

 

Item 5. Market Price of and Dividends on the Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.

 

Principal Market

 

Our common stock is listed on the Nasdaq Capital Market under the symbol “CELH.” As of February 14, 2023, there were 40 holders of record of our common stock and in excess of 5,000 beneficial owners of our common stock. The holders of record do not include stockholders whose shares are held of record by banks, brokers and other financial institutions.

 

Dividends

 

Pepsi

 

On August 1, 2022, the Company issued 1,466,666 shares of the Series A Preferred Stock to Pepsi, which entitles Pepsi to cumulative dividends, which are payable quarterly in arrears either in cash, in-kind, or a combination thereof, at the Company’s election (“Regular Series A Dividends”). Regular Series A Dividends accrue on each share Series A Preferred Stock at the rate of 5.00% per annum, subject to adjustment as set forth in the Series A Certificate. In addition to such quarterly Regular Series A Dividends, shares of Series A also entitle the holder participate in any dividends paid on the Company’s common stock on an as-converted basis. During the year ended December 31, 2022, the Company declared and paid $11.5 million in Regular Series A Dividends, which amounted to $7.86 per share of Series A Preferred Stock. There were no cumulative undeclared dividends on the Series A Preferred Stock at December 31, 2022. In addition, there were no dividends issued to common stockholders as of the years ended December 31, 2022 and 2021.

 

With the exception of the Regular Series A Dividends paid to Pepsi, we have never paid cash dividends. We do not expect to pay cash dividends on our common stock at any time in the foreseeable future. The future payment of dividends directly depends upon our future earnings, capital requirements, financial requirements and other factors that our board of directors will consider.

 

Recent Sales of Unregistered Securities

 

None, except as previously disclosed in filings with the SEC.

 

29

 

 

Performance Graph

 

The following graph shows a five-year comparison of cumulative total returns.*

 

 

*The graph assumes that $100 was invested on December 31, 2017, including reinvestment of dividends. The Company’s self-selected peer group is comprised of: Monster Beverage Corporation, National Beverage Corp, Primo Water Corp, Keurig Dr Pepper, PepsiCo, and The Coca-Cola Company. Cumulative total returns for the companies included in the peer group have been weighted on the basis of the total market capitalization for each company.

 

Issuer Purchases of Equity Securities

 

None.

 

Item 6. Reserved.

 

30

 

 

Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

You should read the following discussion in conjunction with the audited financial statements and the corresponding notes included elsewhere in this information statement. This Item 7 contains forward-looking statements. The matters discussed in these forward-looking statements are subject to risk, uncertainties, and other factors that could cause actual results to differ materially from those made, projected or implied in the forward-looking statements. Please refer to “Item 1A. Risk Factors” for a discussion of the uncertainties, risks and assumptions associated with these statements.

 

This Management’s Discussion and Analysis of Financial Condition and Results of Operations of the Annual Report on Form 10-K generally discusses 2022 and 2021 items and year-to-year comparisons between 2022 and 2021. A detailed discussion of 2021 items and year-to-year comparisons between 2021 and 2020 that are not included in this Annual Report on Form 10-K can be found in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in Part II, Item 7 of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2021.

 

Executive Summary/Items Affecting Reported Results

 

The COVID-19 pandemic has presented and continues to present a substantial public health and economic challenge around the world and is affecting our communities and business operations, as well as the global economy and financial markets. The human and economic consequences of the COVID-19 pandemic as well as the measures taken or that may be taken in the future by governments, businesses (including the Company and our suppliers, distributors, co-packers and other service providers) and the public at large to limit new variants could directly and indirectly impact our business and results of operations. See “Part I. Item 1A - Risk Factors.” In spite of the global pandemic, we have worked together with our employees, distributors, co-packers and suppliers around the world to deliver another record year in net sales.

 

Pepsi Transaction and Distribution Agreement

 

On August 1, 2022, the Company issued 1,466,666 shares of non-voting Series A Preferred stock to Pepsi. On an as-converted basis the Series A held by Pepsi accounts for approximately 8.5% of the Company’s outstanding Common Stock, both on the date of issuance and as of December 31, 2022. Also, as discussed Note 14, the Purchase Agreement granted Pepsi the right to designate a nominee for election to the Company’s nine-member board of directors, so long as Pepsi meets certain ownership requirements with respect to the Company’s stock. During the year ended December 31, 2022, a Pepsi executive was nominated by Pepsi and elected to the Company’s board of directors.

 

Also, on August 1, 2022, the Company entered into a Distribution Agreement with Pepsi relating to the sale and distribution of certain of the Company’s beverage products in existing channels and distribution methods in the United States, excluding certain existing customer accounts, sales channels, Puerto Rico and the U.S. Virgin Islands. Under the Distribution Agreement, the Company granted Pepsi the right to sell and distribute its existing beverage products in existing channels and distribution methods and future beverage products that are added from time to time as licensed products under the Distribution Agreement in defined territories.

 

Distribution and Supply Chain

 

In 2022 and 2021, the Company, as well as the international beverage sector, experienced a number of supply chain challenges which adversely impacted our operations in the form of longer transportation lead times as well as increased ingredient and other input costs, including aluminum, shipping and freight, labor, co-packing fees, and secondary packaging materials, which resulted in increased costs of revenues and increased operating costs. The Company has successfully managed through these challenges, none of which, have impacted the Company’s ability to expand its footprint across the U.S.

 

31

 

 

Results of Operations

 

Year ended December 31, 2022 compared to year ended December 31, 2021

 

Revenue

 

For the year ended December 31, 2022, revenue was approximately $653.6 million, an increase of $339.3 million or 108% from $314.3 million for the year ended December 31, 2021. This growth was as a result of an increase in North America in 2022, of $344.4 million or 126% from 2021. Asia revenues (which primarily consist of royalty revenues from our China licensee) for the year ended December 31, 2022 had an increase of $1.1 million when compared to the year ended December 31, 2021. Other international markets had an increase of $0.8 million or 129% for 2022, when compared to 2021. This was offset by a decrease in Europe revenues in 2022, of $7.0 million or 18% from 2021.

 

The total increase in revenue from 2021 to 2022 was largely attributable to increases in sales volume, as opposed to increases in product pricing. The primary factors behind the increase in North America’s sales volume were related to continued strong triple-digit growth in traditional distribution channels, combined with an increase in and optimization of our products’ presence in world class retailers. Additionally, the continued expansion of our DSD network and our transition to the Pepsi distribution network in the fourth quarter, resulted in significant growth of our distributor revenues when compared to the prior year period.

 

The following table sets forth the amount of revenues by category and changes therein for the years ended December 31, 2022 and December 31, 2021:

 

   Years Ended
December 31,		 
Revenue Source  2022   2021 
Total revenue  $653,604   $314,272 
           
North America revenue   617,457    273,005 
           
Europe revenue   31,054    38,097 
           
Asia revenue   3,647    2,538 
           
Other revenue   1,446    632 

 

Gross profit

 

For the year ended December 31, 2022, gross profit increased by $142.7 million or 111% to $270.9 million, from $128.2 million for the year ended December 31, 2021. Gross profit margins increased to 41.4% for the year ended December 31, 2022 from 40.8% for the year ended December 31, 2021. The increase in gross profit dollars is related to increases in sales volumes, while the increase in gross profit margins from 2021 to 2022 is mainly related to our ability to leverage the increased volumes associated with our significant growth as well as increased pricing and improved processes and freight lanes, offset in part by increases in raw material costs (including high priced aluminum cans that were significantly depleted throughout 2022). The increase in gross profit dollars, includes $339.3 million related to purchase and volume increases, which was offset in part by increases in costs of $196.6 million.

 

32

 

 

Sales and marketing expenses

 

Sales and marketing expenses for the year ended December 31, 2022 were $352.8 million, an increase of $278.0 million or 372% from $74.7 million for the year ended December 31, 2021. We increased incremental marketing investment activities of $48.4 million from the 2021 period in comparison to 2022. Additionally, employee costs increased by $8.3 million from the 2021 year ago period as we continued to invest in this area in order to have the proper infrastructure to support our growth. Similarly, we experienced increases in other sales expense in the amount of $196.3 million mainly related to termination fees and trade-marketing activities to support our continued expansion of our DSD network. Lastly, storage and distribution as well as broker costs accounted for the remainder of the increase in this area in the amount of $25.0 million when compared to the prior year period, mainly related to the increase in business volume.

 

General and administrative expenses

 

General and administrative expenses for the year ended December 31, 2022 were $75.9 million, an increase of $18.4 million or 32% from $57.5 million for the year ended December 31, 2021. Employee costs for the year ended December 31, 2022 reflect an increase of $5.2 million or 67%, as investments in this area were also required to properly support our higher business volume and commercial and operational areas of the business. Administrative expenses amounted to $37.0 million or an increase of $26.0 million or approximately 237%, when compared to the prior year period. This variance is mainly related to an increase in audit costs, legal expenses, insurance costs and office rent. Depreciation, amortization and impairment had an increase of $3.0 million when compared to the prior year due to investments in operational equipment (e.g., coolers) and the impairment of the Func Food brand name. The increased expenses were offset by a lower stock option expense in 2022, which was $20.7 million, a decrease of $15.8 million from the prior year period. This change in stock option expense was mainly attributable to the revaluation of certain share-based payment awards that were modified during 2021. Management deems it very important to motivate employees by providing them ownership in the business in order to promote over performance which translates into the continued success of our business based on key performance attributes.

 

Other Income/(expense)

 

Total net other income for the year ended December 31, 2022, was $5.1 million which reflects an increase of $5.1 million when compared to net total other income of $31.0 thousand for the year ended December 31, 2021. The variance of $5.1 million is mainly related to interest income related to our money market accounts.

 

Income tax (expense)/benefit

 

An income tax expense of $34.6 million was obtained during the 2022 year, primarily due to the tax impact of the $282.5 million Series A Preferred Stock fair value adjustment which will be expensed over twenty years for book purposes. As this expense is non-deductible for tax purposes, the Company recorded a $72.1 million deferred tax liability in 2022 deferred tax expense. The effective income tax rate for the twelve months ending December 31, 2022 was also impacted by disallowed stock-based compensation expense, state and local income taxes and the release of certain state income tax reserves. An income tax benefit of approximately $8.0 million was obtained during the 2021 year, mainly related to the release of our U.S. valuation allowance and windfall benefits on stock-based compensation awards.

 

Net (loss)/income attributed to common stockholders

 

Net loss attributed to common stockholders for the year ended December 31, 2022, was $198.8 million or a loss of $2.63 per share based on a weighted average of 75,649 shares outstanding. In comparison, for the year ended December 31, 2021 the Company had net income attributed to common stockholders of $3.9 million with a weighted average of 73,781 shares outstanding and a dilutive weighted average of 77,689 shares outstanding, with a $0.05 per share for each.

 

33

 

 

Liquidity and Capital Resources

 

General

 

As of December 31, 2022, and December 31, 2021, we had unrestricted cash of $614.2 million and $16.3 million, respectively, and working capital of $756.7 million and $169.2 million, respectively.

 

We believe that cash available from operations, including our cash resources, will be sufficient for our working capital needs, including purchase commitments for raw materials and inventory, increases in accounts receivable and other assets, purchases of capital assets, and equipment, for the next twelve (12) months, with respect to our current operating plan. Please refer to “Risk Factors” in Part 1, item 1A, for these and other factors that may have a material effect on our operations. Our primary sources of cash included cash from operations, and proceeds from the issuance of Series A convertible preferred shares. These sources of cash are available to fund cash outflows that have both a short and long-term component.

 

Purchases of inventories, increases in accounts receivable and other assets, equipment (including coolers), advances for our distributors, co-packers, payments of accounts payable, and income taxes payable are expected to remain our principal recurring use of cash.

 

In addition to cash flow from operations, our primary sources of working capital have been the proceeds from private placements including a private placement of 1,466,666 shares of Series A Preferred as part of our strategic transaction with Pepsi at a price of $375 per share, completed in August of 2022.

 

Cash flows provided by (used in) operating activities

 

Cash flows provided by operating activities totaled $108.2 million in 2022, which compares to $96.6 million net cash used by operating activities for the year ended December 31, 2021. The $204.8 million increase in cash generation was driven by continued growth in the operations of the Company as well as timing of cash receipts and payments associated with the Pepsi transition. The use of cash in 2021was primarily driven by higher inventory levels in order to properly service the demand for our products and to mitigate inefficiencies of the global supply chain.

 

Cash flows (used in) provided by investing activities

 

Cash flows used in investing activities totaled $5.7 million in 2022, which compares to cash used in investing activities of $1.3 million for the year ended December 31, 2021. The change in the cash used in investing activities when compared to the 2021 period was primarily due to the investment of approximately $8.3 million mainly pertaining to equipment which was partially offset by note receivable payments from our China licensee of approximately $2.6 million.

 

Cash flows provided by financing activities

 

Cash flows provided by financing activities totaled $534.1 million for 2022, representing a $462.7 million increase from $71.4 million in 2021. The increase of cash provided by financing activities is mainly related to the net proceeds of $542 million from the issuance of Series A convertible preferred shares related to Pepsi, net of issuance costs. Net proceeds were received from a public offering in June 2021 for approximately $67.8 million.

 

Off Balance Sheet Arrangements

 

As of December 31, 2022 and 2021, we had no off-balance sheet arrangements.

 

34

 

 

Critical Accounting Estimates

 

Our consolidated financial statements are prepared in accordance with U.S. GAAP. In connection with the preparation of our consolidated financial statements, we are required to make judgments and estimates that significantly affect the reported amounts of assets, liabilities, revenues and expenses and related disclosures. Our estimates are based on historical experience, current trends and various other assumptions we believe to be relevant under the circumstances. We review the underlying factors used in our estimates regularly, including reviewing the significant accounting policies impacting the estimates, to ensure compliance with U.S. GAAP. However, due to the uncertainty inherent in our estimates, actual results may be materially different. We have identified the accounting estimates below as critical to understanding and evaluating the financial results reported in our consolidated financial statements.

 

For a complete description of our significant accounting policies and recent accounting pronouncements, see Item 8 Financial Statements and Supplementary Data, Note 2. Basis of Presentation and Summary of Significant Accounting Policies.

 

Promotional (Billbacks) Allowance

 

The Company’s billbacks are calculated based on various programs with distributors and retail customers, and accruals are established at the time of initial product sale for the Company’s anticipated liabilities. These accruals are based on agreed upon terms as well as the Company’s historical experience with similar programs and require management’s judgment with respect to estimating consumer participation and/or distributor and retail customer performance levels. Differences between such estimated expenses and actual expenses for promotional and other allowance costs have historically been insignificant and are recognized in earnings in the period such differences are determined. Promotional and other allowances primarily include consideration given to distributors or retail customers, including, but not limited to, the following: (i) discounts granted off list prices to support price promotions to end consumers by retailers; (ii) reimbursements given to distributors for agreed portions of their promotional spend with retailers, including slotting, shelf space allowances, and other fees for both new and existing products; (iii) agreed share of fees given to distributors and/or directly to retailers for advertising, in-store marketing, and promotional activities; (iv) agreed share of slotting, shelf space allowances, and other fees given directly to retailers, club stores and/or wholesalers; (v) incentives given to distributors and/or retailers for achieving or exceeding certain predetermined volumes goals; (vi) discounted products; (vii) contractual fees given to distributors related to sales made by the Company directly to certain customers that fall within the distributors’ sales territories; and (viii) contractual fees given to distributors for items sold below defined pricing targets. The promotional programs are of varying durations, typically ranging from one week to one year based on the agreed-upon terms. The nature of such programs is determined on a per retail customer or distributor basis, and in certain instances, the same program is set for multiple customers or distributors. The billback fees are recorded as a reduction to net sales in the period the underlying sale occurs.

 

Total promotional expenditures included as a reduction to revenue were $158.5 million for the year ended December 31, 2022, and accrued promotional allowances were $36.0 million as of December 31, 2022.

 

Revenue Recognition

 

The Company recognizes revenue in accordance with ASC Topic 606 Revenue from Contracts with Customers. The Company recognizes revenue when performance obligations under the terms of a contract with the customer are satisfied. Product sales occur once control or title is transferred based on the commercial terms. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring goods. Product sales are recorded net of variable consideration, such as provisions for returns, discounts and allowances. Such provisions are calculated using historical averages and adjusted for any expected changes due to current business conditions. Consideration given to customers for cooperative advertising is recognized as a reduction of revenue except to the extent that there is a distinct good or service, in which case the expense is classified as selling or marketing expense. The amount of consideration the Company receives and revenue the Company recognizes varies with changes in customer incentives the Company offers to its customers and their customers. Additionally, for any agreements which are one year or less, the practical expedient under ASC 340-40-25-4 is applied to expense contract acquisition costs when incurred if the amortization period of the contract asset would have otherwise been recognized in one year or less. Sales taxes and other similar taxes are excluded from revenue. Management believes that adequate provision has been made for cash discounts, returns and spoilage based on the Company’s historical experience.

 

35

 

 

Goodwill and Intangible Assets Valuation

 

We evaluate the carrying value of our goodwill and indefinite-lived intangible assets for impairment at least annually or when an interim triggering event occurs that would indicate impairment may have taken place. We evaluate our other definite-lived intangible assets for impairment when evidence exists that certain events or changes in circumstances indicate that the carrying amount of these assets may not be recoverable. Judgments and assumptions are required in such impairment evaluations. During the third quarter of 2022, we entered into a long term distribution agreement with Pepsi. The addition of the Pepsi distribution network has shifted the Company’s focus to the US market and as a consequence it was determined that impairment indicators for the Func Foods brands indefinite intangible asset were present. The Company no longer anticipates focusing on the expansion of Func Food branded products and the Company plans to focus on Celsius branded products. As a result of the strategic shift, which the Company considered a triggering event, the Company quantitatively tested the Func Foods brand name for impairment utilizing the relief from royalty method to determine fair value. As a result of the quantitative assessment, the Company recorded an impairment charge of $2.5 million which is presented within General and Administrative expenses on the Consolidated Statements of Operations and Comprehensive (Loss) Income.

 

Our annual impairment evaluation of goodwill involves qualitative aspects, including comparing our single reporting unit’s fair value to its respective carrying value. Some of the qualitative aspects evaluated included macro-economic conditions, industry and market considerations, cost factors regarding our raw materials and operations and overall financial performance of our business.

 

We use the income approach to determine the fair value of our definite-lived customer relationships intangible asset. In accordance with FASB ASC 350, intangible assets with indefinite lives are not amortized but instead are measured for impairment at least annually, or when events indicate that an impairment exists. The Company calculates impairment as the excess of the carrying value of its indefinite-lived assets over their estimated fair value. If the carrying value exceeds the estimate of fair value a write-down is recorded. The Company amortizes its trademarks with finite useful lives over their respective useful lives.

 

Changes in economic and operating conditions impacting these assumptions could result in goodwill and intangible assets impaired in future periods. Additionally, disruptions to our business such as prolonged recessionary periods or unexpected significant declines in operating results could result in impairment of goodwill and other intangible assets in future periods.

 

Changes in the factors used in our fair value estimates, including the impacts of the cost inflation or other margin erosion, and discount rates used, could have a significant impact on the fair values of the reporting unit and indefinite-lived intangible assets.

 

Item 7A. Quantitative and Qualitative Disclosures about Market Risk.

 

In the normal course of business our financial position is routinely subject to a variety of risks. The principal market risks (i.e., the risk of loss arising from adverse changes in market rates and prices) to which we are exposed are fluctuations in commodity and other input prices affecting the costs of our raw materials (including, but not limited to increases in the price of aluminum cans, sucralose, caffeine, vitamins, fluctuations in energy and fuel prices). We generally do not use hedging agreements or alternative instruments to manage the risks associated with securing sufficient ingredients or raw materials. We are also subject to market risks with respect to the cost of commodities and other inputs because our ability to recover increased costs through higher pricing is limited by the competitive environment in which we operate.

 

We do not use derivative financial instruments to protect ourselves from fluctuations in interest rates and generally do not hedge against fluctuations in commodity prices.

 

Our net sales to customers outside of the United States were approximately 6% and 13% of consolidated net sales for the years ended December 31, 2022 and 2021, respectively. Our growth strategy includes expanding our international business. As a result, we are subject to risks from changes in foreign currency exchange rates.

 

As of December 31, 2022, we had $0.5 million in cash which is not subject to general credit, liquidity, market and interest rate risks.

 

Item 8. Financial Statements and Supplementary Data

 

The information required by this Item 8 is set forth following the signature page to this Report.

 

36

 

 

Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

 

Not applicable.

 

Item 9A. Controls and Procedures.

 

Disclosure controls and procedures

 

Evaluation of Disclosure Controls and Procedures

 

Disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) are designed to ensure that information required to be disclosed by us in the reports filed or submitted by us under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the rules and forms adopted by the SEC, including to ensure that information required to be disclosed by us in the reports filed or submitted by us under the Exchange Act is accumulated and communicated to the Company’s management, including our President and Chief Executive Officer (our principal executive officer) and our Chief Financial Officer (our principal financial and accounting officer), or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

 

Our President and Chief Executive Officer as well as our Chief Financial Officer, have evaluated the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, as of the end of the period covered by this Report. Based on that evaluation, our President and Chief Executive Officer and our Chief Financial Officer have concluded that our disclosure controls and procedures were not effective as of the end of the period covered by this annual report because of the material weaknesses in internal control over financial reporting described below.

 

Notwithstanding the conclusion by our President and Chief Executive Officer and our Chief Financial Officer that our disclosure controls and procedures as of December 31, 2022 were not effective, and notwithstanding the material weaknesses in our internal control over financial reporting described below, management believes that the consolidated financial statements and related financial information included in this Annual Report on Form 10-K fairly present in all material respects our financial condition, results of operations and cash flows as of the dates presented, and for the periods ended on such dates, in conformity with U.S. GAAP.

 

Management’s report on internal control over financial reporting

 

Our management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act). Internal control over financial reporting is a process designed by, or under the supervision of, the Company’s principal executive and financial officers and effected by the Company’s board of directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles and includes those policies and procedures that:

 

●Pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of the assets of the Company;

 

●Provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the Company are being made only in accordance with authorizations of management and directors of the Company; and

 

●Provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the Company’s assets that could have a material effect on the financial statements.

 

37

 

 

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

 

Our President and Chief Executive Officer and our Chief Financial Officer conducted an evaluation of the effectiveness of internal control over financial reporting as of December 31, 2022 based on the criteria set forth in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013) (the “COSO Framework”).

 

A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Company’s annual or interim financial statements will not be prevented or detected on a timely basis.

 

As of December 31, 2022, management has identified the following material weaknesses in internal controls:

 

a)Management did not design effective information technology general controls (ITGCs) relating to appropriate segregation of duties over program change management for certain applications impacting the Company’s business processes that are relevant to the Company’s internal control over financial reporting; and

 

b)Management did not design and implement components of the COSO Framework to address all relevant risks of material misstatement, including elements of the control environment, information and communication, control activities and monitoring activities components, relating to the identification, design, implementation, and monitoring of sufficient business process controls related to the Company’s financial statement accounts to ascertain whether the components of internal control are present and functioning effectively.

 

As a result of the material weaknesses described above, the Company’s management has concluded that, as of December 31, 2022, our internal control over financial reporting was ineffective.

 

Remediation Plan

 

As of the date of this Annual Report on Form 10-K, management is re-assessing the design of controls and modifying processes designed to improve our internal control over financial reporting and remediate the control deficiencies that led to the material weaknesses, including but not limited to (a) improving consistency in change management supported by standard operating procedures to govern the authorization, testing and approval of changes to information technology systems supporting all of the Company’s internal control processes, (b) enhancing design and implementation of our control environment, including the expansion of formal accounting and IT policies and procedures and financial reporting controls, (c) continuing to identify and design and implement effective review and approval controls, and (d) implementing appropriate timely review and oversight responsibilities within the accounting and financial reporting functions.

 

Changes in Internal Controls Over Financial Reporting

 

Except for the determination by management of the material weaknesses in internal controls over financial reporting described above, there have been no other changes in our internal controls over financial reporting that occurred during the year ended December 31, 2022, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

Item 9B. Other Information.

 

None.

 

Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections.

 

Not applicable.

 

38

 

 

PART III

 

Item 10. Directors, Executive Officers and Corporate Governance.

 

For information with respect to the executive officers of the Company, see “Information About Our Executive Officers” included in Part I of this Report, which is incorporated herein by reference. The information required by this item regarding our directors is included under the caption “Proposal One – Election of Directors” in our Proxy Statement for our 2023 Annual Meeting of Stockholders to be filed with the SEC within 120 days after the end of the fiscal year ended December 31, 2022 (the “2023 Proxy Statement”) and is incorporated herein by reference.

 

Information concerning compliance with Section 16(a) of the Exchange Act is included under the caption “Delinquent Section 16(a) Reports” in our 2023 Proxy Statement and is incorporated herein by reference. Information concerning the Audit Committee and the Audit Committee Financial Expert is reported under the caption “Audit Committee; Report of the Audit Committee; Duties and Responsibilities” in our 2023 Proxy Statement and is incorporated herein by reference.

 

Code of Business Conduct and Ethics

 

We have adopted a Code of Business Conduct and Ethics that applies to all our directors, officers (including our principal executive officer and principal financial officer) and employees. We will disclose information pertaining to any amendment to, or waiver from, the provisions of the Code of Business Conduct and Ethics that apply to the Company’s principal executive officer, principal financial officer, principal accounting officer or persons performing similar functions and that relate to any element of the Code of Business Conduct and Ethics enumerated in the SEC rules and regulations by posting this information on the Company’s website, https://www.celsiusholdingsinc.com/. The information on the Company’s website or linked to or from the Company’s website is not incorporated by reference into, and does not constitute a part of, this report or any other documents the Company files with, or furnishes to, the SEC.

 

Item 11. Executive Compensation

 

Information concerning the compensation of our directors and executive officers and Compensation Committee Interlocks and Insider Participation is reported under the captions “Compensation Discussion and Analysis”, “Executive Compensation”, “Director Compensation”, “Compensation Committee Interlocks and Insider Participation” and “Compensation Committee Report,” respectively, in our 2023 Proxy Statement and is incorporated herein by reference.

 

Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

 

Information related to equity compensation plan information will be presented in our 2023 Proxy Statement and is incorporated herein by reference.

 

Information concerning the beneficial ownership of the Company’s common stock by (a) those persons known to the Company to be the beneficial owners of more than 5% of the Company’s common stock; (b) each of the Company’s directors and nominees for director; and (c) the Company’s executive officers and all of the Company’s current directors and executive officers as a group is reported under the caption “Security Ownership of Certain Beneficial Owners and Management” in our 2023 Proxy Statement and is incorporated herein by reference.

 

Item 13. Certain Relationships and Related Transactions and Director Independence.

 

Information concerning certain relationships and related transactions will be reported under the caption “Certain Relationships and Related Transactions and Director Independence” in our 2023 Proxy Statement and is incorporated herein by reference.

 

Item 14. Principal Accountant Fees and Services.

 

Information concerning our accountant fees and our audit committee’s pre-approval of audit and permissible non-audit services of our independent registered public accounting firm is reported under the captions “Fees of Independent Registered Public Accounting Firm” and “Pre-Approval of Audit and Non-Audit Services,” respectively, in our 2023 Proxy Statement and is incorporated herein by reference.

 

39

 

 

Item 15. Financial Statements and Exhibits

 

(a)The following documents are filed as part of this Report:

 

(1)Financial Statements. The following consolidated financial statements and the report of our independent registered public accounting firm are filed as “Item 8. Financial Statements and Supplementary Data” of this Report:

 

Reports of Independent Registered Public Accounting Firms

 

Consolidated Balance Sheets as of December 31, 2022 and 2021

 

Consolidated Statements of Operations and Comprehensive (Loss) Income for the years ended December 31, 2022, 2021 and 2020

 

Consolidated Statements of Changes in Stockholders’ Equity and Mezzanine Equity for the years ended December 31, 2022, 2021 and 2020

 

Consolidated Statements of Cash Flows for the years ended December 31, 2022, 2021 and 2020

 

Notes to Consolidated Financial Statements

 

(2)Financial Statement Schedules.

 

Financial Statement Schedules are omitted because the information required is not applicable or the required information is shown in the financial statements or notes thereto.

 

(3)Exhibits.

 

Item 16. Form 10-K Summary

 

None

 

40

 

 

3.1   Articles of Incorporation of Celsius Holdings, Inc., as amended . (Previously filed as Exhibit 3.1 to the Company’s Form 10-Q dated August 9, 2022 and incorporated herein by reference)
     
3.2   Celsius Holdings, Inc. Certificate of Designation of Series A Convertible Preferred Stock. (Previously filed as Exhibit 3.1 to the Company’s Form 8-K dated August 3, 2022 and incorporated herein by reference)
     
3.3   Amended and Restated Bylaws, as amended. (Previously filed as Exhibit 3.2 to the Company’s Form 10-Q dated August 9, 2022 and incorporated herein by reference)
     
10.1+   Amended 2006 Incentive Stock Plan. (Previously filed as an Exhibit to the Company’s Registration Statement on Form 10 and incorporated herein by reference, Management compensation plan or arrangement)
     
10.2+   2015 Incentive Stock Plan. (Previously filed as an Exhibit to the Company’s Registration Statement on Form 10 and incorporated herein by reference)
     
10.3+   Employment Agreement between the Company and John Fieldly dated August 1, 2020. (Previously filed as an Exhibit to the Company’s Current Report on Form 8-K dated August 4, 2020 and incorporated herein by reference)
     
10.4+   Employment Agreement between the Company and Jarrod Langhans, effective April 18, 2022. (Previously filed as an Exhibit to the Company’s Current Report on Form 8-K dated April 18, 2022 and incorporated herein by reference)
     
10.5   Securities Purchase Agreement, dated August 1, 2022, between PepsiCo, Inc. and Celsius Holdings, Inc. (Previously filed as Exhibit 10.1 to the Company’s Form 10-Q dated August 9, 2022 and incorporated herein by reference)
     
10.6   Form of Lock-Up Agreement. (Previously filed as Exhibit 10.2 to the Company’s Form 10-Q dated August 9, 2022 and incorporated herein by reference)
     
10.7   Registration Rights Agreement, dated August 1, 2022, between PepsiCo, Inc. and Celsius Holdings, Inc. (Previously filed as Exhibit 10.3 to the Company’s Form 10-Q dated August 9, 2022 and incorporated herein by reference)
     
10.8   Distribution Agreement, dated August 1, 2022, between PepsiCo, Inc. and Celsius Holdings, Inc. (Previously filed as Exhibit 10.4 to the Company’s Form 10-Q dated August 9, 2022 and incorporated herein by reference)
     
10.9   Channel Transition Agreement, dated August 1, 2022, between PepsiCo, Inc. and Celsius Holdings, Inc. (Previously filed as Exhibit 10.5 to the Company’s Form 10-Q dated August 9, 2022 and incorporated herein by reference)
     
21.1*   Subsidiaries of Registrant.
     
23.1*   Consent of Ernst & Young LLP
     
23.2*   Consent of Assurance Dimensions, Inc
     
31.1*   Section 302 Certification by Chief Executive Officer
     
31.2*   Section 302 Certification by Chief Financial Officer
     
32.1*   Section 906 Certification by Chief Executive Officer
     
32.2*   Section 906 Certification by Chief Financial Officer

 

41

 

 

101.INS   Inline XBRL Instance Document
     
101.SCH   Inline XBRL Taxonomy Extension Schema Document
     
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document
     
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document
     
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase Document
     
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase Document
     
104   The cover page of this Amendment No. 1 to the Annual Report on Form 10-K for the year ended December 31, 2022, formatted in Inline XBRL (included within the Exhibit 101 attachment)

 

 
* Filed herewith.
+ A management contract or compensatory plan or arrangements required to be filed as exhibits pursuant to Item 15(b) of Form 10-K.

 

42

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

Date: April 18, 2023 CELSIUS HOLDINGS, INC.
   
  By: /s/ John Fieldly
   

John Fieldly, Chief Executive Officer

(Principal executive officer)

 

  By: /s/ Jarrod Langhans
   

Jarrod Langhans, Chief Financial Officer

(Principal financial and accounting officer)

 

In accordance with the Exchange Act, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

 

Signatures   Title(s)   Date
         
/s/ John Fieldly   President, Chief Executive Officer and Director   April 18, 2023
John Fieldly   (Principal executive officer)    
         
/s/ Jarrod Langhans   Chief Financial Officer   April 18, 2023
Jarrod Langhans   (Principal financial and accounting officer)    
         
/s/ Cheryl S. Miller   Director   April 18, 2023
Cheryl S. Miller        
         
/s/ Hal Kravitz   Director   April 18, 2023
Hal Kravitz        
         
/s/ Joyce Russell   Director   April 18, 2023
Joyce Russell        
         
/s/ Damon DeSantis   Director   April 18, 2023
Damon DeSantis        
         
/s/ Nicholas Castaldo   Director   April 18, 2023
Nicholas Castaldo        
         
/s/ Caroline Levy   Director   April 18, 2023
Caroline Levy        
         
/s/ Alexandre Ruberti   Director   April 18, 2023
Alexandre Ruberti        
         
/s/ James Lee   Director   April 18, 2023
James Lee        

 

43

 

 

INDEX TO CONSOLIDATED FINANCIAL STATEMENTS

 

    Page
Reports of Independent Registered Public Accounting Firm Ernst & Young LLP PCAOB ID: 42   F-2
     
Reports of Independent Registered Public Accounting Firm Assurance Dimensions PCAOB ID: 5036   F-6
     
Consolidated Balance Sheets as of December 31, 2022 and 2021   F-8
     
Consolidated Statements of Operations and Comprehensive (Loss) Income for the years ended December 31, 2022, 2021 and 2020   F-9
     
Consolidated Statements of Changes in Stockholders’ Equity and Mezzanine Equity for the years ended December 31, 2022, 2021 and 2020.   F-10
     
Consolidated Statements of Cash Flows for the years ended December 31, 2022, 2021 and 2020.   F-11
     
Notes to Consolidated Financial Statements   F-12

 

F-1

 

 

Report of Independent Registered Public Accounting Firm

 

To the Stockholders and the Board of Directors of Celsius Holdings, Inc.

 

Opinion on Internal Control Over Financial Reporting

 

We have audited Celsius Holdings, Inc.’s internal control over financial reporting as of December 31, 2022, based on criteria established in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) (the COSO criteria). In our opinion, because of the effect of the material weaknesses described below on the achievement of the objectives of the control criteria, Celsius Holdings, Inc. (the Company) has not maintained effective internal control over financial reporting as of December 31, 2022, based on the COSO criteria.

 

A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company’s annual or interim financial statements will not be prevented or detected on a timely basis. The following material weaknesses have been identified and included in management’s assessment. Management has identified material weaknesses relating to:

 

a)the ineffective design of information technology general controls (ITGCs) relating to appropriate segregation of duties over program change management for certain applications impacting the Company’s business processes that are relevant to the Company’s internal control over financial reporting; and

 

b)the Company did not design and implement components of the COSO framework to address all relevant risks of material misstatement, including elements of the control environment, information and communication, control activities and monitoring activities components, relating to the identification, design, implementation, and monitoring of sufficient business process controls related to the Company’s financial statement accounts to ascertain whether the components of internal control are present and functioning effectively.

 

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the 2022 consolidated financial statements of the Company. These material weaknesses were considered in determining the nature, timing and extent of audit tests applied in our audit of the 2022 consolidated financial statements, and this report does not affect our report dated March 1, 2023, which expressed an unqualified opinion thereon.

 

Basis for Opinion

 

The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting included in the accompanying Management’s Annual Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects.

 

Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.

 

F-2

 

 

Definition and Limitations of Internal Control Over Financial Reporting

 

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

 

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

 

/s/ Ernst & Young LLP

 

We have served as the Company’s auditor since 2021.

 

Boca Raton, Florida

March 1, 2023

 

F-3

 

 

Report of Independent Registered Public Accounting Firm

 

The Board of Directors and Stockholders of Celsius Holdings, Inc.

 

Opinion on the Financial Statements

 

We have audited the accompanying consolidated balance sheets of Celsius Holdings, Inc. (the Company) as of December 31, 2022 and 2021, the related consolidated statements of operations and comprehensive (loss) income, statement of changes in stockholders’ equity and mezzanine equity, and cash flows for each of the two years in the period ended December 31, 2022, and the related notes (collectively referred to as the “consolidated financial statements”). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at December 31, 2022 and 2021, and the results of its operations and its cash flows for each of the two years in the period ended December 31, 2022 and 2021, in conformity with U.S. generally accepted accounting principles.

 

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company’s internal control over financial reporting as of December 31, 2022, based on criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) and our report dated March 1, 2023 expressed an adverse opinion thereon.

 

Basis for Opinion

 

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

 

Critical Audit Matter

 

The critical audit matter communicated below is a matter arising from the current period audit of the financial statements that was communicated or required to be communicated to the audit committee and that: (1) relates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of the critical audit matter does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.

 

F-4

 

 

   

Accrued Promotional Allowances

     
Description of the Matter  

As discussed in Notes 2 and 4, the Company’s promotional allowances are calculated based on various programs with its distributors and retail customers, and accruals are established at the time of the initial product sale for the Company’s anticipated liabilities. These accruals are based on agreed-upon terms as well as the Company’s historical experience with similar programs and require management’s judgment with respect to estimating consumer participation and/or distributor and retail customer performance levels. Promotional allowances primarily include consideration given to distributors or retail customers, including, but not limited to, the following: (i) discounts granted off list prices to support price promotions to end consumers by retailers; (ii) reimbursements given to distributors for agreed portions of their promotional spend with retailers, including slotting, shelf space allowances, and other fees for both new and existing products; (iii) agreed share of fees given to distributors and/or directly to retailers for advertising, in-store marketing, and promotional activities; (iv) agreed share of slotting, shelf space allowances, and other fees given directly to retailers, club stores and/or wholesalers; (v) incentives given to distributors and/or retailers for achieving or exceeding certain predetermined volumes; (vi) discounted products; (vii) contractual fees given to distributors related to sales made by the Company directly to certain customers that fall within the distributors’ sales territories; and (viii) contractual fees given to distributors for items sold below defined pricing targets. The promotional programs are of varying durations, typically ranging from one week to one year based on the agreed-upon terms. The promotional expenditures are recorded to the corresponding income statement caption in the period the underlying sale occurs. Total promotional expenditures included as a reduction to revenue were $158.5 million for the year ended December 31, 2022, and accrued promotional allowances were $36.0 million as of December 31, 2022.

     
    We identified accrued promotional allowances as a critical audit matter because of the extent and subjective nature of management judgment required with respect to estimating consumer participation and/or distributor and retail customer performance levels and future promotional claims.
     

How We Addressed the Matter in Our Audit

  

To test the accrued promotional allowances, our audit procedures included, among others, evaluating management’s judgment regarding levels of consumer participation and/or distributor and retail customer performance levels and future promotional claims. We selected a sample of accrued promotional allowances recorded for specific distributors and retail customers and sent confirmation requests of the accrual recorded directly to the distributor or retail customer. We compared the confirmation response to the accrued amount recorded by the Company. In instances of nonreplies to our confirmation request from the distributor or retail customer, we compared subsequent settlements to the accrual. If not settled, we developed an independent expectation of the accrual using historical claim and payment data and compared it to the recorded accrued promotional allowance. We tested the promotional expenditure amount recorded as a reduction to net sales and assessed the reasonableness of management’s estimate by developing an expectation of the amount, based on historical promotional expenditure amounts recorded as a percentage of sales, and compared our expectation to the recorded promotional expenditure amount. We performed inquiries of the Company’s sales and marketing personnel to corroborate our understanding of new and existing promotional programs that may alter the relationship between gross billings and promotional allowances, as such programs are considered by management when estimating future promotional claims. We also evaluated management’s ability to estimate promotional allowances by comparing the actual promotional allowances subsequently paid to the original estimates of management.

 

/s/ Ernst & Young LLP

 

We have served as the Company’s auditor since 2021.

 

Boca Raton, Florida

March 1, 2023

 

F-5

 

 

Text Description automatically generated

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

To the Board of Directors and Stockholders of Celsius Holdings, Inc.

 

Opinion on the Financial Statements

 

We have audited the accompanying consolidated balance sheet of Celsius Holdings, Inc. (the Company) as of December 31, 2020, and the related consolidated statements of income, comprehensive income, stockholders’ equity, and cash flows for the year ended December 31, 2020, and the related notes (collectively referred to as the consolidated financial statements). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2020, and the results of its operations and its cash flows for the year ended December 31, 2020, in conformity with accounting principles generally accepted in the United States of America.

 

Basis for Opinion

 

These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

 

Our audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides a reasonable basis for our opinion.

 

Critical Audit Matters

 

The critical audit matters communicated below are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.

 

F-6

 

 

Collectability of Note Receivable

 

Description of the Matter

 

Effective January 1, 2019, the Company entered into a separate economic agreement for the repayment of its marketing investment in China with Qifeng. Under the repayment agreement, Qifeng agreed to refund the Company over a five-year period. The repayment was formalized via a Note Receivable (“Note”) from Qifeng. The initial outstanding principal under the Note was approximately $12.2 million and was denominated in the Chinese Renminbi (CNY). Installment payments under the Note are due on March 31 each year and the first installment payment on the Note was due March 31, 2020. This payment was delayed and paid in September 2020 due to the COVID 19 pandemic. The next installment payment due March 31, 2021 will be paid via a release of 62,000 shares of Celsius common stock owned by Qifeng. This release will provide sufficient funds to pay the full amount that is due under the second installment payment. Under a separate guarantee agreement the Company will maintain control over 275,079 Celsius common shares which serves as collateral for the payment on the remaining amounts that will become due over the next three-years.

 

We determined based on the fact pattern noted above the long term collectability of the remaining Note balance was as a critical audit matter. The Note is collateralized by the Company’s shares, however we noted that there is volatility relating to the value of the collateral which is based on the share price of the Company’s stock.

 

How We Addressed the Matter in Our Audit

 

The primary procedures we performed to address this critical audit matter included the following: 1. Obtaining and testing for reasonableness of management’s analysis to support the collectability of the remaining Note balance. 2. Obtained, a confirmation from Qifeng of the remaining balance due under the Note as of December 31, 2020 as well as confirming their intent and ability to pay the next installment keeping them current with the agreement. 3. Reviewed a signed guarantee letter from Qifeng over the Company shares that are being used as collateral associated with the remainder of the Note. 4. Obtained the Qifeng account statement from the Company’s transfer agent verifying the number of shares owned by Qifeng. The value of the collateral shares at December 31, 2020 was in excess of the total note receivable balance as of December 31, 2020. Based on the procedures performed and evidence obtained we concluded that no allowance for collectability was required related to the Note as of December 31, 2020.

 

/s/ Assurance Dimensions  
 

We have served as the Company’s auditor from 2017 to 2021

 

Margate, Florida

March 10, 2021

 

F-7

 

 

Celsius Holdings, Inc.

Consolidated Balance Sheets

(in thousands, except par values)

 

           
   December 31,
2022		   December 31,
2021		 
ASSETS          
           
Current assets:          
Cash and cash equivalents  $614,159   $16,255 
Restricted cash   38,768    - 
Accounts receivable-net   63,311    38,741 
Note receivable-current   2,979    2,588 
Inventories-net   173,289    191,222 
Prepaid expenses and other current assets   11,341    13,555 
Deferred other costs-current   14,124    - 
Total current assets  $917,971   $262,361 
           
Note receivable   3,574    7,117 
Property and equipment-net   10,185    3,180 
Deferred tax asset   501    9,019 
Right of use assets-operating leases   972    1,128 
Right of use assets-finance leases   208    86 
Other long-term assets   263    299 
Deferred other costs-non-current   262,462    - 
Intangibles   12,254    16,301 
Goodwill   13,679    14,527 
Total Assets  $1,222,069   $314,018 
           
LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS’ EQUITY          
           
Current liabilities:          
Accounts payable and accrued expenses  $107,340   $72,442 
Accrued distributor termination fees   3,986    - 
Accrued promotional allowance   35,977    19,037 
Lease liability obligation-operating leases   661    512 
Lease liability obligation-finance leases   70    157 
Deferred revenue-current   9,675    - 
Other current liabilities   3,586    976 
Total current liabilities   161,295    93,124 
           
Long-term liabilities:          
Lease liability obligation-operating leases   326    658 
Lease liability obligation-finance leases   162    45 
Deferred tax liability   15,919    3,146 
Deferred revenue-non-current   179,788    - 
Total Liabilities   357,490    96,973 
           
Commitment and contingencies (Note 19)          
           
Mezzanine Equity:          
Series A convertible preferred shares, $0.001 par value, 5% cumulative dividends; 1,467 and 0 shares issued and outstanding at December 31, 2022 and December 31,2021, respectively, aggregate liquidation preference of $550,000 and $0 as of December 31, 2022 and December 31, 2021, respectively   824,488    - 
           
Stockholders’ Equity:          
Common stock, $0.001 par value; 100,000 shares authorized, 76,382 and 74,909 shares issued and outstanding at December 31, 2022 and December 31, 2021, respectively   76    75 
Additional paid-in capital   280,668    267,846 
Accumulated other comprehensive (loss) income   (1,881)   614 
Accumulated deficit   (238,772)   (51,490)
Total Stockholders’ Equity   40,091    217,045 
Total Liabilities, Mezzanine Equity and Stockholders’ Equity  $1,222,069   $314,018 

 

The accompanying notes are an integral part of these consolidated financial statements

 

F-8

 

 

Celsius Holdings, Inc.

Consolidated Statements of Operations and Comprehensive (Loss) Income

(in thousands, except per share amounts)

 

                
   For the years ended
December 31,		 
   2022   2021   2020 
Revenue  $653,604   $314,272   $130,726 
Cost of revenue   382,735    186,103    69,752 
Gross profit   270,869    128,169    60,974 
                
Selling and marketing expenses   352,767    74,739    34,875 
General and administrative expenses   75,903    57,520    18,187 
Total operating expense   428,670    132,259    53,062 
                
(Loss) income from operations   (157,801)   (4,090)   7,912 
                
Other Income/(Expense):               
Interest income on note receivable   237    315    356 
Interest income (expense), net   5,292    (8)   (66)
Interest expense on bonds   -    -    (432)
Amortization of discount on bonds payable   -    -    (576)
Gain on lease cancellations   -    -    152 
Foreign exchange (loss) gain   (392)   (276)   1,376 
European deferred tax   -    -    (82)
Total other income   5,137    31    728 
                
Net (loss) income before income taxes   (152,664)   (4,059)   8,640 
                
Income tax (expense) benefit   (34,618)   7,996    (116)
                
Net (loss) income  $(187,282)  $3,937   $8,524 
                
Less: dividends on Series A convertible preferred shares  $(11,526)  $-   $- 
Net (loss) income attributed to common stockholders  $(198,808)  $3,937   $8,524 
                
Other comprehensive income:               
Foreign currency translation (loss) gain   (2,495)   817    551 
Comprehensive (loss) income  $(201,303)  $4,754   $9,075 
                
(Loss) income per share:               
Basic  $(2.63)  $0.05   $0.12 
Dilutive  $(2.63)  $0.05   $0.11 
Weighted average shares outstanding:               
Basic   75,649    73,781    70,195 
Dilutive   75,649    77,689    74,444 

 

The accompanying notes are an integral part of these consolidated financial statements

 

F-9

 

 

Celsius Holdings, Inc.

Consolidated Statements of Changes in Stockholders’ Equity and Mezzanine Equity

(in thousands)

 

                                         
   Stockholders’ Equity   Mezzanine Equity 
   Common Stock   Additional
Paid-In		   Accumulated
Other-
Comprehensive		   Accumulated   Total
Stockholders’		   Preferred       
   Shares   Amount   Capital   Income (Loss)   Deficit   Equity   Shares   Amount 
Balance at December 31, 2019   68,941   $69   $127,553   $(754)  $(63,409)  $63,459   $-   $- 
                                         
Issuance of common stock from private placement   1,438    1    21,891    -    -    21,892    -    - 
Share-based expense   -    -    6,340    -    -    6,340    -    - 
Issuance of common stock pursuant to exercise of stock options - Cashless   568    1    (1)   -    -    -    -    - 
Issuance of common stock pursuant to exercise of stock options - Cash   1,316    1    4,125    -    -    4,126    -    - 
Cash paid for taxes on restricted stock awards   -    -    (115)   -    (542)   (657)   -    - 
Foreign currency translation   -    -    -    551    -    551    -    - 
Short swing payment   -    -    91    -    -    91    -    - 
Net income   -    -    -    -    8,524    8,524    -    - 
Balance at December 31, 2020   72,263    72   $159,884   $(203)  $(55,427)  $104,326    -   $- 
                                         
Issuance of common stock   1,134    1    67,768    -    -    67,769    -    - 
Share-based expense   -    -    36,475    -    -    36,475    -    - 
Issuance of common stock pursuant to exercise of stock options - Cashless   540    1    -    -    -    1    -    - 
Issuance of common stock pursuant to exercise of stock options - Cash   972    1    3,719    -    -    3,720    -    - 
Foreign currency translation   -    -    -    817    -    817    -    - 
Net income   -    -    -    -    3,937    3,937    -    - 
Balance at December 31, 2021   74,909    75    267,846    614    (51,490)   217,045    -    - 
                                         
Share-based expense   -    -    20,665    -    -    20,665    -    - 
Issuance of common stock pursuant to exercise of stock options - Cashless   448    -    -    -    -    -    -    - 
Issuance of common stock pursuant to exercise of stock options - Cash   1,025    1    3,683    -    -    3,684    -    - 
Issuance of Series A convertible preferred shares - net of issuance costs   -    -    -    -    -    -    1,467    824,488 
Dividends paid to Series A convertible preferred shares   -    -    (11,526)        -    (11,526)   -      
Foreign currency translation   -    -    -    (2,495)   -    (2,495)   -    - 
Net loss   -    -    -    -    (187,282)   (187,282)   -    - 
Balance at December 31, 2022   76,382    76    280,668    (1,881)   (238,772)   40,091    1,467    824,488 

 

The accompanying notes are an integral part of these consolidated financial statements

 

F-10

 

 

Celsius Holdings, Inc.

Consolidated Statements of Cash Flows

(in thousands)

 

                
   For the years ended
December 31,		 
   2022   2021   2020 
Cash flows from operating activities:               
Net (loss) income  $(187,282)  $3,937   $8,524 
Adjustments to reconcile net (loss) income to net cash (used in)/provided by operating activities:               
Depreciation   1,362    550    127 
Amortization   555    714    1,484 
Impairment of intangible assets   2,379    -    - 
Bad debt expense   2,352    1,494    257 
Amortization of deferred other costs   5,885    -    - 
Inventory excess and obsolescence   6,131    2,355    748 
Share-based payment expense   20,665    36,475    6,340 
Deferred income taxes   20,244    (9,201)   - 
Foreign exchange loss (gain)   483    880    (323)
Gain on lease cancellations   -    (28)   (152)
Changes in operating assets and liabilities:               
Accounts receivable-net   (26,369)   (25,249)   (7,469)
Inventory-net   11,802    (175,174)   (3,859)
Prepaid expenses and other current assets   2,214    1,072    (10,457)
Accounts payable and accrued expenses   34,908    51,807    4,743 
Accrued promotional allowance   16,940    13,379    3,377 
Accrued distributor termination fees   3,986    -    - 
Other assets   37    -    - 
Other current liabilities   2,610    374    (96)
Change in right of use and lease obligation-net   (183)   29    151 
Deferred revenue   189,463    -    - 
Net cash provided by (used in) operating activities   108,182    (96,586)   3,395 
                
Cash flows from investing activities:               
Proceeds from note receivable   2,592    1,886    1,331 
Purchase of property and equipment   (8,264)   (3,150)   (574)
Net cash (used in) provided by in investing activities   (5,672)   (1,264)   757 
                
Cash flows from financing activities:               
Payments on bonds payable   -    -    (9,602)
Principal payments on finance lease obligations   (63)   (94)   (280)
Proceeds from exercise of stock options   3,683    3,720    4,127 
Cash paid on taxes on restricted stock awards   -    -    (657)
Proceeds from issuance of Series A preferred shares, net of issuance costs   542,018    -    - 
Dividends paid on preferred shares   (11,526)   -    - 
Net proceeds from collection of section 16b short swing profit   -    -    91 
Net proceeds from sale of common stock   -    67,769    21,892 
Net cash provided by financing activities   534,112    71,395    15,571 
                
Effect on exchange rate changes on cash and cash equivalents   50    (538)   434 
Net increase (decrease) in cash, cash equivalents and restricted cash   636,672    (26,993)   20,157 
Cash, cash equivalents and restricted cash at beginning of the period   16,255    43,248    23,091 
                
Cash, cash equivalents and restricted cash at end of the period  $652,927   $16,255   $43,248 
                
Supplemental disclosures:               
Cash paid during period for:               
Taxes  $14,335   $-   $- 
Interest  $-   $7   $448 
European Acquisition Adjustment:               
Goodwill  $-   $-   $396 
Other liabilities  $-   $-   $(396)

 

The accompanying notes are an integral part of these consolidated financial statements

 

F-11

 

 

1.ORGANIZATION AND DESCRIPTION OF BUSINESS

 

Business — Celsius Holdings, Inc. (the “Company” or “Celsius Holdings”) was incorporated under the laws of the State of Nevada on April 26, 2005. On January 24, 2007, the Company entered into a merger agreement and plan of reorganization with Elite FX, Inc., a Florida corporation. Under the terms of the Merger Agreement, Elite FX, Inc. was merged into the Company’s subsidiary, Celsius, Inc. and became a wholly-owned subsidiary of the Company on January 26, 2007. In addition, on March 28, 2007 the Company established Celsius Netshipments, Inc. a Florida corporation as a subsidiary of the Company.

 

On February 7, 2018, the Company established Celsius Asia Holdings Limited, a Hong Kong corporation, as a wholly-owned subsidiary of the Company. On February 7, 2018 Celsius China Holdings Limited, a Hong Kong corporation, became a wholly-owned subsidiary of Celsius Asia Holdings Limited and on May 9, 2018, Celsius Asia Holdings Limited established Celsius (Beijing) Beverage Limited, a China corporation, as a wholly-owned subsidiary of Celsius Asia Holdings Limited.

 

On October 25, 2019, the Company acquired 100% of Func Food Group, Oyj (“Func Food”). The Acquisition was structured as a purchase of all of Func Food’s equity shares and a restructuring of Func Food’s pre-existing debt. Func Food was the Nordic distributor for the Company since 2015. Func Food is a marketer and distributor of nutritional supplements, health food products, and beverages.

 

On August 1, 2022 (“Effective Date”), the Company and PepsiCo Inc. (“Pepsi”), entered into multiple agreements, including a Securities Purchase Agreement (“Purchase Agreement”), Lock-Up Agreements, Registration Rights Agreement, a distribution agreement (“Distribution Agreement”), and a Channel Transition Agreement (“Transition Agreement”). The Securities Purchase Agreement, Lock-Up Agreements and Registration Rights Agreement pertain to the Company’s issuance of 1,466,666 shares of Series A Convertible Preferred Stock (“Series A” or “Series A Preferred Stock”) in exchange for cash proceeds of $550 million, excluding transaction costs. The Transition Agreement specifies payments to be made by Pepsi to Celsius for transitioning certain existing distribution rights to Pepsi. The Distribution Agreement resulted in Pepsi becoming the Company’s primary distribution supplier for the Company’s products in the United States. See Note 13. Related Party Transactions and Note 14. Mezzanine Equity for more information.

 

In connection with the Distribution Agreement and Transition Agreement, the Company terminated agreements with existing suppliers to transition territory rights to Pepsi. The Company recognized total termination expenses of $193.8 million, which are presented in Sales and marketing expenses on the consolidated statement of operations and comprehensive (loss) income for the year ended December 31, 2022. These expenses were recognized by the Company upon delivery of termination notices to the other distributors, in accordance with ASC Topic 420 Exit or Disposal Cost Obligations.

 

The Company is engaged in the development, marketing, sale and distribution of “functional” calorie-burning functional energy drinks and liquid supplements under the Celsius® brand name.

 

F-12

 

 

2.BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation — The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) and the rules and regulations of the SEC.

 

Consolidation Policy — The accompanying consolidated financial statements include the accounts of Celsius Holdings, Inc. and its subsidiaries. All inter-company balances and transactions have been eliminated in consolidation.

 

Significant Estimates — The preparation of consolidated financial statements and accompanying disclosures in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue and expenses and disclosure of contingent assets and liabilities at the date of the financial statements. Although these estimates are based on management’s best knowledge of current events and actions that the Company may undertake in the future, actual results may differ from those estimates. Significant estimates include the allowance for doubtful accounts, allowance for inventory obsolescence and sales returns, preferred share valuation, the useful lives of property and equipment, impairment of goodwill and intangibles, deferred tax asset valuation allowance, promotional allowance, and valuation of stock-based compensation. Additionally, the business and economic uncertainty resulting from the novel coronavirus (COVID-19) pandemic has made such estimates and assumptions more difficult to calculate. Accordingly, actual results and outcomes could differ from those estimates.

 

Segment Reporting — Operating segments are defined as components of an enterprise that engage in business activities, have discrete financial information, and whose operating results are regularly reviewed by the chief operating decision maker (“CODM”) to make decisions about allocating resources and to assess performance. Even though the Company has operations in several geographies, it operates as a single enterprise. The Company’s operations and strategies are centrally designed and executed given that our geographical components are very similar. Our CODM, the CEO, reviews operating results primarily from a consolidated perspective, and makes decisions and allocates resources based on that review. The reason the Company’s CODM focuses on consolidated results in making decisions and allocating resources is because of the significant economic interdependencies between the Company’s geographical operations and the Company’s U.S. entity.

 

Concentrations of Risk — Substantially all of the Company’s revenue derives from the sale of Celsius ® functional energy drinks and liquid supplements.

 

Pepsi and the Company signed a distribution agreement on August 1, 2022, resulting in Pepsi acting as the Company’s preferred distributor performing the direct store delivery for a majority of the Company’s U.S. operations.

 

Revenue of our customers accounting for more than 10%, for the years ended December 31, 2022, 2021 and 2020, are as follows:

 

               
   2022   2021   2020 
Pepsi   22.2%   -    - 
Costco   16.7%   12.7%   2.9%
Amazon   8.8%   10.1%   15.1%
All other   52.3%   77.2%   82.0%
Total   100.0%   100.0%   100.0%

 

F-13

 

 

Accounts receivable of our customers accounting for more than 10%, for the years ended December 31, 2022, and 2021, are as follows:

 

           
   2022   2021 
Pepsi   47.6%   - 
Amazon   11.8%   22.7%
Publix   1.4%   10.3%
All other   39.2%   67.0%
Total   100.0%   100.0%

 

Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable. The Company places its cash and cash equivalents with high-quality financial institutions. At times, balances in the Company’s cash accounts may exceed the Federal Deposit Insurance Corporation limit. At December 31, 2022 and 2021, the Company had approximately $652.4 million and $16.0 million, respectively, including $38.8 million in restricted cash for 2022, in excess of the Federal Deposit Insurance Corporation limit.

 

Cash and Cash Equivalents — The Company considers all highly liquid instruments with an original maturity of three months or less when purchased to be cash equivalents.

 

Restricted Cash — As disclosed in Note 4. Revenues, the Company received upfront payments from Pepsi during 2022, which are contractually restricted and can only be used to satisfy termination payments due to former distributors or have to be repaid to Pepsi. These upfront payments received from Pepsi cannot be used for general operating activities of the Company and have been classified as restricted cash based on the terms of the Transition Agreement.

 

Accounts Receivable — Accounts receivable are reported at net realizable value. The Company establishes an allowance for doubtful accounts based upon factors pertaining to the credit risk of specific customers, historical trends, and other information. Delinquent accounts are written-off when it is determined that the amounts are uncollectible. Accounts receivable are presented net of billbacks, for customers that are allowed the right to net settle. At December 31, 2022 and December 31, 2021, there was an allowance for doubtful accounts of approximately $2.1 million and $0.8 million, respectively.

 

Inventories — Inventories are valued at the lower of cost or net realizable value. Cost is determined using the first-in, first-out (FIFO) method. At December 31, 2022 and December 31, 2021, the Company recorded an allowance of approximately $8.4 million and $2.6 million respectively. The changes in the allowance are included in cost of revenue.

 

Property and Equipment — Property and equipment are stated at cost less accumulated depreciation and amortization. Depreciation of property and equipment is calculated using the straight-line method over the estimated useful life of the asset generally ranging from three to seven years.

 

Impairment of Long-Lived Assets — In accordance with ASC Topic 360, Property, Plant, and Equipment the Company reviews the carrying value of long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. An impairment loss is determined regarding a long-lived asset if its carrying amount is not recoverable and exceeds its fair value. The carrying amount is not recoverable when it exceeds the sum of the undiscounted cash flows expected to result from use of the asset over its remaining useful life and final disposition. The Company did not record any impairments related to long lived assets during the years ended December 31, 2022 and December 31, 2021.

 

F-14

 

 

Long-lived Asset Geographic Data

 

The following table contains long-lived asset information which includes property and equipment and lease right of use assets and excludes goodwill and intangibles, where individual countries represent a material portion of the total:

 

          
   December 31,   December 31, 
   2022   2021 
United States  $9,750   $3,043 
Sweden   1,251    1,050 
Finland   363    301 
Other   1    - 
Long-lived assets related to foreign operations   1,615    1,351 
Total long-lived assets-net  $11,365   $4,394 

 

Goodwill — The Company records goodwill when the consideration paid for the acquisition of a business exceeds the fair value of net tangible and intangible assets acquired, including related tax effects. Goodwill is not amortized; instead, goodwill is tested for impairment on an annual basis as of October 1st, or more frequently if the Company believes indicators of impairment exist. The Company first assesses qualitative factors such as macro-economic conditions, industry and market conditions, and cost factors as well as other relevant events, to determine whether it is more-likely-than-not that the fair value of a reporting unit is less than its carrying value. If it is more likely than not that the fair value of a reporting unit is less than its carrying value, then the Company will calculate the estimated fair value of the reporting unit. If the Company determines that the fair value is less than the carrying value, the Company will recognize an impairment charge based on the excess of a reporting unit’s carrying value over its fair value. At December 31, 2022, there were no indicators of impairment.

 

Intangible assets— Intangible assets are comprised of customer relationships and brands acquired in a business combination. The Company amortizes intangible assets with a definitive life over their respective useful lives. The addition of the Pepsi distribution network has shifted the Company’s focus to the US market and as a consequence it was determined that impairment indicators for the Func Foods brands indefinite intangible asset were present. The Company no longer anticipates focusing on the expansion of Func Food branded products and the Company plans to focus on Celsius branded products. As a result of the strategic shift, which the Company considered a triggering event, the Company quantitatively tested the Func Foods brand name for impairment utilizing the relief from royalty method to determine fair value as of September 30, 2022. As a result of the quantitative assessment, the Company recorded an impairment charge of $2.5 million during the year ended December 31, 2022 which is presented within General and Administrative expenses on the Consolidated Statements of Operations.

 

Revenue Recognition — The Company recognizes revenue in accordance with ASC Topic 606 Revenue from Contracts with Customers. The Company recognizes revenue when performance obligations under the terms of a contract with the customer are satisfied. Product sales occur once control or title is transferred based on the commercial terms. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring goods. Product sales are recorded net of variable consideration, such as provisions for returns, discounts and promotional allowances. Such provisions are calculated using historical averages and adjusted for any expected changes due to current business conditions. Consideration given to customers for cooperative advertising is recognized as a reduction of revenue except to the extent that there is a distinct good or service, in which case the expense is classified as selling or marketing expense. The amount of consideration the Company receives and revenue the Company recognizes varies with changes in customer incentives the Company offers to its customers and their customers. Additionally, for any agreements which are one year or less, the practical expedient under ASC 340-40-25-4 is applied to expense contract acquisition costs when incurred if the amortization period of the contract asset would have otherwise been recognized in one year or less. Sales taxes and other similar taxes are excluded from revenue. Management believes that adequate provision has been made for cash discounts, returns, spoilage and promotional allowances based on the Company’s historical experience.

 

F-15

 

 

Deferred Revenue — The Company receives payments from certain distributors in new territories as reimbursement for contract termination costs paid to the prior distributors in those territories. Amounts received pursuant to these new and/or amended distribution agreements entered into with certain distributors relating to the costs associated with terminating the Company’s prior distributors, are accounted for as deferred revenue and recognized ratably over the anticipated life of the respective new distribution agreements. As of December 31, 2022, the Company had approximately $189.5 million in deferred revenue, of which $179.8 million is classified as deferred revenue-non-current and $9.7 million is classified as deferred revenue-current which are presented within the consolidated balance sheets and are contract liabilities related to termination payments received from Pepsi. Refer to Note 13, Related Party Transactions for more information. The deferred revenues will be recognized by the Company, ratably over the twenty-year agreement term. As of December 31, 2021, the Company did not have any deferred revenue related to contract liabilities.

 

Accrued Distributor Termination Fees — Termination charges related to certain of the Company’s prior distributors are included in selling and marketing expenses upon termination. The Company recognized distributor termination expenses of approximately $193.8 million, $0.6 million, and $0.2 million for the year ended December 31, 2022, 2021, and 2020, respectively. The Company also has a balance of $4.0 million in accrued distributor termination fees related to distributors terminated as a result of the Pepsi agreement as well as payment due back to Pepsi in the amount of $34.8 million as the projected payments to the prior distributors was less than the payment received from Pepsi, which are located within accounts payable and accrued expenses, on the Company’s consolidated balance sheets.

 

Customer Advances — From time to time the Company requires deposits in advance of delivery of products and/or production runs. Such amounts are initially recorded as customer advances liability within other current liabilities. The Company recognizes such revenue as it is earned in accordance with revenue recognition policies. As of December 31, 2022 and 2021, the Company did not have any customer advances.

 

Advertising Costs — Advertising costs are expensed as incurred. The Company uses mainly radio, local sampling events, sponsorships, endorsements, and digital advertising. The Company incurred advertising expenses of approximately $85.1 million, $36.7 million and $14.2 million, during years ended December 31, 2022, 2021, and 2020, respectively.

 

Research and Development — Research and development costs are charged to general and administrative expenses as incurred and consist primarily of consulting fees, raw material usage and test productions of beverages. The Company incurred expenses of approximately $0.4 million, $1.0 million and $0.5 million during years ended December 31, 2022, 2021, and 2020, respectively.

 

Foreign Currency Gain/Losses — Foreign subsidiaries’ functional currency is the local currency of operations and the net assets of foreign operations are translated into U.S. dollars using current exchange rates. The foreign subsidiaries perform re-measurements of their assets and liabilities denominated in non-functional currencies on a periodic basis and the gain or losses from these adjustments are included in the consolidated statement of operations and comprehensive (loss) income as foreign exchange gains or losses. For the year ended December 31, 2022 exchange losses have amounted to approximately $0.4 million while during the years ended December 31, 2021 and 2020, the Company recognized a foreign currency loss and gain of approximately $0.3 million and $1.4 million, respectively, mainly related to fluctuations in exchange rates. Translation gains and losses that arise from the translation of net assets from functional currency to the reporting currency, as well as exchange gains and losses on intercompany balances of long-term investment nature, are included in Other Comprehensive Income. The Company incurred foreign currency translation net loss during the year ended December 31, 2022 of approximately $2.5 million and a net gain of approximately $0.8 million and $0.6 million during the year ended December 31, 2021 and 2020. The Company’s operations in different countries required that it transacts in the following currencies:

 

Chinese-Yuan

Norwegian-Krone

Swedish-Krona

Finland-Euro

 

F-16

 

 

Fair Value of Financial Instruments — The carrying value of cash, cash equivalents, restricted cash, accounts receivable, accounts payable, accrued expenses and other current liabilities approximate fair value due to their relative short-term maturity and market interest rates.

 

Income Taxes — The Company accounts for income taxes pursuant to the provisions of ASC Topic 740 Accounting for Income Taxes, which requires, among other things, an asset and liability approach to calculating deferred income taxes. The asset and liability approach require the recognition of deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the carrying amounts and the tax bases of assets and liabilities. A valuation allowance is provided to offset any net deferred tax assets for which management believes it is more likely than not that the net deferred asset will not be realized. The Company follows the provisions of the ASC 740-10 related to Accounting for Uncertain Income Tax Positions. When tax returns are filed, it is highly certain that some positions taken would be sustained upon examination by the taxing authorities, while others are subject to uncertainty about the merits of the position taken or the amount of the position that would be ultimately sustained. In accordance with the guidance of ASC 740-10, the benefit of a tax position is recognized in the financial statements in the period during which, based on all available evidence, management believes it is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any.

 

Tax positions taken are not offset or aggregated with other positions. Tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with the applicable taxing authority. The portion of the benefits associated with tax positions taken that exceeds the amount measured as described above is reflected as a liability for uncertain tax benefits in the accompanying consolidated balance sheet, along with any associated interest and penalties that would be payable to the taxing authorities upon examination.

 

The Company has adopted ASC 740-10-25 Definition of Settlement, which provides guidance on how an entity should determine whether a tax position is effectively settled for the purpose of recognizing previously unrecognized tax benefits and provides that a tax position can be effectively settled upon the completion of an examination by a taxing authority without being legally extinguished. For tax positions considered effectively settled, an entity would recognize the full amount of tax benefit, even if the tax position is not considered more likely than not to be sustained based solely on the basis of its technical merits and the statute of limitations remains open.

 

The Company’s tax returns for tax years in 2019 through 2021 remain subject to potential examination by the taxing authorities.

 

Earnings per Share — The Company computes earnings per share in accordance with ASC Topic 260 Earnings per Share (“ASC 260”), which requires earnings per share (“EPS”) for each class of stock (common stock and participating preferred stock) to be calculated using the two-class method. The two-class method is an allocation of earnings (distributed and undistributed) between the holders of common stock and a company’s participating security holders. Under the two-class method, earnings for the reporting period are allocated between common stockholders and other security holders based on their respective participation rights in undistributed earnings.

 

Basic earnings per common share is computed by dividing income or loss available to common stockholders by the weighted average number of shares of basic common stock outstanding. The Company’s Series A Convertible Preferred Stock is classified as a participating security in accordance with ASC 260. Net income allocated to the holders of Series A Convertible Preferred Stock will be calculated based on the stockholders’ proportionate share of weighted average shares of common stock outstanding on an if-converted basis. See Note 3. Earnings Per Share for more information.

 

Share-Based Payments — The Company follows the provisions of ASC Topic 718 Compensation — Stock Compensation and related interpretations. As such, compensation cost is measured on the date of grant at the fair value of the share-based payments. Such compensation amounts, if any, are amortized over the respective vesting periods of the grants. On April 30, 2015, the Company adopted the 2015 Stock Incentive Plan (the “2015 Plan”). This 2015 Plan is intended to provide incentives which will attract and retain highly competent persons at all levels as employees of the Company, as well as independent contractors providing consulting or advisory services to the Company, by providing them opportunities to acquire the Company’s common stock. The 2015 Plan permits the grant of options and other share-based awards for up to 5.0 million shares. Provisions have been made to permit the grant of options and other share-based awards for up to 5.0 million shares.

 

F-17

 

 

Cost of Revenue — Cost of Revenue consists of the cost of concentrates and or liquid bases, the costs of raw materials utilized in the manufacture of products, co-packing fees, repacking fees, in-bound & out-bound freight charges, as well as certain internal transfer costs, warehouse expenses incurred prior to the manufacture of the Company’s finished products, inventory allowance for excess and obsolete products, and certain quality control costs. Raw materials account for the largest portion of the cost of sales. Raw materials include cans, other containers, flavors, ingredients and packaging materials.

 

Operating Expenses — Operating expenses include selling expenses such as warehousing expenses after manufacture, as well as expenses for advertising, samplings and in-store demonstrations costs, costs for merchandise displays, point-of-sale materials and premium items, sponsorship expenses, other marketing expenses and design expenses. Operating expenses also include such costs as payroll costs, travel costs, professional service fees (including legal fees), depreciation and other general and administrative costs.

 

Shipping and Handling Costs — Shipping and handling costs for freight expense on goods shipped are included in cost of sales. Freight expense on goods shipped for the years ended December 31, 2022, 2021 and 2020 was approximately $26.8 million, $26.9 million and $9.5 million, respectively.

 

Certain reclassification of prior period balances have been made to conform to current presentation. Please refer to consolidated balance sheets, Consolidated Statement of Cash Flows and Note 11. Accounts Payable and Accrued Expenses

 

Recent Accounting Pronouncements

 

The Company adopts all applicable, new accounting pronouncements as of the specified effective dates.

 

In September 2016, the FASB issued ASU No. 2016-13, Financial Instruments – Credit Losses (Topic 326) (“ASU 2016-13”), which requires the immediate recognition of management’s estimates of current and expected credit losses. In November 2019, the FASB issued ASU 2019-10, which delays the effective date of Topic 326 for Smaller Reporting Companies to interim and annual periods beginning after December 15, 2022, with early adoption permitted. The Company has elected the relief provided. Topic 326 is effective for the Company in the first quarter of 2023. Adoption of the new standard is not expected to have a material impact on our consolidated financial statements or disclosures.

 

Liquidity — These financial statements have been prepared assuming the Company will be able to continue as a going concern. At December 31, 2022, the Company had an accumulated deficit of approximately $238.8 million which includes a net loss available to common stockholders of approximately $198.8 million for year ended December 31, 2022. During the year ended December 31, 2022 the Company’s net cash provided by operating activities totaled approximately $108.2 million. As of December 31, 2021, the Company had an accumulated deficit of $51.5 million which includes a net income available to common stockholders of $3.9 million for year ended December 31, 2021. During the year ended December 31, 2021 the Company’s net cash used by operating activities totaled approximately $96.6 million.

 

If our sales volumes do not meet our projections, expenses exceed our expectations, or our plans change, we may be unable to generate enough cash flow from operations to cover our working capital requirements. In such case, we may be required to adjust our business plan, by reducing marketing, lower our working capital requirements and reduce other expenses or seek additional financing. Furthermore, our business and results of operations may be adversely affected by changes in the global macro-economic environment related to the pandemic and public health crises related to the COVID-19 outbreak.

 

F-18

 

 

3.EARNINGS PER SHARE

 

The Company computes earnings per share in accordance with ASC Topic 260 Earnings per Share (“ASC 260”), which requires earnings per share for each class of stock (common stock and participating preferred stock) to be calculated using the two-class method. The two-class method is an allocation of earnings (distributed and undistributed) between the holders of common stock and a company’s participating security holders. Under the two-class method, earnings for the reporting period are allocated between common stockholders and other security holders based on their respective participation rights in undistributed earnings.

 

Basic earnings per common share is computed by dividing income or loss available to common stockholders by the weighted average number of shares of basic common stock outstanding. The Company’s Series A Convertible Preferred Stock is classified as a participating security in accordance with ASC 260. Net income allocated to the holders of Series A Convertible Preferred Stock consistent of preferred dividends declared and paid during 2022. The Series A Convertible Preferred Stock do not participate in losses, thus no such losses have been allocated to the Series A Convertible Preferred Stock in the periods presented below.

 

For purposes of determining diluted earnings per common share, basic earnings per common share was further adjusted to include the effect of potential dilutive common shares outstanding, including unvested restricted stock and performance-based stock units, using the more dilutive of either the two-class method or the treasury stock method, and Series A Convertible Preferred Stock using the if-converted method. Stock options and warrants that were out-of-the-money were not included in the denominator for the calculation of diluted EPS. Under the two-class method of calculating diluted earnings per share, net income is reallocated to common stock, the Series A Convertible Preferred Stock, and all dilutive securities based on the contractual participating rights of the security to share in the current earnings as if all of the earnings for the period had been distributed.

 

               
  

For the years ended

December 31,

 
   2022   2021   2020 
Net (loss) income attributed to common stockholders               
Net (loss) income  $(187,282)  $3,937   $8,524 
Less: dividends paid to Series A convertible preferred stockholders   (11,526)   -    - 
Net (loss) income attributed to common stockholders  $(198,808)  $3,937   $8,524 
Net (loss) income per common share:               
Basic  $(2.63)  $0.05   $0.12 
Dilutive  $(2.63)  $0.05   $0.11 
Weighted average common stock outstanding:               
Basic   75,649    73,781    70,195 
Dilutive   75,649    77,689    74,444 

 

For the year ended December 31, 2022, 10.2 million of potentially dilutive securities were excluded from the computation of diluted net loss per share related to common stockholders as their effect was antidilutive.

 

F-19

 

 

4.REVENUE

 

The Company recognizes revenue in accordance with ASC Topic 606 Revenue from Contracts with Customers. The Company recognizes revenue when performance obligations under the terms of a contract with the customer are satisfied. Product sales occur once control is transferred, based on the commercial terms. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring goods. Product sales are recorded net of variable consideration, such as provisions for returns, discounts and allowances. Such provisions are calculated using historical averages and adjusted for any expected changes due to current business conditions. Consideration given to customers for cooperative advertising is recognized as a reduction of revenue except to the extent that there is a distinct good or service, in which case the expense is classified as selling or marketing expense. The amount of consideration the Company receives and revenue the Company recognizes varies with changes in customer incentives the Company offers to its customers and their customers. Additionally, for any agreements which are one year or less, the practical expedient under ASC 340-40-25-4 is applied to expense contract acquisition costs when incurred if the amortization period of the contract asset would have otherwise been recognized in one year or less.

 

Promotional (Billback) Allowance

 

The Company’s billback allowance programs with its distributors and/or retailers are executed through separate agreements in the ordinary course of business. These agreements generally provide for one or more of the arrangements described above and are of varying durations, typically ranging from one week to one year. The Company’s billbacks are calculated based on various programs with distributors and retail customers, and accruals are established for the Company’s anticipated liabilities. These accruals are based on agreed upon terms as well as the Company’s historical experience with similar programs and require management’s judgment with respect to estimating consumer participation and/or distributor and retail customer performance levels. Differences between such estimated expenses and actual expenses for promotional and other allowance costs have historically been insignificant and are recognized in earnings in the period such differences are determined.

 

Billbacks (variable consideration) recorded as a reduction to net sales, primarily include consideration given to the Company’s distributors or retail customers including, but not limited to the following:

 

●discounts granted off list prices to support price promotions to end-consumers by retailers;

 

●reimbursements given to the Company’s distributors for agreed portions of their promotional spend with retailers, including slotting, shelf space allowances and other fees for both new and existing products;

 

●the Company’s agreed share of fees given to distributors and/or directly to retailers for advertising, in-store marketing and promotional activities;

 

●the Company’s agreed share of slotting, shelf space allowances and other fees given directly to retailers, club stores and/or wholesalers;

 

●incentives given to the Company’s distributors and/or retailers for achieving or exceeding certain predetermined volume goals;

 

●discounted products;

 

●contractual fees given to the Company’s distributors related to sales made directly by the Company to certain customers that fall within the distributors’ sales territories; and

 

●contractual fees given to distributors for items sold below defined pricing targets.

 

For the years ended December 31, 2022, 2021, and 2020, promotional allowance included as a reduction of revenue were $158.5 million, $64.2 million, and $28.7 million, respectively.

 

F-20

 

 

Information about the Company’s net sales by geographical location for the years ended December 31, 2022, 2021 and 2020 is as follows:

 

               
   For the years ended 
   December 31,
2022		   December 31,
2021		   December 31,
2020		 
North America  $617,457   $273,005   $95,480 
Europe   31,054    38,097    33,727 
Asia   3,647    2,538    1,093 
Other   1,446    632    426 
Net sales  $653,604   $314,272   $130,726 

 

All of the Company’s North America revenue is derived from the United States, which is the Company’s country of domicile. Of the Company’s total foreign revenues of approximately $36.1 million, $41.3 million and $35.2 million for the years ended December 31, 2022, 2021, and 2020, respectively, Sweden represented the largest foreign portion of total consolidated revenue of approximately $21.7 million, $26.9 million, and $23.4 million for the years ended December 31, 2022, 2021, and 2020, respectively.

 

Agreements with PepsiCo, Inc.

 

The Company executed multiple agreements with Pepsi on August 1, 2022, including a Distribution Agreement relating to the sale and distribution of certain of the Company’s beverage products in existing channels and distribution methods in the United States, excluding certain existing customer accounts, sales channels, Puerto Rico and the US Virgin Islands (the “Territory”). Under the Distribution Agreement, the Company has granted Pepsi the right to sell and distribute its existing beverage products in existing channels and distribution methods and future beverage products that are added from time to time as licensed products under the Distribution Agreement in defined territories. The Distribution Agreement represents a master service agreement and can be cancelled by either party without cause in the nineteenth year of the term (i.e., 2041), the twenty-ninth year of the term (i.e., 2051) and each ten (10) year period thereafter (i.e., 2061, 2071, etc.) by providing twelve (12) months’ written notice on August 1st of each such year to the other party. Except for a termination by the Company “with cause” or a termination by Pepsi “without cause”, the Company is required to pay the Purchaser certain compensation upon a termination as specified in the Distribution Agreement.

 

The Company agreed to provide Pepsi a right of first offer in the event the Company intends to (i) manufacture, distribute or sell products in certain additional countries as specified in the Distribution Agreement or (ii) distribute or sell products in any future channels and distribution methods during the term of the Agreement. Additionally, pursuant to the Distribution Agreement, the Company and Pepsi agreed to use commercially reasonable efforts to negotiate and execute with Pepsi a distribution agreement reasonably consistent with the Distribution Agreement for the sale and distribution of the products covered by the Distribution Agreement in Canada, and Pepsi agreed to meet and confer in good faith with the Company regarding the terms and conditions upon which Pepsi may be willing to sell or distribute such products, either directly or through local sub-distributors in certain other additional countries. The Distribution Agreement includes other customary provisions, including non-competition covenants in favor of the Company, representations and warranties, indemnification provisions, insurance provisions and confidentiality provisions.

 

On August 1, 2022, the Company and Pepsi also executed the Transition Agreement, providing for the Company’s transition of certain existing distribution rights in the Territory to Pepsi. Under the terms of the Transition Agreement, Pepsi would pay the Company up to $250 million in multiple tranches to facilitate the Company’s transition of certain distribution rights to Pepsi. Amounts received from Pepsi were contractually restricted to only be used to pay termination fees due to other distributors; any excess cash received over amounts due to other distributors is to be refunded back to Pepsi. During 2022, the Company received $227.8 million in payments from Pepsi. As of December 31, 2022, the Company had recorded $193.8 million in total termination expenses in Selling and marketing expenses, of which $193.0 million in termination expenses are related to the Pepsi transition.

 

F-21

 

 

Accounting for the agreements executed with PepsiCo, Inc.

 

The Company evaluated the Security Purchase Agreement, Transition Agreement, Distribution Agreement, and other agreements executed with Pepsi on August 1, 2022, as one combined contract since the agreements were executed on the same day, with the same counterparty, in contemplation of one another and contractual terms are defined and referenced across the agreements. These agreements will be referred to as the “Pepsi Arrangement” herein. Management concluded the Pepsi Arrangement was partially in the scope of ASC 606 Revenue from Contracts with Customers (“ASC 606”) and partially in the scopes of ASC 505, Equity (“ASC 505”) and ASC 480, Distinguishing liabilities from equity (“ASC 480”). The Company first applied the measurement and classification criteria in ASC 505 and ASC 480 with respect to the Company’s issuance of 1,446,666 shares of Series A Convertible Preferred Stock, as the substance of the issuance of the Series A Convertible Preferred Stock was determined to be a financing transaction. See Note 14. Mezzanine Equity for the Company’s accounting conclusions with respect to the issuance of the Series A Convertible Preferred Stock.

 

After application of the measurement and classification principles in ASC 505, and ASC 480, the Company accounted for the residual revenue elements of the Pepsi Arrangement under ASC 606. The revenue elements of the Pepsi Arrangement consisted of (i) $227.8 million in payments received from Pepsi under the Transition Agreement and (ii) a $282.5 million implicit payment made to Pepsi by Celsius, representing the excess fair value over issuance proceeds received for the Series A Convertible Preferred Stock.

 

The $227.8 million upfront payment received from Pepsi was only to be used by Celsius to transition territory rights from terminated distributors to Pepsi; any excess cash received from Pepsi over transition payments made by Celsius to the Company’s terminated distributors was contractually restricted and due back to Pepsi. As of December 31, 2022, the Company has recorded a refund liability of $34.8 million in accounts payable and accrued expenses representing cash refunds due back to Pepsi and recognized the difference of $193.0 million as part of deferred revenues. The deferred revenues will be recognized by Celsius ratably over the twenty-year agreement term. The Company recognized $4.2 million of total deferred revenues in the consolidated statement of separations in the year ended December 31, 2022.

 

The $282.5 million excess fair value over issuance proceeds of the Series A Convertible Preferred Stock represents an implicit payment made to a customer. The Company concluded that this implicit payment meets the definition of an asset, and has been recorded as a Deferred Other Cost current and non-current, in the Company’s consolidated balance sheets. The Company will amortize the asset balance as contra-revenues ratably over a twenty-year period consistent with the term of the Distribution Agreement. The Company recognized contra-revenues of $5.9 million in the consolidated statement of operations and comprehensive (loss) income in the year ended December 31, 2022 related to the upfront payment included in Deferred Other Cost current and non-current. The Company will assess the Deferred Other Cost asset for impairment at each reporting period.

 

For product sales under the Distribution Agreement, the Company will recognize revenues when control of the underlying goods are transferred to Pepsi based on the contractual terms of noncancellable purchase orders issued by Pepsi.

 

License Agreement

 

In January 2019, the Company entered into a license and repayment of investment agreement with Qifeng Food Technology (Beijing) Co., Ltd (“Qifeng”). Under the agreement, Qifeng was granted the exclusive license rights to manufacture, market and commercialize Celsius branded products in China. The term of the agreement is 50 years, with annual royalty fees due from Qifeng after the end of each calendar year. The royalty fees are based on a percentage of Qifeng’s sales of Celsius branded products; however, the fees are fixed for the first five years of the agreement, totaling approximately $6.9 million, and then are subject to annual guaranteed minimums over the remaining term of the agreement.

 

Under the agreement, the Company grants Qifeng exclusive license rights and provides ongoing support in product development, brand promotion and technical expertise. The ongoing support is integral to the exclusive license rights and, as such, both of these represent a combined, single performance obligation. The transaction price consists of the guaranteed minimums and the variable royalty fees, all of which are allocated to the single performance obligation.

 

The Company recognizes revenue from the agreement over time because the customer simultaneously receives and consumes the benefits from the services. The Company uses the passage of time to measure progress towards satisfying its performance obligation because of its ongoing efforts in providing the exclusive license rights including providing continuous access, updates and support. Total revenue recognized under the agreement was approximately $2.0 million, $1.6 million, and $0.8 million for the year ended December 31, 2022, 2021, and 2020 which is reflected in the revenues from Asia.

 

F-22

 

 

5.INVENTORIES

 

Inventories consist of the following at:

 

          
   December 31,   December 31, 
   2022   2021 
Finished goods  $119,229   $123,594 
Raw Materials   62,491    70,201 
Less: Inventory reserve   (8,431)   (2,573)
Inventories  $173,289   $191,222 

 

6.PREPAID EXPENSES AND OTHER CURRENT ASSETS

 

Prepaid expenses and other current assets total approximately $11.3 million and $13.6 million, at December 31, 2022 and 2021, respectively, and consist mainly of prepaid advances to co-packers related to inventory production, advertising, prepaid insurance, prepaid slotting fees, value added tax payments and deposits on purchases.

 

7.NOTE RECEIVABLE

 

Note receivable consists of the following at:

 

          
   December 31,   December 31, 
   2022   2021 
Note Receivable-current  $2,979   $2,588 
Note Receivable-non-current   3,574    7,117 
Total Note Receivable  $6,553   $9,705 

 

Effective January 1, 2019, the Company restructured its China distribution efforts by entering into two separate economic agreements as it relates to the commercialization of its Celsius products (i.e., the license and repayment of investment agreement with Qifeng, as described above). See Note 4 for information regarding the license agreement with Qifeng. Under a separate economic agreement, Qifeng will repay the marketing investments made by Celsius into the China market through 2018, over the same five-year period as the license agreement. The repayment, which was formalized via a note receivable from Qifeng (the “Note”), will need to be serviced even if the licensing agreement is cancelled or terminated. The Note is denominated in Chinese-Yuan.

 

The Note accrues interest at a rate per annum equal to the weighted average of 5% of the outstanding principal up to $5 million and 2% of the outstanding principal above $5 million. On June 12, 2020, it was agreed to fix the interest rate at 3.21% which reflected the weighted average interest rate for the 5-year period of the Note. Scheduled principal payments plus accrued interest for the Note are due annually on March 31 of each year starting in 2020. For the year ended December 31, 2022, 2021, and 2020, interest income for the Note was approximately $0.2 million, $0.3 million, and $0.4 million respectively.

 

The Company assesses the note receivable for impairment at each reporting period, by evaluating whether it is probable that the Company will be unable to collect all the contractual principal and interest payments as scheduled in the Note, based on historical experience of Qifeng’s ability to pay, the current economic environment and other factors. If the Note is determined to be impaired, the impairment is measured based on the present value of the expected future cash flows under the Note, discounted at the Note’s effective interest rate. At December 31, 2022 and 2021, the Note was not deemed to be impaired. As of December 31, 2022, Qifeng is current on all amounts due under the Note and the license agreement.

 

As evidence of solvency for the Note, a stock certificate in Celsius Holding’s Inc. which amounts to 30.0 thousand of shares owned by an affiliate under common control of Qifeng is being held at a brokerage account. A letter of guarantee was executed with several restrictions regarding their shares. In particular, it was agreed that the stock would not be sold or transferred without the prior written consent from Celsius. There are other restrictions and agreements, which include that a statement of account will be provided to Celsius on a quarterly basis to confirm and validate the existence of the remaining shares. The shares serve as one component of management’s consideration when evaluating impairment indicators.

 

F-23

 

 

8.LEASES

 

The Company’s leasing activities include an operating lease of its corporate office space from a related party (see Note 13) and other operating and finance leases of vehicles and office space for the Company’s European operations.

 

At the inception of a contract, the Company assesses whether the contract is, or contains, a lease. The Company’s assessment is based on: (1) whether the contract involves the use of a distinct identified asset, (2) whether the Company obtains the right to substantially all the economic benefit from the use of the asset throughout the term, and (3) whether the Company has the right to direct the use of the asset. The Company allocates the consideration in the contract to each lease and non-lease component based on the component’s relative stand-alone price to determine the lease payments. Lease and non-lease components are accounted for separately.

 

Leases are classified as either finance leases or operating leases based on criteria in ASC Topic 842 Leases. The Company’s operating leases are generally comprised of real estate and vehicles, and the Company’s finance leases are generally comprised of vehicles.

 

At lease commencement, the Company records a lease liability equal to the present value of the remaining lease payments, discounted using the rate implicit in the lease or, if that rate cannot be readily determined, the Company’s incremental borrowing rate. A corresponding right-of-use asset (“ROU asset”) is recorded, measured based on the initial measurement of the lease liability. ROU assets also include any lease payments made and exclude lease incentives. Lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option.

 

Lease expense for operating leases is recognized on a straight-line basis over the lease term and is included in general and administrative expenses. Included in lease expense are any variable lease payments incurred in the period that were not included in the initial lease liability. Lease expense for finance leases consists of the amortization of the ROU asset on a straight-line basis over the shorter of the useful life of the asset or the lease term, and interest expense is calculated using the effective interest rate method.

 

The future annual minimum lease payments required under the Company’s leases as of December 31, 2022 are as follows:

 

               
   Operating   Finance     
Future minimum lease payments  Leases   Leases   Total 
2023  $698   $76   $774 
2024   328    39    367 
2025   7    67    74 
2026   -    64    64 
Total future minimum lease payments   1,033    246    1,279 
Less: Amount representing interest   (46)   (14)   (60)
Present value of lease liabilities   987    232    1,219 
Less: current portion   (661)   (70)   (731)
Long-term portion  $326   $162   $488 

 

9.PROPERTY AND EQUIPMENT

 

Property and equipment consist of the following at:

 

             
   Estimated Useful   December 31,   December 31, 
   Life in Years  2022   2021 
Merchandising equipment - coolers  5-7  $9,885   $3,052 
Office equipment  3-7   1,124    891 
Vehicles  5   1,257    304 
Less: accumulated depreciation      (2,081)   (1,067)
Total     $10,185   $3,180 

 

Depreciation expense amounted to approximately $1.4 million, $0.6 million, and $0.1 million during years ended December 31, 2022, 2021, and 2020, respectively.

 

F-24

 

 

10.GOODWILL AND INTANGIBLES

 

At December 31, 2022, goodwill consists of approximately $13.7 million resulting from the excess of the consideration paid and the fair value of net tangible and intangible assets acquired from the Func Food acquisition.

 

Intangible assets consist of acquired customer relationships and brands from the Func Food acquisition. The gross carrying amount and accumulated amortization of intangible assets were as follows as of December 31, 2022 and December 31, 2021:

 

          
   December 31,   December 31, 
   2022   2021 
Definite-lived intangible assets          
Customer relationships  $13,418   $14,248 
Less: accumulated amortization   (1,610)   (1,140)
Definite-lived intangible assets, net  $11,808   $13,108 
           
Indefinite-lived intangible assets          
Brands  $2,984   $3,193 
Less: Impairment   (2,538)   - 
Indefinite-lived intangible assets, net  $446   $3,193 
Total Intangibles  $12,254   $16,301 

 

Customer relationships are amortized over an estimated useful life of 25 years and brands have an indefinite life. Amortization expense for the years ended December 31, 2022, 2021, and 2020 was approximately $0.5 million, $0.6 million, and $0.6 million, respectively and is reflected in general and administrative expenses. See note 2. Basis of Presentation and Summary of Significant Accounting Policies, for more information regarding our indefinite-lived intangible asset, Brands.

 

Other fluctuations in the amounts of intangible assets are due to currency translation adjustments.

 

The following is the future estimated amortization expense related to customer relationships as of December 31, 2022:

 

     
Years ending December 31,    
2023  $537 
2024   537 
2025   537 
2026   537 
2027   537 
Thereafter   9,123 
Total  $11,808 

 

F-25

 

 

11.ACCOUNTS PAYABLE AND ACCRUED EXPENSES

 

Accounts payable and accrued expenses consist of the following at:

 

          
   December 31,   December 31, 
   2022   2021 
Accounts payable  $36,248   $35,820 
Due to Pepsi   34,807    - 
Accrued freight   8,532    15,872 
Accrued expenses   19,081    15,311 
Unbilled purchases   8,672    5,439 
Total  $107,340   $72,442 

 

12.OTHER CURRENT LIABILITIES

 

Other current liabilities consist of the following at:

 

          
   December 31,   December 31, 
   2022   2021 
Short-term          
VAT payable  $198   $- 
State Beverage Container Deposit   3,388    976 
Total  $3,586   $976 

 

F-26

 

 

13.RELATED PARTY TRANSACTIONS

 

Transactions with PepsiCo, Inc.

 

As further described in Note 14 Mezzanine Equity, on August 1, 2022, the Company issued 1,466,666 shares of non-voting Series A Convertible Preferred stock (“Series A”) to Pepsi. On an as-converted basis the Series A held by Pepsi accounts for approximately 8.5% of the Company’s outstanding Common Stock, both on the date of issuance and as of December 31, 2022. Also, as discussed Note 14, the Securities Purchase Agreement entered into on August 1, 2022 (the “Purchase Agreement”) granted Pepsi the right to designate a nominee for election to the Company’s nine-member board of directors, so long as Pepsi meets certain ownership requirements with respect to the Company’s stock. During the year ended December 31, 2022, a Pepsi executive was nominated by Pepsi and elected to the Company’s board of directors.

 

Based on Pepsi’s contractual representation rights for a seat on the Company’s Board of Directors, the Company has concluded that Pepsi represents a related party to the Company. As of and for the year ended December 31, 2022, the following transactions were recognized in the Company’s financial statements:

 

●Net sales to Pepsi amounted to $142.3 million for the year ended December 31, 2022 and are included in Revenue on the accompanying consolidated statement of operations and comprehensive (loss) income.

 

●Accounts receivable due from Pepsi on December 31, 2022, were $31.6 million and are included in Accounts receivable, net on the Company’s consolidated balance sheets.

 

●Pepsi paid the Company $227.8 million in cash in 2022 under the Transition Agreement. This amount was restricted and used to pay termination fees owed by the Company to terminated distributors. The Company has recorded deferred revenues of $189.5 million, which is presented net of $4.2 million of revenue recognized at December 31, 2022, and a liability payable due to Pepsi of $34.8 million, representing refund liabilities owed to Pepsi under the Transition Agreement which are included in Accounts payable and accrued expenses on the accompanying consolidated balance sheets as of December 31, 2022. The $34.8 million represents the excess of payments received from Pepsi less amounts paid and expected to be paid to terminated distributors.

 

●The issuance of Series A to Pepsi was recorded at fair value, determined to be $832.5 million, on August 1, 2022. Cash proceeds from the issuance of Series A received from Pepsi were $550.0 million. See Note 14 for more information.

 

●The Company has recorded a $282.5 million asset as Deferred other costs, representing the excess of the $832.5 million fair value of the Series A Preferred Stock over the issuance proceeds of $550.0 million. Amounts representing the unamortized deferred other costs of $14.1 million and $262.5 million are presented in Deferred other costs-current and Deferred other costs-non-current, respectively, net of $5.9 million of accumulated amortization recognized as an offset to Revenue in the accompanying consolidated statement of operations and comprehensive (loss) income and consolidated balance sheets as of and for the year ended December 31, 2022.

 

See Notes 1. Organization and Description of Business, 2. Basis of Presentation Significant Accounting Policies, 11. Accounts Payable and Accrued Expenses, and 14. Mezzanine Equity for more information.

 

Related Party Leases

 

The Company’s office is rented from a company affiliated with CD Financial, LLC which is controlled by one of our major stockholders. The lease extends until December 2024 with a monthly rent of $37.6 thousand.

 

F-27

 

 

14.MEZZANINE EQUITY

 

Series A Convertible Preferred Stock

 

As of December 31, 2022, Company has designated and authorized 1,466,666 shares of Series A Convertible Preferred Stock with a par value of $0.001 per share and a stated value of $375 per share. The stated value per share may be increased from time-to-time in the event dividends on the Series A are paid-in-kind (“PIK dividends”) pursuant to the Series A Certification of Designation (the “Series A Certificate”). On August 1, 2022, pursuant to the Purchase Agreement, the Company issued 1,466,666 shares of Series A, representing 100% of the authorized Series A shares, to Pepsi for stated cash consideration aggregating $550 million, excluding issuance costs. The Series A was issued concurrently with the execution of Distribution Agreement and the Transition Agreement. The Company determined that the aggregate fair value of the Series A on the issuance date was $832.5 million, or approximately $568 per share. Accordingly, the Series A Convertible Preferred Stock was recorded at that amount, net of issuance costs of $8.0 million, in the Company’s consolidated balance sheets and statement of changes in stockholders’ equity and mezzanine equity.

 

Mezzanine Classification

 

The Series A Convertible Preferred Stock is redeemable in the event of a change in control as defined in the Series A Certificate. S99-3A(2) of the SEC’s Accounting Series Release No. 268 (“ASR 268”) requires preferred securities that are redeemable for cash or other assets to be classified outside of permanent equity if they are redeemable (i) at a fixed or determinable price on a fixed or determinable date, (ii) at the option of the holder, or (iii) upon the occurrence of an event that is not solely within the control of the issuer. Preferred securities that are mandatorily redeemable are required to be classified by the issuer as liabilities whereas under ASR 268 guidance an issuer should classify a preferred security whose redemption is contingent on an event not entirely in control of the issuer as mezzanine equity. The Series A is not mandatorily redeemable, however, a change in control is not solely in control of the Company, accordingly, the Company determined that mezzanine treatment is appropriate for the Series A and has presented it as such in our consolidated balance sheets and statement of changes in stockholders’ equity and mezzanine equity, as of and for the year ending December 31, 2022.

 

Pursuant to the Purchase Agreement, Pepsi, together with its affiliates, has certain rights and is also subject to various restrictions with respect to the Company’s outstanding common shares on an as-converted basis through purchases of the Company’s Common Stock in the open market and the accumulation of PIK dividends. Additionally, pursuant to the Purchase Agreement, Pepsi has the right to designate one nominee for election to Company’s board of directors, for so long as Pepsi (together with its affiliates) beneficially owns at least 3,666,665 shares of the Company’s outstanding Common Stock on an as-converted basis. In August of 2022, the Company expanded the number of seats from eight to nine in connection with the election of a Pepsi representative to the Company’s board of directors.

 

Liquidation Preference

 

The Series A ranks, with respect to distribution rights and rights on liquidation, winding-up and dissolution, (i) senior and in priority of payment to the Company’s Common Stock, (ii) on parity with any class or series of capital stock of the Company expressly designated as ranking on parity with the Series A, and (iii) junior to any class or series of capital stock of the Company expressly designated as ranking senior to the Series A. The aggregate liquidation preference of the Series A is $550.0 million on December 31, 2022.

 

Voting

 

The Series A confers no voting rights, except as otherwise required by applicable law, and with respect to matters that adversely change the powers, preferences, privileges, rights or restrictions given to the Series A or provided for its benefit, or would result in securities that would be senior to or pari passu with the Series A. As described above, Pepsi does have a contractual right to representation on the Company’s Board of Directors, subject to certain share holdings thresholds.

 

F-28

 

 

Dividends

 

The Series A entitles the holder to cumulative dividends, which are payable quarterly in arrears either in cash, in-kind, or a combination thereof, at the Company’s election. Regular Series A Dividends accrue on each share Series A at the rate of 5.00% per annum, subject to adjustment as set forth in the Series A Certificate. In addition to such quarterly Regular Series A Dividends, shares of Series A also entitle the holder participate in any dividends paid on the Company’s Common Stock on an as-converted basis. During the year ended December 31, 2022, the Company declared and paid $11.5 million in Regular Series A Dividends, which amounted to $7.86 per share of Series A. There are no cumulative undeclared dividends on the Series A at December 31, 2022. In addition, there were no dividends issued to common stockholders as of the years ended December 31, 2022 and 2021.

 

Redemption

 

Pursuant to certain conditions set forth in the Series A Certificate, Series A may be redeemed at a price per share of Series A equal to the sum of (i) the stated value of such share of Series A as of the applicable Redemption Date, plus (ii) without duplication, all accrued and unpaid dividends previously added to the stated value of such share of Series A, and all accrued and unpaid dividends per share of Series A through such Redemption Date (the “Redemption Price”).

 

Company’s Optional Redemption

 

At any time from and after the earlier of (i) August 1, 2029, if the ten-day volume weighted average price of the Company’s Common Stock (the “Ten-Day VWAP”) does not exceed the conversion price on the date immediately prior to the date the Company delivers a redemption notice to the holders, and (ii) the cancellation of the Distribution Agreement by the Company, if the Ten-Day VWAP does not exceed the Conversion Price on the date immediately prior to the date the Company delivers a redemption notice to the holders, the Company shall have the right to redeem all (and not less than all) of the then-outstanding shares of Series A, at the Redemption Price. In the event of a Company optional redemption, the Company shall affect such redemption by paying the entire Redemption Price on or before the date that is thirty days after the delivery of the Company’s redemption notice and by redeeming all the shares of Series A on such date.

 

Change in Control Redemption

 

In the event of (i) a sale or transfer, directly or indirectly, of all or substantially all of the assets of the Company in any transaction or series of related transactions (other than sales in the ordinary course of business); or (ii) any merger, consolidation or reorganization of the Company with or into any other entity or entities as a result of which the holders of the Company’s outstanding capital stock (on a fully-diluted basis) immediately prior to the merger, consolidation or reorganization no longer represent at least a majority of the voting power of the surviving or resulting Company or other entity; or (iii) any sale or series of sales, directly or indirectly, beneficially or of record, of shares of the Company’s capital stock by the holders thereof which results in any Person or group of Affiliated Persons owning capital stock holding more than 50% of the voting power of the Company (a “Change in Control”) the Company (or its successor) shall redeem all (and not less than all) of the then-issued and outstanding shares of Series A. Upon such redemption, the Company will pay or deliver, as applicable, to each holder in respect of each share of Series A held by such holder, an amount equal to the greater of (A) cash in an amount equal to the Redemption Price and (B) the amount of cash and/or other assets (including securities) such holder would have received had each share of Series A held by such holder as of the close of business on the business day immediately prior to the effective date of such transaction resulting in a Change of Control, converted into a number of shares of Common Stock equal to the then-applicable Conversion Ratio and participated in such transaction resulting in such Change of Control as a holder of shares of Common Stock (such greater amount, the “Change of Control Redemption Price”). If, in connection with a transaction resulting in a Change of Control, the Company or its successor shall not have sufficient funds legally available under the Nevada law governing distributions to stockholders to redeem all outstanding shares of Series A, then the Company shall (A) redeem, pro rata among the holders, a number of shares of Series A equal to the number of shares of Series A that can be redeemed with the maximum amount legally available for the redemption of such shares of Series A under the Nevada law governing distributions to stockholders, and (B) redeem all remaining shares of Series A not redeemed because of the foregoing limitations at the applicable Change of Control Redemption Price as soon as practicable after the Company (or its successor) is able to make such redemption out of assets legally available for the purchase of such share of Series A. The inability of the Company (or its successor) to make a redemption payment for any reason shall not relieve the Company (or its successor) from its obligation to affect any required redemption when, as and if permitted by applicable law.

 

F-29

 

 

Holder Right to Request Redemption

 

On each of August 1, 2029, August 1, 2032, and the August 1, 2035, the majority holders shall have the right, upon no less than six months prior written notice to the Company, to request that the Company redeem all (and not less than all) of the then-outstanding shares of Series A, at the Redemption Price.

 

In the event of a holder optional redemption, the Redemption Price shall be payable, and the shares of Series A redeemed by the Company, in three equal installments, commencing on August 1, 2029, August 1, 2032, or August 1, 2035, as applicable, and in each case on the fifteenth- and thirtieth-month anniversary thereafter (each a “Redemption Date”). On each Redemption Date for a holder optional redemption, the Company shall redeem, on a pro rata basis in accordance with the number of shares of Series A owned by each holder, that number of outstanding shares of Series A determined by dividing (i) the total number of shares of Series A outstanding immediately prior to such Redemption Date by (ii) the number of remaining Redemption Dates (including the Redemption Date to which such calculation applies). If, on any Redemption Date, Nevada law governing distributions to stockholders or the terms of any indebtedness of the Company to banks and other financial institutions engaged in the business of lending money prevent the Company from redeeming all share of Series A to be redeemed, the Company shall ratably redeem the maximum number of shares that it may redeem consistent with such law, and shall redeem the remaining shares as soon as it may lawfully do so under such law.

 

If any shares of Series A scheduled for redemption on a Redemption Date are not redeemed for any reason on such Redemption Date, (x) from such Redemption Date until the fifteen-month anniversary of such Redemption Date, the dividend rate with respect to such unredeemed share of Series A shall automatically increase to 8% per annum, (y) from such fifteenth-month anniversary of such Redemption Date until the thirtieth-month anniversary of such Redemption Date, the dividend rate with respect to such unredeemed share of Series A shall automatically increase to 10% per annum and (z) from and after such thirtieth-month anniversary of such Redemption Date, the dividend rate with respect to any such unredeemed share of Series A shall automatically increase to 12% per annum, in each case until such share is duly redeemed or converted.

 

Conversion

 

The shares of Series A may be converted into shares of the Company’s Common Stock pursuant to the Series A Certificate either at the option of the Company or subject to an automatic conversion as discussed below. The Series A was issued with a conversion price of $75 which is potentially subject to adjustment pursuant to the Series A Certificate. The Conversion Ratio is calculated as the quotient of (a) the sum of (x) the stated value of such share of Series A as of the applicable conversion date, plus (y) of all accrued and unpaid dividends previously added to the stated value of such share of Series A, and without duplication, all accrued and unpaid dividends per share of Series A through the applicable conversion date; divided by (b) the conversion Price as of the conversion date. As of December 31, 2022, the conversion ratio of the Series A into common was 1 to 5. At December 31, 2022, 7,333,330 shares of the Company’s Common Stock are issuable upon conversion of the Series A Convertible Preferred Stock.

 

The calculations of earnings per share for all periods presented herein during which the Series A was outstanding do not treat conversion of the Series A as if it had occurred, as the effect of conversion would be anti-dilutive.

 

Company Optional Conversion

 

At any time from and after August 1, 2029, provided the Ten-Day VWAP immediately prior to the date the Company delivers a conversion notice to the holders of Series A exceeds the Conversion Price, the Company may elect to convert all, but not less than all, of the outstanding shares of Series A into shares of the Company’s Common Stock.

 

F-30

 

 

Automatic Conversion

 

The Series A will convert automatically into shares of the Company’s Common Stock upon the occurrence of any of the following, each, an “Automatic Conversion Event”:

 

●Any date from and after the valid termination of the Distribution Agreement by the Company or Pepsi, if the Ten-Day VWAP immediately preceding such date exceeds the Conversion Price of such share as of such date.

 

●Any date from and after August 1, 2028, on which (x) the Company’s products meet a market share requirement during a specified period (as defined in the Distribution Agreement) and (y) the Ten-Day VWAP immediately prior to such date exceeds the Conversion Price of such share as of such date. In the case of an automatic conversion, each share of Series A then outstanding shall be converted into the number of shares of Common Stock equal to the Conversion Ratio of such share in effect as of the automatic conversion date. The occurrence of an Automatic Conversion Event will terminate any right of the holder to receive a redemption at their request even if such request has already been submitted, provided that the Series A shares have not already been redeemed.

 

As of December 31, 2022, the Series A is not probable of becoming redeemable as the most likely method of settlement is through conversion which is likely to occur before the holder right to request redemption becomes exercisable.

 

Other Accounting Matters

 

The Company has adopted Accounting Standards Update 2020-06 (“ASU 2020-06”), effective January 1, 2022. The provisions of ASU 2020-06 prohibit the recognition of a beneficial conversion feature (“BCF”) on preferred shares issued after the adoption of the ASU. The Company adopted ASU 2020-06d for the Preferred Series A for the year ended December 31, 2022.

 

FASB ASC 815 generally requires an analysis of embedded terms and features that have characteristics of derivatives to be evaluated for bifurcation and separate accounting in instances where their economic risks and characteristics are not clearly and closely related to the risks of the host contract. We performed an evaluation and determined the Series A and the host instrument is more akin to equity. The Company identified certain embedded redemption and conversion features which it evaluated for bifurcation and determined no bifurcation of these embedded or conversion features was required.

 

F-31

 

 

15.STOCKHOLDERS’ EQUITY

 

Issuance of common stock pursuant to incentive stock plan exercises

 

During the year ended December 31, 2022, the Company issued an aggregate of approximately 1.5 million shares of its common stock pursuant to the exercise of stock options granted under the 2015 Plan. The Company received aggregate proceeds of $3.7 million for approximately 1.0 million options exercised for cash, with the balance of the options having been exercised on a “cashless” basis.

 

During the year ended December 31, 2021, the Company issued an aggregate of approximately 1.5 million shares of its common stock pursuant to the exercise of stock options granted under the 2015 Plan and 2006 Incentive Plan (collectively, the “Stock Incentive Plans”). The Company received aggregate proceeds of $3.7 million for approximately 1.0 million options exercised for cash, with the balance of the grants having been exercised on a “cashless” basis.

 

During the year ended December 31, 2020, the Company issued an aggregate of approximately 1.9 million shares of its common stock pursuant to the exercise of stock options granted under the Company’s Stock Incentive Plans. The Company received aggregate proceeds of $4.1 million for approximately 1.3 million options exercised for cash, with the balance of the options having been exercised on a “cashless” basis.

 

June 2021 Public Offering

 

On June 9, 2021, the Company and certain selling stockholders (the “Selling Stockholders”) entered into an underwriting agreement (the “Underwriting Agreement”) with UBS Securities LLC and Jefferies LLC, as representatives (the “Representatives”) of the several underwriters (the “Underwriters”), relating to the sale of 6,518,267 shares of common stock, par value $0.001 per share, of the Company at a public offering price of $62.50 per share less underwriting discounts and commissions in a registered public offering (the “Offering”). The Company and certain Selling Stockholders also granted the Underwriters an option, exercisable for 30 days, to purchase up to an additional 977,740 shares of its common stock. The Underwriters partially exercised their option to purchase 873,141 shares of the Company’s common stock on June 11, 2021; 1,133,953 of which were sold by the Company and 739,188 of which were sold by certain of the Selling Stockholders. The Offering closed on June 14, 2021. The Company issued and sold 1,133,953 shares of common stock, and the Selling Stockholders sold 6,257,455 shares, in the aggregate, of common stock in the Offering. The Offering generated net proceeds for the Company of $67,769,386 and net proceeds for the Selling Stockholders of $375,447,300. The Company intends to use the proceeds for general corporate purposes. The Company did not receive any proceeds from the sale of shares by the Selling Stockholders.

 

F-32

 

 

16.FAIR VALUE MEASUREMENTS

 

ASC 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Additionally, ASC 820 requires the use of valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs. These inputs are prioritized below:

 

  Level 1: Observable inputs such as quoted market prices in active markets for identical assets or liabilities.
     
  Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data.
     
  Level 3: Unobservable inputs for which there is little or no market data, which require the use of the reporting entity’s own assumptions.

 

The Company engaged a third-party valuation provider to assist in determining the fair value of the 1,466,666 shares of Series A Convertible Preferred Stock issued on August 1, 2022. The Series A Convertible Preferred Stock is classified in mezzanine equity, see Note 14, Mezzanine Equity, and the valuation of the Series A Convertible Preferred Stock represents a non-recurring fair value measurement. We used a Monte Carlo simulation model to determine the fair value of the Series A Convertible Preferred Stock on August 1, 2022. The Monte Carlo simulation utilized multiple input variables to determine the value of the Series A Convertible Preferred Stock including a volatility rate of 45%, risk free interest rate of 2.69%, 5.0% dividend rate, the closing price of the Company’s common stock on the issuance date of $98.87, a debt discount rate of 12.5% and a discount for lack of marketability attributed to the registration period of the underlying stock. The selected historical volatility was based on Celsius and a certain peer group. The risk-free interest rate was based on the US STRIPS Rate with a corresponding term as of issuance date. The 5.0% dividend rate is consistent with the provisions of the Series A Convertible Preferred Stock and with the Company’s past payments made in cash. The debt discount rate was based on estimated credit analysis and corresponding market yields as of the issuance date. The Company applied a nominal discount for lack of marketability with respect to the assumed registration period of the underlying shares.

 

The Company used the relief from royalty method model to determine the fair value of the Brand Name during the year ended December 31, 2022. The fundamental concept underlying this method is that in lieu of ownership, the acquirer can obtain comparable rights to use the subject asset via a license from a hypothetical third-party owner. The Relief from Royalty method utilized multiple input variables to determine the value of the Brand Name including forecasted sales, discount rate, and royalty rates. The selected royalty rate was based on comparable brands. The debt discount rate was based on an expected debt and equity rate of return as of September 30, 2022.

 

The following is a tabular presentation of the non-recurring fair value measurement along with the level within the fair value hierarchy at December 31, 2022:

 

               
   December 31, 2022 
   Level 1   Level 2   Level 3 
Mezzanine equity:               
Series A convertible preferred shares  $-   $824,488   $- 
Indefinite-lived intangible assets:               
Brands   -    -    446 
Total  $-   $824,488   $446 

 

Other than those noted in previous notes, the Company did not have any other non-recurring assets or liabilities measured at fair value at December 31, 2022 and 2021.

 

F-33

 

 

17.INCOME TAXES

 

The domestic and foreign components of the Company’s income before provision for income taxes are as follows:

 

               
   2022   2021   2020 
Domestic  $(151,551)  $(4,176)  $8,111 
Foreign   (1,113)   117    529 
Income (loss) before provision for income taxes  $(152,664)  $(4,059)  $8,640 

 

The provision (benefit) for income taxes consists of the following:

 

               
Current:  2022   2021   2020 
Domestic  $10,498   $-   $- 
State   2,601    1,523    - 
Foreign   -    (38)   116 
Current federal, state and local, tax expense  $13,099   $1,485   $116 

 

Deferred  2022   2021   2020 
Domestic  $18,558   $(7,142)  $- 
State and local   4,034    (1,878)   - 
Foreign   (1,073)   (461)   - 
Deferred federal, state and local, tax expense   21,519   $(9,481)  $- 
Income tax expense (benefit)   34,618    (7,996)   116 

 

The reconciliation of the U.S. federal statutory rate to the Company’s effective rate on income before provision (benefit) for income taxes is as follows:

 

               
   2022   2021   2020 
U.S. Statutory federal rate   21.0%   21.0%   21.0%
State taxes, net of federal benefit   (3.9)%   (12.5)%   4.4%
Tax effect of Pepsi valuation premium   (38.9)%          
Permanent differences, including stock-based compensation   -    -    6.7%
Stock based compensation   (0.9)%   50.5%   - 
Change in valuation allowance   0.4%   219.8%   (29.8)%
Change in deferred balances   -    (80.6)%   - 
Other   (0.4)%   (0.9)%   - 
Effective tax rate   (22.7)%   197.2%   2.3%

 

The Tax Cuts and Jobs Act introduced a provision to tax global intangible low-taxed income (“GILTI”) of foreign subsidiaries and a measure to tax certain intercompany payments under the base erosion anti-abuse tax “BEAT” regime. For the years ended December 31, 2022, and 2021, the Company did not generate intercompany transactions that met the BEAT threshold but does have to include GILTI relating to the Company’s foreign subsidiaries. The Company elected to account for GILTI as a current period cost.

 

F-34

 

 

Deferred income taxes reflect the net tax effects of temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and the amounts for income tax purposes. Deferred tax assets and liabilities consisted of the following:

 

          
   December 31,
2022		   December 31,
2021		 
Net operating loss carryforwards  $4,774   $6,685 
Charitable contributions   17    17 
Fixed assets   (1,158)   (627)
Pepsi valuation premium   (70,637)     
Right of use liability   154    134 
Right of use asset   (146)   (122)
Distributor termination fees   46,859    - 
Uncertain tax position   -    132 
Stock-based compensation   5,236    6,190 
Inventory allowance   5,423    800 
Intangibles   (2,516)   (3,317)
Total deferred tax (liabilities) assets   (11,994)   9,892 
Valuation allowance   (3,424)   (4,019)
Net deferred tax (liabilities) assets   (15,418)   5,873 

 

At December 31, 2022, the Company has approximately $2.3 million of Federal net operating loss carryforwards and $8.7 million of state net operating loss carryforwards, which will begin to expire in 2027. The Federal and State NOLs are subject to limitation under Section 382 due to a December 2008 ownership change of greater than 50% over a three-year testing period. The ownership change resulted in approximately $4.5 million of NOLs that will not be realized. The $4.5 million has been removed from the available NOL carryforward and US NOL deferred tax asset. The Company had foreign NOL carryforwards of approximately $21.9 million, some of which will begin to expire in 2023.

 

The Company considers the earnings of its foreign entities to be permanently reinvested outside the United States based on estimates that future cash generation will be sufficient to meet future domestic cash needs. Accordingly, deferred taxes have not been recorded for the undistributed earnings of the Company’s foreign subsidiaries. All other outside basis differences not related to earnings were impractical to account for at this period of time and are currently considered as being permanent in duration.

 

As required by the authoritative guidance on accounting for income taxes, the Company evaluates the realizability of deferred tax assets on a jurisdictional basis at each reporting date. Accounting for income taxes requires that a valuation allowance be established when it is more likely than not that all or a portion of the deferred taxes will not be realized. In circumstances where there is sufficient negative evidence indicating that the deferred tax assets are not more likely than not realizable, the Company establishes a valuation allowance. Through the year ended December 31, 2020, the Company maintained a full valuation allowance on its worldwide net deferred tax assets. During the fourth quarter of 2021, the Company concluded that it is more likely than not that its US deferred tax assets would be realized. This conclusion was based on the US profitability and NOL utilization in 2021 and 2020 as well as future forecasts of US profitability. For the year ended December 31, 2021, the Company released its US valuation allowance for deferred tax assets of approximately $6.0 million. For the year ended December 31, 2022, the Company reported a release of non-U.S. valuation of $0.5 million. The Company continues to maintain a valuation allowance on its foreign net operating losses as it is not more likely than not that the losses in those specific jurisdictions will be realized.

 

F-35

 

 

A reconciliation of the beginning and ending amounts of unrecognized tax benefits is as follows:

 

          
   2022   2021 
Gross unrecognized tax benefit, beginning of period  $1,080   $82 
Additions based on tax positions related to the current year   -    - 
Additions based on tax positions related to the prior years   -    998 
Reductions due to lapse in statute of limitations and settlements   (378)   - 
Gross unrecognized tax benefit, end of period  $702   $1,080 

 

The Company recognizes only those tax positions that meet the more-likely-than-not recognition threshold and establishes tax reserves for uncertain tax positions that do not meet this threshold. To the extent these unrecognized tax benefits are ultimately recognized, approximately $0.7 million will impact the Company’s effective tax rate in future periods. Interest and penalties associated with income tax matters are included in the provision for income taxes. As of December 31, 2022, the Company had uncertain tax positions of approximately $0.8 million, inclusive of $0.1 million of interest and penalties.

 

The Company files U.S., state, and foreign income tax returns in jurisdictions with various statutes of limitations. Below is a summary of the filing jurisdictions and open tax years:

 

   
   Open Years
U.S. Federal  2019-2021
U.S State and local  2018-2021
Non-U.S.  2016-2021

 

F-36

 

 

18.STOCK-BASED COMPENSATION

 

The Company adopted the 2006 Incentive Stock Plan on January 18, 2007. This plan was intended to provide incentives to attract and retain highly competent persons at all levels as employees of the Company, as well as independent contractors providing consulting or advisory services to the Company, by providing them opportunities to acquire the Company’s common stock. While the plan terminated 10 years after the adoption date, issued awards have their own schedule of terminations. As such, the Company is no longer granting awards under this plan and there are no unvested awards as of December 31, 2022.

 

The Company adopted the 2015 Plan on April 30, 2015. The 2015 Plan is intended to provide incentives which will attract and retain highly competent persons at all levels as employees of the Company, as well as independent contractors providing consulting or advisory services to the Company, by providing them opportunities to acquire the Company’s common stock or to receive monetary payments based on the value of such shares pursuant to awards issued. The 2015 Plan permits the grant of options and shares for up to 5 million shares. In addition, there is a provision in the 2015 Plan for an annual increase to the maximum number of shares authorized under the 2015 Plan, which increase shall be added on the first day of the calendar year beginning January 1, 2016, equal to 15% of the number of shares outstanding as of such date (Note 15). Provisions have been made to permit the grant of options and other share-based awards for up to 5.0 million shares.

 

For the years ended December 31, 2022, 2021, and 2020, the Company recognized non-cash compensation expense of approximately $20.7 million, $36.5 million, and $6.3 million respectively, (included in General and administrative expense in the accompanying Consolidated Statements of Operations).

 

Stock Options

 

The Company used straight-line amortization of compensation expense over the two to three-year requisite service or vesting period of the grant. The maximum contractual term of the Company’s stock options is 10 years. The Company recognizes forfeitures as they occur. There are options to purchase approximately 1.9 million shares that have vested as of December 31, 2022 and 2021.

 

Under the 2015 Plan, the Company has issued stock options to purchase approximately 2.3 million shares at an average price of $9.66 with a fair value of $213.9 million. No options were issued during the years ended December 31, 2022 and 2021. Upon exercise, shares of new common stock are issued by the Company.

 

The Company determines the fair value of restricted stock-based awards based on the market price on the date of grant. The Company uses the Black-Scholes option-pricing model to estimate the fair value of its stock option awards and warrant issuances and recognizes forfeitures as they occur. This model uses an exercise price, dividend yields, risk-free interest rate, and expected annual volatility, as inputs.

 

The calculation of the fair value of the awards using the Black-Scholes option-pricing model is affected by the Company’s stock price on the date of grant as well as assumptions regarding the following:

 

            
   Years ended
December 31,		 
   2022(1)  2021  2020 
Expected volatility  NA   69.2 - 81.1%   69.2 - 81.1% 
Expected term  NA   4.5 - 5.0 Years   4.8 - 5.0 Years 
Risk-free interest rate  NA   0.3% - 1.4%   0.2% - 1.4% 
Forfeiture Rate  NA   0.0%   0.0% 

 

 
(1)No stock options were issued during 2022.

 

F-37

 

 

The expected volatility was determined with reference to the historical volatility of the Company’s stock. The Company uses historical data to estimate option exercise and employee termination within the valuation model. The expected term of options granted represents the period of time that options granted are expected to be outstanding. The risk-free interest rate for periods within the contractual life of the option is based on the U.S. Treasury rate in effect at the time of grant.

 

A summary of the status of the Company’s outstanding stock options as of December 31, 2022 and 2021 and changes during the periods ended on that date is as follows:

 

                           
       Weighted Average   Aggregate   Weighted  
   Shares   Exercise   Grant Date   Intrinsic
Value		   Average
Remaining		  
   (000’s)   Price   Fair Value   (000’s)   Term (Yrs)  
Options                            
At December 31, 2020   5,198   $4.23        $240,866     6.89  
Granted   305    42.37   $30.32              
Exercised   (1,460)   3.85    80.58    84,371         
Forfeiture and cancelled   (443)   5.01                   
At December 31, 2021   3,600   $7.47        $241,515     6.37  
Granted   -    -                   
Exercised   (1,273)  $3.67   $80.70   $102,283         
Forfeiture and cancelled   (61)   5.46                   
At December 31, 2022   2,266   $9.66        $213,914     5.43  
Exercisable at December 31, 2022   1,928   $6.41        $188,261     5.05  

 

The following table summarizes information about employee stock options outstanding at December 31, 2022:

 

                              
   Outstanding Options   Vested Options 
Range of Exercise Price   Number
Outstanding at
December 31,
2022
(000’s)		     Weighted
Average
Remaining
Life		     Weighted
Average
Exercise
Price		     Number
Exercisable at
December 31,
2022
(000’s)		     Weighted
Average
Exercise
Price		     Weighted
Average
Remaining
Life		  
$0.34 - $1.05   30    1.44   $0.58    30   $0.58    1.44 
$1.97 - $2.95   5    3.01    1.97    5    1.97    3.01 
$3.23 - $4.85   1,465    5.38    3.81    1,412    3.80    5.34 
$5.59 - $8.38   389    3.51    5.70    331    5.72    2.88 
$14.53 - $21.79   61    7.58    14.53    40    14.53    7.58 
$21.80 - $32.70   16    7.83    21.80    10    21.80    7.83 
$42.64 - $63.96   300    8.01    42.67    100    42.67    8.01 
Outstanding options   2,266    5.43   $9.66    1,928   $6.41    5.05 

 

As of December 31, 2022, the Company had approximately $3.4 million of unrecognized pre-tax non-cash compensation expense related to options to purchase shares, which the Company expects to recognize, based on a weighted-average period of 1.0 year.

 

F-38

 

 

Restricted Stock Awards

 

Restricted stock awards are awards of common stock that are subject to restrictions on transfer and to a risk of forfeiture if the holder leaves the Company before the restrictions lapse. The holders of a restricted stock award are generally entitled after the release to transact and obtain the same rights as rights of a stockholder of the Company, including the right to vote the shares. The holders of unvested restricted stock awards do not have the same rights as stockholders including but not limited to any dividends which may be declared by the Company, and do not have the right to vote. The value of restricted stock awards that vest over time is established by the market price on the date of its grant and generally vests over a period of 3 years. A summary of the Company’s restricted stock activity for the years ended December 31, 2022 and 2021 is presented in the following table:

 

                    
   For the twelve months ended 
   December 31,
2022		   December 31,
2021		 
    Shares     Weighted
Average
Grant Date
Fair Value		     Shares     Weighted
Average
Grant Date
Fair Value		  
Unvested at beginning of period   0.3   $14.72    66.2   $28.11 
Transfers to restricted stock units   -    -    (45.9)   34.02 
Granted   -    -    -    - 
Vested   -    -    (18.9)   14.79 
Forfeited and cancelled   (0.3)   14.72    (1.1)   14.72 
Unvested at end of period   -   $-    0.3   $14.72 

 

There were no shares granted, vested or outstanding during and as of the year ended December 31, 2022.

 

Restricted Stock Units

 

Restricted stock units are awards that give the holder the right to receive one share of common stock for each restricted stock unit upon meeting service-based vesting conditions (typically annual vesting in three equal annual installments, with a requirement that the holder remains in the continuous employment of the Company). The holders of unvested units do not have the same rights as stockholders including but not limited to any dividends which may be declared by the Company, and do not have the right to vote. The value of restricted stock units that vest over time is established by the market price on the date of its grant. A summary of the Company’s restricted stock unit activity for the years ended December 31, 2022 and 2021 is presented in the following table:

 

                    
   For the twelve months ended 
   December 31,
2022		   December 31,
2021		 
    Shares
(000’s)		     Weighted
Average
Grant Date
Fair Value		     Shares
(000’s)		     Weighted
Average
Grant Date
Fair Value		  
Unvested at beginning of period   566   $52.66    -   $- 
Transfers to restricted stock awards   -    -    46    34.02 
Granted   248    74.14    574    54.40 
Vested   (205)   54.17    (19)   64.58 
Forfeited and cancelled   (70)   61.99    (35)   50.46 
Unvested at end of period   539   $60.73    566   $52.66 

 

The total fair value of shares vested during the year ended December 31, 2022, was approximately $11.6 million. Unrecognized compensation expense related to outstanding restricted stock units to employees and directors as of December 31, 2022 was approximately $20.3 million and is expected to be expensed over the next 2.0 years.

 

F-39

 

 

Performance-based Stock Awards

 

The Company issues stock-based awards to third-party consultants for providing marketing, sales, and general business development services related to Celsius products, as well as to certain employees as discussed below. The stock-based awards are in the form of restricted stock units with performance vesting conditions (“performance stock units” or “PSUs”). The holders of unvested PSUs do not have the same rights as stockholders including but not limited to any dividends which may be declared by the Company, and do not have the right to vote. Some of the PSU performance vesting conditions are linked to the consultants obtaining specified incremental earnings for the Company in a given year over the performance vesting period, typically five years and some of the awards are linked to employees of the Company and have specific performance-based metrics to be met in year one and year two of the issuance as discussed below. The fair value of PSUs is based on the market price of the underlying stock on the grant date. The Company recognizes compensation cost for performance stock awards issued to non-employees in the same manner and periods as though cash had been paid for services received.

 

In the third quarter of 2022, the Human Resources and Compensation Committee of the Board of Directors approved the issuance of PSUs to certain employees which represented restricted stock units with performance-based vesting. The aggregate grant date fair value of $7.5 million included an immediate vesting of 20% of the shares as well as specific performance-based metrics to be met in year one and year two of the issuance. The Company believes the performance-based metrics are probable of being achieved and will recognize expense each tranche of the awards separately according to ASC 718.

 

A summary of the Company’s PSU activity for the years ended December 31, 2022 and 2021 is presented in the following table:

 

                    
   For the twelve months ended 
   December 31,
2022		   December 31,
2021		 
    Shares
(000’s)		     Weighted
Average
Grant Date
Fair Value		     Shares
(000’s)		     Weighted
Average
Grant Date
Fair Value		  
Unvested at beginning of period   15   $64.65    -   $- 
Granted   76    98.28    15    64.65 
Vested   (15)   98.28    -    - 
Forfeited and cancelled   -    -    -    - 
Unvested at end of period   76   $91.48    15   $64.65 

 

Unrecognized compensation expense related to outstanding PSUs issued to employees and non-employee consultants as of December 31, 2022, was approximately $4.3 million and is expected to be expensed over the next 1.6 years.

 

Modifications

 

There were certain Board of Directors members and employees whose service was terminated during 2021. In connection with their terminations, the vesting conditions of the previously granted awards were modified to accelerate the vesting of specified un-vested awards pursuant to Board resolutions or severance agreements. Pursuant ASC 718, these were modifications which required re-valuation of un-vested awards to modification date fair value with recognition of compensation expense over the remaining service period. The Company modified awards resulting in approximately $19.3 million in incremental compensation cost during the year ended December 31, 2021.

 

F-40

 

 

19.COMMITMENTS AND CONTINGENCIES

 

Legal

 

In November of 2020, McGovern Capital, Inc. and Kevin McGovern (collectively “McGovern”) filed a claim in arbitration related to its Representative Agreement with the Company as amended by the first amendment dated August 6, 2016. Pursuant to the Representative Agreement, McGovern is entitled to receive a fee of three percent (3%) of “Net Revenues” received by the Company from sales of the Company’s products in the People’s Republic of China for a period of four years from Initial Commercial Sale (which was September 1, 2017). “Net Revenues” are defined in the Representative Agreement as “the Company’s revenues net of actual discounts applied, credits and returns.” Effective January 1, 2019, the Company restructured its China operations from a distribution arrangement with Qifeng Food Technology (Beijing) Co. Ltd. (“Qifeng”), to a license and royalty arrangement and a loan, pursuant to which Qifeng will market and distribute the Company’s products in China, and the Company will receive an annual royalty payment. The Company intended to pay McGovern its percentage of the annual royalty payment, but McGovern had objected, claiming that McGovern is entitled to be paid commissions on the entire royalty payment and the amount of the loan to Qifeng. During the year ended December 31, 2022, a confidential settlement agreement was signed for an amount included in the consolidated Statements of Operations and Comprehensive Income for year ended December 31, 2022 that is not material to the financial results of the Company.

 

In March of 2019, Daniel Prescod filed a putative class action lawsuit against the Company in the Superior Court for the State of California, County of Los Angeles, filed on March 19, 2019, (the “Prescod Litigation”). Daniel Prescod asserts that the Company’s use of citric acid in its products while simultaneously claiming “no preservatives” violates California Consumer Legal Remedies Act, California Business and Professions Code Section 17200, et seq., and California Business and Professions Code Section 17500, et seq., because citric acid acts as a preservative. The Company does not use citric acid as a preservative in its products, but rather as a flavoring, and therefore it believes that its “no preservatives” claim is fair and not deceptive. A motion to certify the case as a class action was filed and on August 2, 2021, that motion was granted. No fact discovery was conducted on the merits. On October 12, 2022, the Company and Mr. Prescod notified the courts that an agreement in principle to settle had been reached to resolve the case for an aggregate amount of $7.8 million. The Company and Mr. Prescod submitted the settlement agreement to the court, which entered its preliminary approval on November 23, 2022 and set a final Fairness Hearing for March 31, 2023. As of December 31, 2022, $7.8 million was accrued and included in accounts payable and accrued expenses in the consolidated balance sheets.

 

On November 23, 2021, a case related to the Prescod Litigation, Amit Heli and Joseph Nina v. Celsius Holdings, Inc. was filed in the United States District Court for the Southern District of New York, Case No. 1:21-cv-09892. The Company answered the complaint on February 11, 2022. Like the Prescod Litigation, the plaintiffs in this case allege that the Company’s use of citric acid in its products while simultaneously claiming “no preservatives” constitutes false advertising and unfair or deceptive trade practices. Unlike the Prescod Litigation, in this case the violations alleged are of New York’s General Business Law. As with the Prescod Litigation, the Company does not use citric acid as a preservative in its products, but rather as a flavoring, and therefore it believes that its “no preservatives” claim is fair and not deceptive. No discovery has been conducted and this matter is still in its initial stages. On October 12, 2022, the Company and Mr. Prescod notified the courts that an agreement in principle to settle had been reached to resolve the Prescod and Heli case for an aggregate amount of $7.8 million. The Company and Mr. Prescod submitted the settlement agreement to the court, which entered its preliminary approval on November 23, 2022 and set a final Fairness Hearing for March 31, 2023 for judicial approval and await final judgment and entry in the coming weeks. As of December 31, 2022, $7.8 million was accrued and included in accounts payable and accrued expenses in the consolidated balance sheets.

 

F-41

 

 

On January 8, 2021, the Company received a letter from the SEC Division of Enforcement seeking the production of documents in connection with a non-public fact-finding inquiry by the SEC to determine whether violations of the federal securities laws have occurred. Subsequent to January 8, 2021, the Company received subpoenas for production of documents in connection with the matter. The investigation and requests from the SEC do not represent that the SEC has concluded that the Company or anyone else has violated the federal securities laws. The Company has cooperated and will continue to cooperate with the SEC staff in its investigation and requests. At this time, however, the Company cannot predict the length, scope, or results of the investigation or the impact, if any, of the investigation on our results of operations.

 

On March 16, 2022, Christian McCallion filed a class action lawsuit against the Company in the United States District Court for the Southern District of Florida. Plaintiff McCallion asserts that because of the Company’s delay in filing its Annual Report on Form 10-K for the year ended December 31, 2021, there was a decline in the market value of the Company’s securities and as a result, class members suffered significant losses and damages. On June 6, 2022 Judge Middlebrooks appointed a lead class plaintiff and the Company filed its Motion to Dismiss on August 5, 2022. As the Company has previously disclosed in its periodic reports filed with the SEC, prior to filing an application for an automatic fifteen (15) day extension of the original filing date, the Company experienced staffing limitations, unanticipated delays and identified material errors in previous filings. The Company does not believe it has committed any federal securities violations or made false and/or misleading statements and/or material omissions as alleged in the complaint. The Company intends to contest the claims vigorously on the merits.

 

On January 11, 2023, Doreen R. Lampert filed a derivative stockholder complaint against certain of the Company’s directors and a former officer and, nominally, against the Company, in the United Stated District Court of the District of Nevada. Plaintiff Lampert asserts that the same allegations giving rise to the McCallion class action lawsuit also support claims for breach of fiduciary duty against the directors and former officer, among other claims. The deadline to respond to the complaint will be March 21, 2023. The Company does not believe its directors or former officer have breached any fiduciary duties or are otherwise liable under the theories plead in the complaint and the Company intends to contest the claims.

 

On May 4, 2021, Plaintiffs Strong Arm Productions USA, Inc., Tramar Dillard p/k/a Flo Rida, and D3M Licensing Group, LLC filed a lawsuit against the Company in the Circuit Court of the 17th Judicial Circuit in and for Broward County, Florida. Plaintiffs asserted that the Company breached two endorsement and licensing agreements that were entered into between Plaintiffs and the Company in 2014 and 2016. Plaintiffs alleged the Company had reached certain revenue and sales benchmarks set forth in the 2014 agreement that entitled them to receive 750,000 shares of the Company’s stock. In addition, Plaintiffs claimed they were entitled to receive unspecified royalties under the 2016 agreement.

 

A jury trial commenced on this matter on January 10, 2023. On January 18, 2023, the jury rendered a verdict against the Company for $82.6 million in compensatory damages. On February 2, 2023, the Company filed post-trial motions seeking (i) judgment in favor of the Company dismissing the case notwithstanding the verdict based on the plain language of the contracts at issue; (ii) in the alternative, granting a new trial due to the numerous errors at trial; or (iii) in the alternative, reducing the award of damages to $2.1 million, which reflects the Company’s stock price on the date that the jury found the relevant revenue and sales benchmarks at issue were met. The judgment will accrue post-judgement interest at 5.52 percent per year as of February 13, 2023

 

We believe that the jury verdict is not supported by the facts of the case or applicable law, is the result of significant trial error, and there are strong grounds for appeal. We will seek to overturn the verdict in post-trial motions before the trial court and the Company filed a notice of appeal to the Fourth District Court of Appeal for the State of Florida on February 21, 2023. The appeal is suspended pending disposition of the pending post-trial motions. We intend to vigorously challenge the judgment through all appropriate post-trial motions and appeal processes.

 

F-42

 

 

As a result, we believe that the likelihood that the amount of the judgment will be affirmed is not probable. We have taken into consideration the events that have occurred after the reporting period and before the financial statements were issued. We currently estimate a range of possible outcomes between $2.1 million and $82.6 million, and we have accrued a liability as of December 31, 2022 at the lower end of the range, which is the amount we believe is the most likely estimate for a probable loss on this matter. This amount is reflected in Accounts payable and accrued expenses, and General and administrative expenses in our consolidated financial statements as of and for the year ended December 31, 2022. The ultimate loss to the Company of the litigation matter could be materially different from the amount the Company has accrued. The Company cannot predict or estimate the duration or ultimate outcome of this matter.

 

In addition to the foregoing, from time to time, we may become party to litigation or other legal proceedings that we consider to be a part of the ordinary course of our business.

 

Commitments

 

The Company has entered into distribution agreements with liquidated damages in case the Company cancels the distribution agreements without cause. Cause has been defined in various ways. If management makes the decision to terminate an agreement without cause, an estimate of expected damages is accrued, and an expense is recorded within operating expenses during the period in which termination was initiated.

 

As of December 31, 2022 and 2021, we have contingent commitment to third parties of $30.7 million. Our contingent commitments are primarily related to third party suppliers and have arisen through the normal course of business. The contingent commitments may have various terms, and none are individually significant.

 

Additionally, our business and results of operations may be adversely affected by the business and economic uncertainty resulting from the pandemic and public health crises related to the COVID-19 outbreak, which is affecting the macro-economic environment.

 

20.SUBSEQUENT EVENTS

 

The Company evaluates subsequent events and transactions that occur after the balance sheet date up to the date the consolidated financial statements are issued. Except for the matters discussed in Note 19, there were no other subsequent events that would have required adjustment or disclosure in the consolidated financial statements.

 

F-43

 EX-21.1 2 celsiusholdings_ex21-1.htm EXHIBIT 21.1

 

Exhibit 21.1

 

Subsidiaries of Celsius Holdings, Inc.

 

Entity   Jurisdiction of Organization
     
Celsius Netshipments, Inc.   Florida
     
Celsius, Inc.   Nevada
     
Celsius Asia Holdings Ltd.   Hong Kong
     
Celsius China Holdings Ltd.   Hong Kong
     
Celsius (Beijing) Beverage Co. Ltd   China
Celsius European Holdings, B.V.   Netherlands
Func Food Group Oyj   Finland
Func Food Finland Oy   Finland
Suomen Lisaravinne Oy   Finland
Func Food Sweden AB   Sweden
Peoples Choice AB   Sweden
Freddy Store AB   Sweden
Func Food Norge AS   Norway

 

 

 

 EX-23.1 3 celsiusholdings_ex23-1.htm EXHIBIT 23.1

 

Exhibit 23.1

 

Consent of Independent Registered Public Accounting Firm

 

We consent to the incorporation by reference in the following Registration Statements:

 

(1)Registration Statement (Form S-8 No. 333-216029) pertaining to the 2006 Stock Incentive Plan and 2015 Stock Incentive Plan of Celsius Holdings, Inc., and
   
(2)Registration Statement (Form S-3 No. 333-256930) of Celsius Holdings, Inc. and in the related Prospectus

 

of our reports dated March 1, 2023, with respect to the consolidated financial statements of Celsius Holdings, Inc., and the effectiveness of internal control over financial reporting of Celsius Holdings, Inc., included in this Form 10-K/A.

 

/s/ Ernst & Young LLP  

 

Boca Raton, Florida

April 18, 2023

 

 

 EX-23.2 4 celsiusholdings_ex23-2.htm EXHIBIT 23.2

 

Exhibit 23.2

 

Consent of Independent Registered Public Accounting Firm

 

We consent to the incorporation by reference in the Form S-8 Registration Statement dated February 13, 2017, and Form S-3 Registration Statement and Prospectus dated June 9, 2021, of our report dated March 10, 2021, with respect to the consolidated financial statements of Celsius Holdings, Inc. subsidiaries included in this Annual Report (Form 10-K/A) of Celsius Holdings, Inc. for the year ended December 31, 2020.

 

/s/ Assurance Dimensions, Inc.  

Assurance Dimensions

 

Margate, FL

 

April 18, 2023

 

 

 EX-31.1 5 celsiusholdings_ex31-1.htm EXHIBIT 31.1

 

Exhibit 31.1

 

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, John Fieldly, certify that:

 

1.I have reviewed this Annual Report on Form 10-K/A for the year ended December 31, 2022 of Celsius Holdings, Inc.;

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e)and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15 (f) and 15d-15(f)) for the registrant and have:

 

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s fourth fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.The registrant’s other certifying officer and I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and,

 

b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal control over financial reporting.

 

Date: April 18, 2023

 

  /s/ John Fieldly
  Name: John Fieldly
    Chief Executive Officer

 

 

 EX-31.2 6 celsiusholdings_ex31-2.htm EXHIBIT 31.2

 

Exhibit 31.2

 

CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Jarrod Langhans, certify that:

 

1.I have reviewed this Annual Report on Form 10-K/A for the year ended December 31, 2022 of Celsius Holdings, Inc.;

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e)and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15 (f) and 15d-15(f)) for the registrant and have:

 

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s fourth fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.The registrant’s other certifying officer and I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and,

 

b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal control over financial reporting.

 

Date: April 18, 2023

 

  /s/ Jarrod Langhans
  Name: Jarrod Langhans
    Chief Financial Officer

 

 

 EX-32.1 7 celsiusholdings_ex32-1.htm EXHIBIT 32.1

 

Exhibit 32.1

 

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Annual Report of Celsius Holdings, Inc., a Nevada corporation (the “Company”) on Form 10-K/A for the year ended December 31, 2022, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, John Fieldly, the President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that:

 

1.The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: April 18, 2023

 

  CELSIUS HOLDINGS, INC.
     
  By: /s/ John Fieldly
    John Fieldly, President and Chief Executive Officer
    (Principal Executive Officer)

 

 

 EX-32.2 8 celsiusholdings_ex32-2.htm EXHIBIT 32.2

 

Exhibit 32.2

 

CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Annual Report of Celsius Holdings, Inc., a Nevada corporation (the “Company”) on Form 10-K/A for the year ended December 31, 2022, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Jarrod Langhans, the Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that:

 

1.The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: April 18, 2023

 

  CELSIUS HOLDINGS, INC.
     
  By: /s/ Jarrod Langhans
    Jarrod Langhans, Chief Financial Officer
    (Principal Financial and Accounting Officer)

 

 

 GRAPHIC 9 img_001.jpg GRAPHIC begin 644 img_001.jpg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end GRAPHIC 10 img_002.jpg GRAPHIC begin 644 img_002.jpg M_]C_X 02D9)1@ ! 0$ 8 !@ #_VP!# @&!@<&!0@'!P<)"0@*#!0-# L+ M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$ P$! 0$! M 0$! 0 $" P0%!@<("0H+_\0 M1$ @$"! 0#! <%! 0 0)W $" M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,! (1 Q$ /P#W^BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *X33/^2GZM_NI_*N[KA-, M_P"2H:K_ +J?^@UG/=>I4>IW=%%%:$A1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %<)IG_)4-5_W4_]!KNZ MX33/^2H:K_NI_P"@UG/=>I4>IW=%%%:$A1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<)IG_)4-5_W4_P#0 M:[NN$TS_ )*AJO\ NI_Z#6<]UZE1ZG=T445H2%%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5PFF?\E0U7_= M3_T&N[KA-,_Y*AJO^ZG_ *#6<]UZE1ZG=T445H2%%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5PFF?\E0U7 M_=3_ -!KNZX33/\ DJ&J_P"ZG_H-9SW7J5'J=W1116A(4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1136=5^\P'U- #J*B^TP9QY\>?3>*K7&LZ;:@ M^=>P+CJ"XH O45S%U\0O#%F2)M308Z[03_*LN?XP^"("5&K^8_\ =CA=C_*E M= =W17F$OQMT(R;+2TOK@^ULX'YXJK_PN6ZD?_1O"]Y.OL=I/YBBZ'8]9HKR M@?$OQE=C%IX#N%ST+SK43>(_BM=9^S^%H(@3QNN1Q1<+'KE%>.F7XRN0X@LX M2V<#I ^M-,T0ZR(/JPKQT^!? MB-=\7/BW9GJ$@ IO_"GO$MRN+GQK=8/4+'BB[ ]D\Z+;N\Q,>NX5$]_9QYWW M4*X]9!7CO_"AKN7'G^,M2(]!G _#-/'[/]MD[_$6H2 _WG.31=@>I3>)-'@. M)-0@'_ Q5*7QUX;A^_JL Q[UP,?P T8']]J%U+]9#_C5J+X#>&$^^)7^KFEJ M&AU$GQ-\(Q??UB$8]ZKR_%SP-$Q!U^W8C^[DUE1_ [P!UZ:NK?\ 3567XW^#D^[>[OH*O+\'O R_P#,#B/U8T]? MA%X%7_F7[<_4G_&C4#"E^/'A9#\LCO\ 055?X_Z"/N6TK<=@?\*ZU?A7X+10 M$T*V0#^Z.M.'PP\(*G?\(!X9SG^RXJ7_ (0/PT#G^RX?RHU#0\N/[18[>&+G/N__ -:F']HM M\?+X9F_%J]6_X07PY_T#(?RI#X$\-DY_LN'\J-0T/*#^T5-CCPU*/^!&F_\ M#1%P>GAZ4?5Q7J__ @/AG_H%P_@*0_#[PP1C^RH:-0T/*/^&B;C_H /_P!] MBD_X:*G_ .@ _P#W\%>JM\.O"S==*BIC?#7PFPP=)BHM(-#RW_AHJ;OH#_\ M?P4H_:,D'70'/_;45Z?_ ,*Q\'D_-HT##T;D5 ?A)X&/_,OVP^F?\:-0T/.A M^T:W?P\WX3"GC]HU?XO#LA^DPKOC\'_ I_Y@,(^A-1-\&O!#=-'C7_@1_P : M-0T.('[1T7?PY-_W_6GC]HZUS\WARXQ[3K75R?!+P51Z-(,BID_:"TMCSI[C_@569?@)H3G]W.Z?AFJ MDG[/FFM]W4I$^BTO>'H64^/VA'[]NZ_\"JTOQV\-?QEE Z]\5AR_LZ6A8F+Q M#;<^HJTGQH\$-][5E7_@)- M>;3?L_:E&3Y6IB0>Z#-9TWP*\1Q@^4\'9L;-3A.?>KT/B#29_\ 5W\!S_MBODV?P!XMM/5]8@P1>7RD<9O#\N//B>'UR:VK;XS^"9L>9JR0G_:!IW0K'?T5R]O\ $3PK M=-B#5X'!Z$'@UL6VN:9> &"^@?/^V*=P-"BF>=%Q^\3GI\PYIP((R""/:@!: M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N$TS_DJ&J_[J?\ H-=W M7":9_P E0U7_ '4_]!K.>Z]2H]3NZ***T)"BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHI"0!DD >] "T4QIHD4LTB@ M#KS61<^*M)M)"DL[A@<<1DT ;5%83>(OM"_\2RV:Z)Z9RO\ .JPU?Q(TC1MX M?$8[2"=6%*X'34A( R2 />N9;3?$EY\_]L&R_P!A(E;^=1_\(UK-RQ&H:\9X M\8VI#L_D: .F^TP X\Z//IN%9][XCTK3\_:+M1C^[S_*LD_#SP]+\T]J\DO_ M #T\U@1^1J[:>#=#LG#0V?(_ON6_G1J!GR?$OPO$6#WLH(]8'Y^G%5W^((N< MC2=-FO#VR"H/XUUZ6=LD818(MH[;!4BPQ)]V)%^B@4:@<3_PE'C*8*+;P8#G M.9'O54#\,57-WX_OR0+*/3P>^X/BO0:*+#//E\.^/;A&W>+A;%O2U5L?3-1R M_#[Q!=L1>>+IID]H0I/Y&O1:*+!<\ZB^$6DN0U["YL^7I21$]U)XKT&BE9!<\BN_@'H4N?LT[P9Z #.*RKG]G>$J6M]>F1N?E M,0(_"O?#SQ78$_:=).!W1MU8MQI.H6C;9].N5]#Y+$'\<5]N%$;[RJ?J M*:]O"Z;6B0KZ%14\@[GPWY<@',?"'P7=I@Z1&C_P!]2UV?[0.CSN/M%A+;(? M[S D?E7367QC\%W:M-:U6P(-MJ-PN.@: M0L!^!-/G"Q]M9R,BBODJP^+/C;3L"/4XY$'\,D0.:ZC3/C]K%KM%_IXNO7:0 MO^>]/G0K'T;17CVG_M :/<2#[;8RV:'&2S9Q^5==I_Q4\'ZD$$&KQ;V'W3D$ M55T%CLZ*JVVHV=Y")K>YB=#W#"K((89!!'M3$+1110 4444 %%%% !1110 4 M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5PFF?\E0U7_=3 M_P!!KNZX33/^2H:K_NI_Z#6<]UZE1ZG=T445H2%%%% !1110 4444 %%%% ! M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %% M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444 M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %% M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444 M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %% M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444 M4 %%%% !1110 4444 %%%% !1110 4444 %5;F>YBD416IE4]2&QBK5% &=- M;ZA<+N2Z%NWH%#4U-+EE7;?733CT VUIT4 9*>&],C?*-'\-VOVC5+V.!"2!D\DUXWXN M^/$TIDM/#$!0AB!=R %6'L*\=O\ 4;[5[M[G4+N6>9SD[F)7/L,U#FD-(]QO M?VA[.&Z>.TT2:YA5B!+Y@ 8>HJJ_[1@Q\GAR0'_:F%>'X].E''K4<['8]QC_ M &C%_P"6GAR4_P"[,*I%'.QV/<#^T7Z>')/QE%1 MM^T5*1QX>8'_ *ZBO$^,]Z<#QW%'.PL>S-^T1='IH;#_ (&*A;]H742>-'Q_ MP,5X]DD4?[W^>W]:.=A8];;]H'53]W2P/JPJ-OCYK3 A;%0?K7E/H,<)F'"J,_[(KS0D@?XGZ__7H/&2>H MY-',PL>CO\;_ !4>C(OU45$?C7XN/2YC'_ !7GN,<8YR!T_S_G-'!Z 8_P#U M?_KI0Y[!H@14)^,_CLY_P")E;CZ6XKAACTZTUCW[ =: M?,Q6/HOX-^+/$_BV749]8O8Y;:W*HJK$%Y/->N5Y1\!K!K;P?)=8P+I]WXCB MO5ZV6Q+"BBBF(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ IIC0MN*+GUQ3J* , MR_\ #VE:FI%W8PR9ZY45R^H_"'P=?Q_\@J..7M(O!KNZ*5@/%;_]GRRFWM9Z MM+;GJJA 17':E\#?$ULY%CY=T.<%F"U]-T4N5#N?&>I>#?$>D.RWFE3 C_GD M"_\ *L1DD3.^*1,==Z$8_.ON4QHQR44GU(K%U/P=H&LDG4-,@GSU#+P:EP'< M^,N#Z&E"\\97W%?2FK_ GPY?.38/)I^<_P"JYQ^=<'J_P'UVT7VUY?V;;K:]N8R.PE;!_#-=3I?Q1\8:4GEPZDKQ<<.F36;JW@_Q! MHCF._P!,D5QGF,%_Y5BE&4E65D;LKJ5_SU_G4W:'8]@T?]H&\ML)JFE/SH.:^(XGG@<-!=3Q,#U20K_ "-=5HGQ M*\5:''Y-O?B2#(^1URWYFJ51"Y3ZSHKQ#1_CY&4BCU/3'0]'FW#!]\5Z-HOQ M#\,Z\R)9:G$TK#E"<%3Z&K4DQ6.IHI%=6^ZP/T-+5""BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "N$TS_ )*AJO\ NI_Z#7=UPFF?\E0U M7_=3_P!!K.>Z]2H]3NZ***T)"BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBJ][?VNG6LES=SI%#&NYF8XP* +%4M3U>QT>TDNKZYCABC&6+' MM7DWC'XZ6%GYMGX=3[;(5P+E2-B'^M>):YXEUCQ)>-=:I>/(S=40E5Q]*AR2 M&D>Q>,?CK$GGV?AR/S&QA;OJ ?I^%>,ZQKFIZ]=R76I74DKOU&2%_*L\#'4< M?2E4Y^O/0<]JS3G]1Q_GZ_A2< M?\]:3 (7C/MCMSG_ #^G8@"CH#].?\_AW[=^Y_B!CWQ_G_.*3MNZX')';\?\ MX^E*< ]N..G\OS_I0 =,=>G_ -8=_P#/ZT?3IVQ_3\NU X.!P?;\OZ8_R:.I M[U*?F)&0<_X__7_7\*0E!R1R1GG\S_ /6_G]: \Y/4'/Z]/\ /_UJ8WS#'4L0!^-.Z@<<\=/7_/\ M/M4MI"UUJ5I!&NYI)T QWR?_ -=" ^M?AG8C3?A[I%MMPRP@OQCYCUKK*JZ= M;)9Z=;VZ#"I&!^E6JZ3(**** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@!CPQR??C1OJH-!=;\-2?Z7;,\!)"21Y8D>I_P ]ZPE"43123.4VYXQT]: A4[E+(WJA MP?TJP(^.*41\_P#UJRYB[&WH?CCQ-X>8?8=19H_XDF!?(^IKTO0?CFC"*'6; M(Q_W[@,,?E7C(CSC/XTOECTYJU5:)<$SZVT?Q1HVO1&33K^*91Z'%;&6 M144#)+'% #ZAN;J"TB,MQ*D: 9RQQ7FOB[XTZ+H8,&F$7]T"594/W",UX7XD M\=Z_XIFS>WCK"K$I'&2N,^N.O%2Y)#L>T^+OCCI6EI);:-&U]BD=< 8],=>?_ *__ .KFI&(,X'?C\/\ /^!HR-OMTYZ?YZ__ *ND MUO;7%Y*(K:&2=V.,(I/)X';W_P ]_5?"/P0U#4\7.N2&UB&"(E.?,''7BFDV M%SR50SG"1O(?15R?<$#_ K3MO#FMWJ_N--N#D?QQLI_STKZJT/X?>&O#XC: MQTR%)5 S(1DL?>ND$$(.1$@/^Z*OV8N8^.I?!?B.")Y9=-<1CEB,\#O6&<_- MDA8QY4!/('-?'3-ND=V_B=FY]^?\_3ZU,HV& MG<,?-CKSC_ZW3_(Q]:3J!]#SCVZ_Y/84I';_ .MU_P ?\X-!YW'\_;O_ (__ M *ZD8'D].3GCOS_];'_UJ/7OGT[]O\_2CN?<],]?;_/K1U]3WR._O_G\/2D M')!Q@DCTSVQ_G_. X.>X/Z_Y'Y_I1U';],=/\_A1WYZ<=>X_SC_/-, //'?I M^F!_7_/4S@[OQX[_ .>!_@*0=![C^N/\_P J#QG\^>/?_'_ZW- "]...,?IQ M_P#6_P XHR.#NXXYS[?Y/TH/1L9Z=OR_I_\ JIP[?AT_S_ #KI M/A]IW]J^/=,M3V8R=,@8.?>N;Z'Z'\>O_P"O_.:].^!=B9_&KWNW<+>(IGZ@ M<_I3CN)GTLH(4 G)Q2T45T&84444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %0W-K!>0-#<1K)&PP0PS4U% M 'B_CKX51P&74M#C"QGYGMU'"^I'US7DKP%'*,N&4X8'L:^P2H8$, 0>H->% M?%7PI#I&K1:E9Q*EO=DJR+P XY)_&N*O3Y5S(WIROHSS+R>U A'H?SJYY7-' ME>P_&N+G-^4IB(>E+Y7&*MF+@X H,7/04F^$O MBS=Z]>=&+V_S_G^5'E\XV^M7&K*+NF2X)[GU;INJ66KV M<=W87"3PN,JR&K=?,?AKQ+J/AJ[$MK,_DL?GB)R"/;TKZ!\+^)K+Q/I:W5LZ MB0<2Q9Y0^E=]*NJFG4YYTW'4VZ***Z#,**** "BBB@ HHHH **** "BBB@ K MA-,_Y*AJO^ZG_H-=W7":9_R5#5?]U/\ T&LY[KU*CU.[HHHK0D**** "BBB@ M HHHH **** "BBB@ HHK@_$_Q6T+POK;Z7=/NG10S;>V: .\HKRL_';PT!U: MNU\)>+M-\8:7]MTZ4,%.V1,\J?2E= ;]%%%, HHHH **** "BBB@ HIDLL<* M%Y75% R2QQ7":S\8/">D[HUOTGG4D&-.V* .^HKQ>;]H*P1\1:5)(O\ >WXI ML7[0EDS 2:1(B^OF9J>9#LSVJBN"\*_%?0?%&H)I\3F*[<96-N]=[5""BBB@ M HHHH **** "BL77/%FB>'(U?5=0BMU8X&XUY_J'QZT&WD9;.%KI1T8'&:3: M06/6J*\3_P"&A;7)QHLF/^NE7;/X^Z+*P^U6CVXSR2OT5GZ)K5EX@ MTF'4M/E$EO,,JU:%4(**** "BBB@ HHKA_%7Q/T;PGJ@L+XGS",\4 =Q17F% MK\;_ [=7D5M'O+R,% ^IQ7IJ,'16'1@#2O&B HT5PVG_%SP;J#*B:M&DI. C9S79VUU!>0K+;RI(A&< MJ5-\=_#0 Y;.0/I7I6F:E:ZOIL%_9R"2WG0.C#N#1<"W1113 ** M** "BBB@ HHHH **\^\1_%O1/#>O3Z3=Y\Z$ L<^M9G_ O;PT'0,6 9@"?3 MGK2NAV/5**K:?J%KJEE%>64Z302KN5U/459IB"BBN*\6_$O1_"%]':7Q;S'Y MX[4 =K17F^D_&70-7U>#3H-WFS' SZUZ.#D CH:5P%HHHI@%%%% !1110 44 M5F:QX@TO0;7[3J5W'!'ZDT :=%>7:K\.ZUB-^T+:!L#1I"/7 MS*GF0['ME%>-VO[0&E2,!<:>\(S@DOG%>A^%/&6D^,+-Y],G$ABP)%_NDTTT MPL=#1113$%%%% !1110 45Q'BSXFZ1X1U)+*^W>8PSQ6%_PO;PUCJ_Y4KH=C MU2BO+/\ A>OAK_;_ "H_X7KX:]7_ "HN@L>IT5Q_@_XB:5XRN;B"PSNAQG-= MA3$%%%% !1110 445GZSJ]OHFGO>7)Q&M)M)78TKZ&A17&_\+)T7^\Y^@)H_ MX63HF3\TG_?)K+V]+^8KVBBBJ$%%%% !1110 44C':I/H M,UR,_P 1-'MYGBD07]JES;N'C<9!%3U:=] M42%%%% !16;K6N66A6GVB\E"@\*O=C6;I'C33-9U);*U8F1E+<^U0ZD4^5O4 MI1;5SI****LD**** "BBB@ HHKG=8\8Z;HM[]ENF(?&:F4XQ5Y,:3>B.BHKC M#\2M%[&0_13_ (4O_"RM%/>3_OD_X5G[>E_,5[.78[*BN-'Q)T5G109,LP4? M*>YQZ5V((901T(S5PJ1G\+N)Q:W%HHHJR0HHHH **** "BN8U/QQI6E:E-8S MN?-B +8]ZU-%UZQUVU\ZTE#$<,O<&LU4@WRIZE.+2O8TZ***T)"BBL'7/%FG MZ!/'#=L0TG2IE)15V-)O1&]14%G=)>VD=Q']QQD5/5)W$%%%% !1110 444$ MX&3TH **Q-3\5Z1I6]9[I?,0?<7DUS\GQ.L@3Y-EQHC6A)V3!PDM6C7HH MHK4@**** "BBB@ HIDTJP0O*_P!U!DU@Z-XPT[6[QK:U)+J2#^%2YQ32;W&H MMJZ.AHHHJA!1110 4444 %%%% !15"_UK3M,&;NZCC^IKF)_B9I2,1;Q2S@= M"BDYK.56$=V4H2>R.VHK@?\ A9]J,[M.N@/78:U=/\>Z->Y#2F%@<$.,5*KT MV[)C=.2Z'4T4R*:.>)98G#(PR".]/K8@**** "BBB@ HHHH **K7]['I]E)= M2_QU]%-1UDC5T(*L,@BG59(44 M4A( )/04 +17-Z7XVTO5=6&G6['SCN 'TKI*F,XR5XL;36X44450@HHHH ** M** "BHKBXAM86FGD5(U&2S&N7O\ XAZ+:2M%#(URZ]?+!-1.I&'Q,I1;V1UM M%<$?B?:=M.NL?]H,B! M&Z_C7A'B_P"*/B#Q4S0+<-:6':*/Y6_$@U+DD.Q[;XN^,.@>&PT%M(-0O5)! M@B/W?K7A'BGXC>(?%;E+B[:"TW$I#%\I'U(KD^Y8DLQZECDG\:2?7N:=MXHSTZ9I1T&/P_S],?YS4C$QP<=#S_G_ #WHQ@1 MF.-L:[C^0^O^(FBN=0)L+%UW!P,L?PQQ_^OUKVCPC\+]#\+I% M-Y*7-\@(,[+R<]:[=5"J%4 = !6JAW):]U_:# MU!3#I&GJ>3*SO@^U>'K'TW8Z=*PF]2XC,?-Q^G'M_G^E-&"!Z''3W&/\_P"1 M5C 'XT5G6QQD9XQS_G_']:FHP:+@1;&(_#O^=!1@ M3@>_Z_\ U_\ />;!QTH"DBBX6(O+/.#CT.3G% C..#M^E3;31M-*X6(A'Q[] MN.!_GB@1@#!Y_3_/6I=AI0E%PL1A0#D"D*98DGGMBIM@I"G-*X[$!CP#@]!Q M^5>Z_L]Z<%LM7U!AS)*JIQVQFO$"F <^E?37P:TTV7@"RF9=K7 WX]JUIZLB M6QZ%111709A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %>;?%Z1#I-I"2"S29 [CCK7H%_?VVFV MO\ *N+&55"'+U9O1@W*YR_E M"E\H<\5>$6>0/S_S_G\:7R?8?C7C\YV\IG^2OI^M)Y/%:!AR,XS_ %I#"#QB MCG"QGF'M2>5[5?,([9IIBI\P6*/E]./_ *]:_AS6KCP]JJ7D#LJDXD )P1WX M^E5#$1FD\O)Q5*;3NA.-SZ8TS4(=5TV"^MV#13(&!%6Z\P^$FJDVUUIDA.U& M#19],=*]/KW:-3VD%(\^<>65@HHHK4@**** "BBB@ HHHH **** "N$TS_DJ M&J_[J?\ H-=W7":9_P E0U7_ '4_]!K.>Z]2H]3NZ***T)"BBB@ HHHH *** M* "BBB@ HHHH S=?UB#0-!O-4N3^ZMHRYYQFOC34]0FU;5;K4+ER\MQ*QYY. M">!7M7QZ\4CRX/#MM.0S'?:;=:>D+W4#HL_^KW*1N^E>A?!/Q0-#\6/I<\BI9WZEBS= X K MT7XU>%_MW@>.\MXU4Z7^]VJ!]WSE;SM;7$%PF0\3JXP<'@@_Y^M+X6/<^ MX\Y&117/^"]?7Q+X6LM2!&^2,;U]#705L0%%%% !1110 4A(52Q. !DFEILB MEXV4'!((H ^;/BYX]O-5U^?1[&Y:.P@ !*,06;OR#7G.E:3=:UJD.GV47FW4 MQX!Y/N:U_'6F7.C^-K^UN5(+9D#6^O3I)Z&,$5Z+X9^ M(/A_Q1#']COXOM)7+PDX*'TKJ5=7&58,/4'-:\J)NSP;P?\ "K7O"OQ$L+YU M2XL8E<--G!&1Q7O5%%-*P@HHHI@%%%% !7(?$?Q:/"7A:>ZB8?:W&V >IKKZ M\J^.FE75[X26\@4LEJ2T@'H:3V&CYXU+4;O5[V2\OKAY7<[CEB0/H.U=EX)^ M%6I^,8$O&D^QV#_=F"Y+>O6N"^\F..1_G_/^1[A\*OBEINDZ%;Z#JY%NEL-D M4V/O9/\ ]>L8ZO4IET?L]6(&TZW<$8^]L&[/\JP]8_9^O[2!WTW5&O'P=L'_ MAIFHQ"*YA!#J# MG')KKJ**H04444 %%%% !7S5\=L?\)C%D?PC^5?2M?-/QU_Y'"(?[-1/8:W. M"\-@#Q+I_ XE7MGO7V?;_P#'M%_N#^5?&/AS_D9K#_KJO\Q7V=!_Q[Q?[@_E M2ICD25B^+/\ D6+_ #_SR;^5;58WBO\ Y%F^_P"N3?RK1DGQD57?+QCYV_G7 MOO[/8 TO4R !EUKP,_ZR7_KHWX?Y_P ]:]\_9\_Y!6I_[Z_RK&/Q%O8]IHHH MK8@**** "BBB@#SWXT_\DUU'Z#^=?+.%$>=HX'^?YU]3?&G_ ))KJ.>F!W]Q M7RR?]5_P'_#BLIE1/5_!GP6C\6>&+769=7DM?M )6)(@<#/O6GJ/[/,UO:/) M8ZV]Q,HR(WB"[ORKT7X/_P#)+M&_ZYG_ -"-=PS*BEF("CJ2>E7RJPKGQ/JV MCW>A:E+87T7DW,1R0#VSP<_A75_#;QUJ'A;Q+;PR7$DNG7<@CEB=LG<2 ""> MF*G^,.HV>I>.I7M&5EC10TBG@XS_ "YKE?#.DW.N>)=/L+5"[^*A MX<\&SPQ.5O+U3% 0<8/60Y ))-=U\6O%7_"1^+I8;>?? M8VGRH!_?Y!K2^!WALZMXNDU>6,-;6"LGS#@L>G:LG[SL4M$>:W=G+8W4EK:X+P1X@E\,>,+'4HN5R(9%[%6P#27NL>Z/L:BHK:=+FWCFC8,CJ&!%2UL M0%%%% !1110 4444 ?)WQ=4'XH:GQ_ G3Z5Q6%&> /PKM?B[S\4-4_ZYI_*J MOP_\)V_C/7I=+N+EK?\ =M(K!<\CMZ5@U=EK8Z;X3?$8^'=1CT;5)<:=.P6. M4GB(\ #Z5]**P90RD$$9!'>OB[Q'X>OO"^NSZ5J"E98VS'(.CKV(/TKV+X.? M$82+'X< M$8@!Z%O>OG35M8U#6KQKO4;R661NQ8[1]!FHK^^GU/4KG4+F1I)II&?'-6\-0:G9:M:K!*&4@J?RKS2PLOM^HP6:X#3,%'XG%>E_' MC_D;+7_=KS_PZ1_PDEAG _>#Z=16$MRUL>EK\ =19%;^TURPS]P4O_#/^H_] M!)?^^!7O\,\(@C'G1_='\8]*D^T0_P#/:/\ [Z%::_#+X;77@B^O)Y[ MOSA-@ 5Z=35=7&48,/8YIU4A!1113 **** "N3^(O'A*Z/L/YUUEAI_#BU"O/I,TEK,O*(KX!/7->HVUS#>6T=Q X>*095AW%]ZJE)TY>RE\A37,N='5U'/-';PO-*P5$&234E>?>.- M=:ZG70[.9E>0XD*K44(W,X1YG8P]3FU'QQXAEM[.,BUAR.>@QWS MTJMX(@:U\?PP/PT:2J1[@5Z/X6T)-!T;R]@%Q(-TK=R<5YUX,F-Q\1A+C!8S M\?C7GRIN,H2ENV=*E=22V1[)1117J'(%%%% !1110 5Y%\1L?\))"#CED'YG M_P#77KM>1?$8_P#%20#_ &D_G7)C/X9M1^(]'MM#TTVT1^R1?=!^Z/2IO[#T MW_GTC_[Y%6K3_CSA_P!P?RJ:NA1C;8S;9G?V%IN0?LD>0_$.XMF?9YFP;NN*M/#?^ ]8B8L9;1OXP.QZ MU'X@/_%S9/7='7IFK:/!K.F?9Y?E;;\CXR5->9"ESRFUNF=4IV23VL6M/OX- M2L8KNW6?%$#^TM/X!^;TKU.O+?BC_P A*P_WO\*SQ?\ "95' MXST#0>-$M0/[E:59N@_\@2U_W*TJZ(_"C)[A1115""BBB@ KBOB#X@DTNT@M M;=\2W!(./3%=K7!?$C19[NTBOH(C(8"2^.H&.PK#$+[.6PBTZZ803Q (@;C<*[D,& M&5((]C2H*'(N4*G-S:E>;3[2X4K+;QL#ZK4.G:-8Z4\[6<(C,S;GQW-7Z*VY M5>]B+O8****H04444 %%%% %;4/^0?/_ +AKRWX;?\A^Y/\ M-_.O4M0_P"0 M?/\ [AKRWX;_ /(?N?\ >;^=<5;^- WI_!(];HHHKM, HHHH **** "N+\9^ M,?[''V&Q(:\8HKH:*TE",E9HE2:V/)5DU7P)JFS>SV#D<,2>_;->GZ9J$.J6$5W P*.H/! MZ5F>+]+BU/0+A6CW2QJ6C/<&N/\ ACJA2XN=.8DAFRO/3%B^'KS7UN_L2J7@.""< U[)X MF_Y%Z\_W*XCX5?\ 'QJG^\*X*\%.M&+.BFW&#:)? OB:>VE?1-35E,;;8V;@ MKVP<]:](SD9%<)XX\,>>#JUD"EQ&-SE!UQ5GP1XLCU>U%E=.%O8N,$_ZP#N* MTI3<)>RG\B9I27/$[*FR?ZI_]TTZFR?ZI_\ =-=9B>+^!^/'T? ^]-_.O:J\ M5\#_ /(_Q?[TW\Z]JKBP7P/U-Z_Q!1117:8!1110 4=!12$9!'6@#R+5]2N_ M%GBT:8'9;57*K&&QG'!)KT/2?"NEZ5;1I%;1F11\TA'+'O7F]_:W/A;Q>+]P M2GF,V_'0,>:]0TG7;+5[<203+N ^9<]#7!A[.4N?XCHJ7LN78O?9H,8\E,?[ MHJE>:!I=^,7%G$_.?NUI45W.*>Z,+M$=O EM L,8PBC %%244Q!1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1103@9- !2$A022 !U)KF M?$_C[0/"MN[7U]%Y^/DA5LLY]*\*\7?&?7/$!EM]*!T^R<;&! +L/7(/%)R2 M'8]K\6?$G0?"D4B7%RDMXJY2W4\M7A/B[XNZ[XD:6"U8V6GN,&+^+OW!K@G9 MY7,DTLDKGDF1BQ_,TG'Y?Y_^M]:R<[E)",7E??([22'DLYR?S- ''\J7'H.O M3'?I3@IR<#OGGOT_P_SWBX[#,8__ %4O0@D\@_\ ZS_G_P"M3Q&%QENX]JU] M!\+ZQXBO$MM*LWD/=W!5<#WZ4MQF+RF.H[?_ *OT_P YKI/#?@37?%$VVSM6 M6%6VN\@*[0<=,CGCFO9/!WP0TW36BO==;[=/MR8''RH>/SKU>UM+>RA6&VA2 M)%& %&*U4.Y+D>=>$?@WHF@;;B^47UXI#+)(/NFO2418UVHH4>@&*=16B5B MHHHI@%%%% !112.2$8CKCB@#YJ^-=VT_CHVFXLL$:L/8G/%><[/>NE\;WG]I M>-M2NB]'EGW/X4>!S3MA/;.:G,?!'-*4_K_G]?\YHY@L5]K>AI-N.= MOZ59*9'3'T[?YS^E!3DG!S1S!8J[7$ !7 MR]HEC]OUVQML%@TR$_0,,U]=1*J0HJ_="@"NJAK=F50?111709!1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1 M2$A1DD >]8FK^+=(T='\^Z0R@<1J>34RE&*O)C2;T1N5A:_XJT[08F$TJM<8 M^6('DUY[KGQ'U'4=\.G1BU@/!9AEB/;TKCV:2:0R32/(YY+.V3FO-K8]+2F= M5/#-ZR-?Q#XDO?$-QF:1EMU.5B''YUC"+GIBITC]?6I5CX'K_G^M>/.I*3NV M=T8I*R*PBR/;K3O)'(QFK80#KS3MGXD=ZSYRK%$P\]/\_P"<4AA[#]*T/+./ MN\4ACSU&:7./E,XQ$GI^%-,1QVK1\OCZTTQ?E5I4>IW=%%%:$A1110 4444 %%%% !1110 55U M*_@TS3I[VYD$<,*%F8]JM5X]\=_%1L="BT*UE4RWK%9U!Y5,9YI-V \.\2:Y M<>(?$-YJMR^\NY"_[@)Q^E>P? 3PSB.Z\07$0W,=EN_JN.:\+QQCKQC'KUKI M]&^(/BOP]IR6&E7;0VR_=1H-V*QB];LM['UO?6<.H6,]I.@>*9"C*>X-?&GB M/1YM \27^ES+M:.1F4 Y^4G(KI/^%N^/O^@D3_V[5RNK:K?ZWJ4FHZFSR74N M \A3:#C^55)I@D>J? ;Q1]EU>X\/3EBMR/-@)/"X X%?0M?$>EZA/I&K6>HP M,5E@D5C@]5SR*^RM!UB#7M$M=3MCF*= PYS50>A+-*BBBK$%%%% !1110!QG MCGXB6U# M$XR2 M,^M?2GB#P/H/B09U"QC>0#"N!T]Z^;/B)X&D\#:TENDQGLKD$P2,,,/48]JS M:<=BMSW3P%\5M,\8S?890+/4<96!SS( .2*]"KX?L[F6RU"UNX'9)4F1MRM@ M]0<<5]HZ)>MJ.C6MTPPTD8)^N*N,KDM6+]%%%6(**** "H;NT@OK62VN(Q)# M(I5E/<5-1D9Z]: / _&?P,N5N9+SPTXD$K9:U<[0OT->2ZGH6K:/.T-_83(R M\$JA('XU]K56NK"TO87AN+>.1'&&!4BLY( M'X9KU'PM\=]1M)%A\0Q"X1F ,Z *$'')%=-X\^#.F7.ESWV@H+2[A4OY0'RR M^Q/:OGDYW,C#E6*M]1Q4:Q'HS[:TO5++6M-@U#3[A)[:90R.IZBKE>!_L_:O M,D^I:669H"P= 6)"<=AVKWRM4[HEA1113$%%%% !7S3\=>?&,0[[1_*OI:OG M7X^Z?)#KUC>%3Y<^4S[XJ9[#6YYOX:Y\2V'_ %T4G\\U]G0#%O$/]@?RKXGT MRZ^QZO8W1/RI,A;'IN&3],5]I:==V]_I\%S:R+)#(@*LOIBIICD6JQO%?_(L M7_\ UR;^5;-*]\_9[_Y M!6IOHKX!V$EOX9N+ME(2X8;21UQ64-RWL>NT445 ML0%%%% !1110!Y[\:3CX:ZB?8?S%?+2CY%'J /\ /^>_Y_4OQH./AKJ/T'?W M%?+/2//0[>O3M_G]/PRF7$[;0OBEXB\.Z/!I=DZBV@R$^3) ZT[5_BUXNUBT M:TDO8XK9QA@D>&/XYKUGX8>#- U3X>:9=WFG1R3S(3(YZMS7-_$_X3V^G6\N MLZ!;&.!%S+;Q#.W'<"BTK"T//_!W@;4O'5Q-]FG5$B8"621OFR?0?C7T-X(^ M&VE>#(M\1-Q>$?-.X&37R[H^MZAH-^M]IMRT$R-\P!.TXQP17T_\./'UOXRT MK;(P6_@ $J$C)]Z(6!G<4445J2%%%% !1110 5R/Q(\3KX7\'7=TDJI=R*4M MU)Y9CZ5UQ.!DU\S?&WQ2=:\5II,$H:SL #E3P7(.?K4R=D-'F;O)-(9&):29 MR2>^6_\ KU]5_"?PVOA_P7:M)$([JZ42S>Y[?I7RH"=P**Q8$,-O/3)'^?I7 M90_%;QS;0)!#J&V.,;5'V;H*SB[;E-'T-\2/#@\2^"[^U2-6N5C+PL>Q'-?( MNTKF-@0R$K^(_P FNV?XL^/)4:-]2.U@0<6W:N,)=I&9T8.QW'5*H/< MX"DU]:*P90PZ$9%:1=T2Q:***H04444 %%%% 'R?\7?^2H:IW^1/Y5H?!,9\ M>QGT5OY5G_%WGXHZGW.Q/Y?Y_P \5H?!+!\>H>ORG!_"L?M%]#VGXD>!;?QC MHK%(P-0@!:!\KR?XO?#A-?M&US2X M@NIPK^\"C_7*.QJY1ZH29>^%?Q&7Q3ID>GZBVW58%VLQ( FQW%>>?'O_ )&. MRYQQ7FFF:G?:#J\5]:LT-S;R?,ISS@\@UT7C_P ;IXXNK*Z%I]GE@&'!;.:G MFNAVU*GP]_Y'_2_KZU]?I]Q?I7Q_\/1_Q7VE@$?>_2OL!/\ 5K]!50V%(=11 M15DA1110 5P'QEF>+X:ZF%.-R@$_C7?US'Q"T>37? NJ6$2[I9(B8Q_M#I28 M'Q]G]UU_AR/R_P#U?YZ?2?P(2)/!A,>-[OE\>O05\WE6B9HW4JR.4<>F.#7K M'P2\90:'>W&C7YVPW3!XY">%.!Q^-90W+>Q]&T4BLKJ&5@RGD$'(-+6Q 444 M4 %%%% !1110 4444 ?-GQYY\66H_P!G%>812212*\182#H1U_SFO3_CQSXM MM1_L^M>?>'@&\2:>&&5\Y21CKR*PEN6MAXUGQ"!@3Z@![*]']M>(<$>=J'_? M#_X5]CPV=J8(S]FBQL&/D'I3_L=K_P ^\7_? J^05SR_X&75Y<^';AKUK@RA M\?OE(_G7J],CBCA7;&BH/11BGU:)"BBBF 4444 %Q"MT-UI3=^IV=%%%=I@%%%% !1110!S'Q _ MY$R^Y_A%9/PP_P"07/\ [PK6^('_ ")E]SV%9/PP_P"07/\ [P_D*XY?[RO0 MW7\)G>T445V& 4444 %%%% #7_U;?0UY%X:.?B:OL9:]=?\ U;?0UY%X:Y^) MJ_67O7'B?CAZF]+X9'KS*'4JP!!&"#7E6O6-SX.\2P:E9C9:3.=Q'(YY((KU M:J&KZ7#J^GR6LW 8<-Z&MJU/GCINMC.$N5Z[&/K/BN"T\,#48)$\Z9/W2]3G MZ5A^ O#\DSMK6H(3-(2R%^20?KTK!T;P=JHY_]6WT->,>!/\ D?T^L_\ .O9Y/]6W MT->,>!/^1_3ZS_SHQ/\ $AZA2^&1[31117:8!1110 4444 %>0_$C_D84'J! MCZUZ]7D7Q&_Y&2W_ -Y./QKCQG\,VH?$:-L/B-]FC\AK?RL?+OQG'O4N/B7_ M 'K3]*]!M/\ CSAS_<'\JFJU0T^)_>)U/)'%Z!_PG U>/^V#;?8MIW[<9SV_ MK7:445M"'*K7OZD2=PHHHJR0HHHH **** /'O$'/Q,?O\R?UKU^/_5I]!7D/ MB#GXF/\ 6.O7H_\ 5)_NBN/#?%/U-ZNT3G_%GAN/7;!MB+]J0$H3QDUS'@;Q M+/93OHFJ*RF-ML;-U7'&#GK7I-<1XX\,?;%&J6(V79#IQ<:EF>A:!SH=J?]@5I5FZ"AKGEAXMWCH_(T51K1ZG$Z1\1+2XD2VU2%K*?H2_0FNTBECF MC#QN&4]"*YOQ'X1M-5MI)(8E2YQG/3..E;^=> MI:A_R#Y_]P_RKRWX;_\ (?N?]YOYUQ5OXT#>G\$CUNBBBNTP"BBB@ HHHH P M_&#.GA/46C7LB$5Y9X$OQHWB66 MTNSY0E)0Y_O X%<5;W:\)/8WAK3:/8**,Y&117:8!1110!#=@&SF#=-A_E7D MGPYR?%LF.F)/I]ZO1_%6IQ:9H%S*\@5V4K&.Y-<7\,=-:2>YU%@0 V%R.N:X MJWO5H)=#>&D),].HHHKM, HHHH **** ,CQ-QX>NS_L5Q'PK_P"/G4_]\?RK MN/$W_(O7G^Y7$?"L_P"DZG_OBN.I_O$#>/\ #9Z:1GK7F/BOP_-H.I?VQI*E M86;,L:CHK352-NIG"7*S)\,>((=?TQ95;$Z8 M65#U4ULR?ZI_]TUY5J%G>>"/$GVR$L]G,>'';U!'2O2=/U&'5=,6Z@8,KIV/ M3BHHU'*\);H(_#DRV^L6S7$*<>8B]O/G&X]:\4\5_&^^O-UMX?A^SH"1]H?D..>@SQ4N26XTKGL?B#QCHGAFW\W4 M;V-">BALDUX?XK^->J:J#!I"?8H,D&1N=X_SS7FUU=7=_.]3B/IDTHB/O^-9 M\Q5B$( ,'FG8]NGZ5,(J<(P*7,.Q!M-36UG/>7,=M;IOFD("KG&2>.M." 5+ M"TD$JRPDHXZ-2YAV/8O"?P2CB\FZ\231NV,O;*P*_G7K^FZ=IVD6<=K91Q11 M1C"@8X%?*K>*-?D.Y]3E)QU+&F-XBUL]=1D_,ULJL5L0X-GUSYL?]]?SH\Z+ M_GJG_?0KY&_X2'6@?^0A+^9I#K^L'KJ,_P! YI^WB+V;/KDSPCK*@_X$*/M$ M/_/:/_OH5\B'7-6)YU";/^^:9_:NJ321I]ON"7D5ID[)L:5V?,,[-<7=Q,YRSRNQ)]S353_(_S_G%3I%D= M.3S4GE_2O,E$>?\ /^?>K7EY["E$>.GZ4N8=BKY1]_\ /^33A%[59$>>@)IWE^Q_S_D4 MN8+%7R<>E.\NK/E<],?Y_P _E2B/CM2YAV*PC HV#WJUY?/^?\]Z41^Y/^?_ M *]+F'8J[,>HIOEU;\OGBD\LT^/+0L!LB1G.1GGM7TF!@8KQ/ MX,Z>)=6OKLC_ %&%!QZBO;*]/#?!O:98Y\^[C7'OFDY);L: M3>QHT5R-]\1-$MB5AF\]QV6L.\^*?&RUT]B3_&6XKGEBJ,=Y&BHS?0]*IC2Q MHI9G4 =23TKQN[^(&O7*,L4J0JW^SDU@W.H:A?9%S=RMGJ Y _*N:>8P7PJY MJL-)[L]GOO&.AZ>'\Z]30]%?(Q]:\U\O/7+?4YIX MBSP.1Z5QSS"H]M#>.&BMS8U3QEK6JC8]QY<778@P?SK#8-(Q9V9R>I8YJ81' MGC\ZD6+!'''T_P _Y_3BG5E+63N;Q@ELB%8_;/TJ9(^.G;_/]:E6/U_QJ98L M]N?6L7(T2(U3MZU*L?&2:E2+H:E6+@<'CBLG(M(A$8/3I3_+R.WY5.(_\C_/ ML:>(QZ#FHWC"(H[5Z^"PZ]2H]3NZ***T)"BBB@ HHHH **** "BB MB@"*YGCM;:2>5@J1J6)/05\?^-_$3>)_%MYJ+@JFXQ(,] I('M7U;XIT1_$7 MAZZTI+IK;[0NTRKU KR\?L^:>!_R%)/^^/\ /O423>PT><_"?PTGB3QE&+FW M\VRMU+2\9&[J*^D_^$1T, #^SX<#C[HK*\!> ;3P+:744$QGDN'#/(1@\#%= MA3BK(&S%_P"$2T/_ *!T/_?(KG_&O@#2]5\)W\%G8Q+>B(M!(%Y5AR*[JD(W M*0>A&*=A'PVR-&\D+C#1L8V'N.*]W^ OBKSK:X\/W4X,D7S6R'KL YK2U;X$ MZ9J.LW%]'>M DS%C$$! )))JQX=^#,7AK7K?5;'5Y!+""N"GW@>M9J+3*;N> MJ44@R ,G)]:6M20HHHH *;+_ *I\?W33J0@,I4C((P10!\X2?%K7?#'BB[M' M<7MA"YVP]#C/K76V?[0&DS &YT^6VSCAFS_*M;Q'\%=!UJ^EO+;-G-*-;SQIJJW M=TOE01Y,,)/*_P"/_P!:O1H_V=I"_P ^ONH]1$,UMZ;\ ='M;A6O+Z2\C'57 M4+G\J34F"L>*^%?#&H>*?$%I86<+,F\.\AR%"*1GFOL*RM4L;*&VC "QJ%&* MIZ+X4;NI]:3 \@T/]H"6&V6#5M,>6 M7',Z. /RKI$^//AYHR6C=6_NYK.NOV>["8L;?6)K+?CHVI:?+I^C64D#2 @W#L,8]A7C2YED(3,DC$GY>23GVKW6 MV_9WA4;KC7IG/]SRAC\:[3PY\)/#.@E)GLTN;M#D32H3'<'I7L%(J*BA44*HX P!2UHE8D****8!1110 5PWQ M1\%OXQ\-F.V56OK;,EN&.,MCI7E=QX M,^*^K^$8([61/MMB@PL6<$#ZU] >)/A_X>\3AY+ZPC-P1A90,%37G5Y^SS:N MS/::W-#SD)Y8(ZUERM/0JZ9$W[1D.SY?#=P']YEQ7FWC+X@ZOXUE47KB"Q1M MR6ZG'/\ M>O6O05_9XFW8.ON%]1$/\^E;.F_L_Z3:RH][J,UZN\.ZCXIUB#3=.@9VA0>&_#UGI-N2T=M&%W' MN>YHT/PWI/ANU:WTJSCMHV.2%'4UJU48V$W<****H04444 %%%% 'GWQH./A MKJ/..!_,5\L9Q%Z97_/\_P#/;[*\8>&8_%OARXTB68PK,/O@9Q7FO_#/FG[< M?VH_3'W!6Q"2WG3:RFO)O\ AGS3P3C5) -Q M(^3H,]*S<7>Z*N>E>$O%=EXNT2+4+3Y691YD1()0^E;U>>>#/AE)X+U7[19Z MQ(]M(#YUN4X<]C[5Z'5HD****8!1110!S_C3Q GAGPM>ZD<%XXSL4G[QKX]N M;AKJZGNI&RTSLY+'/4YQ_*OK#Q[X$_X3B*S@DU![:"!BS(H^_D=ZX@_L^6!Z M:K)_WQ6'[32;QC(^ZW/X5Z?XI^#5IXG\37.LRZB\33JH\L+G&/>I_"'PCM?" M6OQZI#?O(44KL*]D-X^TO)_BSU[U]@)]Q?H*\IT3X(66 MBZ[;:FFI.[P'(4H.:]7 VJ .PQ3BK(38M%%%6(**** "@@$$$9!HHH ^>OBK M\*KBQO9_$&@PA[1QNN+=>#&>I(]&?$#2S36*1W,@_UJ]16'H(K:X(OK.(8 M1. V/=J[1?VC+?:-_ANXW>TZT^[_ &>+=SNMML^*[?4;O5[F.5@RA%C M3:%%85I^SS9QMONM^HM#H MJ***L04444 %%%% 'S;\>2/^$JMP<'CIGKQ7FFGW?]GZE;W@&\P2!PO3=@Y_ MS]:^FO&WPLM_&>JI>S7[PE!C8%R*YO\ X9^T_P#Z"DG7KLK*47WUF+4'E:%& M4(5ZY[YKTZK5^HF%%%%,04444 %XO,XC0O">H:U?C5M=.$R&CASG/?D5Z.B+&BH@ 51@ 4[&!@45I3I*FM M"93<@HHHK4@**** "BBB@#F/B!_R)E]_NC^=9/PP_P"05/\ [P_E76:YI2:U MI,UA(Y191@D54\.>'(O#L4L4,I=7(/(Z5S.G+VRGTL:J2]FXFY111729!111 M0 4444 -D_U;?0UY%X:(/Q-7G_GK7KS#";?3M>75A.SRC=P1ZU MS5JN3T;P+:Z/K0U))F:0%S@C^]7-6IRE.#71FL)))IG6T445TF0444 M4 %%%% !7D/Q&X\20^S(3^=>O5RVN>"K;7=1^USSLO& .E<^)IRG"T36E)1 ME=F[9W=L;*$B>/&P?Q#TJ?[5;_\ />/_ +Z%<3_PK&Q'2\N1])"*/^%967_/ M[<_]_#0IU?Y?Q"T.YVWVJW_Y[Q_]]"I 0PR""#W%<)_PK&RP,7MR#_UT-=CI MMD-.T^*U#EQ&, FKA*;?O*WS)DHK9ENBBBM2 HHHH **** /'O$ S\3),\C* M<5Z^G^K7Z"N6U'P1;ZAKKZJTY64E<+C(XKJE&U0O7 Q7-1IRC*3?5FLY)I6% MI" 1@@$>AI:*Z3(\U\6>'IM%U$:WI*[8RP::)>G'.:YCQ-XD_P"$C>R=K?R9 M(#\W.3SBNYMV />N"MAYN_L]F=$*B^UT M.GT'G1+4_P"P*TJK:?:"QL8K8,6$8QDU9KMBK)(P>X44450@HHHH *RK[Q#8 M:9>I;7DHB9_N9/6M6L+7O"FF^("CW47[U/NN#@BHGS6]S6]Q&)( MID93W!J8.I. P_.N!;X:>2VZQUFZMR?O '(- ^'^IL,/XDN@.G YK+VE7K#\ M2^6'2 K C,=S CD\\>M=-8 M?#C2[6=9;F22[*\_OCGFNMMK6&SMT@MXUCC48"@5'LYU)J4]$N@^:,4U'J34 M445UF(4444 %%%% %;4/^/"?_<->6_#;_D/W'^\W\Z]7GB$\#Q$XW#&:YK0? M!=OH5^UU#,6+$DC'K7-5IRE4C);(UA)*+3.IHHHKI,@HHHH **** "O/_&/A M.1YSJ>GK^\'S$#C;CG->@4$ C!&16=2FJBLRHR<7=' >&_'<2[-/U@F"91M\ MQQC)KN8+NWN8A)#,CH>X-9&K>$M)U?>T]LHE8?? P17.O\-3"2UAK-U;9ZJ# MD&L5[:&EKHT?)+78[W>G]Y?SK)U;Q/I>D0N]Q=1[QTC!R2?2N7_X5]J4G$GB M.Y"]#@8J]8?#C2K699+AI+LKS^].>:;G6>BC;U8N6"W9S%Q-J?CS5%"121V$ M;?*"",CUS7IFDZ;#I.GQ6D(&$&"0.M36MI!9PK%;Q*B+T %3U5*ER/F;NV*4 M[Z+8****W,PHHHH **** ,GQ-_R+UY_N&N(^%?\ Q]:IC^^/Y5Z%J=B-1T^6 MU+[!(,9K(\-^%(/#DMP\,Q?SB"01TKFG3DZL9+9&L9)0:.BHHHKI,BEJNF0: MM826LZ@AAP2.AKRZTU2_\ ZQUD.Y4SP?0@UZ]6-XA\.VGB&S$,XVNI MRD@'(KGK4G+WH?$C2$TM'L>9>#IQ=?$*&X5=HD$CXSG&>:]FKDM&\"6FC:M# MJ$4S,\:D8(]:ZVEAJ016R)(R 0ZD'H0:XV^^&^E7-P\T!>W+L6/EL1R:I M_P#"N;R'Y+7Q!=1Q=E/.*YE.LMXW^9KRP>S.]:6-%+-(H4=23TKSGQ[K]OJ- MNFF63&9V;G8,YJZOP[FE1EO-;NIPDE'2+?*G1VZTIJK47 M+:R&N2+O>Y!X&T:72-#7S^)954LOIC/^-%=/C P**Z(14(J*,I.[NPHHHJA! M1110 4444 %%%% !1110 4444 %%4]1U2RTJTDN;VX2&*,98L:\E\6?&I$$U MIX>C\QL86ZZ@'Z5+DEN-)L]6U77-,T2V:XU&]BMXU&27;I7CGBOXXRRE[7PU M#M(8@75;L:*'<=?WU]JM MT]S?W,L\K$L=S';^ JOM([8JQY?M^=*(\"L7(TL0",^^/7%*(_8Y^E61'SP/ MTIPB(_A_2IYAV*PC%.\MJM"$^U.$/M4\X[%7R@/P]_K3A&/05:$6.U/\KU'Z M5/..Q4\LG/![TOEDDY'^<5<\H_W31Y7M^M+G'8J>6?:CRR,]*N>7GL/SHV9[ M#\Z7.%BGY9H,1]*M^7D=/UI#'[&GS"L5?+/=?TK5\+V!O_%&G6^S=F57VXZX M(-4]@KMOA18+<>.(9G7E6%BQT%/6/IQ7D.9V*)7$>?7V]O\XI?*]C5KR_>G>7QT_2HY MRK%41#Z4OEGM5KRP3C'Z4X1G^[_G_)I7GM5H1<=*=Y38I1H-Q.5QY\F[/K@8KT>N;\!V7V#P=I\1^\8]S? MC725[]%6II'GS=Y,****U("BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH ***;O0=67\Z '44WS$ SO7!]ZADOK6($O<1C'^T M*5T!8HK+E\0Z5#]^\C'XU3F\;>'KR.@HKDI?B+ MH"?ZNX,A[8%4I?B;IZ'$<#OZ//$,V%CNDC'LG/>LZ M7Q'K5QS+>L0?[O%9/,::V3+6%EU9[HT\2+N:5%'J6%4;C7],ML^;=QC'7FO" MY9[JX8>;<3G_ (&RW7CWP];%E%\DCCLH MS65/\3K",GRK9Y1VP0,UY@(QC@#_ #_G_.:<(O8X[X'^??\ 2L)9C5>UD6L- M [:Z^*%W+D6]CY/H6.:R+GQWXAN!M2Y2)?0)S6 (\>Q_S_G\J=Y?MQ_G_/YU MSRQ=66\C548+H33ZOJ5SGSKR4YZ[6(JGM8\EG;/JQ/\ GI5@1G/<4OEU@ZC> M[-%%(K"/D_*/\_Y%.$9/3'/^?\*LB,< #Z4H08QCC'Z5',.Q7\L^AS[_ .?8 M4OE8SQQZ'_/^>:LB+/88/Z_Y_K3Q%WXS2YA\I6$?<=<\I!%UQT]JER*Y2JL6><>^?2I!$>G0^_%6EA]A4BP@'_ #S4.0U$K+%Z>]2I M$1TJPL7/3\Z>(^HJ',JQ$L>T@D?Y_P _SJ18SZ#T_P _K4H3TS3MGK4.15B( M)QGI3@G/8BI0,5+#;37#[8HG8^P./SI*[=D#LMRMC':C;GMFNEL?"5Y.5:YQ M$A]#DUTEAX:L++YC&)),YWL*]&CEM>IJU9>9RU,53CMJ<38>'[V_Y2+8G$[2R)DF ED..O:N@"A1@ #Z4M>YA\NHT=7J_,X*F)G/39"*H484 #VI M:**]$Y0HHHH **** "BBB@ HHHH **** "BBB@ KA-,_Y*AJO^ZG_H-=W7": M9_R5#5?]U/\ T&LY[KU*CU.[HHHK0D**** "BBB@ HHHH **** "BBB@ HHH MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BHYKB&VC,DTBQH.['%><>)_B_INFH\&E1F\N#E0P("H? M>IE-1W&DWL>B7=Y;V-N\]S*D42#6^*OC-96GFVFA1_:Y","X#?*A_ MK7E6N^)M:\27'FZE>,P[1QDHH'H1GFLE8<=OTKEGB.QLJ?-(QXVH2JX^E9H3)R!^E61%BGB+V)QZ"N9U+[FBB51$3CCBGB$\/FNU_[YI_\ PJ+4LY^U#\!2]E4[#YX=SS3R^/\ MZU*(O;C->E_\*CU+_G\&?]W_ .M2CX1ZCD9O!_WS2]C5[#YX=SS4Q4>5[?K7 MIG_"HK_ _P!-_3_ZU'_"HK[/_'Y^G_UJ/8U>P<\.YYGY-!BKTX?"&^_Y_B/P M%+_PJ"]Q_P A#_QVCV-7L'/#N>7^7CGFD\OTR/3_ #_GM7J7_"G[OG_B8?\ MCM+_ ,*>NSG_ (F7YI1[&KV#GAW/*_+/;M7JGP6TXF74KUU^565$/X4?\*;N MN?\ B:8/^X*[GP3X4/A33)+=IS*\K;F) '-=%"C-33DC.I.+CHSJ****]$Y0 MHHHH *\ ^(=V+WQK=$?=C15'UKWV1@L3,W0 DU\XZG-]MUB[N02P:5MI'H#7 MGXZ=HI'3AXW;9F)$3P*D6+UJ<1\9[>W^?I4@BYXQS7CN1VJ)6$>,4.PR?I2^5G^G%+G' MRE7RO2E$7UJT(\^O^?\ /^8O\ZNF/G&.?\_Y_*HVCYXYJE(EH]_TV2TMM-MXXYX]BH,?,!5K M[7;_ //>+_OL5\YMYG_/>8#T$AJ,B7/$\_\ W\/^>]>JLPT^$XWAO,^C9]0L M[9=TMQ&H_P!X5!_;NF?\_L7_ 'U7SN5E(YFG.?5R?\_Y]:;LD_OR?]]FC^T' M_*'U;S/HK^W-,_Y_8?\ OJC^W-,_Y_8O^^J^=MDG]^3_ +[-+L;_ )Z2_P#? M1Y_SQ^=']H/^4/JR[GOC^+]#C;\S2A. MG+?B:G^T)=A_5EW/>?\ A,M"_P"?]/R--;QIX>12SZE$@_VLC->$A/K^9H\O M(Y&1Z9I?VA/LA_5EW/'"(8''^ M?\YI?*& ./PI?VA/LA_5HGM__"?^&1_S%(_P!II^(7AD?\Q)#_P$UXF(P1C MS],THC'0"E_:-3L@^K1/:3\1/#7;4 ?^ FF'XC>'>=MWN ]C7C7E#T'2E\L> M@I/,:G9#^K1/7V^).A#I,3^%1M\3-'!PNYJ\E$0/0#/T_P ^M+Y?'_UJG^T* MOD/ZM ]4;XG::"=L+M^-1-\4;/\ AM'/_ @*\Q$63T_3K3Q&N!P*]?E^_J!_!<57?7-5E_UE[(?H35<1G(_P ,?Y[T M!#T/^?\ //YUFZTWO)E^SCV$ENKRX(\RZN&QT'F-_C4)$AZR2G_@1_SZ59\O M/7K_ )_QH\O_ #FH5R1@C_/\ G_)JSY?UI0F.V/7\Z7,.Q6V>WY_Y_P _R7R\?KUY]:LB,XY7 M]*7R\47CU_+ZT[RZL"*E\OFIY@Y2MY??CVIVP]OPJR(^.1_G_)IWE4 ME*(N!Q^M6A'Q_C3A'VI*G"8__5_G_/ZJ$.*GF'8A$8')Q[?K_A3_ "_;MW_S]*E" M>N!3@OHI/T&:GF"Q&$YR/6GJHR-HJS!875SCRH'.>F5(K7MO"NI2J#(@C5O? M)K6%"K4^&+9,JD([LP2FT8(Q[4X+QW/TKM+;P7$BJ9IRQ[C%:]OX?TZV50EN MN5[^M=]/*J\OBLCFEC*:VU//8+&ZN2!# QSTR,"MJV\(7LQ F<1*>XYKNEC1 M J* .F!3J]"EE%*/QN_X'-/&S?PZ'/V?A*QMW#2CSB.[5M06L%NFR*-5'TJ M:BO3IT*=)6A%(Y)5)3^)A1116Q 4444 %%%% !1110 4444 %%%% !1110 4 M444 %%%% !7":9_R5#5?]U/_ $&N[KA-,_Y*AJO^ZG_H-9SW7J5'J=W1116A M(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %% M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444 M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %% M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444 M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %% M%% !1110 4444 %%%% !1110 4444 %%%% !12$@#)( ]ZXSQ)\2M'T'=%"X MO+M2088SR,5,IQBKMC2;V.R=UC7<[!1ZDUP/B3XJZ1I ,-B1>W()!1#]VO+? M$/CC7/$\7:UXCES=7 M+K$"2J1Y7'Y=:P1$,=!5D1'CM4@BXX KCE4;=VS=1L51'^/TIXBX_P :M+$3 M3EBK-S*Y2J(O;CV%/$7J*T+6PN+R58K:%Y7)P-JDUZ)X>^%4TY6;67\M1@^2 MG(8>]7",ZCM%"DXQW/.M,T6]U:[%M96[NQZD*=H_&O4/#/PHBB,5SK+>8V,F M#L#VKT73=(L-(M_(L;9(8_115ZO0IX51UEJSFE6;V*]E8VVGVR6]M$L<:#"@ M"K%%%=FQ@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 9GB M"._%*8SZ59\H]J7R_Y4N8+%7R\=!P/:D,>.,=* MM^7G/-(8_P#)HYAV*10<<8&*C:/@_K5XQ]R.OI49B-4I$V*+1^N?Q_S]/SIA MB.<8_P _Y(J\4(YP<'O3#&#V_P#U5:D*Q1\KC&*/+!J[Y?K1Y8I\XK%+R@>W M7T_S[THB]OTJX(QCUI?+'^/^?\]:.<+%01>GZ'_/^?K1Y7^?\_Y_.KGE^U*( ML?PXQ2YQ\I3\OU_S_G!IWD]>#^ _SZ5;$1'0''2CRN.5X ]*7.'*5/*]L_AU M_P X_6E\O'8G_/\ ]85;\H^U+Y9[TAJUY9]:7RO_U& MES#Y2J(_;T_S^E CZ9_E5L1'/_UJ7ROZ4@I1'[5:\KVI?*IQ%6Q&#T%+Y?H#2YAV*GED]NE+Y1Q@#V Q5ORQ@=_U]:/+_P!D4/S_P ^U+F" MQ6\KV_6G>6.G%6?+]1^5'E_3_/X4BY@L0;#V[TH3ICO4^W ML<=.:4KSSW]:7,%B 1_7_/\ ]:E$8'I4X7)Y]<^E 3CZ>]+F'8BV>Y)Q_G_/ M_P!>E*@GD?Y_S_GK4WEGKL<_09J>*QN9\&.&0Y]5/-"O+9 [+W^?\_E M0%Z=CZ5L1>'-5F.8[41S&PC M'^?\]*79CT^E=O!X'11F:[9CZ <5?@\(:9'S)'YA]S73'*\3+>R,7BZ2\SSL M*3V)'L,YJQ%8W$ZJ4@D8'H2IYKTZ+1K"$YCMD7Z"K@BC48"*!Z 5UPR=_;G] MQC+'+[*/-K;PQJ=Q\P@55]2>:T8/!-S(1YUQY8]N37= =!177#*L/'>[,98 MRH]M#FH/!EC&1YK&4>C5K0Z+I\!!CMU7'2K]%=L,-1I_#%'/*K.6[&+%&H 5 M% '3BGT45T&84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 5PFF?\E0U7_=3_T&N[KA-,_Y*AJO^ZG_ *#6<]UZE1ZG M=T445H2%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%9.J^)-*T8?Z;=I&V,A<\TG))78 MTF]C5) &20!ZFN6\0>/=(T)9(_.6>Y4<1*>M><^*OB#?ZO))!I\IALR<$8Y/ MXUQ+!G2?4G)/XU:$?MT[_ .?K3UB)K@E5E)W;.E12V*HB],4\15:$.??Z5)Y.#P,5 MDY%6*8C]JD$)]/Q_.KT5NTCA%!+'H!U_SQ_G%=3H/@+4-6,2_?\OS MIP4INT4#M%79QT5K)*ZI&C2,QP @R:[?P]\-+[4?+GU$_9;<_,%7EF'H<]*] M(T/PEINAHC0PJTX'S2DNZLW-GL M4Z:A&R(EC'8?G4@C'''/L*F6/U'^?\_RJ0)S_G_/_P"NN9R-;%?RQCIQ2[#Z M?I5@+CT_"EVX_#_ZU+F'8@V>QI?+_P _I4XC]CUH$? XI6/\ /^?\_P UV#_/^?I_GK/L%*%YSZ4K MA8K^7Z@_Y_S_ )[FP8SCCV[U/M7Z4%1G-%PL5C'UIABSVS5O8..AI-G^F/I5SR_;]*79Z?F M/\^P_*CG"Q3\D]"/;I1Y7L:N>6/3BE\L^G/K_G_/2CG"Q3\G)I1#CVJYY?\ MG/\ G_(%)Y9^G%+G'8J^3QTS1Y6*M;?;GUH"'J :.8+%;R>_'UI?*[59V'/2 MCR^_^12Y@L5A$3TI?+XZ\U8V=!CBC8<4^8+%?RQ2^6*GV?D:#'G.<4N8+$'E M\<#/T_S]:7RQSQ4^WOD9HV^XHY@L0;![^M*4X/M^/^?\_A+@ _>&:7RSGCFE M<+$.P'C']?\ /3_/-+CC_/\ G_\ 7^4QC]C@^U&PC^!SGT4T7 A"9[#FC9VV M_ACM5A()9'4+#*Q/3Y35E=,O' VV[8^G>J49RV3$VENS.VDC)'U]_P#.*7;_ M /KK570M2D VVI_'BK$?A;5I",VRJ#U):M%0K2V@_N)=2"W:,+;^'^?_ -7Y M4NWZX^E=,GA#4#][:H^M3IX)N6^_<[3["M5@L2]H$/$4E]HY(IP>/\_Y_F:7 M9^/^?\_Y-=O%X&1<^9>,WT'%6$\%V@QND9JVCEF)?2WS(>+I+J:7R\\CFO1X_".E+]Z#=^-6X_#VEQ*%2U08K:.45GO)$/&PZ)GEPC./N,?HM M2Q6L\I.R"4^^P@5ZK'IUI%C9 @Q[58$:+T11^%;1R;^:?X&;QW:)Y6FBZA-] MRW)'O5R#PIJLF2T"H.WS=:])V@= *6NB.44E\3;,WC9]$<#%X,NVX>0)QVYJ MY#X% 8-->L1W517945O'+,,OLW^9F\75?4YJ+P98J1YC,X]ZO0^&=*@^Y:KN MQC<>36O171'"4([01DZU1[LJQ:;:0_<@4?A5@(@& JX],4ZBMU%+9&;;>X M=!BBBBJ$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M !1110 4444 %%%% !1110 4444 %%%% !1110 5PFF?\E0U7_=3_P!!KNZX M33/^2H:K_NI_Z#6<]UZE1ZG=T445H2%%%% !1110 4444 %%%% !1110 444 M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %% M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444 M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %% M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444 M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 >3>(_B M-J%TSVVDV-U%&,@S&(G=]*\\DAO9I&DFBNY'8DDLC-S^-?3/E1G^!?RH\F/^ MXOY5P5,+.H[RF=$:RBM$?,XM9L _99_IY1IPMIN@M9_^_1Y_2OI;RH_[B_E1 MY4?]Q?RK/ZA_>+^L>1\W"UG'/V>?OSY1]Z>+.;_GVG_&(_X5]'>5'_SS7\J/ M*C_N+^52\O\ [WX#^L^1\Z"UFZ_9I_QB/^%6+?3[FXE"1VLQ9B /W9 YZ\@^M>1RGAKP59:9 D]W;I)>$9)/.WV%=8%"C"@ M>@I:*].G3C35HHY927ZM/XKU7Y)[=HH1G")U_&L9=#U)?O6KY]Z]IV+_='Y4;%_NC M\J\^IET:CO*39TQQ+BK)(\<&BZ@@^:V< <=*D73+H'_CW<'_ ':]>V)_=7\J M78O]T?E7.\HB_MFBQK['D8TZZ _X]W_[YJ,02?\ /"7G_8->P;%SG:,_2C8O M]T?E4O)ETG^!7UY_RGD B?/^JD_[Y-'EN.D4G_?!KUWRD_N+^5'E1_W14_V- M_?\ P']>_N_B>1;'_P">4G_?!I?+;_GG+_WP:];\B(_P"D^S0_\ /-?RI?V- M_?\ P#Z]_=/)O*8_P2?]\G_"@H1U1P<>AKUG[-#_ ,\U_*D^RP_\\Q1_8W]_ M\ ^O?W3R@1G_ )YO_P!\FG;&_N/_ -\&O5OLT(_Y9K1]FA_YYK^5']C?W_P# MZ]_=/*"K#_EG)_WP:3:W_/*3_O@UZQ]FA_YYK^5+]GB'_+,4?V-_?_ /KW]T M\FVN>/*D_P"^#2;&_P">4G_?!KUL0QC^ ?E1Y2#^ ?E1_8W]_P##_@A]>_NG MD?E2'_EE*?\ @!J5+*X= P@EP>A*$5ZP$4=%'Y4NQ3_"/RJEDRZS_ 7UY_RG MDXT^Z/2%OQ!IW]FWF,^2V/I7JVQ?[H_*C:O]T?E5?V-#^9B^O/L>5C2;YONV M[&E&C:AT^S/^5>I;%/51^5+M'H*:R>G_ #,7UZ78\P&@ZD>EL:4>'=7;[MI] M,MBO3L#T%+5?V/1_F8OKL^R/-!X7UEN?LJX_WZ?'X5UAG ,"*.Y+]*](HJEE M%#N_O_X OKM3LCSX>$=0)Y 'XTX>#KX]6 KOZ*O^RL/Y_>3]H_M&(OA32 M% S; _4U8'A_3 ,"U3'I6G16BP]%;17W(EU9O=LHKH]BO2W7\JF2QMD^["H_ M"K%%:*G!;(ER;ZC1%&O1%'T%+L7^Z/RI:*NQ(F .@%+110 4444 %%%% !11 M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M%%%% !7!Z8?^+HZL,'A4[>U=Y52/3+.*_DOD@ N9!AY,G)[?2HE&[0T[%NBB MBK$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % J%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '__9 end EX-101.SCH 11 celh-20221231.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Consolidated Statements of Operations and Comprehensive (Loss) Income link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Consolidated Statements of Changes in Stockholders' Equity and Mezzanine Equity link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - ORGANIZATION AND DESCRIPTION OF BUSINESS link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - EARNINGS PER SHARE link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - REVENUE link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - INVENTORIES link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - PREPAID EXPENSES AND OTHER CURRENT ASSETS link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - NOTE RECEIVABLE link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - LEASES link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - PROPERTY AND EQUIPMENT link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - GOODWILL AND INTANGIBLES link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED EXPENSES link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - OTHER CURRENT LIABILITIES link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - RELATED PARTY TRANSACTIONS link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - MEZZANINE EQUITY link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - STOCKHOLDERS’ EQUITY link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - FAIR VALUE MEASUREMENTS link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - INCOME TAXES link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - STOCK-BASED COMPENSATION link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - EARNINGS PER SHARE (Tables) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - REVENUE (Tables) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - INVENTORIES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - NOTE RECEIVABLE (Tables) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - LEASES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - PROPERTY AND EQUIPMENT (Tables) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - GOODWILL AND INTANGIBLES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000037 - Disclosure - OTHER CURRENT LIABILITIES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000038 - Disclosure - FAIR VALUE MEASUREMENTS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000039 - Disclosure - INCOME TAXES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000040 - Disclosure - STOCK-BASED COMPENSATION (Tables) link:presentationLink link:calculationLink link:definitionLink 00000041 - Disclosure - ORGANIZATION AND DESCRIPTION OF BUSINESS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000042 - Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) link:presentationLink link:calculationLink link:definitionLink 00000043 - Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000044 - Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000045 - Disclosure - EARNINGS PER SHARE (Details) link:presentationLink link:calculationLink link:definitionLink 00000046 - Disclosure - EARNINGS PER SHARE (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000047 - Disclosure - REVENUE (Details) link:presentationLink link:calculationLink link:definitionLink 00000048 - Disclosure - REVENUE (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000049 - Disclosure - INVENTORIES (Details) link:presentationLink link:calculationLink link:definitionLink 00000050 - Disclosure - PREPAID EXPENSES AND OTHER CURRENT ASSETS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000051 - Disclosure - NOTE RECEIVABLE (Details) link:presentationLink link:calculationLink link:definitionLink 00000052 - Disclosure - NOTE RECEIVABLE (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000053 - Disclosure - LEASES (Details) link:presentationLink link:calculationLink link:definitionLink 00000054 - Disclosure - PROPERTY AND EQUIPMENT (Details) link:presentationLink link:calculationLink link:definitionLink 00000055 - Disclosure - PROPERTY AND EQUIPMENT (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000056 - Disclosure - GOODWILL AND INTANGIBLES (Details) link:presentationLink link:calculationLink link:definitionLink 00000057 - Disclosure - GOODWILL AND INTANGIBLES (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000058 - Disclosure - GOODWILL AND INTANGIBLES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000059 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details) link:presentationLink link:calculationLink link:definitionLink 00000060 - Disclosure - OTHER CURRENT LIABILITIES (Details) link:presentationLink link:calculationLink link:definitionLink 00000061 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000062 - Disclosure - MEZZANINE EQUITY (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000063 - Disclosure - STOCKHOLDERS’ EQUITY (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000064 - Disclosure - FAIR VALUE MEASUREMENTS (Details) link:presentationLink link:calculationLink link:definitionLink 00000065 - Disclosure - FAIR VALUE MEASUREMENTS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000066 - Disclosure - INCOME TAXES (Details) link:presentationLink link:calculationLink link:definitionLink 00000067 - Disclosure - INCOME TAXES (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000068 - Disclosure - INCOME TAXES (Details 2) link:presentationLink link:calculationLink link:definitionLink 00000069 - Disclosure - INCOME TAXES (Details 3) link:presentationLink link:calculationLink link:definitionLink 00000070 - Disclosure - INCOME TAXES (Details 4) link:presentationLink link:calculationLink link:definitionLink 00000071 - Disclosure - INCOME TAXES (Details 5) link:presentationLink link:calculationLink link:definitionLink 00000072 - Disclosure - INCOME TAXES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000073 - Disclosure - STOCK-BASED COMPENSATION (Details) link:presentationLink link:calculationLink link:definitionLink 00000074 - Disclosure - STOCK-BASED COMPENSATION (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000075 - Disclosure - STOCK-BASED COMPENSATION (Details 2) link:presentationLink link:calculationLink link:definitionLink 00000076 - Disclosure - STOCK-BASED COMPENSATION (Details 3) link:presentationLink link:calculationLink link:definitionLink 00000077 - Disclosure - STOCK-BASED COMPENSATION (Details 4) link:presentationLink link:calculationLink link:definitionLink 00000078 - Disclosure - STOCK-BASED COMPENSATION (Details 5) link:presentationLink link:calculationLink link:definitionLink 00000079 - Disclosure - STOCK-BASED COMPENSATION (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000080 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 12 celh-20221231_cal.xml XBRL CALCULATION FILE EX-101.DEF 13 celh-20221231_def.xml XBRL DEFINITION FILE EX-101.LAB 14 celh-20221231_lab.xml XBRL LABEL FILE Class of Stock [Axis] Series A Preferred Stock [Member] Equity Components [Axis] Common Stock [Member] Additional Paid-in Capital [Member] AOCI Attributable to Parent [Member] Retained Earnings [Member] Preferred Stock [Member] Business Acquisition [Axis] Func Food Group [Member] Plan Name [Axis] Transition Agreement [Member] Convertible Preferred Stock [Member] Concentration Risk Benchmark [Axis] Revenue Benchmark [Member] Concentration Risk Type [Axis] Customer Concentration Risk Total [Member] Geographical [Axis] PepsiCo Inc [Member] Costco [Member] Amazon [Member] All Other [Member] Accounts Receivable [Member] Publix [Member] Statistical Measurement [Axis] Minimum [Member] Maximum [Member] UNITED STATES SWEDEN FINLAND Other [Member] Income Statement Location [Axis] Foreign Revenues [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] License Agreement [Member] North America [Member] Europe [Member] Asia [Member] Long-Lived Tangible Asset [Axis] Merchandising Equipment Coolers [Member] Office Equipment [Member] Vehicles [Member] Related Party [Axis] Balance Sheet Location [Axis] Contract Assets Current [Member] Contract Assets Non Current [Member] Building [Member] Majority Shareholder [Member] Legal Entity [Axis] C D Financial L L C [Member] Series A Convertible Preferred Stock [Member] Securities Purchase Agreement [Member] Eight Percentage [Member] Ten Percentage [Member] Twelve Percentage [Member] Stock Incentive Plan2015 [Member] Company [Member] Selling Stockholders [Member] Fair Value Hierarchy and NAV [Axis] Fair Value, Inputs, Level 1 [Member] Fair Value, Inputs, Level 2 [Member] Fair Value, Inputs, Level 3 [Member] Indefinite-Lived Intangible Assets [Member] Domestic Tax Authority [Member] Foreign Tax Authority [Member] Non-US [Member] U.S. Federal [Member] U.S State and local [Member] Stock Incentive Plan [Member] General and Administrative Expense [Member] Derivative Instrument [Axis] Vested [Member] Award Type [Axis] Restricted Stock Units (RSUs) [Member] Performance Shares [Member] Exercise Price Range [Axis] Range Of Exercise Price1 [Member] Range Of Exercise Price2 [Member] Range Of Exercise Price3 [Member] Range Of Exercise Price4 [Member] Range Of Exercise Price5 [Member] Range Of Exercise Price6 [Member] Range Of Exercise Price7 [Member] Restricted Stock [Member] NEW YORK Award Date [Axis] November Twenty Three Two Thousens Twenty One [Member] FLORIDA DThreeM Licensing Group [Member] Subsequent Event Type [Axis] Subsequent Event [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] ICFR Auditor Attestation Flag Auditor Firm ID Auditor Name Auditor Location Statement of Financial Position [Abstract] ASSETS Current assets: Cash and cash equivalents Restricted cash Accounts receivable-net Note receivable-current Inventories-net Prepaid expenses and other current assets Deferred other costs-current Total current assets Note receivable Property and equipment-net Deferred tax asset Right of use assets-operating leases Right of use assets-finance leases Other long-term assets Deferred other costs-non-current Intangibles Goodwill Total Assets LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS’ EQUITY Current liabilities: Accounts payable and accrued expenses Accrued distributor termination fees Accrued promotional allowance Lease liability obligation-operating leases Lease liability obligation-finance leases Deferred revenue-current Other current liabilities Total current liabilities Long-term liabilities: Lease liability obligation-operating leases Lease liability obligation-finance leases Deferred tax liability Deferred revenue-non-current Total Liabilities Commitment and contingencies (Note 19) Mezzanine Equity: Series A convertible preferred shares, $0.001 par value, 5% cumulative dividends; 1,467 and 0 shares issued and outstanding at December 31, 2022 and December 31,2021, respectively, aggregate liquidation preference of $550,000 and $0 as of December 31, 2022 and December 31, 2021, respectively Stockholders’ Equity: Common stock, $0.001 par value; 100,000 shares authorized, 76,382 and 74,909 shares issued and outstanding at December 31, 2022 and December 31, 2021, respectively Additional paid-in capital Accumulated other comprehensive (loss) income Accumulated deficit Total Stockholders’ Equity Total Liabilities, Mezzanine Equity and Stockholders’ Equity Statement [Table] Statement [Line Items] Preferred stock, par value Preferred stock cumulative dividend percentage Preferred stock, shares issued Preferred stock, shares outstanding Preferred stock, redemption amount Common stock, par value Common stock, authorized Common stock, issued Common stock, outstanding Income Statement [Abstract] Revenue Cost of revenue Gross profit Selling and marketing expenses General and administrative expenses Total operating expense (Loss) income from operations Other Income/(Expense): Interest income on note receivable Interest income (expense), net Interest expense on bonds Amortization of discount on bonds payable Gain on lease cancellations Foreign exchange (loss) gain European deferred tax Total other income Net (loss) income before income taxes Income tax (expense) benefit Net (loss) income Less: dividends on Series A convertible preferred shares Net (loss) income attributed to common stockholders Other comprehensive income: Foreign currency translation (loss) gain Comprehensive (loss) income (Loss) income per share: Basic Dilutive Weighted average shares outstanding: Basic Dilutive Beginning balance, value Beginning Balances, shares Issuance of common stock Issuance of common stock, shares Issuance of common stock from private placement Issuance of common stock from private placement, shares Share-based expense Issuance of common stock pursuant to exercise of stock options - Cashless Issuance of common stock pursuant to exercise of stock options - Cashless, shares Issuance of common stock pursuant to exercise of stock options - Cash Issuance of common stock pursuant to exercise of stock options - Cash, shares Issuance of Series A convertible preferred shares - net of issuance costs Issuance of Series A convertible preferred shares - net of issuance costs, shares Dividends paid to Series A convertible preferred shares Cash paid for taxes on restricted stock awards Foreign currency translation Short swing payment Net loss Ending balance, value Ending Balance, shares Statement of Cash Flows [Abstract] Cash flows from operating activities: Net (loss) income Adjustments to reconcile net (loss) income to net cash (used in)/provided by operating activities: Depreciation Amortization Impairment of intangible assets Bad debt expense Amortization of deferred other costs Inventory excess and obsolescence Share-based payment expense Deferred income taxes Foreign exchange loss (gain) Gain on lease cancellations Changes in operating assets and liabilities: Accounts receivable-net Inventory-net Prepaid expenses and other current assets Accounts payable and accrued expenses Accrued promotional allowance Accrued distributor termination fees Other assets Other current liabilities Change in right of use and lease obligation-net Deferred revenue Net cash provided by (used in) operating activities Cash flows from investing activities: Proceeds from note receivable Purchase of property and equipment Net cash (used in) provided by in investing activities Cash flows from financing activities: Payments on bonds payable Principal payments on finance lease obligations Proceeds from exercise of stock options Cash paid on taxes on restricted stock awards Proceeds from issuance of Series A preferred shares, net of issuance costs Dividends paid on preferred shares Net proceeds from collection of section 16b short swing profit Net proceeds from sale of common stock Net cash provided by financing activities Effect on exchange rate changes on cash and cash equivalents Net increase (decrease) in cash, cash equivalents and restricted cash Cash, cash equivalents and restricted cash at beginning of the period Cash, cash equivalents and restricted cash at end of the period Supplemental disclosures: Cash paid during period for: Taxes Interest European Acquisition Adjustment: Goodwill Other liabilities Organization, Consolidation and Presentation of Financial Statements [Abstract] ORGANIZATION AND DESCRIPTION OF BUSINESS Accounting Policies [Abstract] BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Earnings Per Share [Abstract] EARNINGS PER SHARE Revenue REVENUE Inventory Disclosure [Abstract] INVENTORIES Prepaid Expenses And Other Current Assets PREPAID EXPENSES AND OTHER CURRENT ASSETS Note Receivable NOTE RECEIVABLE Leases LEASES Property, Plant and Equipment [Abstract] PROPERTY AND EQUIPMENT Goodwill and Intangible Assets Disclosure [Abstract] GOODWILL AND INTANGIBLES Payables and Accruals [Abstract] ACCOUNTS PAYABLE AND ACCRUED EXPENSES OTHER CURRENT LIABILITIES Related Party Transactions [Abstract] RELATED PARTY TRANSACTIONS Investments, Debt and Equity Securities [Abstract] MEZZANINE EQUITY Equity [Abstract] STOCKHOLDERS’ EQUITY Fair Value Disclosures [Abstract] FAIR VALUE MEASUREMENTS Income Tax Disclosure [Abstract] INCOME TAXES Share-Based Payment Arrangement [Abstract] STOCK-BASED COMPENSATION Commitments and Contingencies Disclosure [Abstract] COMMITMENTS AND CONTINGENCIES Subsequent Events [Abstract] SUBSEQUENT EVENTS Basis of Presentation Consolidation Policy Significant Estimates Segment Reporting Concentrations of Risk Cash and Cash Equivalents Restricted Cash Accounts Receivable Inventories Property and Equipment Impairment of Long-Lived Assets Long-lived Asset Geographic Data Goodwill Intangible assets Revenue Recognition Deferred Revenue Accrued Distributor Termination Fees Customer Advances Advertising Costs Research and Development Foreign Currency Gain/Losses Fair Value of Financial Instruments Income Taxes Earnings per Share Share-Based Payments Cost of Revenue Operating Expenses Shipping and Handling Costs Recent Accounting Pronouncements Liquidity Schedule of revenue & accounts receivable with customers Schedule of long-lived asset geographic data Schedule of earnings per share, basic and diluted Schedule of net sales by reporting segment Schedule of inventories Schedule of note receivable Schedule of future minimum lease payments Schedule of property and equipment Schedule of accumulated amortization of intangible assets Schedule of future estimated amortization expense Schedule of accounts payable and accrued expenses Schedule of other current liabilities Summary of preferred shares Schedule of domestic and foreign components Schedule of provision for income taxes Schedule of effective rate on income before provision (benefit) for income taxes Schedule of deferred tax assets Schedule of reconciliation of the beginning and ending amounts of unrecognized tax benefits Summary of the filing jurisdictions and open tax years Schedule of black scholes option-pricing model valuation assumption Schedule of outstanding stock options Schedule of employee stock options outstanding Schedule of restricted stock activity Schedule of restricted stock unit activity Schedule of stock-based awards issued to non-employee consultants Schedule of Restructuring and Related Costs [Table] Restructuring Cost and Reserve [Line Items] Date of Acquisition Equity acquired Stock Issued During Period, Shares Proceeds from issuance of convertible preferred stock Termination expenses Schedule of Product Information [Table] Product Information [Line Items] Total Total long-lived assets-net Long-lived assets related to foreign operations Property, Plant and Equipment [Table] Property, Plant and Equipment [Line Items] Amount excess of FDIC limit Allowance for doubtful accounts Inventory reserve Property and equipment estimated useful life Impairment of long lived assets Deferred revenue Deferred Revenue, Noncurrent Deferred revenue-current Termination Expense Termination Payable Distribution agreements termination expense Customer advances Advertising expense Research and development expense Exchange losses Recognized foreign currency gains Foreign Currency Transaction Gain Before Tax Foreign Currency Translation Freight expense Accumulated deficit Net (loss) income Net cash provided by (used in) operating activities Net (loss) income attributed to common shareholders Net cash provided by (used in) operating activities Less: dividends paid to Series A convertible preferred stockholders Net (loss) income attributed to common stockholders Potentially Dilutive Shares Outstanding Net sales Promotional allowance included as a reduction of revenue Revenues Total Payment Payment received Termination expenses sales and marketing Contract with Customer, Liability Upfront payment received Implicit Payment Refund liability Deferred Revenue excess fair value over issuance proceeds contra-revenues Finished goods Raw Materials Less: Inventory reserve Inventories Note Receivable-current Note Receivable-non-current Total Note Receivable Note Receivable description Weighted average interest rate Outstanding principal amount Interest income Instalment collateral shares 2023 2023 2023 2024 2024 2024 2025 2025 2025 2026 2026 2026 Total future minimum lease payments Total future minimum lease payments Total future minimum lease payments Less: Amount representing interest Less: Amount representing interest Less: Amount representing interest Present value of lease liabilities Present value of lease liabilities Present value of lease liabilities Less: current portion Less: current portion Less: current portion Long-term portion Long-term portion Long-term portion Property, Plant and Equipment, Useful Life Property, plant and equipment, gross Less: accumulated depreciation Total Customer relationships Less: accumulated amortization Definite-lived intangible assets, net Brands Less: Impairment Indefinite-lived intangible assets, net Total Intangibles 2023 2024 2025 2026 2027 Thereafter Total Intangible Assets, Net (Including Goodwill) Amortized over estimated useful life Amortization expense Accounts payable Due to Pepsi Accrued freight Accrued expenses Unbilled purchases Total VAT payable State Beverage Container Deposit Total Schedule of Related Party Transactions, by Related Party [Table] Related Party Transaction [Line Items] Preferred stock issued Percentage of Related Party Common Stock Outstanding Net Sales Accounts receivable from related party Related party cash payment Related Party Liability Payable Due Excess of payments from related party Issuance of preferred stock fair value Deferred contract asset in other assets Issuance of deferred contract asset in other assets excess Unamortized deferred contract costs Accumulated amortization of other deferred costs Monthly expense Debt Securities, Available-for-Sale [Table] Debt Securities, Available-for-Sale [Line Items] Preferred Stock, Shares Authorized Preferred Stock Par Value Preferred Stock Stated Value Preferred Stock, Shares Issued Percentage of Share Authorized Cash Consideration to Related Party Issuance Of Preferred Stock Fair Value Per Share of Aggregate Fair Value of Preferred Share Debt Issuance Costs, Net Common Stock, Other Shares, Outstanding Preferred Stock, Liquidation Preference, Value Accrued dividend Dividends Preferred Stock, Dividends Per Share, Declared Percentage of Voting Right, Preferred Stock Preferred Stock, Dividend Rate, Percentage Preferred Stock, Convertible, Conversion Ratio Preferred Stock, Convertible, Shares Issuable Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Number of option shares granted Number of options exercised Sales of common stock Share price Public offering price Additional share purchase Fair Value, Recurring and Nonrecurring [Table] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Preferred stock, value, issued Volatility Rate Risk free interest rate Dividend rate Closing Price Debt discount rate Income before provision for income taxes Current: Domestic State Foreign Current federal, state and local, tax expense Deferred Domestic State and local Foreign Deferred federal, state and local, tax expense Income tax expense (benefit) U.S. Statutory federal rate State taxes, net of federal benefit Tax effect of Pepsi valuation premium Permanent differences, including stock-based compensation Stock based compensation Change in valuation allowance Change in deferred balances Other Effective tax rate Net operating loss carryforwards Charitable contributions Fixed assets Pepsi valuation premium Right of use liability Right of use asset Distributor termination fees Uncertain tax position Stock-based compensation Inventory allowance Intangibles Total deferred tax (liabilities) assets Valuation allowance Net deferred tax (liabilities) assets Gross unrecognized tax benefit, beginning of period Additions based on tax positions related to the current year Additions based on tax positions related to the prior years Reductions due to lapse in statute of limitations and settlements Gross unrecognized tax benefit, end of period Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Table] Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items] Open Tax Year Operating Loss Carryforwards, Federal Operating Loss Carryforwards, State Ownership change Unrealized NOLs due to ownership change Removed from the available NOL carryforward and US NOL deferred tax asset. Operating Loss Carryforwards, Foreign Valuation allowance Unrecognized tax benefits that would impact effective tax rate Uncertain tax positions Unrecognized tax benefits, Interest and penalties Expected volatility Expected term Risk-free interest rate Forfeiture Rate Options outstanding, Balance at Beginning Weighted Average Exercise Price, Balance at beginning Aggregate Intrinsic Value Balance at beginning Weighted Average Remaining Term Ending Balance Options outstanding, Granted Weighted Average Exercise Price, options granted Weighted Average Grant Date Fair Value Granted Options outstanding, Exercised Weighted Average Exercise Price, Exercised Weighted Average Grant Date Fair Value Exercised Aggregate Intrinsic Value Exercised Options outstanding, Forfeiture and cancelled Weighted Average Exercise Price, Forfeiture and cancelled Options outstanding, Balance at end Weighted Average Exercise Price, Balance at end Aggregate Intrinsic Value Balance at end Options outstanding, Exercisable at end Weighted Average Exercise Price, Options Exercisable Aggregate Intrinsic Value Exercisable Weighted Average Remaining Term, exercisable Share-Based Payment Arrangement, Option, Exercise Price Range [Table] Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items] Number outstanding options Weighted average remaining life, outstanding options Weighted average exercise price, outstanding options Number vested options, exercisable Weighted average exercise price, vested options Weighted average remaining life, vested options Unvested at beginning of period Unvested at beginning of period (in Dollars per share) Transfers to restricted stock units Restricted stock Transfers to restricted stock units(in Dollars per share) Granted Restricted stock granted (in Dollars per share) Vested Restricted stock vested (in Dollars per share) Vested Forfeited and cancelled Restricted stock Forfeiture and cancelled (in Dollars per share) Unvested at end of period Unvested at end of period (in Dollars per share) Forfeited and cancelled Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period Number of shares authorized Stock incentive plan, description Provisions of options grant and other share based awards permitted Non-cash compensation expense (in Dollars) Share-based compensation service or vesting period of grant Options to purchase vested Stock Issued During Period, Value, Stock Options Exercised Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Fair value of shares issued (in Dollars) Unrecognized pre-tax non-cash compensation expense (in Dollars) Period unrecognized pre-tax non-cash compensation expense Fair value of shares vested Unrecognized compensation expense Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Aggregate Target Payout If Circumstances Met Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage Incremental compensation cost Product Liability Contingency [Table] Product Liability Contingency [Line Items] Percentage of Fee Received Gain (Loss) Related to Litigation Settlement Sales revenue bench mark receive shares Compensatory damages Reducing award damages value Post-judgment interest rate Accrued liability Contingent commitment to third parties Mezzanine Equity [Abstract] Preferred Stock Cumulative Dividend Percentage Func Food Group [Member] Transition Agreement [Member] Termination expenses sales and marketing Long-lived assets related to foreign operations Represents the other member. Amount paid for Issuance of common stock pursuant to exercise of stock options Cashless. Number of shares Issuance of common stock pursuant to exercise of stock options Cashless. Issuance of common stock pursuant to exercise of stock options - Cash. Cash paid for taxes on restricted stock awards Percentage of Fee Received November Twenty Three Two Thousens Twenty One [Member] Contingent commitment to third parties. Post Judgment Interest Sales revenue bench mark receive shares DThreeM Licensing Group [Member] Reducing award damages value Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award. Weighted Average Grant Date Fair Value Granted Weighted Average Grant Date Fair Value Exercised Weighted Average Remaining Term Ending Balance Information related to range of exercise price. Information related to range of exercise price. Information related to range of exercise price. Information related to range of exercise price. Information related to range of exercise price. Range of exercise price6 Member. Range of exercise price7 Member. Transfers to restricted stock units Unvested at beginning of period (in Dollars per share) Restricted stock Transfers to restricted stock units(in Dollars per share) Restricted stock vested (in Dollars per share) Restricted stock Forfeiture and cancelled (in Dollars per share) Equity-based payment arrangement where one or more employees receive shares of stock (units), stock (unit) options, or other equity instruments, or the employer incurs a liability to the employee in amounts based on the price of the employer's stock (unit). It represents 2015 stock incentive plan during the period. Share based compensation arrangement by share based payment award equity instruments other than options aggregate target payout if circumstances met Fair value of shares issued. Provisions Of Options Grant And Other Share Based Awards Permitted Domestic Domestic Effective Income Tax Rate Reconciliation, Tax Effect of Pepsi Valuation Premium, Percent Permanent Difference Including Stock based Compensation1 Deferred Tax Assets, Pepsi Valuation Premium Deferred Tax Assets, Right of Use Liability Deferred Tax Assets, Right of Use Asset Deferred Tax Assets, Distributor Termination Fees U.S. Federal Member U.S State and local Member Unrealized net operating loss carryforward due to ownership change. Removed from the available NOL carryforward and US NOL deferred tax asset. Ownership change RiskFreeInterestRate Twelve percentage. Public offering price Additional share purchase Preferred stock par value. Preferred stock stated value. Securities Purchase Agreement [Member]. Percentage of share authorized. Cash consideration to related party. Issuance Of Preferred Stock Fair Value Per share of aggregate fair value of preferred share. Accrued dividend Eight percentage. Ten percentage. Percentage of voting right, preferred stock. PepsiCo Inc [Member] Percentage of Related Party Common Stock Outstanding NetSales Related Party Cash Payment Related Party Liability Payable Due Excess Of Payments From Related Party Deferred Contract Asset in Other Assets Proceeds of Issuance of Deferred Contract Asset in Other Assets Excess Unamortized Deferred Contract Costs Contract Assets Current [Member] Contract Assets Non Current [Member] It represents legal entity associated with the company. Value added tax payment. State beverage container deposit Accrued freight Unbilled purchases. Brands total carrying amount Indefinite Lived Intangible Assets, Impairment TotalIntangibles Merchandising Equipment Coolers [Member] Total lease liability payments due next twelve months. Total lease liability payments due year two. Total lease liability payments due year three. Total lease liability payments due year four. Total lease liability payments due. Total lease liability undiscounted excess amount. Total lease liability. Total lease liability current. Total lease liability noncurrent. The description of note receivable. Instalment collateral shares. Promotional allowance included as a reduction of revenue Total payment Payment received Upfront payment received Implicit Payment Refund liability excess fair value over issuance proceeds contra-revenues The information of license agreement. Potentially dilutive shares outstanding. Total long-lived assets. Termination Expense Termination Payable. Distribution agreements termination expense. Exchange losses Freight expense. Assets, Current Assets Liabilities, Current Finance Lease, Liability, Noncurrent Liabilities Stockholders' Equity Attributable to Parent Liabilities and Equity Gross Profit Operating Expenses [Default Label] Operating Income (Loss) Interest Expense, Subordinated Notes and Debentures EuropeanDeferredTax Nonoperating Income (Expense) Income Tax Expense (Benefit) Preferred Stock Dividends, Income Statement Impact Comprehensive Income (Loss), Net of Tax, Attributable to Parent Weighted Average Number of Shares Outstanding, Basic Weighted Average Number of Shares Outstanding, Diluted Shares, Outstanding Dividends, Preferred Stock, Cash InventoryAllowanceForExcessAndObsoleteProducts Foreign Currency Transaction Gain (Loss), Unrealized GainOnLeaseCancellations Increase (Decrease) in Accounts Receivable Increase (Decrease) in Inventories Increase (Decrease) in Prepaid Expense and Other Assets Increase (Decrease) in Accounts Payable and Accrued Liabilities IncreaseDecreaseInAccruedPromotionalAllowance IncreaseDecreaseInAccruedDistributorTerminationsFees Increase (Decrease) in Other Operating Assets IncreaseDecreaseInDeferredRevenueAndOtherCurrentLiabilities Payments to Acquire Property, Plant, and Equipment Net Cash Provided by (Used in) Investing Activities PaymentsOnBondsPayable Finance Lease, Principal Payments Payments of Ordinary Dividends, Preferred Stock and Preference Stock Net Cash Provided by (Used in) Financing Activities Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Goodwill, Impairment Loss Noncash or Part Noncash Acquisition, Other Liabilities Assumed Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block] Deferred Revenue [Default Label] Contract with Customer, Liability, Current Deferred Revenue, Revenue Recognized LessInventoryAllowanceForExcessAndObsoleteProducts Financing Receivable, after Allowance for Credit Loss Finance Lease, Liability, to be Paid, Year One Total Lease Liability Payments Due Next Twelve Months Finance Lease, Liability, to be Paid, Year Two Total Lease Liability Payments Due Year Two Finance Lease, Liability, to be Paid, Year Three Total Lease Liability Payments Due Year Three Finance Lease, Liability, to be Paid, Year Four Total Lease Liability Payments Due Year Four Finance Lease, Liability, to be Paid Total Lease Liability Payments Due Lessee, Operating Lease, Liability, Undiscounted Excess Amount Finance Lease, Liability, Undiscounted Excess Amount Finance Lease, Liability Total Lease Liability Total Lease Liability Noncurrent Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Finite-Lived Intangible Assets, Accumulated Amortization Finite-Lived Intangible Assets, Gross Indefinite-Lived Intangible Assets (Excluding Goodwill) Total Intangibles Finite-Lived Intangible Asset, Expected Amortization, Year One Finite-Lived Intangible Asset, Expected Amortization, Year Two Finite-Lived Intangible Asset, Expected Amortization, Year Three Finite-Lived Intangible Asset, Expected Amortization, Year Four Finite-Lived Intangible Assets, Net Current Federal, State and Local, Tax Expense (Benefit) Deferred Domestic Income Tax Expense Benefit Deferred Foreign Income Tax Expense (Benefit) Deferred Federal, State and Local, Tax Expense (Benefit) Deferred Tax Liabilities, Property, Plant and Equipment Deferred Tax Assets, Right of Use Liability Deferred Tax Assets, Goodwill and Intangible Assets DeferredTaxAssetsLiabilitiesGross Deferred Tax Assets, Valuation Allowance Unrecognized Tax Benefits Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Unvested Weighted Average Grant Date Fair Value EX-101.PRE 15 celh-20221231_pre.xml XBRL PRESENTATION FILE XML 16 R1.htm IDEA: XBRL DOCUMENT v3.23.1
Cover - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Feb. 14, 2023
Jun. 30, 2022
Cover [Abstract]      
Document Type 10-K/A    
Amendment Flag true    
Amendment Description This Amendment No. 1 on Form 10-K/A (“Amendment No. 1”) is being filed to amend Celsius Holdings, Inc.’s (together with its consolidated subsidiaries, the “Company”) Annual Report on Form 10-K for the fiscal year ended December 31, 2022 (“Original Filing”), filed with the U.S. Securities and Exchange Commission (“SEC”) on March 1, 2023 (“Original Filing Date”). The sole purpose of this Amendment No. 1 is to amend Exhibits 31.2 and 32.2 to reflect that Jarrod Langhans was the Chief Financial Officer at the time of the Original Filing and to correct paragraph 4(c) of the certifications of its Chief Executive Officer filed as Exhibit 31.1 and Chief Financial Officer filed as Exhibit 31.2 to the Original Form 10-K. The corrected certifications are filed as Exhibits 31.1, 31.2 and 32.2 to this Amendment No. 1.   In addition, the Company is including in this Amendment No. 1 a currently dated consents of Ernst & Young LLP and Assurance Dimensions, Inc., its auditors, attached hereto as Exhibit 23.1 and 23.2, and as required by Rule 12b-15 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), the Company’s principal executive officer and principal financial officer are providing new currently dated certifications required pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant Section 302 of the Sarbanes-Oxley Act of 2002, which are filed hereto as Exhibits 31.1 and 31.2.   Except as described above, this Amendment No. 1 does not amend, update or change any other items or disclosures in the Original Filing. This Amendment No. 1 speaks only as of the Original Filing Date, and the Company has not undertaken herein to amend, supplement or update any information contained in the Original Filing to give effect to any subsequent events. Accordingly, this Amendment No. 1 should be read in conjunction with the Company’s filings made with the SEC subsequent to the filing of the Original Filing, including any amendment to those filings.    
Document Annual Report true    
Document Transition Report false    
Document Period End Date Dec. 31, 2022    
Document Fiscal Period Focus FY    
Document Fiscal Year Focus 2022    
Current Fiscal Year End Date --12-31    
Entity File Number 001-38149    
Entity Registrant Name CELSIUS HOLDINGS, INC.    
Entity Central Index Key 0001341766    
Entity Tax Identification Number 20-2745790    
Entity Incorporation, State or Country Code NV    
Entity Address, Address Line One 2424 N. Federal Highway    
Entity Address, Address Line Two Suite 208    
Entity Address, City or Town Boca Raton    
Entity Address, State or Province FL    
Entity Address, Postal Zip Code 33431    
City Area Code (561)    
Local Phone Number 276-2239    
Title of 12(b) Security Common Stock, $0.001 par value    
Trading Symbol CELH    
Security Exchange Name NASDAQ    
Entity Well-known Seasoned Issuer Yes    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Large Accelerated Filer    
Entity Small Business false    
Entity Emerging Growth Company false    
Entity Shell Company false    
Entity Public Float     $ 4,935,115,169
Entity Common Stock, Shares Outstanding   76,706,874  
Documents Incorporated by Reference [Text Block] Portions of the registrant’s Definitive Proxy Statement to be filed subsequent to the date hereof with the Securities and Exchange Commission (the “SEC”) pursuant to Regulation 14A in connection with the registrant’s 2023 Annual Meeting of Stockholders are incorporated by reference into Part III of this Report. Such Definitive Proxy Statement will be filed with the SEC no later than 120 days after the conclusion of the registrant’s fiscal year ended December 31, 2022.    
ICFR Auditor Attestation Flag true    
Auditor Firm ID 42    
Auditor Name Ernst & Young LLP    
Auditor Location Boca Raton, Florida    
XML 17 R2.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 614,159 $ 16,255
Restricted cash 38,768
Accounts receivable-net 63,311 38,741
Note receivable-current 2,979 2,588
Inventories-net 173,289 191,222
Prepaid expenses and other current assets 11,341 13,555
Deferred other costs-current 14,124
Total current assets 917,971 262,361
Note receivable 3,574 7,117
Property and equipment-net 10,185 3,180
Deferred tax asset 501 9,019
Right of use assets-operating leases 972 1,128
Right of use assets-finance leases 208 86
Other long-term assets 263 299
Deferred other costs-non-current 262,462
Intangibles 12,254 16,301
Goodwill 13,679 14,527
Total Assets 1,222,069 314,018
Current liabilities:    
Accounts payable and accrued expenses 107,340 72,442
Accrued distributor termination fees 3,986
Accrued promotional allowance 35,977 19,037
Lease liability obligation-operating leases 661 512
Lease liability obligation-finance leases 70 157
Deferred revenue-current 9,675
Other current liabilities 3,586 976
Total current liabilities 161,295 93,124
Long-term liabilities:    
Lease liability obligation-operating leases 326 658
Lease liability obligation-finance leases 162 45
Deferred tax liability 15,919 3,146
Deferred revenue-non-current 179,788
Total Liabilities 357,490 96,973
Mezzanine Equity:    
Series A convertible preferred shares, $0.001 par value, 5% cumulative dividends; 1,467 and 0 shares issued and outstanding at December 31, 2022 and December 31,2021, respectively, aggregate liquidation preference of $550,000 and $0 as of December 31, 2022 and December 31, 2021, respectively 824,488
Stockholders’ Equity:    
Common stock, $0.001 par value; 100,000 shares authorized, 76,382 and 74,909 shares issued and outstanding at December 31, 2022 and December 31, 2021, respectively 76 75
Additional paid-in capital 280,668 267,846
Accumulated other comprehensive (loss) income (1,881) 614
Accumulated deficit (238,772) (51,490)
Total Stockholders’ Equity 40,091 217,045
Total Liabilities, Mezzanine Equity and Stockholders’ Equity $ 1,222,069 $ 314,018
XML 18 R3.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Common stock, par value $ 0.001 $ 0.001
Common stock, authorized 100,000,000 100,000,000
Common stock, issued 76,382,000 74,909,000
Common stock, outstanding 76,382,000 74,909,000
Series A Preferred Stock [Member]    
Preferred stock, par value $ 0.001 $ 0.001
Preferred stock cumulative dividend percentage 5.00% 5.00%
Preferred stock, shares issued 1,467,000 0
Preferred stock, shares outstanding 1,467,000 0
Preferred stock, redemption amount $ 550,000 $ 0
XML 19 R4.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Operations and Comprehensive (Loss) Income - USD ($)
shares in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Income Statement [Abstract]      
Revenue $ 653,604 $ 314,272 $ 130,726
Cost of revenue 382,735 186,103 69,752
Gross profit 270,869 128,169 60,974
Selling and marketing expenses 352,767 74,739 34,875
General and administrative expenses 75,903 57,520 18,187
Total operating expense 428,670 132,259 53,062
(Loss) income from operations (157,801) (4,090) 7,912
Other Income/(Expense):      
Interest income on note receivable 237 315 356
Interest income (expense), net 5,292 (8) (66)
Interest expense on bonds (432)
Amortization of discount on bonds payable (576)
Gain on lease cancellations 152
Foreign exchange (loss) gain (392) (276) 1,376
European deferred tax (82)
Total other income 5,137 31 728
Net (loss) income before income taxes (152,664) (4,059) 8,640
Income tax (expense) benefit (34,618) 7,996 (116)
Net (loss) income (187,282) 3,937 8,524
Less: dividends on Series A convertible preferred shares (11,526)
Net (loss) income attributed to common stockholders (198,808) 3,937 8,524
Other comprehensive income:      
Foreign currency translation (loss) gain (2,495) 817 551
Comprehensive (loss) income $ (201,303) $ 4,754 $ 9,075
(Loss) income per share:      
Basic $ (2.63) $ 0.05 $ 0.12
Dilutive $ (2.63) $ 0.05 $ 0.11
Weighted average shares outstanding:      
Basic 75,649 73,781 70,195
Dilutive 75,649 77,689 74,444
XML 20 R5.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Changes in Stockholders' Equity and Mezzanine Equity - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
AOCI Attributable to Parent [Member]
Retained Earnings [Member]
Total
Preferred Stock [Member]
Beginning balance, value at Dec. 31, 2019 $ 69 $ 127,553 $ (754) $ (63,409) $ 63,459
Beginning Balances, shares at Dec. 31, 2019 68,941        
Issuance of common stock from private placement $ 1 21,891 21,892
Issuance of common stock from private placement, shares 1,438          
Share-based expense 6,340 6,340
Issuance of common stock pursuant to exercise of stock options - Cashless $ 1 (1)
Issuance of common stock pursuant to exercise of stock options - Cashless, shares 568          
Issuance of common stock pursuant to exercise of stock options - Cash $ 1 4,125 4,126
Issuance of common stock pursuant to exercise of stock options - Cash, shares 1,316          
Cash paid for taxes on restricted stock awards (115) (542) (657)
Foreign currency translation 551 551
Short swing payment 91 91
Net loss 8,524 8,524
Ending balance, value at Dec. 31, 2020 $ 72 159,884 (203) (55,427) 104,326
Ending Balance, shares at Dec. 31, 2020 72,263        
Issuance of common stock $ 1 67,768 67,769
Issuance of common stock, shares 1,134          
Share-based expense 36,475 36,475
Issuance of common stock pursuant to exercise of stock options - Cashless $ 1 1
Issuance of common stock pursuant to exercise of stock options - Cashless, shares 540          
Issuance of common stock pursuant to exercise of stock options - Cash $ 1 3,719 3,720
Issuance of common stock pursuant to exercise of stock options - Cash, shares 972          
Foreign currency translation 817 817
Net loss 3,937 3,937
Ending balance, value at Dec. 31, 2021 $ 75 267,846 614 (51,490) 217,045
Ending Balance, shares at Dec. 31, 2021 74,909        
Share-based expense 20,665 20,665
Issuance of common stock pursuant to exercise of stock options - Cashless
Issuance of common stock pursuant to exercise of stock options - Cashless, shares 448          
Issuance of common stock pursuant to exercise of stock options - Cash $ 1 3,683 3,684
Issuance of common stock pursuant to exercise of stock options - Cash, shares 1,025          
Issuance of Series A convertible preferred shares - net of issuance costs $ 824,488
Issuance of Series A convertible preferred shares - net of issuance costs, shares           1,467
Dividends paid to Series A convertible preferred shares (11,526)   (11,526)  
Foreign currency translation (2,495) (2,495)
Net loss (187,282) (187,282)
Ending balance, value at Dec. 31, 2022 $ 76 $ 280,668 $ (1,881) $ (238,772) $ 40,091 $ 824,488
Ending Balance, shares at Dec. 31, 2022 76,382         1,467
XML 21 R6.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Cash flows from operating activities:      
Net (loss) income $ (187,282) $ 3,937 $ 8,524
Adjustments to reconcile net (loss) income to net cash (used in)/provided by operating activities:      
Depreciation 1,362 550 127
Amortization 555 714 1,484
Impairment of intangible assets 2,379
Bad debt expense 2,352 1,494 257
Amortization of deferred other costs 5,885
Inventory excess and obsolescence 6,131 2,355 748
Share-based payment expense 20,665 36,475 6,340
Deferred income taxes 20,244 (9,201)
Foreign exchange loss (gain) 483 880 (323)
Gain on lease cancellations (28) (152)
Changes in operating assets and liabilities:      
Accounts receivable-net (26,369) (25,249) (7,469)
Inventory-net 11,802 (175,174) (3,859)
Prepaid expenses and other current assets 2,214 1,072 (10,457)
Accounts payable and accrued expenses 34,908 51,807 4,743
Accrued promotional allowance 16,940 13,379 3,377
Accrued distributor termination fees 3,986
Other assets 37
Other current liabilities 2,610 374 (96)
Change in right of use and lease obligation-net (183) 29 151
Deferred revenue 189,463
Net cash provided by (used in) operating activities 108,182 (96,586) 3,395
Cash flows from investing activities:      
Proceeds from note receivable 2,592 1,886 1,331
Purchase of property and equipment (8,264) (3,150) (574)
Net cash (used in) provided by in investing activities (5,672) (1,264) 757
Cash flows from financing activities:      
Payments on bonds payable (9,602)
Principal payments on finance lease obligations (63) (94) (280)
Proceeds from exercise of stock options 3,683 3,720 4,127
Cash paid on taxes on restricted stock awards (657)
Proceeds from issuance of Series A preferred shares, net of issuance costs 542,018
Dividends paid on preferred shares (11,526)
Net proceeds from collection of section 16b short swing profit 91
Net proceeds from sale of common stock 67,769 21,892
Net cash provided by financing activities 534,112 71,395 15,571
Effect on exchange rate changes on cash and cash equivalents 50 (538) 434
Net increase (decrease) in cash, cash equivalents and restricted cash 636,672 (26,993) 20,157
Cash, cash equivalents and restricted cash at beginning of the period 16,255 43,248 23,091
Cash, cash equivalents and restricted cash at end of the period 652,927 16,255 43,248
Supplemental disclosures:      
Taxes 14,335
Interest 7 448
Goodwill 396
Other liabilities $ (396)
XML 22 R7.htm IDEA: XBRL DOCUMENT v3.23.1
ORGANIZATION AND DESCRIPTION OF BUSINESS
 12 Months Ended
Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
ORGANIZATION AND DESCRIPTION OF BUSINESS

 

1.ORGANIZATION AND DESCRIPTION OF BUSINESS

 

Business — Celsius Holdings, Inc. (the “Company” or “Celsius Holdings”) was incorporated under the laws of the State of Nevada on April 26, 2005. On January 24, 2007, the Company entered into a merger agreement and plan of reorganization with Elite FX, Inc., a Florida corporation. Under the terms of the Merger Agreement, Elite FX, Inc. was merged into the Company’s subsidiary, Celsius, Inc. and became a wholly-owned subsidiary of the Company on January 26, 2007. In addition, on March 28, 2007 the Company established Celsius Netshipments, Inc. a Florida corporation as a subsidiary of the Company.

 

On February 7, 2018, the Company established Celsius Asia Holdings Limited, a Hong Kong corporation, as a wholly-owned subsidiary of the Company. On February 7, 2018 Celsius China Holdings Limited, a Hong Kong corporation, became a wholly-owned subsidiary of Celsius Asia Holdings Limited and on May 9, 2018, Celsius Asia Holdings Limited established Celsius (Beijing) Beverage Limited, a China corporation, as a wholly-owned subsidiary of Celsius Asia Holdings Limited.

 

On October 25, 2019, the Company acquired 100% of Func Food Group, Oyj (“Func Food”). The Acquisition was structured as a purchase of all of Func Food’s equity shares and a restructuring of Func Food’s pre-existing debt. Func Food was the Nordic distributor for the Company since 2015. Func Food is a marketer and distributor of nutritional supplements, health food products, and beverages.

 

On August 1, 2022 (“Effective Date”), the Company and PepsiCo Inc. (“Pepsi”), entered into multiple agreements, including a Securities Purchase Agreement (“Purchase Agreement”), Lock-Up Agreements, Registration Rights Agreement, a distribution agreement (“Distribution Agreement”), and a Channel Transition Agreement (“Transition Agreement”). The Securities Purchase Agreement, Lock-Up Agreements and Registration Rights Agreement pertain to the Company’s issuance of 1,466,666 shares of Series A Convertible Preferred Stock (“Series A” or “Series A Preferred Stock”) in exchange for cash proceeds of $550 million, excluding transaction costs. The Transition Agreement specifies payments to be made by Pepsi to Celsius for transitioning certain existing distribution rights to Pepsi. The Distribution Agreement resulted in Pepsi becoming the Company’s primary distribution supplier for the Company’s products in the United States. See Note 13. Related Party Transactions and Note 14. Mezzanine Equity for more information.

 

In connection with the Distribution Agreement and Transition Agreement, the Company terminated agreements with existing suppliers to transition territory rights to Pepsi. The Company recognized total termination expenses of $193.8 million, which are presented in Sales and marketing expenses on the consolidated statement of operations and comprehensive (loss) income for the year ended December 31, 2022. These expenses were recognized by the Company upon delivery of termination notices to the other distributors, in accordance with ASC Topic 420 Exit or Disposal Cost Obligations.

 

The Company is engaged in the development, marketing, sale and distribution of “functional” calorie-burning functional energy drinks and liquid supplements under the Celsius® brand name.

 
XML 23 R8.htm IDEA: XBRL DOCUMENT v3.23.1
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
 12 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

2.BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation — The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) and the rules and regulations of the SEC.

 

Consolidation Policy — The accompanying consolidated financial statements include the accounts of Celsius Holdings, Inc. and its subsidiaries. All inter-company balances and transactions have been eliminated in consolidation.

 

Significant Estimates — The preparation of consolidated financial statements and accompanying disclosures in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue and expenses and disclosure of contingent assets and liabilities at the date of the financial statements. Although these estimates are based on management’s best knowledge of current events and actions that the Company may undertake in the future, actual results may differ from those estimates. Significant estimates include the allowance for doubtful accounts, allowance for inventory obsolescence and sales returns, preferred share valuation, the useful lives of property and equipment, impairment of goodwill and intangibles, deferred tax asset valuation allowance, promotional allowance, and valuation of stock-based compensation. Additionally, the business and economic uncertainty resulting from the novel coronavirus (COVID-19) pandemic has made such estimates and assumptions more difficult to calculate. Accordingly, actual results and outcomes could differ from those estimates.

 

Segment Reporting — Operating segments are defined as components of an enterprise that engage in business activities, have discrete financial information, and whose operating results are regularly reviewed by the chief operating decision maker (“CODM”) to make decisions about allocating resources and to assess performance. Even though the Company has operations in several geographies, it operates as a single enterprise. The Company’s operations and strategies are centrally designed and executed given that our geographical components are very similar. Our CODM, the CEO, reviews operating results primarily from a consolidated perspective, and makes decisions and allocates resources based on that review. The reason the Company’s CODM focuses on consolidated results in making decisions and allocating resources is because of the significant economic interdependencies between the Company’s geographical operations and the Company’s U.S. entity.

 

Concentrations of Risk — Substantially all of the Company’s revenue derives from the sale of Celsius ® functional energy drinks and liquid supplements.

 

Pepsi and the Company signed a distribution agreement on August 1, 2022, resulting in Pepsi acting as the Company’s preferred distributor performing the direct store delivery for a majority of the Company’s U.S. operations.

 

Revenue of our customers accounting for more than 10%, for the years ended December 31, 2022, 2021 and 2020, are as follows:

 

               
   2022   2021   2020 
Pepsi   22.2%   -    - 
Costco   16.7%   12.7%   2.9%
Amazon   8.8%   10.1%   15.1%
All other   52.3%   77.2%   82.0%
Total   100.0%   100.0%   100.0%

 

Accounts receivable of our customers accounting for more than 10%, for the years ended December 31, 2022, and 2021, are as follows:

 

           
   2022   2021 
Pepsi   47.6%   - 
Amazon   11.8%   22.7%
Publix   1.4%   10.3%
All other   39.2%   67.0%
Total   100.0%   100.0%

 

Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable. The Company places its cash and cash equivalents with high-quality financial institutions. At times, balances in the Company’s cash accounts may exceed the Federal Deposit Insurance Corporation limit. At December 31, 2022 and 2021, the Company had approximately $652.4 million and $16.0 million, respectively, including $38.8 million in restricted cash for 2022, in excess of the Federal Deposit Insurance Corporation limit.

 

Cash and Cash Equivalents — The Company considers all highly liquid instruments with an original maturity of three months or less when purchased to be cash equivalents.

 

Restricted Cash — As disclosed in Note 4. Revenues, the Company received upfront payments from Pepsi during 2022, which are contractually restricted and can only be used to satisfy termination payments due to former distributors or have to be repaid to Pepsi. These upfront payments received from Pepsi cannot be used for general operating activities of the Company and have been classified as restricted cash based on the terms of the Transition Agreement.

 

Accounts Receivable — Accounts receivable are reported at net realizable value. The Company establishes an allowance for doubtful accounts based upon factors pertaining to the credit risk of specific customers, historical trends, and other information. Delinquent accounts are written-off when it is determined that the amounts are uncollectible. Accounts receivable are presented net of billbacks, for customers that are allowed the right to net settle. At December 31, 2022 and December 31, 2021, there was an allowance for doubtful accounts of approximately $2.1 million and $0.8 million, respectively.

 

Inventories — Inventories are valued at the lower of cost or net realizable value. Cost is determined using the first-in, first-out (FIFO) method. At December 31, 2022 and December 31, 2021, the Company recorded an allowance of approximately $8.4 million and $2.6 million respectively. The changes in the allowance are included in cost of revenue.

 

Property and Equipment — Property and equipment are stated at cost less accumulated depreciation and amortization. Depreciation of property and equipment is calculated using the straight-line method over the estimated useful life of the asset generally ranging from three to seven years.

 

Impairment of Long-Lived Assets — In accordance with ASC Topic 360, Property, Plant, and Equipment the Company reviews the carrying value of long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. An impairment loss is determined regarding a long-lived asset if its carrying amount is not recoverable and exceeds its fair value. The carrying amount is not recoverable when it exceeds the sum of the undiscounted cash flows expected to result from use of the asset over its remaining useful life and final disposition. The Company did not record any impairments related to long lived assets during the years ended December 31, 2022 and December 31, 2021.

 

Long-lived Asset Geographic Data

 

The following table contains long-lived asset information which includes property and equipment and lease right of use assets and excludes goodwill and intangibles, where individual countries represent a material portion of the total:

 

          
   December 31,   December 31, 
   2022   2021 
United States  $9,750   $3,043 
Sweden   1,251    1,050 
Finland   363    301 
Other   1    - 
Long-lived assets related to foreign operations   1,615    1,351 
Total long-lived assets-net  $11,365   $4,394 

 

Goodwill — The Company records goodwill when the consideration paid for the acquisition of a business exceeds the fair value of net tangible and intangible assets acquired, including related tax effects. Goodwill is not amortized; instead, goodwill is tested for impairment on an annual basis as of October 1st, or more frequently if the Company believes indicators of impairment exist. The Company first assesses qualitative factors such as macro-economic conditions, industry and market conditions, and cost factors as well as other relevant events, to determine whether it is more-likely-than-not that the fair value of a reporting unit is less than its carrying value. If it is more likely than not that the fair value of a reporting unit is less than its carrying value, then the Company will calculate the estimated fair value of the reporting unit. If the Company determines that the fair value is less than the carrying value, the Company will recognize an impairment charge based on the excess of a reporting unit’s carrying value over its fair value. At December 31, 2022, there were no indicators of impairment.

 

Intangible assets— Intangible assets are comprised of customer relationships and brands acquired in a business combination. The Company amortizes intangible assets with a definitive life over their respective useful lives. The addition of the Pepsi distribution network has shifted the Company’s focus to the US market and as a consequence it was determined that impairment indicators for the Func Foods brands indefinite intangible asset were present. The Company no longer anticipates focusing on the expansion of Func Food branded products and the Company plans to focus on Celsius branded products. As a result of the strategic shift, which the Company considered a triggering event, the Company quantitatively tested the Func Foods brand name for impairment utilizing the relief from royalty method to determine fair value as of September 30, 2022. As a result of the quantitative assessment, the Company recorded an impairment charge of $2.5 million during the year ended December 31, 2022 which is presented within General and Administrative expenses on the Consolidated Statements of Operations.

 

Revenue Recognition — The Company recognizes revenue in accordance with ASC Topic 606 Revenue from Contracts with Customers. The Company recognizes revenue when performance obligations under the terms of a contract with the customer are satisfied. Product sales occur once control or title is transferred based on the commercial terms. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring goods. Product sales are recorded net of variable consideration, such as provisions for returns, discounts and promotional allowances. Such provisions are calculated using historical averages and adjusted for any expected changes due to current business conditions. Consideration given to customers for cooperative advertising is recognized as a reduction of revenue except to the extent that there is a distinct good or service, in which case the expense is classified as selling or marketing expense. The amount of consideration the Company receives and revenue the Company recognizes varies with changes in customer incentives the Company offers to its customers and their customers. Additionally, for any agreements which are one year or less, the practical expedient under ASC 340-40-25-4 is applied to expense contract acquisition costs when incurred if the amortization period of the contract asset would have otherwise been recognized in one year or less. Sales taxes and other similar taxes are excluded from revenue. Management believes that adequate provision has been made for cash discounts, returns, spoilage and promotional allowances based on the Company’s historical experience.

 

Deferred Revenue — The Company receives payments from certain distributors in new territories as reimbursement for contract termination costs paid to the prior distributors in those territories. Amounts received pursuant to these new and/or amended distribution agreements entered into with certain distributors relating to the costs associated with terminating the Company’s prior distributors, are accounted for as deferred revenue and recognized ratably over the anticipated life of the respective new distribution agreements. As of December 31, 2022, the Company had approximately $189.5 million in deferred revenue, of which $179.8 million is classified as deferred revenue-non-current and $9.7 million is classified as deferred revenue-current which are presented within the consolidated balance sheets and are contract liabilities related to termination payments received from Pepsi. Refer to Note 13, Related Party Transactions for more information. The deferred revenues will be recognized by the Company, ratably over the twenty-year agreement term. As of December 31, 2021, the Company did not have any deferred revenue related to contract liabilities.

 

Accrued Distributor Termination Fees — Termination charges related to certain of the Company’s prior distributors are included in selling and marketing expenses upon termination. The Company recognized distributor termination expenses of approximately $193.8 million, $0.6 million, and $0.2 million for the year ended December 31, 2022, 2021, and 2020, respectively. The Company also has a balance of $4.0 million in accrued distributor termination fees related to distributors terminated as a result of the Pepsi agreement as well as payment due back to Pepsi in the amount of $34.8 million as the projected payments to the prior distributors was less than the payment received from Pepsi, which are located within accounts payable and accrued expenses, on the Company’s consolidated balance sheets.

 

Customer Advances — From time to time the Company requires deposits in advance of delivery of products and/or production runs. Such amounts are initially recorded as customer advances liability within other current liabilities. The Company recognizes such revenue as it is earned in accordance with revenue recognition policies. As of December 31, 2022 and 2021, the Company did not have any customer advances.

 

Advertising Costs — Advertising costs are expensed as incurred. The Company uses mainly radio, local sampling events, sponsorships, endorsements, and digital advertising. The Company incurred advertising expenses of approximately $85.1 million, $36.7 million and $14.2 million, during years ended December 31, 2022, 2021, and 2020, respectively.

 

Research and Development — Research and development costs are charged to general and administrative expenses as incurred and consist primarily of consulting fees, raw material usage and test productions of beverages. The Company incurred expenses of approximately $0.4 million, $1.0 million and $0.5 million during years ended December 31, 2022, 2021, and 2020, respectively.

 

Foreign Currency Gain/Losses — Foreign subsidiaries’ functional currency is the local currency of operations and the net assets of foreign operations are translated into U.S. dollars using current exchange rates. The foreign subsidiaries perform re-measurements of their assets and liabilities denominated in non-functional currencies on a periodic basis and the gain or losses from these adjustments are included in the consolidated statement of operations and comprehensive (loss) income as foreign exchange gains or losses. For the year ended December 31, 2022 exchange losses have amounted to approximately $0.4 million while during the years ended December 31, 2021 and 2020, the Company recognized a foreign currency loss and gain of approximately $0.3 million and $1.4 million, respectively, mainly related to fluctuations in exchange rates. Translation gains and losses that arise from the translation of net assets from functional currency to the reporting currency, as well as exchange gains and losses on intercompany balances of long-term investment nature, are included in Other Comprehensive Income. The Company incurred foreign currency translation net loss during the year ended December 31, 2022 of approximately $2.5 million and a net gain of approximately $0.8 million and $0.6 million during the year ended December 31, 2021 and 2020. The Company’s operations in different countries required that it transacts in the following currencies:

 

Chinese-Yuan

Norwegian-Krone

Swedish-Krona

Finland-Euro

 

Fair Value of Financial Instruments — The carrying value of cash, cash equivalents, restricted cash, accounts receivable, accounts payable, accrued expenses and other current liabilities approximate fair value due to their relative short-term maturity and market interest rates.

 

Income Taxes — The Company accounts for income taxes pursuant to the provisions of ASC Topic 740 Accounting for Income Taxes, which requires, among other things, an asset and liability approach to calculating deferred income taxes. The asset and liability approach require the recognition of deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the carrying amounts and the tax bases of assets and liabilities. A valuation allowance is provided to offset any net deferred tax assets for which management believes it is more likely than not that the net deferred asset will not be realized. The Company follows the provisions of the ASC 740-10 related to Accounting for Uncertain Income Tax Positions. When tax returns are filed, it is highly certain that some positions taken would be sustained upon examination by the taxing authorities, while others are subject to uncertainty about the merits of the position taken or the amount of the position that would be ultimately sustained. In accordance with the guidance of ASC 740-10, the benefit of a tax position is recognized in the financial statements in the period during which, based on all available evidence, management believes it is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any.

 

Tax positions taken are not offset or aggregated with other positions. Tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with the applicable taxing authority. The portion of the benefits associated with tax positions taken that exceeds the amount measured as described above is reflected as a liability for uncertain tax benefits in the accompanying consolidated balance sheet, along with any associated interest and penalties that would be payable to the taxing authorities upon examination.

 

The Company has adopted ASC 740-10-25 Definition of Settlement, which provides guidance on how an entity should determine whether a tax position is effectively settled for the purpose of recognizing previously unrecognized tax benefits and provides that a tax position can be effectively settled upon the completion of an examination by a taxing authority without being legally extinguished. For tax positions considered effectively settled, an entity would recognize the full amount of tax benefit, even if the tax position is not considered more likely than not to be sustained based solely on the basis of its technical merits and the statute of limitations remains open.

 

The Company’s tax returns for tax years in 2019 through 2021 remain subject to potential examination by the taxing authorities.

 

Earnings per Share — The Company computes earnings per share in accordance with ASC Topic 260 Earnings per Share (“ASC 260”), which requires earnings per share (“EPS”) for each class of stock (common stock and participating preferred stock) to be calculated using the two-class method. The two-class method is an allocation of earnings (distributed and undistributed) between the holders of common stock and a company’s participating security holders. Under the two-class method, earnings for the reporting period are allocated between common stockholders and other security holders based on their respective participation rights in undistributed earnings.

 

Basic earnings per common share is computed by dividing income or loss available to common stockholders by the weighted average number of shares of basic common stock outstanding. The Company’s Series A Convertible Preferred Stock is classified as a participating security in accordance with ASC 260. Net income allocated to the holders of Series A Convertible Preferred Stock will be calculated based on the stockholders’ proportionate share of weighted average shares of common stock outstanding on an if-converted basis. See Note 3. Earnings Per Share for more information.

 

Share-Based Payments — The Company follows the provisions of ASC Topic 718 Compensation — Stock Compensation and related interpretations. As such, compensation cost is measured on the date of grant at the fair value of the share-based payments. Such compensation amounts, if any, are amortized over the respective vesting periods of the grants. On April 30, 2015, the Company adopted the 2015 Stock Incentive Plan (the “2015 Plan”). This 2015 Plan is intended to provide incentives which will attract and retain highly competent persons at all levels as employees of the Company, as well as independent contractors providing consulting or advisory services to the Company, by providing them opportunities to acquire the Company’s common stock. The 2015 Plan permits the grant of options and other share-based awards for up to 5.0 million shares. Provisions have been made to permit the grant of options and other share-based awards for up to 5.0 million shares.

 

Cost of Revenue — Cost of Revenue consists of the cost of concentrates and or liquid bases, the costs of raw materials utilized in the manufacture of products, co-packing fees, repacking fees, in-bound & out-bound freight charges, as well as certain internal transfer costs, warehouse expenses incurred prior to the manufacture of the Company’s finished products, inventory allowance for excess and obsolete products, and certain quality control costs. Raw materials account for the largest portion of the cost of sales. Raw materials include cans, other containers, flavors, ingredients and packaging materials.

 

Operating Expenses — Operating expenses include selling expenses such as warehousing expenses after manufacture, as well as expenses for advertising, samplings and in-store demonstrations costs, costs for merchandise displays, point-of-sale materials and premium items, sponsorship expenses, other marketing expenses and design expenses. Operating expenses also include such costs as payroll costs, travel costs, professional service fees (including legal fees), depreciation and other general and administrative costs.

 

Shipping and Handling Costs — Shipping and handling costs for freight expense on goods shipped are included in cost of sales. Freight expense on goods shipped for the years ended December 31, 2022, 2021 and 2020 was approximately $26.8 million, $26.9 million and $9.5 million, respectively.

 

Certain reclassification of prior period balances have been made to conform to current presentation. Please refer to consolidated balance sheets, Consolidated Statement of Cash Flows and Note 11. Accounts Payable and Accrued Expenses

 

Recent Accounting Pronouncements

 

The Company adopts all applicable, new accounting pronouncements as of the specified effective dates.

 

In September 2016, the FASB issued ASU No. 2016-13, Financial Instruments – Credit Losses (Topic 326) (“ASU 2016-13”), which requires the immediate recognition of management’s estimates of current and expected credit losses. In November 2019, the FASB issued ASU 2019-10, which delays the effective date of Topic 326 for Smaller Reporting Companies to interim and annual periods beginning after December 15, 2022, with early adoption permitted. The Company has elected the relief provided. Topic 326 is effective for the Company in the first quarter of 2023. Adoption of the new standard is not expected to have a material impact on our consolidated financial statements or disclosures.

 

Liquidity — These financial statements have been prepared assuming the Company will be able to continue as a going concern. At December 31, 2022, the Company had an accumulated deficit of approximately $238.8 million which includes a net loss available to common stockholders of approximately $198.8 million for year ended December 31, 2022. During the year ended December 31, 2022 the Company’s net cash provided by operating activities totaled approximately $108.2 million. As of December 31, 2021, the Company had an accumulated deficit of $51.5 million which includes a net income available to common stockholders of $3.9 million for year ended December 31, 2021. During the year ended December 31, 2021 the Company’s net cash used by operating activities totaled approximately $96.6 million.

 

If our sales volumes do not meet our projections, expenses exceed our expectations, or our plans change, we may be unable to generate enough cash flow from operations to cover our working capital requirements. In such case, we may be required to adjust our business plan, by reducing marketing, lower our working capital requirements and reduce other expenses or seek additional financing. Furthermore, our business and results of operations may be adversely affected by changes in the global macro-economic environment related to the pandemic and public health crises related to the COVID-19 outbreak.

 
XML 24 R9.htm IDEA: XBRL DOCUMENT v3.23.1
EARNINGS PER SHARE
 12 Months Ended
Dec. 31, 2022
(Loss) income per share:  
EARNINGS PER SHARE

 

3.EARNINGS PER SHARE

 

The Company computes earnings per share in accordance with ASC Topic 260 Earnings per Share (“ASC 260”), which requires earnings per share for each class of stock (common stock and participating preferred stock) to be calculated using the two-class method. The two-class method is an allocation of earnings (distributed and undistributed) between the holders of common stock and a company’s participating security holders. Under the two-class method, earnings for the reporting period are allocated between common stockholders and other security holders based on their respective participation rights in undistributed earnings.

 

Basic earnings per common share is computed by dividing income or loss available to common stockholders by the weighted average number of shares of basic common stock outstanding. The Company’s Series A Convertible Preferred Stock is classified as a participating security in accordance with ASC 260. Net income allocated to the holders of Series A Convertible Preferred Stock consistent of preferred dividends declared and paid during 2022. The Series A Convertible Preferred Stock do not participate in losses, thus no such losses have been allocated to the Series A Convertible Preferred Stock in the periods presented below.

 

For purposes of determining diluted earnings per common share, basic earnings per common share was further adjusted to include the effect of potential dilutive common shares outstanding, including unvested restricted stock and performance-based stock units, using the more dilutive of either the two-class method or the treasury stock method, and Series A Convertible Preferred Stock using the if-converted method. Stock options and warrants that were out-of-the-money were not included in the denominator for the calculation of diluted EPS. Under the two-class method of calculating diluted earnings per share, net income is reallocated to common stock, the Series A Convertible Preferred Stock, and all dilutive securities based on the contractual participating rights of the security to share in the current earnings as if all of the earnings for the period had been distributed.

 

               
  

For the years ended

December 31,

 
   2022   2021   2020 
Net (loss) income attributed to common stockholders               
Net (loss) income  $(187,282)  $3,937   $8,524 
Less: dividends paid to Series A convertible preferred stockholders   (11,526)   -    - 
Net (loss) income attributed to common stockholders  $(198,808)  $3,937   $8,524 
Net (loss) income per common share:               
Basic  $(2.63)  $0.05   $0.12 
Dilutive  $(2.63)  $0.05   $0.11 
Weighted average common stock outstanding:               
Basic   75,649    73,781    70,195 
Dilutive   75,649    77,689    74,444 

 

For the year ended December 31, 2022, 10.2 million of potentially dilutive securities were excluded from the computation of diluted net loss per share related to common stockholders as their effect was antidilutive.

 
XML 25 R10.htm IDEA: XBRL DOCUMENT v3.23.1
REVENUE
 12 Months Ended
Dec. 31, 2022
Disclosure Revenue Abstract  
REVENUE

 

4.REVENUE

 

The Company recognizes revenue in accordance with ASC Topic 606 Revenue from Contracts with Customers. The Company recognizes revenue when performance obligations under the terms of a contract with the customer are satisfied. Product sales occur once control is transferred, based on the commercial terms. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring goods. Product sales are recorded net of variable consideration, such as provisions for returns, discounts and allowances. Such provisions are calculated using historical averages and adjusted for any expected changes due to current business conditions. Consideration given to customers for cooperative advertising is recognized as a reduction of revenue except to the extent that there is a distinct good or service, in which case the expense is classified as selling or marketing expense. The amount of consideration the Company receives and revenue the Company recognizes varies with changes in customer incentives the Company offers to its customers and their customers. Additionally, for any agreements which are one year or less, the practical expedient under ASC 340-40-25-4 is applied to expense contract acquisition costs when incurred if the amortization period of the contract asset would have otherwise been recognized in one year or less.

 

Promotional (Billback) Allowance

 

The Company’s billback allowance programs with its distributors and/or retailers are executed through separate agreements in the ordinary course of business. These agreements generally provide for one or more of the arrangements described above and are of varying durations, typically ranging from one week to one year. The Company’s billbacks are calculated based on various programs with distributors and retail customers, and accruals are established for the Company’s anticipated liabilities. These accruals are based on agreed upon terms as well as the Company’s historical experience with similar programs and require management’s judgment with respect to estimating consumer participation and/or distributor and retail customer performance levels. Differences between such estimated expenses and actual expenses for promotional and other allowance costs have historically been insignificant and are recognized in earnings in the period such differences are determined.

 

Billbacks (variable consideration) recorded as a reduction to net sales, primarily include consideration given to the Company’s distributors or retail customers including, but not limited to the following:

 

●discounts granted off list prices to support price promotions to end-consumers by retailers;

 

●reimbursements given to the Company’s distributors for agreed portions of their promotional spend with retailers, including slotting, shelf space allowances and other fees for both new and existing products;

 

●the Company’s agreed share of fees given to distributors and/or directly to retailers for advertising, in-store marketing and promotional activities;

 

●the Company’s agreed share of slotting, shelf space allowances and other fees given directly to retailers, club stores and/or wholesalers;

 

●incentives given to the Company’s distributors and/or retailers for achieving or exceeding certain predetermined volume goals;

 

●discounted products;

 

●contractual fees given to the Company’s distributors related to sales made directly by the Company to certain customers that fall within the distributors’ sales territories; and

 

●contractual fees given to distributors for items sold below defined pricing targets.

 

For the years ended December 31, 2022, 2021, and 2020, promotional allowance included as a reduction of revenue were $158.5 million, $64.2 million, and $28.7 million, respectively.

 

Information about the Company’s net sales by geographical location for the years ended December 31, 2022, 2021 and 2020 is as follows:

 

               
   For the years ended 
   December 31,
2022		   December 31,
2021		   December 31,
2020		 
North America  $617,457   $273,005   $95,480 
Europe   31,054    38,097    33,727 
Asia   3,647    2,538    1,093 
Other   1,446    632    426 
Net sales  $653,604   $314,272   $130,726 

 

All of the Company’s North America revenue is derived from the United States, which is the Company’s country of domicile. Of the Company’s total foreign revenues of approximately $36.1 million, $41.3 million and $35.2 million for the years ended December 31, 2022, 2021, and 2020, respectively, Sweden represented the largest foreign portion of total consolidated revenue of approximately $21.7 million, $26.9 million, and $23.4 million for the years ended December 31, 2022, 2021, and 2020, respectively.

 

Agreements with PepsiCo, Inc.

 

The Company executed multiple agreements with Pepsi on August 1, 2022, including a Distribution Agreement relating to the sale and distribution of certain of the Company’s beverage products in existing channels and distribution methods in the United States, excluding certain existing customer accounts, sales channels, Puerto Rico and the US Virgin Islands (the “Territory”). Under the Distribution Agreement, the Company has granted Pepsi the right to sell and distribute its existing beverage products in existing channels and distribution methods and future beverage products that are added from time to time as licensed products under the Distribution Agreement in defined territories. The Distribution Agreement represents a master service agreement and can be cancelled by either party without cause in the nineteenth year of the term (i.e., 2041), the twenty-ninth year of the term (i.e., 2051) and each ten (10) year period thereafter (i.e., 2061, 2071, etc.) by providing twelve (12) months’ written notice on August 1st of each such year to the other party. Except for a termination by the Company “with cause” or a termination by Pepsi “without cause”, the Company is required to pay the Purchaser certain compensation upon a termination as specified in the Distribution Agreement.

 

The Company agreed to provide Pepsi a right of first offer in the event the Company intends to (i) manufacture, distribute or sell products in certain additional countries as specified in the Distribution Agreement or (ii) distribute or sell products in any future channels and distribution methods during the term of the Agreement. Additionally, pursuant to the Distribution Agreement, the Company and Pepsi agreed to use commercially reasonable efforts to negotiate and execute with Pepsi a distribution agreement reasonably consistent with the Distribution Agreement for the sale and distribution of the products covered by the Distribution Agreement in Canada, and Pepsi agreed to meet and confer in good faith with the Company regarding the terms and conditions upon which Pepsi may be willing to sell or distribute such products, either directly or through local sub-distributors in certain other additional countries. The Distribution Agreement includes other customary provisions, including non-competition covenants in favor of the Company, representations and warranties, indemnification provisions, insurance provisions and confidentiality provisions.

 

On August 1, 2022, the Company and Pepsi also executed the Transition Agreement, providing for the Company’s transition of certain existing distribution rights in the Territory to Pepsi. Under the terms of the Transition Agreement, Pepsi would pay the Company up to $250 million in multiple tranches to facilitate the Company’s transition of certain distribution rights to Pepsi. Amounts received from Pepsi were contractually restricted to only be used to pay termination fees due to other distributors; any excess cash received over amounts due to other distributors is to be refunded back to Pepsi. During 2022, the Company received $227.8 million in payments from Pepsi. As of December 31, 2022, the Company had recorded $193.8 million in total termination expenses in Selling and marketing expenses, of which $193.0 million in termination expenses are related to the Pepsi transition.

 

Accounting for the agreements executed with PepsiCo, Inc.

 

The Company evaluated the Security Purchase Agreement, Transition Agreement, Distribution Agreement, and other agreements executed with Pepsi on August 1, 2022, as one combined contract since the agreements were executed on the same day, with the same counterparty, in contemplation of one another and contractual terms are defined and referenced across the agreements. These agreements will be referred to as the “Pepsi Arrangement” herein. Management concluded the Pepsi Arrangement was partially in the scope of ASC 606 Revenue from Contracts with Customers (“ASC 606”) and partially in the scopes of ASC 505, Equity (“ASC 505”) and ASC 480, Distinguishing liabilities from equity (“ASC 480”). The Company first applied the measurement and classification criteria in ASC 505 and ASC 480 with respect to the Company’s issuance of 1,446,666 shares of Series A Convertible Preferred Stock, as the substance of the issuance of the Series A Convertible Preferred Stock was determined to be a financing transaction. See Note 14. Mezzanine Equity for the Company’s accounting conclusions with respect to the issuance of the Series A Convertible Preferred Stock.

 

After application of the measurement and classification principles in ASC 505, and ASC 480, the Company accounted for the residual revenue elements of the Pepsi Arrangement under ASC 606. The revenue elements of the Pepsi Arrangement consisted of (i) $227.8 million in payments received from Pepsi under the Transition Agreement and (ii) a $282.5 million implicit payment made to Pepsi by Celsius, representing the excess fair value over issuance proceeds received for the Series A Convertible Preferred Stock.

 

The $227.8 million upfront payment received from Pepsi was only to be used by Celsius to transition territory rights from terminated distributors to Pepsi; any excess cash received from Pepsi over transition payments made by Celsius to the Company’s terminated distributors was contractually restricted and due back to Pepsi. As of December 31, 2022, the Company has recorded a refund liability of $34.8 million in accounts payable and accrued expenses representing cash refunds due back to Pepsi and recognized the difference of $193.0 million as part of deferred revenues. The deferred revenues will be recognized by Celsius ratably over the twenty-year agreement term. The Company recognized $4.2 million of total deferred revenues in the consolidated statement of separations in the year ended December 31, 2022.

 

The $282.5 million excess fair value over issuance proceeds of the Series A Convertible Preferred Stock represents an implicit payment made to a customer. The Company concluded that this implicit payment meets the definition of an asset, and has been recorded as a Deferred Other Cost current and non-current, in the Company’s consolidated balance sheets. The Company will amortize the asset balance as contra-revenues ratably over a twenty-year period consistent with the term of the Distribution Agreement. The Company recognized contra-revenues of $5.9 million in the consolidated statement of operations and comprehensive (loss) income in the year ended December 31, 2022 related to the upfront payment included in Deferred Other Cost current and non-current. The Company will assess the Deferred Other Cost asset for impairment at each reporting period.

 

For product sales under the Distribution Agreement, the Company will recognize revenues when control of the underlying goods are transferred to Pepsi based on the contractual terms of noncancellable purchase orders issued by Pepsi.

 

License Agreement

 

In January 2019, the Company entered into a license and repayment of investment agreement with Qifeng Food Technology (Beijing) Co., Ltd (“Qifeng”). Under the agreement, Qifeng was granted the exclusive license rights to manufacture, market and commercialize Celsius branded products in China. The term of the agreement is 50 years, with annual royalty fees due from Qifeng after the end of each calendar year. The royalty fees are based on a percentage of Qifeng’s sales of Celsius branded products; however, the fees are fixed for the first five years of the agreement, totaling approximately $6.9 million, and then are subject to annual guaranteed minimums over the remaining term of the agreement.

 

Under the agreement, the Company grants Qifeng exclusive license rights and provides ongoing support in product development, brand promotion and technical expertise. The ongoing support is integral to the exclusive license rights and, as such, both of these represent a combined, single performance obligation. The transaction price consists of the guaranteed minimums and the variable royalty fees, all of which are allocated to the single performance obligation.

 

The Company recognizes revenue from the agreement over time because the customer simultaneously receives and consumes the benefits from the services. The Company uses the passage of time to measure progress towards satisfying its performance obligation because of its ongoing efforts in providing the exclusive license rights including providing continuous access, updates and support. Total revenue recognized under the agreement was approximately $2.0 million, $1.6 million, and $0.8 million for the year ended December 31, 2022, 2021, and 2020 which is reflected in the revenues from Asia.

 
XML 26 R11.htm IDEA: XBRL DOCUMENT v3.23.1
INVENTORIES
 12 Months Ended
Dec. 31, 2022
Inventory Disclosure [Abstract]  
INVENTORIES

 

5.INVENTORIES

 

Inventories consist of the following at:

 

          
   December 31,   December 31, 
   2022   2021 
Finished goods  $119,229   $123,594 
Raw Materials   62,491    70,201 
Less: Inventory reserve   (8,431)   (2,573)
Inventories  $173,289   $191,222 
XML 27 R12.htm IDEA: XBRL DOCUMENT v3.23.1
PREPAID EXPENSES AND OTHER CURRENT ASSETS
 12 Months Ended
Dec. 31, 2022
Prepaid Expenses And Other Current Assets  
PREPAID EXPENSES AND OTHER CURRENT ASSETS

 

6.PREPAID EXPENSES AND OTHER CURRENT ASSETS

 

Prepaid expenses and other current assets total approximately $11.3 million and $13.6 million, at December 31, 2022 and 2021, respectively, and consist mainly of prepaid advances to co-packers related to inventory production, advertising, prepaid insurance, prepaid slotting fees, value added tax payments and deposits on purchases.
XML 28 R13.htm IDEA: XBRL DOCUMENT v3.23.1
NOTE RECEIVABLE
 12 Months Ended
Dec. 31, 2022
Note Receivable  
NOTE RECEIVABLE

 

7.NOTE RECEIVABLE

 

Note receivable consists of the following at:

 

          
   December 31,   December 31, 
   2022   2021 
Note Receivable-current  $2,979   $2,588 
Note Receivable-non-current   3,574    7,117 
Total Note Receivable  $6,553   $9,705 

 

Effective January 1, 2019, the Company restructured its China distribution efforts by entering into two separate economic agreements as it relates to the commercialization of its Celsius products (i.e., the license and repayment of investment agreement with Qifeng, as described above). See Note 4 for information regarding the license agreement with Qifeng. Under a separate economic agreement, Qifeng will repay the marketing investments made by Celsius into the China market through 2018, over the same five-year period as the license agreement. The repayment, which was formalized via a note receivable from Qifeng (the “Note”), will need to be serviced even if the licensing agreement is cancelled or terminated. The Note is denominated in Chinese-Yuan.

 

The Note accrues interest at a rate per annum equal to the weighted average of 5% of the outstanding principal up to $5 million and 2% of the outstanding principal above $5 million. On June 12, 2020, it was agreed to fix the interest rate at 3.21% which reflected the weighted average interest rate for the 5-year period of the Note. Scheduled principal payments plus accrued interest for the Note are due annually on March 31 of each year starting in 2020. For the year ended December 31, 2022, 2021, and 2020, interest income for the Note was approximately $0.2 million, $0.3 million, and $0.4 million respectively.

 

The Company assesses the note receivable for impairment at each reporting period, by evaluating whether it is probable that the Company will be unable to collect all the contractual principal and interest payments as scheduled in the Note, based on historical experience of Qifeng’s ability to pay, the current economic environment and other factors. If the Note is determined to be impaired, the impairment is measured based on the present value of the expected future cash flows under the Note, discounted at the Note’s effective interest rate. At December 31, 2022 and 2021, the Note was not deemed to be impaired. As of December 31, 2022, Qifeng is current on all amounts due under the Note and the license agreement.

 

As evidence of solvency for the Note, a stock certificate in Celsius Holding’s Inc. which amounts to 30.0 thousand of shares owned by an affiliate under common control of Qifeng is being held at a brokerage account. A letter of guarantee was executed with several restrictions regarding their shares. In particular, it was agreed that the stock would not be sold or transferred without the prior written consent from Celsius. There are other restrictions and agreements, which include that a statement of account will be provided to Celsius on a quarterly basis to confirm and validate the existence of the remaining shares. The shares serve as one component of management’s consideration when evaluating impairment indicators.

 
XML 29 R14.htm IDEA: XBRL DOCUMENT v3.23.1
LEASES
 12 Months Ended
Dec. 31, 2022
Leases  
LEASES

 

8.LEASES

 

The Company’s leasing activities include an operating lease of its corporate office space from a related party (see Note 13) and other operating and finance leases of vehicles and office space for the Company’s European operations.

 

At the inception of a contract, the Company assesses whether the contract is, or contains, a lease. The Company’s assessment is based on: (1) whether the contract involves the use of a distinct identified asset, (2) whether the Company obtains the right to substantially all the economic benefit from the use of the asset throughout the term, and (3) whether the Company has the right to direct the use of the asset. The Company allocates the consideration in the contract to each lease and non-lease component based on the component’s relative stand-alone price to determine the lease payments. Lease and non-lease components are accounted for separately.

 

Leases are classified as either finance leases or operating leases based on criteria in ASC Topic 842 Leases. The Company’s operating leases are generally comprised of real estate and vehicles, and the Company’s finance leases are generally comprised of vehicles.

 

At lease commencement, the Company records a lease liability equal to the present value of the remaining lease payments, discounted using the rate implicit in the lease or, if that rate cannot be readily determined, the Company’s incremental borrowing rate. A corresponding right-of-use asset (“ROU asset”) is recorded, measured based on the initial measurement of the lease liability. ROU assets also include any lease payments made and exclude lease incentives. Lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option.

 

Lease expense for operating leases is recognized on a straight-line basis over the lease term and is included in general and administrative expenses. Included in lease expense are any variable lease payments incurred in the period that were not included in the initial lease liability. Lease expense for finance leases consists of the amortization of the ROU asset on a straight-line basis over the shorter of the useful life of the asset or the lease term, and interest expense is calculated using the effective interest rate method.

 

The future annual minimum lease payments required under the Company’s leases as of December 31, 2022 are as follows:

 

               
   Operating   Finance     
Future minimum lease payments  Leases   Leases   Total 
2023  $698   $76   $774 
2024   328    39    367 
2025   7    67    74 
2026   -    64    64 
Total future minimum lease payments   1,033    246    1,279 
Less: Amount representing interest   (46)   (14)   (60)
Present value of lease liabilities   987    232    1,219 
Less: current portion   (661)   (70)   (731)
Long-term portion  $326   $162   $488 
XML 30 R15.htm IDEA: XBRL DOCUMENT v3.23.1
PROPERTY AND EQUIPMENT
 12 Months Ended
Dec. 31, 2022
Property, Plant and Equipment [Abstract]  
PROPERTY AND EQUIPMENT

 

9.PROPERTY AND EQUIPMENT

 

Property and equipment consist of the following at:

 

             
   Estimated Useful   December 31,   December 31, 
   Life in Years  2022   2021 
Merchandising equipment - coolers  5-7  $9,885   $3,052 
Office equipment  3-7   1,124    891 
Vehicles  5   1,257    304 
Less: accumulated depreciation      (2,081)   (1,067)
Total     $10,185   $3,180 

 

Depreciation expense amounted to approximately $1.4 million, $0.6 million, and $0.1 million during years ended December 31, 2022, 2021, and 2020, respectively.

 
XML 31 R16.htm IDEA: XBRL DOCUMENT v3.23.1
GOODWILL AND INTANGIBLES
 12 Months Ended
Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]  
GOODWILL AND INTANGIBLES

 

10.GOODWILL AND INTANGIBLES

 

At December 31, 2022, goodwill consists of approximately $13.7 million resulting from the excess of the consideration paid and the fair value of net tangible and intangible assets acquired from the Func Food acquisition.

 

Intangible assets consist of acquired customer relationships and brands from the Func Food acquisition. The gross carrying amount and accumulated amortization of intangible assets were as follows as of December 31, 2022 and December 31, 2021:

 

          
   December 31,   December 31, 
   2022   2021 
Definite-lived intangible assets          
Customer relationships  $13,418   $14,248 
Less: accumulated amortization   (1,610)   (1,140)
Definite-lived intangible assets, net  $11,808   $13,108 
           
Indefinite-lived intangible assets          
Brands  $2,984   $3,193 
Less: Impairment   (2,538)   - 
Indefinite-lived intangible assets, net  $446   $3,193 
Total Intangibles  $12,254   $16,301 

 

Customer relationships are amortized over an estimated useful life of 25 years and brands have an indefinite life. Amortization expense for the years ended December 31, 2022, 2021, and 2020 was approximately $0.5 million, $0.6 million, and $0.6 million, respectively and is reflected in general and administrative expenses. See note 2. Basis of Presentation and Summary of Significant Accounting Policies, for more information regarding our indefinite-lived intangible asset, Brands.

 

Other fluctuations in the amounts of intangible assets are due to currency translation adjustments.

 

The following is the future estimated amortization expense related to customer relationships as of December 31, 2022:

 

     
Years ending December 31,    
2023  $537 
2024   537 
2025   537 
2026   537 
2027   537 
Thereafter   9,123 
Total  $11,808 

 
XML 32 R17.htm IDEA: XBRL DOCUMENT v3.23.1
ACCOUNTS PAYABLE AND ACCRUED EXPENSES
 12 Months Ended
Dec. 31, 2022
Payables and Accruals [Abstract]  
ACCOUNTS PAYABLE AND ACCRUED EXPENSES

 

11.ACCOUNTS PAYABLE AND ACCRUED EXPENSES

 

Accounts payable and accrued expenses consist of the following at:

 

          
   December 31,   December 31, 
   2022   2021 
Accounts payable  $36,248   $35,820 
Due to Pepsi   34,807    - 
Accrued freight   8,532    15,872 
Accrued expenses   19,081    15,311 
Unbilled purchases   8,672    5,439 
Total  $107,340   $72,442 
XML 33 R18.htm IDEA: XBRL DOCUMENT v3.23.1
OTHER CURRENT LIABILITIES
 12 Months Ended
Dec. 31, 2022
Payables and Accruals [Abstract]  
OTHER CURRENT LIABILITIES

 

12.OTHER CURRENT LIABILITIES

 

Other current liabilities consist of the following at:

 

          
   December 31,   December 31, 
   2022   2021 
Short-term          
VAT payable  $198   $- 
State Beverage Container Deposit   3,388    976 
Total  $3,586   $976 

 
XML 34 R19.htm IDEA: XBRL DOCUMENT v3.23.1
RELATED PARTY TRANSACTIONS
 12 Months Ended
Dec. 31, 2022
Related Party Transactions [Abstract]  
RELATED PARTY TRANSACTIONS

 

13.RELATED PARTY TRANSACTIONS

 

Transactions with PepsiCo, Inc.

 

As further described in Note 14 Mezzanine Equity, on August 1, 2022, the Company issued 1,466,666 shares of non-voting Series A Convertible Preferred stock (“Series A”) to Pepsi. On an as-converted basis the Series A held by Pepsi accounts for approximately 8.5% of the Company’s outstanding Common Stock, both on the date of issuance and as of December 31, 2022. Also, as discussed Note 14, the Securities Purchase Agreement entered into on August 1, 2022 (the “Purchase Agreement”) granted Pepsi the right to designate a nominee for election to the Company’s nine-member board of directors, so long as Pepsi meets certain ownership requirements with respect to the Company’s stock. During the year ended December 31, 2022, a Pepsi executive was nominated by Pepsi and elected to the Company’s board of directors.

 

Based on Pepsi’s contractual representation rights for a seat on the Company’s Board of Directors, the Company has concluded that Pepsi represents a related party to the Company. As of and for the year ended December 31, 2022, the following transactions were recognized in the Company’s financial statements:

 

●Net sales to Pepsi amounted to $142.3 million for the year ended December 31, 2022 and are included in Revenue on the accompanying consolidated statement of operations and comprehensive (loss) income.

 

●Accounts receivable due from Pepsi on December 31, 2022, were $31.6 million and are included in Accounts receivable, net on the Company’s consolidated balance sheets.

 

●Pepsi paid the Company $227.8 million in cash in 2022 under the Transition Agreement. This amount was restricted and used to pay termination fees owed by the Company to terminated distributors. The Company has recorded deferred revenues of $189.5 million, which is presented net of $4.2 million of revenue recognized at December 31, 2022, and a liability payable due to Pepsi of $34.8 million, representing refund liabilities owed to Pepsi under the Transition Agreement which are included in Accounts payable and accrued expenses on the accompanying consolidated balance sheets as of December 31, 2022. The $34.8 million represents the excess of payments received from Pepsi less amounts paid and expected to be paid to terminated distributors.

 

●The issuance of Series A to Pepsi was recorded at fair value, determined to be $832.5 million, on August 1, 2022. Cash proceeds from the issuance of Series A received from Pepsi were $550.0 million. See Note 14 for more information.

 

●The Company has recorded a $282.5 million asset as Deferred other costs, representing the excess of the $832.5 million fair value of the Series A Preferred Stock over the issuance proceeds of $550.0 million. Amounts representing the unamortized deferred other costs of $14.1 million and $262.5 million are presented in Deferred other costs-current and Deferred other costs-non-current, respectively, net of $5.9 million of accumulated amortization recognized as an offset to Revenue in the accompanying consolidated statement of operations and comprehensive (loss) income and consolidated balance sheets as of and for the year ended December 31, 2022.

 

See Notes 1. Organization and Description of Business, 2. Basis of Presentation Significant Accounting Policies, 11. Accounts Payable and Accrued Expenses, and 14. Mezzanine Equity for more information.

 

Related Party Leases

 

The Company’s office is rented from a company affiliated with CD Financial, LLC which is controlled by one of our major stockholders. The lease extends until December 2024 with a monthly rent of $37.6 thousand.

 
XML 35 R20.htm IDEA: XBRL DOCUMENT v3.23.1
MEZZANINE EQUITY
 12 Months Ended
Dec. 31, 2022
Investments, Debt and Equity Securities [Abstract]  
MEZZANINE EQUITY

 

14.MEZZANINE EQUITY

 

Series A Convertible Preferred Stock

 

As of December 31, 2022, Company has designated and authorized 1,466,666 shares of Series A Convertible Preferred Stock with a par value of $0.001 per share and a stated value of $375 per share. The stated value per share may be increased from time-to-time in the event dividends on the Series A are paid-in-kind (“PIK dividends”) pursuant to the Series A Certification of Designation (the “Series A Certificate”). On August 1, 2022, pursuant to the Purchase Agreement, the Company issued 1,466,666 shares of Series A, representing 100% of the authorized Series A shares, to Pepsi for stated cash consideration aggregating $550 million, excluding issuance costs. The Series A was issued concurrently with the execution of Distribution Agreement and the Transition Agreement. The Company determined that the aggregate fair value of the Series A on the issuance date was $832.5 million, or approximately $568 per share. Accordingly, the Series A Convertible Preferred Stock was recorded at that amount, net of issuance costs of $8.0 million, in the Company’s consolidated balance sheets and statement of changes in stockholders’ equity and mezzanine equity.

 

Mezzanine Classification

 

The Series A Convertible Preferred Stock is redeemable in the event of a change in control as defined in the Series A Certificate. S99-3A(2) of the SEC’s Accounting Series Release No. 268 (“ASR 268”) requires preferred securities that are redeemable for cash or other assets to be classified outside of permanent equity if they are redeemable (i) at a fixed or determinable price on a fixed or determinable date, (ii) at the option of the holder, or (iii) upon the occurrence of an event that is not solely within the control of the issuer. Preferred securities that are mandatorily redeemable are required to be classified by the issuer as liabilities whereas under ASR 268 guidance an issuer should classify a preferred security whose redemption is contingent on an event not entirely in control of the issuer as mezzanine equity. The Series A is not mandatorily redeemable, however, a change in control is not solely in control of the Company, accordingly, the Company determined that mezzanine treatment is appropriate for the Series A and has presented it as such in our consolidated balance sheets and statement of changes in stockholders’ equity and mezzanine equity, as of and for the year ending December 31, 2022.

 

Pursuant to the Purchase Agreement, Pepsi, together with its affiliates, has certain rights and is also subject to various restrictions with respect to the Company’s outstanding common shares on an as-converted basis through purchases of the Company’s Common Stock in the open market and the accumulation of PIK dividends. Additionally, pursuant to the Purchase Agreement, Pepsi has the right to designate one nominee for election to Company’s board of directors, for so long as Pepsi (together with its affiliates) beneficially owns at least 3,666,665 shares of the Company’s outstanding Common Stock on an as-converted basis. In August of 2022, the Company expanded the number of seats from eight to nine in connection with the election of a Pepsi representative to the Company’s board of directors.

 

Liquidation Preference

 

The Series A ranks, with respect to distribution rights and rights on liquidation, winding-up and dissolution, (i) senior and in priority of payment to the Company’s Common Stock, (ii) on parity with any class or series of capital stock of the Company expressly designated as ranking on parity with the Series A, and (iii) junior to any class or series of capital stock of the Company expressly designated as ranking senior to the Series A. The aggregate liquidation preference of the Series A is $550.0 million on December 31, 2022.

 

Voting

 

The Series A confers no voting rights, except as otherwise required by applicable law, and with respect to matters that adversely change the powers, preferences, privileges, rights or restrictions given to the Series A or provided for its benefit, or would result in securities that would be senior to or pari passu with the Series A. As described above, Pepsi does have a contractual right to representation on the Company’s Board of Directors, subject to certain share holdings thresholds.

 

Dividends

 

The Series A entitles the holder to cumulative dividends, which are payable quarterly in arrears either in cash, in-kind, or a combination thereof, at the Company’s election. Regular Series A Dividends accrue on each share Series A at the rate of 5.00% per annum, subject to adjustment as set forth in the Series A Certificate. In addition to such quarterly Regular Series A Dividends, shares of Series A also entitle the holder participate in any dividends paid on the Company’s Common Stock on an as-converted basis. During the year ended December 31, 2022, the Company declared and paid $11.5 million in Regular Series A Dividends, which amounted to $7.86 per share of Series A. There are no cumulative undeclared dividends on the Series A at December 31, 2022. In addition, there were no dividends issued to common stockholders as of the years ended December 31, 2022 and 2021.

 

Redemption

 

Pursuant to certain conditions set forth in the Series A Certificate, Series A may be redeemed at a price per share of Series A equal to the sum of (i) the stated value of such share of Series A as of the applicable Redemption Date, plus (ii) without duplication, all accrued and unpaid dividends previously added to the stated value of such share of Series A, and all accrued and unpaid dividends per share of Series A through such Redemption Date (the “Redemption Price”).

 

Company’s Optional Redemption

 

At any time from and after the earlier of (i) August 1, 2029, if the ten-day volume weighted average price of the Company’s Common Stock (the “Ten-Day VWAP”) does not exceed the conversion price on the date immediately prior to the date the Company delivers a redemption notice to the holders, and (ii) the cancellation of the Distribution Agreement by the Company, if the Ten-Day VWAP does not exceed the Conversion Price on the date immediately prior to the date the Company delivers a redemption notice to the holders, the Company shall have the right to redeem all (and not less than all) of the then-outstanding shares of Series A, at the Redemption Price. In the event of a Company optional redemption, the Company shall affect such redemption by paying the entire Redemption Price on or before the date that is thirty days after the delivery of the Company’s redemption notice and by redeeming all the shares of Series A on such date.

 

Change in Control Redemption

 

In the event of (i) a sale or transfer, directly or indirectly, of all or substantially all of the assets of the Company in any transaction or series of related transactions (other than sales in the ordinary course of business); or (ii) any merger, consolidation or reorganization of the Company with or into any other entity or entities as a result of which the holders of the Company’s outstanding capital stock (on a fully-diluted basis) immediately prior to the merger, consolidation or reorganization no longer represent at least a majority of the voting power of the surviving or resulting Company or other entity; or (iii) any sale or series of sales, directly or indirectly, beneficially or of record, of shares of the Company’s capital stock by the holders thereof which results in any Person or group of Affiliated Persons owning capital stock holding more than 50% of the voting power of the Company (a “Change in Control”) the Company (or its successor) shall redeem all (and not less than all) of the then-issued and outstanding shares of Series A. Upon such redemption, the Company will pay or deliver, as applicable, to each holder in respect of each share of Series A held by such holder, an amount equal to the greater of (A) cash in an amount equal to the Redemption Price and (B) the amount of cash and/or other assets (including securities) such holder would have received had each share of Series A held by such holder as of the close of business on the business day immediately prior to the effective date of such transaction resulting in a Change of Control, converted into a number of shares of Common Stock equal to the then-applicable Conversion Ratio and participated in such transaction resulting in such Change of Control as a holder of shares of Common Stock (such greater amount, the “Change of Control Redemption Price”). If, in connection with a transaction resulting in a Change of Control, the Company or its successor shall not have sufficient funds legally available under the Nevada law governing distributions to stockholders to redeem all outstanding shares of Series A, then the Company shall (A) redeem, pro rata among the holders, a number of shares of Series A equal to the number of shares of Series A that can be redeemed with the maximum amount legally available for the redemption of such shares of Series A under the Nevada law governing distributions to stockholders, and (B) redeem all remaining shares of Series A not redeemed because of the foregoing limitations at the applicable Change of Control Redemption Price as soon as practicable after the Company (or its successor) is able to make such redemption out of assets legally available for the purchase of such share of Series A. The inability of the Company (or its successor) to make a redemption payment for any reason shall not relieve the Company (or its successor) from its obligation to affect any required redemption when, as and if permitted by applicable law.

 

Holder Right to Request Redemption

 

On each of August 1, 2029, August 1, 2032, and the August 1, 2035, the majority holders shall have the right, upon no less than six months prior written notice to the Company, to request that the Company redeem all (and not less than all) of the then-outstanding shares of Series A, at the Redemption Price.

 

In the event of a holder optional redemption, the Redemption Price shall be payable, and the shares of Series A redeemed by the Company, in three equal installments, commencing on August 1, 2029, August 1, 2032, or August 1, 2035, as applicable, and in each case on the fifteenth- and thirtieth-month anniversary thereafter (each a “Redemption Date”). On each Redemption Date for a holder optional redemption, the Company shall redeem, on a pro rata basis in accordance with the number of shares of Series A owned by each holder, that number of outstanding shares of Series A determined by dividing (i) the total number of shares of Series A outstanding immediately prior to such Redemption Date by (ii) the number of remaining Redemption Dates (including the Redemption Date to which such calculation applies). If, on any Redemption Date, Nevada law governing distributions to stockholders or the terms of any indebtedness of the Company to banks and other financial institutions engaged in the business of lending money prevent the Company from redeeming all share of Series A to be redeemed, the Company shall ratably redeem the maximum number of shares that it may redeem consistent with such law, and shall redeem the remaining shares as soon as it may lawfully do so under such law.

 

If any shares of Series A scheduled for redemption on a Redemption Date are not redeemed for any reason on such Redemption Date, (x) from such Redemption Date until the fifteen-month anniversary of such Redemption Date, the dividend rate with respect to such unredeemed share of Series A shall automatically increase to 8% per annum, (y) from such fifteenth-month anniversary of such Redemption Date until the thirtieth-month anniversary of such Redemption Date, the dividend rate with respect to such unredeemed share of Series A shall automatically increase to 10% per annum and (z) from and after such thirtieth-month anniversary of such Redemption Date, the dividend rate with respect to any such unredeemed share of Series A shall automatically increase to 12% per annum, in each case until such share is duly redeemed or converted.

 

Conversion

 

The shares of Series A may be converted into shares of the Company’s Common Stock pursuant to the Series A Certificate either at the option of the Company or subject to an automatic conversion as discussed below. The Series A was issued with a conversion price of $75 which is potentially subject to adjustment pursuant to the Series A Certificate. The Conversion Ratio is calculated as the quotient of (a) the sum of (x) the stated value of such share of Series A as of the applicable conversion date, plus (y) of all accrued and unpaid dividends previously added to the stated value of such share of Series A, and without duplication, all accrued and unpaid dividends per share of Series A through the applicable conversion date; divided by (b) the conversion Price as of the conversion date. As of December 31, 2022, the conversion ratio of the Series A into common was 1 to 5. At December 31, 2022, 7,333,330 shares of the Company’s Common Stock are issuable upon conversion of the Series A Convertible Preferred Stock.

 

The calculations of earnings per share for all periods presented herein during which the Series A was outstanding do not treat conversion of the Series A as if it had occurred, as the effect of conversion would be anti-dilutive.

 

Company Optional Conversion

 

At any time from and after August 1, 2029, provided the Ten-Day VWAP immediately prior to the date the Company delivers a conversion notice to the holders of Series A exceeds the Conversion Price, the Company may elect to convert all, but not less than all, of the outstanding shares of Series A into shares of the Company’s Common Stock.

 

Automatic Conversion

 

The Series A will convert automatically into shares of the Company’s Common Stock upon the occurrence of any of the following, each, an “Automatic Conversion Event”:

 

●Any date from and after the valid termination of the Distribution Agreement by the Company or Pepsi, if the Ten-Day VWAP immediately preceding such date exceeds the Conversion Price of such share as of such date.

 

●Any date from and after August 1, 2028, on which (x) the Company’s products meet a market share requirement during a specified period (as defined in the Distribution Agreement) and (y) the Ten-Day VWAP immediately prior to such date exceeds the Conversion Price of such share as of such date. In the case of an automatic conversion, each share of Series A then outstanding shall be converted into the number of shares of Common Stock equal to the Conversion Ratio of such share in effect as of the automatic conversion date. The occurrence of an Automatic Conversion Event will terminate any right of the holder to receive a redemption at their request even if such request has already been submitted, provided that the Series A shares have not already been redeemed.

 

As of December 31, 2022, the Series A is not probable of becoming redeemable as the most likely method of settlement is through conversion which is likely to occur before the holder right to request redemption becomes exercisable.

 

Other Accounting Matters

 

The Company has adopted Accounting Standards Update 2020-06 (“ASU 2020-06”), effective January 1, 2022. The provisions of ASU 2020-06 prohibit the recognition of a beneficial conversion feature (“BCF”) on preferred shares issued after the adoption of the ASU. The Company adopted ASU 2020-06d for the Preferred Series A for the year ended December 31, 2022.

 

FASB ASC 815 generally requires an analysis of embedded terms and features that have characteristics of derivatives to be evaluated for bifurcation and separate accounting in instances where their economic risks and characteristics are not clearly and closely related to the risks of the host contract. We performed an evaluation and determined the Series A and the host instrument is more akin to equity. The Company identified certain embedded redemption and conversion features which it evaluated for bifurcation and determined no bifurcation of these embedded or conversion features was required.

 
XML 36 R21.htm IDEA: XBRL DOCUMENT v3.23.1
STOCKHOLDERS’ EQUITY
 12 Months Ended
Dec. 31, 2022
Equity [Abstract]  
STOCKHOLDERS’ EQUITY

 

15.STOCKHOLDERS’ EQUITY

 

Issuance of common stock pursuant to incentive stock plan exercises

 

During the year ended December 31, 2022, the Company issued an aggregate of approximately 1.5 million shares of its common stock pursuant to the exercise of stock options granted under the 2015 Plan. The Company received aggregate proceeds of $3.7 million for approximately 1.0 million options exercised for cash, with the balance of the options having been exercised on a “cashless” basis.

 

During the year ended December 31, 2021, the Company issued an aggregate of approximately 1.5 million shares of its common stock pursuant to the exercise of stock options granted under the 2015 Plan and 2006 Incentive Plan (collectively, the “Stock Incentive Plans”). The Company received aggregate proceeds of $3.7 million for approximately 1.0 million options exercised for cash, with the balance of the grants having been exercised on a “cashless” basis.

 

During the year ended December 31, 2020, the Company issued an aggregate of approximately 1.9 million shares of its common stock pursuant to the exercise of stock options granted under the Company’s Stock Incentive Plans. The Company received aggregate proceeds of $4.1 million for approximately 1.3 million options exercised for cash, with the balance of the options having been exercised on a “cashless” basis.

 

June 2021 Public Offering

 

On June 9, 2021, the Company and certain selling stockholders (the “Selling Stockholders”) entered into an underwriting agreement (the “Underwriting Agreement”) with UBS Securities LLC and Jefferies LLC, as representatives (the “Representatives”) of the several underwriters (the “Underwriters”), relating to the sale of 6,518,267 shares of common stock, par value $0.001 per share, of the Company at a public offering price of $62.50 per share less underwriting discounts and commissions in a registered public offering (the “Offering”). The Company and certain Selling Stockholders also granted the Underwriters an option, exercisable for 30 days, to purchase up to an additional 977,740 shares of its common stock. The Underwriters partially exercised their option to purchase 873,141 shares of the Company’s common stock on June 11, 2021; 1,133,953 of which were sold by the Company and 739,188 of which were sold by certain of the Selling Stockholders. The Offering closed on June 14, 2021. The Company issued and sold 1,133,953 shares of common stock, and the Selling Stockholders sold 6,257,455 shares, in the aggregate, of common stock in the Offering. The Offering generated net proceeds for the Company of $67,769,386 and net proceeds for the Selling Stockholders of $375,447,300. The Company intends to use the proceeds for general corporate purposes. The Company did not receive any proceeds from the sale of shares by the Selling Stockholders.

 
XML 37 R22.htm IDEA: XBRL DOCUMENT v3.23.1
FAIR VALUE MEASUREMENTS
 12 Months Ended
Dec. 31, 2022
Fair Value Disclosures [Abstract]  
FAIR VALUE MEASUREMENTS

 

16.FAIR VALUE MEASUREMENTS

 

ASC 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Additionally, ASC 820 requires the use of valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs. These inputs are prioritized below:

 

  Level 1: Observable inputs such as quoted market prices in active markets for identical assets or liabilities.
     
  Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data.
     
  Level 3: Unobservable inputs for which there is little or no market data, which require the use of the reporting entity’s own assumptions.

 

The Company engaged a third-party valuation provider to assist in determining the fair value of the 1,466,666 shares of Series A Convertible Preferred Stock issued on August 1, 2022. The Series A Convertible Preferred Stock is classified in mezzanine equity, see Note 14, Mezzanine Equity, and the valuation of the Series A Convertible Preferred Stock represents a non-recurring fair value measurement. We used a Monte Carlo simulation model to determine the fair value of the Series A Convertible Preferred Stock on August 1, 2022. The Monte Carlo simulation utilized multiple input variables to determine the value of the Series A Convertible Preferred Stock including a volatility rate of 45%, risk free interest rate of 2.69%, 5.0% dividend rate, the closing price of the Company’s common stock on the issuance date of $98.87, a debt discount rate of 12.5% and a discount for lack of marketability attributed to the registration period of the underlying stock. The selected historical volatility was based on Celsius and a certain peer group. The risk-free interest rate was based on the US STRIPS Rate with a corresponding term as of issuance date. The 5.0% dividend rate is consistent with the provisions of the Series A Convertible Preferred Stock and with the Company’s past payments made in cash. The debt discount rate was based on estimated credit analysis and corresponding market yields as of the issuance date. The Company applied a nominal discount for lack of marketability with respect to the assumed registration period of the underlying shares.

 

The Company used the relief from royalty method model to determine the fair value of the Brand Name during the year ended December 31, 2022. The fundamental concept underlying this method is that in lieu of ownership, the acquirer can obtain comparable rights to use the subject asset via a license from a hypothetical third-party owner. The Relief from Royalty method utilized multiple input variables to determine the value of the Brand Name including forecasted sales, discount rate, and royalty rates. The selected royalty rate was based on comparable brands. The debt discount rate was based on an expected debt and equity rate of return as of September 30, 2022.

 

The following is a tabular presentation of the non-recurring fair value measurement along with the level within the fair value hierarchy at December 31, 2022:

 

               
   December 31, 2022 
   Level 1   Level 2   Level 3 
Mezzanine equity:               
Series A convertible preferred shares  $-   $824,488   $- 
Indefinite-lived intangible assets:               
Brands   -    -    446 
Total  $-   $824,488   $446 

 

Other than those noted in previous notes, the Company did not have any other non-recurring assets or liabilities measured at fair value at December 31, 2022 and 2021.

 
XML 38 R23.htm IDEA: XBRL DOCUMENT v3.23.1
INCOME TAXES
 12 Months Ended
Dec. 31, 2022
Income Tax Disclosure [Abstract]  
INCOME TAXES

 

17.INCOME TAXES

 

The domestic and foreign components of the Company’s income before provision for income taxes are as follows:

 

               
   2022   2021   2020 
Domestic  $(151,551)  $(4,176)  $8,111 
Foreign   (1,113)   117    529 
Income (loss) before provision for income taxes  $(152,664)  $(4,059)  $8,640 

 

The provision (benefit) for income taxes consists of the following:

 

               
Current:  2022   2021   2020 
Domestic  $10,498   $-   $- 
State   2,601    1,523    - 
Foreign   -    (38)   116 
Current federal, state and local, tax expense  $13,099   $1,485   $116 

 

Deferred  2022   2021   2020 
Domestic  $18,558   $(7,142)  $- 
State and local   4,034    (1,878)   - 
Foreign   (1,073)   (461)   - 
Deferred federal, state and local, tax expense   21,519   $(9,481)  $- 
Income tax expense (benefit)   34,618    (7,996)   116 

 

The reconciliation of the U.S. federal statutory rate to the Company’s effective rate on income before provision (benefit) for income taxes is as follows:

 

               
   2022   2021   2020 
U.S. Statutory federal rate   21.0%   21.0%   21.0%
State taxes, net of federal benefit   (3.9)%   (12.5)%   4.4%
Tax effect of Pepsi valuation premium   (38.9)%          
Permanent differences, including stock-based compensation   -    -    6.7%
Stock based compensation   (0.9)%   50.5%   - 
Change in valuation allowance   0.4%   219.8%   (29.8)%
Change in deferred balances   -    (80.6)%   - 
Other   (0.4)%   (0.9)%   - 
Effective tax rate   (22.7)%   197.2%   2.3%

 

The Tax Cuts and Jobs Act introduced a provision to tax global intangible low-taxed income (“GILTI”) of foreign subsidiaries and a measure to tax certain intercompany payments under the base erosion anti-abuse tax “BEAT” regime. For the years ended December 31, 2022, and 2021, the Company did not generate intercompany transactions that met the BEAT threshold but does have to include GILTI relating to the Company’s foreign subsidiaries. The Company elected to account for GILTI as a current period cost.

 

Deferred income taxes reflect the net tax effects of temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and the amounts for income tax purposes. Deferred tax assets and liabilities consisted of the following:

 

          
   December 31,
2022		   December 31,
2021		 
Net operating loss carryforwards  $4,774   $6,685 
Charitable contributions   17    17 
Fixed assets   (1,158)   (627)
Pepsi valuation premium   (70,637)     
Right of use liability   154    134 
Right of use asset   (146)   (122)
Distributor termination fees   46,859    - 
Uncertain tax position   -    132 
Stock-based compensation   5,236    6,190 
Inventory allowance   5,423    800 
Intangibles   (2,516)   (3,317)
Total deferred tax (liabilities) assets   (11,994)   9,892 
Valuation allowance   (3,424)   (4,019)
Net deferred tax (liabilities) assets   (15,418)   5,873 

 

At December 31, 2022, the Company has approximately $2.3 million of Federal net operating loss carryforwards and $8.7 million of state net operating loss carryforwards, which will begin to expire in 2027. The Federal and State NOLs are subject to limitation under Section 382 due to a December 2008 ownership change of greater than 50% over a three-year testing period. The ownership change resulted in approximately $4.5 million of NOLs that will not be realized. The $4.5 million has been removed from the available NOL carryforward and US NOL deferred tax asset. The Company had foreign NOL carryforwards of approximately $21.9 million, some of which will begin to expire in 2023.

 

The Company considers the earnings of its foreign entities to be permanently reinvested outside the United States based on estimates that future cash generation will be sufficient to meet future domestic cash needs. Accordingly, deferred taxes have not been recorded for the undistributed earnings of the Company’s foreign subsidiaries. All other outside basis differences not related to earnings were impractical to account for at this period of time and are currently considered as being permanent in duration.

 

As required by the authoritative guidance on accounting for income taxes, the Company evaluates the realizability of deferred tax assets on a jurisdictional basis at each reporting date. Accounting for income taxes requires that a valuation allowance be established when it is more likely than not that all or a portion of the deferred taxes will not be realized. In circumstances where there is sufficient negative evidence indicating that the deferred tax assets are not more likely than not realizable, the Company establishes a valuation allowance. Through the year ended December 31, 2020, the Company maintained a full valuation allowance on its worldwide net deferred tax assets. During the fourth quarter of 2021, the Company concluded that it is more likely than not that its US deferred tax assets would be realized. This conclusion was based on the US profitability and NOL utilization in 2021 and 2020 as well as future forecasts of US profitability. For the year ended December 31, 2021, the Company released its US valuation allowance for deferred tax assets of approximately $6.0 million. For the year ended December 31, 2022, the Company reported a release of non-U.S. valuation of $0.5 million. The Company continues to maintain a valuation allowance on its foreign net operating losses as it is not more likely than not that the losses in those specific jurisdictions will be realized.

 

A reconciliation of the beginning and ending amounts of unrecognized tax benefits is as follows:

 

          
   2022   2021 
Gross unrecognized tax benefit, beginning of period  $1,080   $82 
Additions based on tax positions related to the current year   -    - 
Additions based on tax positions related to the prior years   -    998 
Reductions due to lapse in statute of limitations and settlements   (378)   - 
Gross unrecognized tax benefit, end of period  $702   $1,080 

 

The Company recognizes only those tax positions that meet the more-likely-than-not recognition threshold and establishes tax reserves for uncertain tax positions that do not meet this threshold. To the extent these unrecognized tax benefits are ultimately recognized, approximately $0.7 million will impact the Company’s effective tax rate in future periods. Interest and penalties associated with income tax matters are included in the provision for income taxes. As of December 31, 2022, the Company had uncertain tax positions of approximately $0.8 million, inclusive of $0.1 million of interest and penalties.

 

The Company files U.S., state, and foreign income tax returns in jurisdictions with various statutes of limitations. Below is a summary of the filing jurisdictions and open tax years:

 

   
   Open Years
U.S. Federal  2019-2021
U.S State and local  2018-2021
Non-U.S.  2016-2021

 
XML 39 R24.htm IDEA: XBRL DOCUMENT v3.23.1
STOCK-BASED COMPENSATION
 12 Months Ended
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]  
STOCK-BASED COMPENSATION

 

18.STOCK-BASED COMPENSATION

 

The Company adopted the 2006 Incentive Stock Plan on January 18, 2007. This plan was intended to provide incentives to attract and retain highly competent persons at all levels as employees of the Company, as well as independent contractors providing consulting or advisory services to the Company, by providing them opportunities to acquire the Company’s common stock. While the plan terminated 10 years after the adoption date, issued awards have their own schedule of terminations. As such, the Company is no longer granting awards under this plan and there are no unvested awards as of December 31, 2022.

 

The Company adopted the 2015 Plan on April 30, 2015. The 2015 Plan is intended to provide incentives which will attract and retain highly competent persons at all levels as employees of the Company, as well as independent contractors providing consulting or advisory services to the Company, by providing them opportunities to acquire the Company’s common stock or to receive monetary payments based on the value of such shares pursuant to awards issued. The 2015 Plan permits the grant of options and shares for up to 5 million shares. In addition, there is a provision in the 2015 Plan for an annual increase to the maximum number of shares authorized under the 2015 Plan, which increase shall be added on the first day of the calendar year beginning January 1, 2016, equal to 15% of the number of shares outstanding as of such date (Note 15). Provisions have been made to permit the grant of options and other share-based awards for up to 5.0 million shares.

 

For the years ended December 31, 2022, 2021, and 2020, the Company recognized non-cash compensation expense of approximately $20.7 million, $36.5 million, and $6.3 million respectively, (included in General and administrative expense in the accompanying Consolidated Statements of Operations).

 

Stock Options

 

The Company used straight-line amortization of compensation expense over the two to three-year requisite service or vesting period of the grant. The maximum contractual term of the Company’s stock options is 10 years. The Company recognizes forfeitures as they occur. There are options to purchase approximately 1.9 million shares that have vested as of December 31, 2022 and 2021.

 

Under the 2015 Plan, the Company has issued stock options to purchase approximately 2.3 million shares at an average price of $9.66 with a fair value of $213.9 million. No options were issued during the years ended December 31, 2022 and 2021. Upon exercise, shares of new common stock are issued by the Company.

 

The Company determines the fair value of restricted stock-based awards based on the market price on the date of grant. The Company uses the Black-Scholes option-pricing model to estimate the fair value of its stock option awards and warrant issuances and recognizes forfeitures as they occur. This model uses an exercise price, dividend yields, risk-free interest rate, and expected annual volatility, as inputs.

 

The calculation of the fair value of the awards using the Black-Scholes option-pricing model is affected by the Company’s stock price on the date of grant as well as assumptions regarding the following:

 

            
   Years ended
December 31,		 
   2022(1)  2021  2020 
Expected volatility  NA   69.2 - 81.1%   69.2 - 81.1% 
Expected term  NA   4.5 - 5.0 Years   4.8 - 5.0 Years 
Risk-free interest rate  NA   0.3% - 1.4%   0.2% - 1.4% 
Forfeiture Rate  NA   0.0%   0.0% 

 

 
(1)No stock options were issued during 2022.

 

The expected volatility was determined with reference to the historical volatility of the Company’s stock. The Company uses historical data to estimate option exercise and employee termination within the valuation model. The expected term of options granted represents the period of time that options granted are expected to be outstanding. The risk-free interest rate for periods within the contractual life of the option is based on the U.S. Treasury rate in effect at the time of grant.

 

A summary of the status of the Company’s outstanding stock options as of December 31, 2022 and 2021 and changes during the periods ended on that date is as follows:

 

                           
       Weighted Average   Aggregate   Weighted  
   Shares   Exercise   Grant Date   Intrinsic
Value		   Average
Remaining		  
   (000’s)   Price   Fair Value   (000’s)   Term (Yrs)  
Options                            
At December 31, 2020   5,198   $4.23        $240,866     6.89  
Granted   305    42.37   $30.32              
Exercised   (1,460)   3.85    80.58    84,371         
Forfeiture and cancelled   (443)   5.01                   
At December 31, 2021   3,600   $7.47        $241,515     6.37  
Granted   -    -                   
Exercised   (1,273)  $3.67   $80.70   $102,283         
Forfeiture and cancelled   (61)   5.46                   
At December 31, 2022   2,266   $9.66        $213,914     5.43  
Exercisable at December 31, 2022   1,928   $6.41        $188,261     5.05  

 

The following table summarizes information about employee stock options outstanding at December 31, 2022:

 

                              
   Outstanding Options   Vested Options 
Range of Exercise Price   Number
Outstanding at
December 31,
2022
(000’s)		     Weighted
Average
Remaining
Life		     Weighted
Average
Exercise
Price		     Number
Exercisable at
December 31,
2022
(000’s)		     Weighted
Average
Exercise
Price		     Weighted
Average
Remaining
Life		  
$0.34 - $1.05   30    1.44   $0.58    30   $0.58    1.44 
$1.97 - $2.95   5    3.01    1.97    5    1.97    3.01 
$3.23 - $4.85   1,465    5.38    3.81    1,412    3.80    5.34 
$5.59 - $8.38   389    3.51    5.70    331    5.72    2.88 
$14.53 - $21.79   61    7.58    14.53    40    14.53    7.58 
$21.80 - $32.70   16    7.83    21.80    10    21.80    7.83 
$42.64 - $63.96   300    8.01    42.67    100    42.67    8.01 
Outstanding options   2,266    5.43   $9.66    1,928   $6.41    5.05 

 

As of December 31, 2022, the Company had approximately $3.4 million of unrecognized pre-tax non-cash compensation expense related to options to purchase shares, which the Company expects to recognize, based on a weighted-average period of 1.0 year.

 

Restricted Stock Awards

 

Restricted stock awards are awards of common stock that are subject to restrictions on transfer and to a risk of forfeiture if the holder leaves the Company before the restrictions lapse. The holders of a restricted stock award are generally entitled after the release to transact and obtain the same rights as rights of a stockholder of the Company, including the right to vote the shares. The holders of unvested restricted stock awards do not have the same rights as stockholders including but not limited to any dividends which may be declared by the Company, and do not have the right to vote. The value of restricted stock awards that vest over time is established by the market price on the date of its grant and generally vests over a period of 3 years. A summary of the Company’s restricted stock activity for the years ended December 31, 2022 and 2021 is presented in the following table:

 

                    
   For the twelve months ended 
   December 31,
2022		   December 31,
2021		 
    Shares     Weighted
Average
Grant Date
Fair Value		     Shares     Weighted
Average
Grant Date
Fair Value		  
Unvested at beginning of period   0.3   $14.72    66.2   $28.11 
Transfers to restricted stock units   -    -    (45.9)   34.02 
Granted   -    -    -    - 
Vested   -    -    (18.9)   14.79 
Forfeited and cancelled   (0.3)   14.72    (1.1)   14.72 
Unvested at end of period   -   $-    0.3   $14.72 

 

There were no shares granted, vested or outstanding during and as of the year ended December 31, 2022.

 

Restricted Stock Units

 

Restricted stock units are awards that give the holder the right to receive one share of common stock for each restricted stock unit upon meeting service-based vesting conditions (typically annual vesting in three equal annual installments, with a requirement that the holder remains in the continuous employment of the Company). The holders of unvested units do not have the same rights as stockholders including but not limited to any dividends which may be declared by the Company, and do not have the right to vote. The value of restricted stock units that vest over time is established by the market price on the date of its grant. A summary of the Company’s restricted stock unit activity for the years ended December 31, 2022 and 2021 is presented in the following table:

 

                    
   For the twelve months ended 
   December 31,
2022		   December 31,
2021		 
    Shares
(000’s)		     Weighted
Average
Grant Date
Fair Value		     Shares
(000’s)		     Weighted
Average
Grant Date
Fair Value		  
Unvested at beginning of period   566   $52.66    -   $- 
Transfers to restricted stock awards   -    -    46    34.02 
Granted   248    74.14    574    54.40 
Vested   (205)   54.17    (19)   64.58 
Forfeited and cancelled   (70)   61.99    (35)   50.46 
Unvested at end of period   539   $60.73    566   $52.66 

 

The total fair value of shares vested during the year ended December 31, 2022, was approximately $11.6 million. Unrecognized compensation expense related to outstanding restricted stock units to employees and directors as of December 31, 2022 was approximately $20.3 million and is expected to be expensed over the next 2.0 years.

 

Performance-based Stock Awards

 

The Company issues stock-based awards to third-party consultants for providing marketing, sales, and general business development services related to Celsius products, as well as to certain employees as discussed below. The stock-based awards are in the form of restricted stock units with performance vesting conditions (“performance stock units” or “PSUs”). The holders of unvested PSUs do not have the same rights as stockholders including but not limited to any dividends which may be declared by the Company, and do not have the right to vote. Some of the PSU performance vesting conditions are linked to the consultants obtaining specified incremental earnings for the Company in a given year over the performance vesting period, typically five years and some of the awards are linked to employees of the Company and have specific performance-based metrics to be met in year one and year two of the issuance as discussed below. The fair value of PSUs is based on the market price of the underlying stock on the grant date. The Company recognizes compensation cost for performance stock awards issued to non-employees in the same manner and periods as though cash had been paid for services received.

 

In the third quarter of 2022, the Human Resources and Compensation Committee of the Board of Directors approved the issuance of PSUs to certain employees which represented restricted stock units with performance-based vesting. The aggregate grant date fair value of $7.5 million included an immediate vesting of 20% of the shares as well as specific performance-based metrics to be met in year one and year two of the issuance. The Company believes the performance-based metrics are probable of being achieved and will recognize expense each tranche of the awards separately according to ASC 718.

 

A summary of the Company’s PSU activity for the years ended December 31, 2022 and 2021 is presented in the following table:

 

                    
   For the twelve months ended 
   December 31,
2022		   December 31,
2021		 
    Shares
(000’s)		     Weighted
Average
Grant Date
Fair Value		     Shares
(000’s)		     Weighted
Average
Grant Date
Fair Value		  
Unvested at beginning of period   15   $64.65    -   $- 
Granted   76    98.28    15    64.65 
Vested   (15)   98.28    -    - 
Forfeited and cancelled   -    -    -    - 
Unvested at end of period   76   $91.48    15   $64.65 

 

Unrecognized compensation expense related to outstanding PSUs issued to employees and non-employee consultants as of December 31, 2022, was approximately $4.3 million and is expected to be expensed over the next 1.6 years.

 

Modifications

 

There were certain Board of Directors members and employees whose service was terminated during 2021. In connection with their terminations, the vesting conditions of the previously granted awards were modified to accelerate the vesting of specified un-vested awards pursuant to Board resolutions or severance agreements. Pursuant ASC 718, these were modifications which required re-valuation of un-vested awards to modification date fair value with recognition of compensation expense over the remaining service period. The Company modified awards resulting in approximately $19.3 million in incremental compensation cost during the year ended December 31, 2021.

 
XML 40 R25.htm IDEA: XBRL DOCUMENT v3.23.1
COMMITMENTS AND CONTINGENCIES
 12 Months Ended
Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENCIES

 

19.COMMITMENTS AND CONTINGENCIES

 

Legal

 

In November of 2020, McGovern Capital, Inc. and Kevin McGovern (collectively “McGovern”) filed a claim in arbitration related to its Representative Agreement with the Company as amended by the first amendment dated August 6, 2016. Pursuant to the Representative Agreement, McGovern is entitled to receive a fee of three percent (3%) of “Net Revenues” received by the Company from sales of the Company’s products in the People’s Republic of China for a period of four years from Initial Commercial Sale (which was September 1, 2017). “Net Revenues” are defined in the Representative Agreement as “the Company’s revenues net of actual discounts applied, credits and returns.” Effective January 1, 2019, the Company restructured its China operations from a distribution arrangement with Qifeng Food Technology (Beijing) Co. Ltd. (“Qifeng”), to a license and royalty arrangement and a loan, pursuant to which Qifeng will market and distribute the Company’s products in China, and the Company will receive an annual royalty payment. The Company intended to pay McGovern its percentage of the annual royalty payment, but McGovern had objected, claiming that McGovern is entitled to be paid commissions on the entire royalty payment and the amount of the loan to Qifeng. During the year ended December 31, 2022, a confidential settlement agreement was signed for an amount included in the consolidated Statements of Operations and Comprehensive Income for year ended December 31, 2022 that is not material to the financial results of the Company.

 

In March of 2019, Daniel Prescod filed a putative class action lawsuit against the Company in the Superior Court for the State of California, County of Los Angeles, filed on March 19, 2019, (the “Prescod Litigation”). Daniel Prescod asserts that the Company’s use of citric acid in its products while simultaneously claiming “no preservatives” violates California Consumer Legal Remedies Act, California Business and Professions Code Section 17200, et seq., and California Business and Professions Code Section 17500, et seq., because citric acid acts as a preservative. The Company does not use citric acid as a preservative in its products, but rather as a flavoring, and therefore it believes that its “no preservatives” claim is fair and not deceptive. A motion to certify the case as a class action was filed and on August 2, 2021, that motion was granted. No fact discovery was conducted on the merits. On October 12, 2022, the Company and Mr. Prescod notified the courts that an agreement in principle to settle had been reached to resolve the case for an aggregate amount of $7.8 million. The Company and Mr. Prescod submitted the settlement agreement to the court, which entered its preliminary approval on November 23, 2022 and set a final Fairness Hearing for March 31, 2023. As of December 31, 2022, $7.8 million was accrued and included in accounts payable and accrued expenses in the consolidated balance sheets.

 

On November 23, 2021, a case related to the Prescod Litigation, Amit Heli and Joseph Nina v. Celsius Holdings, Inc. was filed in the United States District Court for the Southern District of New York, Case No. 1:21-cv-09892. The Company answered the complaint on February 11, 2022. Like the Prescod Litigation, the plaintiffs in this case allege that the Company’s use of citric acid in its products while simultaneously claiming “no preservatives” constitutes false advertising and unfair or deceptive trade practices. Unlike the Prescod Litigation, in this case the violations alleged are of New York’s General Business Law. As with the Prescod Litigation, the Company does not use citric acid as a preservative in its products, but rather as a flavoring, and therefore it believes that its “no preservatives” claim is fair and not deceptive. No discovery has been conducted and this matter is still in its initial stages. On October 12, 2022, the Company and Mr. Prescod notified the courts that an agreement in principle to settle had been reached to resolve the Prescod and Heli case for an aggregate amount of $7.8 million. The Company and Mr. Prescod submitted the settlement agreement to the court, which entered its preliminary approval on November 23, 2022 and set a final Fairness Hearing for March 31, 2023 for judicial approval and await final judgment and entry in the coming weeks. As of December 31, 2022, $7.8 million was accrued and included in accounts payable and accrued expenses in the consolidated balance sheets.

 

On January 8, 2021, the Company received a letter from the SEC Division of Enforcement seeking the production of documents in connection with a non-public fact-finding inquiry by the SEC to determine whether violations of the federal securities laws have occurred. Subsequent to January 8, 2021, the Company received subpoenas for production of documents in connection with the matter. The investigation and requests from the SEC do not represent that the SEC has concluded that the Company or anyone else has violated the federal securities laws. The Company has cooperated and will continue to cooperate with the SEC staff in its investigation and requests. At this time, however, the Company cannot predict the length, scope, or results of the investigation or the impact, if any, of the investigation on our results of operations.

 

On March 16, 2022, Christian McCallion filed a class action lawsuit against the Company in the United States District Court for the Southern District of Florida. Plaintiff McCallion asserts that because of the Company’s delay in filing its Annual Report on Form 10-K for the year ended December 31, 2021, there was a decline in the market value of the Company’s securities and as a result, class members suffered significant losses and damages. On June 6, 2022 Judge Middlebrooks appointed a lead class plaintiff and the Company filed its Motion to Dismiss on August 5, 2022. As the Company has previously disclosed in its periodic reports filed with the SEC, prior to filing an application for an automatic fifteen (15) day extension of the original filing date, the Company experienced staffing limitations, unanticipated delays and identified material errors in previous filings. The Company does not believe it has committed any federal securities violations or made false and/or misleading statements and/or material omissions as alleged in the complaint. The Company intends to contest the claims vigorously on the merits.

 

On January 11, 2023, Doreen R. Lampert filed a derivative stockholder complaint against certain of the Company’s directors and a former officer and, nominally, against the Company, in the United Stated District Court of the District of Nevada. Plaintiff Lampert asserts that the same allegations giving rise to the McCallion class action lawsuit also support claims for breach of fiduciary duty against the directors and former officer, among other claims. The deadline to respond to the complaint will be March 21, 2023. The Company does not believe its directors or former officer have breached any fiduciary duties or are otherwise liable under the theories plead in the complaint and the Company intends to contest the claims.

 

On May 4, 2021, Plaintiffs Strong Arm Productions USA, Inc., Tramar Dillard p/k/a Flo Rida, and D3M Licensing Group, LLC filed a lawsuit against the Company in the Circuit Court of the 17th Judicial Circuit in and for Broward County, Florida. Plaintiffs asserted that the Company breached two endorsement and licensing agreements that were entered into between Plaintiffs and the Company in 2014 and 2016. Plaintiffs alleged the Company had reached certain revenue and sales benchmarks set forth in the 2014 agreement that entitled them to receive 750,000 shares of the Company’s stock. In addition, Plaintiffs claimed they were entitled to receive unspecified royalties under the 2016 agreement.

 

A jury trial commenced on this matter on January 10, 2023. On January 18, 2023, the jury rendered a verdict against the Company for $82.6 million in compensatory damages. On February 2, 2023, the Company filed post-trial motions seeking (i) judgment in favor of the Company dismissing the case notwithstanding the verdict based on the plain language of the contracts at issue; (ii) in the alternative, granting a new trial due to the numerous errors at trial; or (iii) in the alternative, reducing the award of damages to $2.1 million, which reflects the Company’s stock price on the date that the jury found the relevant revenue and sales benchmarks at issue were met. The judgment will accrue post-judgement interest at 5.52 percent per year as of February 13, 2023

 

We believe that the jury verdict is not supported by the facts of the case or applicable law, is the result of significant trial error, and there are strong grounds for appeal. We will seek to overturn the verdict in post-trial motions before the trial court and the Company filed a notice of appeal to the Fourth District Court of Appeal for the State of Florida on February 21, 2023. The appeal is suspended pending disposition of the pending post-trial motions. We intend to vigorously challenge the judgment through all appropriate post-trial motions and appeal processes.

 

As a result, we believe that the likelihood that the amount of the judgment will be affirmed is not probable. We have taken into consideration the events that have occurred after the reporting period and before the financial statements were issued. We currently estimate a range of possible outcomes between $2.1 million and $82.6 million, and we have accrued a liability as of December 31, 2022 at the lower end of the range, which is the amount we believe is the most likely estimate for a probable loss on this matter. This amount is reflected in Accounts payable and accrued expenses, and General and administrative expenses in our consolidated financial statements as of and for the year ended December 31, 2022. The ultimate loss to the Company of the litigation matter could be materially different from the amount the Company has accrued. The Company cannot predict or estimate the duration or ultimate outcome of this matter.

 

In addition to the foregoing, from time to time, we may become party to litigation or other legal proceedings that we consider to be a part of the ordinary course of our business.

 

Commitments

 

The Company has entered into distribution agreements with liquidated damages in case the Company cancels the distribution agreements without cause. Cause has been defined in various ways. If management makes the decision to terminate an agreement without cause, an estimate of expected damages is accrued, and an expense is recorded within operating expenses during the period in which termination was initiated.

 

As of December 31, 2022 and 2021, we have contingent commitment to third parties of $30.7 million. Our contingent commitments are primarily related to third party suppliers and have arisen through the normal course of business. The contingent commitments may have various terms, and none are individually significant.

 

Additionally, our business and results of operations may be adversely affected by the business and economic uncertainty resulting from the pandemic and public health crises related to the COVID-19 outbreak, which is affecting the macro-economic environment.
XML 41 R26.htm IDEA: XBRL DOCUMENT v3.23.1
SUBSEQUENT EVENTS
 12 Months Ended
Dec. 31, 2022
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS

 

20.SUBSEQUENT EVENTS

 

The Company evaluates subsequent events and transactions that occur after the balance sheet date up to the date the consolidated financial statements are issued. Except for the matters discussed in Note 19, there were no other subsequent events that would have required adjustment or disclosure in the consolidated financial statements.
XML 42 R27.htm IDEA: XBRL DOCUMENT v3.23.1
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
 12 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
Basis of Presentation

Basis of Presentation — The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) and the rules and regulations of the SEC.

 
Consolidation Policy

Consolidation Policy — The accompanying consolidated financial statements include the accounts of Celsius Holdings, Inc. and its subsidiaries. All inter-company balances and transactions have been eliminated in consolidation.

 
Significant Estimates

Significant Estimates — The preparation of consolidated financial statements and accompanying disclosures in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue and expenses and disclosure of contingent assets and liabilities at the date of the financial statements. Although these estimates are based on management’s best knowledge of current events and actions that the Company may undertake in the future, actual results may differ from those estimates. Significant estimates include the allowance for doubtful accounts, allowance for inventory obsolescence and sales returns, preferred share valuation, the useful lives of property and equipment, impairment of goodwill and intangibles, deferred tax asset valuation allowance, promotional allowance, and valuation of stock-based compensation. Additionally, the business and economic uncertainty resulting from the novel coronavirus (COVID-19) pandemic has made such estimates and assumptions more difficult to calculate. Accordingly, actual results and outcomes could differ from those estimates.

 
Segment Reporting

Segment Reporting — Operating segments are defined as components of an enterprise that engage in business activities, have discrete financial information, and whose operating results are regularly reviewed by the chief operating decision maker (“CODM”) to make decisions about allocating resources and to assess performance. Even though the Company has operations in several geographies, it operates as a single enterprise. The Company’s operations and strategies are centrally designed and executed given that our geographical components are very similar. Our CODM, the CEO, reviews operating results primarily from a consolidated perspective, and makes decisions and allocates resources based on that review. The reason the Company’s CODM focuses on consolidated results in making decisions and allocating resources is because of the significant economic interdependencies between the Company’s geographical operations and the Company’s U.S. entity.

 
Concentrations of Risk

Concentrations of Risk — Substantially all of the Company’s revenue derives from the sale of Celsius ® functional energy drinks and liquid supplements.

 

Pepsi and the Company signed a distribution agreement on August 1, 2022, resulting in Pepsi acting as the Company’s preferred distributor performing the direct store delivery for a majority of the Company’s U.S. operations.

 

Revenue of our customers accounting for more than 10%, for the years ended December 31, 2022, 2021 and 2020, are as follows:

 

               
   2022   2021   2020 
Pepsi   22.2%   -    - 
Costco   16.7%   12.7%   2.9%
Amazon   8.8%   10.1%   15.1%
All other   52.3%   77.2%   82.0%
Total   100.0%   100.0%   100.0%

 

Accounts receivable of our customers accounting for more than 10%, for the years ended December 31, 2022, and 2021, are as follows:

 

           
   2022   2021 
Pepsi   47.6%   - 
Amazon   11.8%   22.7%
Publix   1.4%   10.3%
All other   39.2%   67.0%
Total   100.0%   100.0%

 

Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable. The Company places its cash and cash equivalents with high-quality financial institutions. At times, balances in the Company’s cash accounts may exceed the Federal Deposit Insurance Corporation limit. At December 31, 2022 and 2021, the Company had approximately $652.4 million and $16.0 million, respectively, including $38.8 million in restricted cash for 2022, in excess of the Federal Deposit Insurance Corporation limit.

 
Cash and Cash Equivalents

Cash and Cash Equivalents — The Company considers all highly liquid instruments with an original maturity of three months or less when purchased to be cash equivalents.

 
Restricted Cash

Restricted Cash — As disclosed in Note 4. Revenues, the Company received upfront payments from Pepsi during 2022, which are contractually restricted and can only be used to satisfy termination payments due to former distributors or have to be repaid to Pepsi. These upfront payments received from Pepsi cannot be used for general operating activities of the Company and have been classified as restricted cash based on the terms of the Transition Agreement.

 
Accounts Receivable

Accounts Receivable — Accounts receivable are reported at net realizable value. The Company establishes an allowance for doubtful accounts based upon factors pertaining to the credit risk of specific customers, historical trends, and other information. Delinquent accounts are written-off when it is determined that the amounts are uncollectible. Accounts receivable are presented net of billbacks, for customers that are allowed the right to net settle. At December 31, 2022 and December 31, 2021, there was an allowance for doubtful accounts of approximately $2.1 million and $0.8 million, respectively.

 
Inventories

Inventories — Inventories are valued at the lower of cost or net realizable value. Cost is determined using the first-in, first-out (FIFO) method. At December 31, 2022 and December 31, 2021, the Company recorded an allowance of approximately $8.4 million and $2.6 million respectively. The changes in the allowance are included in cost of revenue.

 
Property and Equipment

Property and Equipment — Property and equipment are stated at cost less accumulated depreciation and amortization. Depreciation of property and equipment is calculated using the straight-line method over the estimated useful life of the asset generally ranging from three to seven years.

 
Impairment of Long-Lived Assets

Impairment of Long-Lived Assets — In accordance with ASC Topic 360, Property, Plant, and Equipment the Company reviews the carrying value of long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. An impairment loss is determined regarding a long-lived asset if its carrying amount is not recoverable and exceeds its fair value. The carrying amount is not recoverable when it exceeds the sum of the undiscounted cash flows expected to result from use of the asset over its remaining useful life and final disposition. The Company did not record any impairments related to long lived assets during the years ended December 31, 2022 and December 31, 2021.

 
Long-lived Asset Geographic Data

Long-lived Asset Geographic Data

 

The following table contains long-lived asset information which includes property and equipment and lease right of use assets and excludes goodwill and intangibles, where individual countries represent a material portion of the total:

 

          
   December 31,   December 31, 
   2022   2021 
United States  $9,750   $3,043 
Sweden   1,251    1,050 
Finland   363    301 
Other   1    - 
Long-lived assets related to foreign operations   1,615    1,351 
Total long-lived assets-net  $11,365   $4,394 

 
Goodwill

Goodwill — The Company records goodwill when the consideration paid for the acquisition of a business exceeds the fair value of net tangible and intangible assets acquired, including related tax effects. Goodwill is not amortized; instead, goodwill is tested for impairment on an annual basis as of October 1st, or more frequently if the Company believes indicators of impairment exist. The Company first assesses qualitative factors such as macro-economic conditions, industry and market conditions, and cost factors as well as other relevant events, to determine whether it is more-likely-than-not that the fair value of a reporting unit is less than its carrying value. If it is more likely than not that the fair value of a reporting unit is less than its carrying value, then the Company will calculate the estimated fair value of the reporting unit. If the Company determines that the fair value is less than the carrying value, the Company will recognize an impairment charge based on the excess of a reporting unit’s carrying value over its fair value. At December 31, 2022, there were no indicators of impairment.

 
Intangible assets

Intangible assets— Intangible assets are comprised of customer relationships and brands acquired in a business combination. The Company amortizes intangible assets with a definitive life over their respective useful lives. The addition of the Pepsi distribution network has shifted the Company’s focus to the US market and as a consequence it was determined that impairment indicators for the Func Foods brands indefinite intangible asset were present. The Company no longer anticipates focusing on the expansion of Func Food branded products and the Company plans to focus on Celsius branded products. As a result of the strategic shift, which the Company considered a triggering event, the Company quantitatively tested the Func Foods brand name for impairment utilizing the relief from royalty method to determine fair value as of September 30, 2022. As a result of the quantitative assessment, the Company recorded an impairment charge of $2.5 million during the year ended December 31, 2022 which is presented within General and Administrative expenses on the Consolidated Statements of Operations.

 
Revenue Recognition

Revenue Recognition — The Company recognizes revenue in accordance with ASC Topic 606 Revenue from Contracts with Customers. The Company recognizes revenue when performance obligations under the terms of a contract with the customer are satisfied. Product sales occur once control or title is transferred based on the commercial terms. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring goods. Product sales are recorded net of variable consideration, such as provisions for returns, discounts and promotional allowances. Such provisions are calculated using historical averages and adjusted for any expected changes due to current business conditions. Consideration given to customers for cooperative advertising is recognized as a reduction of revenue except to the extent that there is a distinct good or service, in which case the expense is classified as selling or marketing expense. The amount of consideration the Company receives and revenue the Company recognizes varies with changes in customer incentives the Company offers to its customers and their customers. Additionally, for any agreements which are one year or less, the practical expedient under ASC 340-40-25-4 is applied to expense contract acquisition costs when incurred if the amortization period of the contract asset would have otherwise been recognized in one year or less. Sales taxes and other similar taxes are excluded from revenue. Management believes that adequate provision has been made for cash discounts, returns, spoilage and promotional allowances based on the Company’s historical experience.

 
Deferred Revenue

Deferred Revenue — The Company receives payments from certain distributors in new territories as reimbursement for contract termination costs paid to the prior distributors in those territories. Amounts received pursuant to these new and/or amended distribution agreements entered into with certain distributors relating to the costs associated with terminating the Company’s prior distributors, are accounted for as deferred revenue and recognized ratably over the anticipated life of the respective new distribution agreements. As of December 31, 2022, the Company had approximately $189.5 million in deferred revenue, of which $179.8 million is classified as deferred revenue-non-current and $9.7 million is classified as deferred revenue-current which are presented within the consolidated balance sheets and are contract liabilities related to termination payments received from Pepsi. Refer to Note 13, Related Party Transactions for more information. The deferred revenues will be recognized by the Company, ratably over the twenty-year agreement term. As of December 31, 2021, the Company did not have any deferred revenue related to contract liabilities.

 
Accrued Distributor Termination Fees

Accrued Distributor Termination Fees — Termination charges related to certain of the Company’s prior distributors are included in selling and marketing expenses upon termination. The Company recognized distributor termination expenses of approximately $193.8 million, $0.6 million, and $0.2 million for the year ended December 31, 2022, 2021, and 2020, respectively. The Company also has a balance of $4.0 million in accrued distributor termination fees related to distributors terminated as a result of the Pepsi agreement as well as payment due back to Pepsi in the amount of $34.8 million as the projected payments to the prior distributors was less than the payment received from Pepsi, which are located within accounts payable and accrued expenses, on the Company’s consolidated balance sheets.

 
Customer Advances

Customer Advances — From time to time the Company requires deposits in advance of delivery of products and/or production runs. Such amounts are initially recorded as customer advances liability within other current liabilities. The Company recognizes such revenue as it is earned in accordance with revenue recognition policies. As of December 31, 2022 and 2021, the Company did not have any customer advances.

 
Advertising Costs

Advertising Costs — Advertising costs are expensed as incurred. The Company uses mainly radio, local sampling events, sponsorships, endorsements, and digital advertising. The Company incurred advertising expenses of approximately $85.1 million, $36.7 million and $14.2 million, during years ended December 31, 2022, 2021, and 2020, respectively.

 
Research and Development

Research and Development — Research and development costs are charged to general and administrative expenses as incurred and consist primarily of consulting fees, raw material usage and test productions of beverages. The Company incurred expenses of approximately $0.4 million, $1.0 million and $0.5 million during years ended December 31, 2022, 2021, and 2020, respectively.

 
Foreign Currency Gain/Losses

Foreign Currency Gain/Losses — Foreign subsidiaries’ functional currency is the local currency of operations and the net assets of foreign operations are translated into U.S. dollars using current exchange rates. The foreign subsidiaries perform re-measurements of their assets and liabilities denominated in non-functional currencies on a periodic basis and the gain or losses from these adjustments are included in the consolidated statement of operations and comprehensive (loss) income as foreign exchange gains or losses. For the year ended December 31, 2022 exchange losses have amounted to approximately $0.4 million while during the years ended December 31, 2021 and 2020, the Company recognized a foreign currency loss and gain of approximately $0.3 million and $1.4 million, respectively, mainly related to fluctuations in exchange rates. Translation gains and losses that arise from the translation of net assets from functional currency to the reporting currency, as well as exchange gains and losses on intercompany balances of long-term investment nature, are included in Other Comprehensive Income. The Company incurred foreign currency translation net loss during the year ended December 31, 2022 of approximately $2.5 million and a net gain of approximately $0.8 million and $0.6 million during the year ended December 31, 2021 and 2020. The Company’s operations in different countries required that it transacts in the following currencies:

 

Chinese-Yuan

Norwegian-Krone

Swedish-Krona

Finland-Euro

 
Fair Value of Financial Instruments

Fair Value of Financial Instruments — The carrying value of cash, cash equivalents, restricted cash, accounts receivable, accounts payable, accrued expenses and other current liabilities approximate fair value due to their relative short-term maturity and market interest rates.

 
Income Taxes

Income Taxes — The Company accounts for income taxes pursuant to the provisions of ASC Topic 740 Accounting for Income Taxes, which requires, among other things, an asset and liability approach to calculating deferred income taxes. The asset and liability approach require the recognition of deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the carrying amounts and the tax bases of assets and liabilities. A valuation allowance is provided to offset any net deferred tax assets for which management believes it is more likely than not that the net deferred asset will not be realized. The Company follows the provisions of the ASC 740-10 related to Accounting for Uncertain Income Tax Positions. When tax returns are filed, it is highly certain that some positions taken would be sustained upon examination by the taxing authorities, while others are subject to uncertainty about the merits of the position taken or the amount of the position that would be ultimately sustained. In accordance with the guidance of ASC 740-10, the benefit of a tax position is recognized in the financial statements in the period during which, based on all available evidence, management believes it is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any.

 

Tax positions taken are not offset or aggregated with other positions. Tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with the applicable taxing authority. The portion of the benefits associated with tax positions taken that exceeds the amount measured as described above is reflected as a liability for uncertain tax benefits in the accompanying consolidated balance sheet, along with any associated interest and penalties that would be payable to the taxing authorities upon examination.

 

The Company has adopted ASC 740-10-25 Definition of Settlement, which provides guidance on how an entity should determine whether a tax position is effectively settled for the purpose of recognizing previously unrecognized tax benefits and provides that a tax position can be effectively settled upon the completion of an examination by a taxing authority without being legally extinguished. For tax positions considered effectively settled, an entity would recognize the full amount of tax benefit, even if the tax position is not considered more likely than not to be sustained based solely on the basis of its technical merits and the statute of limitations remains open.

 

The Company’s tax returns for tax years in 2019 through 2021 remain subject to potential examination by the taxing authorities.

 
Earnings per Share

Earnings per Share — The Company computes earnings per share in accordance with ASC Topic 260 Earnings per Share (“ASC 260”), which requires earnings per share (“EPS”) for each class of stock (common stock and participating preferred stock) to be calculated using the two-class method. The two-class method is an allocation of earnings (distributed and undistributed) between the holders of common stock and a company’s participating security holders. Under the two-class method, earnings for the reporting period are allocated between common stockholders and other security holders based on their respective participation rights in undistributed earnings.

 

Basic earnings per common share is computed by dividing income or loss available to common stockholders by the weighted average number of shares of basic common stock outstanding. The Company’s Series A Convertible Preferred Stock is classified as a participating security in accordance with ASC 260. Net income allocated to the holders of Series A Convertible Preferred Stock will be calculated based on the stockholders’ proportionate share of weighted average shares of common stock outstanding on an if-converted basis. See Note 3. Earnings Per Share for more information.

 
Share-Based Payments

Share-Based Payments — The Company follows the provisions of ASC Topic 718 Compensation — Stock Compensation and related interpretations. As such, compensation cost is measured on the date of grant at the fair value of the share-based payments. Such compensation amounts, if any, are amortized over the respective vesting periods of the grants. On April 30, 2015, the Company adopted the 2015 Stock Incentive Plan (the “2015 Plan”). This 2015 Plan is intended to provide incentives which will attract and retain highly competent persons at all levels as employees of the Company, as well as independent contractors providing consulting or advisory services to the Company, by providing them opportunities to acquire the Company’s common stock. The 2015 Plan permits the grant of options and other share-based awards for up to 5.0 million shares. Provisions have been made to permit the grant of options and other share-based awards for up to 5.0 million shares.

 
Cost of Revenue

Cost of Revenue — Cost of Revenue consists of the cost of concentrates and or liquid bases, the costs of raw materials utilized in the manufacture of products, co-packing fees, repacking fees, in-bound & out-bound freight charges, as well as certain internal transfer costs, warehouse expenses incurred prior to the manufacture of the Company’s finished products, inventory allowance for excess and obsolete products, and certain quality control costs. Raw materials account for the largest portion of the cost of sales. Raw materials include cans, other containers, flavors, ingredients and packaging materials.

 
Operating Expenses

Operating Expenses — Operating expenses include selling expenses such as warehousing expenses after manufacture, as well as expenses for advertising, samplings and in-store demonstrations costs, costs for merchandise displays, point-of-sale materials and premium items, sponsorship expenses, other marketing expenses and design expenses. Operating expenses also include such costs as payroll costs, travel costs, professional service fees (including legal fees), depreciation and other general and administrative costs.

 
Shipping and Handling Costs

Shipping and Handling Costs — Shipping and handling costs for freight expense on goods shipped are included in cost of sales. Freight expense on goods shipped for the years ended December 31, 2022, 2021 and 2020 was approximately $26.8 million, $26.9 million and $9.5 million, respectively.

 

Certain reclassification of prior period balances have been made to conform to current presentation. Please refer to consolidated balance sheets, Consolidated Statement of Cash Flows and Note 11. Accounts Payable and Accrued Expenses

 
Recent Accounting Pronouncements

Recent Accounting Pronouncements

 

The Company adopts all applicable, new accounting pronouncements as of the specified effective dates.

 

In September 2016, the FASB issued ASU No. 2016-13, Financial Instruments – Credit Losses (Topic 326) (“ASU 2016-13”), which requires the immediate recognition of management’s estimates of current and expected credit losses. In November 2019, the FASB issued ASU 2019-10, which delays the effective date of Topic 326 for Smaller Reporting Companies to interim and annual periods beginning after December 15, 2022, with early adoption permitted. The Company has elected the relief provided. Topic 326 is effective for the Company in the first quarter of 2023. Adoption of the new standard is not expected to have a material impact on our consolidated financial statements or disclosures.

 
Liquidity

Liquidity — These financial statements have been prepared assuming the Company will be able to continue as a going concern. At December 31, 2022, the Company had an accumulated deficit of approximately $238.8 million which includes a net loss available to common stockholders of approximately $198.8 million for year ended December 31, 2022. During the year ended December 31, 2022 the Company’s net cash provided by operating activities totaled approximately $108.2 million. As of December 31, 2021, the Company had an accumulated deficit of $51.5 million which includes a net income available to common stockholders of $3.9 million for year ended December 31, 2021. During the year ended December 31, 2021 the Company’s net cash used by operating activities totaled approximately $96.6 million.

 

If our sales volumes do not meet our projections, expenses exceed our expectations, or our plans change, we may be unable to generate enough cash flow from operations to cover our working capital requirements. In such case, we may be required to adjust our business plan, by reducing marketing, lower our working capital requirements and reduce other expenses or seek additional financing. Furthermore, our business and results of operations may be adversely affected by changes in the global macro-economic environment related to the pandemic and public health crises related to the COVID-19 outbreak.

 
XML 43 R28.htm IDEA: XBRL DOCUMENT v3.23.1
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
 12 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
Schedule of revenue & accounts receivable with customers
               
   2022   2021   2020 
Pepsi   22.2%   -    - 
Costco   16.7%   12.7%   2.9%
Amazon   8.8%   10.1%   15.1%
All other   52.3%   77.2%   82.0%
Total   100.0%   100.0%   100.0%

 

Accounts receivable of our customers accounting for more than 10%, for the years ended December 31, 2022, and 2021, are as follows:

 

           
   2022   2021 
Pepsi   47.6%   - 
Amazon   11.8%   22.7%
Publix   1.4%   10.3%
All other   39.2%   67.0%
Total   100.0%   100.0%
Schedule of long-lived asset geographic data
          
   December 31,   December 31, 
   2022   2021 
United States  $9,750   $3,043 
Sweden   1,251    1,050 
Finland   363    301 
Other   1    - 
Long-lived assets related to foreign operations   1,615    1,351 
Total long-lived assets-net  $11,365   $4,394 
XML 44 R29.htm IDEA: XBRL DOCUMENT v3.23.1
EARNINGS PER SHARE (Tables)
 12 Months Ended
Dec. 31, 2022
(Loss) income per share:  
Schedule of earnings per share, basic and diluted
               
  

For the years ended

December 31,

 
   2022   2021   2020 
Net (loss) income attributed to common stockholders               
Net (loss) income  $(187,282)  $3,937   $8,524 
Less: dividends paid to Series A convertible preferred stockholders   (11,526)   -    - 
Net (loss) income attributed to common stockholders  $(198,808)  $3,937   $8,524 
Net (loss) income per common share:               
Basic  $(2.63)  $0.05   $0.12 
Dilutive  $(2.63)  $0.05   $0.11 
Weighted average common stock outstanding:               
Basic   75,649    73,781    70,195 
Dilutive   75,649    77,689    74,444 
XML 45 R30.htm IDEA: XBRL DOCUMENT v3.23.1
REVENUE (Tables)
 12 Months Ended
Dec. 31, 2022
Disclosure Revenue Abstract  
Schedule of net sales by reporting segment
               
   For the years ended 
   December 31,
2022		   December 31,
2021		   December 31,
2020		 
North America  $617,457   $273,005   $95,480 
Europe   31,054    38,097    33,727 
Asia   3,647    2,538    1,093 
Other   1,446    632    426 
Net sales  $653,604   $314,272   $130,726 
XML 46 R31.htm IDEA: XBRL DOCUMENT v3.23.1
INVENTORIES (Tables)
 12 Months Ended
Dec. 31, 2022
Inventory Disclosure [Abstract]  
Schedule of inventories
          
   December 31,   December 31, 
   2022   2021 
Finished goods  $119,229   $123,594 
Raw Materials   62,491    70,201 
Less: Inventory reserve   (8,431)   (2,573)
Inventories  $173,289   $191,222 
XML 47 R32.htm IDEA: XBRL DOCUMENT v3.23.1
NOTE RECEIVABLE (Tables)
 12 Months Ended
Dec. 31, 2022
Note Receivable  
Schedule of note receivable
          
   December 31,   December 31, 
   2022   2021 
Note Receivable-current  $2,979   $2,588 
Note Receivable-non-current   3,574    7,117 
Total Note Receivable  $6,553   $9,705 
XML 48 R33.htm IDEA: XBRL DOCUMENT v3.23.1
LEASES (Tables)
 12 Months Ended
Dec. 31, 2022
Leases  
Schedule of future minimum lease payments
               
   Operating   Finance     
Future minimum lease payments  Leases   Leases   Total 
2023  $698   $76   $774 
2024   328    39    367 
2025   7    67    74 
2026   -    64    64 
Total future minimum lease payments   1,033    246    1,279 
Less: Amount representing interest   (46)   (14)   (60)
Present value of lease liabilities   987    232    1,219 
Less: current portion   (661)   (70)   (731)
Long-term portion  $326   $162   $488 
XML 49 R34.htm IDEA: XBRL DOCUMENT v3.23.1
PROPERTY AND EQUIPMENT (Tables)
 12 Months Ended
Dec. 31, 2022
Property, Plant and Equipment [Abstract]  
Schedule of property and equipment
             
   Estimated Useful   December 31,   December 31, 
   Life in Years  2022   2021 
Merchandising equipment - coolers  5-7  $9,885   $3,052 
Office equipment  3-7   1,124    891 
Vehicles  5   1,257    304 
Less: accumulated depreciation      (2,081)   (1,067)
Total     $10,185   $3,180 
XML 50 R35.htm IDEA: XBRL DOCUMENT v3.23.1
GOODWILL AND INTANGIBLES (Tables)
 12 Months Ended
Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of accumulated amortization of intangible assets
          
   December 31,   December 31, 
   2022   2021 
Definite-lived intangible assets          
Customer relationships  $13,418   $14,248 
Less: accumulated amortization   (1,610)   (1,140)
Definite-lived intangible assets, net  $11,808   $13,108 
           
Indefinite-lived intangible assets          
Brands  $2,984   $3,193 
Less: Impairment   (2,538)   - 
Indefinite-lived intangible assets, net  $446   $3,193 
Total Intangibles  $12,254   $16,301 
Schedule of future estimated amortization expense
     
Years ending December 31,    
2023  $537 
2024   537 
2025   537 
2026   537 
2027   537 
Thereafter   9,123 
Total  $11,808 
XML 51 R36.htm IDEA: XBRL DOCUMENT v3.23.1
ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Tables)
 12 Months Ended
Dec. 31, 2022
Payables and Accruals [Abstract]  
Schedule of accounts payable and accrued expenses
          
   December 31,   December 31, 
   2022   2021 
Accounts payable  $36,248   $35,820 
Due to Pepsi   34,807    - 
Accrued freight   8,532    15,872 
Accrued expenses   19,081    15,311 
Unbilled purchases   8,672    5,439 
Total  $107,340   $72,442 
XML 52 R37.htm IDEA: XBRL DOCUMENT v3.23.1
OTHER CURRENT LIABILITIES (Tables)
 12 Months Ended
Dec. 31, 2022
Payables and Accruals [Abstract]  
Schedule of other current liabilities
          
   December 31,   December 31, 
   2022   2021 
Short-term          
VAT payable  $198   $- 
State Beverage Container Deposit   3,388    976 
Total  $3,586   $976 
XML 53 R38.htm IDEA: XBRL DOCUMENT v3.23.1
FAIR VALUE MEASUREMENTS (Tables)
 12 Months Ended
Dec. 31, 2022
Fair Value Disclosures [Abstract]  
Summary of preferred shares
               
   December 31, 2022 
   Level 1   Level 2   Level 3 
Mezzanine equity:               
Series A convertible preferred shares  $-   $824,488   $- 
Indefinite-lived intangible assets:               
Brands   -    -    446 
Total  $-   $824,488   $446 
XML 54 R39.htm IDEA: XBRL DOCUMENT v3.23.1
INCOME TAXES (Tables)
 12 Months Ended
Dec. 31, 2022
Income Tax Disclosure [Abstract]  
Schedule of domestic and foreign components
               
   2022   2021   2020 
Domestic  $(151,551)  $(4,176)  $8,111 
Foreign   (1,113)   117    529 
Income (loss) before provision for income taxes  $(152,664)  $(4,059)  $8,640 
Schedule of provision for income taxes
               
Current:  2022   2021   2020 
Domestic  $10,498   $-   $- 
State   2,601    1,523    - 
Foreign   -    (38)   116 
Current federal, state and local, tax expense  $13,099   $1,485   $116 

 

Deferred  2022   2021   2020 
Domestic  $18,558   $(7,142)  $- 
State and local   4,034    (1,878)   - 
Foreign   (1,073)   (461)   - 
Deferred federal, state and local, tax expense   21,519   $(9,481)  $- 
Income tax expense (benefit)   34,618    (7,996)   116 
Schedule of effective rate on income before provision (benefit) for income taxes
               
   2022   2021   2020 
U.S. Statutory federal rate   21.0%   21.0%   21.0%
State taxes, net of federal benefit   (3.9)%   (12.5)%   4.4%
Tax effect of Pepsi valuation premium   (38.9)%          
Permanent differences, including stock-based compensation   -    -    6.7%
Stock based compensation   (0.9)%   50.5%   - 
Change in valuation allowance   0.4%   219.8%   (29.8)%
Change in deferred balances   -    (80.6)%   - 
Other   (0.4)%   (0.9)%   - 
Effective tax rate   (22.7)%   197.2%   2.3%
Schedule of deferred tax assets
          
   December 31,
2022		   December 31,
2021		 
Net operating loss carryforwards  $4,774   $6,685 
Charitable contributions   17    17 
Fixed assets   (1,158)   (627)
Pepsi valuation premium   (70,637)     
Right of use liability   154    134 
Right of use asset   (146)   (122)
Distributor termination fees   46,859    - 
Uncertain tax position   -    132 
Stock-based compensation   5,236    6,190 
Inventory allowance   5,423    800 
Intangibles   (2,516)   (3,317)
Total deferred tax (liabilities) assets   (11,994)   9,892 
Valuation allowance   (3,424)   (4,019)
Net deferred tax (liabilities) assets   (15,418)   5,873 
Schedule of reconciliation of the beginning and ending amounts of unrecognized tax benefits
          
   2022   2021 
Gross unrecognized tax benefit, beginning of period  $1,080   $82 
Additions based on tax positions related to the current year   -    - 
Additions based on tax positions related to the prior years   -    998 
Reductions due to lapse in statute of limitations and settlements   (378)   - 
Gross unrecognized tax benefit, end of period  $702   $1,080 
Summary of the filing jurisdictions and open tax years
   
   Open Years
U.S. Federal  2019-2021
U.S State and local  2018-2021
Non-U.S.  2016-2021
XML 55 R40.htm IDEA: XBRL DOCUMENT v3.23.1
STOCK-BASED COMPENSATION (Tables)
 12 Months Ended
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]  
Schedule of black scholes option-pricing model valuation assumption
            
   Years ended
December 31,		 
   2022(1)  2021  2020 
Expected volatility  NA   69.2 - 81.1%   69.2 - 81.1% 
Expected term  NA   4.5 - 5.0 Years   4.8 - 5.0 Years 
Risk-free interest rate  NA   0.3% - 1.4%   0.2% - 1.4% 
Forfeiture Rate  NA   0.0%   0.0% 

 

 
(1)No stock options were issued during 2022.
Schedule of outstanding stock options
                           
       Weighted Average   Aggregate   Weighted  
   Shares   Exercise   Grant Date   Intrinsic
Value		   Average
Remaining		  
   (000’s)   Price   Fair Value   (000’s)   Term (Yrs)  
Options                            
At December 31, 2020   5,198   $4.23        $240,866     6.89  
Granted   305    42.37   $30.32              
Exercised   (1,460)   3.85    80.58    84,371         
Forfeiture and cancelled   (443)   5.01                   
At December 31, 2021   3,600   $7.47        $241,515     6.37  
Granted   -    -                   
Exercised   (1,273)  $3.67   $80.70   $102,283         
Forfeiture and cancelled   (61)   5.46                   
At December 31, 2022   2,266   $9.66        $213,914     5.43  
Exercisable at December 31, 2022   1,928   $6.41        $188,261     5.05  
Schedule of employee stock options outstanding
                              
   Outstanding Options   Vested Options 
Range of Exercise Price   Number
Outstanding at
December 31,
2022
(000’s)		     Weighted
Average
Remaining
Life		     Weighted
Average
Exercise
Price		     Number
Exercisable at
December 31,
2022
(000’s)		     Weighted
Average
Exercise
Price		     Weighted
Average
Remaining
Life		  
$0.34 - $1.05   30    1.44   $0.58    30   $0.58    1.44 
$1.97 - $2.95   5    3.01    1.97    5    1.97    3.01 
$3.23 - $4.85   1,465    5.38    3.81    1,412    3.80    5.34 
$5.59 - $8.38   389    3.51    5.70    331    5.72    2.88 
$14.53 - $21.79   61    7.58    14.53    40    14.53    7.58 
$21.80 - $32.70   16    7.83    21.80    10    21.80    7.83 
$42.64 - $63.96   300    8.01    42.67    100    42.67    8.01 
Outstanding options   2,266    5.43   $9.66    1,928   $6.41    5.05 
Schedule of restricted stock activity
                    
   For the twelve months ended 
   December 31,
2022		   December 31,
2021		 
    Shares     Weighted
Average
Grant Date
Fair Value		     Shares     Weighted
Average
Grant Date
Fair Value		  
Unvested at beginning of period   0.3   $14.72    66.2   $28.11 
Transfers to restricted stock units   -    -    (45.9)   34.02 
Granted   -    -    -    - 
Vested   -    -    (18.9)   14.79 
Forfeited and cancelled   (0.3)   14.72    (1.1)   14.72 
Unvested at end of period   -   $-    0.3   $14.72 
Schedule of restricted stock unit activity
                    
   For the twelve months ended 
   December 31,
2022		   December 31,
2021		 
    Shares
(000’s)		     Weighted
Average
Grant Date
Fair Value		     Shares
(000’s)		     Weighted
Average
Grant Date
Fair Value		  
Unvested at beginning of period   566   $52.66    -   $- 
Transfers to restricted stock awards   -    -    46    34.02 
Granted   248    74.14    574    54.40 
Vested   (205)   54.17    (19)   64.58 
Forfeited and cancelled   (70)   61.99    (35)   50.46 
Unvested at end of period   539   $60.73    566   $52.66 
Schedule of stock-based awards issued to non-employee consultants
                    
   For the twelve months ended 
   December 31,
2022		   December 31,
2021		 
    Shares
(000’s)		     Weighted
Average
Grant Date
Fair Value		     Shares
(000’s)		     Weighted
Average
Grant Date
Fair Value		  
Unvested at beginning of period   15   $64.65    -   $- 
Granted   76    98.28    15    64.65 
Vested   (15)   98.28    -    - 
Forfeited and cancelled   -    -    -    - 
Unvested at end of period   76   $91.48    15   $64.65 
XML 56 R41.htm IDEA: XBRL DOCUMENT v3.23.1
ORGANIZATION AND DESCRIPTION OF BUSINESS (Details Narrative) - USD ($)
$ in Thousands
 12 Months Ended
Aug. 01, 2022
Dec. 31, 2022
Transition Agreement [Member]    
Restructuring Cost and Reserve [Line Items]    
Termination expenses   $ 193,800
Transition Agreement [Member] | Convertible Preferred Stock [Member]    
Restructuring Cost and Reserve [Line Items]    
Stock Issued During Period, Shares 1,466,666  
Proceeds from issuance of convertible preferred stock $ 55,000  
Func Food Group [Member]    
Restructuring Cost and Reserve [Line Items]    
Date of Acquisition   Oct. 25, 2019
Equity acquired   100.00%
XML 57 R42.htm IDEA: XBRL DOCUMENT v3.23.1
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Customer Concentration Risk Total [Member]
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Revenue Benchmark [Member]      
Product Information [Line Items]      
Total 100.00% 100.00% 100.00%
Revenue Benchmark [Member] | PepsiCo Inc [Member]      
Product Information [Line Items]      
Total 22.20%
Revenue Benchmark [Member] | Costco [Member]      
Product Information [Line Items]      
Total 16.70% 12.70% 2.90%
Revenue Benchmark [Member] | Amazon [Member]      
Product Information [Line Items]      
Total 8.80% 10.10% 15.10%
Revenue Benchmark [Member] | All Other [Member]      
Product Information [Line Items]      
Total 52.30% 77.20% 82.00%
Accounts Receivable [Member]      
Product Information [Line Items]      
Total 100.00% 100.00%  
Accounts Receivable [Member] | PepsiCo Inc [Member]      
Product Information [Line Items]      
Total 47.60%  
Accounts Receivable [Member] | Amazon [Member]      
Product Information [Line Items]      
Total 11.80% 22.70%  
Accounts Receivable [Member] | All Other [Member]      
Product Information [Line Items]      
Total 39.20% 67.00%  
Accounts Receivable [Member] | Publix [Member]      
Product Information [Line Items]      
Total 1.40% 10.30%  
XML 58 R43.htm IDEA: XBRL DOCUMENT v3.23.1
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Total long-lived assets-net $ 11,365 $ 4,394
Long-lived assets related to foreign operations 1,615 1,351
UNITED STATES    
Total long-lived assets-net 9,750 3,043
SWEDEN    
Long-lived assets related to foreign operations 1,251 1,050
FINLAND    
Long-lived assets related to foreign operations 363 301
Other [Member]    
Long-lived assets related to foreign operations $ 1
XML 59 R44.htm IDEA: XBRL DOCUMENT v3.23.1
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Property, Plant and Equipment [Line Items]      
Amount excess of FDIC limit $ 652,400 $ 16,000  
Restricted cash 38,768  
Allowance for doubtful accounts 2,100 800  
Inventory reserve 8,400 2,600  
Impairment of long lived assets 2,500    
Deferred revenue 189,500    
Deferred Revenue, Noncurrent 179,800    
Deferred revenue-current 9,700    
Termination Expense 193,800 600 $ 200
Termination Payable 4,000    
Distribution agreements termination expense 34,800    
Customer advances 0 0  
Advertising expense 85,100 36,700 14,200
Research and development expense 400 1,000 500
Exchange losses 400 300  
Recognized foreign currency gains     1,400
Foreign Currency Transaction Gain Before Tax 2,500    
Foreign Currency Translation   800 600
Freight expense 26,800 26,900 9,500
Accumulated deficit 238,772 51,490  
Net (loss) income 198,808 (3,937) (8,524)
Net cash provided by (used in) operating activities 108,182 (96,586) 3,395
Net (loss) income attributed to common shareholders (198,808) 3,937 8,524
Net cash provided by (used in) operating activities $ (108,182) $ 96,586 $ (3,395)
Minimum [Member]      
Property, Plant and Equipment [Line Items]      
Property and equipment estimated useful life 3 years    
Maximum [Member]      
Property, Plant and Equipment [Line Items]      
Property and equipment estimated useful life 7 years    
XML 60 R45.htm IDEA: XBRL DOCUMENT v3.23.1
EARNINGS PER SHARE (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
(Loss) income per share:      
Net (loss) income $ (187,282) $ 3,937 $ 8,524
Less: dividends paid to Series A convertible preferred stockholders (11,526)
Net (loss) income attributed to common stockholders $ (198,808) $ 3,937 $ 8,524
Basic $ (2.63) $ 0.05 $ 0.12
Dilutive $ (2.63) $ 0.05 $ 0.11
Basic 75,649 73,781 70,195
Dilutive 75,649 77,689 74,444
XML 61 R46.htm IDEA: XBRL DOCUMENT v3.23.1
EARNINGS PER SHARE (Details Narrative)
 12 Months Ended
Dec. 31, 2022
shares
(Loss) income per share:  
Potentially Dilutive Shares Outstanding 10,200,000
XML 62 R47.htm IDEA: XBRL DOCUMENT v3.23.1
REVENUE (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Net sales $ 653,604 $ 314,272 $ 130,726
North America [Member]      
Net sales 617,457 273,005 95,480
Europe [Member]      
Net sales 31,054 38,097 33,727
Asia [Member]      
Net sales 3,647 2,538 1,093
Other [Member]      
Net sales $ 1,446 $ 632 $ 426
XML 63 R48.htm IDEA: XBRL DOCUMENT v3.23.1
REVENUE (Details Narrative) - USD ($)
$ in Thousands
 12 Months Ended
Aug. 01, 2022
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Promotional allowance included as a reduction of revenue   $ 158,500 $ 64,200 $ 28,700
Revenues   653,604 314,272 130,726
Contract with Customer, Liability   193,000    
Upfront payment received   227,800    
Transition Agreement [Member]        
Termination expenses sales and marketing   193,800    
PepsiCo Inc [Member]        
Total Payment $ 250,000      
Payment received 227,800      
Termination expenses sales and marketing   193,000    
Upfront payment received 227,800      
Implicit Payment $ 282,500      
Refund liability   34,800    
Deferred Revenue   4,200    
excess fair value over issuance proceeds   282,500    
contra-revenues   5,900    
License Agreement [Member]        
Revenues   2,000 1,600 800
SWEDEN        
Revenues   21,700 26,900 23,400
Foreign Revenues [Member]        
Revenues   $ 36,100 $ 41,300 $ 35,200
XML 64 R49.htm IDEA: XBRL DOCUMENT v3.23.1
INVENTORIES (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Inventory Disclosure [Abstract]    
Finished goods $ 119,229 $ 123,594
Raw Materials 62,491 70,201
Less: Inventory reserve (8,431) (2,573)
Inventories $ 173,289 $ 191,222
XML 65 R50.htm IDEA: XBRL DOCUMENT v3.23.1
PREPAID EXPENSES AND OTHER CURRENT ASSETS (Details Narrative) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Prepaid Expenses And Other Current Assets    
Prepaid expenses and other current assets $ 11,341 $ 13,555
XML 66 R51.htm IDEA: XBRL DOCUMENT v3.23.1
NOTE RECEIVABLE (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Note Receivable    
Note Receivable-current $ 2,979 $ 2,588
Note Receivable-non-current 3,574 7,117
Total Note Receivable $ 6,553 $ 9,705
XML 67 R52.htm IDEA: XBRL DOCUMENT v3.23.1
NOTE RECEIVABLE (Details Narrative) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Note Receivable description The Note accrues interest at a rate per annum equal to the weighted average of 5% of the outstanding principal up to $5 million and 2% of the outstanding principal above $5 million.    
Weighted average interest rate 3.21%    
Interest income $ 200 $ 300 $ 400
Instalment collateral shares 30,000.0    
Maximum [Member]      
Weighted average interest rate 5.00%    
Outstanding principal amount $ 5,000    
Minimum [Member]      
Weighted average interest rate 2.00%    
Outstanding principal amount $ 5,000    
XML 68 R53.htm IDEA: XBRL DOCUMENT v3.23.1
LEASES (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Leases    
2023 $ 698  
2023 76  
2023 774  
2024 328  
2024 39  
2024 367  
2025 7  
2025 67  
2025 74  
2026  
2026 64  
2026 64  
Total future minimum lease payments 1,033  
Total future minimum lease payments 246  
Total future minimum lease payments 1,279  
Less: Amount representing interest (46)  
Less: Amount representing interest (14)  
Less: Amount representing interest (60)  
Present value of lease liabilities 987  
Present value of lease liabilities 232  
Present value of lease liabilities 1,219  
Less: current portion (661) $ (512)
Less: current portion (70) (157)
Less: current portion (731)  
Long-term portion 326 658
Long-term portion 162 $ 45
Long-term portion $ 488  
XML 69 R54.htm IDEA: XBRL DOCUMENT v3.23.1
PROPERTY AND EQUIPMENT (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Property, Plant and Equipment [Line Items]    
Less: accumulated depreciation $ (2,081) $ (1,067)
Total 10,185 3,180
Merchandising Equipment Coolers [Member]    
Property, Plant and Equipment [Line Items]    
Property, plant and equipment, gross 9,885 3,052
Office Equipment [Member]    
Property, Plant and Equipment [Line Items]    
Property, plant and equipment, gross $ 1,124 891
Vehicles [Member]    
Property, Plant and Equipment [Line Items]    
Property, Plant and Equipment, Useful Life 5 years  
Property, plant and equipment, gross $ 1,257 $ 304
Minimum [Member]    
Property, Plant and Equipment [Line Items]    
Property, Plant and Equipment, Useful Life 3 years  
Minimum [Member] | Merchandising Equipment Coolers [Member]    
Property, Plant and Equipment [Line Items]    
Property, Plant and Equipment, Useful Life 5 years  
Minimum [Member] | Office Equipment [Member]    
Property, Plant and Equipment [Line Items]    
Property, Plant and Equipment, Useful Life 3 years  
Maximum [Member]    
Property, Plant and Equipment [Line Items]    
Property, Plant and Equipment, Useful Life 7 years  
Maximum [Member] | Merchandising Equipment Coolers [Member]    
Property, Plant and Equipment [Line Items]    
Property, Plant and Equipment, Useful Life 7 years  
Maximum [Member] | Office Equipment [Member]    
Property, Plant and Equipment [Line Items]    
Property, Plant and Equipment, Useful Life 7 years  
XML 70 R55.htm IDEA: XBRL DOCUMENT v3.23.1
PROPERTY AND EQUIPMENT (Details Narrative) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Property, Plant and Equipment [Abstract]      
Depreciation $ 1,362 $ 550 $ 127
XML 71 R56.htm IDEA: XBRL DOCUMENT v3.23.1
GOODWILL AND INTANGIBLES (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]    
Customer relationships $ 13,418 $ 14,248
Less: accumulated amortization (1,610) (1,140)
Definite-lived intangible assets, net 11,808 13,108
Brands 2,984 3,193
Less: Impairment (2,538)
Indefinite-lived intangible assets, net 446 3,193
Total Intangibles $ 12,254 $ 16,301
XML 72 R57.htm IDEA: XBRL DOCUMENT v3.23.1
GOODWILL AND INTANGIBLES (Details 1)
$ in Thousands
Dec. 31, 2022
USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]  
2023 $ 537
2024 537
2025 537
2026 537
2027 537
Thereafter 9,123
Total $ 11,808
XML 73 R58.htm IDEA: XBRL DOCUMENT v3.23.1
GOODWILL AND INTANGIBLES (Details Narrative) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]      
Intangible Assets, Net (Including Goodwill) $ 13,700    
Amortized over estimated useful life 25 years    
Amortization expense $ 500 $ 600 $ 600
XML 74 R59.htm IDEA: XBRL DOCUMENT v3.23.1
ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Payables and Accruals [Abstract]    
Accounts payable $ 36,248 $ 35,820
Due to Pepsi 34,807
Accrued freight 8,532 15,872
Accrued expenses 19,081 15,311
Unbilled purchases 8,672 5,439
Total $ 107,340 $ 72,442
XML 75 R60.htm IDEA: XBRL DOCUMENT v3.23.1
OTHER CURRENT LIABILITIES (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Payables and Accruals [Abstract]    
VAT payable $ 198
State Beverage Container Deposit 3,388 976
Total $ 3,586 $ 976
XML 76 R61.htm IDEA: XBRL DOCUMENT v3.23.1
RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)
 12 Months Ended
Aug. 01, 2022
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Related Party Transaction [Line Items]        
Deferred revenue   $ 189,500,000    
Revenues   653,604,000 $ 314,272,000 $ 130,726,000
Net proceeds from sale of common stock   $ 67,769,000 $ 21,892,000
Series A Preferred Stock [Member]        
Related Party Transaction [Line Items]        
Preferred stock issued 1,466,666 1,467,000 0  
Issuance of preferred stock fair value   $ 832,500,000    
PepsiCo Inc [Member]        
Related Party Transaction [Line Items]        
Percentage of Related Party Common Stock Outstanding   8.50%    
Net Sales   $ 142,300,000    
Accounts receivable from related party   31,600,000    
Related party cash payment   227,800,000    
Deferred revenue   189,500,000    
Revenues   4,200,000    
Related Party Liability Payable Due   34,800,000    
Issuance of preferred stock fair value $ 832,500,000      
Deferred contract asset in other assets   282,500,000    
Accumulated amortization of other deferred costs   5,900,000    
PepsiCo Inc [Member] | Contract Assets Current [Member]        
Related Party Transaction [Line Items]        
Unamortized deferred contract costs   14,100,000    
PepsiCo Inc [Member] | Contract Assets Non Current [Member]        
Related Party Transaction [Line Items]        
Unamortized deferred contract costs   262,500,000    
PepsiCo Inc [Member] | Series A Preferred Stock [Member]        
Related Party Transaction [Line Items]        
Preferred stock issued 1,466,666      
Excess of payments from related party   34,800,000    
Issuance of preferred stock fair value   832,500,000    
Net proceeds from sale of common stock $ 550,000,000.0      
Issuance of deferred contract asset in other assets excess   550,000,000.0    
Majority Shareholder [Member] | Building [Member] | C D Financial L L C [Member]        
Related Party Transaction [Line Items]        
Monthly expense   $ 37,600    
XML 77 R62.htm IDEA: XBRL DOCUMENT v3.23.1
MEZZANINE EQUITY (Details Narrative) - USD ($)
$ / shares in Units, $ in Thousands
 12 Months Ended
Aug. 01, 2022
Dec. 31, 2022
Dec. 31, 2021
Debt Securities, Available-for-Sale [Line Items]      
Percentage of Voting Right, Preferred Stock   50.00%  
Series A Convertible Preferred Stock [Member]      
Debt Securities, Available-for-Sale [Line Items]      
Preferred Stock, Shares Authorized   1,466,666  
Series A Preferred Stock [Member]      
Debt Securities, Available-for-Sale [Line Items]      
Preferred Stock Par Value   $ 0.001  
Preferred Stock Stated Value   $ 375  
Preferred Stock, Shares Issued 1,466,666 1,467,000 0
Percentage of Share Authorized   100.00%  
Issuance Of Preferred Stock Fair Value   $ 832,500  
Per Share of Aggregate Fair Value of Preferred Share   $ 568  
Debt Issuance Costs, Net   $ 8,000  
Preferred Stock, Liquidation Preference, Value   $ 550,000  
Accrued dividend   5.00%  
Dividends   $ 11,500  
Preferred Stock, Dividends Per Share, Declared   $ 7.86  
Preferred Stock, Dividend Rate, Percentage 5.00% 5.00%  
Preferred Stock, Convertible, Shares Issuable   7,333,330  
Series A Preferred Stock [Member] | Minimum [Member]      
Debt Securities, Available-for-Sale [Line Items]      
Preferred Stock, Convertible, Conversion Ratio   1  
Series A Preferred Stock [Member] | Maximum [Member]      
Debt Securities, Available-for-Sale [Line Items]      
Preferred Stock, Convertible, Conversion Ratio   5  
Series A Preferred Stock [Member] | Securities Purchase Agreement [Member]      
Debt Securities, Available-for-Sale [Line Items]      
Preferred Stock, Shares Issued   1,466,666  
Cash Consideration to Related Party   $ 550,000  
Common Stock, Other Shares, Outstanding   3,666,665  
Eight Percentage [Member]      
Debt Securities, Available-for-Sale [Line Items]      
Preferred Stock, Dividend Rate, Percentage   8.00%  
Ten Percentage [Member]      
Debt Securities, Available-for-Sale [Line Items]      
Preferred Stock, Dividend Rate, Percentage   10.00%  
Twelve Percentage [Member]      
Debt Securities, Available-for-Sale [Line Items]      
Preferred Stock, Dividend Rate, Percentage   12.00%  
XML 78 R63.htm IDEA: XBRL DOCUMENT v3.23.1
STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)
$ / shares in Units, $ in Thousands
 12 Months Ended
Jun. 14, 2021
Jun. 11, 2021
Jun. 09, 2021
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]            
Proceeds from exercise of stock options       $ 3,683 $ 3,720 $ 4,127
Number of options exercised 873,141     1,273 1,460  
Sales of common stock     6,518,267      
Share price     $ 0.001      
Public offering price     $ 62.50      
Additional share purchase     977,740      
Net proceeds from sale of common stock       $ 67,769 $ 21,892
Company [Member]            
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]            
Sales of common stock 1,133,953          
Net proceeds from sale of common stock $ 67,769,386          
Selling Stockholders [Member]            
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]            
Sales of common stock 6,257,455 739,188        
Net proceeds from sale of common stock $ 375,447,300          
Stock Incentive Plan2015 [Member]            
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]            
Number of option shares granted       1,500,000 1,500,000 1,900,000
Proceeds from exercise of stock options       $ 3,700 $ 3,700 $ 4,100
Number of options exercised       1,000,000.0 1,000,000.0 1,300,000
XML 79 R64.htm IDEA: XBRL DOCUMENT v3.23.1
FAIR VALUE MEASUREMENTS (Details)
$ in Thousands
Dec. 31, 2022
USD ($)
Fair Value, Inputs, Level 1 [Member]  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Preferred stock, value, issued
Fair Value, Inputs, Level 1 [Member] | Series A Preferred Stock [Member]  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Preferred stock, value, issued
Fair Value, Inputs, Level 1 [Member] | Indefinite-Lived Intangible Assets [Member]  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Preferred stock, value, issued
Fair Value, Inputs, Level 2 [Member]  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Preferred stock, value, issued 824,488
Fair Value, Inputs, Level 2 [Member] | Series A Preferred Stock [Member]  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Preferred stock, value, issued 824,488
Fair Value, Inputs, Level 2 [Member] | Indefinite-Lived Intangible Assets [Member]  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Preferred stock, value, issued
Fair Value, Inputs, Level 3 [Member]  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Preferred stock, value, issued 446
Fair Value, Inputs, Level 3 [Member] | Series A Preferred Stock [Member]  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Preferred stock, value, issued
Fair Value, Inputs, Level 3 [Member] | Indefinite-Lived Intangible Assets [Member]  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Preferred stock, value, issued $ 446
XML 80 R65.htm IDEA: XBRL DOCUMENT v3.23.1
FAIR VALUE MEASUREMENTS (Details Narrative) - Series A Preferred Stock [Member] - $ / shares
 12 Months Ended
Aug. 01, 2022
Dec. 31, 2022
Dec. 31, 2021
Preferred stock issued 1,466,666 1,467,000 0
Volatility Rate 45.00%    
Risk free interest rate 2.69%    
Dividend rate 5.00% 5.00%  
Closing Price $ 98.87    
Debt discount rate 12.50%    
XML 81 R66.htm IDEA: XBRL DOCUMENT v3.23.1
INCOME TAXES (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Income before provision for income taxes $ (152,664) $ (4,059) $ 8,640
Domestic Tax Authority [Member]      
Income before provision for income taxes (151,551) (4,176) 8,111
Foreign Tax Authority [Member]      
Income before provision for income taxes $ (1,113) $ 117 $ 529
XML 82 R67.htm IDEA: XBRL DOCUMENT v3.23.1
INCOME TAXES (Details 1) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Current:      
Domestic $ 10,498
State 2,601 1,523
Foreign (38) 116
Current federal, state and local, tax expense 13,099 1,485 116
Deferred      
Domestic 18,558 (7,142)
State and local 4,034 (1,878)
Foreign (1,073) (461)
Deferred federal, state and local, tax expense 21,519 (9,481)
Income tax expense (benefit) $ 34,618 $ (7,996) $ 116
XML 83 R68.htm IDEA: XBRL DOCUMENT v3.23.1
INCOME TAXES (Details 2)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Income Tax Disclosure [Abstract]      
U.S. Statutory federal rate 21.00% 21.00% 21.00%
State taxes, net of federal benefit (3.90%) (12.50%) 4.40%
Tax effect of Pepsi valuation premium (38.90%)    
Permanent differences, including stock-based compensation 6.70%
Stock based compensation (0.90%) 50.50%
Change in valuation allowance 0.40% 219.80% (29.80%)
Change in deferred balances (80.60%)
Other (0.40%) (0.90%)
Effective tax rate (22.70%) 197.20% 2.30%
XML 84 R69.htm IDEA: XBRL DOCUMENT v3.23.1
INCOME TAXES (Details 3) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Income Tax Disclosure [Abstract]    
Net operating loss carryforwards $ 4,774 $ 6,685
Charitable contributions 17 17
Fixed assets (1,158) (627)
Pepsi valuation premium (70,637)  
Right of use liability 154 134
Right of use asset (146) (122)
Distributor termination fees 46,859
Uncertain tax position 132
Stock-based compensation 5,236 6,190
Inventory allowance 5,423 800
Intangibles (2,516) (3,317)
Total deferred tax (liabilities) assets (11,994) 9,892
Valuation allowance (3,424) (4,019)
Net deferred tax (liabilities) assets $ (15,418) $ 5,873
XML 85 R70.htm IDEA: XBRL DOCUMENT v3.23.1
INCOME TAXES (Details 4) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Income Tax Disclosure [Abstract]    
Gross unrecognized tax benefit, beginning of period $ 1,080 $ 82
Additions based on tax positions related to the current year
Additions based on tax positions related to the prior years 998
Reductions due to lapse in statute of limitations and settlements (378)
Gross unrecognized tax benefit, end of period $ 702 $ 1,080
XML 86 R71.htm IDEA: XBRL DOCUMENT v3.23.1
INCOME TAXES (Details 5)
 12 Months Ended
Dec. 31, 2022
Minimum [Member] | Non-US [Member]  
Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]  
Open Tax Year 2019
Minimum [Member] | U.S. Federal [Member]  
Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]  
Open Tax Year 2018
Minimum [Member] | U.S State and local [Member]  
Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]  
Open Tax Year 2021
Maximum [Member] | Non-US [Member]  
Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]  
Open Tax Year 2021
Maximum [Member] | U.S. Federal [Member]  
Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]  
Open Tax Year 2016
Maximum [Member] | U.S State and local [Member]  
Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]  
Open Tax Year 2021
XML 87 R72.htm IDEA: XBRL DOCUMENT v3.23.1
INCOME TAXES (Details Narrative) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Income Tax Disclosure [Abstract]    
Operating Loss Carryforwards, Federal   $ 2,300
Operating Loss Carryforwards, State   $ 8,700
Ownership change   50.00%
Unrealized NOLs due to ownership change   $ 4,500
Removed from the available NOL carryforward and US NOL deferred tax asset.   4,500
Operating Loss Carryforwards, Foreign   21,900
Valuation allowance $ 6,000 $ 500
Unrecognized tax benefits that would impact effective tax rate 700  
Uncertain tax positions 800  
Unrecognized tax benefits, Interest and penalties $ 100  
XML 88 R73.htm IDEA: XBRL DOCUMENT v3.23.1
STOCK-BASED COMPENSATION (Details)
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Forfeiture Rate 0.00% 0.00%
Minimum [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Expected volatility 69.20% 69.20%
Expected term 4 years 6 months 4 years 9 months 18 days
Risk-free interest rate 0.30% 0.20%
Maximum [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Expected volatility 81.10% 81.10%
Expected term 5 years 5 years
Risk-free interest rate 1.40% 1.40%
XML 89 R74.htm IDEA: XBRL DOCUMENT v3.23.1
STOCK-BASED COMPENSATION (Details 1) - USD ($)
$ / shares in Units, $ in Thousands
 12 Months Ended
Jun. 14, 2021
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Share-Based Payment Arrangement [Abstract]        
Options outstanding, Balance at Beginning   3,600 5,198  
Weighted Average Exercise Price, Balance at beginning   $ 7.47 $ 4.23  
Aggregate Intrinsic Value Balance at beginning   $ 241,515 $ 240,866  
Weighted Average Remaining Term Ending Balance   5 years 5 months 4 days 6 years 4 months 13 days 6 years 10 months 20 days
Options outstanding, Granted   305  
Weighted Average Exercise Price, options granted   $ 42.37  
Weighted Average Grant Date Fair Value Granted     $ 30.32  
Options outstanding, Exercised (873,141) (1,273) (1,460)  
Weighted Average Exercise Price, Exercised   $ 3.67 $ 3.85  
Weighted Average Grant Date Fair Value Exercised   $ 80.70 $ 80.58  
Aggregate Intrinsic Value Exercised   $ 102,283 $ 84,371  
Options outstanding, Forfeiture and cancelled   (61) (443)  
Weighted Average Exercise Price, Forfeiture and cancelled   $ 5.46 $ 5.01  
Options outstanding, Balance at end   2,266 3,600 5,198
Weighted Average Exercise Price, Balance at end   $ 9.66 $ 7.47 $ 4.23
Aggregate Intrinsic Value Balance at end   $ 213,914 $ 241,515 $ 240,866
Options outstanding, Exercisable at end   1,928    
Weighted Average Exercise Price, Options Exercisable   $ 6.41    
Aggregate Intrinsic Value Exercisable   $ 188,261    
Weighted Average Remaining Term, exercisable   5 years 18 days    
XML 90 R75.htm IDEA: XBRL DOCUMENT v3.23.1
STOCK-BASED COMPENSATION (Details 2)
 12 Months Ended
Dec. 31, 2022
$ / shares
shares
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Number outstanding options | shares 2,266,000
Weighted average remaining life, outstanding options 5 years 5 months 4 days
Weighted average exercise price, outstanding options | $ / shares $ 9.66
Number vested options, exercisable | shares 1,928,000
Weighted average exercise price, vested options | $ / shares $ 6.41
Weighted average remaining life, vested options 5 years 18 days
Range Of Exercise Price1 [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Number outstanding options | shares 30,000
Weighted average remaining life, outstanding options 1 year 5 months 8 days
Weighted average exercise price, outstanding options | $ / shares $ 0.58
Number vested options, exercisable | shares 30,000
Weighted average exercise price, vested options | $ / shares $ 0.58
Weighted average remaining life, vested options 1 year 5 months 8 days
Range Of Exercise Price2 [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Number outstanding options | shares 5,000
Weighted average remaining life, outstanding options 3 years 3 days
Weighted average exercise price, outstanding options | $ / shares $ 1.97
Number vested options, exercisable | shares 5,000
Weighted average exercise price, vested options | $ / shares $ 1.97
Weighted average remaining life, vested options 3 years 3 days
Range Of Exercise Price3 [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Number outstanding options | shares 1,465,000
Weighted average remaining life, outstanding options 5 years 4 months 17 days
Weighted average exercise price, outstanding options | $ / shares $ 3.81
Number vested options, exercisable | shares 1,412,000
Weighted average exercise price, vested options | $ / shares $ 3.80
Weighted average remaining life, vested options 5 years 4 months 2 days
Range Of Exercise Price4 [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Number outstanding options | shares 389,000
Weighted average remaining life, outstanding options 3 years 6 months 3 days
Weighted average exercise price, outstanding options | $ / shares $ 5.70
Number vested options, exercisable | shares 331,000
Weighted average exercise price, vested options | $ / shares $ 5.72
Weighted average remaining life, vested options 2 years 10 months 17 days
Range Of Exercise Price5 [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Number outstanding options | shares 61,000
Weighted average remaining life, outstanding options 7 years 6 months 29 days
Weighted average exercise price, outstanding options | $ / shares $ 14.53
Number vested options, exercisable | shares 40,000
Weighted average exercise price, vested options | $ / shares $ 14.53
Weighted average remaining life, vested options 7 years 6 months 29 days
Range Of Exercise Price6 [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Number outstanding options | shares 16,000
Weighted average remaining life, outstanding options 7 years 9 months 29 days
Weighted average exercise price, outstanding options | $ / shares $ 21.80
Number vested options, exercisable | shares 10,000
Weighted average exercise price, vested options | $ / shares $ 21.80
Weighted average remaining life, vested options 7 years 9 months 29 days
Range Of Exercise Price7 [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Number outstanding options | shares 300,000
Weighted average remaining life, outstanding options 8 years 3 days
Weighted average exercise price, outstanding options | $ / shares $ 42.67
Number vested options, exercisable | shares 100,000
Weighted average exercise price, vested options | $ / shares $ 42.67
Weighted average remaining life, vested options 8 years 3 days
XML 91 R76.htm IDEA: XBRL DOCUMENT v3.23.1
STOCK-BASED COMPENSATION (Details 3) - Restricted Stock [Member] - $ / shares
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Unvested at beginning of period 300 66,200
Unvested at beginning of period (in Dollars per share) $ 14.72 $ 28.11
Transfers to restricted stock units (45,900)
Restricted stock Transfers to restricted stock units(in Dollars per share) $ 34.02
Granted
Restricted stock granted (in Dollars per share)
Vested 18,900
Restricted stock vested (in Dollars per share) $ 14.79
Vested (18,900)
Forfeited and cancelled (300) (1,100)
Restricted stock Forfeiture and cancelled (in Dollars per share) $ 14.72 $ 14.72
Unvested at end of period 300
Unvested at end of period (in Dollars per share) $ 14.72
XML 92 R77.htm IDEA: XBRL DOCUMENT v3.23.1
STOCK-BASED COMPENSATION (Details 4) - Restricted Stock Units (RSUs) [Member] - $ / shares
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Unvested at beginning of period 566,000
Unvested at beginning of period (in Dollars per share) $ 52.66
Transfers to restricted stock units 46,000
Restricted stock Transfers to restricted stock units(in Dollars per share) $ 34.02
Granted 248,000 574,000
Restricted stock granted (in Dollars per share) $ 74.14 $ 54.40
Vested (205,000) (19,000)
Restricted stock vested (in Dollars per share) $ 54.17 $ 64.58
Forfeited and cancelled (70,000) (35,000)
Restricted stock Forfeiture and cancelled (in Dollars per share) $ 61.99 $ 50.46
Unvested at end of period 539,000 566,000
Unvested at end of period (in Dollars per share) $ 60.73 $ 52.66
XML 93 R78.htm IDEA: XBRL DOCUMENT v3.23.1
STOCK-BASED COMPENSATION (Details 5) - Performance Shares [Member] - $ / shares
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Unvested at beginning of period 15,000
Unvested at beginning of period (in Dollars per share) $ 64.65
Granted 76,000 15,000
Restricted stock granted (in Dollars per share) $ 98.28 $ 64.65
Vested (15,000)
Restricted stock vested (in Dollars per share) $ 98.28
Forfeited and cancelled
Restricted stock Forfeiture and cancelled (in Dollars per share)
Unvested at end of period 76,000 15,000
Unvested at end of period (in Dollars per share) $ 91.48 $ 64.65
XML 94 R79.htm IDEA: XBRL DOCUMENT v3.23.1
STOCK-BASED COMPENSATION (Details Narrative) - USD ($)
$ / shares in Units, $ in Thousands
 1 Months Ended 12 Months Ended
Apr. 30, 2015
Jan. 18, 2007
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]          
Number of shares authorized 5,000,000        
Share-based compensation service or vesting period of grant     10 years    
Options to purchase vested     1,900,000 1,900,000  
Stock Issued During Period, Value, Stock Options Exercised     $ 3,684 $ 3,720 $ 4,126
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price     $ 42.37  
Unrecognized pre-tax non-cash compensation expense (in Dollars)     $ 3,400    
Period unrecognized pre-tax non-cash compensation expense     1 year    
Incremental compensation cost       $ 19,300  
Restricted Stock Units (RSUs) [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]          
Unrecognized compensation expense     $ 20,300    
Performance Shares [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]          
Period unrecognized pre-tax non-cash compensation expense     1 year 7 months 6 days    
Unrecognized compensation expense     $ 4,300    
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Aggregate Target Payout If Circumstances Met     $ 7,500    
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage     20.00%    
Vested [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]          
Fair value of shares vested     $ 11,600    
Maximum [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]          
Stock incentive plan, description     The Company used straight-line amortization of compensation expense over the two to three-year requisite service or vesting period of the grant. The maximum contractual term of the Company’s stock options is 10 years. The Company recognizes forfeitures as they occur. There are options to purchase approximately 1.9 million shares that have vested as of December 31, 2022 and 2021.    
Share-based compensation service or vesting period of grant     3 years    
Minimum [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]          
Share-based compensation service or vesting period of grant     2 years    
General and Administrative Expense [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]          
Non-cash compensation expense (in Dollars)     $ 20,700 $ 36,500 $ 6,300
Stock Incentive Plan [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]          
Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period   10 years      
Stock Incentive Plan2015 [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]          
Stock incentive plan, description In addition, there is a provision in the 2015 Plan for an annual increase to the maximum number of shares authorized under the 2015 Plan, which increase shall be added on the first day of the calendar year beginning January 1, 2016, equal to 15% of the number of shares outstanding as of such date (Note 15). Provisions have been made to permit the grant of options and other share-based awards for up to 5.0 million shares.        
Provisions of options grant and other share based awards permitted 5,000,000.0        
Stock Issued During Period, Value, Stock Options Exercised     $ 2,300    
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price     $ 9.66    
Fair value of shares issued (in Dollars)     $ 213,900    
XML 95 R80.htm IDEA: XBRL DOCUMENT v3.23.1
COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)
$ in Thousands
 1 Months Ended 12 Months Ended
Oct. 12, 2022
May 04, 2021
Feb. 13, 2023
Jan. 18, 2023
Nov. 30, 2020
Dec. 31, 2022
Dec. 31, 2021
Product Liability Contingency [Line Items]              
Percentage of Fee Received         (3.00%)    
Gain (Loss) Related to Litigation Settlement $ 7,800         $ 7,800  
Contingent commitment to third parties           30,700 $ 30,700
Minimum [Member]              
Product Liability Contingency [Line Items]              
Accrued liability           2,100  
Maximum [Member]              
Product Liability Contingency [Line Items]              
Accrued liability           82,600  
Subsequent Event [Member]              
Product Liability Contingency [Line Items]              
Compensatory damages       $ 82,600      
Reducing award damages value       $ 2,100      
Post-judgment interest rate     5.52%        
NEW YORK | November Twenty Three Two Thousens Twenty One [Member]              
Product Liability Contingency [Line Items]              
Gain (Loss) Related to Litigation Settlement $ 7,800         $ 7,800  
FLORIDA | DThreeM Licensing Group [Member]              
Product Liability Contingency [Line Items]              
Sales revenue bench mark receive shares   750,000          
XML 96 celsiusholdings_10ka_htm.xml IDEA: XBRL DOCUMENT 0001341766 2022-01-01 2022-12-31 0001341766 2022-06-30 0001341766 2023-02-14 0001341766 2022-12-31 0001341766 2021-12-31 0001341766 us-gaap:SeriesAPreferredStockMember 2022-12-31 0001341766 us-gaap:SeriesAPreferredStockMember 2021-12-31 0001341766 2021-01-01 2021-12-31 0001341766 2020-01-01 2020-12-31 0001341766 us-gaap:CommonStockMember 2019-12-31 0001341766 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001341766 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0001341766 us-gaap:RetainedEarningsMember 2019-12-31 0001341766 2019-12-31 0001341766 us-gaap:PreferredStockMember 2019-12-31 0001341766 us-gaap:CommonStockMember 2020-12-31 0001341766 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001341766 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001341766 us-gaap:RetainedEarningsMember 2020-12-31 0001341766 2020-12-31 0001341766 us-gaap:PreferredStockMember 2020-12-31 0001341766 us-gaap:CommonStockMember 2021-12-31 0001341766 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001341766 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001341766 us-gaap:RetainedEarningsMember 2021-12-31 0001341766 us-gaap:PreferredStockMember 2021-12-31 0001341766 us-gaap:CommonStockMember 2020-01-01 2020-12-31 0001341766 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-12-31 0001341766 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-12-31 0001341766 us-gaap:RetainedEarningsMember 2020-01-01 2020-12-31 0001341766 us-gaap:PreferredStockMember 2020-01-01 2020-12-31 0001341766 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0001341766 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0001341766 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-12-31 0001341766 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0001341766 us-gaap:PreferredStockMember 2021-01-01 2021-12-31 0001341766 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001341766 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001341766 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-12-31 0001341766 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001341766 us-gaap:PreferredStockMember 2022-01-01 2022-12-31 0001341766 us-gaap:CommonStockMember 2022-12-31 0001341766 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001341766 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001341766 us-gaap:RetainedEarningsMember 2022-12-31 0001341766 us-gaap:PreferredStockMember 2022-12-31 0001341766 celh:FuncFoodGroupMember 2022-01-01 2022-12-31 0001341766 celh:FuncFoodGroupMember 2022-12-31 0001341766 celh:TransitionAgreementMember us-gaap:ConvertiblePreferredStockMember 2022-07-29 2022-08-01 0001341766 celh:TransitionAgreementMember 2022-01-01 2022-12-31 0001341766 celh:PepsicoIncMember us-gaap:SalesRevenueNetMember celh:CustomerConcentrationRiskTotalMember 2022-01-01 2022-12-31 0001341766 celh:PepsicoIncMember us-gaap:SalesRevenueNetMember celh:CustomerConcentrationRiskTotalMember 2021-01-01 2021-12-31 0001341766 celh:PepsicoIncMember us-gaap:SalesRevenueNetMember celh:CustomerConcentrationRiskTotalMember 2020-01-01 2020-12-31 0001341766 celh:CostcoMember us-gaap:SalesRevenueNetMember celh:CustomerConcentrationRiskTotalMember 2022-01-01 2022-12-31 0001341766 celh:CostcoMember us-gaap:SalesRevenueNetMember celh:CustomerConcentrationRiskTotalMember 2021-01-01 2021-12-31 0001341766 celh:CostcoMember us-gaap:SalesRevenueNetMember celh:CustomerConcentrationRiskTotalMember 2020-01-01 2020-12-31 0001341766 celh:AmazonMember us-gaap:SalesRevenueNetMember celh:CustomerConcentrationRiskTotalMember 2022-01-01 2022-12-31 0001341766 celh:AmazonMember us-gaap:SalesRevenueNetMember celh:CustomerConcentrationRiskTotalMember 2021-01-01 2021-12-31 0001341766 celh:AmazonMember us-gaap:SalesRevenueNetMember celh:CustomerConcentrationRiskTotalMember 2020-01-01 2020-12-31 0001341766 celh:AllOtherMember us-gaap:SalesRevenueNetMember celh:CustomerConcentrationRiskTotalMember 2022-01-01 2022-12-31 0001341766 celh:AllOtherMember us-gaap:SalesRevenueNetMember celh:CustomerConcentrationRiskTotalMember 2021-01-01 2021-12-31 0001341766 celh:AllOtherMember us-gaap:SalesRevenueNetMember celh:CustomerConcentrationRiskTotalMember 2020-01-01 2020-12-31 0001341766 us-gaap:SalesRevenueNetMember celh:CustomerConcentrationRiskTotalMember 2022-01-01 2022-12-31 0001341766 us-gaap:SalesRevenueNetMember celh:CustomerConcentrationRiskTotalMember 2021-01-01 2021-12-31 0001341766 us-gaap:SalesRevenueNetMember celh:CustomerConcentrationRiskTotalMember 2020-01-01 2020-12-31 0001341766 celh:PepsicoIncMember us-gaap:AccountsReceivableMember celh:CustomerConcentrationRiskTotalMember 2022-01-01 2022-12-31 0001341766 celh:PepsicoIncMember us-gaap:AccountsReceivableMember celh:CustomerConcentrationRiskTotalMember 2021-01-01 2021-12-31 0001341766 celh:AmazonMember us-gaap:AccountsReceivableMember celh:CustomerConcentrationRiskTotalMember 2022-01-01 2022-12-31 0001341766 celh:AmazonMember us-gaap:AccountsReceivableMember celh:CustomerConcentrationRiskTotalMember 2021-01-01 2021-12-31 0001341766 celh:PublixMember us-gaap:AccountsReceivableMember celh:CustomerConcentrationRiskTotalMember 2022-01-01 2022-12-31 0001341766 celh:PublixMember us-gaap:AccountsReceivableMember celh:CustomerConcentrationRiskTotalMember 2021-01-01 2021-12-31 0001341766 celh:AllOtherMember us-gaap:AccountsReceivableMember celh:CustomerConcentrationRiskTotalMember 2022-01-01 2022-12-31 0001341766 celh:AllOtherMember us-gaap:AccountsReceivableMember celh:CustomerConcentrationRiskTotalMember 2021-01-01 2021-12-31 0001341766 us-gaap:AccountsReceivableMember celh:CustomerConcentrationRiskTotalMember 2022-01-01 2022-12-31 0001341766 us-gaap:AccountsReceivableMember celh:CustomerConcentrationRiskTotalMember 2021-01-01 2021-12-31 0001341766 srt:MinimumMember 2022-01-01 2022-12-31 0001341766 srt:MaximumMember 2022-01-01 2022-12-31 0001341766 country:US 2022-12-31 0001341766 country:US 2021-12-31 0001341766 country:SE 2022-12-31 0001341766 country:SE 2021-12-31 0001341766 country:FI 2022-12-31 0001341766 country:FI 2021-12-31 0001341766 celh:OtherMember 2022-12-31 0001341766 celh:OtherMember 2021-12-31 0001341766 celh:ForeignRevenuesMember 2022-01-01 2022-12-31 0001341766 celh:ForeignRevenuesMember 2021-01-01 2021-12-31 0001341766 celh:ForeignRevenuesMember 2020-01-01 2020-12-31 0001341766 country:SE 2022-01-01 2022-12-31 0001341766 country:SE 2021-01-01 2021-12-31 0001341766 country:SE 2020-01-01 2020-12-31 0001341766 celh:PepsicoIncMember 2022-07-29 2022-08-01 0001341766 celh:PepsicoIncMember 2022-12-31 0001341766 celh:PepsicoIncMember 2022-01-01 2022-12-31 0001341766 celh:LicenseAgreementMember 2022-01-01 2022-12-31 0001341766 celh:LicenseAgreementMember 2021-01-01 2021-12-31 0001341766 celh:LicenseAgreementMember 2020-01-01 2020-12-31 0001341766 srt:NorthAmericaMember 2022-01-01 2022-12-31 0001341766 srt:NorthAmericaMember 2021-01-01 2021-12-31 0001341766 srt:NorthAmericaMember 2020-01-01 2020-12-31 0001341766 srt:EuropeMember 2022-01-01 2022-12-31 0001341766 srt:EuropeMember 2021-01-01 2021-12-31 0001341766 srt:EuropeMember 2020-01-01 2020-12-31 0001341766 srt:AsiaMember 2022-01-01 2022-12-31 0001341766 srt:AsiaMember 2021-01-01 2021-12-31 0001341766 srt:AsiaMember 2020-01-01 2020-12-31 0001341766 celh:OtherMember 2022-01-01 2022-12-31 0001341766 celh:OtherMember 2021-01-01 2021-12-31 0001341766 celh:OtherMember 2020-01-01 2020-12-31 0001341766 srt:MaximumMember 2022-12-31 0001341766 srt:MinimumMember 2022-12-31 0001341766 srt:MinimumMember celh:MerchandisingEquipmentCoolersMember 2022-01-01 2022-12-31 0001341766 srt:MaximumMember celh:MerchandisingEquipmentCoolersMember 2022-01-01 2022-12-31 0001341766 celh:MerchandisingEquipmentCoolersMember 2022-12-31 0001341766 celh:MerchandisingEquipmentCoolersMember 2021-12-31 0001341766 srt:MinimumMember us-gaap:OfficeEquipmentMember 2022-01-01 2022-12-31 0001341766 srt:MaximumMember us-gaap:OfficeEquipmentMember 2022-01-01 2022-12-31 0001341766 us-gaap:OfficeEquipmentMember 2022-12-31 0001341766 us-gaap:OfficeEquipmentMember 2021-12-31 0001341766 us-gaap:VehiclesMember 2022-01-01 2022-12-31 0001341766 us-gaap:VehiclesMember 2022-12-31 0001341766 us-gaap:VehiclesMember 2021-12-31 0001341766 celh:PepsicoIncMember us-gaap:SeriesAPreferredStockMember 2022-08-01 0001341766 celh:PepsicoIncMember 2022-01-01 2022-12-31 0001341766 celh:PepsicoIncMember 2022-12-31 0001341766 celh:PepsicoIncMember us-gaap:SeriesAPreferredStockMember 2022-01-01 2022-12-31 0001341766 celh:PepsicoIncMember 2022-07-29 2022-08-01 0001341766 celh:PepsicoIncMember us-gaap:SeriesAPreferredStockMember 2022-07-29 2022-08-01 0001341766 celh:ContractAssetsCurrentMember celh:PepsicoIncMember 2022-01-01 2022-12-31 0001341766 celh:ContractAssetsNonCurrentMember celh:PepsicoIncMember 2022-01-01 2022-12-31 0001341766 us-gaap:BuildingMember us-gaap:MajorityShareholderMember celh:CDFinancialLLCMember 2022-01-01 2022-12-31 0001341766 celh:SeriesAConvertiblePreferredStockMember 2022-12-31 0001341766 celh:SecuritiesPurchaseAgreementMember us-gaap:SeriesAPreferredStockMember 2022-12-31 0001341766 celh:SecuritiesPurchaseAgreementMember us-gaap:SeriesAPreferredStockMember 2022-01-01 2022-12-31 0001341766 us-gaap:SeriesAPreferredStockMember 2022-01-01 2022-12-31 0001341766 celh:EightPercentageMember 2022-01-01 2022-12-31 0001341766 celh:TenPercentageMember 2022-01-01 2022-12-31 0001341766 celh:TwelvePercentageMember 2022-01-01 2022-12-31 0001341766 srt:MinimumMember us-gaap:SeriesAPreferredStockMember 2022-12-31 0001341766 srt:MaximumMember us-gaap:SeriesAPreferredStockMember 2022-12-31 0001341766 celh:StockIncentivePlan2015Member 2022-01-01 2022-12-31 0001341766 celh:StockIncentivePlan2015Member 2021-01-01 2021-12-31 0001341766 celh:StockIncentivePlan2015Member 2020-01-01 2020-12-31 0001341766 2021-06-01 2021-06-09 0001341766 2021-06-09 0001341766 2021-06-01 2021-06-14 0001341766 celh:CompanyMember 2021-06-01 2021-06-14 0001341766 celh:SellingStockholdersMember 2021-06-01 2021-06-11 0001341766 celh:SellingStockholdersMember 2021-06-01 2021-06-14 0001341766 us-gaap:SeriesAPreferredStockMember 2022-08-01 0001341766 us-gaap:SeriesAPreferredStockMember 2022-07-29 2022-08-01 0001341766 us-gaap:FairValueInputsLevel1Member us-gaap:SeriesAPreferredStockMember 2022-12-31 0001341766 us-gaap:FairValueInputsLevel2Member us-gaap:SeriesAPreferredStockMember 2022-12-31 0001341766 us-gaap:FairValueInputsLevel3Member us-gaap:SeriesAPreferredStockMember 2022-12-31 0001341766 us-gaap:FairValueInputsLevel1Member us-gaap:IndefinitelivedIntangibleAssetsMember 2022-12-31 0001341766 us-gaap:FairValueInputsLevel2Member us-gaap:IndefinitelivedIntangibleAssetsMember 2022-12-31 0001341766 us-gaap:FairValueInputsLevel3Member us-gaap:IndefinitelivedIntangibleAssetsMember 2022-12-31 0001341766 us-gaap:FairValueInputsLevel1Member 2022-12-31 0001341766 us-gaap:FairValueInputsLevel2Member 2022-12-31 0001341766 us-gaap:FairValueInputsLevel3Member 2022-12-31 0001341766 us-gaap:DomesticCountryMember 2022-01-01 2022-12-31 0001341766 us-gaap:DomesticCountryMember 2021-01-01 2021-12-31 0001341766 us-gaap:DomesticCountryMember 2020-01-01 2020-12-31 0001341766 us-gaap:ForeignCountryMember 2022-01-01 2022-12-31 0001341766 us-gaap:ForeignCountryMember 2021-01-01 2021-12-31 0001341766 us-gaap:ForeignCountryMember 2020-01-01 2020-12-31 0001341766 srt:MinimumMember us-gaap:NonUsMember 2022-01-01 2022-12-31 0001341766 srt:MaximumMember us-gaap:NonUsMember 2022-01-01 2022-12-31 0001341766 srt:MinimumMember celh:USFederalMember 2022-01-01 2022-12-31 0001341766 srt:MinimumMember celh:USStateAndLocalMember 2022-01-01 2022-12-31 0001341766 srt:MaximumMember celh:USFederalMember 2022-01-01 2022-12-31 0001341766 srt:MaximumMember celh:USStateAndLocalMember 2022-01-01 2022-12-31 0001341766 celh:StockIncentivePlanMember 2007-01-01 2007-01-18 0001341766 2015-04-30 0001341766 celh:StockIncentivePlan2015Member 2015-04-01 2015-04-30 0001341766 us-gaap:GeneralAndAdministrativeExpenseMember 2022-01-01 2022-12-31 0001341766 us-gaap:GeneralAndAdministrativeExpenseMember 2021-01-01 2021-12-31 0001341766 us-gaap:GeneralAndAdministrativeExpenseMember 2020-01-01 2020-12-31 0001341766 celh:VestedMember 2022-01-01 2022-12-31 0001341766 us-gaap:RestrictedStockUnitsRSUMember 2022-12-31 0001341766 us-gaap:PerformanceSharesMember 2022-01-01 2022-12-31 0001341766 us-gaap:PerformanceSharesMember 2022-12-31 0001341766 srt:MinimumMember 2021-01-01 2021-12-31 0001341766 srt:MaximumMember 2021-01-01 2021-12-31 0001341766 srt:MinimumMember 2020-01-01 2020-12-31 0001341766 srt:MaximumMember 2020-01-01 2020-12-31 0001341766 celh:RangeOfExercisePrice1Member 2022-12-31 0001341766 celh:RangeOfExercisePrice1Member 2022-01-01 2022-12-31 0001341766 celh:RangeOfExercisePrice2Member 2022-12-31 0001341766 celh:RangeOfExercisePrice2Member 2022-01-01 2022-12-31 0001341766 celh:RangeOfExercisePrice3Member 2022-12-31 0001341766 celh:RangeOfExercisePrice3Member 2022-01-01 2022-12-31 0001341766 celh:RangeOfExercisePrice4Member 2022-12-31 0001341766 celh:RangeOfExercisePrice4Member 2022-01-01 2022-12-31 0001341766 celh:RangeOfExercisePrice5Member 2022-12-31 0001341766 celh:RangeOfExercisePrice5Member 2022-01-01 2022-12-31 0001341766 celh:RangeOfExercisePrice6Member 2022-12-31 0001341766 celh:RangeOfExercisePrice6Member 2022-01-01 2022-12-31 0001341766 celh:RangeOfExercisePrice7Member 2022-12-31 0001341766 celh:RangeOfExercisePrice7Member 2022-01-01 2022-12-31 0001341766 us-gaap:RestrictedStockMember 2021-12-31 0001341766 us-gaap:RestrictedStockMember 2020-12-31 0001341766 us-gaap:RestrictedStockMember 2022-01-01 2022-12-31 0001341766 us-gaap:RestrictedStockMember 2021-01-01 2021-12-31 0001341766 us-gaap:RestrictedStockMember 2022-12-31 0001341766 us-gaap:RestrictedStockUnitsRSUMember 2021-12-31 0001341766 us-gaap:RestrictedStockUnitsRSUMember 2020-12-31 0001341766 us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-12-31 0001341766 us-gaap:RestrictedStockUnitsRSUMember 2021-01-01 2021-12-31 0001341766 us-gaap:PerformanceSharesMember 2021-12-31 0001341766 us-gaap:PerformanceSharesMember 2020-12-31 0001341766 us-gaap:PerformanceSharesMember 2021-01-01 2021-12-31 0001341766 2020-11-01 2020-11-30 0001341766 stpr:NY celh:NovemberTwentyThreeTwoThousensTwentyOneMember 2022-10-01 2022-10-12 0001341766 2022-10-01 2022-10-12 0001341766 stpr:NY celh:NovemberTwentyThreeTwoThousensTwentyOneMember 2022-01-01 2022-12-31 0001341766 stpr:FL celh:DthreemLicensingGroupMember 2021-05-01 2021-05-04 0001341766 us-gaap:SubsequentEventMember 2023-01-01 2023-01-18 0001341766 us-gaap:SubsequentEventMember 2023-02-01 2023-02-13 iso4217:USD shares iso4217:USD shares pure 0001341766 true FY 2022 Yes No Yes Yes 10-K/A true 2022-12-31 --12-31 false 001-38149 CELSIUS HOLDINGS, INC. NV 20-2745790 2424 N. Federal Highway Suite 208 Boca Raton FL 33431 (561) 276-2239 Common Stock, $0.001 par value CELH NASDAQ Large Accelerated Filer false false true false 4935115169000 76706874 Portions of the registrant’s Definitive Proxy Statement to be filed subsequent to the date hereof with the Securities and Exchange Commission (the “SEC”) pursuant to Regulation 14A in connection with the registrant’s 2023 Annual Meeting of Stockholders are incorporated by reference into Part III of this Report. Such Definitive Proxy Statement will be filed with the SEC no later than 120 days after the conclusion of the registrant’s fiscal year ended December 31, 2022. This Amendment No. 1 on Form 10-K/A (“Amendment No. 1”) is being filed to amend Celsius Holdings, Inc.’s (together with its consolidated subsidiaries, the “Company”) Annual Report on Form 10-K for the fiscal year ended December 31, 2022 (“Original Filing”), filed with the U.S. Securities and Exchange Commission (“SEC”) on March 1, 2023 (“Original Filing Date”). The sole purpose of this Amendment No. 1 is to amend Exhibits 31.2 and 32.2 to reflect that Jarrod Langhans was the Chief Financial Officer at the time of the Original Filing and to correct paragraph 4(c) of the certifications of its Chief Executive Officer filed as Exhibit 31.1 and Chief Financial Officer filed as Exhibit 31.2 to the Original Form 10-K. The corrected certifications are filed as Exhibits 31.1, 31.2 and 32.2 to this Amendment No. 1.   In addition, the Company is including in this Amendment No. 1 a currently dated consents of Ernst & Young LLP and Assurance Dimensions, Inc., its auditors, attached hereto as Exhibit 23.1 and 23.2, and as required by Rule 12b-15 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), the Company’s principal executive officer and principal financial officer are providing new currently dated certifications required pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant Section 302 of the Sarbanes-Oxley Act of 2002, which are filed hereto as Exhibits 31.1 and 31.2.   Except as described above, this Amendment No. 1 does not amend, update or change any other items or disclosures in the Original Filing. This Amendment No. 1 speaks only as of the Original Filing Date, and the Company has not undertaken herein to amend, supplement or update any information contained in the Original Filing to give effect to any subsequent events. Accordingly, this Amendment No. 1 should be read in conjunction with the Company’s filings made with the SEC subsequent to the filing of the Original Filing, including any amendment to those filings. 42 Ernst & Young LLP Boca Raton, Florida 614159000 16255000 38768000 63311000 38741000 2979000 2588000 173289000 191222000 11341000 13555000 14124000 917971000 262361000 3574000 7117000 10185000 3180000 501000 9019000 972000 1128000 208000 86000 263000 299000 262462000 12254000 16301000 13679000 14527000 1222069000 314018000 107340000 72442000 3986000 35977000 19037000 661000 512000 70000 157000 9675000 3586000 976000 161295000 93124000 326000 658000 162000 45000 15919000 3146000 179788000 357490000 96973000 0.001 0.001 0.05 0.05 1467000 1467000 0 0 550000000 0 824488000 0.001 0.001 100000000 100000000 76382000 76382000 74909000 74909000 76000 75000 280668000 267846000 -1881000 614000 -238772000 -51490000 40091000 217045000 1222069000 314018000 653604000 314272000 130726000 382735000 186103000 69752000 270869000 128169000 60974000 352767000 74739000 34875000 75903000 57520000 18187000 428670000 132259000 53062000 -157801000 -4090000 7912000 237000 315000 356000 5292000 -8000 -66000 432000 -576000 152000 -392000 -276000 1376000 82000 5137000 31000 728000 -152664000 -4059000 8640000 34618000 -7996000 116000 -187282000 3937000 8524000 11526000 -198808000 3937000 8524000 -2495000 817000 551000 -201303000 4754000 9075000 -2.63 0.05 0.12 -2.63 0.05 0.11 75649000 73781000 70195000 75649000 77689000 74444000 68941 69000 127553000 -754000 -63409000 63459000 1438 1000 21891000 21892000 6340000 6340000 568 1000 -1000 1316 1000 4125000 4126000 -115000 -542000 -657000 551000 551000 91000 91000 8524000 8524000 72263 72000 159884000 -203000 -55427000 104326000 1134 1000 67768000 67769000 36475000 36475000 540 1000 1000 972 1000 3719000 3720000 817000 817000 3937000 3937000 74909 75000 267846000 614000 -51490000 217045000 20665000 20665000 448 1025 1000 3683000 3684000 1467 824488000 11526000 11526000 -2495000 -2495000 -187282000 -187282000 76382 76000 280668000 -1881000 -238772000 40091000 1467 824488000 -187282000 3937000 8524000 1362000 550000 127000 555000 714000 1484000 2379000 2352000 1494000 257000 5885000 -6131000 -2355000 -748000 20665000 36475000 6340000 20244000 -9201000 -483000 -880000 323000 28000 152000 26369000 25249000 7469000 -11802000 175174000 3859000 -2214000 -1072000 10457000 34908000 51807000 4743000 16940000 13379000 3377000 3986000 -37000 2610000 374000 -96000 -183000 29000 151000 189463000 108182000 -96586000 3395000 2592000 1886000 1331000 8264000 3150000 574000 -5672000 -1264000 757000 9602000 63000 94000 280000 3683000 3720000 4127000 -657000 542018000 11526000 91000 67769000 21892000 534112000 71395000 15571000 50000 -538000 434000 636672000 -26993000 20157000 16255000 43248000 23091000 652927000 16255000 43248000 14335000 7000 448000 396000 396000 <p id="xdx_807_eus-gaap--NatureOfOperations_zCSPjXIWvMA2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="b_007"/><span id="xdx_822_zfb9Vh6VXPa">ORGANIZATION AND DESCRIPTION OF BUSINESS</span></b></span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Business </i>— Celsius Holdings, Inc. (the “Company” or “Celsius Holdings”) was incorporated under the laws of the State of Nevada on April 26, 2005. On January 24, 2007, the Company entered into a merger agreement and plan of reorganization with Elite FX, Inc., a Florida corporation. Under the terms of the Merger Agreement, Elite FX, Inc. was merged into the Company’s subsidiary, Celsius, Inc. and became a wholly-owned subsidiary of the Company on January 26, 2007. In addition, on March 28, 2007 the Company established Celsius Netshipments, Inc. a Florida corporation as a subsidiary of the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 7, 2018, the Company established Celsius Asia Holdings Limited, a Hong Kong corporation, as a wholly-owned subsidiary of the Company. On February 7, 2018 Celsius China Holdings Limited, a Hong Kong corporation, became a wholly-owned subsidiary of Celsius Asia Holdings Limited and on May 9, 2018, Celsius Asia Holdings Limited established Celsius (Beijing) Beverage Limited, a China corporation, as a wholly-owned subsidiary of Celsius Asia Holdings Limited.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On <span id="xdx_905_eus-gaap--BusinessAcquisitionEffectiveDateOfAcquisition1_dd_c20220101__20221231__us-gaap--BusinessAcquisitionAxis__custom--FuncFoodGroupMember_zg91KIT8VQX7" title="Date of Acquisition">October 25, 2019</span>, the Company acquired <span id="xdx_904_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_c20221231__us-gaap--BusinessAcquisitionAxis__custom--FuncFoodGroupMember_pdd" title="Equity acquired">100%</span> of Func Food Group, Oyj (“Func Food”). The Acquisition was structured as a purchase of all of Func Food’s equity shares and a restructuring of Func Food’s pre-existing debt. Func Food was the Nordic distributor for the Company since 2015. Func Food is a marketer and distributor of nutritional supplements, health food products, and beverages.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 1, 2022 (“Effective Date”), the Company and PepsiCo Inc. (“Pepsi”), entered into multiple agreements, including a Securities Purchase Agreement (“Purchase Agreement”), Lock-Up Agreements, Registration Rights Agreement, a distribution agreement (“Distribution Agreement”), and a Channel Transition Agreement (“Transition Agreement”). The Securities Purchase Agreement, Lock-Up Agreements and Registration Rights Agreement pertain to the Company’s issuance of <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220729__20220801__us-gaap--PlanNameAxis__custom--TransitionAgreementMember__us-gaap--StatementClassOfStockAxis__us-gaap--ConvertiblePreferredStockMember_pdd" title="Stock Issued During Period, Shares">1,466,666</span> shares of Series A Convertible Preferred Stock (“Series A” or “Series A Preferred Stock”) in exchange for cash proceeds of $<span id="xdx_903_eus-gaap--ProceedsFromIssuanceOfConvertiblePreferredStock_pn3n2_dm_c20220729__20220801__us-gaap--PlanNameAxis__custom--TransitionAgreementMember__us-gaap--StatementClassOfStockAxis__us-gaap--ConvertiblePreferredStockMember_z9c8mVfdeeGi" title="Proceeds from issuance of convertible preferred stock">550</span> million, excluding transaction costs. The Transition Agreement specifies payments to be made by Pepsi to Celsius for transitioning certain existing distribution rights to Pepsi. The Distribution Agreement resulted in Pepsi becoming the Company’s primary distribution supplier for the Company’s products in the United States. See Note 13. <i>Related Party Transactions</i> and Note 14. <i>Mezzanine Equity</i> for more information.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with the Distribution Agreement and Transition Agreement, the Company terminated agreements with existing suppliers to transition territory rights to Pepsi. The Company recognized total termination expenses of $<span id="xdx_90A_ecustom--TerminationExpensesSalesAndMarketing_pn3n3_dm_c20220101__20221231__us-gaap--PlanNameAxis__custom--TransitionAgreementMember_z3nmIMlJyLTk" title="Termination expenses">193.8</span> million, which are presented in Sales and marketing expenses on the consolidated statement of operations and comprehensive (loss) income for the year ended December 31, 2022. These expenses were recognized by the Company upon delivery of termination notices to the other distributors, in accordance with ASC Topic 420 <i>Exit or Disposal Cost Obligations</i>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is engaged in the development, marketing, sale and distribution of “functional” calorie-burning functional energy drinks and liquid supplements under the Celsius<sup>®</sup> brand name.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 2019-10-25 1 1466666 55000000 193800000 <p id="xdx_809_eus-gaap--BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_zA6ocG8ryRh1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_828_znn5F5rojOUk">BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></b></span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84A_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zgr6epbTIQu8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86A_zuexltRqN2o8">Basis of Presentation</span> </i>— The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) and the rules and regulations of the SEC.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_eus-gaap--ConsolidationPolicyTextBlock_zWuyKOFWpUuc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_862_z4dHu29Gotoe">Consolidation Policy</span></i> — The accompanying consolidated financial statements include the accounts of Celsius Holdings, Inc. and its subsidiaries. All inter-company balances and transactions have been eliminated in consolidation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84B_eus-gaap--UseOfEstimates_zGBw6zb5Ie5b" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_867_zEPu3prmX198">Significant Estimates</span> — </i>The preparation of consolidated financial statements and accompanying disclosures in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue and expenses and disclosure of contingent assets and liabilities at the date of the financial statements. Although these estimates are based on management’s best knowledge of current events and actions that the Company may undertake in the future, actual results may differ from those estimates. Significant estimates include the allowance for doubtful accounts, allowance for inventory obsolescence and sales returns, preferred share valuation, the useful lives of property and equipment, impairment of goodwill and intangibles, deferred tax asset valuation allowance, promotional allowance, and valuation of stock-based compensation. Additionally, the business and economic uncertainty resulting from the novel coronavirus (COVID-19) pandemic has made such estimates and assumptions more difficult to calculate. Accordingly, actual results and outcomes could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_eus-gaap--SegmentReportingPolicyPolicyTextBlock_zxgoIoerGwha" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_869_zxucLwQp4hid">Segment Reporting</span></i> — Operating segments are defined as components of an enterprise that engage in business activities, have discrete financial information, and whose operating results are regularly reviewed by the chief operating decision maker (“CODM”) to make decisions about allocating resources and to assess performance. Even though the Company has operations in several geographies, it operates as a single enterprise. The Company’s operations and strategies are centrally designed and executed given that our geographical components are very similar. Our CODM, the CEO, reviews operating results primarily from a consolidated perspective, and makes decisions and allocates resources based on that review. The reason the Company’s CODM focuses on consolidated results in making decisions and allocating resources is because of the significant economic interdependencies between the Company’s geographical operations and the Company’s U.S. entity.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_eus-gaap--ConcentrationRiskCreditRisk_zracWkZSCXz3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86D_zM9zurE2Hsw1">Concentrations of Risk</span></i> — Substantially all of the Company’s revenue derives from the sale of Celsius <sup>®</sup> functional energy drinks and liquid supplements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pepsi and the Company signed a distribution agreement on August 1, 2022, resulting in Pepsi acting as the Company’s preferred distributor performing the direct store delivery for a majority of the Company’s U.S. operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue of our customers accounting for more than 10%, for the years ended December 31, 2022, 2021 and 2020, are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_pn3n3_zuLViPDQSDcf" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8B2_zTWJTWaH1hnb" style="display: none">Schedule of revenue &amp; accounts receivable with customers</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_498_20220101__20221231_zXjWJMjont2c" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_495_20210101__20211231_zXjfv9kXiRtc" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49B_20200101__20201231_zBgV4665nLsk" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2022</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2020</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr id="xdx_408_eus-gaap--ConcentrationRiskPercentage1_pid_dp_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRiskTotalMember__srt--StatementGeographicalAxis__custom--PepsicoIncMember_zJiRcCWluc8g" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 64%; text-align: left">Pepsi</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">22.2</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0772">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0773">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--ConcentrationRiskPercentage1_pid_dp_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRiskTotalMember__srt--StatementGeographicalAxis__custom--CostcoMember_zk1ET4WmqX7i" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Costco</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">16.7</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">12.7</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2.9</td><td style="text-align: left">%</td></tr> <tr id="xdx_409_eus-gaap--ConcentrationRiskPercentage1_pid_dp_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRiskTotalMember__srt--StatementGeographicalAxis__custom--AmazonMember_zaEE9PbJpqCk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Amazon</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">8.8</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">10.1</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">15.1</td><td style="text-align: left">%</td></tr> <tr id="xdx_403_eus-gaap--ConcentrationRiskPercentage1_pid_dp_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRiskTotalMember__srt--StatementGeographicalAxis__custom--AllOtherMember_zznzdC8oHTNk" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">All other</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">52.3</td><td style="padding-bottom: 1pt; text-align: left">%</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">77.2</td><td style="padding-bottom: 1pt; text-align: left">%</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">82.0</td><td style="padding-bottom: 1pt; text-align: left">%</td></tr> <tr id="xdx_403_eus-gaap--ConcentrationRiskPercentage1_pid_dp_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRiskTotalMember_zAq5vjfc3YDg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">100.0</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">%</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">100.0</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">%</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">100.0</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">%</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts receivable of our customers accounting for more than 10%, for the years ended December 31, 2022, and 2021, are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_498_20220101__20221231_zxZ1urKWbHad" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_495_20210101__20211231_zDHqYSiBkqn4" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2022</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr id="xdx_40F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRiskTotalMember__srt--StatementGeographicalAxis__custom--PepsicoIncMember_zje0syWDtOmd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left">Pepsi</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">47.6</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0793">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--ConcentrationRiskPercentage1_pid_dp_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRiskTotalMember__srt--StatementGeographicalAxis__custom--AmazonMember_zgelW1NxCmwc" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Amazon</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">11.8</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">22.7</td><td style="text-align: left">%</td></tr> <tr id="xdx_401_eus-gaap--ConcentrationRiskPercentage1_pid_dp_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRiskTotalMember__srt--StatementGeographicalAxis__custom--PublixMember_z7wa3uh5IFG8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Publix</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1.4</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">10.3</td><td style="text-align: left">%</td></tr> <tr id="xdx_401_eus-gaap--ConcentrationRiskPercentage1_pid_dp_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRiskTotalMember__srt--StatementGeographicalAxis__custom--AllOtherMember_zyI16XjiKWI7" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">All other</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">39.2</td><td style="padding-bottom: 1pt; text-align: left">%</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">67.0</td><td style="padding-bottom: 1pt; text-align: left">%</td></tr> <tr id="xdx_409_eus-gaap--ConcentrationRiskPercentage1_pid_dp_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRiskTotalMember_z2XT9lRxJVNj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">100.0</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">%</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">100.0</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">%</td></tr> </table> <p id="xdx_8AB_zMt2rNHgCyEb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable. The Company places its cash and cash equivalents with high-quality financial institutions. At times, balances in the Company’s cash accounts may exceed the Federal Deposit Insurance Corporation limit. At December 31, 2022 and 2021, the Company had approximately $<span id="xdx_908_eus-gaap--CashUninsuredAmount_iI_pn3n3_dm_c20221231_zT87JPyhlVog" title="Amount excess of FDIC limit">652.4</span> million and $<span id="xdx_90E_eus-gaap--CashUninsuredAmount_iI_pn3n3_dm_c20211231_zYAeR69HjW0a" title="Amount excess of FDIC limit">16.0</span> million, respectively, including $38.8 <span id="xdx_909_eus-gaap--RestrictedCash_iI_pn3n3_c20221231_zQkYlUfKp0ri" style="display: none" title="Restricted cash">38,768</span> million in restricted cash for 2022, in excess of the Federal Deposit Insurance Corporation limit.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_846_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_z6KZ0C5sd9ne" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_867_zNQlsZ21vQ2e">Cash and Cash Equivalents</span></i> — The Company considers all highly liquid instruments with an original maturity of three months or less when purchased to be cash equivalents.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_eus-gaap--CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_z0xlxoXkvs8c" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86A_zZbo0KuZIdm7">Restricted Cash</span></i> — As disclosed in Note 4. <i>Revenues</i>, the Company received upfront payments from Pepsi during 2022, which are contractually restricted and can only be used to satisfy termination payments due to former distributors or have to be repaid to Pepsi. These upfront payments received from Pepsi cannot be used for general operating activities of the Company and have been classified as restricted cash based on the terms of the Transition Agreement.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_843_eus-gaap--ReceivablesPolicyTextBlock_zNLYmVUfFIs8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86E_zW6s32vKjx">Accounts Receivable</span></i> — Accounts receivable are reported at net realizable value. The Company establishes an allowance for doubtful accounts based upon factors pertaining to the credit risk of specific customers, historical trends, and other information. Delinquent accounts are written-off when it is determined that the amounts are uncollectible. Accounts receivable are presented net of billbacks, for customers that are allowed the right to net settle. At December 31, 2022 and December 31, 2021, there was an allowance for doubtful accounts of approximately $<span id="xdx_906_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_pn3n3_dm_c20221231_zOoAh4PlJN66" title="Allowance for doubtful accounts">2.1</span> million and $<span id="xdx_903_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_pn3n3_dm_c20211231_zqE9F3BWL78a" title="Allowance for doubtful accounts">0.8</span> million, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_847_eus-gaap--InventoryPolicyTextBlock_zarVNg9sKBZk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86E_z6VGUsgrYOWb">Inventories</span> </i>— Inventories are valued at the lower of cost or net realizable value. Cost is determined using the first-in, first-out (FIFO) method. At December 31, 2022 and December 31, 2021, the Company recorded an allowance of approximately $<span id="xdx_902_eus-gaap--InventoryValuationReserves_iI_pn3n3_dm_c20221231_zZedmUZh9Rqa" title="Inventory reserve">8.4</span> million and $<span id="xdx_901_eus-gaap--InventoryValuationReserves_iI_pn3n3_dm_c20211231_zfaNZv4Ca9T5" title="Inventory reserve">2.6</span> million respectively. The changes in the allowance are included in cost of revenue.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zxb1hsgkqn48" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_861_zTmTxcFoZjAl">Property and Equipment</span></i> — Property and equipment are stated at cost less accumulated depreciation and amortization. Depreciation of property and equipment is calculated using the straight-line method over the estimated useful life of the asset generally ranging from three <span id="xdx_903_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_zcwzKDhePDw2" style="display: none" title="Property and equipment estimated useful life">3</span> to seven <span id="xdx_908_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_zNsJW17tJGZb" style="display: none" title="Property and equipment estimated useful life">7</span> years.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zYCRyH6hAFBb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86B_z1KBDaJcbgxe">Impairment of Long-Lived Assets</span></i> — In accordance with ASC Topic 360, <i>Property, Plant, and Equipment</i> the Company reviews the carrying value of long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. An impairment loss is determined regarding a long-lived asset if its carrying amount is not recoverable and exceeds its fair value. The carrying amount is not recoverable when it exceeds the sum of the undiscounted cash flows expected to result from use of the asset over its remaining useful life and final disposition. The Company did not record any impairments related to long lived assets during the years ended December 31, 2022 and December 31, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_ecustom--LonglivedAssetGeographicDataPolicyTextBlock_z8qN0v48dBAh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86A_zh6N3wLsjrw8">Long-lived Asset Geographic Data</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table contains long-lived asset information which includes property and equipment and lease right of use assets and excludes goodwill and intangibles, where individual countries represent a material portion of the total:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--LongLivedAssetsByGeographicAreasTableTextBlock_pn3n3_zclo8m5RXUUh" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8B8_z1PgH8lM4fm4" style="display: none">Schedule of long-lived asset geographic data</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_497_20221231_zgn7TFaq9XL8" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_496_20211231_ztETcCMUzjvg" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">December 31,</td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">December 31,</td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2022</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr id="xdx_402_ecustom--TotalLonglivedAssets_iI_pn3n3_hsrt--StatementGeographicalAxis__country--US_zkKC1KFJXv99" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left">United States</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">9,750</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">3,043</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40A_ecustom--LonglivedAssetsRelatedToForeignOperations_iI_pn3n3_hsrt--StatementGeographicalAxis__country--SE_zYAjLKlHJXM1" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Sweden</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,251</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,050</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_ecustom--LonglivedAssetsRelatedToForeignOperations_iI_pn3n3_hsrt--StatementGeographicalAxis__country--FI_zVYcC04P45K9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Finland</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">363</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">301</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_ecustom--LonglivedAssetsRelatedToForeignOperations_iI_pn3n3_hsrt--StatementGeographicalAxis__custom--OtherMember_z9CuilloqUWd" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Other</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0852">-</span></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40E_ecustom--LonglivedAssetsRelatedToForeignOperations_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt">Long-lived assets related to foreign operations</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,615</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,351</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_403_ecustom--TotalLonglivedAssets_iI_pn3n3" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total long-lived assets-net</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">11,365</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">4,394</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <p id="xdx_8A9_z8vSm07z28nd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"> </p> <p id="xdx_842_eus-gaap--GoodwillAndIntangibleAssetsGoodwillPolicy_zh2yMS5kxOWi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86B_z3KDW0Iqb42d">Goodwill</span> </i>— The Company records goodwill when the consideration paid for the acquisition of a business exceeds the fair value of net tangible and intangible assets acquired, including related tax effects. Goodwill is not amortized; instead, goodwill is tested for impairment on an annual basis as of October 1<sup>st</sup>, or more frequently if the Company believes indicators of impairment exist. The Company first assesses qualitative factors such as macro-economic conditions, industry and market conditions, and cost factors as well as other relevant events, to determine whether it is more-likely-than-not that the fair value of a reporting unit is less than its carrying value. If it is more likely than not that the fair value of a reporting unit is less than its carrying value, then the Company will calculate the estimated fair value of the reporting unit. If the Company determines that the fair value is less than the carrying value, the Company will recognize an impairment charge based on the excess of a reporting unit’s carrying value over its fair value. At December 31, 2022, there were no indicators of impairment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_zZr25g22L50l" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_867_zRp0jLz1ceZ5">Intangible assets</span></i>— Intangible assets are comprised of customer relationships and brands acquired in a business combination. The Company amortizes intangible assets with a definitive life over their respective useful lives. The addition of the Pepsi distribution network has shifted the Company’s focus to the US market and as a consequence it was determined that impairment indicators for the Func Foods brands indefinite intangible asset were present. The Company no longer anticipates focusing on the expansion of Func Food branded products and the Company plans to focus on Celsius branded products. As a result of the strategic shift, which the Company considered a triggering event, the Company quantitatively tested the Func Foods brand name for impairment utilizing the relief from royalty method to determine fair value as of September 30, 2022. As a result of the quantitative assessment, the Company recorded an impairment charge of $<span id="xdx_905_eus-gaap--ImpairmentOfLongLivedAssetsToBeDisposedOf_pn3n3_dm_c20220101__20221231_zLby0NKgftng" title="Impairment of long lived assets">2.5</span> million during the year ended December 31, 2022 which is presented within General and Administrative expenses on the Consolidated Statements of Operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_eus-gaap--RevenueRecognitionPolicyTextBlock_zvJ6z7bpOOEc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_867_z4iWHMk0KDpc">Revenue Recognition</span></i> — The Company recognizes revenue in accordance with ASC Topic 606 <i>Revenue from Contracts with Customers</i>. The Company recognizes revenue when performance obligations under the terms of a contract with the customer are satisfied. Product sales occur once control or title is transferred based on the commercial terms. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring goods. Product sales are recorded net of variable consideration, such as provisions for returns, discounts and promotional allowances. Such provisions are calculated using historical averages and adjusted for any expected changes due to current business conditions. Consideration given to customers for cooperative advertising is recognized as a reduction of revenue except to the extent that there is a distinct good or service, in which case the expense is classified as selling or marketing expense. The amount of consideration the Company receives and revenue the Company recognizes varies with changes in customer incentives the Company offers to its customers and their customers. Additionally, for any agreements which are one year or less, the practical expedient under ASC 340-40-25-4 is applied to expense contract acquisition costs when incurred if the amortization period of the contract asset would have otherwise been recognized in one year or less. Sales taxes and other similar taxes are excluded from revenue. Management believes that adequate provision has been made for cash discounts, returns, spoilage and promotional allowances based on the Company’s historical experience.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_847_ecustom--DeferredRevenuePolicyTextBlock_zM1yWF8ISPga" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86F_zRtvpRfGcFda">Deferred Revenue</span></i> — The Company receives payments from certain distributors in new territories as reimbursement for contract termination costs paid to the prior distributors in those territories. Amounts received pursuant to these new and/or amended distribution agreements entered into with certain distributors relating to the costs associated with terminating the Company’s prior distributors, are accounted for as deferred revenue and recognized ratably over the anticipated life of the respective new distribution agreements. As of December 31, 2022, the Company had approximately $<span id="xdx_904_eus-gaap--DeferredRevenue_iI_pn3n3_dm_c20221231_zxuiaCWGnucc" title="Deferred revenue">189.5</span> million in deferred revenue, of which $<span id="xdx_909_eus-gaap--DeferredRevenueNoncurrent_iI_pn3n3_dm_c20221231_zvS9NYSGq2gb" title="Deferred Revenue, Noncurrent">179.8</span> million is classified as deferred revenue-non-current and $<span id="xdx_90B_eus-gaap--ContractWithCustomerLiabilityCurrent_iI_pn3n3_dm_c20221231_z3h9a5JYPd92" title="Deferred revenue-current">9.7</span> million is classified as deferred revenue-current which are presented within the consolidated balance sheets and are contract liabilities related to termination payments received from Pepsi. Refer to Note 13, <i>Related Party Transactions </i>for more information. The deferred revenues will be recognized by the Company, ratably over the twenty-year agreement term. As of December 31, 2021, the Company did not have any deferred revenue related to contract liabilities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84E_ecustom--AccruedDistributorTerminationFeesPolicyTextBlock_zvm8Fp8rKrF9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86D_zTHN5AY707jh">Accrued Distributor Termination Fees</span> </i>— Termination charges related to certain of the Company’s prior distributors are included in selling and marketing expenses upon termination. The Company recognized distributor termination expenses of approximately $<span id="xdx_90D_ecustom--TerminationExpense_pn3n3_dm_c20220101__20221231_z8STezYKUa6e" title="Termination Expense">193.8</span> million, $<span id="xdx_90F_ecustom--TerminationExpense_pn3n3_dm_c20210101__20211231_ztLYTp83Rb3g" title="Termination Expense">0.6</span> million, and $<span id="xdx_90F_ecustom--TerminationExpense_pn3n3_dm_c20200101__20201231_zS8Q683czWc9" title="Termination Expense">0.2</span> million for the year ended December 31, 2022, 2021, and 2020, respectively. The Company also has a balance of $<span id="xdx_905_ecustom--TerminationPayable_pn3n3_dm_c20220101__20221231_zdPMKXZAYM6k" title="Termination Payable">4.0</span> million in accrued distributor termination fees related to distributors terminated as a result of the Pepsi agreement as well as payment due back to Pepsi in the amount of $<span id="xdx_900_ecustom--DistributionAgreementsTerminationExpense_pn3n3_dm_c20220101__20221231_zj90GkzU6zV8" title="Distribution agreements termination expense">34.8</span> million as the projected payments to the prior distributors was less than the payment received from Pepsi, which are located within accounts payable and accrued expenses, on the Company’s consolidated balance sheets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_ecustom--CustomerAdvancePoliciesTextBlock_zXZ1ovJ0WKa1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86B_zB26Pmundyaj">Customer Advances</span></i> — From time to time the Company requires deposits in advance of delivery of products and/or production runs. Such amounts are initially recorded as customer advances liability within other current liabilities. The Company recognizes such revenue as it is earned in accordance with revenue recognition policies. As of December 31, 2022 and 2021, the Company did <span id="xdx_903_eus-gaap--ContractWithCustomerLiabilityNoncurrent_iI_pn3n3_do_c20221231_z8pWv8p3tdLh" title="Customer advances"><span id="xdx_902_eus-gaap--ContractWithCustomerLiabilityNoncurrent_iI_pn3n3_do_c20211231_zloH22gtvxk4" title="Customer advances">no</span></span>t have any customer advances.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84A_eus-gaap--AdvertisingCostsPolicyTextBlock_zzyzn5JMFFG" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86A_zG6JkTTHrPN8">Advertising Costs</span></i> — Advertising costs are expensed as incurred. The Company uses mainly radio, local sampling events, sponsorships, endorsements, and digital advertising. The Company incurred advertising expenses of approximately $<span id="xdx_907_eus-gaap--AdvertisingExpense_pn3n3_dm_c20220101__20221231_zLXOliAQzuq2" title="Advertising expense">85.1</span> million, $<span id="xdx_907_eus-gaap--AdvertisingExpense_pn3n3_dm_c20210101__20211231_zLI5EULQu6w5" title="Advertising expense">36.7 </span>million and $<span id="xdx_900_eus-gaap--AdvertisingExpense_pn3n3_dm_c20200101__20201231_zeeRDQxreGWf" title="Advertising expense">14.2</span> million, during years ended December 31, 2022, 2021, and 2020, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84F_eus-gaap--ResearchAndDevelopmentExpensePolicy_zOMgFP0ncUxb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_862_zhGaZHvPgVS6">Research and Development</span></i> — Research and development costs are charged to general and administrative expenses as incurred and consist primarily of consulting fees, raw material usage and test productions of beverages. The Company incurred expenses of approximately $<span id="xdx_90E_eus-gaap--ResearchAndDevelopmentExpense_pn3n3_dm_c20220101__20221231_zI8flwAcdFx6" title="Research and development expense">0.4</span> million, $<span id="xdx_90D_eus-gaap--ResearchAndDevelopmentExpense_pn3n3_dm_c20210101__20211231_zn1TyY7nhJI" title="Research and development expense">1.0</span> million and $<span id="xdx_905_eus-gaap--ResearchAndDevelopmentExpense_pn3n3_dm_c20200101__20201231_zj6CFQxaNDpk" title="Research and development expense">0.5</span> million during years ended December 31, 2022, 2021, and 2020, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zvY5KeU9hTek" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86A_zuwHqZEPZtl4">Foreign Currency Gain/Losses</span></i> — Foreign subsidiaries’ functional currency is the local currency of operations and the net assets of foreign operations are translated into U.S. dollars using current exchange rates. The foreign subsidiaries perform re-measurements of their assets and liabilities denominated in non-functional currencies on a periodic basis and the gain or losses from these adjustments are included in the consolidated statement of operations and comprehensive (loss) income as foreign exchange gains or losses. For the year ended December 31, 2022 exchange losses have amounted to approximately $<span id="xdx_90F_ecustom--ExchangeLosses_pn3n3_dm_c20220101__20221231_zQVmw0ZSz0Y9" title="Exchange losses">0.4</span> million while during the years ended December 31, 2021 and 2020, the Company recognized a foreign currency loss and gain of approximately $<span id="xdx_90B_ecustom--ExchangeLosses_pn3n3_dm_c20210101__20211231_z28qK0I0ch98" title="Exchange losses">0.3</span> million and $<span id="xdx_901_eus-gaap--ForeignCurrencyTransactionGainLossRealized_pn3n3_dm_c20200101__20201231_zDLwqzYD24wd" title="Recognized foreign currency gains">1.4</span> million, respectively, mainly related to fluctuations in exchange rates. Translation gains and losses that arise from the translation of net assets from functional currency to the reporting currency, as well as exchange gains and losses on intercompany balances of long-term investment nature, are included in Other Comprehensive Income. The Company incurred foreign currency translation net loss during the year ended December 31, 2022 of approximately $<span id="xdx_902_eus-gaap--ForeignCurrencyTransactionLossBeforeTax_pn3n3_dm_c20220101__20221231_zrU5gxMNNrc1" title="Foreign Currency Transaction Gain Before Tax">2.5</span> million and a net gain of approximately $<span id="xdx_902_eus-gaap--ForeignCurrencyTransactionGainBeforeTax_pn3n3_dm_c20210101__20211231_zTD9Vkn1zqW" title="Foreign Currency Translation">0.8</span> million and $<span id="xdx_90F_eus-gaap--ForeignCurrencyTransactionGainBeforeTax_pn3n3_dm_c20200101__20201231_zwk4mToqdEW4" title="Foreign Currency Translation">0.6</span> million during the year ended December 31, 2021 and 2020. The Company’s operations in different countries required that it transacts in the following currencies:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chinese-Yuan</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Norwegian-Krone</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Swedish-Krona</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Finland-Euro</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_841_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zu17OGBKXyO8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86B_zM8k4ESrqStj">Fair Value of Financial Instruments</span></i> — The carrying value of cash, cash equivalents, restricted cash, accounts receivable, accounts payable, accrued expenses and other current liabilities approximate fair value due to their relative short-term maturity and market interest rates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_847_eus-gaap--IncomeTaxPolicyTextBlock_zGmeqjPHAeA8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86F_znVivjfOukr8">Income Taxes</span> —</i> The Company accounts for income taxes pursuant to the provisions of ASC Topic 740 <i>Accounting for Income Taxes</i>, which requires, among other things, an asset and liability approach to calculating deferred income taxes. The asset and liability approach require the recognition of deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the carrying amounts and the tax bases of assets and liabilities. A valuation allowance is provided to offset any net deferred tax assets for which management believes it is more likely than not that the net deferred asset will not be realized. The Company follows the provisions of the ASC 740-10 related to <i>Accounting for Uncertain Income Tax Positions.</i> When tax returns are filed, it is highly certain that some positions taken would be sustained upon examination by the taxing authorities, while others are subject to uncertainty about the merits of the position taken or the amount of the position that would be ultimately sustained. In accordance with the guidance of ASC 740-10, the benefit of a tax position is recognized in the financial statements in the period during which, based on all available evidence, management believes it is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tax positions taken are not offset or aggregated with other positions. Tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with the applicable taxing authority. The portion of the benefits associated with tax positions taken that exceeds the amount measured as described above is reflected as a liability for uncertain tax benefits in the accompanying consolidated balance sheet, along with any associated interest and penalties that would be payable to the taxing authorities upon examination.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has adopted ASC 740-10-25 <i>Definition of Settlement,</i> which provides guidance on how an entity should determine whether a tax position is effectively settled for the purpose of recognizing previously unrecognized tax benefits and provides that a tax position can be effectively settled upon the completion of an examination by a taxing authority without being legally extinguished. For tax positions considered effectively settled, an entity would recognize the full amount of tax benefit, even if the tax position is not considered more likely than not to be sustained based solely on the basis of its technical merits and the statute of limitations remains open.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s tax returns for tax years in 2019 through 2021 remain subject to potential examination by the taxing authorities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_eus-gaap--EarningsPerSharePolicyTextBlock_zSz7j8aJ2ogc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_865_z7aaKPhSXY1j">Earnings per Share</span></i> — The Company computes earnings per share in accordance with ASC Topic 260 <i>Earnings per Share</i> (“ASC 260”), which requires earnings per share (“EPS”) for each class of stock (common stock and participating preferred stock) to be calculated using the two-class method. The two-class method is an allocation of earnings (distributed and undistributed) between the holders of common stock and a company’s participating security holders. Under the two-class method, earnings for the reporting period are allocated between common stockholders and other security holders based on their respective participation rights in undistributed earnings.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic earnings per common share is computed by dividing income or loss available to common stockholders by the weighted average number of shares of basic common stock outstanding. The Company’s Series A Convertible Preferred Stock is classified as a participating security in accordance with ASC 260. Net income allocated to the holders of Series A Convertible Preferred Stock will be calculated based on the stockholders’ proportionate share of weighted average shares of common stock outstanding on an if-converted basis. See Note 3. <i>Earnings Per Share</i> for more information.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zjidxJXJHK04" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86B_zowKjBwFaPu2">Share-Based Payments</span></i> — The Company follows the provisions of ASC Topic 718 <i>Compensation — Stock Compensation</i> and related interpretations. As such, compensation cost is measured on the date of grant at the fair value of the share-based payments. Such compensation amounts, if any, are amortized over the respective vesting periods of the grants. On April 30, 2015, the Company adopted the 2015 Stock Incentive Plan (the “2015 Plan”). This 2015 Plan is intended to provide incentives which will attract and retain highly competent persons at all levels as employees of the Company, as well as independent contractors providing consulting or advisory services to the Company, by providing them opportunities to acquire the Company’s common stock. The 2015 Plan permits the grant of options and other share-based awards for up to 5.0 million shares. Provisions have been made to permit the grant of options and other share-based awards for up to 5.0 million shares.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_eus-gaap--CostOfSalesPolicyTextBlock_zqkblyhA9aoc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86C_zcPUIkWKDgSd">Cost of Revenue</span></i> — Cost of Revenue consists of the cost of concentrates and or liquid bases, the costs of raw materials utilized in the manufacture of products, co-packing fees, repacking fees, in-bound &amp; out-bound freight charges, as well as certain internal transfer costs, warehouse expenses incurred prior to the manufacture of the Company’s finished products, inventory allowance for excess and obsolete products, and certain quality control costs. Raw materials account for the largest portion of the cost of sales. Raw materials include cans, other containers, flavors, ingredients and packaging materials.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_843_ecustom--OperatingExpensesPolicyTextBlock_zvFe4DlNZuDb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_863_ze22LD4QE5ic">Operating Expenses</span></i> — Operating expenses include selling expenses such as warehousing expenses after manufacture, as well as expenses for advertising, samplings and in-store demonstrations costs, costs for merchandise displays, point-of-sale materials and premium items, sponsorship expenses, other marketing expenses and design expenses. Operating expenses also include such costs as payroll costs, travel costs, professional service fees (including legal fees), depreciation and other general and administrative costs.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_eus-gaap--ShippingAndHandlingCostPolicyTextBlock_zP5P3tjlzuml" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86F_ziz5V59qs1hj">Shipping and Handling Costs</span></i> — Shipping and handling costs for freight expense on goods shipped are included in cost of sales. Freight expense on goods shipped for the years ended December 31, 2022, 2021 and 2020 was approximately $<span id="xdx_90A_ecustom--FreightExpense_pn3n3_dm_c20220101__20221231_zHjJ9bv1bX44" title="Freight expense">26.8 </span>million, $<span id="xdx_903_ecustom--FreightExpense_pn3n3_dm_c20210101__20211231_zEV0j5K5FAx4" title="Freight expense">26.9 </span>million and $<span id="xdx_900_ecustom--FreightExpense_pn3n3_dm_c20200101__20201231_zdKe1hLwc9V9" title="Freight expense">9.5</span> million, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain reclassification of prior period balances have been made to conform to current presentation. Please refer to consolidated balance sheets, Consolidated Statement of Cash Flows and Note 11. <i>Accounts Payable and Accrued Expenses</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84E_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_z95T7I5ULpK4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_862_z1f7z6FNiXgb">Recent Accounting Pronouncements</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company adopts all applicable, new accounting pronouncements as of the specified effective dates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In September 2016, the FASB issued ASU No. 2016-13, Financial Instruments – Credit Losses (Topic 326) (“ASU 2016-13”), which requires the immediate recognition of management’s estimates of current and expected credit losses. In November 2019, the FASB issued ASU 2019-10, which delays the effective date of Topic 326 for Smaller Reporting Companies to interim and annual periods beginning after December 15, 2022, with early adoption permitted. The Company has elected the relief provided. Topic 326 is effective for the Company in the first quarter of 2023. Adoption of the new standard is not expected to have a material impact on our consolidated financial statements or disclosures.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_zoQWAgLgI5Mj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_865_z6I7zlUwjFL7">Liquidity</span> </i>— These financial statements have been prepared assuming the Company will be able to continue as a going concern. At December 31, 2022, the Company had an accumulated deficit of approximately $<span title="Accumulated deficit">238.8</span> <span id="xdx_90B_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pn3n3_di_c20221231_z3LQk14iBsch" style="display: none" title="Accumulated deficit">238,772</span> million which includes a net loss available to common stockholders of approximately $<span title="Net (loss) income">198.8</span> <span id="xdx_90C_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_iN_pn3n3_dmi_c20220101__20221231_zjpXCfPCbzga" style="display: none" title="Net (loss) income">198,808</span> million for year ended December 31, 2022. During the year ended December 31, 2022 the Company’s net cash provided by operating activities totaled approximately $<span title="Net cash provided by (used in) operating activities">108.2</span> <span id="xdx_90F_eus-gaap--NetCashProvidedByUsedInOperatingActivities_pn3n3_dm_c20220101__20221231_zcaeLYcsWaq9" style="display: none" title="Net cash provided by (used in) operating activities">108,182</span> million<b>. </b>As of December 31, 2021, the Company had an accumulated deficit of $<span title="Accumulated deficit">51.5</span> <span id="xdx_90F_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pn3n3_di_c20211231_zJJqgASxNmsh" style="display: none" title="Accumulated deficit">51,490</span> million which includes a net income available to common stockholders of $<span title="Net (loss) income attributed to common shareholders">3.9</span> <span id="xdx_908_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pn3n3_dm_c20210101__20211231_zATHa8etlsyb" style="display: none" title="Net (loss) income attributed to common shareholders">3,937</span> million for year ended December 31, 2021. During the year ended December 31, 2021 the Company’s net cash used by operating activities totaled approximately $<span title="Net cash provided by (used in) operating activities">96.6</span> <span id="xdx_905_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iN_pn3n3_dmi_c20210101__20211231_z5ccGrBdEgub" style="display: none" title="Net cash provided by (used in) operating activities">96,586</span> million<b>.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If our sales volumes do not meet our projections, expenses exceed our expectations, or our plans change, we may be unable to generate enough cash flow from operations to cover our working capital requirements. In such case, we may be required to adjust our business plan, by reducing marketing, lower our working capital requirements and reduce other expenses or seek additional financing. Furthermore, our business and results of operations may be adversely affected by changes in the global macro-economic environment related to the pandemic and public health crises related to the COVID-19 outbreak.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"> </p> <p id="xdx_84A_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zgr6epbTIQu8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86A_zuexltRqN2o8">Basis of Presentation</span> </i>— The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) and the rules and regulations of the SEC.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_eus-gaap--ConsolidationPolicyTextBlock_zWuyKOFWpUuc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_862_z4dHu29Gotoe">Consolidation Policy</span></i> — The accompanying consolidated financial statements include the accounts of Celsius Holdings, Inc. and its subsidiaries. All inter-company balances and transactions have been eliminated in consolidation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84B_eus-gaap--UseOfEstimates_zGBw6zb5Ie5b" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_867_zEPu3prmX198">Significant Estimates</span> — </i>The preparation of consolidated financial statements and accompanying disclosures in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue and expenses and disclosure of contingent assets and liabilities at the date of the financial statements. Although these estimates are based on management’s best knowledge of current events and actions that the Company may undertake in the future, actual results may differ from those estimates. Significant estimates include the allowance for doubtful accounts, allowance for inventory obsolescence and sales returns, preferred share valuation, the useful lives of property and equipment, impairment of goodwill and intangibles, deferred tax asset valuation allowance, promotional allowance, and valuation of stock-based compensation. Additionally, the business and economic uncertainty resulting from the novel coronavirus (COVID-19) pandemic has made such estimates and assumptions more difficult to calculate. Accordingly, actual results and outcomes could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_eus-gaap--SegmentReportingPolicyPolicyTextBlock_zxgoIoerGwha" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_869_zxucLwQp4hid">Segment Reporting</span></i> — Operating segments are defined as components of an enterprise that engage in business activities, have discrete financial information, and whose operating results are regularly reviewed by the chief operating decision maker (“CODM”) to make decisions about allocating resources and to assess performance. Even though the Company has operations in several geographies, it operates as a single enterprise. The Company’s operations and strategies are centrally designed and executed given that our geographical components are very similar. Our CODM, the CEO, reviews operating results primarily from a consolidated perspective, and makes decisions and allocates resources based on that review. The reason the Company’s CODM focuses on consolidated results in making decisions and allocating resources is because of the significant economic interdependencies between the Company’s geographical operations and the Company’s U.S. entity.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_eus-gaap--ConcentrationRiskCreditRisk_zracWkZSCXz3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86D_zM9zurE2Hsw1">Concentrations of Risk</span></i> — Substantially all of the Company’s revenue derives from the sale of Celsius <sup>®</sup> functional energy drinks and liquid supplements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pepsi and the Company signed a distribution agreement on August 1, 2022, resulting in Pepsi acting as the Company’s preferred distributor performing the direct store delivery for a majority of the Company’s U.S. operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue of our customers accounting for more than 10%, for the years ended December 31, 2022, 2021 and 2020, are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_pn3n3_zuLViPDQSDcf" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8B2_zTWJTWaH1hnb" style="display: none">Schedule of revenue &amp; accounts receivable with customers</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_498_20220101__20221231_zXjWJMjont2c" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_495_20210101__20211231_zXjfv9kXiRtc" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49B_20200101__20201231_zBgV4665nLsk" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2022</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2020</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr id="xdx_408_eus-gaap--ConcentrationRiskPercentage1_pid_dp_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRiskTotalMember__srt--StatementGeographicalAxis__custom--PepsicoIncMember_zJiRcCWluc8g" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 64%; text-align: left">Pepsi</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">22.2</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0772">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0773">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--ConcentrationRiskPercentage1_pid_dp_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRiskTotalMember__srt--StatementGeographicalAxis__custom--CostcoMember_zk1ET4WmqX7i" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Costco</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">16.7</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">12.7</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2.9</td><td style="text-align: left">%</td></tr> <tr id="xdx_409_eus-gaap--ConcentrationRiskPercentage1_pid_dp_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRiskTotalMember__srt--StatementGeographicalAxis__custom--AmazonMember_zaEE9PbJpqCk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Amazon</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">8.8</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">10.1</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">15.1</td><td style="text-align: left">%</td></tr> <tr id="xdx_403_eus-gaap--ConcentrationRiskPercentage1_pid_dp_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRiskTotalMember__srt--StatementGeographicalAxis__custom--AllOtherMember_zznzdC8oHTNk" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">All other</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">52.3</td><td style="padding-bottom: 1pt; text-align: left">%</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">77.2</td><td style="padding-bottom: 1pt; text-align: left">%</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">82.0</td><td style="padding-bottom: 1pt; text-align: left">%</td></tr> <tr id="xdx_403_eus-gaap--ConcentrationRiskPercentage1_pid_dp_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRiskTotalMember_zAq5vjfc3YDg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">100.0</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">%</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">100.0</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">%</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">100.0</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">%</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts receivable of our customers accounting for more than 10%, for the years ended December 31, 2022, and 2021, are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_498_20220101__20221231_zxZ1urKWbHad" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_495_20210101__20211231_zDHqYSiBkqn4" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2022</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr id="xdx_40F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRiskTotalMember__srt--StatementGeographicalAxis__custom--PepsicoIncMember_zje0syWDtOmd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left">Pepsi</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">47.6</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0793">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--ConcentrationRiskPercentage1_pid_dp_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRiskTotalMember__srt--StatementGeographicalAxis__custom--AmazonMember_zgelW1NxCmwc" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Amazon</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">11.8</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">22.7</td><td style="text-align: left">%</td></tr> <tr id="xdx_401_eus-gaap--ConcentrationRiskPercentage1_pid_dp_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRiskTotalMember__srt--StatementGeographicalAxis__custom--PublixMember_z7wa3uh5IFG8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Publix</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1.4</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">10.3</td><td style="text-align: left">%</td></tr> <tr id="xdx_401_eus-gaap--ConcentrationRiskPercentage1_pid_dp_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRiskTotalMember__srt--StatementGeographicalAxis__custom--AllOtherMember_zyI16XjiKWI7" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">All other</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">39.2</td><td style="padding-bottom: 1pt; text-align: left">%</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">67.0</td><td style="padding-bottom: 1pt; text-align: left">%</td></tr> <tr id="xdx_409_eus-gaap--ConcentrationRiskPercentage1_pid_dp_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRiskTotalMember_z2XT9lRxJVNj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">100.0</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">%</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">100.0</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">%</td></tr> </table> <p id="xdx_8AB_zMt2rNHgCyEb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable. The Company places its cash and cash equivalents with high-quality financial institutions. At times, balances in the Company’s cash accounts may exceed the Federal Deposit Insurance Corporation limit. At December 31, 2022 and 2021, the Company had approximately $<span id="xdx_908_eus-gaap--CashUninsuredAmount_iI_pn3n3_dm_c20221231_zT87JPyhlVog" title="Amount excess of FDIC limit">652.4</span> million and $<span id="xdx_90E_eus-gaap--CashUninsuredAmount_iI_pn3n3_dm_c20211231_zYAeR69HjW0a" title="Amount excess of FDIC limit">16.0</span> million, respectively, including $38.8 <span id="xdx_909_eus-gaap--RestrictedCash_iI_pn3n3_c20221231_zQkYlUfKp0ri" style="display: none" title="Restricted cash">38,768</span> million in restricted cash for 2022, in excess of the Federal Deposit Insurance Corporation limit.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_pn3n3_zuLViPDQSDcf" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8B2_zTWJTWaH1hnb" style="display: none">Schedule of revenue &amp; accounts receivable with customers</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_498_20220101__20221231_zXjWJMjont2c" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_495_20210101__20211231_zXjfv9kXiRtc" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49B_20200101__20201231_zBgV4665nLsk" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2022</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2020</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr id="xdx_408_eus-gaap--ConcentrationRiskPercentage1_pid_dp_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRiskTotalMember__srt--StatementGeographicalAxis__custom--PepsicoIncMember_zJiRcCWluc8g" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 64%; text-align: left">Pepsi</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">22.2</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0772">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0773">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--ConcentrationRiskPercentage1_pid_dp_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRiskTotalMember__srt--StatementGeographicalAxis__custom--CostcoMember_zk1ET4WmqX7i" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Costco</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">16.7</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">12.7</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2.9</td><td style="text-align: left">%</td></tr> <tr id="xdx_409_eus-gaap--ConcentrationRiskPercentage1_pid_dp_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRiskTotalMember__srt--StatementGeographicalAxis__custom--AmazonMember_zaEE9PbJpqCk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Amazon</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">8.8</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">10.1</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">15.1</td><td style="text-align: left">%</td></tr> <tr id="xdx_403_eus-gaap--ConcentrationRiskPercentage1_pid_dp_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRiskTotalMember__srt--StatementGeographicalAxis__custom--AllOtherMember_zznzdC8oHTNk" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">All other</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">52.3</td><td style="padding-bottom: 1pt; text-align: left">%</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">77.2</td><td style="padding-bottom: 1pt; text-align: left">%</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">82.0</td><td style="padding-bottom: 1pt; text-align: left">%</td></tr> <tr id="xdx_403_eus-gaap--ConcentrationRiskPercentage1_pid_dp_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRiskTotalMember_zAq5vjfc3YDg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">100.0</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">%</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">100.0</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">%</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">100.0</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">%</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts receivable of our customers accounting for more than 10%, for the years ended December 31, 2022, and 2021, are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_498_20220101__20221231_zxZ1urKWbHad" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_495_20210101__20211231_zDHqYSiBkqn4" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2022</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr id="xdx_40F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRiskTotalMember__srt--StatementGeographicalAxis__custom--PepsicoIncMember_zje0syWDtOmd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left">Pepsi</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">47.6</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0793">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--ConcentrationRiskPercentage1_pid_dp_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRiskTotalMember__srt--StatementGeographicalAxis__custom--AmazonMember_zgelW1NxCmwc" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Amazon</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">11.8</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">22.7</td><td style="text-align: left">%</td></tr> <tr id="xdx_401_eus-gaap--ConcentrationRiskPercentage1_pid_dp_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRiskTotalMember__srt--StatementGeographicalAxis__custom--PublixMember_z7wa3uh5IFG8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Publix</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1.4</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">10.3</td><td style="text-align: left">%</td></tr> <tr id="xdx_401_eus-gaap--ConcentrationRiskPercentage1_pid_dp_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRiskTotalMember__srt--StatementGeographicalAxis__custom--AllOtherMember_zyI16XjiKWI7" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">All other</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">39.2</td><td style="padding-bottom: 1pt; text-align: left">%</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">67.0</td><td style="padding-bottom: 1pt; text-align: left">%</td></tr> <tr id="xdx_409_eus-gaap--ConcentrationRiskPercentage1_pid_dp_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRiskTotalMember_z2XT9lRxJVNj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">100.0</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">%</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">100.0</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">%</td></tr> </table> 0.222 0.167 0.127 0.029 0.088 0.101 0.151 0.523 0.772 0.820 1.000 1.000 1.000 0.476 0.118 0.227 0.014 0.103 0.392 0.670 1.000 1.000 652400000 16000000.0 38768000 <p id="xdx_846_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_z6KZ0C5sd9ne" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_867_zNQlsZ21vQ2e">Cash and Cash Equivalents</span></i> — The Company considers all highly liquid instruments with an original maturity of three months or less when purchased to be cash equivalents.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_eus-gaap--CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_z0xlxoXkvs8c" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86A_zZbo0KuZIdm7">Restricted Cash</span></i> — As disclosed in Note 4. <i>Revenues</i>, the Company received upfront payments from Pepsi during 2022, which are contractually restricted and can only be used to satisfy termination payments due to former distributors or have to be repaid to Pepsi. These upfront payments received from Pepsi cannot be used for general operating activities of the Company and have been classified as restricted cash based on the terms of the Transition Agreement.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_843_eus-gaap--ReceivablesPolicyTextBlock_zNLYmVUfFIs8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86E_zW6s32vKjx">Accounts Receivable</span></i> — Accounts receivable are reported at net realizable value. The Company establishes an allowance for doubtful accounts based upon factors pertaining to the credit risk of specific customers, historical trends, and other information. Delinquent accounts are written-off when it is determined that the amounts are uncollectible. Accounts receivable are presented net of billbacks, for customers that are allowed the right to net settle. At December 31, 2022 and December 31, 2021, there was an allowance for doubtful accounts of approximately $<span id="xdx_906_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_pn3n3_dm_c20221231_zOoAh4PlJN66" title="Allowance for doubtful accounts">2.1</span> million and $<span id="xdx_903_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_pn3n3_dm_c20211231_zqE9F3BWL78a" title="Allowance for doubtful accounts">0.8</span> million, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 2100000 800000 <p id="xdx_847_eus-gaap--InventoryPolicyTextBlock_zarVNg9sKBZk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86E_z6VGUsgrYOWb">Inventories</span> </i>— Inventories are valued at the lower of cost or net realizable value. Cost is determined using the first-in, first-out (FIFO) method. At December 31, 2022 and December 31, 2021, the Company recorded an allowance of approximately $<span id="xdx_902_eus-gaap--InventoryValuationReserves_iI_pn3n3_dm_c20221231_zZedmUZh9Rqa" title="Inventory reserve">8.4</span> million and $<span id="xdx_901_eus-gaap--InventoryValuationReserves_iI_pn3n3_dm_c20211231_zfaNZv4Ca9T5" title="Inventory reserve">2.6</span> million respectively. The changes in the allowance are included in cost of revenue.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 8400000 2600000 <p id="xdx_849_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zxb1hsgkqn48" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_861_zTmTxcFoZjAl">Property and Equipment</span></i> — Property and equipment are stated at cost less accumulated depreciation and amortization. Depreciation of property and equipment is calculated using the straight-line method over the estimated useful life of the asset generally ranging from three <span id="xdx_903_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_zcwzKDhePDw2" style="display: none" title="Property and equipment estimated useful life">3</span> to seven <span id="xdx_908_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_zNsJW17tJGZb" style="display: none" title="Property and equipment estimated useful life">7</span> years.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> P3Y P7Y <p id="xdx_845_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zYCRyH6hAFBb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86B_z1KBDaJcbgxe">Impairment of Long-Lived Assets</span></i> — In accordance with ASC Topic 360, <i>Property, Plant, and Equipment</i> the Company reviews the carrying value of long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. An impairment loss is determined regarding a long-lived asset if its carrying amount is not recoverable and exceeds its fair value. The carrying amount is not recoverable when it exceeds the sum of the undiscounted cash flows expected to result from use of the asset over its remaining useful life and final disposition. The Company did not record any impairments related to long lived assets during the years ended December 31, 2022 and December 31, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_ecustom--LonglivedAssetGeographicDataPolicyTextBlock_z8qN0v48dBAh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86A_zh6N3wLsjrw8">Long-lived Asset Geographic Data</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table contains long-lived asset information which includes property and equipment and lease right of use assets and excludes goodwill and intangibles, where individual countries represent a material portion of the total:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--LongLivedAssetsByGeographicAreasTableTextBlock_pn3n3_zclo8m5RXUUh" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8B8_z1PgH8lM4fm4" style="display: none">Schedule of long-lived asset geographic data</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_497_20221231_zgn7TFaq9XL8" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_496_20211231_ztETcCMUzjvg" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">December 31,</td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">December 31,</td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2022</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr id="xdx_402_ecustom--TotalLonglivedAssets_iI_pn3n3_hsrt--StatementGeographicalAxis__country--US_zkKC1KFJXv99" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left">United States</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">9,750</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">3,043</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40A_ecustom--LonglivedAssetsRelatedToForeignOperations_iI_pn3n3_hsrt--StatementGeographicalAxis__country--SE_zYAjLKlHJXM1" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Sweden</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,251</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,050</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_ecustom--LonglivedAssetsRelatedToForeignOperations_iI_pn3n3_hsrt--StatementGeographicalAxis__country--FI_zVYcC04P45K9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Finland</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">363</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">301</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_ecustom--LonglivedAssetsRelatedToForeignOperations_iI_pn3n3_hsrt--StatementGeographicalAxis__custom--OtherMember_z9CuilloqUWd" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Other</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0852">-</span></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40E_ecustom--LonglivedAssetsRelatedToForeignOperations_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt">Long-lived assets related to foreign operations</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,615</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,351</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_403_ecustom--TotalLonglivedAssets_iI_pn3n3" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total long-lived assets-net</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">11,365</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">4,394</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <p id="xdx_8A9_z8vSm07z28nd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--LongLivedAssetsByGeographicAreasTableTextBlock_pn3n3_zclo8m5RXUUh" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8B8_z1PgH8lM4fm4" style="display: none">Schedule of long-lived asset geographic data</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_497_20221231_zgn7TFaq9XL8" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_496_20211231_ztETcCMUzjvg" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">December 31,</td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">December 31,</td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2022</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr id="xdx_402_ecustom--TotalLonglivedAssets_iI_pn3n3_hsrt--StatementGeographicalAxis__country--US_zkKC1KFJXv99" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left">United States</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">9,750</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">3,043</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40A_ecustom--LonglivedAssetsRelatedToForeignOperations_iI_pn3n3_hsrt--StatementGeographicalAxis__country--SE_zYAjLKlHJXM1" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Sweden</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,251</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,050</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_ecustom--LonglivedAssetsRelatedToForeignOperations_iI_pn3n3_hsrt--StatementGeographicalAxis__country--FI_zVYcC04P45K9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Finland</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">363</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">301</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_ecustom--LonglivedAssetsRelatedToForeignOperations_iI_pn3n3_hsrt--StatementGeographicalAxis__custom--OtherMember_z9CuilloqUWd" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Other</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0852">-</span></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40E_ecustom--LonglivedAssetsRelatedToForeignOperations_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt">Long-lived assets related to foreign operations</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,615</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,351</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_403_ecustom--TotalLonglivedAssets_iI_pn3n3" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total long-lived assets-net</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">11,365</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">4,394</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> 9750000 3043000 1251000 1050000 363000 301000 1000 1615000 1351000 11365000 4394000 <p id="xdx_842_eus-gaap--GoodwillAndIntangibleAssetsGoodwillPolicy_zh2yMS5kxOWi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86B_z3KDW0Iqb42d">Goodwill</span> </i>— The Company records goodwill when the consideration paid for the acquisition of a business exceeds the fair value of net tangible and intangible assets acquired, including related tax effects. Goodwill is not amortized; instead, goodwill is tested for impairment on an annual basis as of October 1<sup>st</sup>, or more frequently if the Company believes indicators of impairment exist. The Company first assesses qualitative factors such as macro-economic conditions, industry and market conditions, and cost factors as well as other relevant events, to determine whether it is more-likely-than-not that the fair value of a reporting unit is less than its carrying value. If it is more likely than not that the fair value of a reporting unit is less than its carrying value, then the Company will calculate the estimated fair value of the reporting unit. If the Company determines that the fair value is less than the carrying value, the Company will recognize an impairment charge based on the excess of a reporting unit’s carrying value over its fair value. At December 31, 2022, there were no indicators of impairment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_zZr25g22L50l" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_867_zRp0jLz1ceZ5">Intangible assets</span></i>— Intangible assets are comprised of customer relationships and brands acquired in a business combination. The Company amortizes intangible assets with a definitive life over their respective useful lives. The addition of the Pepsi distribution network has shifted the Company’s focus to the US market and as a consequence it was determined that impairment indicators for the Func Foods brands indefinite intangible asset were present. The Company no longer anticipates focusing on the expansion of Func Food branded products and the Company plans to focus on Celsius branded products. As a result of the strategic shift, which the Company considered a triggering event, the Company quantitatively tested the Func Foods brand name for impairment utilizing the relief from royalty method to determine fair value as of September 30, 2022. As a result of the quantitative assessment, the Company recorded an impairment charge of $<span id="xdx_905_eus-gaap--ImpairmentOfLongLivedAssetsToBeDisposedOf_pn3n3_dm_c20220101__20221231_zLby0NKgftng" title="Impairment of long lived assets">2.5</span> million during the year ended December 31, 2022 which is presented within General and Administrative expenses on the Consolidated Statements of Operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 2500000 <p id="xdx_840_eus-gaap--RevenueRecognitionPolicyTextBlock_zvJ6z7bpOOEc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_867_z4iWHMk0KDpc">Revenue Recognition</span></i> — The Company recognizes revenue in accordance with ASC Topic 606 <i>Revenue from Contracts with Customers</i>. The Company recognizes revenue when performance obligations under the terms of a contract with the customer are satisfied. Product sales occur once control or title is transferred based on the commercial terms. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring goods. Product sales are recorded net of variable consideration, such as provisions for returns, discounts and promotional allowances. Such provisions are calculated using historical averages and adjusted for any expected changes due to current business conditions. Consideration given to customers for cooperative advertising is recognized as a reduction of revenue except to the extent that there is a distinct good or service, in which case the expense is classified as selling or marketing expense. The amount of consideration the Company receives and revenue the Company recognizes varies with changes in customer incentives the Company offers to its customers and their customers. Additionally, for any agreements which are one year or less, the practical expedient under ASC 340-40-25-4 is applied to expense contract acquisition costs when incurred if the amortization period of the contract asset would have otherwise been recognized in one year or less. Sales taxes and other similar taxes are excluded from revenue. Management believes that adequate provision has been made for cash discounts, returns, spoilage and promotional allowances based on the Company’s historical experience.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_847_ecustom--DeferredRevenuePolicyTextBlock_zM1yWF8ISPga" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86F_zRtvpRfGcFda">Deferred Revenue</span></i> — The Company receives payments from certain distributors in new territories as reimbursement for contract termination costs paid to the prior distributors in those territories. Amounts received pursuant to these new and/or amended distribution agreements entered into with certain distributors relating to the costs associated with terminating the Company’s prior distributors, are accounted for as deferred revenue and recognized ratably over the anticipated life of the respective new distribution agreements. As of December 31, 2022, the Company had approximately $<span id="xdx_904_eus-gaap--DeferredRevenue_iI_pn3n3_dm_c20221231_zxuiaCWGnucc" title="Deferred revenue">189.5</span> million in deferred revenue, of which $<span id="xdx_909_eus-gaap--DeferredRevenueNoncurrent_iI_pn3n3_dm_c20221231_zvS9NYSGq2gb" title="Deferred Revenue, Noncurrent">179.8</span> million is classified as deferred revenue-non-current and $<span id="xdx_90B_eus-gaap--ContractWithCustomerLiabilityCurrent_iI_pn3n3_dm_c20221231_z3h9a5JYPd92" title="Deferred revenue-current">9.7</span> million is classified as deferred revenue-current which are presented within the consolidated balance sheets and are contract liabilities related to termination payments received from Pepsi. Refer to Note 13, <i>Related Party Transactions </i>for more information. The deferred revenues will be recognized by the Company, ratably over the twenty-year agreement term. As of December 31, 2021, the Company did not have any deferred revenue related to contract liabilities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 189500000 179800000 9700000 <p id="xdx_84E_ecustom--AccruedDistributorTerminationFeesPolicyTextBlock_zvm8Fp8rKrF9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86D_zTHN5AY707jh">Accrued Distributor Termination Fees</span> </i>— Termination charges related to certain of the Company’s prior distributors are included in selling and marketing expenses upon termination. The Company recognized distributor termination expenses of approximately $<span id="xdx_90D_ecustom--TerminationExpense_pn3n3_dm_c20220101__20221231_z8STezYKUa6e" title="Termination Expense">193.8</span> million, $<span id="xdx_90F_ecustom--TerminationExpense_pn3n3_dm_c20210101__20211231_ztLYTp83Rb3g" title="Termination Expense">0.6</span> million, and $<span id="xdx_90F_ecustom--TerminationExpense_pn3n3_dm_c20200101__20201231_zS8Q683czWc9" title="Termination Expense">0.2</span> million for the year ended December 31, 2022, 2021, and 2020, respectively. The Company also has a balance of $<span id="xdx_905_ecustom--TerminationPayable_pn3n3_dm_c20220101__20221231_zdPMKXZAYM6k" title="Termination Payable">4.0</span> million in accrued distributor termination fees related to distributors terminated as a result of the Pepsi agreement as well as payment due back to Pepsi in the amount of $<span id="xdx_900_ecustom--DistributionAgreementsTerminationExpense_pn3n3_dm_c20220101__20221231_zj90GkzU6zV8" title="Distribution agreements termination expense">34.8</span> million as the projected payments to the prior distributors was less than the payment received from Pepsi, which are located within accounts payable and accrued expenses, on the Company’s consolidated balance sheets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 193800000 600000 200000 4000000.0 34800000 <p id="xdx_840_ecustom--CustomerAdvancePoliciesTextBlock_zXZ1ovJ0WKa1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86B_zB26Pmundyaj">Customer Advances</span></i> — From time to time the Company requires deposits in advance of delivery of products and/or production runs. Such amounts are initially recorded as customer advances liability within other current liabilities. The Company recognizes such revenue as it is earned in accordance with revenue recognition policies. As of December 31, 2022 and 2021, the Company did <span id="xdx_903_eus-gaap--ContractWithCustomerLiabilityNoncurrent_iI_pn3n3_do_c20221231_z8pWv8p3tdLh" title="Customer advances"><span id="xdx_902_eus-gaap--ContractWithCustomerLiabilityNoncurrent_iI_pn3n3_do_c20211231_zloH22gtvxk4" title="Customer advances">no</span></span>t have any customer advances.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 0 0 <p id="xdx_84A_eus-gaap--AdvertisingCostsPolicyTextBlock_zzyzn5JMFFG" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86A_zG6JkTTHrPN8">Advertising Costs</span></i> — Advertising costs are expensed as incurred. The Company uses mainly radio, local sampling events, sponsorships, endorsements, and digital advertising. The Company incurred advertising expenses of approximately $<span id="xdx_907_eus-gaap--AdvertisingExpense_pn3n3_dm_c20220101__20221231_zLXOliAQzuq2" title="Advertising expense">85.1</span> million, $<span id="xdx_907_eus-gaap--AdvertisingExpense_pn3n3_dm_c20210101__20211231_zLI5EULQu6w5" title="Advertising expense">36.7 </span>million and $<span id="xdx_900_eus-gaap--AdvertisingExpense_pn3n3_dm_c20200101__20201231_zeeRDQxreGWf" title="Advertising expense">14.2</span> million, during years ended December 31, 2022, 2021, and 2020, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 85100000 36700000 14200000 <p id="xdx_84F_eus-gaap--ResearchAndDevelopmentExpensePolicy_zOMgFP0ncUxb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_862_zhGaZHvPgVS6">Research and Development</span></i> — Research and development costs are charged to general and administrative expenses as incurred and consist primarily of consulting fees, raw material usage and test productions of beverages. The Company incurred expenses of approximately $<span id="xdx_90E_eus-gaap--ResearchAndDevelopmentExpense_pn3n3_dm_c20220101__20221231_zI8flwAcdFx6" title="Research and development expense">0.4</span> million, $<span id="xdx_90D_eus-gaap--ResearchAndDevelopmentExpense_pn3n3_dm_c20210101__20211231_zn1TyY7nhJI" title="Research and development expense">1.0</span> million and $<span id="xdx_905_eus-gaap--ResearchAndDevelopmentExpense_pn3n3_dm_c20200101__20201231_zj6CFQxaNDpk" title="Research and development expense">0.5</span> million during years ended December 31, 2022, 2021, and 2020, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 400000 1000000.0 500000 <p id="xdx_840_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zvY5KeU9hTek" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86A_zuwHqZEPZtl4">Foreign Currency Gain/Losses</span></i> — Foreign subsidiaries’ functional currency is the local currency of operations and the net assets of foreign operations are translated into U.S. dollars using current exchange rates. The foreign subsidiaries perform re-measurements of their assets and liabilities denominated in non-functional currencies on a periodic basis and the gain or losses from these adjustments are included in the consolidated statement of operations and comprehensive (loss) income as foreign exchange gains or losses. For the year ended December 31, 2022 exchange losses have amounted to approximately $<span id="xdx_90F_ecustom--ExchangeLosses_pn3n3_dm_c20220101__20221231_zQVmw0ZSz0Y9" title="Exchange losses">0.4</span> million while during the years ended December 31, 2021 and 2020, the Company recognized a foreign currency loss and gain of approximately $<span id="xdx_90B_ecustom--ExchangeLosses_pn3n3_dm_c20210101__20211231_z28qK0I0ch98" title="Exchange losses">0.3</span> million and $<span id="xdx_901_eus-gaap--ForeignCurrencyTransactionGainLossRealized_pn3n3_dm_c20200101__20201231_zDLwqzYD24wd" title="Recognized foreign currency gains">1.4</span> million, respectively, mainly related to fluctuations in exchange rates. Translation gains and losses that arise from the translation of net assets from functional currency to the reporting currency, as well as exchange gains and losses on intercompany balances of long-term investment nature, are included in Other Comprehensive Income. The Company incurred foreign currency translation net loss during the year ended December 31, 2022 of approximately $<span id="xdx_902_eus-gaap--ForeignCurrencyTransactionLossBeforeTax_pn3n3_dm_c20220101__20221231_zrU5gxMNNrc1" title="Foreign Currency Transaction Gain Before Tax">2.5</span> million and a net gain of approximately $<span id="xdx_902_eus-gaap--ForeignCurrencyTransactionGainBeforeTax_pn3n3_dm_c20210101__20211231_zTD9Vkn1zqW" title="Foreign Currency Translation">0.8</span> million and $<span id="xdx_90F_eus-gaap--ForeignCurrencyTransactionGainBeforeTax_pn3n3_dm_c20200101__20201231_zwk4mToqdEW4" title="Foreign Currency Translation">0.6</span> million during the year ended December 31, 2021 and 2020. The Company’s operations in different countries required that it transacts in the following currencies:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chinese-Yuan</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Norwegian-Krone</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Swedish-Krona</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Finland-Euro</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 400000 300000 1400000 2500000 800000 600000 <p id="xdx_841_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zu17OGBKXyO8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86B_zM8k4ESrqStj">Fair Value of Financial Instruments</span></i> — The carrying value of cash, cash equivalents, restricted cash, accounts receivable, accounts payable, accrued expenses and other current liabilities approximate fair value due to their relative short-term maturity and market interest rates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_847_eus-gaap--IncomeTaxPolicyTextBlock_zGmeqjPHAeA8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86F_znVivjfOukr8">Income Taxes</span> —</i> The Company accounts for income taxes pursuant to the provisions of ASC Topic 740 <i>Accounting for Income Taxes</i>, which requires, among other things, an asset and liability approach to calculating deferred income taxes. The asset and liability approach require the recognition of deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the carrying amounts and the tax bases of assets and liabilities. A valuation allowance is provided to offset any net deferred tax assets for which management believes it is more likely than not that the net deferred asset will not be realized. The Company follows the provisions of the ASC 740-10 related to <i>Accounting for Uncertain Income Tax Positions.</i> When tax returns are filed, it is highly certain that some positions taken would be sustained upon examination by the taxing authorities, while others are subject to uncertainty about the merits of the position taken or the amount of the position that would be ultimately sustained. In accordance with the guidance of ASC 740-10, the benefit of a tax position is recognized in the financial statements in the period during which, based on all available evidence, management believes it is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tax positions taken are not offset or aggregated with other positions. Tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with the applicable taxing authority. The portion of the benefits associated with tax positions taken that exceeds the amount measured as described above is reflected as a liability for uncertain tax benefits in the accompanying consolidated balance sheet, along with any associated interest and penalties that would be payable to the taxing authorities upon examination.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has adopted ASC 740-10-25 <i>Definition of Settlement,</i> which provides guidance on how an entity should determine whether a tax position is effectively settled for the purpose of recognizing previously unrecognized tax benefits and provides that a tax position can be effectively settled upon the completion of an examination by a taxing authority without being legally extinguished. For tax positions considered effectively settled, an entity would recognize the full amount of tax benefit, even if the tax position is not considered more likely than not to be sustained based solely on the basis of its technical merits and the statute of limitations remains open.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s tax returns for tax years in 2019 through 2021 remain subject to potential examination by the taxing authorities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_eus-gaap--EarningsPerSharePolicyTextBlock_zSz7j8aJ2ogc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_865_z7aaKPhSXY1j">Earnings per Share</span></i> — The Company computes earnings per share in accordance with ASC Topic 260 <i>Earnings per Share</i> (“ASC 260”), which requires earnings per share (“EPS”) for each class of stock (common stock and participating preferred stock) to be calculated using the two-class method. The two-class method is an allocation of earnings (distributed and undistributed) between the holders of common stock and a company’s participating security holders. Under the two-class method, earnings for the reporting period are allocated between common stockholders and other security holders based on their respective participation rights in undistributed earnings.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic earnings per common share is computed by dividing income or loss available to common stockholders by the weighted average number of shares of basic common stock outstanding. The Company’s Series A Convertible Preferred Stock is classified as a participating security in accordance with ASC 260. Net income allocated to the holders of Series A Convertible Preferred Stock will be calculated based on the stockholders’ proportionate share of weighted average shares of common stock outstanding on an if-converted basis. See Note 3. <i>Earnings Per Share</i> for more information.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zjidxJXJHK04" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86B_zowKjBwFaPu2">Share-Based Payments</span></i> — The Company follows the provisions of ASC Topic 718 <i>Compensation — Stock Compensation</i> and related interpretations. As such, compensation cost is measured on the date of grant at the fair value of the share-based payments. Such compensation amounts, if any, are amortized over the respective vesting periods of the grants. On April 30, 2015, the Company adopted the 2015 Stock Incentive Plan (the “2015 Plan”). This 2015 Plan is intended to provide incentives which will attract and retain highly competent persons at all levels as employees of the Company, as well as independent contractors providing consulting or advisory services to the Company, by providing them opportunities to acquire the Company’s common stock. The 2015 Plan permits the grant of options and other share-based awards for up to 5.0 million shares. Provisions have been made to permit the grant of options and other share-based awards for up to 5.0 million shares.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_eus-gaap--CostOfSalesPolicyTextBlock_zqkblyhA9aoc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86C_zcPUIkWKDgSd">Cost of Revenue</span></i> — Cost of Revenue consists of the cost of concentrates and or liquid bases, the costs of raw materials utilized in the manufacture of products, co-packing fees, repacking fees, in-bound &amp; out-bound freight charges, as well as certain internal transfer costs, warehouse expenses incurred prior to the manufacture of the Company’s finished products, inventory allowance for excess and obsolete products, and certain quality control costs. Raw materials account for the largest portion of the cost of sales. Raw materials include cans, other containers, flavors, ingredients and packaging materials.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_843_ecustom--OperatingExpensesPolicyTextBlock_zvFe4DlNZuDb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_863_ze22LD4QE5ic">Operating Expenses</span></i> — Operating expenses include selling expenses such as warehousing expenses after manufacture, as well as expenses for advertising, samplings and in-store demonstrations costs, costs for merchandise displays, point-of-sale materials and premium items, sponsorship expenses, other marketing expenses and design expenses. Operating expenses also include such costs as payroll costs, travel costs, professional service fees (including legal fees), depreciation and other general and administrative costs.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_eus-gaap--ShippingAndHandlingCostPolicyTextBlock_zP5P3tjlzuml" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86F_ziz5V59qs1hj">Shipping and Handling Costs</span></i> — Shipping and handling costs for freight expense on goods shipped are included in cost of sales. Freight expense on goods shipped for the years ended December 31, 2022, 2021 and 2020 was approximately $<span id="xdx_90A_ecustom--FreightExpense_pn3n3_dm_c20220101__20221231_zHjJ9bv1bX44" title="Freight expense">26.8 </span>million, $<span id="xdx_903_ecustom--FreightExpense_pn3n3_dm_c20210101__20211231_zEV0j5K5FAx4" title="Freight expense">26.9 </span>million and $<span id="xdx_900_ecustom--FreightExpense_pn3n3_dm_c20200101__20201231_zdKe1hLwc9V9" title="Freight expense">9.5</span> million, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain reclassification of prior period balances have been made to conform to current presentation. Please refer to consolidated balance sheets, Consolidated Statement of Cash Flows and Note 11. <i>Accounts Payable and Accrued Expenses</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 26800000 26900000 9500000 <p id="xdx_84E_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_z95T7I5ULpK4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_862_z1f7z6FNiXgb">Recent Accounting Pronouncements</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company adopts all applicable, new accounting pronouncements as of the specified effective dates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In September 2016, the FASB issued ASU No. 2016-13, Financial Instruments – Credit Losses (Topic 326) (“ASU 2016-13”), which requires the immediate recognition of management’s estimates of current and expected credit losses. In November 2019, the FASB issued ASU 2019-10, which delays the effective date of Topic 326 for Smaller Reporting Companies to interim and annual periods beginning after December 15, 2022, with early adoption permitted. The Company has elected the relief provided. Topic 326 is effective for the Company in the first quarter of 2023. Adoption of the new standard is not expected to have a material impact on our consolidated financial statements or disclosures.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_zoQWAgLgI5Mj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_865_z6I7zlUwjFL7">Liquidity</span> </i>— These financial statements have been prepared assuming the Company will be able to continue as a going concern. At December 31, 2022, the Company had an accumulated deficit of approximately $<span title="Accumulated deficit">238.8</span> <span id="xdx_90B_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pn3n3_di_c20221231_z3LQk14iBsch" style="display: none" title="Accumulated deficit">238,772</span> million which includes a net loss available to common stockholders of approximately $<span title="Net (loss) income">198.8</span> <span id="xdx_90C_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_iN_pn3n3_dmi_c20220101__20221231_zjpXCfPCbzga" style="display: none" title="Net (loss) income">198,808</span> million for year ended December 31, 2022. During the year ended December 31, 2022 the Company’s net cash provided by operating activities totaled approximately $<span title="Net cash provided by (used in) operating activities">108.2</span> <span id="xdx_90F_eus-gaap--NetCashProvidedByUsedInOperatingActivities_pn3n3_dm_c20220101__20221231_zcaeLYcsWaq9" style="display: none" title="Net cash provided by (used in) operating activities">108,182</span> million<b>. </b>As of December 31, 2021, the Company had an accumulated deficit of $<span title="Accumulated deficit">51.5</span> <span id="xdx_90F_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pn3n3_di_c20211231_zJJqgASxNmsh" style="display: none" title="Accumulated deficit">51,490</span> million which includes a net income available to common stockholders of $<span title="Net (loss) income attributed to common shareholders">3.9</span> <span id="xdx_908_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pn3n3_dm_c20210101__20211231_zATHa8etlsyb" style="display: none" title="Net (loss) income attributed to common shareholders">3,937</span> million for year ended December 31, 2021. During the year ended December 31, 2021 the Company’s net cash used by operating activities totaled approximately $<span title="Net cash provided by (used in) operating activities">96.6</span> <span id="xdx_905_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iN_pn3n3_dmi_c20210101__20211231_z5ccGrBdEgub" style="display: none" title="Net cash provided by (used in) operating activities">96,586</span> million<b>.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If our sales volumes do not meet our projections, expenses exceed our expectations, or our plans change, we may be unable to generate enough cash flow from operations to cover our working capital requirements. In such case, we may be required to adjust our business plan, by reducing marketing, lower our working capital requirements and reduce other expenses or seek additional financing. Furthermore, our business and results of operations may be adversely affected by changes in the global macro-economic environment related to the pandemic and public health crises related to the COVID-19 outbreak.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"> </p> -238772000 -198808000 108182000 -51490000 3937000 -96586000 <p id="xdx_806_eus-gaap--EarningsPerShareTextBlock_z8Dmg4lg5y43" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_821_zbLw3voidIvb">EARNINGS PER SHARE</span></b></span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company computes earnings per share in accordance with ASC Topic 260 <i>Earnings per Share</i> (“ASC 260”), which requires earnings per share for each class of stock (common stock and participating preferred stock) to be calculated using the two-class method. The two-class method is an allocation of earnings (distributed and undistributed) between the holders of common stock and a company’s participating security holders. Under the two-class method, earnings for the reporting period are allocated between common stockholders and other security holders based on their respective participation rights in undistributed earnings.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic earnings per common share is computed by dividing income or loss available to common stockholders by the weighted average number of shares of basic common stock outstanding. The Company’s Series A Convertible Preferred Stock is classified as a participating security in accordance with ASC 260. Net income allocated to the holders of Series A Convertible Preferred Stock consistent of preferred dividends declared and paid during 2022. The Series A Convertible Preferred Stock do not participate in losses, thus no such losses have been allocated to the Series A Convertible Preferred Stock in the periods presented below.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For purposes of determining diluted earnings per common share, basic earnings per common share was further adjusted to include the effect of potential dilutive common shares outstanding, including unvested restricted stock and performance-based stock units, using the more dilutive of either the two-class method or the treasury stock method, and Series A Convertible Preferred Stock using the if-converted method. Stock options and warrants that were out-of-the-money were not included in the denominator for the calculation of diluted EPS. Under the two-class method of calculating diluted earnings per share, net income is reallocated to common stock, the Series A Convertible Preferred Stock, and all dilutive securities based on the contractual participating rights of the security to share in the current earnings as if all of the earnings for the period had been distributed.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_886_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_pn3n3_zur0Pmx24fyj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - EARNINGS PER SHARE (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.375in; text-align: left; padding-bottom: 1pt"><span id="xdx_8B4_zqiZuKDcCb6k" style="display: none">Schedule of earnings per share, basic and diluted</span></td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td id="xdx_495_20220101__20221231_zCAbmEbZXvud" style="text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td id="xdx_490_20210101__20211231_zBZjs0Ra5kT2" style="text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td id="xdx_492_20200101__20201231_zR9KLlrFIXY3" style="text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="10" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">For the years ended</p> <p style="margin-top: 0; margin-bottom: 0">December 31,</p></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2022</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2020</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Net (loss) income attributed to common stockholders</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--NetIncomeLoss_i_pn3n3" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; width: 64%; text-align: left">Net (loss) income</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(187,282</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">3,937</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">8,524</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--PaymentsOfDividendsPreferredStockAndPreferenceStock_iN_pn3n3_di_z6PZt9UQKunc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt">Less: dividends paid to Series A convertible preferred stockholders</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(11,526</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0972">-</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0973">-</span></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_i_pn3n3" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 2.5pt">Net (loss) income attributed to common stockholders</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(198,808</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,937</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">8,524</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Net (loss) income per common share:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--EarningsPerShareBasic_pid_zaNsmOqBWKDl" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.375in; text-align: left; padding-bottom: 1pt">Basic</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(2.63</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">0.05</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">0.12</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--EarningsPerShareDiluted_pid_z1LEQdXaEk2k" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.375in; text-align: left; padding-bottom: 1pt">Dilutive</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(2.63</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">0.05</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">0.11</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Weighted average common stock outstanding:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_z2PWUpzHV7q4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.375in; text-align: left; padding-bottom: 1pt">Basic</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">75,649</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">73,781</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">70,195</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_zorNWT6FtLKb" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.375in; text-align: left; padding-bottom: 1pt">Dilutive</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">75,649</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">77,689</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">74,444</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the year ended December 31, 2022, <span id="xdx_902_ecustom--PotentiallyDilutiveSharesOutstanding_pin3_dm_c20220101__20221231_zSS3H1YssDo1" title="Potentially Dilutive Shares Outstanding">10.2</span> million of potentially dilutive securities were excluded from the computation of diluted net loss per share related to common stockholders as their effect was antidilutive.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_886_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_pn3n3_zur0Pmx24fyj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - EARNINGS PER SHARE (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.375in; text-align: left; padding-bottom: 1pt"><span id="xdx_8B4_zqiZuKDcCb6k" style="display: none">Schedule of earnings per share, basic and diluted</span></td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td id="xdx_495_20220101__20221231_zCAbmEbZXvud" style="text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td id="xdx_490_20210101__20211231_zBZjs0Ra5kT2" style="text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td id="xdx_492_20200101__20201231_zR9KLlrFIXY3" style="text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="10" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">For the years ended</p> <p style="margin-top: 0; margin-bottom: 0">December 31,</p></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2022</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2020</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Net (loss) income attributed to common stockholders</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--NetIncomeLoss_i_pn3n3" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; width: 64%; text-align: left">Net (loss) income</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(187,282</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">3,937</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">8,524</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--PaymentsOfDividendsPreferredStockAndPreferenceStock_iN_pn3n3_di_z6PZt9UQKunc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt">Less: dividends paid to Series A convertible preferred stockholders</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(11,526</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0972">-</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0973">-</span></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_i_pn3n3" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 2.5pt">Net (loss) income attributed to common stockholders</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(198,808</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,937</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">8,524</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Net (loss) income per common share:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--EarningsPerShareBasic_pid_zaNsmOqBWKDl" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.375in; text-align: left; padding-bottom: 1pt">Basic</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(2.63</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">0.05</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">0.12</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--EarningsPerShareDiluted_pid_z1LEQdXaEk2k" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.375in; text-align: left; padding-bottom: 1pt">Dilutive</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(2.63</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">0.05</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">0.11</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Weighted average common stock outstanding:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_z2PWUpzHV7q4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.375in; text-align: left; padding-bottom: 1pt">Basic</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">75,649</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">73,781</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">70,195</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_zorNWT6FtLKb" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.375in; text-align: left; padding-bottom: 1pt">Dilutive</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">75,649</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">77,689</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">74,444</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> </table> -187282000 3937000 8524000 11526000 -198808000 3937000 8524000 -2.63 0.05 0.12 -2.63 0.05 0.11 75649000 73781000 70195000 75649000 77689000 74444000 10200000 <p id="xdx_80A_ecustom--RevenueTextBlock_zYg7y42RSMw6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>4.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_82C_z36eT9swfmW7">REVENUE</span></b></span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recognizes revenue in accordance with ASC Topic 606 <i>Revenue from Contracts with Customers</i>. The Company recognizes revenue when performance obligations under the terms of a contract with the customer are satisfied. Product sales occur once control is transferred, based on the commercial terms. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring goods. Product sales are recorded net of variable consideration, such as provisions for returns, discounts and allowances. Such provisions are calculated using historical averages and adjusted for any expected changes due to current business conditions. Consideration given to customers for cooperative advertising is recognized as a reduction of revenue except to the extent that there is a distinct good or service, in which case the expense is classified as selling or marketing expense. The amount of consideration the Company receives and revenue the Company recognizes varies with changes in customer incentives the Company offers to its customers and their customers. Additionally, for any agreements which are one year or less, the practical expedient under ASC 340-40-25-4 is applied to expense contract acquisition costs when incurred if the amortization period of the contract asset would have otherwise been recognized in one year or less.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Promotional (Billback) Allowance</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s billback allowance programs with its distributors and/or retailers are executed through separate agreements in the ordinary course of business. These agreements generally provide for one or more of the arrangements described above and are of varying durations, typically ranging from one week to one year. The Company’s billbacks are calculated based on various programs with distributors and retail customers, and accruals are established for the Company’s anticipated liabilities. These accruals are based on agreed upon terms as well as the Company’s historical experience with similar programs and require management’s judgment with respect to estimating consumer participation and/or distributor and retail customer performance levels. Differences between such estimated expenses and actual expenses for promotional and other allowance costs have historically been insignificant and are recognized in earnings in the period such differences are determined.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Billbacks (variable consideration) recorded as a reduction to net sales, primarily include consideration given to the Company’s distributors or retail customers including, but not limited to the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">discounts granted off list prices to support price promotions to end-consumers by retailers;</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reimbursements given to the Company’s distributors for agreed portions of their promotional spend with retailers, including slotting, shelf space allowances and other fees for both new and existing products;</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the Company’s agreed share of fees given to distributors and/or directly to retailers for advertising, in-store marketing and promotional activities;</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the Company’s agreed share of slotting, shelf space allowances and other fees given directly to retailers, club stores and/or wholesalers;</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">incentives given to the Company’s distributors and/or retailers for achieving or exceeding certain predetermined volume goals;</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">discounted products;</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">contractual fees given to the Company’s distributors related to sales made directly by the Company to certain customers that fall within the distributors’ sales territories; and</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">contractual fees given to distributors for items sold below defined pricing targets.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the years ended December 31, 2022, 2021, and 2020, promotional allowance included as a reduction of revenue were $<span id="xdx_906_ecustom--PromotionalAllowanceIncludedAsAReductionOfRevenue_iI_pn3n3_dm_c20221231_zokILQl5FcN5" title="Promotional allowance included as a reduction of revenue">158.5</span> million, $<span id="xdx_90A_ecustom--PromotionalAllowanceIncludedAsAReductionOfRevenue_iI_pn3n3_dm_c20211231_zUp1HYDlwG6i" title="Promotional allowance included as a reduction of revenue">64.2</span> million, and $<span id="xdx_90A_ecustom--PromotionalAllowanceIncludedAsAReductionOfRevenue_iI_pn3n3_dm_c20201231_zO7LFNBJq115" title="Promotional allowance included as a reduction of revenue">28.7</span> million, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information about the Company’s net sales by geographical location for the years ended December 31, 2022, 2021 and 2020 is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_88F_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_pn3n3_zVwhcM2pDfdi" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - REVENUE (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8B9_zNvSLAgmq9M9" style="display: none">Schedule of net sales by reporting segment</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_496_20220101__20221231_zO5DfojdLfQ2" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49B_20210101__20211231_zVCaoUJyJoo8" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_494_20200101__20201231_ztVPctTrNcsa" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="10" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">For the years ended</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">December 31,<br/> 2022</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">December 31,<br/> 2021</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">December 31,<br/> 2020</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr id="xdx_404_eus-gaap--Revenues_hsrt--StatementGeographicalAxis__srt--NorthAmericaMember_zOHh6jqUJTw5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 64%; text-align: left">North America</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">617,457</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">273,005</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">95,480</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--Revenues_hsrt--StatementGeographicalAxis__srt--EuropeMember_zy13TNQ1mTe" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Europe</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">31,054</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">38,097</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">33,727</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--Revenues_hsrt--StatementGeographicalAxis__srt--AsiaMember_zCNJV3znO7ak" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Asia</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,647</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,538</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,093</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--Revenues_hsrt--StatementGeographicalAxis__custom--OtherMember_zXUCdD6g1Pvf" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Other</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,446</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">632</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">426</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--Revenues_i_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Net sales</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">653,604</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">314,272</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">130,726</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All of the Company’s North America revenue is derived from the United States, which is the Company’s country of domicile. Of the Company’s total foreign revenues of approximately $<span id="xdx_908_eus-gaap--Revenues_pn3n3_dm_c20220101__20221231__us-gaap--IncomeStatementLocationAxis__custom--ForeignRevenuesMember_zKRoRDoY5SRj" title="Revenues">36.1</span> million, $<span id="xdx_900_eus-gaap--Revenues_pn3n3_dm_c20210101__20211231__us-gaap--IncomeStatementLocationAxis__custom--ForeignRevenuesMember_z95JORwuMDi5" title="Revenues">41.3</span> million and $<span id="xdx_907_eus-gaap--Revenues_pn3n3_dm_c20200101__20201231__us-gaap--IncomeStatementLocationAxis__custom--ForeignRevenuesMember_zBdck2D4XQoe" title="Revenues">35.2</span> million for the years ended December 31, 2022, 2021, and 2020, respectively, Sweden represented the largest foreign portion of total consolidated revenue of approximately $<span id="xdx_904_eus-gaap--Revenues_pn3n3_dm_c20220101__20221231__srt--StatementGeographicalAxis__country--SE_zcfPiUBlRLt8" title="Revenues">21.7</span> million, $<span id="xdx_90B_eus-gaap--Revenues_pn3n3_dm_c20210101__20211231__srt--StatementGeographicalAxis__country--SE_zJofmNEsw7n3" title="Revenues">26.9</span> million, and $<span id="xdx_906_eus-gaap--Revenues_pn3n3_dm_c20200101__20201231__srt--StatementGeographicalAxis__country--SE_z9F1GAcpTxe3" title="Revenues">23.4</span> million for the years ended December 31, 2022, 2021, and 2020, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Agreements with PepsiCo, Inc.</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company executed multiple agreements with Pepsi on August 1, 2022, including a Distribution Agreement relating to the sale and distribution of certain of the Company’s beverage products in existing channels and distribution methods in the United States, excluding certain existing customer accounts, sales channels, Puerto Rico and the US Virgin Islands (the “Territory”). Under the Distribution Agreement, the Company has granted Pepsi the right to sell and distribute its existing beverage products in existing channels and distribution methods and future beverage products that are added from time to time as licensed products under the Distribution Agreement in defined territories. The Distribution Agreement represents a master service agreement and can be cancelled by either party without cause in the nineteenth year of the term (i.e., 2041), the twenty-ninth year of the term (i.e., 2051) and each ten (10) year period thereafter (i.e., 2061, 2071, etc.) by providing twelve (12) months’ written notice on August 1st of each such year to the other party. Except for a termination by the Company “with cause” or a termination by Pepsi “without cause”, the Company is required to pay the Purchaser certain compensation upon a termination as specified in the Distribution Agreement.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company agreed to provide Pepsi a right of first offer in the event the Company intends to (i) manufacture, distribute or sell products in certain additional countries as specified in the Distribution Agreement or (ii) distribute or sell products in any future channels and distribution methods during the term of the Agreement. Additionally, pursuant to the Distribution Agreement, the Company and Pepsi agreed to use commercially reasonable efforts to negotiate and execute with Pepsi a distribution agreement reasonably consistent with the Distribution Agreement for the sale and distribution of the products covered by the Distribution Agreement in Canada, and Pepsi agreed to meet and confer in good faith with the Company regarding the terms and conditions upon which Pepsi may be willing to sell or distribute such products, either directly or through local sub-distributors in certain other additional countries. The Distribution Agreement includes other customary provisions, including non-competition covenants in favor of the Company, representations and warranties, indemnification provisions, insurance provisions and confidentiality provisions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 1, 2022, the Company and Pepsi also executed the Transition Agreement, providing for the Company’s transition of certain existing distribution rights in the Territory to Pepsi. Under the terms of the Transition Agreement, Pepsi would pay the Company up to $<span id="xdx_907_ecustom--TotalPayment_pn3n3_dm_c20220729__20220801__us-gaap--TypeOfArrangementAxis__custom--PepsicoIncMember_zLWzXKU9eUCe" title="Total Payment">250</span> million in multiple tranches to facilitate the Company’s transition of certain distribution rights to Pepsi. Amounts received from Pepsi were contractually restricted to only be used to pay termination fees due to other distributors; any excess cash received over amounts due to other distributors is to be refunded back to Pepsi. During 2022, the Company received $<span id="xdx_906_ecustom--PaymentReceived_pn3n3_dm_c20220729__20220801__us-gaap--TypeOfArrangementAxis__custom--PepsicoIncMember_zEpAM87GDLqb" title="Payment received">227.8</span> million in payments from Pepsi. As of December 31, 2022, the Company had recorded $<span id="xdx_90C_ecustom--TerminationExpensesSalesAndMarketing_pn3n3_dm_c20220101__20221231__us-gaap--PlanNameAxis__custom--TransitionAgreementMember_zvymQIh0Kmda" title="Termination expenses sales and marketing">193.8</span> million in total termination expenses in Selling and marketing expenses, of which $<span id="xdx_902_eus-gaap--ContractWithCustomerLiability_iI_pn3n3_dm_c20221231_zJm1dMo3uhwf" title="Contract with Customer, Liability">193.0</span> million in termination expenses are related to the Pepsi transition.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Accounting for the agreements executed with PepsiCo, Inc.</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company evaluated the Security Purchase Agreement, Transition Agreement, Distribution Agreement, and other agreements executed with Pepsi on August 1, 2022, as one combined contract since the agreements were executed on the same day, with the same counterparty, in contemplation of one another and contractual terms are defined and referenced across the agreements. These agreements will be referred to as the “Pepsi Arrangement” herein. Management concluded the Pepsi Arrangement was partially in the scope of ASC 606 <i>Revenue from Contracts with Customers</i> (“ASC 606”) and partially in the scopes of ASC 505, <i>Equity</i> (“ASC 505”) and ASC 480, <i>Distinguishing liabilities from equity</i> (“ASC 480”). The Company first applied the measurement and classification criteria in ASC 505 and ASC 480 with respect to the Company’s issuance of 1,446,666 shares of Series A Convertible Preferred Stock, as the substance of the issuance of the Series A Convertible Preferred Stock was determined to be a financing transaction. See Note 14. <i>Mezzanine Equity</i> for the Company’s accounting conclusions with respect to the issuance of the Series A Convertible Preferred Stock.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">After application of the measurement and classification principles in ASC 505, and ASC 480, the Company accounted for the residual revenue elements of the Pepsi Arrangement under ASC 606. The revenue elements of the Pepsi Arrangement consisted of (i) $<span id="xdx_90C_ecustom--UpfrontPaymentReceived_pn3n3_dm_c20220729__20220801__us-gaap--TypeOfArrangementAxis__custom--PepsicoIncMember_zeQBh4r7yr9k" title="Upfront payment received">227.8</span> million in payments received from Pepsi under the Transition Agreement and (ii) a $<span id="xdx_906_ecustom--ImplicitPayment_pn3n3_dm_c20220729__20220801__us-gaap--TypeOfArrangementAxis__custom--PepsicoIncMember_zFtcGnkL4TMb" title="Implicit Payment">282.5</span> million implicit payment made to Pepsi by Celsius, representing the excess fair value over issuance proceeds received for the Series A Convertible Preferred Stock.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The $<span id="xdx_900_ecustom--UpfrontPaymentReceived_pn3n3_dm_c20220101__20221231_zd1DkMurFxgc" title="Upfront payment received">227.8</span> million upfront payment received from Pepsi was only to be used by Celsius to transition territory rights from terminated distributors to Pepsi; any excess cash received from Pepsi over transition payments made by Celsius to the Company’s terminated distributors was contractually restricted and due back to Pepsi. As of December 31, 2022, the Company has recorded a refund liability of $<span id="xdx_906_ecustom--RefundLiability_iI_pn3n3_dm_c20221231__us-gaap--TypeOfArrangementAxis__custom--PepsicoIncMember_zlc4J1V5DpU6" title="Refund liability">34.8</span> million in accounts payable and accrued expenses representing cash refunds due back to Pepsi and recognized the difference of $<span id="xdx_90E_ecustom--TerminationExpensesSalesAndMarketing_pn3n3_dm_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--PepsicoIncMember_zL4MiQmrPPqd" title="Termination expenses sales and marketing">193.0</span> million as part of deferred revenues. The deferred revenues will be recognized by Celsius ratably over the twenty-year agreement term. The Company recognized $<span id="xdx_907_eus-gaap--DeferredRevenueRevenueRecognized1_pn3n3_dm_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--PepsicoIncMember_zBi3RXdmw0s9" title="Deferred Revenue">4.2</span> million of total deferred revenues in the consolidated statement of separations in the year ended December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The $<span id="xdx_90B_ecustom--ExcessFairValueOverIssuanceProceeds_pn3n3_dm_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--PepsicoIncMember_z8uwJs8FMpo2" title="excess fair value over issuance proceeds">282.5</span> million excess fair value over issuance proceeds of the Series A Convertible Preferred Stock represents an implicit payment made to a customer. The Company concluded that this implicit payment meets the definition of an asset, and has been recorded as a Deferred Other Cost current and non-current, in the Company’s consolidated balance sheets. The Company will amortize the asset balance as contra-revenues ratably over a twenty-year period consistent with the term of the Distribution Agreement. The Company recognized contra-revenues of $<span id="xdx_907_ecustom--ContraRevenues_pn3n3_dm_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--PepsicoIncMember_zSNGwxMcNn57" title="contra-revenues">5.9</span> million in the consolidated statement of operations and comprehensive (loss) income in the year ended December 31, 2022 related to the upfront payment included in Deferred Other Cost current and non-current. The Company will assess the Deferred Other Cost asset for impairment at each reporting period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For product sales under the Distribution Agreement, the Company will recognize revenues when control of the underlying goods are transferred to Pepsi based on the contractual terms of noncancellable purchase orders issued by Pepsi.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>License Agreement</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In January 2019, the Company entered into a license and repayment of investment agreement with Qifeng Food Technology (Beijing) Co., Ltd (“Qifeng”). Under the agreement, Qifeng was granted the exclusive license rights to manufacture, market and commercialize Celsius branded products in China. The term of the agreement is 50 years, with annual royalty fees due from Qifeng after the end of each calendar year. The royalty fees are based on a percentage of Qifeng’s sales of Celsius branded products; however, the fees are fixed for the first five years of the agreement, totaling approximately $6.9 million, and then are subject to annual guaranteed minimums over the remaining term of the agreement.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under the agreement, the Company grants Qifeng exclusive license rights and provides ongoing support in product development, brand promotion and technical expertise. The ongoing support is integral to the exclusive license rights and, as such, both of these represent a combined, single performance obligation. The transaction price consists of the guaranteed minimums and the variable royalty fees, all of which are allocated to the single performance obligation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recognizes revenue from the agreement over time because the customer simultaneously receives and consumes the benefits from the services. The Company uses the passage of time to measure progress towards satisfying its performance obligation because of its ongoing efforts in providing the exclusive license rights including providing continuous access, updates and support. Total revenue recognized under the agreement was approximately $<span id="xdx_901_eus-gaap--Revenues_pn3n3_dm_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--LicenseAgreementMember_z9aPAaLSYzY5" title="Revenues">2.0</span> million, $<span id="xdx_902_eus-gaap--Revenues_pn3n3_dm_c20210101__20211231__us-gaap--TypeOfArrangementAxis__custom--LicenseAgreementMember_ziiK92vM77vk" title="Revenues">1.6</span> million, and $<span id="xdx_900_eus-gaap--Revenues_pn3n3_dm_c20200101__20201231__us-gaap--TypeOfArrangementAxis__custom--LicenseAgreementMember_zktOTluM66H6" title="Revenues">0.8</span> million for the year ended December 31, 2022, 2021, and 2020 which is reflected in the revenues from Asia.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 158500000 64200000 28700000 <table cellpadding="0" cellspacing="0" id="xdx_88F_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_pn3n3_zVwhcM2pDfdi" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - REVENUE (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8B9_zNvSLAgmq9M9" style="display: none">Schedule of net sales by reporting segment</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_496_20220101__20221231_zO5DfojdLfQ2" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49B_20210101__20211231_zVCaoUJyJoo8" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_494_20200101__20201231_ztVPctTrNcsa" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="10" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">For the years ended</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">December 31,<br/> 2022</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">December 31,<br/> 2021</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">December 31,<br/> 2020</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr id="xdx_404_eus-gaap--Revenues_hsrt--StatementGeographicalAxis__srt--NorthAmericaMember_zOHh6jqUJTw5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 64%; text-align: left">North America</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">617,457</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">273,005</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">95,480</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--Revenues_hsrt--StatementGeographicalAxis__srt--EuropeMember_zy13TNQ1mTe" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Europe</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">31,054</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">38,097</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">33,727</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--Revenues_hsrt--StatementGeographicalAxis__srt--AsiaMember_zCNJV3znO7ak" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Asia</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,647</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,538</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,093</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--Revenues_hsrt--StatementGeographicalAxis__custom--OtherMember_zXUCdD6g1Pvf" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Other</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,446</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">632</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">426</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--Revenues_i_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Net sales</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">653,604</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">314,272</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">130,726</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> 617457000 273005000 95480000 31054000 38097000 33727000 3647000 2538000 1093000 1446000 632000 426000 653604000 314272000 130726000 36100000 41300000 35200000 21700000 26900000 23400000 250000000 227800000 193800000 193000000.0 227800000 282500000 227800000 34800000 193000000.0 4200000 282500000 5900000 2000000.0 1600000 800000 <p id="xdx_80C_eus-gaap--InventoryDisclosureTextBlock_zTd7DUn0FGC7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_826_ziSuo4IA6675">INVENTORIES</span></b></span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventories consist of the following at:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_88D_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_pn3n3_zIVX1zrecX74" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INVENTORIES (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8B5_z3p6pjLykge1" style="display: none">Schedule of inventories</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_497_20221231_zUcJo9VvQ9z1" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49C_20211231_z28yhrc1Aok7" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">December 31,</td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">December 31,</td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2022</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr id="xdx_40D_eus-gaap--InventoryFinishedGoods_iI_pn3n3_maINzleY_zKoMMSohRtAb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left">Finished goods</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">119,229</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">123,594</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--InventoryRawMaterialsAndSupplies_iI_pn3n3_maINzleY_zMUNVRGRCv7j" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Raw Materials</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">62,491</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">70,201</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_ecustom--LessInventoryAllowanceForExcessAndObsoleteProducts_iNI_pn3n3_di_msINzleY_zA9Pi9wy0Jxb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Less: Inventory reserve</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(8,431</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(2,573</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_407_eus-gaap--InventoryNet_iTI_pn3n3_mtINzleY_zXXHUpoFqq2j" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Inventories</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">173,289</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">191,222</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" id="xdx_88D_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_pn3n3_zIVX1zrecX74" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INVENTORIES (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8B5_z3p6pjLykge1" style="display: none">Schedule of inventories</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_497_20221231_zUcJo9VvQ9z1" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49C_20211231_z28yhrc1Aok7" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">December 31,</td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">December 31,</td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2022</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr id="xdx_40D_eus-gaap--InventoryFinishedGoods_iI_pn3n3_maINzleY_zKoMMSohRtAb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left">Finished goods</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">119,229</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">123,594</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--InventoryRawMaterialsAndSupplies_iI_pn3n3_maINzleY_zMUNVRGRCv7j" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Raw Materials</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">62,491</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">70,201</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_ecustom--LessInventoryAllowanceForExcessAndObsoleteProducts_iNI_pn3n3_di_msINzleY_zA9Pi9wy0Jxb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Less: Inventory reserve</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(8,431</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(2,573</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_407_eus-gaap--InventoryNet_iTI_pn3n3_mtINzleY_zXXHUpoFqq2j" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Inventories</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">173,289</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">191,222</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> 119229000 123594000 62491000 70201000 8431000 2573000 173289000 191222000 <p id="xdx_80F_ecustom--PrepaidExpensesAndOtherCurrentAssetsTextBlock_zxCbzWaidjZ1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>6.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_825_zxnjlHPGib1j">PREPAID EXPENSES AND OTHER CURRENT ASSETS</span></b></span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepaid expenses and other current assets total approximately $<span title="Prepaid expenses and other current assets">11.3</span> <span id="xdx_903_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_iI_pn3n3_c20221231_zQU8OHJ2RUWe" style="display: none" title="Prepaid expenses and other current assets">11,341</span> million and $<span title="Prepaid expenses and other current assets">13.6</span> <span id="xdx_907_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_iI_pn3n3_dm_c20211231_zh03A3ElSUBh" style="display: none" title="Prepaid expenses and other current assets">13,555</span> million, at December 31, 2022 and 2021, respectively, and consist mainly of prepaid advances to co-packers related to inventory production, advertising, prepaid insurance, prepaid slotting fees, value added tax payments and deposits on purchases.</span></p> 11341000 13555000 <p id="xdx_800_ecustom--NoteReceivableTextBlock_zHp2c9DCxPjj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>7.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_823_zOY2pnEJT4xk">NOTE RECEIVABLE</span></b></span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note receivable consists of the following at:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_881_ecustom--ScheduleOfNoteReceivableTableTextBlock_pn3n3_z4sMqvOLEJA5" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE RECEIVABLE (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"><span id="xdx_8BB_zddL8nxzGQ7k" style="display: none">Schedule of note receivable</span></td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td id="xdx_49E_20221231_zQExB3jKwxXa" style="text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td id="xdx_492_20211231_z6YBlN87rxjj" style="text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">December 31,</td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">December 31,</td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2022</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr id="xdx_40F_eus-gaap--NotesAndLoansReceivableNetCurrent_iI_pn3n3_maNRNzBqU_z9UZJyGiBgth" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left">Note Receivable-current</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">2,979</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">2,588</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--NotesAndLoansReceivableNetNoncurrent_iI_pn3n3_maNRNzBqU_ziyJ33KI8iNb" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Note Receivable-non-current</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">3,574</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">7,117</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--NotesReceivableNet_iTI_pn3n3_mtNRNzBqU_zjUT0pVXQZb5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total Note Receivable</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">6,553</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">9,705</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective January 1, 2019, the Company restructured its China distribution efforts by entering into two separate economic agreements as it relates to the commercialization of its Celsius products (i.e., the license and repayment of investment agreement with Qifeng, as described above). See Note 4 for information regarding the license agreement with Qifeng. Under a separate economic agreement, Qifeng will repay the marketing investments made by Celsius into the China market through 2018, over the same five-year period as the license agreement. The repayment, which was formalized via a note receivable from Qifeng (the “Note”), will need to be serviced even if the licensing agreement is cancelled or terminated. The Note is denominated in Chinese-Yuan.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_ecustom--NoteReceivableDescription_c20220101__20221231" title="Note Receivable description">The Note accrues interest at a rate per annum equal to the weighted average of <span id="xdx_901_eus-gaap--LongtermDebtWeightedAverageInterestRate_c20221231__srt--RangeAxis__srt--MaximumMember_pdd" title="Weighted average interest rate">5%</span> of the outstanding principal up to $<span id="xdx_901_eus-gaap--LongTermDebtAverageAmountOutstanding_pn3n3_dm_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_zjnFW3eO1Uak" title="Outstanding principal amount">5</span> million and <span id="xdx_903_eus-gaap--LongtermDebtWeightedAverageInterestRate_c20221231__srt--RangeAxis__srt--MinimumMember_pdd" title="Weighted average interest rate">2%</span> of the outstanding principal above $<span id="xdx_905_eus-gaap--LongTermDebtAverageAmountOutstanding_pn3n3_dm_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_zXRFDkQB2cjl" title="Outstanding principal amount">5</span> million.</span> On June 12, 2020, it was agreed to fix the interest rate at <span id="xdx_90C_eus-gaap--LongtermDebtWeightedAverageInterestRate_c20221231_pdd" title="Weighted average interest rate">3.21%</span> which reflected the weighted average interest rate for the 5-year period of the Note. Scheduled principal payments plus accrued interest for the Note are due annually on March 31 of each year starting in 2020. For the year ended December 31, 2022, 2021, and 2020, interest income for the Note was approximately $<span id="xdx_908_eus-gaap--InterestIncomeOperating_pn3n3_dm_c20220101__20221231_zqyQrKqFz025" title="Interest income">0.2</span> million, $<span id="xdx_90A_eus-gaap--InterestIncomeOperating_pn3n3_dm_c20210101__20211231_zWspwaP9muI6" title="Interest income">0.3</span> million, and $<span id="xdx_909_eus-gaap--InterestIncomeOperating_pn3n3_dm_c20200101__20201231_zZHwpkSq5tH4" title="Interest income">0.4</span> million respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company assesses the note receivable for impairment at each reporting period, by evaluating whether it is probable that the Company will be unable to collect all the contractual principal and interest payments as scheduled in the Note, based on historical experience of Qifeng’s ability to pay, the current economic environment and other factors. If the Note is determined to be impaired, the impairment is measured based on the present value of the expected future cash flows under the Note, discounted at the Note’s effective interest rate. At December 31, 2022 and 2021, the Note was not deemed to be impaired. As of December 31, 2022, Qifeng is current on all amounts due under the Note and the license agreement.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As evidence of solvency for the Note, a stock certificate in Celsius Holding’s Inc. which amounts to <span id="xdx_906_ecustom--InstalmentCollateralShares_iI_pp0n3_c20221231_zCmqdmZvVDml" title="Instalment collateral shares">30.0</span> thousand of shares owned by an affiliate under common control of Qifeng is being held at a brokerage account. A letter of guarantee was executed with several restrictions regarding their shares. In particular, it was agreed that the stock would not be sold or transferred without the prior written consent from Celsius. There are other restrictions and agreements, which include that a statement of account will be provided to Celsius on a quarterly basis to confirm and validate the existence of the remaining shares. The shares serve as one component of management’s consideration when evaluating impairment indicators.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_881_ecustom--ScheduleOfNoteReceivableTableTextBlock_pn3n3_z4sMqvOLEJA5" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTE RECEIVABLE (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"><span id="xdx_8BB_zddL8nxzGQ7k" style="display: none">Schedule of note receivable</span></td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td id="xdx_49E_20221231_zQExB3jKwxXa" style="text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td id="xdx_492_20211231_z6YBlN87rxjj" style="text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">December 31,</td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">December 31,</td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2022</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr id="xdx_40F_eus-gaap--NotesAndLoansReceivableNetCurrent_iI_pn3n3_maNRNzBqU_z9UZJyGiBgth" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left">Note Receivable-current</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">2,979</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">2,588</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--NotesAndLoansReceivableNetNoncurrent_iI_pn3n3_maNRNzBqU_ziyJ33KI8iNb" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Note Receivable-non-current</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">3,574</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">7,117</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--NotesReceivableNet_iTI_pn3n3_mtNRNzBqU_zjUT0pVXQZb5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total Note Receivable</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">6,553</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">9,705</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> 2979000 2588000 3574000 7117000 6553000 9705000 The Note accrues interest at a rate per annum equal to the weighted average of 5% of the outstanding principal up to $5 million and 2% of the outstanding principal above $5 million. 0.05 5000000 0.02 5000000 0.0321 200000 300000 400000 30000.0 <p id="xdx_800_eus-gaap--LesseeOperatingLeasesTextBlock_z4qZ8Y4fCVkh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>8.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_82D_zZ2c3Wxv6Yzj">LEASES</span></b></span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s leasing activities include an operating lease of its corporate office space from a related party (see Note 13) and other operating and finance leases of vehicles and office space for the Company’s European operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At the inception of a contract, the Company assesses whether the contract is, or contains, a lease. The Company’s assessment is based on: (1) whether the contract involves the use of a distinct identified asset, (2) whether the Company obtains the right to substantially all the economic benefit from the use of the asset throughout the term, and (3) whether the Company has the right to direct the use of the asset. The Company allocates the consideration in the contract to each lease and non-lease component based on the component’s relative stand-alone price to determine the lease payments. Lease and non-lease components are accounted for separately.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leases are classified as either finance leases or operating leases based on criteria in ASC Topic 842 <i>Leases</i>. The Company’s operating leases are generally comprised of real estate and vehicles, and the Company’s finance leases are generally comprised of vehicles.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At lease commencement, the Company records a lease liability equal to the present value of the remaining lease payments, discounted using the rate implicit in the lease or, if that rate cannot be readily determined, the Company’s incremental borrowing rate. A corresponding right-of-use asset (“ROU asset”) is recorded, measured based on the initial measurement of the lease liability. ROU assets also include any lease payments made and exclude lease incentives. Lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease expense for operating leases is recognized on a straight-line basis over the lease term and is included in general and administrative expenses. Included in lease expense are any variable lease payments incurred in the period that were not included in the initial lease liability. Lease expense for finance leases consists of the amortization of the ROU asset on a straight-line basis over the shorter of the useful life of the asset or the lease term, and interest expense is calculated using the effective interest rate method.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The future annual minimum lease payments required under the Company’s leases as of December 31, 2022 are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_88F_ecustom--ScheduleOfMaturitiesOfOperatingAndFinanceLeasesLiabilitiesTableTextBlock_pn3n3_zEgWBUwYhmWf" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - LEASES (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span id="xdx_8B0_zGzg5Wx45f2e" style="display: none">Schedule of future minimum lease payments</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Operating</td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Finance</td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; vertical-align: bottom"> </td> <td colspan="2" style="vertical-align: bottom; text-align: center"> </td><td style="text-align: center; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: left">Future minimum lease payments</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Leases</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Leases</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Total</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; width: 64%; text-align: left">2023</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_c20221231_pn3n3" style="width: 9%; text-align: right" title="2023">698</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_c20221231_pn3n3" style="width: 9%; text-align: right" title="2023">76</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_ecustom--TotalLeaseLiabilityPaymentsDueNextTwelveMonths_c20220101__20221231_pn3n3" style="width: 9%; text-align: right" title="2023">774</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">2024</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_c20221231_pn3n3" style="text-align: right" title="2024">328</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearTwo_c20221231_pn3n3" style="text-align: right" title="2024">39</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_ecustom--TotalLeaseLiabilityPaymentsDueYearTwo_c20220101__20221231_pn3n3" style="text-align: right" title="2024">367</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">2025</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_c20221231_pn3n3" style="text-align: right" title="2025">7</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearThree_c20221231_pn3n3" style="text-align: right" title="2025">67</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_ecustom--TotalLeaseLiabilityPaymentsDueYearThree_c20220101__20221231_pn3n3" style="text-align: right" title="2025">74</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt">2026</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_c20221231_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="2026"><span style="-sec-ix-hidden: xdx2ixbrl1148">-</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFour_c20221231_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="2026">64</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_ecustom--TotalLeaseLiabilityPaymentsDueYearFour_c20220101__20221231_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="2026">64</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Total future minimum lease payments</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_c20221231_pn3n3" style="text-align: right" title="Total future minimum lease payments">1,033</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--FinanceLeaseLiabilityPaymentsDue_c20221231_pn3n3" style="text-align: right" title="Total future minimum lease payments">246</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--TotalLeaseLiabilityPaymentsDue_c20220101__20221231_pn3n3" style="text-align: right" title="Total future minimum lease payments">1,279</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Less: Amount representing interest</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_pn3n3_di_c20221231_zYYw9LVFf1a7" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Amount representing interest">(46</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--FinanceLeaseLiabilityUndiscountedExcessAmount_iNI_pn3n3_di_c20221231_zzZwbMtZGJQ8" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Amount representing interest">(14</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_ecustom--TotalLeaseLiabilityUndiscountedExcessAmount_c20220101__20221231_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Amount representing interest">(60</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Present value of lease liabilities</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--OperatingLeaseLiability_c20221231_pn3n3" style="text-align: right" title="Present value of lease liabilities">987</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--FinanceLeaseLiability_c20221231_pn3n3" style="text-align: right" title="Present value of lease liabilities">232</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_ecustom--TotalLeaseLiability_c20220101__20221231_pn3n3" style="text-align: right" title="Present value of lease liabilities">1,219</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Less: current portion</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--OperatingLeaseLiabilityCurrent_iNI_pn3n3_di_c20221231_zORmC2wQZ0Fj" style="border-bottom: Black 1pt solid; text-align: right" title="Less: current portion">(661</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--FinanceLeaseLiabilityCurrent_iNI_pn3n3_di_c20221231_zzmAwi8Xgu78" style="border-bottom: Black 1pt solid; text-align: right" title="Less: current portion">(70</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_ecustom--TotalLeaseLiabilityCurrent_c20220101__20221231_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Less: current portion">(731</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt">Long-term portion</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--OperatingLeaseLiabilityNoncurrent_c20221231_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Long-term portion">326</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--FinanceLeaseLiabilityNoncurrent_c20221231_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Long-term portion">162</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_ecustom--TotalLeaseLiabilityNoncurrent_c20220101__20221231_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Long-term portion">488</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" id="xdx_88F_ecustom--ScheduleOfMaturitiesOfOperatingAndFinanceLeasesLiabilitiesTableTextBlock_pn3n3_zEgWBUwYhmWf" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - LEASES (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span id="xdx_8B0_zGzg5Wx45f2e" style="display: none">Schedule of future minimum lease payments</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Operating</td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Finance</td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; vertical-align: bottom"> </td> <td colspan="2" style="vertical-align: bottom; text-align: center"> </td><td style="text-align: center; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: left">Future minimum lease payments</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Leases</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Leases</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Total</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; width: 64%; text-align: left">2023</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_c20221231_pn3n3" style="width: 9%; text-align: right" title="2023">698</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_c20221231_pn3n3" style="width: 9%; text-align: right" title="2023">76</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_ecustom--TotalLeaseLiabilityPaymentsDueNextTwelveMonths_c20220101__20221231_pn3n3" style="width: 9%; text-align: right" title="2023">774</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">2024</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_c20221231_pn3n3" style="text-align: right" title="2024">328</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearTwo_c20221231_pn3n3" style="text-align: right" title="2024">39</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_ecustom--TotalLeaseLiabilityPaymentsDueYearTwo_c20220101__20221231_pn3n3" style="text-align: right" title="2024">367</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">2025</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_c20221231_pn3n3" style="text-align: right" title="2025">7</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearThree_c20221231_pn3n3" style="text-align: right" title="2025">67</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_ecustom--TotalLeaseLiabilityPaymentsDueYearThree_c20220101__20221231_pn3n3" style="text-align: right" title="2025">74</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt">2026</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_c20221231_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="2026"><span style="-sec-ix-hidden: xdx2ixbrl1148">-</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFour_c20221231_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="2026">64</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_ecustom--TotalLeaseLiabilityPaymentsDueYearFour_c20220101__20221231_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="2026">64</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Total future minimum lease payments</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_c20221231_pn3n3" style="text-align: right" title="Total future minimum lease payments">1,033</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--FinanceLeaseLiabilityPaymentsDue_c20221231_pn3n3" style="text-align: right" title="Total future minimum lease payments">246</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--TotalLeaseLiabilityPaymentsDue_c20220101__20221231_pn3n3" style="text-align: right" title="Total future minimum lease payments">1,279</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Less: Amount representing interest</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_pn3n3_di_c20221231_zYYw9LVFf1a7" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Amount representing interest">(46</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--FinanceLeaseLiabilityUndiscountedExcessAmount_iNI_pn3n3_di_c20221231_zzZwbMtZGJQ8" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Amount representing interest">(14</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_ecustom--TotalLeaseLiabilityUndiscountedExcessAmount_c20220101__20221231_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Amount representing interest">(60</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Present value of lease liabilities</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--OperatingLeaseLiability_c20221231_pn3n3" style="text-align: right" title="Present value of lease liabilities">987</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--FinanceLeaseLiability_c20221231_pn3n3" style="text-align: right" title="Present value of lease liabilities">232</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_ecustom--TotalLeaseLiability_c20220101__20221231_pn3n3" style="text-align: right" title="Present value of lease liabilities">1,219</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Less: current portion</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--OperatingLeaseLiabilityCurrent_iNI_pn3n3_di_c20221231_zORmC2wQZ0Fj" style="border-bottom: Black 1pt solid; text-align: right" title="Less: current portion">(661</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--FinanceLeaseLiabilityCurrent_iNI_pn3n3_di_c20221231_zzmAwi8Xgu78" style="border-bottom: Black 1pt solid; text-align: right" title="Less: current portion">(70</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_ecustom--TotalLeaseLiabilityCurrent_c20220101__20221231_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Less: current portion">(731</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt">Long-term portion</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--OperatingLeaseLiabilityNoncurrent_c20221231_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Long-term portion">326</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--FinanceLeaseLiabilityNoncurrent_c20221231_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Long-term portion">162</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_ecustom--TotalLeaseLiabilityNoncurrent_c20220101__20221231_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Long-term portion">488</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 698000 76000 774000 328000 39000 367000 7000 67000 74000 64000 64000 1033000 246000 1279000 46000 14000 -60000 987000 232000 1219000 661000 70000 -731000 326000 162000 488000 <p id="xdx_807_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zq3qmAn2bMg3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>9.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_82D_zpRwHhyKgG64">PROPERTY AND EQUIPMENT</span></b></span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment consist of the following at:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--PropertyPlantAndEquipmentTextBlock_pn3n3_z7uS7sUxLlg2" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - PROPERTY AND EQUIPMENT (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8B0_zdDRdjJVTtve" style="display: none">Schedule of property and equipment</span></td><td> </td> <td style="text-align: center"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49E_20221231_z0LTe2D7pp0h" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_496_20211231_zsfJiycCgm46" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td style="vertical-align: bottom; font-weight: bold; text-align: center">Estimated Useful </td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">December 31,</td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">December 31,</td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"><b> </b></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><b> </b></td> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"><b>Life in Years</b></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"><b> </b></td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><b>2022</b></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"><b> </b></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"><b> </b></td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><b>2021</b></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"><b> </b></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 65%; text-align: left">Merchandising equipment - coolers</td><td style="width: 1%"> </td> <td style="width: 10%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MerchandisingEquipmentCoolersMember_zP8byTuOwx6f" title="Property, Plant and Equipment, Useful Life">5</span>-<span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MerchandisingEquipmentCoolersMember_z9yaE8gQwKBk" title="Property, Plant and Equipment, Useful Life">7</span></span></td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MerchandisingEquipmentCoolersMember_pn3n3" style="width: 9%; text-align: right" title="Property, plant and equipment, gross">9,885</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MerchandisingEquipmentCoolersMember_pn3n3" style="width: 9%; text-align: right" title="Property, plant and equipment, gross">3,052</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Office equipment</td><td> </td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_z0hv7qYI8KI3" title="Property, Plant and Equipment, Useful Life">3</span>-<span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_zhuhbuqfKAbi" title="Property, Plant and Equipment, Useful Life">7</span></span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_pn3n3" style="text-align: right" title="Property, plant and equipment, gross">1,124</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_pn3n3" style="text-align: right" title="Property, plant and equipment, gross">891</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Vehicles</td><td> </td> <td style="text-align: center"><span id="xdx_904_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_z916krb3KUDg" title="Property, Plant and Equipment, Useful Life">5</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentGross_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_pn3n3" style="text-align: right" title="Property, plant and equipment, gross">1,257</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_pn3n3" style="text-align: right" title="Property, plant and equipment, gross">304</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pn3n3_di_zUhNckwcpfBc" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Less: accumulated depreciation</td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(2,081</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(1,067</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_401_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: center"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">10,185</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">3,180</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation expense amounted to approximately $1.4 <span id="xdx_904_eus-gaap--Depreciation_pn3n3_c20220101__20221231_zCDkUokzyXUa" style="display: none" title="Depreciation">1,362</span> million, $<span title="Depreciation">0.6</span> <span id="xdx_908_eus-gaap--Depreciation_pn3n3_c20210101__20211231_zoDzsbjAgaq2" style="display: none" title="Depreciation">550</span> million, and $<span title="Depreciation">0.1</span> <span id="xdx_907_eus-gaap--Depreciation_pn3n3_c20200101__20201231_zhTVGWONg5Yl" style="display: none" title="Depreciation">127</span> million during years ended December 31, 2022, 2021, and 2020, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--PropertyPlantAndEquipmentTextBlock_pn3n3_z7uS7sUxLlg2" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - PROPERTY AND EQUIPMENT (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8B0_zdDRdjJVTtve" style="display: none">Schedule of property and equipment</span></td><td> </td> <td style="text-align: center"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49E_20221231_z0LTe2D7pp0h" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_496_20211231_zsfJiycCgm46" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td style="vertical-align: bottom; font-weight: bold; text-align: center">Estimated Useful </td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">December 31,</td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">December 31,</td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"><b> </b></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><b> </b></td> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"><b>Life in Years</b></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"><b> </b></td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><b>2022</b></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"><b> </b></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"><b> </b></td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><b>2021</b></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"><b> </b></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 65%; text-align: left">Merchandising equipment - coolers</td><td style="width: 1%"> </td> <td style="width: 10%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MerchandisingEquipmentCoolersMember_zP8byTuOwx6f" title="Property, Plant and Equipment, Useful Life">5</span>-<span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MerchandisingEquipmentCoolersMember_z9yaE8gQwKBk" title="Property, Plant and Equipment, Useful Life">7</span></span></td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MerchandisingEquipmentCoolersMember_pn3n3" style="width: 9%; text-align: right" title="Property, plant and equipment, gross">9,885</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MerchandisingEquipmentCoolersMember_pn3n3" style="width: 9%; text-align: right" title="Property, plant and equipment, gross">3,052</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Office equipment</td><td> </td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_z0hv7qYI8KI3" title="Property, Plant and Equipment, Useful Life">3</span>-<span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_zhuhbuqfKAbi" title="Property, Plant and Equipment, Useful Life">7</span></span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_pn3n3" style="text-align: right" title="Property, plant and equipment, gross">1,124</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_pn3n3" style="text-align: right" title="Property, plant and equipment, gross">891</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Vehicles</td><td> </td> <td style="text-align: center"><span id="xdx_904_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_z916krb3KUDg" title="Property, Plant and Equipment, Useful Life">5</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentGross_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_pn3n3" style="text-align: right" title="Property, plant and equipment, gross">1,257</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_pn3n3" style="text-align: right" title="Property, plant and equipment, gross">304</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pn3n3_di_zUhNckwcpfBc" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Less: accumulated depreciation</td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(2,081</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(1,067</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_401_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: center"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">10,185</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">3,180</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> P5Y P7Y 9885000 3052000 P3Y P7Y 1124000 891000 P5Y 1257000 304000 2081000 1067000 10185000 3180000 1362000 550000 127000 <p id="xdx_805_eus-gaap--GoodwillAndIntangibleAssetsDisclosureTextBlock_zv3FjQuwtZi6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>10.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_82B_zIX8GZsHTX57">GOODWILL AND INTANGIBLES</span></b></span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At December 31, 2022, goodwill consists of approximately $<span id="xdx_90E_eus-gaap--IntangibleAssetsNetIncludingGoodwill_iI_pn3n3_dm_c20221231_zZrJ1fpFKbxk" title="Intangible Assets, Net (Including Goodwill)">13.7</span> million resulting from the excess of the consideration paid and the fair value of net tangible and intangible assets acquired from the Func Food acquisition.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible assets consist of acquired customer relationships and brands from the Func Food acquisition. The gross carrying amount and accumulated amortization of intangible assets were as follows as of December 31, 2022 and December 31, 2021:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_pn3n3_zn62cIwnfCN4" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - GOODWILL AND INTANGIBLES (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span id="xdx_8B0_zMFOQ5UUZL7h" style="display: none">Schedule of accumulated amortization of intangible assets</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_49E_20221231_zR0ZMMRgPUYi" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49E_20211231_zpDvXOyUAJ1" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">December 31,</td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">December 31,</td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2022</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; font-style: italic; text-align: left">Definite-lived intangible assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--FiniteLivedCustomerRelationshipsGross_iI_pn3n3_maFLIAGzp1J_zZnwzZ5Hom48" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; width: 76%; text-align: left">Customer relationships</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">13,418</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">14,248</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_pn3n3_di_msFLIAGzp1J_z3Qnup9OUwg6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt">Less: accumulated amortization</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(1,610</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(1,140</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_402_eus-gaap--FiniteLivedIntangibleAssetsGross_iTI_pn3n3_mtFLIAGzp1J_maTzCXx_zSfrCirqsqc6" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt">Definite-lived intangible assets, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">11,808</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">13,108</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; font-style: italic; text-align: left">Indefinite-lived intangible assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_402_ecustom--BrandsTotalCarryingAmount_iI_pn3n3_maILIAEzHFr_zabckqSaZs4k" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Brands</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">2,984</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">3,193</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_ecustom--IndefiniteLivedIntangibleAssetsImpairment_iI_pn3n3_maILIAEzHFr_zZ0YTusxVHh8" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt">Less: Impairment</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(2,538</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1241">-</span></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--IndefiniteLivedIntangibleAssetsExcludingGoodwill_iTI_pn3n3_mtILIAEzHFr_maTzCXx_zNwzvit58J3e" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Indefinite-lived intangible assets, net</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">446</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">3,193</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_402_ecustom--Totalintangibles_iTI_pn3n3_mtTzCXx_zwoN7MLas068" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.375in; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total Intangibles</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">12,254</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">16,301</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <p id="xdx_8AB_zSeCGdUsQQae" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customer relationships are amortized over an estimated useful life of <span id="xdx_901_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20221231_zEYVhmCjpyXd" title="Amortized over estimated useful life">25</span> years and brands have an indefinite life. Amortization expense for the years ended December 31, 2022, 2021, and 2020 was approximately $<span id="xdx_904_eus-gaap--AmortizationOfIntangibleAssets_pn3n3_dm_c20220101__20221231_zbAghn9xlx74" title="Amortization expense">0.5</span> million, $<span id="xdx_905_eus-gaap--AmortizationOfIntangibleAssets_pn3n3_dm_c20210101__20211231_zinCZHEskXTe" title="Amortization expense">0.6</span> million, and $<span id="xdx_909_eus-gaap--AmortizationOfIntangibleAssets_pn3n3_dm_c20200101__20201231_ztQOLzvgrf59" title="Amortization expense">0.6</span> million, respectively and is reflected in general and administrative expenses. See note 2. <i>Basis of Presentation and Summary of Significant Accounting Policies</i>, for more information regarding our indefinite-lived intangible asset, Brands.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other fluctuations in the amounts of intangible assets are due to currency translation adjustments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following is the future estimated amortization expense related to customer relationships as of December 31, 2022:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_pn3n3_zN8NH8uJAeMj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - GOODWILL AND INTANGIBLES (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"><span id="xdx_8B0_zqA3BKW7ydMh" style="display: none">Schedule of future estimated amortization expense</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_49E_20221231_zj11i43DBFJk" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: left">Years ending December 31,</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"> </td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_40C_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pn3n3_maFLIANzNXT_zrzufzkNX4pc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; width: 88%; text-align: left">2023</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">537</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pn3n3_maFLIANzNXT_zg8b88V4NCIh" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">2024</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">537</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pn3n3_maFLIANzNXT_z9VNdDLIrqf6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">2025</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">537</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pn3n3_maFLIANzNXT_zfYZSvP9TxKc" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">2026</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">537</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_pn3n3_maFLIANzNXT_zcACSyqC9xg8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">2027</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">537</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_iI_pn3n3_maFLIANzNXT_zUvIM0skXTj2" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thereafter</span></td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">9,123</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--FiniteLivedIntangibleAssetsNet_iTI_pn3n3_mtFLIANzNXT_z5FpNh2tmKYa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="color: rgb(204,238,255); text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; padding-bottom: 2.5pt; text-align: left">Total</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">11,808</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <p id="xdx_8A8_zKgVL0GBZYA1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p> 13700000 <table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_pn3n3_zn62cIwnfCN4" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - GOODWILL AND INTANGIBLES (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span id="xdx_8B0_zMFOQ5UUZL7h" style="display: none">Schedule of accumulated amortization of intangible assets</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_49E_20221231_zR0ZMMRgPUYi" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49E_20211231_zpDvXOyUAJ1" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">December 31,</td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">December 31,</td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2022</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; font-style: italic; text-align: left">Definite-lived intangible assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--FiniteLivedCustomerRelationshipsGross_iI_pn3n3_maFLIAGzp1J_zZnwzZ5Hom48" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; width: 76%; text-align: left">Customer relationships</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">13,418</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">14,248</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_pn3n3_di_msFLIAGzp1J_z3Qnup9OUwg6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt">Less: accumulated amortization</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(1,610</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(1,140</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_402_eus-gaap--FiniteLivedIntangibleAssetsGross_iTI_pn3n3_mtFLIAGzp1J_maTzCXx_zSfrCirqsqc6" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt">Definite-lived intangible assets, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">11,808</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">13,108</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; font-style: italic; text-align: left">Indefinite-lived intangible assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_402_ecustom--BrandsTotalCarryingAmount_iI_pn3n3_maILIAEzHFr_zabckqSaZs4k" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Brands</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">2,984</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">3,193</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_ecustom--IndefiniteLivedIntangibleAssetsImpairment_iI_pn3n3_maILIAEzHFr_zZ0YTusxVHh8" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt">Less: Impairment</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(2,538</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1241">-</span></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--IndefiniteLivedIntangibleAssetsExcludingGoodwill_iTI_pn3n3_mtILIAEzHFr_maTzCXx_zNwzvit58J3e" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Indefinite-lived intangible assets, net</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">446</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">3,193</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_402_ecustom--Totalintangibles_iTI_pn3n3_mtTzCXx_zwoN7MLas068" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.375in; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total Intangibles</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">12,254</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">16,301</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> 13418000 14248000 1610000 1140000 11808000 13108000 2984000 3193000 -2538000 446000 3193000 12254000 16301000 P25Y 500000 600000 600000 <table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_pn3n3_zN8NH8uJAeMj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - GOODWILL AND INTANGIBLES (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"><span id="xdx_8B0_zqA3BKW7ydMh" style="display: none">Schedule of future estimated amortization expense</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_49E_20221231_zj11i43DBFJk" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: left">Years ending December 31,</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"> </td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_40C_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pn3n3_maFLIANzNXT_zrzufzkNX4pc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; width: 88%; text-align: left">2023</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">537</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pn3n3_maFLIANzNXT_zg8b88V4NCIh" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">2024</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">537</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pn3n3_maFLIANzNXT_z9VNdDLIrqf6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">2025</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">537</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pn3n3_maFLIANzNXT_zfYZSvP9TxKc" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">2026</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">537</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_pn3n3_maFLIANzNXT_zcACSyqC9xg8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">2027</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">537</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_iI_pn3n3_maFLIANzNXT_zUvIM0skXTj2" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thereafter</span></td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">9,123</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--FiniteLivedIntangibleAssetsNet_iTI_pn3n3_mtFLIANzNXT_z5FpNh2tmKYa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="color: rgb(204,238,255); text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; padding-bottom: 2.5pt; text-align: left">Total</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">11,808</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> 537000 537000 537000 537000 537000 9123000 11808000 <p id="xdx_80A_eus-gaap--AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_zsumBzk72jJa" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify; border-collapse: collapse"> <td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>11.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_82E_z7kFZ4S7zOyb">ACCOUNTS PAYABLE AND ACCRUED EXPENSES</span></b></span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts payable and accrued expenses consist of the following at:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_pn3n3_zANAY2D4VEYb" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8B1_zacRol6LLTg7" style="display: none">Schedule of accounts payable and accrued expenses</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_49E_20221231_zZgMFiFO3Ct" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_496_20211231_zZ8sDUQXtn6l" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">December 31,</td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">December 31,</td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2022</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr id="xdx_409_eus-gaap--AccountsPayableCurrent_iI_pn3n3_maAPAALz9sr_zi8N19DQSK4i" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left">Accounts payable</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">36,248</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">35,820</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40D_ecustom--DueToPepsi_iI_pn3n3_maAPAALz9sr_zM3YAzxlde1g" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Due to Pepsi</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">34,807</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1281">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_ecustom--AccruedFreight_iI_pn3n3_maAPAALz9sr_zIfI5ziJNvr6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Accrued freight</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">8,532</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">15,872</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--AccruedLiabilitiesCurrent_iI_pn3n3_maAPAALz9sr_zJ0gN5RM52Ak" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Accrued expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">19,081</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">15,311</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_ecustom--UnbilledPurchases_iI_pn3n3_maAPAALz9sr_zybpQpRalrz2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Unbilled purchases</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">8,672</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">5,439</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_iTI_pn3n3_mtAPAALz9sr_zMXhDNJiBqYi" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">107,340</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">72,442</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_pn3n3_zANAY2D4VEYb" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8B1_zacRol6LLTg7" style="display: none">Schedule of accounts payable and accrued expenses</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_49E_20221231_zZgMFiFO3Ct" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_496_20211231_zZ8sDUQXtn6l" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">December 31,</td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">December 31,</td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2022</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr id="xdx_409_eus-gaap--AccountsPayableCurrent_iI_pn3n3_maAPAALz9sr_zi8N19DQSK4i" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left">Accounts payable</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">36,248</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">35,820</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40D_ecustom--DueToPepsi_iI_pn3n3_maAPAALz9sr_zM3YAzxlde1g" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Due to Pepsi</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">34,807</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1281">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_ecustom--AccruedFreight_iI_pn3n3_maAPAALz9sr_zIfI5ziJNvr6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Accrued freight</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">8,532</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">15,872</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--AccruedLiabilitiesCurrent_iI_pn3n3_maAPAALz9sr_zJ0gN5RM52Ak" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Accrued expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">19,081</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">15,311</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_ecustom--UnbilledPurchases_iI_pn3n3_maAPAALz9sr_zybpQpRalrz2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Unbilled purchases</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">8,672</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">5,439</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_iTI_pn3n3_mtAPAALz9sr_zMXhDNJiBqYi" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">107,340</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">72,442</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> 36248000 35820000 34807000 8532000 15872000 19081000 15311000 8672000 5439000 107340000 72442000 <p id="xdx_807_eus-gaap--OtherCurrentLiabilitiesTableTextBlock_zjezrPMlkaGb" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify; border-collapse: collapse"> <td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>12.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_820_ze09xyEInBHl">OTHER CURRENT LIABILITIES</span></b></span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other current liabilities consist of the following at:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_88C_ecustom--ScheduleOfOtherCurrentLiabilitiesTableTextBlock_pn3n3_zsnmBJ6VNkh3" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OTHER CURRENT LIABILITIES (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8B3_z8rDacYpDlvg" style="display: none">Schedule of other current liabilities</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_490_20221231_zaJO6NqymhUg" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_497_20211231_zplz5NEi3sCk" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">December 31,</td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">December 31,</td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2022</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Short-term</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_408_ecustom--ValueAddedTaxPayment_iI_pn3n3_maOLCzLiM_zuATUyaYB8Ek" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left">VAT payable</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">198</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1300">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_405_ecustom--StateBeverageContainerDeposit_iI_pn3n3_maOLCzLiM_zZnbfCm8dxxj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">State Beverage Container Deposit</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">3,388</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">976</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--OtherLiabilitiesCurrent_iTI_pn3n3_mtOLCzLiM_zihv3GxK94ub" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">3,586</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">976</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_88C_ecustom--ScheduleOfOtherCurrentLiabilitiesTableTextBlock_pn3n3_zsnmBJ6VNkh3" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OTHER CURRENT LIABILITIES (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8B3_z8rDacYpDlvg" style="display: none">Schedule of other current liabilities</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_490_20221231_zaJO6NqymhUg" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_497_20211231_zplz5NEi3sCk" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">December 31,</td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">December 31,</td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2022</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Short-term</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_408_ecustom--ValueAddedTaxPayment_iI_pn3n3_maOLCzLiM_zuATUyaYB8Ek" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left">VAT payable</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">198</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1300">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_405_ecustom--StateBeverageContainerDeposit_iI_pn3n3_maOLCzLiM_zZnbfCm8dxxj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">State Beverage Container Deposit</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">3,388</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">976</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--OtherLiabilitiesCurrent_iTI_pn3n3_mtOLCzLiM_zihv3GxK94ub" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">3,586</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">976</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> 198000 3388000 976000 3586000 976000 <p id="xdx_809_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zx1yluR27m0c" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify; border-collapse: collapse"> <td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>13.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_82D_zOq9hNdCn2G4">RELATED PARTY TRANSACTIONS</span></b></span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Transactions with PepsiCo, Inc.</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As further described in Note 14 <i>Mezzanine Equity</i>, on August 1, 2022, the Company issued <span id="xdx_909_eus-gaap--PreferredStockSharesIssued_iI_c20220801__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--PepsicoIncMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zN59t52pEtFh" title="Preferred stock issued">1,466,666</span> shares of non-voting Series A Convertible Preferred stock (“Series A”) to Pepsi. On an as-converted basis the Series A held by Pepsi accounts for approximately <span id="xdx_90D_ecustom--PercentageOfRelatedPartyCommonStockOutstanding_c20220101__20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--PepsicoIncMember_pdd" title="Percentage of Related Party Common Stock Outstanding">8.5%</span> of the Company’s outstanding Common Stock, both on the date of issuance and as of December 31, 2022. Also, as discussed Note 14, the Securities Purchase Agreement entered into on August 1, 2022 (the “Purchase Agreement”) granted Pepsi the right to designate a nominee for election to the Company’s nine-member board of directors, so long as Pepsi meets certain ownership requirements with respect to the Company’s stock. During the year ended December 31, 2022, a Pepsi executive was nominated by Pepsi and elected to the Company’s board of directors.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based on Pepsi’s contractual representation rights for a seat on the Company’s Board of Directors, the Company has concluded that Pepsi represents a related party to the Company. As of and for the year ended December 31, 2022, the following transactions were recognized in the Company’s financial statements:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net sales to Pepsi amounted to $<span id="xdx_90D_ecustom--Netsales_pn3n3_dm_c20220101__20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--PepsicoIncMember_zziZhDQKCNM5" title="Net Sales">142.3</span> million for the year ended December 31, 2022 and are included in Revenue on the accompanying consolidated statement of operations and comprehensive (loss) income.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts receivable due from Pepsi on December 31, 2022, were $<span id="xdx_902_ecustom--AccountsReceivableFromRelatedParty_iI_pn3n3_dm_c20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--PepsicoIncMember_zPQdx06CKO5h" title="Accounts receivable from related party">31.6</span> million and are included in Accounts receivable, net on the Company’s consolidated balance sheets.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pepsi paid the Company $<span id="xdx_90B_ecustom--RelatedPartyCashPayment_pn3n3_dm_c20220101__20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--PepsicoIncMember_zvLFbSQJP5o2" title="Related party cash payment">227.8</span> million in cash in 2022 under the Transition Agreement. This amount was restricted and used to pay termination fees owed by the Company to terminated distributors. The Company has recorded deferred revenues of $<span id="xdx_90A_eus-gaap--DeferredRevenue_iI_pn3n3_dm_c20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--PepsicoIncMember_z1lCebz9FOd8" title="Deferred revenue">189.5</span> million, which is presented net of $<span id="xdx_901_eus-gaap--Revenues_pn3n3_dm_c20220101__20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--PepsicoIncMember_zZFEVypFHGsd" title="Revenues">4.2</span> million of revenue recognized at December 31, 2022, and a liability payable due to Pepsi of $<span id="xdx_902_ecustom--RelatedPartyLiabilityPayableDue_iI_pn3n3_dm_c20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--PepsicoIncMember_zhOPqHBIpQOd" title="Related Party Liability Payable Due">34.8</span> million, representing refund liabilities owed to Pepsi under the Transition Agreement which are included in Accounts payable and accrued expenses on the accompanying consolidated balance sheets as of December 31, 2022. The $<span id="xdx_901_ecustom--ExcessOfPaymentsFromRelatedParty_pn3n3_dm_c20220101__20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--PepsicoIncMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zE9VMGno3Mv7" title="Excess of payments from related party">34.8</span> million represents the excess of payments received from Pepsi less amounts paid and expected to be paid to terminated distributors.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The issuance of Series A to Pepsi was recorded at fair value, determined to be $<span id="xdx_904_ecustom--IssuanceOfPreferredStockFairValue_pn3n3_dm_c20220729__20220801__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--PepsicoIncMember_zlpBr7ffdtTh" title="Issuance of preferred stock fair value">832.5</span> million, on August 1, 2022. Cash proceeds from the issuance of Series A received from Pepsi were $<span id="xdx_909_eus-gaap--ProceedsFromIssuanceOfCommonStock_pn3n3_dm_c20220729__20220801__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--PepsicoIncMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zk19WfbxXNc3" title="Net proceeds from sale of common stock">550.0</span> million. See Note 14 for more information.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has recorded a $<span id="xdx_90B_ecustom--DeferredContractAssetInOtherAssets_iI_pn3n3_dm_c20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--PepsicoIncMember_zxoFxg0yTyc1" title="Deferred contract asset in other assets">282.5</span> million asset as Deferred other costs, representing the excess of the $<span id="xdx_90C_ecustom--IssuanceOfPreferredStockFairValue_pn3n3_dm_c20220101__20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--PepsicoIncMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_z0vZwZnu1hjb" title="Issuance of preferred stock fair value">832.5</span> million fair value of the Series A Preferred Stock over the issuance proceeds of $<span id="xdx_901_ecustom--ProceedsOfIssuanceOfDeferredContractAssetInOtherAssetsExcess_pn3n3_dm_c20220101__20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--PepsicoIncMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zBkC9n4gUi4f" title="Issuance of deferred contract asset in other assets excess">550.0</span> million. Amounts representing the unamortized deferred other costs of $<span id="xdx_90C_ecustom--UnamortizedDeferredContractCosts_pn3n3_dm_c20220101__20221231__us-gaap--BalanceSheetLocationAxis__custom--ContractAssetsCurrentMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--PepsicoIncMember_zpwGuEdJauL3" title="Unamortized deferred contract costs">14.1</span> million and <span style="background-color: white">$<span id="xdx_903_ecustom--UnamortizedDeferredContractCosts_pn3n3_dm_c20220101__20221231__us-gaap--BalanceSheetLocationAxis__custom--ContractAssetsNonCurrentMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--PepsicoIncMember_zyX4Vcgqmlej" title="Unamortized deferred contract costs">262.5</span> million</span> are presented in Deferred other costs-current and Deferred other costs-non-current, respectively, net of $<span id="xdx_903_eus-gaap--AccumulatedAmortizationOfOtherDeferredCosts_iI_pn3n3_dm_c20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--PepsicoIncMember_zW40P42ipqz7" title="Accumulated amortization of other deferred costs">5.9</span> million of accumulated amortization recognized as an offset to Revenue in the accompanying consolidated statement of operations and comprehensive (loss) income and consolidated balance sheets as of and for the year ended December 31, 2022.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See Notes 1. <i>Organization and Description of Business, </i>2. <i>Basis of Presentation Significant Accounting Policies, </i>11. <i>Accounts Payable and Accrued Expenses, </i>and 14. <i>Mezzanine Equity </i>for more information.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Related Party Leases</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s office is rented from a company affiliated with CD Financial, LLC which is controlled by one of our major stockholders. The lease extends until December 2024 with a monthly rent of $<span id="xdx_909_eus-gaap--OperatingLeaseExpense_pp0n3_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--MajorityShareholderMember__dei--LegalEntityAxis__custom--CDFinancialLLCMember_zdqfdLneTgRd" title="Monthly expense">37.6</span> thousand.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 1466666 0.085 142300000 31600000 227800000 189500000 4200000 34800000 34800000 832500000 550000000.0 282500000 832500000 550000000.0 14100000 262500000 5900000 37600 <p id="xdx_80B_eus-gaap--InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_zIVsmkY9fci1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify; border-collapse: collapse"> <td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>14.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_825_zGhkQnr2e79k">MEZZANINE EQUITY</span></b></span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Series A Convertible Preferred Stock</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2022, Company has designated and authorized <span id="xdx_900_eus-gaap--PreferredStockSharesAuthorized_iI_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesAConvertiblePreferredStockMember_ztG72bDs5Y9d" title="Preferred Stock, Shares Authorized">1,466,666</span> shares of Series A Convertible Preferred Stock with a par value of $<span id="xdx_907_ecustom--PreferredStockParValue_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_pdd" title="Preferred Stock Par Value">0.001</span> per share and a stated value of $<span id="xdx_90F_ecustom--PreferredStockStatedValue_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_pdd" title="Preferred Stock Stated Value">375</span> per share. The stated value per share may be increased from time-to-time in the event dividends on the Series A are paid-in-kind (“PIK dividends”) pursuant to the Series A Certification of Designation (the “Series A Certificate”). On August 1, 2022, pursuant to the Purchase Agreement, the Company issued <span id="xdx_908_eus-gaap--PreferredStockSharesIssued_c20221231__us-gaap--PlanNameAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_pdd" title="Preferred Stock, Shares Issued">1,466,666</span> shares of Series A, representing <span id="xdx_90A_ecustom--PercentageOfShareAuthorized_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_pdd" title="Percentage of Share Authorized">100%</span> of the authorized Series A shares, to Pepsi for stated cash consideration aggregating $<span id="xdx_90A_ecustom--CashConsiderationToRelatedParty_pn3n3_dm_c20220101__20221231__us-gaap--PlanNameAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zquqDYH06gkj" title="Cash Consideration to Related Party">550</span> million, excluding issuance costs. The Series A was issued concurrently with the execution of Distribution Agreement and the Transition Agreement. The Company determined that the aggregate fair value of the Series A on the issuance date was $<span id="xdx_90F_ecustom--IssuanceOfPreferredStockFairValue_pn3n3_dm_c20220101__20221231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_ztZwXtoCaFEf" title="Issuance Of Preferred Stock Fair Value">832.5</span> million, or approximately $<span id="xdx_90D_ecustom--PerShareOfAggregateFairValueOfPreferredShare_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_pdd" title="Per Share of Aggregate Fair Value of Preferred Share">568</span> per share. Accordingly, the Series A Convertible Preferred Stock was recorded at that amount, net of issuance costs of $<span id="xdx_90E_eus-gaap--DeferredFinanceCostsNet_iI_pn3n3_dm_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zE48hixqsUYj" title="Debt Issuance Costs, Net">8.0</span> million, in the Company’s consolidated balance sheets and statement of changes in stockholders’ equity and mezzanine equity.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Mezzanine Classification</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Series A Convertible Preferred Stock is redeemable in the event of a change in control as defined in the Series A Certificate. S99-3A(2) of the SEC’s Accounting Series Release No. 268 (“ASR 268”) requires preferred securities that are redeemable for cash or other assets to be classified outside of permanent equity if they are redeemable (i) at a fixed or determinable price on a fixed or determinable date, (ii) at the option of the holder, or (iii) upon the occurrence of an event that is not solely within the control of the issuer. Preferred securities that are mandatorily redeemable are required to be classified by the issuer as liabilities whereas under ASR 268 guidance an issuer should classify a preferred security whose redemption is contingent on an event not entirely in control of the issuer as mezzanine equity. The Series A is not mandatorily redeemable, however, a change in control is not solely in control of the Company, accordingly, the Company determined that mezzanine treatment is appropriate for the Series A and has presented it as such in our consolidated balance sheets and statement of changes in stockholders’ equity and mezzanine equity, as of and for the year ending December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to the Purchase Agreement, Pepsi, together with its affiliates, has certain rights and is also subject to various restrictions with respect to the Company’s outstanding common shares on an as-converted basis through purchases of the Company’s Common Stock in the open market and the accumulation of PIK dividends. Additionally, pursuant to the Purchase Agreement, Pepsi has the right to designate one nominee for election to Company’s board of directors, for so long as Pepsi (together with its affiliates) beneficially owns at least <span id="xdx_90F_eus-gaap--CommonStockOtherSharesOutstanding_c20221231__us-gaap--PlanNameAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_pdd" title="Common Stock, Other Shares, Outstanding">3,666,665</span> shares of the Company’s outstanding Common Stock on an as-converted basis. In August of 2022, the Company expanded the number of seats from eight to nine in connection with the election of a Pepsi representative to the Company’s board of directors.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Liquidation Preference</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Series A ranks, with respect to distribution rights and rights on liquidation, winding-up and dissolution, (i) senior and in priority of payment to the Company’s Common Stock, (ii) on parity with any class or series of capital stock of the Company expressly designated as ranking on parity with the Series A, and (iii) junior to any class or series of capital stock of the Company expressly designated as ranking senior to the Series A. The aggregate liquidation preference of the Series A is $<span id="xdx_90F_eus-gaap--PreferredStockLiquidationPreferenceValue_iI_pn3n3_dm_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zKna6iMUftIg" title="Preferred Stock, Liquidation Preference, Value">550.0</span> million on December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Voting</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Series A confers no voting rights, except as otherwise required by applicable law, and with respect to matters that adversely change the powers, preferences, privileges, rights or restrictions given to the Series A or provided for its benefit, or would result in securities that would be senior to or <i>pari passu</i> with the Series A. As described above, Pepsi does have a contractual right to representation on the Company’s Board of Directors, subject to certain share holdings thresholds.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Dividends</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Series A entitles the holder to cumulative dividends, which are payable quarterly in arrears either in cash, in-kind, or a combination thereof, at the Company’s election. Regular Series A Dividends accrue on each share Series A at the rate of <span id="xdx_90D_ecustom--AccruedDividend_c20220101__20221231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_pdd" title="Accrued dividend">5.00%</span> per annum, subject to adjustment as set forth in the Series A Certificate. In addition to such quarterly Regular Series A Dividends, shares of Series A also entitle the holder participate in any dividends paid on the Company’s Common Stock on an as-converted basis. During the year ended December 31, 2022, the Company declared and paid $<span id="xdx_90E_eus-gaap--Dividends_pn3n3_dm_c20220101__20221231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zScHPU59NM4" title="Dividends">11.5</span> million in Regular Series A Dividends, which amounted to $<span id="xdx_900_eus-gaap--PreferredStockDividendsPerShareDeclared_c20220101__20221231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_pdd" title="Preferred Stock, Dividends Per Share, Declared">7.86</span> per share of Series A. There are no cumulative undeclared dividends on the Series A at December 31, 2022. In addition, there were no dividends issued to common stockholders as of the years ended December 31, 2022 and 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Redemption</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to certain conditions set forth in the Series A Certificate, Series A may be redeemed at a price per share of Series A equal to the sum of (i) the stated value of such share of Series A as of the applicable Redemption Date, plus (ii) without duplication, all accrued and unpaid dividends previously added to the stated value of such share of Series A, and all accrued and unpaid dividends per share of Series A through such Redemption Date (the “Redemption Price”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Company’s Optional Redemption</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At any time from and after the earlier of (i) August 1, 2029, if the ten-day volume weighted average price of the Company’s Common Stock (the “Ten-Day VWAP”) does not exceed the conversion price on the date immediately prior to the date the Company delivers a redemption notice to the holders, and (ii) the cancellation of the Distribution Agreement by the Company, if the Ten-Day VWAP does not exceed the Conversion Price on the date immediately prior to the date the Company delivers a redemption notice to the holders, the Company shall have the right to redeem all (and not less than all) of the then-outstanding shares of Series A, at the Redemption Price. In the event of a Company optional redemption, the Company shall affect such redemption by paying the entire Redemption Price on or before the date that is thirty days after the delivery of the Company’s redemption notice and by redeeming all the shares of Series A on such date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Change in Control Redemption</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the event of (i) a sale or transfer, directly or indirectly, of all or substantially all of the assets of the Company in any transaction or series of related transactions (other than sales in the ordinary course of business); or (ii) any merger, consolidation or reorganization of the Company with or into any other entity or entities as a result of which the holders of the Company’s outstanding capital stock (on a fully-diluted basis) immediately prior to the merger, consolidation or reorganization no longer represent at least a majority of the voting power of the surviving or resulting Company or other entity; or (iii) any sale or series of sales, directly or indirectly, beneficially or of record, of shares of the Company’s capital stock by the holders thereof which results in any Person or group of Affiliated Persons owning capital stock holding more than <span id="xdx_904_ecustom--PercentageOfVotingRightPreferredStock_c20220101__20221231_pdd" title="Percentage of Voting Right, Preferred Stock">50%</span> of the voting power of the Company (a “Change in Control”) the Company (or its successor) shall redeem all (and not less than all) of the then-issued and outstanding shares of Series A. Upon such redemption, the Company will pay or deliver, as applicable, to each holder in respect of each share of Series A held by such holder, an amount equal to the greater of (A) cash in an amount equal to the Redemption Price and (B) the amount of cash and/or other assets (including securities) such holder would have received had each share of Series A held by such holder as of the close of business on the business day immediately prior to the effective date of such transaction resulting in a Change of Control, converted into a number of shares of Common Stock equal to the then-applicable Conversion Ratio and participated in such transaction resulting in such Change of Control as a holder of shares of Common Stock (such greater amount, the “Change of Control Redemption Price”). If, in connection with a transaction resulting in a Change of Control, the Company or its successor shall not have sufficient funds legally available under the Nevada law governing distributions to stockholders to redeem all outstanding shares of Series A, then the Company shall (A) redeem, pro rata among the holders, a number of shares of Series A equal to the number of shares of Series A that can be redeemed with the maximum amount legally available for the redemption of such shares of Series A under the Nevada law governing distributions to stockholders, and (B) redeem all remaining shares of Series A not redeemed because of the foregoing limitations at the applicable Change of Control Redemption Price as soon as practicable after the Company (or its successor) is able to make such redemption out of assets legally available for the purchase of such share of Series A. The inability of the Company (or its successor) to make a redemption payment for any reason shall not relieve the Company (or its successor) from its obligation to affect any required redemption when, as and if permitted by applicable law.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Holder Right to Request Redemption</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On each of August 1, 2029, August 1, 2032, and the August 1, 2035, the majority holders shall have the right, upon no less than six months prior written notice to the Company, to request that the Company redeem all (and not less than all) of the then-outstanding shares of Series A, at the Redemption Price.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the event of a holder optional redemption, the Redemption Price shall be payable, and the shares of Series A redeemed by the Company, in three equal installments, commencing on August 1, 2029, August 1, 2032, or August 1, 2035, as applicable, and in each case on the fifteenth- and thirtieth-month anniversary thereafter (each a “Redemption Date”). On each Redemption Date for a holder optional redemption, the Company shall redeem, on a pro rata basis in accordance with the number of shares of Series A owned by each holder, that number of outstanding shares of Series A determined by dividing (i) the total number of shares of Series A outstanding immediately prior to such Redemption Date by (ii) the number of remaining Redemption Dates (including the Redemption Date to which such calculation applies). If, on any Redemption Date, Nevada law governing distributions to stockholders or the terms of any indebtedness of the Company to banks and other financial institutions engaged in the business of lending money prevent the Company from redeeming all share of Series A to be redeemed, the Company shall ratably redeem the maximum number of shares that it may redeem consistent with such law, and shall redeem the remaining shares as soon as it may lawfully do so under such law.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If any shares of Series A scheduled for redemption on a Redemption Date are not redeemed for any reason on such Redemption Date, (x) from such Redemption Date until the fifteen-month anniversary of such Redemption Date, the dividend rate with respect to such unredeemed share of Series A shall automatically increase to <span id="xdx_901_eus-gaap--PreferredStockDividendRatePercentage_c20220101__20221231__us-gaap--StatementClassOfStockAxis__custom--EightPercentageMember_pdd" title="Preferred Stock, Dividend Rate, Percentage">8%</span> per annum, (y) from such fifteenth-month anniversary of such Redemption Date until the thirtieth-month anniversary of such Redemption Date, the dividend rate with respect to such unredeemed share of Series A shall automatically increase to <span id="xdx_908_eus-gaap--PreferredStockDividendRatePercentage_c20220101__20221231__us-gaap--StatementClassOfStockAxis__custom--TenPercentageMember_pdd" title="Preferred Stock, Dividend Rate, Percentage">10%</span> per annum and (z) from and after such thirtieth-month anniversary of such Redemption Date, the dividend rate with respect to any such unredeemed share of Series A shall automatically increase to <span id="xdx_901_eus-gaap--PreferredStockDividendRatePercentage_c20220101__20221231__us-gaap--StatementClassOfStockAxis__custom--TwelvePercentageMember_pdd" title="Preferred Stock, Dividend Rate, Percentage">12%</span> per annum, in each case until such share is duly redeemed or converted.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Conversion</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The shares of Series A may be converted into shares of the Company’s Common Stock pursuant to the Series A Certificate either at the option of the Company or subject to an automatic conversion as discussed below. The Series A was issued with a conversion price of $75 which is potentially subject to adjustment pursuant to the Series A Certificate. The Conversion Ratio is calculated as the quotient of (a) the sum of (x) the stated value of such share of Series A as of the applicable conversion date, plus (y) of all accrued and unpaid dividends previously added to the stated value of such share of Series A, and without duplication, all accrued and unpaid dividends per share of Series A through the applicable conversion date; divided by (b) the conversion Price as of the conversion date. As of December 31, 2022, the conversion ratio of the Series A into common was <span id="xdx_900_eus-gaap--PreferredStockConvertibleConversionRatio_c20221231__srt--RangeAxis__srt--MinimumMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_pdd" title="Preferred Stock, Convertible, Conversion Ratio">1</span> to <span id="xdx_902_eus-gaap--PreferredStockConvertibleConversionRatio_c20221231__srt--RangeAxis__srt--MaximumMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_pdd" title="Preferred Stock, Convertible, Conversion Ratio">5</span>. At December 31, 2022, <span id="xdx_900_eus-gaap--PreferredStockConvertibleSharesIssuable_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_pdd" title="Preferred Stock, Convertible, Shares Issuable">7,333,330</span> shares of the Company’s Common Stock are issuable upon conversion of the Series A Convertible Preferred Stock.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The calculations of earnings per share for all periods presented herein during which the Series A was outstanding do not treat conversion of the Series A as if it had occurred, as the effect of conversion would be anti-dilutive.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Company Optional Conversion</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At any time from and after August 1, 2029, provided the Ten-Day VWAP immediately prior to the date the Company delivers a conversion notice to the holders of Series A exceeds the Conversion Price, the Company may elect to convert all, but not less than all, of the outstanding shares of Series A into shares of the Company’s Common Stock.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Automatic Conversion</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Series A will convert automatically into shares of the Company’s Common Stock upon the occurrence of any of the following, each, an “Automatic Conversion Event”:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any date from and after the valid termination of the Distribution Agreement by the Company or Pepsi, if the Ten-Day VWAP immediately preceding such date exceeds the Conversion Price of such share as of such date.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any date from and after August 1, 2028, on which (x) the Company’s products meet a market share requirement during a specified period (as defined in the Distribution Agreement) and (y) the Ten-Day VWAP immediately prior to such date exceeds the Conversion Price of such share as of such date. In the case of an automatic conversion, each share of Series A then outstanding shall be converted into the number of shares of Common Stock equal to the Conversion Ratio of such share in effect as of the automatic conversion date. The occurrence of an Automatic Conversion Event will terminate any right of the holder to receive a redemption at their request even if such request has already been submitted, provided that the Series A shares have not already been redeemed.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2022, the Series A is not probable of becoming redeemable as the most likely method of settlement is through conversion which is likely to occur before the holder right to request redemption becomes exercisable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Other Accounting Matters</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has adopted Accounting Standards Update 2020-06 (“ASU 2020-06”), effective January 1, 2022. The provisions of ASU 2020-06 prohibit the recognition of a beneficial conversion feature (“BCF”) on preferred shares issued after the adoption of the ASU. The Company adopted ASU 2020-06d for the Preferred Series A for the year ended December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FASB ASC 815 generally requires an analysis of embedded terms and features that have characteristics of derivatives to be evaluated for bifurcation and separate accounting in instances where their economic risks and characteristics are not clearly and closely related to the risks of the host contract. We performed an evaluation and determined the Series A and the host instrument is more akin to equity. The Company identified certain embedded redemption and conversion features which it evaluated for bifurcation and determined no bifurcation of these embedded or conversion features was required.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 1466666 0.001 375 1466666 1 550000000 832500000 568 8000000.0 3666665 550000000.0 0.0500 11500000 7.86 0.50 0.08 0.10 0.12 1 5 7333330 <p id="xdx_80C_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_z8XnS4ibYUga" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify; border-collapse: collapse"> <td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>15.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_822_zvEUojffNFO5">STOCKHOLDERS’ EQUITY</span></b></span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Issuance of common stock pursuant to incentive stock plan exercises</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2022, the Company issued an aggregate of approximately <span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_pin3_dm_c20220101__20221231__us-gaap--PlanNameAxis__custom--StockIncentivePlan2015Member_ztanrremnNvb" title="Number of option shares granted">1.5</span> million shares of its common stock pursuant to the exercise of stock options granted under the 2015 Plan. The Company received aggregate proceeds of $<span id="xdx_901_eus-gaap--ProceedsFromStockOptionsExercised_pn3n3_dm_c20220101__20221231__us-gaap--PlanNameAxis__custom--StockIncentivePlan2015Member_zyIUgBiQmBi3" title="Proceeds from exercise of stock options">3.7</span> million for approximately <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pin3_dm_c20220101__20221231__us-gaap--PlanNameAxis__custom--StockIncentivePlan2015Member_zyMw4yMXHZF" title="Number of options exercised">1.0</span> million options exercised for cash, with the balance of the options having been exercised on a “cashless” basis.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2021, the Company issued an aggregate of approximately <span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_pin3_dm_c20210101__20211231__us-gaap--PlanNameAxis__custom--StockIncentivePlan2015Member_zZfwBgujxro2" title="Number of option shares granted">1.5</span> million shares of its common stock pursuant to the exercise of stock options granted under the 2015 Plan and 2006 Incentive Plan (collectively, the “Stock Incentive Plans”). The Company received aggregate proceeds of $<span id="xdx_900_eus-gaap--ProceedsFromStockOptionsExercised_pn3n3_dm_c20210101__20211231__us-gaap--PlanNameAxis__custom--StockIncentivePlan2015Member_zjnr8eqeCjsb" title="Proceeds from exercise of stock options">3.7</span> million for approximately <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pin3_dm_c20210101__20211231__us-gaap--PlanNameAxis__custom--StockIncentivePlan2015Member_zLuLWeWTdDBh" title="Number of options exercised">1.0</span> million options exercised for cash, with the balance of the grants having been exercised on a “cashless” basis.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2020, the Company issued an aggregate of approximately <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_pin3_dm_c20200101__20201231__us-gaap--PlanNameAxis__custom--StockIncentivePlan2015Member_zvHUUwQkBfX4" title="Number of option shares granted">1.9</span> million shares of its common stock pursuant to the exercise of stock options granted under the Company’s Stock Incentive Plans. The Company received aggregate proceeds of $<span id="xdx_905_eus-gaap--ProceedsFromStockOptionsExercised_pn3n3_dm_c20200101__20201231__us-gaap--PlanNameAxis__custom--StockIncentivePlan2015Member_z2PLX9ddbgq1" title="Proceeds from exercise of stock options">4.1</span> million for approximately <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pin3_dm_c20200101__20201231__us-gaap--PlanNameAxis__custom--StockIncentivePlan2015Member_z7woeU8eSeu2" title="Number of options exercised">1.3</span> million options exercised for cash, with the balance of the options having been exercised on a “cashless” basis.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>June 2021 Public Offering</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 9, 2021, the Company and certain selling stockholders (the “Selling Stockholders”) entered into an underwriting agreement (the “Underwriting Agreement”) with UBS Securities LLC and Jefferies LLC, as representatives (the “Representatives”) of the several underwriters (the “Underwriters”), relating to the sale of <span id="xdx_906_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20210601__20210609_pdd" title="Sales of common stock">6,518,267</span> shares of common stock, par value $<span id="xdx_905_eus-gaap--SaleOfStockPricePerShare_c20210609_pdd" title="Share price">0.001</span> per share, of the Company at a public offering price of $<span id="xdx_909_ecustom--PublicOfferingPrice_c20210601__20210609_pdd" title="Public offering price">62.50</span> per share less underwriting discounts and commissions in a registered public offering (the “Offering”). The Company and certain Selling Stockholders also granted the Underwriters an option, exercisable for 30 days, to purchase up to an additional <span id="xdx_90E_ecustom--AdditionalSharePurchase_c20210601__20210609_pdd" title="Additional share purchase">977,740</span> shares of its common stock. The Underwriters partially exercised their option to purchase <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20210601__20210614_pdd" title="Number of options exercised">873,141</span> shares of the Company’s common stock on June 11, 2021; <span id="xdx_902_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20210601__20210614__dei--LegalEntityAxis__custom--CompanyMember_zjOsC4MCiytc" title="Sales of common stock">1,133,953</span> of which were sold by the Company and <span id="xdx_907_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20210601__20210611__dei--LegalEntityAxis__custom--SellingStockholdersMember_pdd" title="Sales of common stock">739,188</span> of which were sold by certain of the Selling Stockholders. The Offering closed on June 14, 2021. The Company issued and sold <span id="xdx_907_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20210601__20210614__dei--LegalEntityAxis__custom--CompanyMember_pdd" title="Sales of common stock">1,133,953</span> shares of common stock, and the Selling Stockholders sold <span id="xdx_902_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20210601__20210614__dei--LegalEntityAxis__custom--SellingStockholdersMember_pdd" title="Sales of common stock">6,257,455</span> shares, in the aggregate, of common stock in the Offering. The Offering generated net proceeds for the Company of $<span id="xdx_900_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20210601__20210614__dei--LegalEntityAxis__custom--CompanyMember_pn3n3" title="Net proceeds from sale of common stock">67,769,386</span> and net proceeds for the Selling Stockholders of $<span id="xdx_90F_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20210601__20210614__dei--LegalEntityAxis__custom--SellingStockholdersMember_pn3n3" title="Net proceeds from sale of common stock">375,447,300</span>. The Company intends to use the proceeds for general corporate purposes. The Company did not receive any proceeds from the sale of shares by the Selling Stockholders.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 1500000 3700000 1000000.0 1500000 3700000 1000000.0 1900000 4100000 1300000 6518267 0.001 62.50 977740 873141 1133953 739188 1133953 6257455 67769386000 375447300000 <p id="xdx_808_eus-gaap--FairValueDisclosuresTextBlock_zvCUhHHXVuUh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify; border-collapse: collapse"> <td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>16.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_82D_zO340PoJk7F8">FAIR VALUE MEASUREMENTS</span></b></span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Additionally, ASC 820 requires the use of valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs. These inputs are prioritized below:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="width: 0.5in"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.65in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1:</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Observable inputs such as quoted market prices in active markets for identical assets or liabilities.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2:</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Observable market-based inputs or unobservable inputs that are corroborated by market data.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3:</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unobservable inputs for which there is little or no market data, which require the use of the reporting entity’s own assumptions.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company engaged a third-party valuation provider to assist in determining the fair value of the <span id="xdx_90C_eus-gaap--PreferredStockSharesIssued_c20220801__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_pdd" title="Preferred stock issued">1,466,666</span> shares of Series A Convertible Preferred Stock issued on August 1, 2022. The Series A Convertible Preferred Stock is classified in mezzanine equity, see Note 14, Mezzanine Equity, and the valuation of the Series A Convertible Preferred Stock represents a non-recurring fair value measurement. We used a Monte Carlo simulation model to determine the fair value of the Series A Convertible Preferred Stock on August 1, 2022. The Monte Carlo simulation utilized multiple input variables to determine the value of the Series A Convertible Preferred Stock including a volatility rate of <span id="xdx_900_eus-gaap--LongDurationContractsAssumptionsByProductAndGuaranteeVolatilityRate_c20220801__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_pdd" title="Volatility Rate">45%</span>, risk free interest rate of <span id="xdx_90B_ecustom--Riskfreeinterestrate_c20220801__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_pdd" title="Risk free interest rate">2.69%</span>, <span id="xdx_902_eus-gaap--PreferredStockDividendRatePercentage_c20220729__20220801__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_pdd" title="Dividend rate">5.0%</span> dividend rate, the closing price of the Company’s common stock on the issuance date of $<span id="xdx_901_ecustom--ClosingPrice_iI_pid_c20220801__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zeKIiJ5piWDa" title="Closing Price">98.87</span>, a debt discount rate of <span id="xdx_909_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_c20220801__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_pdd" title="Debt discount rate">12.5%</span> and a discount for lack of marketability attributed to the registration period of the underlying stock. The selected historical volatility was based on Celsius and a certain peer group. The risk-free interest rate was based on the US STRIPS Rate with a corresponding term as of issuance date. The <span id="xdx_907_eus-gaap--PreferredStockDividendRatePercentage_c20220101__20221231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_pdd" title="Dividend rate">5.0%</span> dividend rate is consistent with the provisions of the Series A Convertible Preferred Stock and with the Company’s past payments made in cash. The debt discount rate was based on estimated credit analysis and corresponding market yields as of the issuance date. The Company applied a nominal discount for lack of marketability with respect to the assumed registration period of the underlying shares.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company used the relief from royalty method model to determine the fair value of the Brand Name during the year ended December 31, 2022. The fundamental concept underlying this method is that in lieu of ownership, the acquirer can obtain comparable rights to use the subject asset via a license from a hypothetical third-party owner. The Relief from Royalty method utilized multiple input variables to determine the value of the Brand Name including forecasted sales, discount rate, and royalty rates. The selected royalty rate was based on comparable brands. The debt discount rate was based on an expected debt and equity rate of return as of September 30, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following is a tabular presentation of the non-recurring fair value measurement along with the level within the fair value hierarchy at December 31, 2022:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_88C_eus-gaap--ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_pn3n3_zHs8VsdZ2Jv6" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - FAIR VALUE MEASUREMENTS (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8B8_zlS45NTWn6F3" style="display: none">Summary of preferred shares</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="10" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">December 31, 2022</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Level 1</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Level 2</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Level 3</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Mezzanine equity:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 64%; text-align: left">Series A convertible preferred shares</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--PreferredStockValue_iI_pn3n3_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zlxprwb4MzNg" style="width: 9%; text-align: right" title="Preferred stock, value, issued"><span style="-sec-ix-hidden: xdx2ixbrl1453">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--PreferredStockValue_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_pn3n3" style="width: 9%; text-align: right" title="Preferred stock, value, issued">824,488</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--PreferredStockValue_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_pn3n3" style="width: 9%; text-align: right" title="Preferred stock, value, issued"><span style="-sec-ix-hidden: xdx2ixbrl1457">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Indefinite-lived intangible assets:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Brands</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--PreferredStockValue_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--StatementClassOfStockAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Preferred stock, value, issued"><span style="-sec-ix-hidden: xdx2ixbrl1459">-</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--PreferredStockValue_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--StatementClassOfStockAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Preferred stock, value, issued"><span style="-sec-ix-hidden: xdx2ixbrl1461">-</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--PreferredStockValue_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--StatementClassOfStockAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Preferred stock, value, issued">446</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_984_eus-gaap--PreferredStockValue_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_pn3n3" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Preferred stock, value, issued"><span style="-sec-ix-hidden: xdx2ixbrl1465">-</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_985_eus-gaap--PreferredStockValue_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_pn3n3" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Preferred stock, value, issued">824,488</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_982_eus-gaap--PreferredStockValue_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_pn3n3" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Preferred stock, value, issued">446</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other than those noted in previous notes, the Company did not have any other non-recurring assets or liabilities measured at fair value at December 31, 2022 and 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 1466666 0.45 0.0269 0.050 98.87 0.125 0.050 <table cellpadding="0" cellspacing="0" id="xdx_88C_eus-gaap--ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_pn3n3_zHs8VsdZ2Jv6" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - FAIR VALUE MEASUREMENTS (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8B8_zlS45NTWn6F3" style="display: none">Summary of preferred shares</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="10" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">December 31, 2022</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Level 1</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Level 2</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Level 3</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Mezzanine equity:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 64%; text-align: left">Series A convertible preferred shares</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--PreferredStockValue_iI_pn3n3_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zlxprwb4MzNg" style="width: 9%; text-align: right" title="Preferred stock, value, issued"><span style="-sec-ix-hidden: xdx2ixbrl1453">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--PreferredStockValue_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_pn3n3" style="width: 9%; text-align: right" title="Preferred stock, value, issued">824,488</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--PreferredStockValue_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_pn3n3" style="width: 9%; text-align: right" title="Preferred stock, value, issued"><span style="-sec-ix-hidden: xdx2ixbrl1457">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Indefinite-lived intangible assets:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Brands</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--PreferredStockValue_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--StatementClassOfStockAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Preferred stock, value, issued"><span style="-sec-ix-hidden: xdx2ixbrl1459">-</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--PreferredStockValue_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--StatementClassOfStockAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Preferred stock, value, issued"><span style="-sec-ix-hidden: xdx2ixbrl1461">-</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--PreferredStockValue_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--StatementClassOfStockAxis__us-gaap--IndefinitelivedIntangibleAssetsMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Preferred stock, value, issued">446</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_984_eus-gaap--PreferredStockValue_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_pn3n3" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Preferred stock, value, issued"><span style="-sec-ix-hidden: xdx2ixbrl1465">-</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_985_eus-gaap--PreferredStockValue_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_pn3n3" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Preferred stock, value, issued">824,488</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_982_eus-gaap--PreferredStockValue_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_pn3n3" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Preferred stock, value, issued">446</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> 824488000 446000 824488000 446000 <p id="xdx_801_eus-gaap--IncomeTaxDisclosureTextBlock_zvnE9xdPyOe2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify; border-collapse: collapse"> <td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>17.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_821_zDS2VHnsEUlb">INCOME TAXES</span></b></span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The domestic and foreign components of the Company’s income before provision for income taxes are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_pn3n3_zxphPEI4Agl3" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"><span id="xdx_8BC_zWkzb71KTika" style="display: none">Schedule of domestic and foreign components</span></td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2022</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2020</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 64%; text-align: left">Domestic</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c20220101__20221231__srt--StatementGeographicalAxis__us-gaap--DomesticCountryMember_pn3n3" style="width: 9%; text-align: right" title="Income before provision for income taxes">(151,551</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c20210101__20211231__srt--StatementGeographicalAxis__us-gaap--DomesticCountryMember_pn3n3" style="width: 9%; text-align: right" title="Income before provision for income taxes">(4,176</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c20200101__20201231__srt--StatementGeographicalAxis__us-gaap--DomesticCountryMember_pn3n3" style="width: 9%; text-align: right" title="Income before provision for income taxes">8,111</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Foreign</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c20220101__20221231__srt--StatementGeographicalAxis__us-gaap--ForeignCountryMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Income before provision for income taxes">(1,113</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c20210101__20211231__srt--StatementGeographicalAxis__us-gaap--ForeignCountryMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Income before provision for income taxes">117</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c20200101__20201231__srt--StatementGeographicalAxis__us-gaap--ForeignCountryMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Income before provision for income taxes">529</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Income (loss) before provision for income taxes</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_988_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c20220101__20221231_pn3n3" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Income before provision for income taxes">(152,664</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c20210101__20211231_pn3n3" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Income before provision for income taxes">(4,059</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_984_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c20200101__20201231_pn3n3" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Income before provision for income taxes">8,640</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <p id="xdx_8A0_zYNWjcMtXirk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The provision (benefit) for income taxes consists of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_pn3n3_z7MRxypKqSY" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"><span id="xdx_8B8_zy78sz4WURk7" style="display: none">Schedule of provision for income taxes</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_49B_20220101__20221231_zAaC4Yl4HIcb" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_498_20210101__20211231_z4LEMqJCKTz3" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_499_20200101__20201231_z6DX6cm5sCz1" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_iB" style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: left">Current:</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2022</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2020</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr id="xdx_406_ecustom--CurrentDomesticTaxExpenseBenefit_i01_pn3n3_maCFSALzyRE_zz7wlu2Kvhw5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Domestic</span></td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">10,498</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1500">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1501">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_i01_pn3n3_maCFSALzyRE_zHIjbCMsKr8k" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">State</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,601</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,523</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1505">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--CurrentForeignTaxExpenseBenefit_i01_pn3n3_maCFSALzyRE_zkyv0lJsyU75" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign</span></td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1507">-</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(38</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">116</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--CurrentFederalStateAndLocalTaxExpenseBenefit_i01T_pn3n3_mtCFSALzyRE_zZdCHDXPW1" style="vertical-align: bottom; background-color: White"> <td style="color: White; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; padding-bottom: 2.5pt; text-align: left">Current federal, state and local, tax expense</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">13,099</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">1,485</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">116</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr id="xdx_40A_eus-gaap--DeferredFederalStateAndLocalTaxExpenseBenefitAbstract_iB" style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: left">Deferred</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2022</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2020</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr id="xdx_403_ecustom--DeferredDomesticIncomeTaxExpenseBenefit_i01_pn3n3_maDFSALzMWt_zC8ay9KDQHNb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 64%; text-align: left">Domestic</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">18,558</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(7,142</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1521">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_i01_pn3n3_maDFSALzMWt_zErdp2X1wIjc" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">State and local</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,034</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,878</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1525">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_i01_pn3n3_maDFSALzMWt_zjRwV0xGffba" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Foreign</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(1,073</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(461</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1529">-</span></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--DeferredFederalStateAndLocalTaxExpenseBenefit_i01T_pn3n3_mtDFSALzMWt_z4kKl23l9GFf" style="vertical-align: bottom; background-color: White"> <td style="color: White; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Deferred federal, state and local, tax expense</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">21,519</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(9,481</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1533">-</span></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--IncomeTaxExaminationPenaltiesExpense_i_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 2.5pt"><b>Income tax expense (benefit)</b></td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">34,618</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(7,996</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">116</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <p id="xdx_8AC_zYDKlXnnPltf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The reconciliation of the U.S. federal statutory rate to the Company’s effective rate on income before provision (benefit) for income taxes is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_pn3n3_zeBraXmyvyUg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES (Details 2)"> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8B0_zcOjqI5594rd" style="display: none">Schedule of effective rate on income before provision (benefit) for income taxes</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_496_20220101__20221231_zKVO02z2wUfe" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_499_20210101__20211231_zqR7LfAC0ds" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_493_20200101__20201231_zCYOzk8JEVOk" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2022</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2020</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr id="xdx_408_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_zGPfZcdUutM6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 64%; text-align: left">U.S. Statutory federal rate</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">21.0</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">21.0</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">21.0</td><td style="width: 1%; text-align: left">%</td></tr> <tr id="xdx_40D_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_pid_dp_zX4rSz0xupB9" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">State taxes, net of federal benefit</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3.9</td><td style="text-align: left">)%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(12.5</td><td style="text-align: left">)%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4.4</td><td style="text-align: left">%</td></tr> <tr id="xdx_40B_ecustom--EffectiveIncomeTaxRateReconciliationTaxEffectOfPepsiValuationPremiumPercent_pid_dp_zPPvheYPkLFd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Tax effect of Pepsi valuation premium</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(38.9</td><td style="text-align: left">)%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_ecustom--PermanentDifferenceIncludingStockBasedCompensation1_pid_dp_zOAU0HBMD2dg" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Permanent differences, including stock-based compensation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1553">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1554">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6.7</td><td style="text-align: left">%</td></tr> <tr id="xdx_402_ecustom--PermanentDifferenceIncludingStockbasedCompensation_pid_dp_zC1HXH42MO22" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Stock based compensation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(0.9</td><td style="text-align: left">)%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">50.5</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1559">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_402_ecustom--ChangeInValuationAllowanceIncludingEffectOfChangeInTaxRate_pid_dp_zKo5XoWj2iJ" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Change in valuation allowance</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.4</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">219.8</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(29.8</td><td style="text-align: left">)%</td></tr> <tr id="xdx_405_eus-gaap--EffectiveIncomeTaxRateReconciliationTaxContingenciesForeign_pid_dp_z0w4yWdrCNr2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Change in deferred balances</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1565">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(80.6</td><td style="text-align: left">)%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1567">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--EffectiveIncomeTaxRateReconciliationTaxContingenciesOther_pid_dp_zaJNogX8uQLj" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Other</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(0.4</td><td style="padding-bottom: 1pt; text-align: left">)%</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(0.9</td><td style="padding-bottom: 1pt; text-align: left">)%</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1571">-</span></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_z3AOi6zDRLC2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt">Effective tax rate</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">(22.7</td><td style="padding-bottom: 2.5pt; text-align: left">)%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">197.2</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">2.3</td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr> </table> <p id="xdx_8AC_zWNuf3RW4M42" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Tax Cuts and Jobs Act introduced a provision to tax global intangible low-taxed income (“GILTI”) of foreign subsidiaries and a measure to tax certain intercompany payments under the base erosion anti-abuse tax “BEAT” regime. For the years ended December 31, 2022, and 2021, the Company did not generate intercompany transactions that met the BEAT threshold but does have to include GILTI relating to the Company’s foreign subsidiaries. The Company elected to account for GILTI as a current period cost.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred income taxes reflect the net tax effects of temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and the amounts for income tax purposes. Deferred tax assets and liabilities consisted of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_89F_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_pn3n3_zPrlIcKgeLn6" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES (Details 3)"> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8B9_ziPlrpjsW4T2" style="display: none">Schedule of deferred tax assets</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_499_20221231_zuvy4JilgxMd" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_492_20211231_zhsBSRxVm2qk" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">December 31,<br/> 2022</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">December 31,<br/> 2021</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr id="xdx_40A_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pn3n3_maDTALGzpVU_zCZxgiL7DGLd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left">Net operating loss carryforwards</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">4,774</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">6,685</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--DeferredTaxAssetsCharitableContributionCarryforwards_iI_pn3n3_maDTALGzpVU_zqxOsdUPCs6" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Charitable contributions</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">17</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">17</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--DeferredTaxLiabilitiesPropertyPlantAndEquipment_iNI_pn3n3_di_msDTALGzpVU_zJXKw82tYY65" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Fixed assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,158</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(627</td><td style="text-align: left">)</td></tr> <tr id="xdx_405_ecustom--DeferredTaxAssetsPepsiValuationPremium_iI_pn3n3_maDTALGzpVU_zPbTosh7iUYa" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Pepsi valuation premium</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(70,637</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_406_ecustom--DeferredTaxAssetsRightOfUseLiability_iNI_pn3n3_di_msDTALGzpVU_z4F8F07v9C3k" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Right of use liability</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">154</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">134</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_ecustom--DeferredTaxAssetsRightOfUseAsset_iI_pn3n3_maDTALGzpVU_zCFyVHkYp0x6" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Right of use asset</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(146</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(122</td><td style="text-align: left">)</td></tr> <tr id="xdx_40D_ecustom--DeferredTaxAssetsDistributorTerminationFees_iI_pn3n3_maDTALGzpVU_zXN2tFH0Zatb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Distributor termination fees</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">46,859</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1599">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_402_ecustom--UncertainTaxPosition_iI_pn3n3_maDTALGzpVU_zAHXjihjJuDe" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Uncertain tax position</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1601">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">132</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--DeferredCompensationPlanAssets_iI_pn3n3_maDTALGzpVU_zf5bCV2RpB1i" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Stock-based compensation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,236</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,190</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--DeferredTaxAssetsInventory_iI_pn3n3_maDTALGzpVU_zqjKw15gPpwd" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Inventory allowance</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,423</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">800</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--DeferredTaxAssetsGoodwillAndIntangibleAssets_iI_pn3n3_maDTALGzpVU_zlK6eGUAVTOi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Intangibles</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(2,516</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(3,317</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_40C_ecustom--DeferredTaxAssetsLiabilitiesGross_iTI_pn3n3_mtDTALGzpVU_zgFRZWZV8p0i" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Total deferred tax (liabilities) assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(11,994</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">9,892</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pn3n3_di_zVmS0X4FhQ1j" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Valuation allowance</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(3,424</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(4,019</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_408_ecustom--NetDeferredTaxLiabilitiesAssets_iI_pn3n3_z6Wfxzq8yLe7" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 2.5pt">Net deferred tax (liabilities) assets</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">(15,418</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">5,873</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A0_zDAtFlPuxV9g" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At December 31, 2022, the Company has approximately $<span id="xdx_90C_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsDomestic_iI_pn3n3_dm_c20211231_zIw5cIk3r3b7" title="Operating Loss Carryforwards, Federal">2.3</span> million of Federal net operating loss carryforwards and $<span id="xdx_90A_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_iI_pn3n3_dm_c20211231_zF8nkn2y5b0g" title="Operating Loss Carryforwards, State">8.7</span> million of state net operating loss carryforwards, which will begin to expire in 2027. The Federal and State NOLs are subject to limitation under Section 382 due to a December 2008 ownership change of greater than <span id="xdx_90F_ecustom--OwnershipChange_c20211231_pdd" title="Ownership change">50%</span> over a three-year testing period. The ownership change resulted in approximately $<span id="xdx_908_ecustom--UnrealizedNetOperatingLossCarryforwardDueToOwnershipChange_pn3n3_dm_c20210101__20211231_zx5nQEnYAdtd" title="Unrealized NOLs due to ownership change">4.5</span> million of NOLs that will not be realized. The $<span id="xdx_906_ecustom--RemovedFromTheAvailableNolCarryforwardAndUsNolDeferredTaxAsset_iI_pn3n3_dm_c20211231_zUQx3YqVBqn7" title="Removed from the available NOL carryforward and US NOL deferred tax asset.">4.5</span> million has been removed from the available NOL carryforward and US NOL deferred tax asset. The Company had foreign NOL carryforwards of approximately $<span id="xdx_90E_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsForeign_iI_pn3n3_dm_c20211231_zkLPlnxqfiaf" title="Operating Loss Carryforwards, Foreign">21.9</span> million, some of which will begin to expire in 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company considers the earnings of its foreign entities to be permanently reinvested outside the United States based on estimates that future cash generation will be sufficient to meet future domestic cash needs. Accordingly, deferred taxes have not been recorded for the undistributed earnings of the Company’s foreign subsidiaries. All other outside basis differences not related to earnings were impractical to account for at this period of time and are currently considered as being permanent in duration.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As required by the authoritative guidance on accounting for income taxes, the Company evaluates the realizability of deferred tax assets on a jurisdictional basis at each reporting date. Accounting for income taxes requires that a valuation allowance be established when it is more likely than not that all or a portion of the deferred taxes will not be realized. In circumstances where there is sufficient negative evidence indicating that the deferred tax assets are not more likely than not realizable, the Company establishes a valuation allowance. Through the year ended December 31, 2020, the Company maintained a full valuation allowance on its worldwide net deferred tax assets. During the fourth quarter of 2021, the Company concluded that it is more likely than not that its US deferred tax assets would be realized. This conclusion was based on the US profitability and NOL utilization in 2021 and 2020 as well as future forecasts of US profitability. For the year ended December 31, 2021, the Company released its US valuation allowance for deferred tax assets of approximately $<span id="xdx_906_eus-gaap--ValuationAllowanceDeferredTaxAssetChangeInAmount_pn3n3_dm_c20220101__20221231_znbfyYSVhgll" title="Valuation allowance">6.0</span> million. For the year ended December 31, 2022, the Company reported a release of non-U.S. valuation of $<span id="xdx_905_eus-gaap--ValuationAllowanceDeferredTaxAssetChangeInAmount_pn3n3_dm_c20210101__20211231_zCQVGmoueBCe" title="Valuation allowance">0.5</span> million. The Company continues to maintain a valuation allowance on its foreign net operating losses as it is not more likely than not that the losses in those specific jurisdictions will be realized.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A reconciliation of the beginning and ending amounts of unrecognized tax benefits is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_pn3n3_zB979ZRWgT7c" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES (Details 4)"> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8B6_zlT7O9OlkgN2" style="display: none">Schedule of reconciliation of the beginning and ending amounts of unrecognized tax benefits</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2022</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left">Gross unrecognized tax benefit, beginning of period</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--UnrecognizedTaxBenefits_iS_pn3n3_c20220101__20221231_zow0Rx2rAbb6" style="width: 9%; text-align: right" title="Gross unrecognized tax benefit, beginning of period">1,080</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--UnrecognizedTaxBenefits_iS_pn3n3_c20210101__20211231_zrTrak0pNCsb" style="width: 9%; text-align: right" title="Gross unrecognized tax benefit, beginning of period">82</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Additions based on tax positions related to the current year</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_c20220101__20221231_pn3n3" style="text-align: right" title="Additions based on tax positions related to the current year"><span style="-sec-ix-hidden: xdx2ixbrl1645">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_c20210101__20211231_pn3n3" style="text-align: right" title="Additions based on tax positions related to the current year"><span style="-sec-ix-hidden: xdx2ixbrl1647">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Additions based on tax positions related to the prior years</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_c20220101__20221231_pn3n3" style="text-align: right" title="Additions based on tax positions related to the prior years"><span style="-sec-ix-hidden: xdx2ixbrl1649">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_c20210101__20211231_pn3n3" style="text-align: right" title="Additions based on tax positions related to the prior years">998</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Reductions due to lapse in statute of limitations and settlements</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_iN_pn3n3_di_c20220101__20221231_zTFuOTxuZ1Ig" style="border-bottom: Black 1pt solid; text-align: right" title="Reductions due to lapse in statute of limitations and settlements">(378</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_iN_pn3n3_di_c20210101__20211231_zdMy9rFu5rhl" style="border-bottom: Black 1pt solid; text-align: right" title="Reductions due to lapse in statute of limitations and settlements"><span style="-sec-ix-hidden: xdx2ixbrl1655">-</span></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt">Gross unrecognized tax benefit, end of period</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_985_eus-gaap--UnrecognizedTaxBenefits_iE_pn3n3_c20220101__20221231_zsUzS6YDuiPa" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Gross unrecognized tax benefit, end of period">702</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_984_eus-gaap--UnrecognizedTaxBenefits_iE_pn3n3_c20210101__20211231_zVYSOqSFBfL1" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Gross unrecognized tax benefit, end of period">1,080</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <p id="xdx_8AA_zTFZg6cJewL3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recognizes only those tax positions that meet the more-likely-than-not recognition threshold and establishes tax reserves for uncertain tax positions that do not meet this threshold. To the extent these unrecognized tax benefits are ultimately recognized, approximately $<span id="xdx_903_eus-gaap--UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_iI_pn3n3_dm_c20221231_z2yIvhoR8Obi" title="Unrecognized tax benefits that would impact effective tax rate">0.7</span> million will impact the Company’s effective tax rate in future periods. Interest and penalties associated with income tax matters are included in the provision for income taxes. As of December 31, 2022, the Company had uncertain tax positions of approximately $<span id="xdx_90B_eus-gaap--UnrecognizedTaxBenefitsPeriodIncreaseDecrease_pn3n3_dm_c20220101__20221231_zZrLWhOcqg25" title="Uncertain tax positions">0.8</span> million, inclusive of $<span id="xdx_901_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestExpense_pn3n3_dm_c20220101__20221231_ziy6xdPXvTNh" title="Unrecognized tax benefits, Interest and penalties">0.1</span> million of interest and penalties.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company files U.S., state, and foreign income tax returns in jurisdictions with various statutes of limitations. Below is a summary of the filing jurisdictions and open tax years:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_898_ecustom--SummaryOfTheFilingJurisdictionsAndOpenTaxYearsTableTextBlock_pn3n3_zO5UBnPV83Eb" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES (Details 5)"> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8B8_zfbiAdmrCzo1" style="display: none">Summary of the filing jurisdictions and open tax years</span></td><td> </td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Open Years</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 87%; text-align: left">U.S. Federal</td><td style="width: 1%"> </td> <td style="width: 12%; text-align: center"><span id="xdx_908_eus-gaap--OpenTaxYear_c20220101__20221231__srt--RangeAxis__srt--MinimumMember__srt--StatementGeographicalAxis__us-gaap--NonUsMember_zxiDB3tJpzw7" title="Open Tax Year">2019</span>-<span id="xdx_902_eus-gaap--OpenTaxYear_c20220101__20221231__srt--RangeAxis__srt--MaximumMember__srt--StatementGeographicalAxis__us-gaap--NonUsMember" title="Open Tax Year">2021</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">U.S State and local</td><td> </td> <td style="text-align: center"><span id="xdx_907_eus-gaap--OpenTaxYear_c20220101__20221231__srt--RangeAxis__srt--MinimumMember__srt--StatementGeographicalAxis__custom--USFederalMember" title="Open Tax Year">2018</span>-<span id="xdx_901_eus-gaap--OpenTaxYear_c20220101__20221231__srt--RangeAxis__srt--MinimumMember__srt--StatementGeographicalAxis__custom--USStateAndLocalMember" title="Open Tax Year">2021</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Non-U.S.</td><td> </td> <td style="text-align: center"><span id="xdx_901_eus-gaap--OpenTaxYear_c20220101__20221231__srt--RangeAxis__srt--MaximumMember__srt--StatementGeographicalAxis__custom--USFederalMember" title="Open Tax Year">2016</span>-<span id="xdx_90F_eus-gaap--OpenTaxYear_c20220101__20221231__srt--RangeAxis__srt--MaximumMember__srt--StatementGeographicalAxis__custom--USStateAndLocalMember" title="Open Tax Year">2021</span></td></tr> </table> <p id="xdx_8A9_zKM8053GBoBb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_pn3n3_zxphPEI4Agl3" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"><span id="xdx_8BC_zWkzb71KTika" style="display: none">Schedule of domestic and foreign components</span></td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2022</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2020</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 64%; text-align: left">Domestic</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c20220101__20221231__srt--StatementGeographicalAxis__us-gaap--DomesticCountryMember_pn3n3" style="width: 9%; text-align: right" title="Income before provision for income taxes">(151,551</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c20210101__20211231__srt--StatementGeographicalAxis__us-gaap--DomesticCountryMember_pn3n3" style="width: 9%; text-align: right" title="Income before provision for income taxes">(4,176</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c20200101__20201231__srt--StatementGeographicalAxis__us-gaap--DomesticCountryMember_pn3n3" style="width: 9%; text-align: right" title="Income before provision for income taxes">8,111</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Foreign</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c20220101__20221231__srt--StatementGeographicalAxis__us-gaap--ForeignCountryMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Income before provision for income taxes">(1,113</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c20210101__20211231__srt--StatementGeographicalAxis__us-gaap--ForeignCountryMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Income before provision for income taxes">117</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c20200101__20201231__srt--StatementGeographicalAxis__us-gaap--ForeignCountryMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Income before provision for income taxes">529</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Income (loss) before provision for income taxes</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_988_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c20220101__20221231_pn3n3" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Income before provision for income taxes">(152,664</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c20210101__20211231_pn3n3" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Income before provision for income taxes">(4,059</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_984_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c20200101__20201231_pn3n3" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Income before provision for income taxes">8,640</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> -151551000 -4176000 8111000 -1113000 117000 529000 -152664000 -4059000 8640000 <table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_pn3n3_z7MRxypKqSY" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"><span id="xdx_8B8_zy78sz4WURk7" style="display: none">Schedule of provision for income taxes</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_49B_20220101__20221231_zAaC4Yl4HIcb" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_498_20210101__20211231_z4LEMqJCKTz3" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_499_20200101__20201231_z6DX6cm5sCz1" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_iB" style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: left">Current:</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2022</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2020</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr id="xdx_406_ecustom--CurrentDomesticTaxExpenseBenefit_i01_pn3n3_maCFSALzyRE_zz7wlu2Kvhw5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Domestic</span></td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">10,498</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1500">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1501">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_i01_pn3n3_maCFSALzyRE_zHIjbCMsKr8k" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">State</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,601</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,523</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1505">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--CurrentForeignTaxExpenseBenefit_i01_pn3n3_maCFSALzyRE_zkyv0lJsyU75" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign</span></td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1507">-</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(38</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">116</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--CurrentFederalStateAndLocalTaxExpenseBenefit_i01T_pn3n3_mtCFSALzyRE_zZdCHDXPW1" style="vertical-align: bottom; background-color: White"> <td style="color: White; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; padding-bottom: 2.5pt; text-align: left">Current federal, state and local, tax expense</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">13,099</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">1,485</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">116</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr id="xdx_40A_eus-gaap--DeferredFederalStateAndLocalTaxExpenseBenefitAbstract_iB" style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: left">Deferred</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2022</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2020</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr id="xdx_403_ecustom--DeferredDomesticIncomeTaxExpenseBenefit_i01_pn3n3_maDFSALzMWt_zC8ay9KDQHNb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 64%; text-align: left">Domestic</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">18,558</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(7,142</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1521">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_i01_pn3n3_maDFSALzMWt_zErdp2X1wIjc" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">State and local</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,034</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,878</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1525">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_i01_pn3n3_maDFSALzMWt_zjRwV0xGffba" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Foreign</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(1,073</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(461</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1529">-</span></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--DeferredFederalStateAndLocalTaxExpenseBenefit_i01T_pn3n3_mtDFSALzMWt_z4kKl23l9GFf" style="vertical-align: bottom; background-color: White"> <td style="color: White; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Deferred federal, state and local, tax expense</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">21,519</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(9,481</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1533">-</span></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--IncomeTaxExaminationPenaltiesExpense_i_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 2.5pt"><b>Income tax expense (benefit)</b></td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">34,618</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(7,996</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">116</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> 10498000 2601000 1523000 -38000 116000 13099000 1485000 116000 18558000 -7142000 4034000 -1878000 -1073000 -461000 21519000 -9481000 34618000 -7996000 116000 <table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_pn3n3_zeBraXmyvyUg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES (Details 2)"> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8B0_zcOjqI5594rd" style="display: none">Schedule of effective rate on income before provision (benefit) for income taxes</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_496_20220101__20221231_zKVO02z2wUfe" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_499_20210101__20211231_zqR7LfAC0ds" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_493_20200101__20201231_zCYOzk8JEVOk" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2022</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2020</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr id="xdx_408_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_zGPfZcdUutM6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 64%; text-align: left">U.S. Statutory federal rate</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">21.0</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">21.0</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">21.0</td><td style="width: 1%; text-align: left">%</td></tr> <tr id="xdx_40D_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_pid_dp_zX4rSz0xupB9" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">State taxes, net of federal benefit</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3.9</td><td style="text-align: left">)%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(12.5</td><td style="text-align: left">)%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4.4</td><td style="text-align: left">%</td></tr> <tr id="xdx_40B_ecustom--EffectiveIncomeTaxRateReconciliationTaxEffectOfPepsiValuationPremiumPercent_pid_dp_zPPvheYPkLFd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Tax effect of Pepsi valuation premium</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(38.9</td><td style="text-align: left">)%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_ecustom--PermanentDifferenceIncludingStockBasedCompensation1_pid_dp_zOAU0HBMD2dg" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Permanent differences, including stock-based compensation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1553">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1554">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6.7</td><td style="text-align: left">%</td></tr> <tr id="xdx_402_ecustom--PermanentDifferenceIncludingStockbasedCompensation_pid_dp_zC1HXH42MO22" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Stock based compensation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(0.9</td><td style="text-align: left">)%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">50.5</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1559">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_402_ecustom--ChangeInValuationAllowanceIncludingEffectOfChangeInTaxRate_pid_dp_zKo5XoWj2iJ" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Change in valuation allowance</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.4</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">219.8</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(29.8</td><td style="text-align: left">)%</td></tr> <tr id="xdx_405_eus-gaap--EffectiveIncomeTaxRateReconciliationTaxContingenciesForeign_pid_dp_z0w4yWdrCNr2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Change in deferred balances</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1565">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(80.6</td><td style="text-align: left">)%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1567">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--EffectiveIncomeTaxRateReconciliationTaxContingenciesOther_pid_dp_zaJNogX8uQLj" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Other</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(0.4</td><td style="padding-bottom: 1pt; text-align: left">)%</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(0.9</td><td style="padding-bottom: 1pt; text-align: left">)%</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1571">-</span></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_z3AOi6zDRLC2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt">Effective tax rate</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">(22.7</td><td style="padding-bottom: 2.5pt; text-align: left">)%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">197.2</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">2.3</td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr> </table> 0.210 0.210 0.210 -0.039 -0.125 0.044 -0.389 0.067 -0.009 0.505 0.004 2.198 -0.298 -0.806 -0.004 -0.009 -0.227 1.972 0.023 <table cellpadding="0" cellspacing="0" id="xdx_89F_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_pn3n3_zPrlIcKgeLn6" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES (Details 3)"> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8B9_ziPlrpjsW4T2" style="display: none">Schedule of deferred tax assets</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_499_20221231_zuvy4JilgxMd" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_492_20211231_zhsBSRxVm2qk" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">December 31,<br/> 2022</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">December 31,<br/> 2021</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr id="xdx_40A_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pn3n3_maDTALGzpVU_zCZxgiL7DGLd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left">Net operating loss carryforwards</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">4,774</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">6,685</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--DeferredTaxAssetsCharitableContributionCarryforwards_iI_pn3n3_maDTALGzpVU_zqxOsdUPCs6" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Charitable contributions</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">17</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">17</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--DeferredTaxLiabilitiesPropertyPlantAndEquipment_iNI_pn3n3_di_msDTALGzpVU_zJXKw82tYY65" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Fixed assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,158</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(627</td><td style="text-align: left">)</td></tr> <tr id="xdx_405_ecustom--DeferredTaxAssetsPepsiValuationPremium_iI_pn3n3_maDTALGzpVU_zPbTosh7iUYa" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Pepsi valuation premium</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(70,637</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_406_ecustom--DeferredTaxAssetsRightOfUseLiability_iNI_pn3n3_di_msDTALGzpVU_z4F8F07v9C3k" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Right of use liability</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">154</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">134</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_ecustom--DeferredTaxAssetsRightOfUseAsset_iI_pn3n3_maDTALGzpVU_zCFyVHkYp0x6" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Right of use asset</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(146</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(122</td><td style="text-align: left">)</td></tr> <tr id="xdx_40D_ecustom--DeferredTaxAssetsDistributorTerminationFees_iI_pn3n3_maDTALGzpVU_zXN2tFH0Zatb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Distributor termination fees</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">46,859</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1599">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_402_ecustom--UncertainTaxPosition_iI_pn3n3_maDTALGzpVU_zAHXjihjJuDe" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Uncertain tax position</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1601">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">132</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--DeferredCompensationPlanAssets_iI_pn3n3_maDTALGzpVU_zf5bCV2RpB1i" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Stock-based compensation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,236</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,190</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--DeferredTaxAssetsInventory_iI_pn3n3_maDTALGzpVU_zqjKw15gPpwd" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Inventory allowance</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,423</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">800</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--DeferredTaxAssetsGoodwillAndIntangibleAssets_iI_pn3n3_maDTALGzpVU_zlK6eGUAVTOi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Intangibles</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(2,516</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(3,317</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_40C_ecustom--DeferredTaxAssetsLiabilitiesGross_iTI_pn3n3_mtDTALGzpVU_zgFRZWZV8p0i" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Total deferred tax (liabilities) assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(11,994</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">9,892</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pn3n3_di_zVmS0X4FhQ1j" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Valuation allowance</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(3,424</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(4,019</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_408_ecustom--NetDeferredTaxLiabilitiesAssets_iI_pn3n3_z6Wfxzq8yLe7" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 2.5pt">Net deferred tax (liabilities) assets</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">(15,418</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">5,873</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 4774000 6685000 17000 17000 1158000 627000 -70637000 -154000 -134000 -146000 -122000 46859000 132000 5236000 6190000 5423000 800000 -2516000 -3317000 -11994000 9892000 3424000 4019000 -15418000 5873000 2300000 8700000 0.50 4500000 4500000 21900000 6000000.0 500000 <table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_pn3n3_zB979ZRWgT7c" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES (Details 4)"> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8B6_zlT7O9OlkgN2" style="display: none">Schedule of reconciliation of the beginning and ending amounts of unrecognized tax benefits</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2022</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left">Gross unrecognized tax benefit, beginning of period</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--UnrecognizedTaxBenefits_iS_pn3n3_c20220101__20221231_zow0Rx2rAbb6" style="width: 9%; text-align: right" title="Gross unrecognized tax benefit, beginning of period">1,080</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--UnrecognizedTaxBenefits_iS_pn3n3_c20210101__20211231_zrTrak0pNCsb" style="width: 9%; text-align: right" title="Gross unrecognized tax benefit, beginning of period">82</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Additions based on tax positions related to the current year</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_c20220101__20221231_pn3n3" style="text-align: right" title="Additions based on tax positions related to the current year"><span style="-sec-ix-hidden: xdx2ixbrl1645">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_c20210101__20211231_pn3n3" style="text-align: right" title="Additions based on tax positions related to the current year"><span style="-sec-ix-hidden: xdx2ixbrl1647">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Additions based on tax positions related to the prior years</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_c20220101__20221231_pn3n3" style="text-align: right" title="Additions based on tax positions related to the prior years"><span style="-sec-ix-hidden: xdx2ixbrl1649">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_c20210101__20211231_pn3n3" style="text-align: right" title="Additions based on tax positions related to the prior years">998</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Reductions due to lapse in statute of limitations and settlements</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_iN_pn3n3_di_c20220101__20221231_zTFuOTxuZ1Ig" style="border-bottom: Black 1pt solid; text-align: right" title="Reductions due to lapse in statute of limitations and settlements">(378</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_iN_pn3n3_di_c20210101__20211231_zdMy9rFu5rhl" style="border-bottom: Black 1pt solid; text-align: right" title="Reductions due to lapse in statute of limitations and settlements"><span style="-sec-ix-hidden: xdx2ixbrl1655">-</span></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt">Gross unrecognized tax benefit, end of period</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_985_eus-gaap--UnrecognizedTaxBenefits_iE_pn3n3_c20220101__20221231_zsUzS6YDuiPa" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Gross unrecognized tax benefit, end of period">702</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_984_eus-gaap--UnrecognizedTaxBenefits_iE_pn3n3_c20210101__20211231_zVYSOqSFBfL1" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Gross unrecognized tax benefit, end of period">1,080</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> 1080000 82000 998000 378000 702000 1080000 700000 800000 100000 <table cellpadding="0" cellspacing="0" id="xdx_898_ecustom--SummaryOfTheFilingJurisdictionsAndOpenTaxYearsTableTextBlock_pn3n3_zO5UBnPV83Eb" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES (Details 5)"> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8B8_zfbiAdmrCzo1" style="display: none">Summary of the filing jurisdictions and open tax years</span></td><td> </td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Open Years</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 87%; text-align: left">U.S. Federal</td><td style="width: 1%"> </td> <td style="width: 12%; text-align: center"><span id="xdx_908_eus-gaap--OpenTaxYear_c20220101__20221231__srt--RangeAxis__srt--MinimumMember__srt--StatementGeographicalAxis__us-gaap--NonUsMember_zxiDB3tJpzw7" title="Open Tax Year">2019</span>-<span id="xdx_902_eus-gaap--OpenTaxYear_c20220101__20221231__srt--RangeAxis__srt--MaximumMember__srt--StatementGeographicalAxis__us-gaap--NonUsMember" title="Open Tax Year">2021</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">U.S State and local</td><td> </td> <td style="text-align: center"><span id="xdx_907_eus-gaap--OpenTaxYear_c20220101__20221231__srt--RangeAxis__srt--MinimumMember__srt--StatementGeographicalAxis__custom--USFederalMember" title="Open Tax Year">2018</span>-<span id="xdx_901_eus-gaap--OpenTaxYear_c20220101__20221231__srt--RangeAxis__srt--MinimumMember__srt--StatementGeographicalAxis__custom--USStateAndLocalMember" title="Open Tax Year">2021</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Non-U.S.</td><td> </td> <td style="text-align: center"><span id="xdx_901_eus-gaap--OpenTaxYear_c20220101__20221231__srt--RangeAxis__srt--MaximumMember__srt--StatementGeographicalAxis__custom--USFederalMember" title="Open Tax Year">2016</span>-<span id="xdx_90F_eus-gaap--OpenTaxYear_c20220101__20221231__srt--RangeAxis__srt--MaximumMember__srt--StatementGeographicalAxis__custom--USStateAndLocalMember" title="Open Tax Year">2021</span></td></tr> </table> 2019 2021 2018 2021 2016 2021 <p id="xdx_807_eus-gaap--DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_zsCKykW2pq6b" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify; border-collapse: collapse"> <td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>18.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_82C_z43MpcppXoch">STOCK-BASED COMPENSATION</span></b></span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company adopted the 2006 Incentive Stock Plan on January 18, 2007. This plan was intended to provide incentives to attract and retain highly competent persons at all levels as employees of the Company, as well as independent contractors providing consulting or advisory services to the Company, by providing them opportunities to acquire the Company’s common stock. While the plan terminated <span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_dtY_c20070101__20070118__us-gaap--PlanNameAxis__custom--StockIncentivePlanMember_zM2rH44avQza">10</span> years after the adoption date, issued awards have their own schedule of terminations. As such, the Company is no longer granting awards under this plan and there are no unvested awards as of December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company adopted the 2015 Plan on April 30, 2015. The 2015 Plan is intended to provide incentives which will attract and retain highly competent persons at all levels as employees of the Company, as well as independent contractors providing consulting or advisory services to the Company, by providing them opportunities to acquire the Company’s common stock or to receive monetary payments based on the value of such shares pursuant to awards issued. The 2015 Plan permits the grant of options and shares for up to <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_pin3_dm_c20150430_ztN1y76GyTbh" title="Number of shares authorized">5</span> million shares. <span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription_c20150401__20150430__us-gaap--PlanNameAxis__custom--StockIncentivePlan2015Member" title="Stock incentive plan, description">In addition, there is a provision in the 2015 Plan for an annual increase to the maximum number of shares authorized under the 2015 Plan, which increase shall be added on the first day of the calendar year beginning January 1, 2016, equal to 15% of the number of shares outstanding as of such date (Note 15). Provisions have been made to permit the grant of options and other share-based awards for up to <span id="xdx_90C_ecustom--ProvisionsOfOptionsGrantAndOtherShareBasedAwardsPermitted_pin3_dm_c20150401__20150430__us-gaap--PlanNameAxis__custom--StockIncentivePlan2015Member_zX1b8jerM5Ta" title="Provisions of options grant and other share based awards permitted">5.0</span> million shares.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the years ended December 31, 2022, 2021, and 2020, the Company recognized non-cash compensation expense of approximately $<span id="xdx_90F_eus-gaap--AllocatedShareBasedCompensationExpense_pn3n3_dm_c20220101__20221231__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_z8zSqyJJsFNl" title="Non-cash compensation expense (in Dollars)">20.7</span> million, $<span id="xdx_90D_eus-gaap--AllocatedShareBasedCompensationExpense_pn3n3_dm_c20210101__20211231__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zmI04dXp5BHl" title="Non-cash compensation expense (in Dollars)">36.5</span> million, and $<span id="xdx_901_eus-gaap--AllocatedShareBasedCompensationExpense_pn3n3_dm_c20200101__20201231__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zALLcC0xnhF4" title="Non-cash compensation expense (in Dollars)">6.3</span> million respectively, (included in General and administrative expense in the accompanying Consolidated Statements of Operations).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Stock Options</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription_c20220101__20221231__srt--RangeAxis__srt--MaximumMember" title="Stock incentive plan, description">The Company used straight-line amortization of compensation expense over the two to three-year requisite service or vesting period of the grant. The maximum contractual term of the Company’s stock options is <span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_dtY_c20220101__20221231_zhhwPjQBkhFb">10</span> years. The Company recognizes forfeitures as they occur. There are options to purchase approximately <span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_pin3_dm_c20220101__20221231_zsJrjW1HMLI9" title="Options to purchase vested"><span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_pin3_dm_c20210101__20211231_zHrrU8PZo1g2" title="Options to purchase vested">1.9</span></span> million shares that have vested as of December 31, 2022 and 2021.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under the 2015 Plan, the Company has issued stock options to purchase approximately <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_pn3n3_dm_c20220101__20221231__us-gaap--PlanNameAxis__custom--StockIncentivePlan2015Member_ze0RFTIDNrb9" title="Stock Issued During Period, Value, Stock Options Exercised">2.3</span> million shares at an average price of $<span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220101__20221231__us-gaap--PlanNameAxis__custom--StockIncentivePlan2015Member_pdd" title="Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price">9.66</span> with a fair value of $<span id="xdx_904_ecustom--FairValueOfSharesIssued_pn3n3_dm_c20220101__20221231__us-gaap--PlanNameAxis__custom--StockIncentivePlan2015Member_zeVUk4PXvGv5" title="Fair value of shares issued (in Dollars)">213.9</span> million. No options were issued during the years ended December 31, 2022 and 2021. Upon exercise, shares of new common stock are issued by the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company determines the fair value of restricted stock-based awards based on the market price on the date of grant. The Company uses the Black-Scholes option-pricing model to estimate the fair value of its stock option awards and warrant issuances and recognizes forfeitures as they occur. This model uses an exercise price, dividend yields, risk-free interest rate, and expected annual volatility, as inputs.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The calculation of the fair value of the awards using the Black-Scholes option-pricing model is affected by the Company’s stock price on the date of grant as well as assumptions regarding the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_pn3n3_z1317QkLavV6" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - STOCK-BASED COMPENSATION (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8B7_zWAnLPh7V72k" style="display: none">Schedule of black scholes option-pricing model valuation assumption</span></td><td style="font-style: italic"> </td> <td style="font-style: italic; text-align: center"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="7" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Years ended<br/> December 31,</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022<sup>(1)</sup></b></span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2021</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2020</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Expected volatility</td><td style="font-style: italic"> </td> <td style="font-style: italic; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>NA</i></span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_c20210101__20211231__srt--RangeAxis__srt--MinimumMember_zLSMmed9BuG5" title="Expected volatility">69.2</span> - <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_c20210101__20211231__srt--RangeAxis__srt--MaximumMember_pdd" title="Expected volatility">81.1%</span></span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_c20200101__20201231__srt--RangeAxis__srt--MinimumMember_zXJvT9p6ojPd" title="Expected volatility">69.2</span> - <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_c20200101__20201231__srt--RangeAxis__srt--MaximumMember_pdd" title="Expected volatility">81.1%</span></span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Expected term</td><td style="font-style: italic"> </td> <td style="font-style: italic; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>NA</i></span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20210101__20211231__srt--RangeAxis__srt--MinimumMember_zohb2Ms39dNg" title="Expected term">4.5</span> - <span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20210101__20211231__srt--RangeAxis__srt--MaximumMember_zHJJg33Ke057" title="Expected term">5.0</span> Years</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20200101__20201231__srt--RangeAxis__srt--MinimumMember_zQQeX0BtvGea" title="Expected term">4.8</span> - <span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20200101__20201231__srt--RangeAxis__srt--MaximumMember_zDmzT5dDpyrf" title="Expected term">5.0</span> Years</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Risk-free interest rate</td><td style="font-style: italic"> </td> <td style="font-style: italic; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>NA</i></span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_c20210101__20211231__srt--RangeAxis__srt--MinimumMember_pdd" title="Risk-free interest rate">0.3%</span> - <span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_c20210101__20211231__srt--RangeAxis__srt--MaximumMember_pdd" title="Risk-free interest rate">1.4%</span></span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_c20200101__20201231__srt--RangeAxis__srt--MinimumMember_pdd" title="Risk-free interest rate">0.2%</span> - <span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_c20200101__20201231__srt--RangeAxis__srt--MaximumMember_pdd" title="Risk-free interest rate">1.4%</span></span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 58%; text-align: left">Forfeiture Rate</td><td style="width: 1%; font-style: italic"> </td> <td style="width: 12%; font-style: italic; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>NA</i></span></td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: center"><span id="xdx_907_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate_c20210101__20211231_pdd" title="Forfeiture Rate">0.0%</span></td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: center"><span id="xdx_909_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate_c20200101__20201231_pdd" title="Forfeiture Rate">0.0%</span></td><td style="width: 1%; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"> </p> <div style="width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt"> </div></div> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify; border-collapse: collapse"> <td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span id="xdx_F0B_zPpbnNHP4kO9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="text-align: justify"><span id="xdx_F1B_zjbe9kfK9f2g" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No stock options were issued during 2022.</span></td> </tr></table> <p id="xdx_8A7_zKkw4oq6ZoO2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The expected volatility was determined with reference to the historical volatility of the Company’s stock. The Company uses historical data to estimate option exercise and employee termination within the valuation model. The expected term of options granted represents the period of time that options granted are expected to be outstanding. The risk-free interest rate for periods within the contractual life of the option is based on the U.S. Treasury rate in effect at the time of grant.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A summary of the status of the Company’s outstanding stock options as of December 31, 2022 and 2021 and changes during the periods ended on that date is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--ScheduleOfStockOptionsRollForwardTableTextBlock_pn3n3_zH4G1C5Q18ul" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - STOCK-BASED COMPENSATION (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8B4_zns7joKfqNRc" style="display: none">Schedule of outstanding stock options</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td> <td> </td><td style="text-align: left"> </td><td> </td> <td style="vertical-align: bottom; text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; text-indent: -0.125in; padding-left: 0.125in; text-align: center"> </td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="vertical-align: bottom; text-align: center"> </td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Weighted Average</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Aggregate</td> <td style="text-align: center; vertical-align: bottom"> </td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td><td colspan="2" style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom">Weighted</td> <td style="text-align: center; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; text-indent: -0.125in; padding-left: 0.125in; text-align: center"> </td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Shares</td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Exercise</td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Grant Date</td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Intrinsic<br/> Value</td> <td style="text-align: center; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td><td colspan="2" style="text-align: center; font-weight: bold; vertical-align: bottom">Average<br/> Remaining</td> <td style="text-align: center; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; vertical-align: bottom; text-indent: -0.125in; padding-left: 0.125in; text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">(000’s)</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Price</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Fair Value</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">(000’s)</td> <td style="padding-bottom: 1pt; text-align: center; vertical-align: bottom"> </td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td><td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold; vertical-align: bottom">Term (Yrs)</td> <td style="padding-bottom: 1pt; text-align: center; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Options</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td> <td> </td><td style="text-align: left"> </td> <td> </td> <td style="text-align: right; vertical-align: bottom"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 40%; text-align: left">At December 31, 2020</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20210101__20211231_zVTZGfUY2kgk" style="width: 9%; text-align: right" title="Options outstanding Balance at beginning">5,198</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20210101__20211231_zGfmkpI5ceT2" style="width: 9%; text-align: right" title="Weighted Average Exercise Price, Balance at beginning">4.23</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right"> </td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pn3n3_c20210101__20211231_zoL8LP520hTd" style="width: 9%; text-align: right" title="Aggregate Intrinsic Value Balance at beginning">240,866</td> <td style="width: 1%"> </td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td id="xdx_985_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerms2_dtY_c20200101__20201231_zEOKGi83j4Na" style="vertical-align: bottom; text-align: right; width: 9%" title="Weighted Average Remaining Term Beginning Balance">6.89</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20210101__20211231_zIusH4Z8uybc" style="text-align: right" title="Options outstanding, Granted">305</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20210101__20211231_zmbbrrdThOka" style="text-align: right" title="Weighted Average Exercise Price, options granted">42.37</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_ecustom--WeightedAveragesGrantDateFairValueGranted_pid_c20210101__20211231_znY1nyWGDs3l" style="text-align: right" title="Weighted Average Grant Date Fair Value Granted">30.32</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td> <td> </td><td style="text-align: left"> </td> <td> </td> <td style="text-align: right; vertical-align: bottom"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_c20210101__20211231_zNkNpQTAIU9f" style="text-align: right" title="Options outstanding, Exercised">(1,460</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20210101__20211231_zRcejghmXwO8" style="text-align: right" title="Weighted Average Exercise Price, Exercised">3.85</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_ecustom--WeightedAveragesGrantDateFairValueExercised_pid_c20210101__20211231_z9xJSvoq9ewh" style="text-align: right" title="Weighted Average Grant Date Fair Value Exercised">80.58</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_c20210101__20211231_pn3n3" style="text-align: right" title="Aggregate Intrinsic Value Exercised">84,371</td> <td> </td><td style="text-align: left"> </td> <td> </td> <td style="text-align: right; vertical-align: bottom"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Forfeiture and cancelled</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20210101__20211231_zfQ42jjRkrG1" style="border-bottom: Black 1pt solid; text-align: right" title="Options outstanding, Forfeiture and cancelled">(443</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_pid_c20210101__20211231_zydKwU1z73t5" style="padding-bottom: 1pt; text-align: right" title="Weighted Average Exercise Price, Forfeiture and cancelled">5.01</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt; text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td> <td> </td><td style="padding-bottom: 1pt; text-align: left"> </td> <td> </td> <td style="text-align: right; vertical-align: bottom"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt">At December 31, 2021</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20220101__20221231_zxy3bYF2jZz2" style="border-bottom: Black 2.5pt double; text-align: right" title="Options outstanding, Balance at Beginning">3,600</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20220101__20221231_zYQCpObNLQEc" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Balance at beginning">7.47</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pn3n3_c20220101__20221231_z3uMvEvJRT28" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregate Intrinsic Value Balance at beginning">241,515</td> <td> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td id="xdx_98A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerms2_dtY_c20210101__20211231_zZ4LHGNgtKja" style="vertical-align: bottom; text-align: right" title="Weighted Average Remaining Term Beginning Balance">6.37</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20220101__20221231_znVmbskEFj4h" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1776">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20220101__20221231_zMTBPWNROYZ2" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1777">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td> <td> </td><td style="text-align: left"> </td> <td> </td> <td style="text-align: right; vertical-align: bottom"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_c20220101__20221231_zJbQWRGXeIx2" style="text-align: right" title="Options outstanding, Exercised">(1,273</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20220101__20221231_zRiZ5Kid3MOi" style="text-align: right" title="Weighted Average Exercise Price, Exercised">3.67</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_981_ecustom--WeightedAveragesGrantDateFairValueExercised_pid_c20220101__20221231_zeGMGyAZr6d" style="text-align: right" title="Weighted Average Grant Date Fair Value Exercised">80.70</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_c20220101__20221231_pn3n3" style="text-align: right" title="Aggregate Intrinsic Value Exercised">102,283</td> <td> </td><td style="text-align: left"> </td> <td> </td> <td style="text-align: right; vertical-align: bottom"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Forfeiture and cancelled</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20220101__20221231_zCImxrceydK2" style="border-bottom: Black 1pt solid; text-align: right" title="Options outstanding, Forfeiture and cancelled">(61</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_pid_c20220101__20221231_zVjgbXlpZBxj" style="padding-bottom: 1pt; text-align: right" title="Weighted Average Exercise Price, Forfeiture and cancelled">5.46</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt; text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td> <td> </td><td style="padding-bottom: 1pt; text-align: left"> </td> <td> </td> <td style="text-align: right; vertical-align: bottom"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt">At December 31, 2022</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20220101__20221231_z5UqzBWRJtL7" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Options outstanding, Balance at end">2,266</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20220101__20221231_zcPFNAjBYIO4" style="padding-bottom: 2.5pt; font-weight: bold; text-align: right" title="Weighted Average Exercise Price, Balance at end">9.66</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pn3n3_c20220101__20221231_zxY7GAKRjUw1" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Aggregate Intrinsic Value Balance at end">213,914</td> <td> </td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td id="xdx_982_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerms2_dtY_c20220101__20221231_zj9ja94uz3R1" style="vertical-align: bottom; font-weight: bold; text-align: right" title="Weighted Average Remaining Term Ending Balance">5.43</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Exercisable at December 31, 2022</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_pid_c20221231_zEwrpDnQDK39" style="font-weight: bold; text-align: right" title="Options outstanding, Exercisable at end">1,928</td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_pid_c20221231_z5aWcPvcoH9" style="font-weight: bold; text-align: right" title="Weighted Average Exercise Price, Options Exercisable">6.41</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_c20221231_pn3n3" style="font-weight: bold; text-align: right" title="Aggregate Intrinsic Value Exercisable">188,261</td> <td> </td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20220101__20221231_zwU5NRvsh1nc" style="vertical-align: bottom; font-weight: bold; text-align: right" title="Weighted Average Remaining Term, exercisable">5.05</td> <td> </td></tr> </table> <p id="xdx_8AA_zXuSDZPdK1Aj" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes information about employee stock options outstanding at December 31, 2022:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_pn3n3_ztpL2SOupVYg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - STOCK-BASED COMPENSATION (Details 2)"> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8B4_zoiSsCejpWGg" style="display: none">Schedule of employee stock options outstanding</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><b> </b></td><td style="font-weight: bold; padding-bottom: 1pt"><b> </b></td> <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><b>Outstanding Options</b></td><td style="padding-bottom: 1pt; font-weight: bold"><b> </b></td><td style="font-weight: bold; padding-bottom: 1pt"><b> </b></td> <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><b>Vested Options</b></td><td style="padding-bottom: 1pt; font-weight: bold"><b> </b></td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: left"><b>Range of Exercise Price</b></td> <td style="padding-bottom: 1pt; font-weight: bold"><b> </b></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><b>Number<br/> Outstanding at<br/> December 31,<br/> 2022<br/> (000’s)</b></td> <td style="padding-bottom: 1pt; font-weight: bold"><b> </b></td> <td style="padding-bottom: 1pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>Weighted<br/> Average<br/> Remaining<br/> Life</b></td> <td style="padding-bottom: 1pt"><b> </b></td> <td style="padding-bottom: 1pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>Weighted<br/> Average<br/> Exercise<br/> Price</b></td> <td style="padding-bottom: 1pt"><b> </b></td> <td style="padding-bottom: 1pt; font-weight: bold"><b> </b></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><b>Number<br/> Exercisable at<br/> December 31,<br/> 2022<br/> (000’s)</b></td> <td style="padding-bottom: 1pt; font-weight: bold"><b> </b></td> <td style="padding-bottom: 1pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>Weighted<br/> Average<br/> Exercise<br/> Price</b></td> <td style="padding-bottom: 1pt"><b> </b></td> <td style="padding-bottom: 1pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>Weighted<br/> Average<br/> Remaining<br/> Life</b></td> <td style="padding-bottom: 1pt"><b> </b></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 28%; text-align: left">$0.34 - $1.05</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pin3_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--RangeOfExercisePrice1Member_zybm051OhuEf" title="Number outstanding options">30</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right"><span id="xdx_909_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--RangeOfExercisePrice1Member_z9Bhxl7ImI08" title="Weighted average remaining life, outstanding options">1.44</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--RangeOfExercisePrice1Member_pdd" style="width: 9%; text-align: right" title="Weighted average exercise price, outstanding options">0.58</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right"><span id="xdx_900_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pin3_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--RangeOfExercisePrice1Member_z1tGRBTbh7me" title="Number vested options, exercisable">30</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span id="xdx_903_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--RangeOfExercisePrice1Member_pdd" title="Weighted average exercise price, vested options">0.58</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right"><span id="xdx_908_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--RangeOfExercisePrice1Member_zYiq7m1anIkb" title="Weighted average remaining life, vested options">1.44</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">$1.97 - $2.95</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_900_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pin3_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--RangeOfExercisePrice2Member_zXAmbH3wvBX6" title="Number outstanding options">5</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--RangeOfExercisePrice2Member_zLdJyXTbU9x3" title="Weighted average remaining life, outstanding options">3.01</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--RangeOfExercisePrice2Member_pdd" title="Weighted average exercise price, outstanding options">1.97</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pin3_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--RangeOfExercisePrice2Member_zubLc6OCjARg" title="Number vested options, exercisable">5</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--RangeOfExercisePrice2Member_pdd" title="Weighted average exercise price, vested options">1.97</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--RangeOfExercisePrice2Member_zXSspTQUn2g3" title="Weighted average remaining life, vested options">3.01</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">$3.23 - $4.85</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pin3_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--RangeOfExercisePrice3Member_zOBrucnkFJOi" title="Number outstanding options">1,465</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--RangeOfExercisePrice3Member_z4u1aza9xS37" title="Weighted average remaining life, outstanding options">5.38</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_909_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--RangeOfExercisePrice3Member_pdd" title="Weighted average exercise price, outstanding options">3.81</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pin3_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--RangeOfExercisePrice3Member_z3fMLmUktoK9" title="Number vested options, exercisable">1,412</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--RangeOfExercisePrice3Member_pdd" title="Weighted average exercise price, vested options">3.80</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--RangeOfExercisePrice3Member_zuYXT90M9PM4" title="Weighted average remaining life, vested options">5.34</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">$5.59 - $8.38</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pin3_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--RangeOfExercisePrice4Member_zTcOXrNbPt14" title="Number outstanding options">389</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_903_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--RangeOfExercisePrice4Member_ziYFI1y2GGyg" title="Weighted average remaining life, outstanding options">3.51</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--RangeOfExercisePrice4Member_pdd" title="Weighted average exercise price, outstanding options">5.70</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pin3_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--RangeOfExercisePrice4Member_zrRkzhvnzUi3" title="Number vested options, exercisable">331</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90C_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--RangeOfExercisePrice4Member_pdd" title="Weighted average exercise price, vested options">5.72</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_900_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--RangeOfExercisePrice4Member_zorfIJvl5fA8" title="Weighted average remaining life, vested options">2.88</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">$14.53 - $21.79</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_904_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pin3_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--RangeOfExercisePrice5Member_zK6zSIFhoxIh" title="Number outstanding options">61</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--RangeOfExercisePrice5Member_zpC6VRg7lK4c" title="Weighted average remaining life, outstanding options">7.58</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90B_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--RangeOfExercisePrice5Member_pdd" title="Weighted average exercise price, outstanding options">14.53</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pin3_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--RangeOfExercisePrice5Member_zWyDIQIM0g35" title="Number vested options, exercisable">40</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--RangeOfExercisePrice5Member_pdd" title="Weighted average exercise price, vested options">14.53</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_909_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--RangeOfExercisePrice5Member_zHXRGMBDLX32" title="Weighted average remaining life, vested options">7.58</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">$21.80 - $32.70</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_903_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pin3_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--RangeOfExercisePrice6Member_zPaCw3l5WlXc" title="Number outstanding options">16</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--RangeOfExercisePrice6Member_zTtmHCOxDcqb" title="Weighted average remaining life, outstanding options">7.83</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--RangeOfExercisePrice6Member_pdd" title="Weighted average exercise price, outstanding options">21.80</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pin3_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--RangeOfExercisePrice6Member_zl4fXbiSERah" title="Number vested options, exercisable">10</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90E_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--RangeOfExercisePrice6Member_pdd" title="Weighted average exercise price, vested options">21.80</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--RangeOfExercisePrice6Member_zVne6ytpcgvj" title="Weighted average remaining life, vested options">7.83</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">$42.64 - $63.96</td><td> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_903_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pin3_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--RangeOfExercisePrice7Member_zd5ToaA0xmch" title="Number outstanding options">300</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--RangeOfExercisePrice7Member_zbmv02y19lt" title="Weighted average remaining life, outstanding options">8.01</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--RangeOfExercisePrice7Member_pdd" title="Weighted average exercise price, outstanding options">42.67</span></td><td style="text-align: left"> </td><td> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90A_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pin3_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--RangeOfExercisePrice7Member_zbhgMtVf3oC7" title="Number vested options, exercisable">100</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_909_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--RangeOfExercisePrice7Member_pdd" title="Weighted average exercise price, vested options">42.67</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--RangeOfExercisePrice7Member_zzt2dqE8nME4" title="Weighted average remaining life, vested options">8.01</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Outstanding options</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span id="xdx_900_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pin3_c20221231_z9tyWtT7ejki" title="Number outstanding options">2,266</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: right"><span id="xdx_90C_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231_zIpQ7AksqNR2" title="Weighted average remaining life, outstanding options">5.43</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">$</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: right"><span id="xdx_90A_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20221231_pdd" title="Weighted average exercise price, outstanding options">9.66</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span id="xdx_901_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pin3_c20221231_zI08uuY5Lxli" title="Number vested options, exercisable">1,928</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">$</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: right"><span id="xdx_90A_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_c20221231_pdd" title="Weighted average exercise price, vested options">6.41</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: right"><span id="xdx_906_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231_zxYe4n6IHBkk" title="Weighted average remaining life, vested options">5.05</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <p id="xdx_8AE_zIA112YtD4e5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2022, the Company had approximately $<span id="xdx_908_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_iI_pn3n3_dm_c20221231_z2J8q0nWAuK1" title="Unrecognized pre-tax non-cash compensation expense (in Dollars)">3.4</span> million of unrecognized pre-tax non-cash compensation expense related to options to purchase shares, which the Company expects to recognize, based on a weighted-average period of <span id="xdx_903_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dtY_c20220101__20221231_zwgW5NqwZPR7" title="Period unrecognized pre-tax non-cash compensation expense">1.0</span> year.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Restricted Stock Awards</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Restricted stock awards are awards of common stock that are subject to restrictions on transfer and to a risk of forfeiture if the holder leaves the Company before the restrictions lapse. The holders of a restricted stock award are generally entitled after the release to transact and obtain the same rights as rights of a stockholder of the Company, including the right to vote the shares. The holders of unvested restricted stock awards do not have the same rights as stockholders including but not limited to any dividends which may be declared by the Company, and do not have the right to vote. The value of restricted stock awards that vest over time is established by the market price on the date of its grant and generally vests over a period of <span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_dtY_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_zsIjlh7l580i" title="Share-based compensation service or vesting period of grant">3</span> years. A summary of the Company’s restricted stock activity for the years ended December 31, 2022 and 2021 is presented in the following table:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_pn3n3_zm0cXxLuycqb" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - STOCK-BASED COMPENSATION (Details 3)"> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span id="xdx_8B6_zjXX7ogj4edd" style="display: none">Schedule of restricted stock activity</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="14" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">For the twelve months ended</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">December 31,<br/> 2022</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">December 31,<br/> 2021</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1pt; text-align: left"><b> </b></td> <td style="padding-bottom: 1pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>Shares</b></td> <td style="padding-bottom: 1pt"><b> </b></td> <td style="padding-bottom: 1pt; font-weight: bold"><b> </b></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><b>Weighted<br/> Average<br/> Grant Date<br/> Fair Value</b></td> <td style="padding-bottom: 1pt; font-weight: bold"><b> </b></td> <td style="padding-bottom: 1pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>Shares</b></td> <td style="padding-bottom: 1pt"><b> </b></td> <td style="padding-bottom: 1pt; font-weight: bold"><b> </b></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><b>Weighted<br/> Average<br/> Grant Date<br/> Fair Value</b></td> <td style="padding-bottom: 1pt; font-weight: bold"><b> </b></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 52%; text-align: left">Unvested at beginning of period</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_pin3_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_ztjtlqvE5Kr4" style="width: 9%; text-align: right" title="Unvested at beginning of period">0.3</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsUnvestedWeightedAverageGrantDateFairValue_iS_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zQloctFvJjab" style="width: 9%; text-align: right" title="Unvested at beginning of period (in Dollars per share)">14.72</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_pin3_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zbR87eL5kFre" style="width: 9%; text-align: right" title="Unvested at beginning of period">66.2</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsUnvestedWeightedAverageGrantDateFairValue_iS_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zQvcD096dkQ7" style="width: 9%; text-align: right" title="Unvested at beginning of period (in Dollars per share)">28.11</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Transfers to restricted stock units</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--TransfersToRestrictedStockUnits_pin3_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zSE3XpO9RTX7" style="text-align: right" title="Transfers to restricted stock units"><span style="-sec-ix-hidden: xdx2ixbrl1922">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_ecustom--RestrictedStockTransfersToRestrictedStockUnitsinDollarsPerShare_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_z9wTVTqQQ9Xf" style="text-align: right" title="Restricted stock Transfers to restricted stock units(in Dollars per share)"><span style="-sec-ix-hidden: xdx2ixbrl1924">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_ecustom--TransfersToRestrictedStockUnits_pin3_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zY65R7Bym24l" style="text-align: right" title="Transfers to restricted stock units">(45.9</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_ecustom--RestrictedStockTransfersToRestrictedStockUnitsinDollarsPerShare_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zCA1yYwqxgFd" style="text-align: right" title="Restricted stock Transfers to restricted stock units(in Dollars per share)">34.02</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pin3_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zAsTApUUHqp9" style="text-align: right" title="Granted"><span style="-sec-ix-hidden: xdx2ixbrl1930">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zP30cUk3AZBd" style="text-align: right" title="Restricted stock granted (in Dollars per share)"><span style="-sec-ix-hidden: xdx2ixbrl1932">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pin3_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zK6xWEOudkn3" style="text-align: right" title="Granted"><span style="-sec-ix-hidden: xdx2ixbrl1934">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zkZoVG67nqg5" style="text-align: right" title="Restricted stock granted (in Dollars per share)"><span style="-sec-ix-hidden: xdx2ixbrl1936">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Vested</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_pin3_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zaPuKyhKeCol" style="text-align: right" title="Vested"><span style="-sec-ix-hidden: xdx2ixbrl1938">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentVestedWeightedAverageGrantDateFairValue_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zpnnLbA1oTfd" style="text-align: right" title="Restricted stock vested (in Dollars per share)"><span style="-sec-ix-hidden: xdx2ixbrl1940">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_pin3_di_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zl5YNCKL24Yl" style="text-align: right" title="Vested">(18.9</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentVestedWeightedAverageGrantDateFairValue_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_z8ogF07dYs3h" style="text-align: right" title="Restricted stock vested (in Dollars per share)">14.79</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt">Forfeited and cancelled</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_iN_pin3_di_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zLtOncG3uCbc" style="border-bottom: Black 1pt solid; text-align: right" title="Forfeited and cancelled">(0.3</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td id="xdx_986_ecustom--RestrictedStockForfeitureAndCancelledInDollarsPerShare_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zoVaq6kgxzec" style="padding-bottom: 1pt; text-align: right" title="Restricted stock Forfeiture and cancelled (in Dollars per share)">14.72</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_iN_pin3_di_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_z8q3srSDgQxl" style="border-bottom: Black 1pt solid; text-align: right" title="Forfeited and cancelled">(1.1</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td id="xdx_98F_ecustom--RestrictedStockForfeitureAndCancelledInDollarsPerShare_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zVUlxfwt4ebf" style="padding-bottom: 1pt; text-align: right" title="Restricted stock Forfeiture and cancelled (in Dollars per share)">14.72</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.375in; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Unvested at end of period</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_pin3_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zgtB2U2bw0a1" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Unvested at end of period"><span style="-sec-ix-hidden: xdx2ixbrl1954">-</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">$</td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsUnvestedWeightedAverageGrantDateFairValue_iE_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_z7FkOZE3prul" style="padding-bottom: 2.5pt; font-weight: bold; text-align: right" title="Unvested at end of period (in Dollars per share)"><span style="-sec-ix-hidden: xdx2ixbrl1956">-</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_pin3_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zhfks1v83Tmb" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Unvested at end of period">0.3</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">$</td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsUnvestedWeightedAverageGrantDateFairValue_iE_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zFi0OufPOn89" style="padding-bottom: 2.5pt; font-weight: bold; text-align: right" title="Unvested at end of period (in Dollars per share)">14.72</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <p id="xdx_8A6_zuth3h99mgD9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There were no shares granted, vested or outstanding during and as of the year ended December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Restricted Stock Units</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Restricted stock units are awards that give the holder the right to receive one share of common stock for each restricted stock unit upon meeting service-based vesting conditions (typically annual vesting in three equal annual installments, with a requirement that the holder remains in the continuous employment of the Company). The holders of unvested units do not have the same rights as stockholders including but not limited to any dividends which may be declared by the Company, and do not have the right to vote. The value of restricted stock units that vest over time is established by the market price on the date of its grant. A summary of the Company’s restricted stock unit activity for the years ended December 31, 2022 and 2021 is presented in the following table:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--ScheduleOfNonvestedShareActivityTableTextBlock_pn3n3_z4nBdmSudp1j" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - STOCK-BASED COMPENSATION (Details 4)"> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span id="xdx_8B1_zB9ldLwbnX82" style="display: none">Schedule of restricted stock unit activity</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><b> </b></td><td style="font-weight: bold; padding-bottom: 1pt"><b> </b></td> <td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><b>For the twelve months ended</b></td><td style="padding-bottom: 1pt; font-weight: bold"><b> </b></td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><b> </b></td><td style="font-weight: bold; padding-bottom: 1pt"><b> </b></td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><b>December 31,<br/> 2022</b></td><td style="padding-bottom: 1pt; font-weight: bold"><b> </b></td><td style="font-weight: bold; padding-bottom: 1pt"><b> </b></td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><b>December 31,<br/> 2021</b></td><td style="padding-bottom: 1pt; font-weight: bold"><b> </b></td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1pt; text-align: left"><b> </b></td> <td style="padding-bottom: 1pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>Shares<br/> (000’s)</b></td> <td style="padding-bottom: 1pt"><b> </b></td> <td style="padding-bottom: 1pt; font-weight: bold"><b> </b></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><b>Weighted<br/> Average<br/> Grant Date<br/> Fair Value</b></td> <td style="padding-bottom: 1pt; font-weight: bold"><b> </b></td> <td style="padding-bottom: 1pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>Shares<br/> (000’s)</b></td> <td style="padding-bottom: 1pt"><b> </b></td> <td style="padding-bottom: 1pt; font-weight: bold"><b> </b></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><b>Weighted<br/> Average<br/> Grant Date<br/> Fair Value</b></td> <td style="padding-bottom: 1pt; font-weight: bold"><b> </b></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 52%; text-align: left">Unvested at beginning of period</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_pin3_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zLgLAELItgpd" style="width: 9%; text-align: right" title="Unvested at beginning of period">566</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsUnvestedWeightedAverageGrantDateFairValue_iS_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zo6xo6fb3p07" style="width: 9%; text-align: right" title="Unvested at beginning of period (in Dollars per share)">52.66</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_pin3_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z3JEMoWgbii4" style="width: 9%; text-align: right" title="Unvested at beginning of period"><span style="-sec-ix-hidden: xdx2ixbrl1968">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsUnvestedWeightedAverageGrantDateFairValue_iS_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z1t9ZrlAHs91" style="width: 9%; text-align: right" title="Unvested at beginning of period (in Dollars per share)"><span style="-sec-ix-hidden: xdx2ixbrl1970">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Transfers to restricted stock awards</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--TransfersToRestrictedStockUnits_pin3_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zGpq5lbQyjh" style="text-align: right" title="Transfers to restricted stock units"><span style="-sec-ix-hidden: xdx2ixbrl1972">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_ecustom--RestrictedStockTransfersToRestrictedStockUnitsinDollarsPerShare_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zJb0IQvIwh6d" style="text-align: right" title="Restricted stock Transfers to restricted stock units(in Dollars per share)"><span style="-sec-ix-hidden: xdx2ixbrl1974">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_ecustom--TransfersToRestrictedStockUnits_pin3_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zPaY9QWi8pMl" style="text-align: right" title="Transfers to restricted stock units">46</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_ecustom--RestrictedStockTransfersToRestrictedStockUnitsinDollarsPerShare_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zPKNDljwpYed" style="text-align: right" title="Restricted stock Transfers to restricted stock units(in Dollars per share)">34.02</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pin3_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zXx2u6bpeMXb" style="text-align: right" title="Granted">248</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zL7rwmRF6h63" style="text-align: right" title="Restricted stock granted (in Dollars per share)">74.14</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pin3_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zhULyQin4u1j" style="text-align: right" title="Granted">574</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zHVTNzRM4E0a" style="text-align: right" title="Restricted stock granted (in Dollars per share)">54.40</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Vested</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_pin3_di_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zyJPyQNY1S59" style="text-align: right" title="Vested">(205</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentVestedWeightedAverageGrantDateFairValue_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z6bciYtv6tWc" style="text-align: right" title="Restricted stock vested (in Dollars per share)">54.17</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_pin3_di_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z9XmWbMBTme3" style="text-align: right" title="Vested">(19</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentVestedWeightedAverageGrantDateFairValue_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zRCpRA6y69Ra" style="text-align: right" title="Restricted stock vested (in Dollars per share)">64.58</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt">Forfeited and cancelled</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_iN_pin3_di_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zdRodQpfwl68" style="border-bottom: Black 1pt solid; text-align: right" title="Forfeited and cancelled">(70</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td id="xdx_984_ecustom--RestrictedStockForfeitureAndCancelledInDollarsPerShare_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zNcpJvuGnuu" style="padding-bottom: 1pt; text-align: right" title="Restricted stock Forfeiture and cancelled (in Dollars per share)">61.99</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_iN_pin3_di_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zTEmzdbl4FMg" style="border-bottom: Black 1pt solid; text-align: right" title="Forfeited and cancelled">(35</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td id="xdx_98D_ecustom--RestrictedStockForfeitureAndCancelledInDollarsPerShare_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zMafy92PNn3c" style="padding-bottom: 1pt; text-align: right" title="Restricted stock Forfeiture and cancelled (in Dollars per share)">50.46</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.375in; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Unvested at end of period</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_pin3_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zlX07gFeEovk" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Unvested at end of period">539</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">$</td><td id="xdx_988_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsUnvestedWeightedAverageGrantDateFairValue_iE_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zToe7h3Qpq9h" style="padding-bottom: 2.5pt; font-weight: bold; text-align: right" title="Unvested at end of period (in Dollars per share)">60.73</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_pin3_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zLw01FRiNbec" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Unvested at end of period">566</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">$</td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsUnvestedWeightedAverageGrantDateFairValue_iE_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zU7Q4ZHdir6i" style="padding-bottom: 2.5pt; font-weight: bold; text-align: right" title="Unvested at end of period (in Dollars per share)">52.66</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <p id="xdx_8AC_zNnzvR0vIAP7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The total fair value of shares vested during the year ended December 31, 2022, was approximately $<span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_pn3n3_dm_c20220101__20221231__us-gaap--DerivativeInstrumentRiskAxis__custom--VestedMember_zz7uKy5p0wGc" title="Fair value of shares vested">11.6</span> million. Unrecognized compensation expense related to outstanding restricted stock units to employees and directors as of December 31, 2022 was approximately $<span id="xdx_900_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_iI_pn3n3_dm_c20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zTqSRkHIVkG7" title="Unrecognized compensation expense">20.3</span> million and is expected to be expensed over the next <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_dtY_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_zTjX7WxAaZPk" title="Share-based compensation service or vesting period of grant">2.0</span> years.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Performance-based Stock Awards</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company issues stock-based awards to third-party consultants for providing marketing, sales, and general business development services related to Celsius products, as well as to certain employees as discussed below. The stock-based awards are in the form of restricted stock units with performance vesting conditions (“performance stock units” or “PSUs”). The holders of unvested PSUs do not have the same rights as stockholders including but not limited to any dividends which may be declared by the Company, and do not have the right to vote. Some of the PSU performance vesting conditions are linked to the consultants obtaining specified incremental earnings for the Company in a given year over the performance vesting period, typically five years and some of the awards are linked to employees of the Company and have specific performance-based metrics to be met in year one and year two of the issuance as discussed below. The fair value of PSUs is based on the market price of the underlying stock on the grant date. The Company recognizes compensation cost for performance stock awards issued to non-employees in the same manner and periods as though cash had been paid for services received.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the third quarter of 2022, the Human Resources and Compensation Committee of the Board of Directors approved the issuance of PSUs to certain employees which represented restricted stock units with performance-based vesting. The aggregate grant date fair value of $<span id="xdx_90C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateTargetPayoutIfCircumstancesMet_pn3n3_dm_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--PerformanceSharesMember_zERqRsIM4oG6" title="Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Aggregate Target Payout If Circumstances Met">7.5</span> million included an immediate vesting of <span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--PerformanceSharesMember_pdd" title="Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage">20%</span> of the shares as well as specific performance-based metrics to be met in year one and year two of the issuance. The Company believes the performance-based metrics are probable of being achieved and will recognize expense each tranche of the awards separately according to ASC 718.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A summary of the Company’s PSU activity for the years ended December 31, 2022 and 2021 is presented in the following table:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_890_ecustom--ScheduleOfStockBasedAwardsIssuedToNonEmployeeConsultantsTableTextBlock_pn3n3_zJaMDqkHtJU6" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - STOCK-BASED COMPENSATION (Details 5)"> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span id="xdx_8B8_zQ68EY0IyBS" style="display: none">Schedule of stock-based awards issued to non-employee consultants</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><b> </b></td><td style="font-weight: bold; padding-bottom: 1pt"><b> </b></td> <td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><b>For the twelve months ended</b></td><td style="padding-bottom: 1pt; font-weight: bold"><b> </b></td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><b> </b></td><td style="font-weight: bold; padding-bottom: 1pt"><b> </b></td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><b>December 31,<br/> 2022</b></td><td style="padding-bottom: 1pt; font-weight: bold"><b> </b></td><td style="font-weight: bold; padding-bottom: 1pt"><b> </b></td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><b>December 31,<br/> 2021</b></td><td style="padding-bottom: 1pt; font-weight: bold"><b> </b></td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1pt; text-align: left"><b> </b></td> <td style="padding-bottom: 1pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>Shares<br/> (000’s)</b></td> <td style="padding-bottom: 1pt"><b> </b></td> <td style="padding-bottom: 1pt; font-weight: bold"><b> </b></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><b>Weighted<br/> Average<br/> Grant Date<br/> Fair Value</b></td> <td style="padding-bottom: 1pt; font-weight: bold"><b> </b></td> <td style="padding-bottom: 1pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>Shares<br/> (000’s)</b></td> <td style="padding-bottom: 1pt"><b> </b></td> <td style="padding-bottom: 1pt; font-weight: bold"><b> </b></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><b>Weighted<br/> Average<br/> Grant Date<br/> Fair Value</b></td> <td style="padding-bottom: 1pt; font-weight: bold"><b> </b></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 52%; text-align: left">Unvested at beginning of period</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_pin3_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--PerformanceSharesMember_zECBpwgp53Rd" style="width: 9%; text-align: right" title="Unvested at beginning of period">15</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsUnvestedWeightedAverageGrantDateFairValue_iS_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--PerformanceSharesMember_z17sNjby7lNf" style="width: 9%; text-align: right" title="Unvested at beginning of period (in Dollars per share)">64.65</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_pin3_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--PerformanceSharesMember_zgfyOukzGz42" style="width: 9%; text-align: right" title="Unvested at beginning of period"><span style="-sec-ix-hidden: xdx2ixbrl2029">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsUnvestedWeightedAverageGrantDateFairValue_iS_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--PerformanceSharesMember_z1hqTYt552ui" style="width: 9%; text-align: right" title="Unvested at beginning of period (in Dollars per share)"><span style="-sec-ix-hidden: xdx2ixbrl2031">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pin3_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--PerformanceSharesMember_zneeZYkZ7sob" style="text-align: right" title="Granted">76</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--PerformanceSharesMember_zBicPchgsRFi" style="text-align: right" title="Restricted stock granted (in Dollars per share)">98.28</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pin3_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--PerformanceSharesMember_zvFdCf5d3co8" style="text-align: right" title="Granted">15</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--PerformanceSharesMember_zmKlTMtFPaV1" style="text-align: right" title="Restricted stock granted (in Dollars per share)">64.65</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Vested</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_pin3_di_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--PerformanceSharesMember_zMvApEPzUJK1" style="text-align: right" title="Vested">(15</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentVestedWeightedAverageGrantDateFairValue_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--PerformanceSharesMember_z5fI2UmAoQv7" style="text-align: right" title="Restricted stock vested (in Dollars per share)">98.28</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_pin3_di_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--PerformanceSharesMember_zl7PaMD9Va45" style="text-align: right" title="Vested"><span style="-sec-ix-hidden: xdx2ixbrl2045">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentVestedWeightedAverageGrantDateFairValue_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--PerformanceSharesMember_z0XoRDimmcLa" style="text-align: right" title="Restricted stock vested (in Dollars per share)"><span style="-sec-ix-hidden: xdx2ixbrl2047">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt">Forfeited and cancelled</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_pin3_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--PerformanceSharesMember_zErtGlmfkCXf" style="border-bottom: Black 1pt solid; text-align: right" title="Forfeited and cancelled"><span style="-sec-ix-hidden: xdx2ixbrl2049">-</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td id="xdx_98B_ecustom--RestrictedStockForfeitureAndCancelledInDollarsPerShare_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--PerformanceSharesMember_zENr8B6Fpifh" style="padding-bottom: 1pt; text-align: right" title="Restricted stock Forfeiture and cancelled (in Dollars per share)"><span style="-sec-ix-hidden: xdx2ixbrl2051">-</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_pin3_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--PerformanceSharesMember_zDp6Lm6t1dJf" style="border-bottom: Black 1pt solid; text-align: right" title="Forfeited and cancelled"><span style="-sec-ix-hidden: xdx2ixbrl2053">-</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td id="xdx_982_ecustom--RestrictedStockForfeitureAndCancelledInDollarsPerShare_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--PerformanceSharesMember_zezKWuHy9lrh" style="padding-bottom: 1pt; text-align: right" title="Restricted stock Forfeiture and cancelled (in Dollars per share)"><span style="-sec-ix-hidden: xdx2ixbrl2055">-</span></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.375in; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Unvested at end of period</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_pin3_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--PerformanceSharesMember_zmKeKMW8yeil" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Unvested at end of period">76</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">$</td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsUnvestedWeightedAverageGrantDateFairValue_iE_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--PerformanceSharesMember_zPryM7Q7gnE2" style="padding-bottom: 2.5pt; font-weight: bold; text-align: right" title="Unvested at end of period (in Dollars per share)">91.48</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_pin3_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--PerformanceSharesMember_zmPkYvuOHnN2" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Unvested at end of period">15</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">$</td><td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsUnvestedWeightedAverageGrantDateFairValue_iE_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--PerformanceSharesMember_zbVaUBzMlPS4" style="padding-bottom: 2.5pt; font-weight: bold; text-align: right" title="Unvested at end of period (in Dollars per share)">64.65</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <p id="xdx_8AC_zpFptXArKFl9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unrecognized compensation expense related to outstanding PSUs issued to employees and non-employee consultants as of December 31, 2022, was approximately $<span id="xdx_903_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_iI_pn3n3_dm_c20221231__us-gaap--AwardTypeAxis__us-gaap--PerformanceSharesMember_z9XiPCeHIXG" title="Unrecognized compensation expense">4.3</span> million and is expected to be expensed over the next <span id="xdx_908_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dtY_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--PerformanceSharesMember_zF7c6ErbpwXh" title="Period unrecognized pre-tax non-cash compensation expense">1.6</span> years.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Modifications</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There were certain Board of Directors members and employees whose service was terminated during 2021. In connection with their terminations, the vesting conditions of the previously granted awards were modified to accelerate the vesting of specified un-vested awards pursuant to Board resolutions or severance agreements. Pursuant ASC 718, these were modifications which required re-valuation of un-vested awards to modification date fair value with recognition of compensation expense over the remaining service period. The Company modified awards resulting in approximately $<span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_pn3n3_dm_c20210101__20211231_zHDd3lq8uWX8" title="Incremental compensation cost">19.3</span> million in incremental compensation cost during the year ended December 31, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> P10Y 5000000 In addition, there is a provision in the 2015 Plan for an annual increase to the maximum number of shares authorized under the 2015 Plan, which increase shall be added on the first day of the calendar year beginning January 1, 2016, equal to 15% of the number of shares outstanding as of such date (Note 15). Provisions have been made to permit the grant of options and other share-based awards for up to 5.0 million shares. 5000000.0 20700000 36500000 6300000 The Company used straight-line amortization of compensation expense over the two to three-year requisite service or vesting period of the grant. The maximum contractual term of the Company’s stock options is 10 years. The Company recognizes forfeitures as they occur. There are options to purchase approximately 1.9 million shares that have vested as of December 31, 2022 and 2021. P10Y 1900000 1900000 2300000 9.66 213900000 <table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_pn3n3_z1317QkLavV6" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - STOCK-BASED COMPENSATION (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8B7_zWAnLPh7V72k" style="display: none">Schedule of black scholes option-pricing model valuation assumption</span></td><td style="font-style: italic"> </td> <td style="font-style: italic; text-align: center"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="7" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Years ended<br/> December 31,</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022<sup>(1)</sup></b></span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2021</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2020</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Expected volatility</td><td style="font-style: italic"> </td> <td style="font-style: italic; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>NA</i></span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_c20210101__20211231__srt--RangeAxis__srt--MinimumMember_zLSMmed9BuG5" title="Expected volatility">69.2</span> - <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_c20210101__20211231__srt--RangeAxis__srt--MaximumMember_pdd" title="Expected volatility">81.1%</span></span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_c20200101__20201231__srt--RangeAxis__srt--MinimumMember_zXJvT9p6ojPd" title="Expected volatility">69.2</span> - <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_c20200101__20201231__srt--RangeAxis__srt--MaximumMember_pdd" title="Expected volatility">81.1%</span></span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Expected term</td><td style="font-style: italic"> </td> <td style="font-style: italic; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>NA</i></span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20210101__20211231__srt--RangeAxis__srt--MinimumMember_zohb2Ms39dNg" title="Expected term">4.5</span> - <span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20210101__20211231__srt--RangeAxis__srt--MaximumMember_zHJJg33Ke057" title="Expected term">5.0</span> Years</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20200101__20201231__srt--RangeAxis__srt--MinimumMember_zQQeX0BtvGea" title="Expected term">4.8</span> - <span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20200101__20201231__srt--RangeAxis__srt--MaximumMember_zDmzT5dDpyrf" title="Expected term">5.0</span> Years</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Risk-free interest rate</td><td style="font-style: italic"> </td> <td style="font-style: italic; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>NA</i></span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_c20210101__20211231__srt--RangeAxis__srt--MinimumMember_pdd" title="Risk-free interest rate">0.3%</span> - <span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_c20210101__20211231__srt--RangeAxis__srt--MaximumMember_pdd" title="Risk-free interest rate">1.4%</span></span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_c20200101__20201231__srt--RangeAxis__srt--MinimumMember_pdd" title="Risk-free interest rate">0.2%</span> - <span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_c20200101__20201231__srt--RangeAxis__srt--MaximumMember_pdd" title="Risk-free interest rate">1.4%</span></span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 58%; text-align: left">Forfeiture Rate</td><td style="width: 1%; font-style: italic"> </td> <td style="width: 12%; font-style: italic; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>NA</i></span></td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: center"><span id="xdx_907_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate_c20210101__20211231_pdd" title="Forfeiture Rate">0.0%</span></td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: center"><span id="xdx_909_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate_c20200101__20201231_pdd" title="Forfeiture Rate">0.0%</span></td><td style="width: 1%; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"> </p> <div style="width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt"> </div></div> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify; border-collapse: collapse"> <td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span id="xdx_F0B_zPpbnNHP4kO9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="text-align: justify"><span id="xdx_F1B_zjbe9kfK9f2g" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No stock options were issued during 2022.</span></td> </tr></table> 0.692 0.811 0.692 0.811 P4Y6M P5Y P4Y9M18D P5Y 0.003 0.014 0.002 0.014 0.000 0.000 <table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--ScheduleOfStockOptionsRollForwardTableTextBlock_pn3n3_zH4G1C5Q18ul" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - STOCK-BASED COMPENSATION (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8B4_zns7joKfqNRc" style="display: none">Schedule of outstanding stock options</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td> <td> </td><td style="text-align: left"> </td><td> </td> <td style="vertical-align: bottom; text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; text-indent: -0.125in; padding-left: 0.125in; text-align: center"> </td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="vertical-align: bottom; text-align: center"> </td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Weighted Average</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Aggregate</td> <td style="text-align: center; vertical-align: bottom"> </td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td><td colspan="2" style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom">Weighted</td> <td style="text-align: center; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; text-indent: -0.125in; padding-left: 0.125in; text-align: center"> </td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Shares</td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Exercise</td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Grant Date</td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Intrinsic<br/> Value</td> <td style="text-align: center; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td><td colspan="2" style="text-align: center; font-weight: bold; vertical-align: bottom">Average<br/> Remaining</td> <td style="text-align: center; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; vertical-align: bottom; text-indent: -0.125in; padding-left: 0.125in; text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">(000’s)</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Price</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Fair Value</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">(000’s)</td> <td style="padding-bottom: 1pt; text-align: center; vertical-align: bottom"> </td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td><td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold; vertical-align: bottom">Term (Yrs)</td> <td style="padding-bottom: 1pt; text-align: center; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Options</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td> <td> </td><td style="text-align: left"> </td> <td> </td> <td style="text-align: right; vertical-align: bottom"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 40%; text-align: left">At December 31, 2020</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20210101__20211231_zVTZGfUY2kgk" style="width: 9%; text-align: right" title="Options outstanding Balance at beginning">5,198</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20210101__20211231_zGfmkpI5ceT2" style="width: 9%; text-align: right" title="Weighted Average Exercise Price, Balance at beginning">4.23</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right"> </td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pn3n3_c20210101__20211231_zoL8LP520hTd" style="width: 9%; text-align: right" title="Aggregate Intrinsic Value Balance at beginning">240,866</td> <td style="width: 1%"> </td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td id="xdx_985_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerms2_dtY_c20200101__20201231_zEOKGi83j4Na" style="vertical-align: bottom; text-align: right; width: 9%" title="Weighted Average Remaining Term Beginning Balance">6.89</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20210101__20211231_zIusH4Z8uybc" style="text-align: right" title="Options outstanding, Granted">305</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20210101__20211231_zmbbrrdThOka" style="text-align: right" title="Weighted Average Exercise Price, options granted">42.37</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_ecustom--WeightedAveragesGrantDateFairValueGranted_pid_c20210101__20211231_znY1nyWGDs3l" style="text-align: right" title="Weighted Average Grant Date Fair Value Granted">30.32</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td> <td> </td><td style="text-align: left"> </td> <td> </td> <td style="text-align: right; vertical-align: bottom"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_c20210101__20211231_zNkNpQTAIU9f" style="text-align: right" title="Options outstanding, Exercised">(1,460</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20210101__20211231_zRcejghmXwO8" style="text-align: right" title="Weighted Average Exercise Price, Exercised">3.85</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_ecustom--WeightedAveragesGrantDateFairValueExercised_pid_c20210101__20211231_z9xJSvoq9ewh" style="text-align: right" title="Weighted Average Grant Date Fair Value Exercised">80.58</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_c20210101__20211231_pn3n3" style="text-align: right" title="Aggregate Intrinsic Value Exercised">84,371</td> <td> </td><td style="text-align: left"> </td> <td> </td> <td style="text-align: right; vertical-align: bottom"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Forfeiture and cancelled</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20210101__20211231_zfQ42jjRkrG1" style="border-bottom: Black 1pt solid; text-align: right" title="Options outstanding, Forfeiture and cancelled">(443</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_pid_c20210101__20211231_zydKwU1z73t5" style="padding-bottom: 1pt; text-align: right" title="Weighted Average Exercise Price, Forfeiture and cancelled">5.01</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt; text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td> <td> </td><td style="padding-bottom: 1pt; text-align: left"> </td> <td> </td> <td style="text-align: right; vertical-align: bottom"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt">At December 31, 2021</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20220101__20221231_zxy3bYF2jZz2" style="border-bottom: Black 2.5pt double; text-align: right" title="Options outstanding, Balance at Beginning">3,600</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20220101__20221231_zYQCpObNLQEc" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Balance at beginning">7.47</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pn3n3_c20220101__20221231_z3uMvEvJRT28" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregate Intrinsic Value Balance at beginning">241,515</td> <td> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td id="xdx_98A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerms2_dtY_c20210101__20211231_zZ4LHGNgtKja" style="vertical-align: bottom; text-align: right" title="Weighted Average Remaining Term Beginning Balance">6.37</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20220101__20221231_znVmbskEFj4h" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1776">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20220101__20221231_zMTBPWNROYZ2" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1777">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td> <td> </td><td style="text-align: left"> </td> <td> </td> <td style="text-align: right; vertical-align: bottom"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_c20220101__20221231_zJbQWRGXeIx2" style="text-align: right" title="Options outstanding, Exercised">(1,273</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20220101__20221231_zRiZ5Kid3MOi" style="text-align: right" title="Weighted Average Exercise Price, Exercised">3.67</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_981_ecustom--WeightedAveragesGrantDateFairValueExercised_pid_c20220101__20221231_zeGMGyAZr6d" style="text-align: right" title="Weighted Average Grant Date Fair Value Exercised">80.70</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_c20220101__20221231_pn3n3" style="text-align: right" title="Aggregate Intrinsic Value Exercised">102,283</td> <td> </td><td style="text-align: left"> </td> <td> </td> <td style="text-align: right; vertical-align: bottom"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Forfeiture and cancelled</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20220101__20221231_zCImxrceydK2" style="border-bottom: Black 1pt solid; text-align: right" title="Options outstanding, Forfeiture and cancelled">(61</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_pid_c20220101__20221231_zVjgbXlpZBxj" style="padding-bottom: 1pt; text-align: right" title="Weighted Average Exercise Price, Forfeiture and cancelled">5.46</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt; text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td> <td> </td><td style="padding-bottom: 1pt; text-align: left"> </td> <td> </td> <td style="text-align: right; vertical-align: bottom"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt">At December 31, 2022</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20220101__20221231_z5UqzBWRJtL7" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Options outstanding, Balance at end">2,266</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20220101__20221231_zcPFNAjBYIO4" style="padding-bottom: 2.5pt; font-weight: bold; text-align: right" title="Weighted Average Exercise Price, Balance at end">9.66</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pn3n3_c20220101__20221231_zxY7GAKRjUw1" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Aggregate Intrinsic Value Balance at end">213,914</td> <td> </td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td id="xdx_982_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerms2_dtY_c20220101__20221231_zj9ja94uz3R1" style="vertical-align: bottom; font-weight: bold; text-align: right" title="Weighted Average Remaining Term Ending Balance">5.43</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Exercisable at December 31, 2022</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_pid_c20221231_zEwrpDnQDK39" style="font-weight: bold; text-align: right" title="Options outstanding, Exercisable at end">1,928</td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_pid_c20221231_z5aWcPvcoH9" style="font-weight: bold; text-align: right" title="Weighted Average Exercise Price, Options Exercisable">6.41</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_c20221231_pn3n3" style="font-weight: bold; text-align: right" title="Aggregate Intrinsic Value Exercisable">188,261</td> <td> </td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20220101__20221231_zwU5NRvsh1nc" style="vertical-align: bottom; font-weight: bold; text-align: right" title="Weighted Average Remaining Term, exercisable">5.05</td> <td> </td></tr> </table> 5198 4.23 240866000 P6Y10M20D 305 42.37 30.32 1460 3.85 80.58 84371000 443 5.01 3600 7.47 241515000 P6Y4M13D 1273 3.67 80.70 102283000 61 5.46 2266 9.66 213914000 P5Y5M4D 1928 6.41 188261000 P5Y18D <table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_pn3n3_ztpL2SOupVYg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - STOCK-BASED COMPENSATION (Details 2)"> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8B4_zoiSsCejpWGg" style="display: none">Schedule of employee stock options outstanding</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><b> </b></td><td style="font-weight: bold; padding-bottom: 1pt"><b> </b></td> <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><b>Outstanding Options</b></td><td style="padding-bottom: 1pt; font-weight: bold"><b> </b></td><td style="font-weight: bold; padding-bottom: 1pt"><b> </b></td> <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><b>Vested Options</b></td><td style="padding-bottom: 1pt; font-weight: bold"><b> </b></td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: left"><b>Range of Exercise Price</b></td> <td style="padding-bottom: 1pt; font-weight: bold"><b> </b></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><b>Number<br/> Outstanding at<br/> December 31,<br/> 2022<br/> (000’s)</b></td> <td style="padding-bottom: 1pt; font-weight: bold"><b> </b></td> <td style="padding-bottom: 1pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>Weighted<br/> Average<br/> Remaining<br/> Life</b></td> <td style="padding-bottom: 1pt"><b> </b></td> <td style="padding-bottom: 1pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>Weighted<br/> Average<br/> Exercise<br/> Price</b></td> <td style="padding-bottom: 1pt"><b> </b></td> <td style="padding-bottom: 1pt; font-weight: bold"><b> </b></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><b>Number<br/> Exercisable at<br/> December 31,<br/> 2022<br/> (000’s)</b></td> <td style="padding-bottom: 1pt; font-weight: bold"><b> </b></td> <td style="padding-bottom: 1pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>Weighted<br/> Average<br/> Exercise<br/> Price</b></td> <td style="padding-bottom: 1pt"><b> </b></td> <td style="padding-bottom: 1pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>Weighted<br/> Average<br/> Remaining<br/> Life</b></td> <td style="padding-bottom: 1pt"><b> </b></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 28%; text-align: left">$0.34 - $1.05</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pin3_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--RangeOfExercisePrice1Member_zybm051OhuEf" title="Number outstanding options">30</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right"><span id="xdx_909_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--RangeOfExercisePrice1Member_z9Bhxl7ImI08" title="Weighted average remaining life, outstanding options">1.44</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--RangeOfExercisePrice1Member_pdd" style="width: 9%; text-align: right" title="Weighted average exercise price, outstanding options">0.58</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right"><span id="xdx_900_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pin3_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--RangeOfExercisePrice1Member_z1tGRBTbh7me" title="Number vested options, exercisable">30</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span id="xdx_903_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--RangeOfExercisePrice1Member_pdd" title="Weighted average exercise price, vested options">0.58</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right"><span id="xdx_908_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--RangeOfExercisePrice1Member_zYiq7m1anIkb" title="Weighted average remaining life, vested options">1.44</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">$1.97 - $2.95</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_900_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pin3_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--RangeOfExercisePrice2Member_zXAmbH3wvBX6" title="Number outstanding options">5</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--RangeOfExercisePrice2Member_zLdJyXTbU9x3" title="Weighted average remaining life, outstanding options">3.01</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--RangeOfExercisePrice2Member_pdd" title="Weighted average exercise price, outstanding options">1.97</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pin3_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--RangeOfExercisePrice2Member_zubLc6OCjARg" title="Number vested options, exercisable">5</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--RangeOfExercisePrice2Member_pdd" title="Weighted average exercise price, vested options">1.97</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--RangeOfExercisePrice2Member_zXSspTQUn2g3" title="Weighted average remaining life, vested options">3.01</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">$3.23 - $4.85</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pin3_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--RangeOfExercisePrice3Member_zOBrucnkFJOi" title="Number outstanding options">1,465</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--RangeOfExercisePrice3Member_z4u1aza9xS37" title="Weighted average remaining life, outstanding options">5.38</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_909_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--RangeOfExercisePrice3Member_pdd" title="Weighted average exercise price, outstanding options">3.81</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pin3_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--RangeOfExercisePrice3Member_z3fMLmUktoK9" title="Number vested options, exercisable">1,412</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--RangeOfExercisePrice3Member_pdd" title="Weighted average exercise price, vested options">3.80</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--RangeOfExercisePrice3Member_zuYXT90M9PM4" title="Weighted average remaining life, vested options">5.34</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">$5.59 - $8.38</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pin3_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--RangeOfExercisePrice4Member_zTcOXrNbPt14" title="Number outstanding options">389</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_903_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--RangeOfExercisePrice4Member_ziYFI1y2GGyg" title="Weighted average remaining life, outstanding options">3.51</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--RangeOfExercisePrice4Member_pdd" title="Weighted average exercise price, outstanding options">5.70</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pin3_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--RangeOfExercisePrice4Member_zrRkzhvnzUi3" title="Number vested options, exercisable">331</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90C_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--RangeOfExercisePrice4Member_pdd" title="Weighted average exercise price, vested options">5.72</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_900_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--RangeOfExercisePrice4Member_zorfIJvl5fA8" title="Weighted average remaining life, vested options">2.88</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">$14.53 - $21.79</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_904_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pin3_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--RangeOfExercisePrice5Member_zK6zSIFhoxIh" title="Number outstanding options">61</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--RangeOfExercisePrice5Member_zpC6VRg7lK4c" title="Weighted average remaining life, outstanding options">7.58</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90B_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--RangeOfExercisePrice5Member_pdd" title="Weighted average exercise price, outstanding options">14.53</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pin3_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--RangeOfExercisePrice5Member_zWyDIQIM0g35" title="Number vested options, exercisable">40</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--RangeOfExercisePrice5Member_pdd" title="Weighted average exercise price, vested options">14.53</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_909_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--RangeOfExercisePrice5Member_zHXRGMBDLX32" title="Weighted average remaining life, vested options">7.58</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">$21.80 - $32.70</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_903_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pin3_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--RangeOfExercisePrice6Member_zPaCw3l5WlXc" title="Number outstanding options">16</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--RangeOfExercisePrice6Member_zTtmHCOxDcqb" title="Weighted average remaining life, outstanding options">7.83</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--RangeOfExercisePrice6Member_pdd" title="Weighted average exercise price, outstanding options">21.80</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pin3_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--RangeOfExercisePrice6Member_zl4fXbiSERah" title="Number vested options, exercisable">10</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90E_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--RangeOfExercisePrice6Member_pdd" title="Weighted average exercise price, vested options">21.80</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--RangeOfExercisePrice6Member_zVne6ytpcgvj" title="Weighted average remaining life, vested options">7.83</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">$42.64 - $63.96</td><td> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_903_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pin3_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--RangeOfExercisePrice7Member_zd5ToaA0xmch" title="Number outstanding options">300</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--RangeOfExercisePrice7Member_zbmv02y19lt" title="Weighted average remaining life, outstanding options">8.01</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--RangeOfExercisePrice7Member_pdd" title="Weighted average exercise price, outstanding options">42.67</span></td><td style="text-align: left"> </td><td> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90A_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pin3_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--RangeOfExercisePrice7Member_zbhgMtVf3oC7" title="Number vested options, exercisable">100</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_909_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--RangeOfExercisePrice7Member_pdd" title="Weighted average exercise price, vested options">42.67</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--RangeOfExercisePrice7Member_zzt2dqE8nME4" title="Weighted average remaining life, vested options">8.01</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Outstanding options</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span id="xdx_900_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pin3_c20221231_z9tyWtT7ejki" title="Number outstanding options">2,266</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: right"><span id="xdx_90C_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231_zIpQ7AksqNR2" title="Weighted average remaining life, outstanding options">5.43</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">$</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: right"><span id="xdx_90A_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20221231_pdd" title="Weighted average exercise price, outstanding options">9.66</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span id="xdx_901_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pin3_c20221231_zI08uuY5Lxli" title="Number vested options, exercisable">1,928</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">$</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: right"><span id="xdx_90A_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_c20221231_pdd" title="Weighted average exercise price, vested options">6.41</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: right"><span id="xdx_906_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231_zxYe4n6IHBkk" title="Weighted average remaining life, vested options">5.05</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> 30000 P1Y5M8D 0.58 30000 0.58 P1Y5M8D 5000 P3Y3D 1.97 5000 1.97 P3Y3D 1465000 P5Y4M17D 3.81 1412000 3.80 P5Y4M2D 389000 P3Y6M3D 5.70 331000 5.72 P2Y10M17D 61000 P7Y6M29D 14.53 40000 14.53 P7Y6M29D 16000 P7Y9M29D 21.80 10000 21.80 P7Y9M29D 300000 P8Y3D 42.67 100000 42.67 P8Y3D 2266000 P5Y5M4D 9.66 1928000 6.41 P5Y18D 3400000 P1Y P3Y <table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_pn3n3_zm0cXxLuycqb" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - STOCK-BASED COMPENSATION (Details 3)"> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span id="xdx_8B6_zjXX7ogj4edd" style="display: none">Schedule of restricted stock activity</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="14" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">For the twelve months ended</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">December 31,<br/> 2022</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">December 31,<br/> 2021</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1pt; text-align: left"><b> </b></td> <td style="padding-bottom: 1pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>Shares</b></td> <td style="padding-bottom: 1pt"><b> </b></td> <td style="padding-bottom: 1pt; font-weight: bold"><b> </b></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><b>Weighted<br/> Average<br/> Grant Date<br/> Fair Value</b></td> <td style="padding-bottom: 1pt; font-weight: bold"><b> </b></td> <td style="padding-bottom: 1pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>Shares</b></td> <td style="padding-bottom: 1pt"><b> </b></td> <td style="padding-bottom: 1pt; font-weight: bold"><b> </b></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><b>Weighted<br/> Average<br/> Grant Date<br/> Fair Value</b></td> <td style="padding-bottom: 1pt; font-weight: bold"><b> </b></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 52%; text-align: left">Unvested at beginning of period</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_pin3_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_ztjtlqvE5Kr4" style="width: 9%; text-align: right" title="Unvested at beginning of period">0.3</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsUnvestedWeightedAverageGrantDateFairValue_iS_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zQloctFvJjab" style="width: 9%; text-align: right" title="Unvested at beginning of period (in Dollars per share)">14.72</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_pin3_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zbR87eL5kFre" style="width: 9%; text-align: right" title="Unvested at beginning of period">66.2</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsUnvestedWeightedAverageGrantDateFairValue_iS_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zQvcD096dkQ7" style="width: 9%; text-align: right" title="Unvested at beginning of period (in Dollars per share)">28.11</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Transfers to restricted stock units</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--TransfersToRestrictedStockUnits_pin3_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zSE3XpO9RTX7" style="text-align: right" title="Transfers to restricted stock units"><span style="-sec-ix-hidden: xdx2ixbrl1922">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_ecustom--RestrictedStockTransfersToRestrictedStockUnitsinDollarsPerShare_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_z9wTVTqQQ9Xf" style="text-align: right" title="Restricted stock Transfers to restricted stock units(in Dollars per share)"><span style="-sec-ix-hidden: xdx2ixbrl1924">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_ecustom--TransfersToRestrictedStockUnits_pin3_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zY65R7Bym24l" style="text-align: right" title="Transfers to restricted stock units">(45.9</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_ecustom--RestrictedStockTransfersToRestrictedStockUnitsinDollarsPerShare_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zCA1yYwqxgFd" style="text-align: right" title="Restricted stock Transfers to restricted stock units(in Dollars per share)">34.02</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pin3_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zAsTApUUHqp9" style="text-align: right" title="Granted"><span style="-sec-ix-hidden: xdx2ixbrl1930">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zP30cUk3AZBd" style="text-align: right" title="Restricted stock granted (in Dollars per share)"><span style="-sec-ix-hidden: xdx2ixbrl1932">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pin3_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zK6xWEOudkn3" style="text-align: right" title="Granted"><span style="-sec-ix-hidden: xdx2ixbrl1934">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zkZoVG67nqg5" style="text-align: right" title="Restricted stock granted (in Dollars per share)"><span style="-sec-ix-hidden: xdx2ixbrl1936">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Vested</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_pin3_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zaPuKyhKeCol" style="text-align: right" title="Vested"><span style="-sec-ix-hidden: xdx2ixbrl1938">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentVestedWeightedAverageGrantDateFairValue_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zpnnLbA1oTfd" style="text-align: right" title="Restricted stock vested (in Dollars per share)"><span style="-sec-ix-hidden: xdx2ixbrl1940">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_pin3_di_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zl5YNCKL24Yl" style="text-align: right" title="Vested">(18.9</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentVestedWeightedAverageGrantDateFairValue_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_z8ogF07dYs3h" style="text-align: right" title="Restricted stock vested (in Dollars per share)">14.79</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt">Forfeited and cancelled</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_iN_pin3_di_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zLtOncG3uCbc" style="border-bottom: Black 1pt solid; text-align: right" title="Forfeited and cancelled">(0.3</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td id="xdx_986_ecustom--RestrictedStockForfeitureAndCancelledInDollarsPerShare_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zoVaq6kgxzec" style="padding-bottom: 1pt; text-align: right" title="Restricted stock Forfeiture and cancelled (in Dollars per share)">14.72</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_iN_pin3_di_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_z8q3srSDgQxl" style="border-bottom: Black 1pt solid; text-align: right" title="Forfeited and cancelled">(1.1</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td id="xdx_98F_ecustom--RestrictedStockForfeitureAndCancelledInDollarsPerShare_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zVUlxfwt4ebf" style="padding-bottom: 1pt; text-align: right" title="Restricted stock Forfeiture and cancelled (in Dollars per share)">14.72</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.375in; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Unvested at end of period</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_pin3_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zgtB2U2bw0a1" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Unvested at end of period"><span style="-sec-ix-hidden: xdx2ixbrl1954">-</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">$</td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsUnvestedWeightedAverageGrantDateFairValue_iE_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_z7FkOZE3prul" style="padding-bottom: 2.5pt; font-weight: bold; text-align: right" title="Unvested at end of period (in Dollars per share)"><span style="-sec-ix-hidden: xdx2ixbrl1956">-</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_pin3_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zhfks1v83Tmb" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Unvested at end of period">0.3</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">$</td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsUnvestedWeightedAverageGrantDateFairValue_iE_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zFi0OufPOn89" style="padding-bottom: 2.5pt; font-weight: bold; text-align: right" title="Unvested at end of period (in Dollars per share)">14.72</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> 300 14.72 66200 28.11 -45900 34.02 18900 14.79 300 14.72 1100 14.72 300 14.72 <table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--ScheduleOfNonvestedShareActivityTableTextBlock_pn3n3_z4nBdmSudp1j" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - STOCK-BASED COMPENSATION (Details 4)"> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span id="xdx_8B1_zB9ldLwbnX82" style="display: none">Schedule of restricted stock unit activity</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><b> </b></td><td style="font-weight: bold; padding-bottom: 1pt"><b> </b></td> <td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><b>For the twelve months ended</b></td><td style="padding-bottom: 1pt; font-weight: bold"><b> </b></td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><b> </b></td><td style="font-weight: bold; padding-bottom: 1pt"><b> </b></td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><b>December 31,<br/> 2022</b></td><td style="padding-bottom: 1pt; font-weight: bold"><b> </b></td><td style="font-weight: bold; padding-bottom: 1pt"><b> </b></td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><b>December 31,<br/> 2021</b></td><td style="padding-bottom: 1pt; font-weight: bold"><b> </b></td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1pt; text-align: left"><b> </b></td> <td style="padding-bottom: 1pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>Shares<br/> (000’s)</b></td> <td style="padding-bottom: 1pt"><b> </b></td> <td style="padding-bottom: 1pt; font-weight: bold"><b> </b></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><b>Weighted<br/> Average<br/> Grant Date<br/> Fair Value</b></td> <td style="padding-bottom: 1pt; font-weight: bold"><b> </b></td> <td style="padding-bottom: 1pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>Shares<br/> (000’s)</b></td> <td style="padding-bottom: 1pt"><b> </b></td> <td style="padding-bottom: 1pt; font-weight: bold"><b> </b></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><b>Weighted<br/> Average<br/> Grant Date<br/> Fair Value</b></td> <td style="padding-bottom: 1pt; font-weight: bold"><b> </b></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 52%; text-align: left">Unvested at beginning of period</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_pin3_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zLgLAELItgpd" style="width: 9%; text-align: right" title="Unvested at beginning of period">566</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsUnvestedWeightedAverageGrantDateFairValue_iS_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zo6xo6fb3p07" style="width: 9%; text-align: right" title="Unvested at beginning of period (in Dollars per share)">52.66</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_pin3_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z3JEMoWgbii4" style="width: 9%; text-align: right" title="Unvested at beginning of period"><span style="-sec-ix-hidden: xdx2ixbrl1968">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsUnvestedWeightedAverageGrantDateFairValue_iS_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z1t9ZrlAHs91" style="width: 9%; text-align: right" title="Unvested at beginning of period (in Dollars per share)"><span style="-sec-ix-hidden: xdx2ixbrl1970">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Transfers to restricted stock awards</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--TransfersToRestrictedStockUnits_pin3_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zGpq5lbQyjh" style="text-align: right" title="Transfers to restricted stock units"><span style="-sec-ix-hidden: xdx2ixbrl1972">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_ecustom--RestrictedStockTransfersToRestrictedStockUnitsinDollarsPerShare_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zJb0IQvIwh6d" style="text-align: right" title="Restricted stock Transfers to restricted stock units(in Dollars per share)"><span style="-sec-ix-hidden: xdx2ixbrl1974">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_ecustom--TransfersToRestrictedStockUnits_pin3_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zPaY9QWi8pMl" style="text-align: right" title="Transfers to restricted stock units">46</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_ecustom--RestrictedStockTransfersToRestrictedStockUnitsinDollarsPerShare_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zPKNDljwpYed" style="text-align: right" title="Restricted stock Transfers to restricted stock units(in Dollars per share)">34.02</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pin3_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zXx2u6bpeMXb" style="text-align: right" title="Granted">248</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zL7rwmRF6h63" style="text-align: right" title="Restricted stock granted (in Dollars per share)">74.14</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pin3_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zhULyQin4u1j" style="text-align: right" title="Granted">574</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zHVTNzRM4E0a" style="text-align: right" title="Restricted stock granted (in Dollars per share)">54.40</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Vested</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_pin3_di_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zyJPyQNY1S59" style="text-align: right" title="Vested">(205</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentVestedWeightedAverageGrantDateFairValue_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z6bciYtv6tWc" style="text-align: right" title="Restricted stock vested (in Dollars per share)">54.17</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_pin3_di_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z9XmWbMBTme3" style="text-align: right" title="Vested">(19</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentVestedWeightedAverageGrantDateFairValue_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zRCpRA6y69Ra" style="text-align: right" title="Restricted stock vested (in Dollars per share)">64.58</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt">Forfeited and cancelled</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_iN_pin3_di_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zdRodQpfwl68" style="border-bottom: Black 1pt solid; text-align: right" title="Forfeited and cancelled">(70</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td id="xdx_984_ecustom--RestrictedStockForfeitureAndCancelledInDollarsPerShare_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zNcpJvuGnuu" style="padding-bottom: 1pt; text-align: right" title="Restricted stock Forfeiture and cancelled (in Dollars per share)">61.99</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_iN_pin3_di_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zTEmzdbl4FMg" style="border-bottom: Black 1pt solid; text-align: right" title="Forfeited and cancelled">(35</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td id="xdx_98D_ecustom--RestrictedStockForfeitureAndCancelledInDollarsPerShare_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zMafy92PNn3c" style="padding-bottom: 1pt; text-align: right" title="Restricted stock Forfeiture and cancelled (in Dollars per share)">50.46</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.375in; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Unvested at end of period</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_pin3_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zlX07gFeEovk" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Unvested at end of period">539</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">$</td><td id="xdx_988_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsUnvestedWeightedAverageGrantDateFairValue_iE_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zToe7h3Qpq9h" style="padding-bottom: 2.5pt; font-weight: bold; text-align: right" title="Unvested at end of period (in Dollars per share)">60.73</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_pin3_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zLw01FRiNbec" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Unvested at end of period">566</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">$</td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsUnvestedWeightedAverageGrantDateFairValue_iE_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zU7Q4ZHdir6i" style="padding-bottom: 2.5pt; font-weight: bold; text-align: right" title="Unvested at end of period (in Dollars per share)">52.66</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> 566000 52.66 46000 34.02 248000 74.14 574000 54.40 205000 54.17 19000 64.58 70000 61.99 35000 50.46 539000 60.73 566000 52.66 11600000 20300000 P2Y 7500000 0.20 <table cellpadding="0" cellspacing="0" id="xdx_890_ecustom--ScheduleOfStockBasedAwardsIssuedToNonEmployeeConsultantsTableTextBlock_pn3n3_zJaMDqkHtJU6" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - STOCK-BASED COMPENSATION (Details 5)"> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span id="xdx_8B8_zQ68EY0IyBS" style="display: none">Schedule of stock-based awards issued to non-employee consultants</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><b> </b></td><td style="font-weight: bold; padding-bottom: 1pt"><b> </b></td> <td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><b>For the twelve months ended</b></td><td style="padding-bottom: 1pt; font-weight: bold"><b> </b></td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><b> </b></td><td style="font-weight: bold; padding-bottom: 1pt"><b> </b></td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><b>December 31,<br/> 2022</b></td><td style="padding-bottom: 1pt; font-weight: bold"><b> </b></td><td style="font-weight: bold; padding-bottom: 1pt"><b> </b></td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><b>December 31,<br/> 2021</b></td><td style="padding-bottom: 1pt; font-weight: bold"><b> </b></td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1pt; text-align: left"><b> </b></td> <td style="padding-bottom: 1pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>Shares<br/> (000’s)</b></td> <td style="padding-bottom: 1pt"><b> </b></td> <td style="padding-bottom: 1pt; font-weight: bold"><b> </b></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><b>Weighted<br/> Average<br/> Grant Date<br/> Fair Value</b></td> <td style="padding-bottom: 1pt; font-weight: bold"><b> </b></td> <td style="padding-bottom: 1pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>Shares<br/> (000’s)</b></td> <td style="padding-bottom: 1pt"><b> </b></td> <td style="padding-bottom: 1pt; font-weight: bold"><b> </b></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><b>Weighted<br/> Average<br/> Grant Date<br/> Fair Value</b></td> <td style="padding-bottom: 1pt; font-weight: bold"><b> </b></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 52%; text-align: left">Unvested at beginning of period</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_pin3_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--PerformanceSharesMember_zECBpwgp53Rd" style="width: 9%; text-align: right" title="Unvested at beginning of period">15</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsUnvestedWeightedAverageGrantDateFairValue_iS_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--PerformanceSharesMember_z17sNjby7lNf" style="width: 9%; text-align: right" title="Unvested at beginning of period (in Dollars per share)">64.65</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_pin3_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--PerformanceSharesMember_zgfyOukzGz42" style="width: 9%; text-align: right" title="Unvested at beginning of period"><span style="-sec-ix-hidden: xdx2ixbrl2029">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsUnvestedWeightedAverageGrantDateFairValue_iS_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--PerformanceSharesMember_z1hqTYt552ui" style="width: 9%; text-align: right" title="Unvested at beginning of period (in Dollars per share)"><span style="-sec-ix-hidden: xdx2ixbrl2031">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pin3_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--PerformanceSharesMember_zneeZYkZ7sob" style="text-align: right" title="Granted">76</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--PerformanceSharesMember_zBicPchgsRFi" style="text-align: right" title="Restricted stock granted (in Dollars per share)">98.28</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pin3_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--PerformanceSharesMember_zvFdCf5d3co8" style="text-align: right" title="Granted">15</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--PerformanceSharesMember_zmKlTMtFPaV1" style="text-align: right" title="Restricted stock granted (in Dollars per share)">64.65</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Vested</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_pin3_di_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--PerformanceSharesMember_zMvApEPzUJK1" style="text-align: right" title="Vested">(15</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentVestedWeightedAverageGrantDateFairValue_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--PerformanceSharesMember_z5fI2UmAoQv7" style="text-align: right" title="Restricted stock vested (in Dollars per share)">98.28</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_pin3_di_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--PerformanceSharesMember_zl7PaMD9Va45" style="text-align: right" title="Vested"><span style="-sec-ix-hidden: xdx2ixbrl2045">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentVestedWeightedAverageGrantDateFairValue_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--PerformanceSharesMember_z0XoRDimmcLa" style="text-align: right" title="Restricted stock vested (in Dollars per share)"><span style="-sec-ix-hidden: xdx2ixbrl2047">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt">Forfeited and cancelled</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_pin3_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--PerformanceSharesMember_zErtGlmfkCXf" style="border-bottom: Black 1pt solid; text-align: right" title="Forfeited and cancelled"><span style="-sec-ix-hidden: xdx2ixbrl2049">-</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td id="xdx_98B_ecustom--RestrictedStockForfeitureAndCancelledInDollarsPerShare_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--PerformanceSharesMember_zENr8B6Fpifh" style="padding-bottom: 1pt; text-align: right" title="Restricted stock Forfeiture and cancelled (in Dollars per share)"><span style="-sec-ix-hidden: xdx2ixbrl2051">-</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_pin3_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--PerformanceSharesMember_zDp6Lm6t1dJf" style="border-bottom: Black 1pt solid; text-align: right" title="Forfeited and cancelled"><span style="-sec-ix-hidden: xdx2ixbrl2053">-</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td id="xdx_982_ecustom--RestrictedStockForfeitureAndCancelledInDollarsPerShare_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--PerformanceSharesMember_zezKWuHy9lrh" style="padding-bottom: 1pt; text-align: right" title="Restricted stock Forfeiture and cancelled (in Dollars per share)"><span style="-sec-ix-hidden: xdx2ixbrl2055">-</span></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.375in; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Unvested at end of period</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_pin3_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--PerformanceSharesMember_zmKeKMW8yeil" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Unvested at end of period">76</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">$</td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsUnvestedWeightedAverageGrantDateFairValue_iE_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--PerformanceSharesMember_zPryM7Q7gnE2" style="padding-bottom: 2.5pt; font-weight: bold; text-align: right" title="Unvested at end of period (in Dollars per share)">91.48</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_pin3_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--PerformanceSharesMember_zmPkYvuOHnN2" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Unvested at end of period">15</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">$</td><td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsUnvestedWeightedAverageGrantDateFairValue_iE_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--PerformanceSharesMember_zbVaUBzMlPS4" style="padding-bottom: 2.5pt; font-weight: bold; text-align: right" title="Unvested at end of period (in Dollars per share)">64.65</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> 15000 64.65 76000 98.28 15000 64.65 15000 98.28 76000 91.48 15000 64.65 4300000 P1Y7M6D 19300000 <p id="xdx_80C_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zfs7tiLLKppg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify; border-collapse: collapse"> <td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>19.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_820_z3KmSRlaMaca">COMMITMENTS AND CONTINGENCIES</span></b></span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Legal</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In November of 2020, McGovern Capital, Inc. and Kevin McGovern (collectively “McGovern”) filed a claim in arbitration related to its Representative Agreement with the Company as amended by the first amendment dated August 6, 2016. Pursuant to the Representative Agreement, McGovern is entitled to receive a fee of three percent <span id="xdx_906_ecustom--PercentageOfFeeReceived_c20201101__20201130_pdd" title="Percentage of Fee Received">(3%)</span> of “Net Revenues” received by the Company from sales of the Company’s products in the People’s Republic of China for a period of four years from Initial Commercial Sale (which was September 1, 2017). “Net Revenues” are defined in the Representative Agreement as “the Company’s revenues net of actual discounts applied, credits and returns.” Effective January 1, 2019, the Company restructured its China operations from a distribution arrangement with Qifeng Food Technology (Beijing) Co. Ltd. (“Qifeng”), to a license and royalty arrangement and a loan, pursuant to which Qifeng will market and distribute the Company’s products in China, and the Company will receive an annual royalty payment. The Company intended to pay McGovern its percentage of the annual royalty payment, but McGovern had objected, claiming that McGovern is entitled to be paid commissions on the entire royalty payment and the amount of the loan to Qifeng. During the year ended December 31, 2022, a confidential settlement agreement was signed for an amount included in the consolidated Statements of Operations and Comprehensive Income for year ended December 31, 2022 that is not material to the financial results of the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In March of 2019, Daniel Prescod filed a putative class action lawsuit against the Company in the Superior Court for the State of California, County of Los Angeles, filed on March 19, 2019, (the “Prescod Litigation”). Daniel Prescod asserts that the Company’s use of citric acid in its products while simultaneously claiming “no preservatives” violates California Consumer Legal Remedies Act, California Business and Professions Code Section 17200, et seq., and California Business and Professions Code Section 17500, et seq., because citric acid acts as a preservative. The Company does not use citric acid as a preservative in its products, but rather as a flavoring, and therefore it believes that its “no preservatives” claim is fair and not deceptive. A motion to certify the case as a class action was filed and on August 2, 2021, that motion was granted. No fact discovery was conducted on the merits. On October 12, 2022, the Company and Mr. Prescod notified the courts that an agreement in principle to settle had been reached to resolve the case for an aggregate amount of $<span id="xdx_90C_eus-gaap--GainLossRelatedToLitigationSettlement_pn3n3_dm_c20221001__20221012__srt--StatementGeographicalAxis__stpr--NY__us-gaap--AwardDateAxis__custom--NovemberTwentyThreeTwoThousensTwentyOneMember_zf6mcT5TF7Ag" title="Gain (Loss) Related to Litigation Settlement">7.8</span> million. The Company and Mr. Prescod submitted the settlement agreement to the court, which entered its preliminary approval on November 23, 2022 and set a final Fairness Hearing for March 31, 2023. As of December 31, 2022, $<span id="xdx_903_eus-gaap--GainLossRelatedToLitigationSettlement_pn3n3_dm_c20221001__20221012_zXCBqgc2BLhj" title="Gain (Loss) Related to Litigation Settlement">7.8</span> million was accrued and included in accounts payable and accrued expenses in the consolidated balance sheets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On November 23, 2021, a case related to the Prescod Litigation, Amit Heli and Joseph Nina v. Celsius Holdings, Inc. was filed in the United States District Court for the Southern District of New York, Case No. 1:21-cv-09892. The Company answered the complaint on February 11, 2022. Like the Prescod Litigation, the plaintiffs in this case allege that the Company’s use of citric acid in its products while simultaneously claiming “no preservatives” constitutes false advertising and unfair or deceptive trade practices. Unlike the Prescod Litigation, in this case the violations alleged are of New York’s General Business Law. As with the Prescod Litigation, the Company does not use citric acid as a preservative in its products, but rather as a flavoring, and therefore it believes that its “no preservatives” claim is fair and not deceptive. No discovery has been conducted and this matter is still in its initial stages. On October 12, 2022, the Company and Mr. Prescod notified the courts that an agreement in principle to settle had been reached to resolve the Prescod and Heli case for an aggregate amount of $<span id="xdx_901_eus-gaap--GainLossRelatedToLitigationSettlement_pn3n3_dm_c20220101__20221231__srt--StatementGeographicalAxis__stpr--NY__us-gaap--AwardDateAxis__custom--NovemberTwentyThreeTwoThousensTwentyOneMember_zZ0eModZUsSl" title="Gain (Loss) Related to Litigation Settlement">7.8</span> million. The Company and Mr. Prescod submitted the settlement agreement to the court, which entered its preliminary approval on November 23, 2022 and set a final Fairness Hearing for March 31, 2023 for judicial approval and await final judgment and entry in the coming weeks. As of December 31, 2022, $<span id="xdx_908_eus-gaap--GainLossRelatedToLitigationSettlement_pn3n3_dm_c20220101__20221231_zLGhbm0wnFTk" title="Gain (Loss) Related to Litigation Settlement">7.8</span> million was accrued and included in accounts payable and accrued expenses in the consolidated balance sheets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 8, 2021, the Company received a letter from the SEC Division of Enforcement seeking the production of documents in connection with a non-public fact-finding inquiry by the SEC to determine whether violations of the federal securities laws have occurred. Subsequent to January 8, 2021, the Company received subpoenas for production of documents in connection with the matter. The investigation and requests from the SEC do not represent that the SEC has concluded that the Company or anyone else has violated the federal securities laws. The Company has cooperated and will continue to cooperate with the SEC staff in its investigation and requests. At this time, however, the Company cannot predict the length, scope, or results of the investigation or the impact, if any, of the investigation on our results of operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 16, 2022, Christian McCallion filed a class action lawsuit against the Company in the United States District Court for the Southern District of Florida. Plaintiff McCallion asserts that because of the Company’s delay in filing its Annual Report on Form 10-K for the year ended December 31, 2021, there was a decline in the market value of the Company’s securities and as a result, class members suffered significant losses and damages. On June 6, 2022 Judge Middlebrooks appointed a lead class plaintiff and the Company filed its Motion to Dismiss on August 5, 2022. As the Company has previously disclosed in its periodic reports filed with the SEC, prior to filing an application for an automatic fifteen (15) day extension of the original filing date, the Company experienced staffing limitations, unanticipated delays and identified material errors in previous filings. The Company does not believe it has committed any federal securities violations or made false and/or misleading statements and/or material omissions as alleged in the complaint. The Company intends to contest the claims vigorously on the merits.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 11, 2023, Doreen R. Lampert filed a derivative stockholder complaint against certain of the Company’s directors and a former officer and, nominally, against the Company, in the United Stated District Court of the District of Nevada. Plaintiff Lampert asserts that the same allegations giving rise to the McCallion class action lawsuit also support claims for breach of fiduciary duty against the directors and former officer, among other claims. The deadline to respond to the complaint will be March 21, 2023. The Company does not believe its directors or former officer have breached any fiduciary duties or are otherwise liable under the theories plead in the complaint and the Company intends to contest the claims.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 4, 2021, Plaintiffs Strong Arm Productions USA, Inc., Tramar Dillard p/k/a Flo Rida, and D3M Licensing Group, LLC filed a lawsuit against the Company in the Circuit Court of the 17th Judicial Circuit in and for Broward County, Florida. Plaintiffs asserted that the Company breached two endorsement and licensing agreements that were entered into between Plaintiffs and the Company in 2014 and 2016. Plaintiffs alleged the Company had reached certain revenue and sales benchmarks set forth in the 2014 agreement that entitled them to receive <span id="xdx_909_ecustom--SalesRevenueBenchMarkReceiveShares_c20210501__20210504__srt--StatementGeographicalAxis__stpr--FL__us-gaap--PlanNameAxis__custom--DthreemLicensingGroupMember_pdd" title="Sales revenue bench mark receive shares">750,000</span> shares of the Company’s stock. In addition, Plaintiffs claimed they were entitled to receive unspecified royalties under the 2016 agreement.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> A jury trial commenced on this matter on January 10, 2023. On January 18, 2023, the jury rendered a verdict against the Company for $<span id="xdx_90B_eus-gaap--LossContingencyDamagesSoughtValue_pn3n3_dm_c20230101__20230118__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zZ5dyBYAxawb" title="Compensatory damages">82.6</span> million in compensatory damages. On February 2, 2023, the Company filed post-trial motions seeking (i) judgment in favor of the Company dismissing the case notwithstanding the verdict based on the plain language of the contracts at issue; (ii) in the alternative, granting a new trial due to the numerous errors at trial; or (iii) in the alternative, reducing the award of damages to $<span id="xdx_90D_ecustom--ReducingAwardDamagesValue_pn3n3_dm_c20230101__20230118__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z87rfUSq0jVe" title="Reducing award damages value">2.1</span> million, which reflects the Company’s stock price on the date that the jury found the relevant revenue and sales benchmarks at issue were met. The judgment will accrue post-judgement interest at <span id="xdx_90E_ecustom--PostJudgmentInterest_dp_c20230201__20230213__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zohX0PbW3Qj2" title="Post-judgment interest rate">5.52</span> percent per year as of February 13, 2023</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> We believe that the jury verdict is not supported by the facts of the case or applicable law, is the result of significant trial error, and there are strong grounds for appeal. We will seek to overturn the verdict in post-trial motions before the trial court and the Company filed a notice of appeal to the Fourth District Court of Appeal for the State of Florida on February 21, 2023. The appeal is suspended pending disposition of the pending post-trial motions. We intend to vigorously challenge the judgment through all appropriate post-trial motions and appeal processes.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> As a result, we believe that the likelihood that the amount of the judgment will be affirmed is not probable. We have taken into consideration the events that have occurred after the reporting period and before the financial statements were issued. We currently estimate a range of possible outcomes between $<span id="xdx_900_eus-gaap--BusinessCombinationContingentConsiderationLiability_iI_pn3n3_dm_c20221231__srt--RangeAxis__srt--MinimumMember_zKrrgQbZNAW9" title="Accrued liability">2.1</span> million and $<span id="xdx_90A_eus-gaap--BusinessCombinationContingentConsiderationLiability_iI_pn3n3_dm_c20221231__srt--RangeAxis__srt--MaximumMember_zbRKaFnknOb7" title="Accrued liability">82.6</span> million, and we have accrued a liability as of December 31, 2022 at the lower end of the range, which is the amount we believe is the most likely estimate for a probable loss on this matter. This amount is reflected in Accounts payable and accrued expenses, and General and administrative expenses in our consolidated financial statements as of and for the year ended December 31, 2022. The ultimate loss to the Company of the litigation matter could be materially different from the amount the Company has accrued. The Company cannot predict or estimate the duration or ultimate outcome of this matter.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In addition to the foregoing, from time to time, we may become party to litigation or other legal proceedings that we consider to be a part of the ordinary course of our business.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Commitments</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has entered into distribution agreements with liquidated damages in case the Company cancels the distribution agreements without cause. Cause has been defined in various ways. If management makes the decision to terminate an agreement without cause, an estimate of expected damages is accrued, and an expense is recorded within operating expenses during the period in which termination was initiated.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2022 and 2021, we have contingent commitment to third parties of $<span id="xdx_908_ecustom--ContingentCommitmentToThirdParties_iI_pn3n3_dm_c20221231_zVE8VfvrSKb2" title="Contingent Commitment To Third Parties"><span id="xdx_909_ecustom--ContingentCommitmentToThirdParties_iI_pn3n3_dm_c20211231_zVQnE1v9Zzai" title="Contingent commitment to third parties">30.7</span></span> million. Our contingent commitments are primarily related to third party suppliers and have arisen through the normal course of business. The contingent commitments may have various terms, and none are individually significant.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally, our business and results of operations may be adversely affected by the business and economic uncertainty resulting from the pandemic and public health crises related to the COVID-19 outbreak, which is affecting the macro-economic environment.</span></p> -0.03 7800000 7800000 7800000 7800000 750000 82600000 2100000 0.0552 2100000 82600000 30700000 30700000 <p id="xdx_80B_eus-gaap--SubsequentEventsTextBlock_z72MM3qYj5tl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify; border-collapse: collapse"> <td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>20.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_823_zG5VTCgqpCnj">SUBSEQUENT EVENTS</span></b></span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company evaluates subsequent events and transactions that occur after the balance sheet date up to the date the consolidated financial statements are issued. Except for the matters discussed in Note 19, there were no other subsequent events that would have required adjustment or disclosure in the consolidated financial statements.</span></p> EXCEL 97 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 99 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 100 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.1 html 219 485 1 false 73 0 false 4 false false R1.htm 00000001 - Document - Cover Sheet http://celsius.com/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - Consolidated Balance Sheets Sheet http://celsius.com/role/BalanceSheets Consolidated Balance Sheets Statements 2 false false R3.htm 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://celsius.com/role/BalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Consolidated Statements of Operations and Comprehensive (Loss) Income Sheet http://celsius.com/role/StatementsOfOperationsAndComprehensiveLossIncome Consolidated Statements of Operations and Comprehensive (Loss) Income Statements 4 false false R5.htm 00000005 - Statement - Consolidated Statements of Changes in Stockholders' Equity and Mezzanine Equity Sheet http://celsius.com/role/StatementsOfChangesInStockholdersEquityAndMezzanineEquity Consolidated Statements of Changes in Stockholders' Equity and Mezzanine Equity Statements 5 false false R6.htm 00000006 - Statement - Consolidated Statements of Cash Flows Sheet http://celsius.com/role/StatementsOfCashFlows Consolidated Statements of Cash Flows Statements 6 false false R7.htm 00000007 - Disclosure - ORGANIZATION AND DESCRIPTION OF BUSINESS Sheet http://celsius.com/role/OrganizationAndDescriptionOfBusiness ORGANIZATION AND DESCRIPTION OF BUSINESS Notes 7 false false R8.htm 00000008 - Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 8 false false R9.htm 00000009 - Disclosure - EARNINGS PER SHARE Sheet http://celsius.com/role/EarningsPerShare EARNINGS PER SHARE Notes 9 false false R10.htm 00000010 - Disclosure - REVENUE Sheet http://celsius.com/role/Revenue REVENUE Notes 10 false false R11.htm 00000011 - Disclosure - INVENTORIES Sheet http://celsius.com/role/Inventories INVENTORIES Notes 11 false false R12.htm 00000012 - Disclosure - PREPAID EXPENSES AND OTHER CURRENT ASSETS Sheet http://celsius.com/role/PrepaidExpensesAndOtherCurrentAssets PREPAID EXPENSES AND OTHER CURRENT ASSETS Notes 12 false false R13.htm 00000013 - Disclosure - NOTE RECEIVABLE Sheet http://celsius.com/role/NoteReceivable NOTE RECEIVABLE Notes 13 false false R14.htm 00000014 - Disclosure - LEASES Sheet http://celsius.com/role/Leases LEASES Notes 14 false false R15.htm 00000015 - Disclosure - PROPERTY AND EQUIPMENT Sheet http://celsius.com/role/PropertyAndEquipment PROPERTY AND EQUIPMENT Notes 15 false false R16.htm 00000016 - Disclosure - GOODWILL AND INTANGIBLES Sheet http://celsius.com/role/GoodwillAndIntangibles GOODWILL AND INTANGIBLES Notes 16 false false R17.htm 00000017 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED EXPENSES Sheet http://celsius.com/role/AccountsPayableAndAccruedExpenses ACCOUNTS PAYABLE AND ACCRUED EXPENSES Notes 17 false false R18.htm 00000018 - Disclosure - OTHER CURRENT LIABILITIES Sheet http://celsius.com/role/OtherCurrentLiabilities OTHER CURRENT LIABILITIES Notes 18 false false R19.htm 00000019 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://celsius.com/role/RelatedPartyTransactions RELATED PARTY TRANSACTIONS Notes 19 false false R20.htm 00000020 - Disclosure - MEZZANINE EQUITY Sheet http://celsius.com/role/MezzanineEquity MEZZANINE EQUITY Notes 20 false false R21.htm 00000021 - Disclosure - STOCKHOLDERS??? EQUITY Sheet http://celsius.com/role/StockholdersEquity STOCKHOLDERS??? EQUITY Notes 21 false false R22.htm 00000022 - Disclosure - FAIR VALUE MEASUREMENTS Sheet http://celsius.com/role/FairValueMeasurements FAIR VALUE MEASUREMENTS Notes 22 false false R23.htm 00000023 - Disclosure - INCOME TAXES Sheet http://celsius.com/role/IncomeTaxes INCOME TAXES Notes 23 false false R24.htm 00000024 - Disclosure - STOCK-BASED COMPENSATION Sheet http://celsius.com/role/Stock-basedCompensation STOCK-BASED COMPENSATION Notes 24 false false R25.htm 00000025 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://celsius.com/role/CommitmentsAndContingencies COMMITMENTS AND CONTINGENCIES Notes 25 false false R26.htm 00000026 - Disclosure - SUBSEQUENT EVENTS Sheet http://celsius.com/role/SubsequentEvents SUBSEQUENT EVENTS Notes 26 false false R27.htm 00000027 - Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 27 false false R28.htm 00000028 - Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Tables http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies 28 false false R29.htm 00000029 - Disclosure - EARNINGS PER SHARE (Tables) Sheet http://celsius.com/role/EarningsPerShareTables EARNINGS PER SHARE (Tables) Tables http://celsius.com/role/EarningsPerShare 29 false false R30.htm 00000030 - Disclosure - REVENUE (Tables) Sheet http://celsius.com/role/RevenueTables REVENUE (Tables) Tables http://celsius.com/role/Revenue 30 false false R31.htm 00000031 - Disclosure - INVENTORIES (Tables) Sheet http://celsius.com/role/InventoriesTables INVENTORIES (Tables) Tables http://celsius.com/role/Inventories 31 false false R32.htm 00000032 - Disclosure - NOTE RECEIVABLE (Tables) Sheet http://celsius.com/role/NoteReceivableTables NOTE RECEIVABLE (Tables) Tables http://celsius.com/role/NoteReceivable 32 false false R33.htm 00000033 - Disclosure - LEASES (Tables) Sheet http://celsius.com/role/LeasesTables LEASES (Tables) Tables http://celsius.com/role/Leases 33 false false R34.htm 00000034 - Disclosure - PROPERTY AND EQUIPMENT (Tables) Sheet http://celsius.com/role/PropertyAndEquipmentTables PROPERTY AND EQUIPMENT (Tables) Tables http://celsius.com/role/PropertyAndEquipment 34 false false R35.htm 00000035 - Disclosure - GOODWILL AND INTANGIBLES (Tables) Sheet http://celsius.com/role/GoodwillAndIntangiblesTables GOODWILL AND INTANGIBLES (Tables) Tables http://celsius.com/role/GoodwillAndIntangibles 35 false false R36.htm 00000036 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Tables) Sheet http://celsius.com/role/AccountsPayableAndAccruedExpensesTables ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Tables) Tables http://celsius.com/role/AccountsPayableAndAccruedExpenses 36 false false R37.htm 00000037 - Disclosure - OTHER CURRENT LIABILITIES (Tables) Sheet http://celsius.com/role/OtherCurrentLiabilitiesTables OTHER CURRENT LIABILITIES (Tables) Tables http://celsius.com/role/OtherCurrentLiabilities 37 false false R38.htm 00000038 - Disclosure - FAIR VALUE MEASUREMENTS (Tables) Sheet http://celsius.com/role/FairValueMeasurementsTables FAIR VALUE MEASUREMENTS (Tables) Tables http://celsius.com/role/FairValueMeasurements 38 false false R39.htm 00000039 - Disclosure - INCOME TAXES (Tables) Sheet http://celsius.com/role/IncomeTaxesTables INCOME TAXES (Tables) Tables http://celsius.com/role/IncomeTaxes 39 false false R40.htm 00000040 - Disclosure - STOCK-BASED COMPENSATION (Tables) Sheet http://celsius.com/role/Stock-basedCompensationTables STOCK-BASED COMPENSATION (Tables) Tables http://celsius.com/role/Stock-basedCompensation 40 false false R41.htm 00000041 - Disclosure - ORGANIZATION AND DESCRIPTION OF BUSINESS (Details Narrative) Sheet http://celsius.com/role/OrganizationAndDescriptionOfBusinessDetailsNarrative ORGANIZATION AND DESCRIPTION OF BUSINESS (Details Narrative) Details http://celsius.com/role/OrganizationAndDescriptionOfBusiness 41 false false R42.htm 00000042 - Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) Sheet http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) Details http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables 42 false false R43.htm 00000043 - Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1) Sheet http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1 BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1) Details http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables 43 false false R44.htm 00000044 - Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Sheet http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Details http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables 44 false false R45.htm 00000045 - Disclosure - EARNINGS PER SHARE (Details) Sheet http://celsius.com/role/EarningsPerShareDetails EARNINGS PER SHARE (Details) Details http://celsius.com/role/EarningsPerShareTables 45 false false R46.htm 00000046 - Disclosure - EARNINGS PER SHARE (Details Narrative) Sheet http://celsius.com/role/EarningsPerShareDetailsNarrative EARNINGS PER SHARE (Details Narrative) Details http://celsius.com/role/EarningsPerShareTables 46 false false R47.htm 00000047 - Disclosure - REVENUE (Details) Sheet http://celsius.com/role/RevenueDetails REVENUE (Details) Details http://celsius.com/role/RevenueTables 47 false false R48.htm 00000048 - Disclosure - REVENUE (Details Narrative) Sheet http://celsius.com/role/RevenueDetailsNarrative REVENUE (Details Narrative) Details http://celsius.com/role/RevenueTables 48 false false R49.htm 00000049 - Disclosure - INVENTORIES (Details) Sheet http://celsius.com/role/InventoriesDetails INVENTORIES (Details) Details http://celsius.com/role/InventoriesTables 49 false false R50.htm 00000050 - Disclosure - PREPAID EXPENSES AND OTHER CURRENT ASSETS (Details Narrative) Sheet http://celsius.com/role/PrepaidExpensesAndOtherCurrentAssetsDetailsNarrative PREPAID EXPENSES AND OTHER CURRENT ASSETS (Details Narrative) Details http://celsius.com/role/PrepaidExpensesAndOtherCurrentAssets 50 false false R51.htm 00000051 - Disclosure - NOTE RECEIVABLE (Details) Sheet http://celsius.com/role/NoteReceivableDetails NOTE RECEIVABLE (Details) Details http://celsius.com/role/NoteReceivableTables 51 false false R52.htm 00000052 - Disclosure - NOTE RECEIVABLE (Details Narrative) Sheet http://celsius.com/role/NoteReceivableDetailsNarrative NOTE RECEIVABLE (Details Narrative) Details http://celsius.com/role/NoteReceivableTables 52 false false R53.htm 00000053 - Disclosure - LEASES (Details) Sheet http://celsius.com/role/LeasesDetails LEASES (Details) Details http://celsius.com/role/LeasesTables 53 false false R54.htm 00000054 - Disclosure - PROPERTY AND EQUIPMENT (Details) Sheet http://celsius.com/role/PropertyAndEquipmentDetails PROPERTY AND EQUIPMENT (Details) Details http://celsius.com/role/PropertyAndEquipmentTables 54 false false R55.htm 00000055 - Disclosure - PROPERTY AND EQUIPMENT (Details Narrative) Sheet http://celsius.com/role/PropertyAndEquipmentDetailsNarrative PROPERTY AND EQUIPMENT (Details Narrative) Details http://celsius.com/role/PropertyAndEquipmentTables 55 false false R56.htm 00000056 - Disclosure - GOODWILL AND INTANGIBLES (Details) Sheet http://celsius.com/role/GoodwillAndIntangiblesDetails GOODWILL AND INTANGIBLES (Details) Details http://celsius.com/role/GoodwillAndIntangiblesTables 56 false false R57.htm 00000057 - Disclosure - GOODWILL AND INTANGIBLES (Details 1) Sheet http://celsius.com/role/GoodwillAndIntangiblesDetails1 GOODWILL AND INTANGIBLES (Details 1) Details http://celsius.com/role/GoodwillAndIntangiblesTables 57 false false R58.htm 00000058 - Disclosure - GOODWILL AND INTANGIBLES (Details Narrative) Sheet http://celsius.com/role/GoodwillAndIntangiblesDetailsNarrative GOODWILL AND INTANGIBLES (Details Narrative) Details http://celsius.com/role/GoodwillAndIntangiblesTables 58 false false R59.htm 00000059 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details) Sheet http://celsius.com/role/AccountsPayableAndAccruedExpensesDetails ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details) Details http://celsius.com/role/AccountsPayableAndAccruedExpensesTables 59 false false R60.htm 00000060 - Disclosure - OTHER CURRENT LIABILITIES (Details) Sheet http://celsius.com/role/OtherCurrentLiabilitiesDetails OTHER CURRENT LIABILITIES (Details) Details http://celsius.com/role/OtherCurrentLiabilitiesTables 60 false false R61.htm 00000061 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative) Sheet http://celsius.com/role/RelatedPartyTransactionsDetailsNarrative RELATED PARTY TRANSACTIONS (Details Narrative) Details http://celsius.com/role/RelatedPartyTransactions 61 false false R62.htm 00000062 - Disclosure - MEZZANINE EQUITY (Details Narrative) Sheet http://celsius.com/role/MezzanineEquityDetailsNarrative MEZZANINE EQUITY (Details Narrative) Details http://celsius.com/role/MezzanineEquity 62 false false R63.htm 00000063 - Disclosure - STOCKHOLDERS??? EQUITY (Details Narrative) Sheet http://celsius.com/role/StockholdersEquityDetailsNarrative STOCKHOLDERS??? EQUITY (Details Narrative) Details http://celsius.com/role/StockholdersEquity 63 false false R64.htm 00000064 - Disclosure - FAIR VALUE MEASUREMENTS (Details) Sheet http://celsius.com/role/FairValueMeasurementsDetails FAIR VALUE MEASUREMENTS (Details) Details http://celsius.com/role/FairValueMeasurementsTables 64 false false R65.htm 00000065 - Disclosure - FAIR VALUE MEASUREMENTS (Details Narrative) Sheet http://celsius.com/role/FairValueMeasurementsDetailsNarrative FAIR VALUE MEASUREMENTS (Details Narrative) Details http://celsius.com/role/FairValueMeasurementsTables 65 false false R66.htm 00000066 - Disclosure - INCOME TAXES (Details) Sheet http://celsius.com/role/IncomeTaxesDetails INCOME TAXES (Details) Details http://celsius.com/role/IncomeTaxesTables 66 false false R67.htm 00000067 - Disclosure - INCOME TAXES (Details 1) Sheet http://celsius.com/role/IncomeTaxesDetails1 INCOME TAXES (Details 1) Details http://celsius.com/role/IncomeTaxesTables 67 false false R68.htm 00000068 - Disclosure - INCOME TAXES (Details 2) Sheet http://celsius.com/role/IncomeTaxesDetails2 INCOME TAXES (Details 2) Details http://celsius.com/role/IncomeTaxesTables 68 false false R69.htm 00000069 - Disclosure - INCOME TAXES (Details 3) Sheet http://celsius.com/role/IncomeTaxesDetails3 INCOME TAXES (Details 3) Details http://celsius.com/role/IncomeTaxesTables 69 false false R70.htm 00000070 - Disclosure - INCOME TAXES (Details 4) Sheet http://celsius.com/role/IncomeTaxesDetails4 INCOME TAXES (Details 4) Details http://celsius.com/role/IncomeTaxesTables 70 false false R71.htm 00000071 - Disclosure - INCOME TAXES (Details 5) Sheet http://celsius.com/role/IncomeTaxesDetails5 INCOME TAXES (Details 5) Details http://celsius.com/role/IncomeTaxesTables 71 false false R72.htm 00000072 - Disclosure - INCOME TAXES (Details Narrative) Sheet http://celsius.com/role/IncomeTaxesDetailsNarrative INCOME TAXES (Details Narrative) Details http://celsius.com/role/IncomeTaxesTables 72 false false R73.htm 00000073 - Disclosure - STOCK-BASED COMPENSATION (Details) Sheet http://celsius.com/role/Stock-basedCompensationDetails STOCK-BASED COMPENSATION (Details) Details http://celsius.com/role/Stock-basedCompensationTables 73 false false R74.htm 00000074 - Disclosure - STOCK-BASED COMPENSATION (Details 1) Sheet http://celsius.com/role/Stock-basedCompensationDetails1 STOCK-BASED COMPENSATION (Details 1) Details http://celsius.com/role/Stock-basedCompensationTables 74 false false R75.htm 00000075 - Disclosure - STOCK-BASED COMPENSATION (Details 2) Sheet http://celsius.com/role/Stock-basedCompensationDetails2 STOCK-BASED COMPENSATION (Details 2) Details http://celsius.com/role/Stock-basedCompensationTables 75 false false R76.htm 00000076 - Disclosure - STOCK-BASED COMPENSATION (Details 3) Sheet http://celsius.com/role/Stock-basedCompensationDetails3 STOCK-BASED COMPENSATION (Details 3) Details http://celsius.com/role/Stock-basedCompensationTables 76 false false R77.htm 00000077 - Disclosure - STOCK-BASED COMPENSATION (Details 4) Sheet http://celsius.com/role/Stock-basedCompensationDetails4 STOCK-BASED COMPENSATION (Details 4) Details http://celsius.com/role/Stock-basedCompensationTables 77 false false R78.htm 00000078 - Disclosure - STOCK-BASED COMPENSATION (Details 5) Sheet http://celsius.com/role/Stock-basedCompensationDetails5 STOCK-BASED COMPENSATION (Details 5) Details http://celsius.com/role/Stock-basedCompensationTables 78 false false R79.htm 00000079 - Disclosure - STOCK-BASED COMPENSATION (Details Narrative) Sheet http://celsius.com/role/Stock-basedCompensationDetailsNarrative STOCK-BASED COMPENSATION (Details Narrative) Details http://celsius.com/role/Stock-basedCompensationTables 79 false false R80.htm 00000080 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative) Sheet http://celsius.com/role/CommitmentsAndContingenciesDetailsNarrative COMMITMENTS AND CONTINGENCIES (Details Narrative) Details http://celsius.com/role/CommitmentsAndContingencies 80 false false All Reports Book All Reports celsiusholdings_10ka.htm celh-20221231.xsd celh-20221231_cal.xml celh-20221231_def.xml celh-20221231_lab.xml celh-20221231_pre.xml celsiusholdings_ex21-1.htm celsiusholdings_ex23-1.htm celsiusholdings_ex23-2.htm celsiusholdings_ex31-1.htm celsiusholdings_ex31-2.htm celsiusholdings_ex32-1.htm celsiusholdings_ex32-2.htm img_001.jpg img_002.jpg http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true JSON 102 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "celsiusholdings_10ka.htm": { "axisCustom": 0, "axisStandard": 20, "baseTaxonomies": { "http://fasb.org/us-gaap/2022": 906, "http://xbrl.sec.gov/dei/2022": 39 }, "contextCount": 219, "dts": { "calculationLink": { "local": [ "celh-20221231_cal.xml" ] }, "definitionLink": { "local": [ "celh-20221231_def.xml" ] }, "inline": { "local": [ "celsiusholdings_10ka.htm" ] }, "labelLink": { "local": [ "celh-20221231_lab.xml" ] }, "presentationLink": { "local": [ "celh-20221231_pre.xml" ] }, "schema": { "local": [ "celh-20221231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd", "https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd" ] } }, "elementCount": 686, "entityCount": 1, "hidden": { "http://celsius.com/20221231": 70, "http://fasb.org/us-gaap/2022": 121, "http://xbrl.sec.gov/dei/2022": 8, "total": 199 }, "keyCustom": 130, "keyStandard": 355, "memberCustom": 36, "memberStandard": 35, "nsprefix": "celh", "nsuri": "http://celsius.com/20221231", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "menuCat": "Cover", "order": "1", "role": "http://celsius.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "celh:RevenueTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000010 - Disclosure - REVENUE", "menuCat": "Notes", "order": "10", "role": "http://celsius.com/role/Revenue", "shortName": "REVENUE", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "celh:RevenueTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000011 - Disclosure - INVENTORIES", "menuCat": "Notes", "order": "11", "role": "http://celsius.com/role/Inventories", "shortName": "INVENTORIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "celh:PrepaidExpensesAndOtherCurrentAssetsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000012 - Disclosure - PREPAID EXPENSES AND OTHER CURRENT ASSETS", "menuCat": "Notes", "order": "12", "role": "http://celsius.com/role/PrepaidExpensesAndOtherCurrentAssets", "shortName": "PREPAID EXPENSES AND OTHER CURRENT ASSETS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "celh:PrepaidExpensesAndOtherCurrentAssetsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "celh:NoteReceivableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000013 - Disclosure - NOTE RECEIVABLE", "menuCat": "Notes", "order": "13", "role": "http://celsius.com/role/NoteReceivable", "shortName": "NOTE RECEIVABLE", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "celh:NoteReceivableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000014 - Disclosure - LEASES", "menuCat": "Notes", "order": "14", "role": "http://celsius.com/role/Leases", "shortName": "LEASES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000015 - Disclosure - PROPERTY AND EQUIPMENT", "menuCat": "Notes", "order": "15", "role": "http://celsius.com/role/PropertyAndEquipment", "shortName": "PROPERTY AND EQUIPMENT", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000016 - Disclosure - GOODWILL AND INTANGIBLES", "menuCat": "Notes", "order": "16", "role": "http://celsius.com/role/GoodwillAndIntangibles", "shortName": "GOODWILL AND INTANGIBLES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000017 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED EXPENSES", "menuCat": "Notes", "order": "17", "role": "http://celsius.com/role/AccountsPayableAndAccruedExpenses", "shortName": "ACCOUNTS PAYABLE AND ACCRUED EXPENSES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherCurrentLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000018 - Disclosure - OTHER CURRENT LIABILITIES", "menuCat": "Notes", "order": "18", "role": "http://celsius.com/role/OtherCurrentLiabilities", "shortName": "OTHER CURRENT LIABILITIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherCurrentLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000019 - Disclosure - RELATED PARTY TRANSACTIONS", "menuCat": "Notes", "order": "19", "role": "http://celsius.com/role/RelatedPartyTransactions", "shortName": "RELATED PARTY TRANSACTIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000002 - Statement - Consolidated Balance Sheets", "menuCat": "Statements", "order": "2", "role": "http://celsius.com/role/BalanceSheets", "shortName": "Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000020 - Disclosure - MEZZANINE EQUITY", "menuCat": "Notes", "order": "20", "role": "http://celsius.com/role/MezzanineEquity", "shortName": "MEZZANINE EQUITY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000021 - Disclosure - STOCKHOLDERS\u2019 EQUITY", "menuCat": "Notes", "order": "21", "role": "http://celsius.com/role/StockholdersEquity", "shortName": "STOCKHOLDERS\u2019 EQUITY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000022 - Disclosure - FAIR VALUE MEASUREMENTS", "menuCat": "Notes", "order": "22", "role": "http://celsius.com/role/FairValueMeasurements", "shortName": "FAIR VALUE MEASUREMENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000023 - Disclosure - INCOME TAXES", "menuCat": "Notes", "order": "23", "role": "http://celsius.com/role/IncomeTaxes", "shortName": "INCOME TAXES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000024 - Disclosure - STOCK-BASED COMPENSATION", "menuCat": "Notes", "order": "24", "role": "http://celsius.com/role/Stock-basedCompensation", "shortName": "STOCK-BASED COMPENSATION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000025 - Disclosure - COMMITMENTS AND CONTINGENCIES", "menuCat": "Notes", "order": "25", "role": "http://celsius.com/role/CommitmentsAndContingencies", "shortName": "COMMITMENTS AND CONTINGENCIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000026 - Disclosure - SUBSEQUENT EVENTS", "menuCat": "Notes", "order": "26", "role": "http://celsius.com/role/SubsequentEvents", "shortName": "SUBSEQUENT EVENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000027 - Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "menuCat": "Policies", "order": "27", "role": "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies", "shortName": "BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "us-gaap:ConcentrationRiskCreditRisk", "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000028 - Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "menuCat": "Tables", "order": "28", "role": "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables", "shortName": "BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:ConcentrationRiskCreditRisk", "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000029 - Disclosure - EARNINGS PER SHARE (Tables)", "menuCat": "Tables", "order": "29", "role": "http://celsius.com/role/EarningsPerShareTables", "shortName": "EARNINGS PER SHARE (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "AsOf2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000003 - Statement - Consolidated Balance Sheets (Parenthetical)", "menuCat": "Statements", "order": "3", "role": "http://celsius.com/role/BalanceSheetsParenthetical", "shortName": "Consolidated Balance Sheets (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "AsOf2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "celh:RevenueTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000030 - Disclosure - REVENUE (Tables)", "menuCat": "Tables", "order": "30", "role": "http://celsius.com/role/RevenueTables", "shortName": "REVENUE (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "celh:RevenueTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000031 - Disclosure - INVENTORIES (Tables)", "menuCat": "Tables", "order": "31", "role": "http://celsius.com/role/InventoriesTables", "shortName": "INVENTORIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "celh:NoteReceivableTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "celh:ScheduleOfNoteReceivableTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000032 - Disclosure - NOTE RECEIVABLE (Tables)", "menuCat": "Tables", "order": "32", "role": "http://celsius.com/role/NoteReceivableTables", "shortName": "NOTE RECEIVABLE (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "celh:NoteReceivableTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "celh:ScheduleOfNoteReceivableTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "celh:ScheduleOfMaturitiesOfOperatingAndFinanceLeasesLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000033 - Disclosure - LEASES (Tables)", "menuCat": "Tables", "order": "33", "role": "http://celsius.com/role/LeasesTables", "shortName": "LEASES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "celh:ScheduleOfMaturitiesOfOperatingAndFinanceLeasesLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000034 - Disclosure - PROPERTY AND EQUIPMENT (Tables)", "menuCat": "Tables", "order": "34", "role": "http://celsius.com/role/PropertyAndEquipmentTables", "shortName": "PROPERTY AND EQUIPMENT (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000035 - Disclosure - GOODWILL AND INTANGIBLES (Tables)", "menuCat": "Tables", "order": "35", "role": "http://celsius.com/role/GoodwillAndIntangiblesTables", "shortName": "GOODWILL AND INTANGIBLES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000036 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Tables)", "menuCat": "Tables", "order": "36", "role": "http://celsius.com/role/AccountsPayableAndAccruedExpensesTables", "shortName": "ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "us-gaap:OtherCurrentLiabilitiesTableTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "celh:ScheduleOfOtherCurrentLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000037 - Disclosure - OTHER CURRENT LIABILITIES (Tables)", "menuCat": "Tables", "order": "37", "role": "http://celsius.com/role/OtherCurrentLiabilitiesTables", "shortName": "OTHER CURRENT LIABILITIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:OtherCurrentLiabilitiesTableTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "celh:ScheduleOfOtherCurrentLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000038 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)", "menuCat": "Tables", "order": "38", "role": "http://celsius.com/role/FairValueMeasurementsTables", "shortName": "FAIR VALUE MEASUREMENTS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000039 - Disclosure - INCOME TAXES (Tables)", "menuCat": "Tables", "order": "39", "role": "http://celsius.com/role/IncomeTaxesTables", "shortName": "INCOME TAXES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000004 - Statement - Consolidated Statements of Operations and Comprehensive (Loss) Income", "menuCat": "Statements", "order": "4", "role": "http://celsius.com/role/StatementsOfOperationsAndComprehensiveLossIncome", "shortName": "Consolidated Statements of Operations and Comprehensive (Loss) Income", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "lang": null, "name": "us-gaap:CostOfRevenue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000040 - Disclosure - STOCK-BASED COMPENSATION (Tables)", "menuCat": "Tables", "order": "40", "role": "http://celsius.com/role/Stock-basedCompensationTables", "shortName": "STOCK-BASED COMPENSATION (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:NatureOfOperations", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-012022-12-31_custom_TransitionAgreementMember", "decimals": "-3", "first": true, "lang": null, "name": "celh:TerminationExpensesSalesAndMarketing", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000041 - Disclosure - ORGANIZATION AND DESCRIPTION OF BUSINESS (Details Narrative)", "menuCat": "Details", "order": "41", "role": "http://celsius.com/role/OrganizationAndDescriptionOfBusinessDetailsNarrative", "shortName": "ORGANIZATION AND DESCRIPTION OF BUSINESS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:NatureOfOperations", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-07-292022-08-01_custom_TransitionAgreementMember_us-gaap_ConvertiblePreferredStockMember", "decimals": "INF", "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "us-gaap:ConcentrationRiskCreditRisk", "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-012022-12-31_us-gaap_SalesRevenueNetMember_custom_CustomerConcentrationRiskTotalMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ConcentrationRiskPercentage1", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000042 - Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)", "menuCat": "Details", "order": "42", "role": "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails", "shortName": "BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "us-gaap:ConcentrationRiskCreditRisk", "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-012022-12-31_us-gaap_SalesRevenueNetMember_custom_CustomerConcentrationRiskTotalMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ConcentrationRiskPercentage1", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock", "celh:LonglivedAssetGeographicDataPolicyTextBlock", "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "celh:TotalLonglivedAssets", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000043 - Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1)", "menuCat": "Details", "order": "43", "role": "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1", "shortName": "BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock", "celh:LonglivedAssetGeographicDataPolicyTextBlock", "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "celh:TotalLonglivedAssets", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:ConcentrationRiskCreditRisk", "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashUninsuredAmount", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000044 - Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)", "menuCat": "Details", "order": "44", "role": "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "shortName": "BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:ConcentrationRiskCreditRisk", "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashUninsuredAmount", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000045 - Disclosure - EARNINGS PER SHARE (Details)", "menuCat": "Details", "order": "45", "role": "http://celsius.com/role/EarningsPerShareDetails", "shortName": "EARNINGS PER SHARE (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R46": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "celh:PotentiallyDilutiveSharesOutstanding", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000046 - Disclosure - EARNINGS PER SHARE (Details Narrative)", "menuCat": "Details", "order": "46", "role": "http://celsius.com/role/EarningsPerShareDetailsNarrative", "shortName": "EARNINGS PER SHARE (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "celh:PotentiallyDilutiveSharesOutstanding", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000047 - Disclosure - REVENUE (Details)", "menuCat": "Details", "order": "47", "role": "http://celsius.com/role/RevenueDetails", "shortName": "REVENUE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "celh:RevenueTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-012022-12-31_srt_NorthAmericaMember", "decimals": "-3", "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "span", "span", "p", "celh:RevenueTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "celh:PromotionalAllowanceIncludedAsAReductionOfRevenue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000048 - Disclosure - REVENUE (Details Narrative)", "menuCat": "Details", "order": "48", "role": "http://celsius.com/role/RevenueDetailsNarrative", "shortName": "REVENUE (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "celh:RevenueTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "celh:PromotionalAllowanceIncludedAsAReductionOfRevenue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InventoryFinishedGoods", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000049 - Disclosure - INVENTORIES (Details)", "menuCat": "Details", "order": "49", "role": "http://celsius.com/role/InventoriesDetails", "shortName": "INVENTORIES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InventoryFinishedGoods", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "AsOf2019-12-31_us-gaap_CommonStockMember", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000005 - Statement - Consolidated Statements of Changes in Stockholders' Equity and Mezzanine Equity", "menuCat": "Statements", "order": "5", "role": "http://celsius.com/role/StatementsOfChangesInStockholdersEquityAndMezzanineEquity", "shortName": "Consolidated Statements of Changes in Stockholders' Equity and Mezzanine Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "AsOf2019-12-31_us-gaap_CommonStockMember", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:PrepaidExpenseAndOtherAssetsCurrent", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000050 - Disclosure - PREPAID EXPENSES AND OTHER CURRENT ASSETS (Details Narrative)", "menuCat": "Details", "order": "50", "role": "http://celsius.com/role/PrepaidExpensesAndOtherCurrentAssetsDetailsNarrative", "shortName": "PREPAID EXPENSES AND OTHER CURRENT ASSETS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": null }, "R51": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:NotesAndLoansReceivableNetCurrent", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000051 - Disclosure - NOTE RECEIVABLE (Details)", "menuCat": "Details", "order": "51", "role": "http://celsius.com/role/NoteReceivableDetails", "shortName": "NOTE RECEIVABLE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "celh:ScheduleOfNoteReceivableTableTextBlock", "celh:NoteReceivableTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "lang": null, "name": "us-gaap:NotesReceivableNet", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "span", "span", "p", "celh:NoteReceivableTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "celh:NoteReceivableDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000052 - Disclosure - NOTE RECEIVABLE (Details Narrative)", "menuCat": "Details", "order": "52", "role": "http://celsius.com/role/NoteReceivableDetailsNarrative", "shortName": "NOTE RECEIVABLE (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "celh:NoteReceivableTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "celh:NoteReceivableDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "celh:ScheduleOfMaturitiesOfOperatingAndFinanceLeasesLiabilitiesTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000053 - Disclosure - LEASES (Details)", "menuCat": "Details", "order": "53", "role": "http://celsius.com/role/LeasesDetails", "shortName": "LEASES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "celh:ScheduleOfMaturitiesOfOperatingAndFinanceLeasesLiabilitiesTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000054 - Disclosure - PROPERTY AND EQUIPMENT (Details)", "menuCat": "Details", "order": "54", "role": "http://celsius.com/role/PropertyAndEquipmentDetails", "shortName": "PROPERTY AND EQUIPMENT (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:Depreciation", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000055 - Disclosure - PROPERTY AND EQUIPMENT (Details Narrative)", "menuCat": "Details", "order": "55", "role": "http://celsius.com/role/PropertyAndEquipmentDetailsNarrative", "shortName": "PROPERTY AND EQUIPMENT (Details Narrative)", "subGroupType": "details", "uniqueAnchor": null }, "R56": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FiniteLivedCustomerRelationshipsGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000056 - Disclosure - GOODWILL AND INTANGIBLES (Details)", "menuCat": "Details", "order": "56", "role": "http://celsius.com/role/GoodwillAndIntangiblesDetails", "shortName": "GOODWILL AND INTANGIBLES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FiniteLivedCustomerRelationshipsGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000057 - Disclosure - GOODWILL AND INTANGIBLES (Details 1)", "menuCat": "Details", "order": "57", "role": "http://celsius.com/role/GoodwillAndIntangiblesDetails1", "shortName": "GOODWILL AND INTANGIBLES (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:IntangibleAssetsNetIncludingGoodwill", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000058 - Disclosure - GOODWILL AND INTANGIBLES (Details Narrative)", "menuCat": "Details", "order": "58", "role": "http://celsius.com/role/GoodwillAndIntangiblesDetailsNarrative", "shortName": "GOODWILL AND INTANGIBLES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:IntangibleAssetsNetIncludingGoodwill", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AccountsPayableCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000059 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details)", "menuCat": "Details", "order": "59", "role": "http://celsius.com/role/AccountsPayableAndAccruedExpensesDetails", "shortName": "ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AccountsPayableCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000006 - Statement - Consolidated Statements of Cash Flows", "menuCat": "Statements", "order": "6", "role": "http://celsius.com/role/StatementsOfCashFlows", "shortName": "Consolidated Statements of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "lang": null, "name": "us-gaap:AdjustmentForAmortization", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "celh:ScheduleOfOtherCurrentLiabilitiesTableTextBlock", "us-gaap:OtherCurrentLiabilitiesTableTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "celh:ValueAddedTaxPayment", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000060 - Disclosure - OTHER CURRENT LIABILITIES (Details)", "menuCat": "Details", "order": "60", "role": "http://celsius.com/role/OtherCurrentLiabilitiesDetails", "shortName": "OTHER CURRENT LIABILITIES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "celh:ScheduleOfOtherCurrentLiabilitiesTableTextBlock", "us-gaap:OtherCurrentLiabilitiesTableTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "celh:ValueAddedTaxPayment", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "span", "span", "p", "celh:DeferredRevenuePolicyTextBlock", "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DeferredRevenue", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000061 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)", "menuCat": "Details", "order": "61", "role": "http://celsius.com/role/RelatedPartyTransactionsDetailsNarrative", "shortName": "RELATED PARTY TRANSACTIONS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-012022-12-31_custom_PepsicoIncMember427882406", "decimals": "INF", "lang": null, "name": "celh:PercentageOfRelatedPartyCommonStockOutstanding", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R62": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "celh:PercentageOfVotingRightPreferredStock", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000062 - Disclosure - MEZZANINE EQUITY (Details Narrative)", "menuCat": "Details", "order": "62", "role": "http://celsius.com/role/MezzanineEquityDetailsNarrative", "shortName": "MEZZANINE EQUITY (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "celh:PercentageOfVotingRightPreferredStock", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R63": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ProceedsFromStockOptionsExercised", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000063 - Disclosure - STOCKHOLDERS\u2019 EQUITY (Details Narrative)", "menuCat": "Details", "order": "63", "role": "http://celsius.com/role/StockholdersEquityDetailsNarrative", "shortName": "STOCKHOLDERS\u2019 EQUITY (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2021-06-012021-06-09", "decimals": "INF", "lang": null, "name": "us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R64": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "AsOf2022-12-31_us-gaap_FairValueInputsLevel2Member", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:PreferredStockValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000064 - Disclosure - FAIR VALUE MEASUREMENTS (Details)", "menuCat": "Details", "order": "64", "role": "http://celsius.com/role/FairValueMeasurementsDetails", "shortName": "FAIR VALUE MEASUREMENTS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "AsOf2022-12-31_us-gaap_FairValueInputsLevel2Member", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:PreferredStockValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R65": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "AsOf2022-08-01_us-gaap_SeriesAPreferredStockMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockSharesIssued", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000065 - Disclosure - FAIR VALUE MEASUREMENTS (Details Narrative)", "menuCat": "Details", "order": "65", "role": "http://celsius.com/role/FairValueMeasurementsDetailsNarrative", "shortName": "FAIR VALUE MEASUREMENTS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "AsOf2022-08-01_us-gaap_SeriesAPreferredStockMember", "decimals": "INF", "lang": null, "name": "us-gaap:LongDurationContractsAssumptionsByProductAndGuaranteeVolatilityRate", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R66": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000066 - Disclosure - INCOME TAXES (Details)", "menuCat": "Details", "order": "66", "role": "http://celsius.com/role/IncomeTaxesDetails", "shortName": "INCOME TAXES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-012022-12-31_us-gaap_DomesticCountryMember", "decimals": "-3", "lang": null, "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R67": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "celh:CurrentDomesticTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000067 - Disclosure - INCOME TAXES (Details 1)", "menuCat": "Details", "order": "67", "role": "http://celsius.com/role/IncomeTaxesDetails1", "shortName": "INCOME TAXES (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "celh:CurrentDomesticTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R68": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000068 - Disclosure - INCOME TAXES (Details 2)", "menuCat": "Details", "order": "68", "role": "http://celsius.com/role/IncomeTaxesDetails2", "shortName": "INCOME TAXES (Details 2)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R69": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000069 - Disclosure - INCOME TAXES (Details 3)", "menuCat": "Details", "order": "69", "role": "http://celsius.com/role/IncomeTaxesDetails3", "shortName": "INCOME TAXES (Details 3)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000007 - Disclosure - ORGANIZATION AND DESCRIPTION OF BUSINESS", "menuCat": "Notes", "order": "7", "role": "http://celsius.com/role/OrganizationAndDescriptionOfBusiness", "shortName": "ORGANIZATION AND DESCRIPTION OF BUSINESS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R70": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "AsOf2021-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:UnrecognizedTaxBenefits", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000070 - Disclosure - INCOME TAXES (Details 4)", "menuCat": "Details", "order": "70", "role": "http://celsius.com/role/IncomeTaxesDetails4", "shortName": "INCOME TAXES (Details 4)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "AsOf2020-12-31", "decimals": "-3", "lang": null, "name": "us-gaap:UnrecognizedTaxBenefits", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R71": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "celh:SummaryOfTheFilingJurisdictionsAndOpenTaxYearsTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-012022-12-31_srt_MinimumMember_us-gaap_NonUsMember", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OpenTaxYear", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000071 - Disclosure - INCOME TAXES (Details 5)", "menuCat": "Details", "order": "71", "role": "http://celsius.com/role/IncomeTaxesDetails5", "shortName": "INCOME TAXES (Details 5)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "celh:SummaryOfTheFilingJurisdictionsAndOpenTaxYearsTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-012022-12-31_srt_MinimumMember_us-gaap_NonUsMember", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OpenTaxYear", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R72": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "AsOf2021-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000072 - Disclosure - INCOME TAXES (Details Narrative)", "menuCat": "Details", "order": "72", "role": "http://celsius.com/role/IncomeTaxesDetailsNarrative", "shortName": "INCOME TAXES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "AsOf2021-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R73": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2021-01-012021-12-31", "decimals": "INF", "first": true, "lang": null, "name": "celh:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000073 - Disclosure - STOCK-BASED COMPENSATION (Details)", "menuCat": "Details", "order": "73", "role": "http://celsius.com/role/Stock-basedCompensationDetails", "shortName": "STOCK-BASED COMPENSATION (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2021-01-012021-12-31", "decimals": "INF", "first": true, "lang": null, "name": "celh:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R74": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "AsOf2021-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000074 - Disclosure - STOCK-BASED COMPENSATION (Details 1)", "menuCat": "Details", "order": "74", "role": "http://celsius.com/role/Stock-basedCompensationDetails1", "shortName": "STOCK-BASED COMPENSATION (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "lang": "en-US", "name": "celh:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerms2", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R75": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "AsOf2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000075 - Disclosure - STOCK-BASED COMPENSATION (Details 2)", "menuCat": "Details", "order": "75", "role": "http://celsius.com/role/Stock-basedCompensationDetails2", "shortName": "STOCK-BASED COMPENSATION (Details 2)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "AsOf2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R76": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "AsOf2021-12-31_us-gaap_RestrictedStockMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000076 - Disclosure - STOCK-BASED COMPENSATION (Details 3)", "menuCat": "Details", "order": "76", "role": "http://celsius.com/role/Stock-basedCompensationDetails3", "shortName": "STOCK-BASED COMPENSATION (Details 3)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "AsOf2020-12-31_us-gaap_RestrictedStockMember", "decimals": "INF", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R77": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "AsOf2021-12-31_us-gaap_RestrictedStockUnitsRSUMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000077 - Disclosure - STOCK-BASED COMPENSATION (Details 4)", "menuCat": "Details", "order": "77", "role": "http://celsius.com/role/Stock-basedCompensationDetails4", "shortName": "STOCK-BASED COMPENSATION (Details 4)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2021-01-012021-12-31_us-gaap_RestrictedStockUnitsRSUMember", "decimals": "INF", "lang": null, "name": "celh:TransfersToRestrictedStockUnits", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R78": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "celh:ScheduleOfStockBasedAwardsIssuedToNonEmployeeConsultantsTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "AsOf2021-12-31_us-gaap_PerformanceSharesMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000078 - Disclosure - STOCK-BASED COMPENSATION (Details 5)", "menuCat": "Details", "order": "78", "role": "http://celsius.com/role/Stock-basedCompensationDetails5", "shortName": "STOCK-BASED COMPENSATION (Details 5)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "celh:ScheduleOfStockBasedAwardsIssuedToNonEmployeeConsultantsTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-012022-12-31_us-gaap_PerformanceSharesMember", "decimals": "INF", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R79": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "AsOf2015-04-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000079 - Disclosure - STOCK-BASED COMPENSATION (Details Narrative)", "menuCat": "Details", "order": "79", "role": "http://celsius.com/role/Stock-basedCompensationDetailsNarrative", "shortName": "STOCK-BASED COMPENSATION (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "AsOf2015-04-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000008 - Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "menuCat": "Notes", "order": "8", "role": "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies", "shortName": "BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R80": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2020-11-012020-11-30", "decimals": "INF", "first": true, "lang": null, "name": "celh:PercentageOfFeeReceived", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000080 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)", "menuCat": "Details", "order": "80", "role": "http://celsius.com/role/CommitmentsAndContingenciesDetailsNarrative", "shortName": "COMMITMENTS AND CONTINGENCIES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2020-11-012020-11-30", "decimals": "INF", "first": true, "lang": null, "name": "celh:PercentageOfFeeReceived", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000009 - Disclosure - EARNINGS PER SHARE", "menuCat": "Notes", "order": "9", "role": "http://celsius.com/role/EarningsPerShare", "shortName": "EARNINGS PER SHARE", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "celsiusholdings_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 73, "tag": { "celh_AccountsReceivableFromRelatedParty": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Accounts receivable from related party" } } }, "localname": "AccountsReceivableFromRelatedParty", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "celh_AccruedDistributorTerminationFeesPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accrued Distributor Termination Fees" } } }, "localname": "AccruedDistributorTerminationFeesPolicyTextBlock", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "celh_AccruedDividend": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Accrued dividend", "label": "Accrued dividend" } } }, "localname": "AccruedDividend", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/MezzanineEquityDetailsNarrative" ], "xbrltype": "percentItemType" }, "celh_AccruedFreight": { "auth_ref": [], "calculation": { "http://celsius.com/role/AccountsPayableAndAccruedExpensesDetails": { "order": 3.0, "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accrued freight", "label": "Accrued freight" } } }, "localname": "AccruedFreight", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/AccountsPayableAndAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "celh_AccruedPromotionalAllowance": { "auth_ref": [], "calculation": { "http://celsius.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Accrued promotional allowance" } } }, "localname": "AccruedPromotionalAllowance", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "celh_AdditionalSharePurchase": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Additional share purchase", "label": "Additional share purchase" } } }, "localname": "AdditionalSharePurchase", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "celh_AllOtherMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "All Other [Member]" } } }, "localname": "AllOtherMember", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "celh_AmazonMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Amazon [Member]" } } }, "localname": "AmazonMember", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "celh_AmortizationOfDeferredOtherCosts": { "auth_ref": [], "calculation": { "http://celsius.com/role/StatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Amortization of deferred other costs" } } }, "localname": "AmortizationOfDeferredOtherCosts", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "celh_AmortizationOfDiscountOnBondsPayable": { "auth_ref": [], "calculation": { "http://celsius.com/role/StatementsOfOperationsAndComprehensiveLossIncome": { "order": 4.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Amortization of discount on bonds payable" } } }, "localname": "AmortizationOfDiscountOnBondsPayable", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/StatementsOfOperationsAndComprehensiveLossIncome" ], "xbrltype": "monetaryItemType" }, "celh_BrandsTotalCarryingAmount": { "auth_ref": [], "calculation": { "http://celsius.com/role/GoodwillAndIntangiblesDetails": { "order": 1.0, "parentTag": "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Brands total carrying amount", "label": "Brands" } } }, "localname": "BrandsTotalCarryingAmount", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/GoodwillAndIntangiblesDetails" ], "xbrltype": "monetaryItemType" }, "celh_CDFinancialLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "It represents legal entity associated with the company.", "label": "C D Financial L L C [Member]" } } }, "localname": "CDFinancialLLCMember", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "celh_CashConsiderationToRelatedParty": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cash consideration to related party.", "label": "Cash Consideration to Related Party" } } }, "localname": "CashConsiderationToRelatedParty", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/MezzanineEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "celh_CashPaidDuringPeriodForabstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash paid during period for:" } } }, "localname": "CashPaidDuringPeriodForabstract", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "celh_CashPaidForTaxesOnRestrictedStockAwards": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Cash paid for taxes on restricted stock awards", "label": "Cash paid for taxes on restricted stock awards" } } }, "localname": "CashPaidForTaxesOnRestrictedStockAwards", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/StatementsOfChangesInStockholdersEquityAndMezzanineEquity" ], "xbrltype": "monetaryItemType" }, "celh_ChangeInRightToUseAndLeaseObligationnet": { "auth_ref": [], "calculation": { "http://celsius.com/role/StatementsOfCashFlows": { "order": 20.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Change in right of use and lease obligation-net" } } }, "localname": "ChangeInRightToUseAndLeaseObligationnet", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "celh_ChangeInValuationAllowanceIncludingEffectOfChangeInTaxRate": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Change in valuation allowance" } } }, "localname": "ChangeInValuationAllowanceIncludingEffectOfChangeInTaxRate", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/IncomeTaxesDetails2" ], "xbrltype": "percentItemType" }, "celh_ClosingPrice": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Closing Price" } } }, "localname": "ClosingPrice", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/FairValueMeasurementsDetailsNarrative" ], "xbrltype": "perShareItemType" }, "celh_CompanyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Company [Member]" } } }, "localname": "CompanyMember", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "celh_ContingentCommitmentToThirdParties": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Contingent commitment to third parties.", "label": "Contingent commitment to third parties" } } }, "localname": "ContingentCommitmentToThirdParties", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "celh_ContraRevenues": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "contra-revenues", "label": "contra-revenues" } } }, "localname": "ContraRevenues", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/RevenueDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "celh_ContractAssetsCurrentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Contract Assets Current [Member]", "label": "Contract Assets Current [Member]" } } }, "localname": "ContractAssetsCurrentMember", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "celh_ContractAssetsNonCurrentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Contract Assets Non Current [Member]", "label": "Contract Assets Non Current [Member]" } } }, "localname": "ContractAssetsNonCurrentMember", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "celh_CostcoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Costco [Member]" } } }, "localname": "CostcoMember", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "celh_CurrentDomesticTaxExpenseBenefit": { "auth_ref": [], "calculation": { "http://celsius.com/role/IncomeTaxesDetails1": { "order": 1.0, "parentTag": "us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Domestic", "label": "Domestic" } } }, "localname": "CurrentDomesticTaxExpenseBenefit", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/IncomeTaxesDetails1" ], "xbrltype": "monetaryItemType" }, "celh_CustomerAdvancePoliciesTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Customer Advances" } } }, "localname": "CustomerAdvancePoliciesTextBlock", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "celh_CustomerConcentrationRiskTotalMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Customer Concentration Risk Total [Member]" } } }, "localname": "CustomerConcentrationRiskTotalMember", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "celh_DeferredContractAssetInOtherAssets": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred Contract Asset in Other Assets", "label": "Deferred contract asset in other assets" } } }, "localname": "DeferredContractAssetInOtherAssets", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "celh_DeferredContractCostsCurrent": { "auth_ref": [], "calculation": { "http://celsius.com/role/BalanceSheets": { "order": 7.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Deferred other costs-current" } } }, "localname": "DeferredContractCostsCurrent", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "celh_DeferredDomesticIncomeTaxExpenseBenefit": { "auth_ref": [], "calculation": { "http://celsius.com/role/IncomeTaxesDetails1": { "order": 1.0, "parentTag": "us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Domestic", "label": "Deferred Domestic Income Tax Expense Benefit", "verboseLabel": "Domestic" } } }, "localname": "DeferredDomesticIncomeTaxExpenseBenefit", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/IncomeTaxesDetails1" ], "xbrltype": "monetaryItemType" }, "celh_DeferredOtherCostsNonCurrent": { "auth_ref": [], "calculation": { "http://celsius.com/role/BalanceSheets": { "order": 8.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Deferred other costs-non-current" } } }, "localname": "DeferredOtherCostsNonCurrent", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "celh_DeferredRevenuePolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred Revenue" } } }, "localname": "DeferredRevenuePolicyTextBlock", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "celh_DeferredTaxAssetsDistributorTerminationFees": { "auth_ref": [], "calculation": { "http://celsius.com/role/IncomeTaxesDetails3": { "order": 7.0, "parentTag": "celh_DeferredTaxAssetsLiabilitiesGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred Tax Assets, Distributor Termination Fees", "label": "Distributor termination fees" } } }, "localname": "DeferredTaxAssetsDistributorTerminationFees", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/IncomeTaxesDetails3" ], "xbrltype": "monetaryItemType" }, "celh_DeferredTaxAssetsLiabilitiesGross": { "auth_ref": [], "calculation": { "http://celsius.com/role/IncomeTaxesDetails3": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "DeferredTaxAssetsLiabilitiesGross", "totalLabel": "Total deferred tax (liabilities) assets" } } }, "localname": "DeferredTaxAssetsLiabilitiesGross", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/IncomeTaxesDetails3" ], "xbrltype": "monetaryItemType" }, "celh_DeferredTaxAssetsPepsiValuationPremium": { "auth_ref": [], "calculation": { "http://celsius.com/role/IncomeTaxesDetails3": { "order": 4.0, "parentTag": "celh_DeferredTaxAssetsLiabilitiesGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred Tax Assets, Pepsi Valuation Premium", "label": "Pepsi valuation premium" } } }, "localname": "DeferredTaxAssetsPepsiValuationPremium", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/IncomeTaxesDetails3" ], "xbrltype": "monetaryItemType" }, "celh_DeferredTaxAssetsRightOfUseAsset": { "auth_ref": [], "calculation": { "http://celsius.com/role/IncomeTaxesDetails3": { "order": 6.0, "parentTag": "celh_DeferredTaxAssetsLiabilitiesGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred Tax Assets, Right of Use Asset", "label": "Right of use asset" } } }, "localname": "DeferredTaxAssetsRightOfUseAsset", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/IncomeTaxesDetails3" ], "xbrltype": "monetaryItemType" }, "celh_DeferredTaxAssetsRightOfUseLiability": { "auth_ref": [], "calculation": { "http://celsius.com/role/IncomeTaxesDetails3": { "order": 5.0, "parentTag": "celh_DeferredTaxAssetsLiabilitiesGross", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Deferred Tax Assets, Right of Use Liability", "label": "Deferred Tax Assets, Right of Use Liability", "negatedLabel": "Right of use liability" } } }, "localname": "DeferredTaxAssetsRightOfUseLiability", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/IncomeTaxesDetails3" ], "xbrltype": "monetaryItemType" }, "celh_DisclosureLeasesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leases" } } }, "localname": "DisclosureLeasesAbstract", "nsuri": "http://celsius.com/20221231", "xbrltype": "stringItemType" }, "celh_DisclosureNoteReceivableAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note Receivable" } } }, "localname": "DisclosureNoteReceivableAbstract", "nsuri": "http://celsius.com/20221231", "xbrltype": "stringItemType" }, "celh_DisclosurePrepaidExpensesAndOtherCurrentAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Prepaid Expenses And Other Current Assets" } } }, "localname": "DisclosurePrepaidExpensesAndOtherCurrentAssetsAbstract", "nsuri": "http://celsius.com/20221231", "xbrltype": "stringItemType" }, "celh_DisclosureRevenueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "verboseLabel": "Revenue" } } }, "localname": "DisclosureRevenueAbstract", "nsuri": "http://celsius.com/20221231", "xbrltype": "stringItemType" }, "celh_DistributionAgreementsTerminationExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Distribution agreements termination expense.", "label": "Distribution agreements termination expense" } } }, "localname": "DistributionAgreementsTerminationExpense", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "celh_DthreemLicensingGroupMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "DThreeM Licensing Group [Member]", "label": "DThreeM Licensing Group [Member]" } } }, "localname": "DthreemLicensingGroupMember", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "celh_DueToPepsi": { "auth_ref": [], "calculation": { "http://celsius.com/role/AccountsPayableAndAccruedExpensesDetails": { "order": 2.0, "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Due to Pepsi" } } }, "localname": "DueToPepsi", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/AccountsPayableAndAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "celh_EffectiveIncomeTaxRateReconciliationTaxEffectOfPepsiValuationPremiumPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Effective Income Tax Rate Reconciliation, Tax Effect of Pepsi Valuation Premium, Percent", "label": "Tax effect of Pepsi valuation premium" } } }, "localname": "EffectiveIncomeTaxRateReconciliationTaxEffectOfPepsiValuationPremiumPercent", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/IncomeTaxesDetails2" ], "xbrltype": "percentItemType" }, "celh_EightPercentageMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Eight percentage.", "label": "Eight Percentage [Member]" } } }, "localname": "EightPercentageMember", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/MezzanineEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "celh_EuropeanAcquisitionAdjustmentabstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "European Acquisition Adjustment:" } } }, "localname": "EuropeanAcquisitionAdjustmentabstract", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "celh_EuropeanDeferredTax": { "auth_ref": [], "calculation": { "http://celsius.com/role/StatementsOfOperationsAndComprehensiveLossIncome": { "order": 7.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "EuropeanDeferredTax", "negatedLabel": "European deferred tax" } } }, "localname": "EuropeanDeferredTax", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/StatementsOfOperationsAndComprehensiveLossIncome" ], "xbrltype": "monetaryItemType" }, "celh_ExcessFairValueOverIssuanceProceeds": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "excess fair value over issuance proceeds", "label": "excess fair value over issuance proceeds" } } }, "localname": "ExcessFairValueOverIssuanceProceeds", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/RevenueDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "celh_ExcessOfPaymentsFromRelatedParty": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Excess Of Payments From Related Party", "label": "Excess of payments from related party" } } }, "localname": "ExcessOfPaymentsFromRelatedParty", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "celh_ExchangeLosses": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Exchange losses", "label": "Exchange losses" } } }, "localname": "ExchangeLosses", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "celh_FairValueOfSharesIssued": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of shares issued.", "label": "Fair value of shares issued (in Dollars)" } } }, "localname": "FairValueOfSharesIssued", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/Stock-basedCompensationDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "celh_ForeignRevenuesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Foreign Revenues [Member]" } } }, "localname": "ForeignRevenuesMember", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/RevenueDetailsNarrative" ], "xbrltype": "domainItemType" }, "celh_FreightExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Freight expense.", "label": "Freight expense" } } }, "localname": "FreightExpense", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "celh_FuncFoodGroupMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Func Food Group [Member]", "label": "Func Food Group [Member]" } } }, "localname": "FuncFoodGroupMember", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/OrganizationAndDescriptionOfBusinessDetailsNarrative" ], "xbrltype": "domainItemType" }, "celh_GainOnLeaseCancellations": { "auth_ref": [], "calculation": { "http://celsius.com/role/StatementsOfCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "GainOnLeaseCancellations", "negatedLabel": "Gain on lease cancellations" } } }, "localname": "GainOnLeaseCancellations", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "celh_ImplicitPayment": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Implicit Payment", "label": "Implicit Payment" } } }, "localname": "ImplicitPayment", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/RevenueDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "celh_IncreaseDecreaseInAccruedDistributorTerminationsFees": { "auth_ref": [], "calculation": { "http://celsius.com/role/StatementsOfCashFlows": { "order": 17.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "IncreaseDecreaseInAccruedDistributorTerminationsFees", "verboseLabel": "Accrued distributor termination fees" } } }, "localname": "IncreaseDecreaseInAccruedDistributorTerminationsFees", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "celh_IncreaseDecreaseInAccruedPromotionalAllowance": { "auth_ref": [], "calculation": { "http://celsius.com/role/StatementsOfCashFlows": { "order": 16.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "IncreaseDecreaseInAccruedPromotionalAllowance", "verboseLabel": "Accrued promotional allowance" } } }, "localname": "IncreaseDecreaseInAccruedPromotionalAllowance", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "celh_IncreaseDecreaseInDeferredRevenueAndOtherCurrentLiabilities": { "auth_ref": [], "calculation": { "http://celsius.com/role/StatementsOfCashFlows": { "order": 19.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "IncreaseDecreaseInDeferredRevenueAndOtherCurrentLiabilities", "verboseLabel": "Other current liabilities" } } }, "localname": "IncreaseDecreaseInDeferredRevenueAndOtherCurrentLiabilities", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "celh_IndefiniteLivedIntangibleAssetsImpairment": { "auth_ref": [], "calculation": { "http://celsius.com/role/GoodwillAndIntangiblesDetails": { "order": 2.0, "parentTag": "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Indefinite Lived Intangible Assets, Impairment", "label": "Less: Impairment" } } }, "localname": "IndefiniteLivedIntangibleAssetsImpairment", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/GoodwillAndIntangiblesDetails" ], "xbrltype": "monetaryItemType" }, "celh_InstalmentCollateralShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Instalment collateral shares.", "label": "Instalment collateral shares" } } }, "localname": "InstalmentCollateralShares", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/NoteReceivableDetailsNarrative" ], "xbrltype": "sharesItemType" }, "celh_InventoryAllowanceForExcessAndObsoleteProducts": { "auth_ref": [], "calculation": { "http://celsius.com/role/StatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "InventoryAllowanceForExcessAndObsoleteProducts", "negatedLabel": "Inventory excess and obsolescence" } } }, "localname": "InventoryAllowanceForExcessAndObsoleteProducts", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "celh_IssuanceOfCommonStock": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Issuance of common stock" } } }, "localname": "IssuanceOfCommonStock", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/StatementsOfChangesInStockholdersEquityAndMezzanineEquity" ], "xbrltype": "monetaryItemType" }, "celh_IssuanceOfCommonStockFromPrivatePlacement": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Issuance of common stock from private placement" } } }, "localname": "IssuanceOfCommonStockFromPrivatePlacement", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/StatementsOfChangesInStockholdersEquityAndMezzanineEquity" ], "xbrltype": "monetaryItemType" }, "celh_IssuanceOfCommonStockFromPrivatePlacementShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Issuance of common stock from private placement, shares" } } }, "localname": "IssuanceOfCommonStockFromPrivatePlacementShares", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/StatementsOfChangesInStockholdersEquityAndMezzanineEquity" ], "xbrltype": "sharesItemType" }, "celh_IssuanceOfCommonStockPursuantToExerciseOfStockOptionsCashInShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Issuance of common stock pursuant to exercise of stock options - Cash.", "label": "Issuance of common stock pursuant to exercise of stock options - Cash, shares" } } }, "localname": "IssuanceOfCommonStockPursuantToExerciseOfStockOptionsCashInShares", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/StatementsOfChangesInStockholdersEquityAndMezzanineEquity" ], "xbrltype": "sharesItemType" }, "celh_IssuanceOfCommonStockPursuantToExerciseOfStockOptionsCashless": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount paid for Issuance of common stock pursuant to exercise of stock options Cashless.", "label": "Issuance of common stock pursuant to exercise of stock options - Cashless" } } }, "localname": "IssuanceOfCommonStockPursuantToExerciseOfStockOptionsCashless", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/StatementsOfChangesInStockholdersEquityAndMezzanineEquity" ], "xbrltype": "monetaryItemType" }, "celh_IssuanceOfCommonStockPursuantToExerciseOfStockOptionsCashlessInShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares Issuance of common stock pursuant to exercise of stock options Cashless.", "label": "Issuance of common stock pursuant to exercise of stock options - Cashless, shares" } } }, "localname": "IssuanceOfCommonStockPursuantToExerciseOfStockOptionsCashlessInShares", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/StatementsOfChangesInStockholdersEquityAndMezzanineEquity" ], "xbrltype": "sharesItemType" }, "celh_IssuanceOfCommonStockShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Issuance of common stock, shares" } } }, "localname": "IssuanceOfCommonStockShares", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/StatementsOfChangesInStockholdersEquityAndMezzanineEquity" ], "xbrltype": "sharesItemType" }, "celh_IssuanceOfPreferredStockFairValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Issuance Of Preferred Stock Fair Value", "label": "Issuance of preferred stock fair value", "verboseLabel": "Issuance Of Preferred Stock Fair Value" } } }, "localname": "IssuanceOfPreferredStockFairValue", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/MezzanineEquityDetailsNarrative", "http://celsius.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "celh_IssuanceOfSeriesConvertiblePreferredSharesNetOfIssuanceCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Issuance of Series A convertible preferred shares - net of issuance costs" } } }, "localname": "IssuanceOfSeriesConvertiblePreferredSharesNetOfIssuanceCosts", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/StatementsOfChangesInStockholdersEquityAndMezzanineEquity" ], "xbrltype": "monetaryItemType" }, "celh_IssuanceOfSeriesConvertiblePreferredSharesNetOfIssuanceCostsShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Issuance of Series A convertible preferred shares - net of issuance costs, shares" } } }, "localname": "IssuanceOfSeriesConvertiblePreferredSharesNetOfIssuanceCostsShares", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/StatementsOfChangesInStockholdersEquityAndMezzanineEquity" ], "xbrltype": "sharesItemType" }, "celh_LessInventoryAllowanceForExcessAndObsoleteProducts": { "auth_ref": [], "calculation": { "http://celsius.com/role/InventoriesDetails": { "order": 3.0, "parentTag": "us-gaap_InventoryNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "LessInventoryAllowanceForExcessAndObsoleteProducts", "negatedLabel": "Less: Inventory reserve" } } }, "localname": "LessInventoryAllowanceForExcessAndObsoleteProducts", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/InventoriesDetails" ], "xbrltype": "monetaryItemType" }, "celh_LiabilitiesMezzanineEquityAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS\u2019 EQUITY" } } }, "localname": "LiabilitiesMezzanineEquityAndStockholdersEquityAbstract", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "celh_LicenseAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The information of license agreement.", "label": "License Agreement [Member]" } } }, "localname": "LicenseAgreementMember", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/RevenueDetailsNarrative" ], "xbrltype": "domainItemType" }, "celh_LonglivedAssetGeographicDataPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Long-lived Asset Geographic Data" } } }, "localname": "LonglivedAssetGeographicDataPolicyTextBlock", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "celh_LonglivedAssetsRelatedToForeignOperations": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Long-lived assets related to foreign operations", "label": "Long-lived assets related to foreign operations" } } }, "localname": "LonglivedAssetsRelatedToForeignOperations", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1" ], "xbrltype": "monetaryItemType" }, "celh_MerchandisingEquipmentCoolersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Merchandising Equipment Coolers [Member]", "label": "Merchandising Equipment Coolers [Member]" } } }, "localname": "MerchandisingEquipmentCoolersMember", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "celh_MezzanineEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Mezzanine Equity [Abstract]", "label": "Mezzanine Equity:" } } }, "localname": "MezzanineEquityAbstract", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "celh_NetDeferredTaxLiabilitiesAssets": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Net deferred tax (liabilities) assets" } } }, "localname": "NetDeferredTaxLiabilitiesAssets", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/IncomeTaxesDetails3" ], "xbrltype": "monetaryItemType" }, "celh_NetProceedsFromCollectionOfSectionShortSwingProfit": { "auth_ref": [], "calculation": { "http://celsius.com/role/StatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Net proceeds from collection of section\u00a016b short swing profit" } } }, "localname": "NetProceedsFromCollectionOfSectionShortSwingProfit", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "celh_Netsales": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "NetSales", "label": "Net Sales" } } }, "localname": "Netsales", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "celh_NoteReceivableDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The description of note receivable.", "label": "Note Receivable description" } } }, "localname": "NoteReceivableDescription", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/NoteReceivableDetailsNarrative" ], "xbrltype": "stringItemType" }, "celh_NoteReceivableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "NOTE RECEIVABLE" } } }, "localname": "NoteReceivableTextBlock", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/NoteReceivable" ], "xbrltype": "textBlockItemType" }, "celh_NovemberTwentyThreeTwoThousensTwentyOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "November Twenty Three Two Thousens Twenty One [Member]", "label": "November Twenty Three Two Thousens Twenty One [Member]" } } }, "localname": "NovemberTwentyThreeTwoThousensTwentyOneMember", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "celh_OperatingExpensesPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Expenses" } } }, "localname": "OperatingExpensesPolicyTextBlock", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "celh_OtherMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the other member.", "label": "Other [Member]" } } }, "localname": "OtherMember", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1", "http://celsius.com/role/RevenueDetails" ], "xbrltype": "domainItemType" }, "celh_OwnershipChange": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Ownership change", "label": "Ownership change" } } }, "localname": "OwnershipChange", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "percentItemType" }, "celh_PaymentReceived": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payment received", "label": "Payment received" } } }, "localname": "PaymentReceived", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/RevenueDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "celh_PaymentsOnBondsPayable": { "auth_ref": [], "calculation": { "http://celsius.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "PaymentsOnBondsPayable", "negatedLabel": "Payments on bonds payable" } } }, "localname": "PaymentsOnBondsPayable", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "celh_PepsicoIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "PepsiCo Inc [Member]", "label": "PepsiCo Inc [Member]" } } }, "localname": "PepsicoIncMember", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails", "http://celsius.com/role/RelatedPartyTransactionsDetailsNarrative", "http://celsius.com/role/RevenueDetailsNarrative" ], "xbrltype": "domainItemType" }, "celh_PerShareOfAggregateFairValueOfPreferredShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share of aggregate fair value of preferred share.", "label": "Per Share of Aggregate Fair Value of Preferred Share" } } }, "localname": "PerShareOfAggregateFairValueOfPreferredShare", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/MezzanineEquityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "celh_PercentageOfFeeReceived": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of Fee Received", "label": "Percentage of Fee Received" } } }, "localname": "PercentageOfFeeReceived", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "percentItemType" }, "celh_PercentageOfRelatedPartyCommonStockOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of Related Party Common Stock Outstanding", "label": "Percentage of Related Party Common Stock Outstanding" } } }, "localname": "PercentageOfRelatedPartyCommonStockOutstanding", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "percentItemType" }, "celh_PercentageOfShareAuthorized": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of share authorized.", "label": "Percentage of Share Authorized" } } }, "localname": "PercentageOfShareAuthorized", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/MezzanineEquityDetailsNarrative" ], "xbrltype": "percentItemType" }, "celh_PercentageOfVotingRightPreferredStock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of voting right, preferred stock.", "label": "Percentage of Voting Right, Preferred Stock" } } }, "localname": "PercentageOfVotingRightPreferredStock", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/MezzanineEquityDetailsNarrative" ], "xbrltype": "percentItemType" }, "celh_PermanentDifferenceIncludingStockBasedCompensation1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Permanent Difference Including Stock based Compensation1", "label": "Permanent differences, including stock-based compensation" } } }, "localname": "PermanentDifferenceIncludingStockBasedCompensation1", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/IncomeTaxesDetails2" ], "xbrltype": "percentItemType" }, "celh_PermanentDifferenceIncludingStockbasedCompensation": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stock based compensation" } } }, "localname": "PermanentDifferenceIncludingStockbasedCompensation", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/IncomeTaxesDetails2" ], "xbrltype": "percentItemType" }, "celh_PostJudgmentInterest": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Post Judgment Interest", "label": "Post-judgment interest rate" } } }, "localname": "PostJudgmentInterest", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "percentItemType" }, "celh_PotentiallyDilutiveSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Potentially dilutive shares outstanding.", "label": "Potentially Dilutive Shares Outstanding" } } }, "localname": "PotentiallyDilutiveSharesOutstanding", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/EarningsPerShareDetailsNarrative" ], "xbrltype": "sharesItemType" }, "celh_PreferredStockCumulativeDividendPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferred Stock Cumulative Dividend Percentage", "label": "Preferred stock cumulative dividend percentage" } } }, "localname": "PreferredStockCumulativeDividendPercentage", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/BalanceSheetsParenthetical" ], "xbrltype": "percentItemType" }, "celh_PreferredStockParValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferred stock par value.", "label": "Preferred Stock Par Value" } } }, "localname": "PreferredStockParValue", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/MezzanineEquityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "celh_PreferredStockStatedValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferred stock stated value.", "label": "Preferred Stock Stated Value" } } }, "localname": "PreferredStockStatedValue", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/MezzanineEquityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "celh_PrepaidExpensesAndOtherCurrentAssetsTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "PREPAID EXPENSES AND OTHER CURRENT ASSETS" } } }, "localname": "PrepaidExpensesAndOtherCurrentAssetsTextBlock", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/PrepaidExpensesAndOtherCurrentAssets" ], "xbrltype": "textBlockItemType" }, "celh_ProceedsOfIssuanceOfDeferredContractAssetInOtherAssetsExcess": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds of Issuance of Deferred Contract Asset in Other Assets Excess", "label": "Issuance of deferred contract asset in other assets excess" } } }, "localname": "ProceedsOfIssuanceOfDeferredContractAssetInOtherAssetsExcess", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "celh_PromotionalAllowanceIncludedAsAReductionOfRevenue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Promotional allowance included as a reduction of revenue", "label": "Promotional allowance included as a reduction of revenue" } } }, "localname": "PromotionalAllowanceIncludedAsAReductionOfRevenue", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/RevenueDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "celh_ProvisionsOfOptionsGrantAndOtherShareBasedAwardsPermitted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Provisions Of Options Grant And Other Share Based Awards Permitted", "label": "Provisions of options grant and other share based awards permitted" } } }, "localname": "ProvisionsOfOptionsGrantAndOtherShareBasedAwardsPermitted", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/Stock-basedCompensationDetailsNarrative" ], "xbrltype": "sharesItemType" }, "celh_PublicOfferingPrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Public offering price", "label": "Public offering price" } } }, "localname": "PublicOfferingPrice", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "celh_PublixMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Publix [Member]" } } }, "localname": "PublixMember", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "celh_RangeOfExercisePrice1Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information related to range of exercise price.", "label": "Range Of Exercise Price1 [Member]" } } }, "localname": "RangeOfExercisePrice1Member", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/Stock-basedCompensationDetails2" ], "xbrltype": "domainItemType" }, "celh_RangeOfExercisePrice2Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information related to range of exercise price.", "label": "Range Of Exercise Price2 [Member]" } } }, "localname": "RangeOfExercisePrice2Member", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/Stock-basedCompensationDetails2" ], "xbrltype": "domainItemType" }, "celh_RangeOfExercisePrice3Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information related to range of exercise price.", "label": "Range Of Exercise Price3 [Member]" } } }, "localname": "RangeOfExercisePrice3Member", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/Stock-basedCompensationDetails2" ], "xbrltype": "domainItemType" }, "celh_RangeOfExercisePrice4Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information related to range of exercise price.", "label": "Range Of Exercise Price4 [Member]" } } }, "localname": "RangeOfExercisePrice4Member", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/Stock-basedCompensationDetails2" ], "xbrltype": "domainItemType" }, "celh_RangeOfExercisePrice5Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information related to range of exercise price.", "label": "Range Of Exercise Price5 [Member]" } } }, "localname": "RangeOfExercisePrice5Member", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/Stock-basedCompensationDetails2" ], "xbrltype": "domainItemType" }, "celh_RangeOfExercisePrice6Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Range of exercise price6 Member.", "label": "Range Of Exercise Price6 [Member]" } } }, "localname": "RangeOfExercisePrice6Member", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/Stock-basedCompensationDetails2" ], "xbrltype": "domainItemType" }, "celh_RangeOfExercisePrice7Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Range of exercise price7 Member.", "label": "Range Of Exercise Price7 [Member]" } } }, "localname": "RangeOfExercisePrice7Member", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/Stock-basedCompensationDetails2" ], "xbrltype": "domainItemType" }, "celh_ReducingAwardDamagesValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Reducing award damages value", "label": "Reducing award damages value" } } }, "localname": "ReducingAwardDamagesValue", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "celh_RefundLiability": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Refund liability", "label": "Refund liability" } } }, "localname": "RefundLiability", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/RevenueDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "celh_RelatedPartyCashPayment": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Related Party Cash Payment", "label": "Related party cash payment" } } }, "localname": "RelatedPartyCashPayment", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "celh_RelatedPartyLiabilityPayableDue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Related Party Liability Payable Due", "label": "Related Party Liability Payable Due" } } }, "localname": "RelatedPartyLiabilityPayableDue", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "celh_RemovedFromTheAvailableNolCarryforwardAndUsNolDeferredTaxAsset": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Removed from the available NOL carryforward and US NOL deferred tax asset.", "label": "Removed from the available NOL carryforward and US NOL deferred tax asset." } } }, "localname": "RemovedFromTheAvailableNolCarryforwardAndUsNolDeferredTaxAsset", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "celh_RestrictedStockForfeitureAndCancelledInDollarsPerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Restricted stock Forfeiture and cancelled (in Dollars per share)", "label": "Restricted stock Forfeiture and cancelled (in Dollars per share)" } } }, "localname": "RestrictedStockForfeitureAndCancelledInDollarsPerShare", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/Stock-basedCompensationDetails3", "http://celsius.com/role/Stock-basedCompensationDetails4", "http://celsius.com/role/Stock-basedCompensationDetails5" ], "xbrltype": "perShareItemType" }, "celh_RestrictedStockTransfersToRestrictedStockUnitsinDollarsPerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Restricted stock Transfers to restricted stock units(in Dollars per share)", "label": "Restricted stock Transfers to restricted stock units(in Dollars per share)" } } }, "localname": "RestrictedStockTransfersToRestrictedStockUnitsinDollarsPerShare", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/Stock-basedCompensationDetails3", "http://celsius.com/role/Stock-basedCompensationDetails4" ], "xbrltype": "perShareItemType" }, "celh_RevenueTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "REVENUE" } } }, "localname": "RevenueTextBlock", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/Revenue" ], "xbrltype": "textBlockItemType" }, "celh_Riskfreeinterestrate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "RiskFreeInterestRate", "label": "Risk free interest rate" } } }, "localname": "Riskfreeinterestrate", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/FairValueMeasurementsDetailsNarrative" ], "xbrltype": "percentItemType" }, "celh_SalesRevenueBenchMarkReceiveShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sales revenue bench mark receive shares", "label": "Sales revenue bench mark receive shares" } } }, "localname": "SalesRevenueBenchMarkReceiveShares", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "sharesItemType" }, "celh_ScheduleOfMaturitiesOfOperatingAndFinanceLeasesLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of future minimum lease payments" } } }, "localname": "ScheduleOfMaturitiesOfOperatingAndFinanceLeasesLiabilitiesTableTextBlock", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "celh_ScheduleOfNoteReceivableTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of note receivable" } } }, "localname": "ScheduleOfNoteReceivableTableTextBlock", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/NoteReceivableTables" ], "xbrltype": "textBlockItemType" }, "celh_ScheduleOfOtherCurrentLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of other current liabilities" } } }, "localname": "ScheduleOfOtherCurrentLiabilitiesTableTextBlock", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/OtherCurrentLiabilitiesTables" ], "xbrltype": "textBlockItemType" }, "celh_ScheduleOfStockBasedAwardsIssuedToNonEmployeeConsultantsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of stock-based awards issued to non-employee consultants" } } }, "localname": "ScheduleOfStockBasedAwardsIssuedToNonEmployeeConsultantsTableTextBlock", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/Stock-basedCompensationTables" ], "xbrltype": "textBlockItemType" }, "celh_SecuritiesPurchaseAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Securities Purchase Agreement [Member].", "label": "Securities Purchase Agreement [Member]" } } }, "localname": "SecuritiesPurchaseAgreementMember", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/MezzanineEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "celh_SellingStockholdersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Selling Stockholders [Member]" } } }, "localname": "SellingStockholdersMember", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "celh_SeriesAConvertiblePreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Series A Convertible Preferred Stock [Member]" } } }, "localname": "SeriesAConvertiblePreferredStockMember", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/MezzanineEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "celh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentVestedWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Restricted stock vested (in Dollars per share)", "label": "Restricted stock vested (in Dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentVestedWeightedAverageGrantDateFairValue", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/Stock-basedCompensationDetails3", "http://celsius.com/role/Stock-basedCompensationDetails4", "http://celsius.com/role/Stock-basedCompensationDetails5" ], "xbrltype": "perShareItemType" }, "celh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateTargetPayoutIfCircumstancesMet": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Share based compensation arrangement by share based payment award equity instruments other than options aggregate target payout if circumstances met", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Aggregate Target Payout If Circumstances Met" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateTargetPayoutIfCircumstancesMet", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/Stock-basedCompensationDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "celh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsUnvestedWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Unvested at beginning of period (in Dollars per share)", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Unvested Weighted Average Grant Date Fair Value", "periodEndLabel": "Unvested at end of period (in Dollars per share)", "periodStartLabel": "Unvested at beginning of period (in Dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsUnvestedWeightedAverageGrantDateFairValue", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/Stock-basedCompensationDetails3", "http://celsius.com/role/Stock-basedCompensationDetails4", "http://celsius.com/role/Stock-basedCompensationDetails5" ], "xbrltype": "perShareItemType" }, "celh_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award.", "label": "Forfeiture Rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/Stock-basedCompensationDetails" ], "xbrltype": "percentItemType" }, "celh_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerms2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted Average Remaining Term Ending Balance", "label": "Weighted Average Remaining Term Ending Balance" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerms2", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/Stock-basedCompensationDetails1" ], "xbrltype": "durationItemType" }, "celh_ShortSwingPayment": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Short swing payment" } } }, "localname": "ShortSwingPayment", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/StatementsOfChangesInStockholdersEquityAndMezzanineEquity" ], "xbrltype": "monetaryItemType" }, "celh_StateBeverageContainerDeposit": { "auth_ref": [], "calculation": { "http://celsius.com/role/OtherCurrentLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "State beverage container deposit", "label": "State Beverage Container Deposit" } } }, "localname": "StateBeverageContainerDeposit", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/OtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "celh_StockIncentivePlan2015Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "It represents 2015 stock incentive plan during the period.", "label": "Stock Incentive Plan2015 [Member]" } } }, "localname": "StockIncentivePlan2015Member", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/Stock-basedCompensationDetailsNarrative", "http://celsius.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "celh_StockIncentivePlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equity-based payment arrangement where one or more employees receive shares of stock (units), stock (unit) options, or other equity instruments, or the employer incurs a liability to the employee in amounts based on the price of the employer's stock (unit).", "label": "Stock Incentive Plan [Member]" } } }, "localname": "StockIncentivePlanMember", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/Stock-basedCompensationDetailsNarrative" ], "xbrltype": "domainItemType" }, "celh_SummaryOfTheFilingJurisdictionsAndOpenTaxYearsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Summary of the filing jurisdictions and open tax years" } } }, "localname": "SummaryOfTheFilingJurisdictionsAndOpenTaxYearsTableTextBlock", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "celh_TenPercentageMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Ten percentage.", "label": "Ten Percentage [Member]" } } }, "localname": "TenPercentageMember", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/MezzanineEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "celh_TerminationExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Termination Expense", "label": "Termination Expense" } } }, "localname": "TerminationExpense", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "celh_TerminationExpensesSalesAndMarketing": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Termination expenses sales and marketing", "label": "Termination expenses", "verboseLabel": "Termination expenses sales and marketing" } } }, "localname": "TerminationExpensesSalesAndMarketing", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/OrganizationAndDescriptionOfBusinessDetailsNarrative", "http://celsius.com/role/RevenueDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "celh_TerminationPayable": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Termination Payable.", "label": "Termination Payable" } } }, "localname": "TerminationPayable", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "celh_TotalLeaseLiability": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total lease liability.", "label": "Total Lease Liability", "verboseLabel": "Present value of lease liabilities" } } }, "localname": "TotalLeaseLiability", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/LeasesDetails" ], "xbrltype": "monetaryItemType" }, "celh_TotalLeaseLiabilityCurrent": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total lease liability current.", "label": "Less: current portion" } } }, "localname": "TotalLeaseLiabilityCurrent", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/LeasesDetails" ], "xbrltype": "monetaryItemType" }, "celh_TotalLeaseLiabilityNoncurrent": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total lease liability noncurrent.", "label": "Total Lease Liability Noncurrent", "verboseLabel": "Long-term portion" } } }, "localname": "TotalLeaseLiabilityNoncurrent", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/LeasesDetails" ], "xbrltype": "monetaryItemType" }, "celh_TotalLeaseLiabilityPaymentsDue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total lease liability payments due.", "label": "Total Lease Liability Payments Due", "verboseLabel": "Total future minimum lease payments" } } }, "localname": "TotalLeaseLiabilityPaymentsDue", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/LeasesDetails" ], "xbrltype": "monetaryItemType" }, "celh_TotalLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total lease liability payments due next twelve months.", "label": "Total Lease Liability Payments Due Next Twelve Months", "verboseLabel": "2023" } } }, "localname": "TotalLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/LeasesDetails" ], "xbrltype": "monetaryItemType" }, "celh_TotalLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total lease liability payments due year four.", "label": "Total Lease Liability Payments Due Year Four", "verboseLabel": "2026" } } }, "localname": "TotalLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/LeasesDetails" ], "xbrltype": "monetaryItemType" }, "celh_TotalLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total lease liability payments due year three.", "label": "Total Lease Liability Payments Due Year Three", "verboseLabel": "2025" } } }, "localname": "TotalLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/LeasesDetails" ], "xbrltype": "monetaryItemType" }, "celh_TotalLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total lease liability payments due year two.", "label": "Total Lease Liability Payments Due Year Two", "verboseLabel": "2024" } } }, "localname": "TotalLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/LeasesDetails" ], "xbrltype": "monetaryItemType" }, "celh_TotalLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total lease liability undiscounted excess amount.", "label": "Less: Amount representing interest" } } }, "localname": "TotalLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/LeasesDetails" ], "xbrltype": "monetaryItemType" }, "celh_TotalLonglivedAssets": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Total long-lived assets.", "label": "Total long-lived assets-net" } } }, "localname": "TotalLonglivedAssets", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1" ], "xbrltype": "monetaryItemType" }, "celh_TotalPayment": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total payment", "label": "Total Payment" } } }, "localname": "TotalPayment", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/RevenueDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "celh_Totalintangibles": { "auth_ref": [], "calculation": { "http://celsius.com/role/GoodwillAndIntangiblesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "TotalIntangibles", "label": "Total Intangibles", "totalLabel": "Total Intangibles" } } }, "localname": "Totalintangibles", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/GoodwillAndIntangiblesDetails" ], "xbrltype": "monetaryItemType" }, "celh_TransfersToRestrictedStockUnits": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Transfers to restricted stock units", "label": "Transfers to restricted stock units" } } }, "localname": "TransfersToRestrictedStockUnits", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/Stock-basedCompensationDetails3", "http://celsius.com/role/Stock-basedCompensationDetails4" ], "xbrltype": "sharesItemType" }, "celh_TransitionAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Transition Agreement [Member]", "label": "Transition Agreement [Member]" } } }, "localname": "TransitionAgreementMember", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/OrganizationAndDescriptionOfBusinessDetailsNarrative", "http://celsius.com/role/RevenueDetailsNarrative" ], "xbrltype": "domainItemType" }, "celh_TwelvePercentageMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Twelve percentage.", "label": "Twelve Percentage [Member]" } } }, "localname": "TwelvePercentageMember", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/MezzanineEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "celh_USFederalMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "U.S. Federal Member", "label": "U.S. Federal [Member]" } } }, "localname": "USFederalMember", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/IncomeTaxesDetails5" ], "xbrltype": "domainItemType" }, "celh_USStateAndLocalMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "U.S State and local Member", "label": "U.S State and local [Member]" } } }, "localname": "USStateAndLocalMember", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/IncomeTaxesDetails5" ], "xbrltype": "domainItemType" }, "celh_UnamortizedDeferredContractCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Unamortized Deferred Contract Costs", "label": "Unamortized deferred contract costs" } } }, "localname": "UnamortizedDeferredContractCosts", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "celh_UnbilledPurchases": { "auth_ref": [], "calculation": { "http://celsius.com/role/AccountsPayableAndAccruedExpensesDetails": { "order": 5.0, "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Unbilled purchases.", "label": "Unbilled purchases" } } }, "localname": "UnbilledPurchases", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/AccountsPayableAndAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "celh_UncertainTaxPosition": { "auth_ref": [], "calculation": { "http://celsius.com/role/IncomeTaxesDetails3": { "order": 8.0, "parentTag": "celh_DeferredTaxAssetsLiabilitiesGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Uncertain tax position" } } }, "localname": "UncertainTaxPosition", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/IncomeTaxesDetails3" ], "xbrltype": "monetaryItemType" }, "celh_UnrealizedNetOperatingLossCarryforwardDueToOwnershipChange": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Unrealized net operating loss carryforward due to ownership change.", "label": "Unrealized NOLs due to ownership change" } } }, "localname": "UnrealizedNetOperatingLossCarryforwardDueToOwnershipChange", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "celh_UpfrontPaymentReceived": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Upfront payment received", "label": "Upfront payment received" } } }, "localname": "UpfrontPaymentReceived", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/RevenueDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "celh_ValueAddedTaxPayment": { "auth_ref": [], "calculation": { "http://celsius.com/role/OtherCurrentLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value added tax payment.", "label": "VAT payable" } } }, "localname": "ValueAddedTaxPayment", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/OtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "celh_VestedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Vested [Member]" } } }, "localname": "VestedMember", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/Stock-basedCompensationDetailsNarrative" ], "xbrltype": "domainItemType" }, "celh_WeightedAveragesGrantDateFairValueExercised": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted Average Grant Date Fair Value Exercised", "label": "Weighted Average Grant Date Fair Value Exercised" } } }, "localname": "WeightedAveragesGrantDateFairValueExercised", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/Stock-basedCompensationDetails1" ], "xbrltype": "perShareItemType" }, "celh_WeightedAveragesGrantDateFairValueGranted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted Average Grant Date Fair Value Granted", "label": "Weighted Average Grant Date Fair Value Granted" } } }, "localname": "WeightedAveragesGrantDateFairValueGranted", "nsuri": "http://celsius.com/20221231", "presentation": [ "http://celsius.com/role/Stock-basedCompensationDetails1" ], "xbrltype": "perShareItemType" }, "country_FI": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "FINLAND" } } }, "localname": "FI", "nsuri": "http://xbrl.sec.gov/country/2022", "presentation": [ "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1" ], "xbrltype": "domainItemType" }, "country_SE": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SWEDEN" } } }, "localname": "SE", "nsuri": "http://xbrl.sec.gov/country/2022", "presentation": [ "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1", "http://celsius.com/role/RevenueDetailsNarrative" ], "xbrltype": "domainItemType" }, "country_US": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "UNITED STATES" } } }, "localname": "US", "nsuri": "http://xbrl.sec.gov/country/2022", "presentation": [ "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1" ], "xbrltype": "domainItemType" }, "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://celsius.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://celsius.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r571" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://celsius.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r571" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://celsius.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditorFirmId": { "auth_ref": [ "r568", "r570", "r571" ], "lang": { "en-us": { "role": { "documentation": "PCAOB issued Audit Firm Identifier", "label": "Auditor Firm ID" } } }, "localname": "AuditorFirmId", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://celsius.com/role/Cover" ], "xbrltype": "nonemptySequenceNumberItemType" }, "dei_AuditorLocation": { "auth_ref": [ "r568", "r570", "r571" ], "lang": { "en-us": { "role": { "label": "Auditor Location" } } }, "localname": "AuditorLocation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://celsius.com/role/Cover" ], "xbrltype": "internationalNameItemType" }, "dei_AuditorName": { "auth_ref": [ "r568", "r570", "r571" ], "lang": { "en-us": { "role": { "label": "Auditor Name" } } }, "localname": "AuditorName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://celsius.com/role/Cover" ], "xbrltype": "internationalNameItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://celsius.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://celsius.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://celsius.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r570" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://celsius.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r568", "r570", "r571" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://celsius.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://celsius.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://celsius.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://celsius.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://celsius.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r569" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://celsius.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r557" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://celsius.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r570" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://celsius.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r570" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://celsius.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r572" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://celsius.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://celsius.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r560" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://celsius.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://celsius.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://celsius.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://celsius.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://celsius.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://celsius.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://celsius.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://celsius.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r563" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://celsius.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r559" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://celsius.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://celsius.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://celsius.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://celsius.com/role/RelatedPartyTransactionsDetailsNarrative", "http://celsius.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r559" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://celsius.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r576" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://celsius.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://celsius.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r559" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://celsius.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://celsius.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r573" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://celsius.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r571" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://celsius.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://celsius.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r559" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://celsius.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r559" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://celsius.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r559" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://celsius.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r559" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://celsius.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://celsius.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r574" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://celsius.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://celsius.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_IcfrAuditorAttestationFlag": { "auth_ref": [ "r568", "r570", "r571" ], "lang": { "en-us": { "role": { "label": "ICFR Auditor Attestation Flag" } } }, "localname": "IcfrAuditorAttestationFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://celsius.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://celsius.com/role/RelatedPartyTransactionsDetailsNarrative", "http://celsius.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://celsius.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://celsius.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r570" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://celsius.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r564" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://celsius.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r565" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://celsius.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r558" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://celsius.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r562" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://celsius.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r561" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://celsius.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r566" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://celsius.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r567" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://celsius.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://celsius.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r575" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://celsius.com/role/Cover" ], "xbrltype": "booleanItemType" }, "srt_AsiaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Asia [Member]" } } }, "localname": "AsiaMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://celsius.com/role/RevenueDetails" ], "xbrltype": "domainItemType" }, "srt_EuropeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Europe [Member]" } } }, "localname": "EuropeMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://celsius.com/role/RevenueDetails" ], "xbrltype": "domainItemType" }, "srt_MaximumMember": { "auth_ref": [ "r299", "r300", "r301", "r302", "r341", "r471", "r498", "r521", "r522", "r540", "r547", "r556", "r620", "r672", "r673", "r674", "r675", "r676", "r677" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://celsius.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://celsius.com/role/IncomeTaxesDetails5", "http://celsius.com/role/MezzanineEquityDetailsNarrative", "http://celsius.com/role/NoteReceivableDetailsNarrative", "http://celsius.com/role/PropertyAndEquipmentDetails", "http://celsius.com/role/Stock-basedCompensationDetails", "http://celsius.com/role/Stock-basedCompensationDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r299", "r300", "r301", "r302", "r341", "r471", "r498", "r521", "r522", "r540", "r547", "r556", "r620", "r672", "r673", "r674", "r675", "r676", "r677" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://celsius.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://celsius.com/role/IncomeTaxesDetails5", "http://celsius.com/role/MezzanineEquityDetailsNarrative", "http://celsius.com/role/NoteReceivableDetailsNarrative", "http://celsius.com/role/PropertyAndEquipmentDetails", "http://celsius.com/role/Stock-basedCompensationDetails", "http://celsius.com/role/Stock-basedCompensationDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_NorthAmericaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "North America [Member]" } } }, "localname": "NorthAmericaMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://celsius.com/role/RevenueDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r299", "r300", "r301", "r302", "r333", "r341", "r370", "r371", "r372", "r470", "r471", "r498", "r521", "r522", "r540", "r547", "r556", "r611", "r620", "r673", "r674", "r675", "r676", "r677" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://celsius.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://celsius.com/role/IncomeTaxesDetails5", "http://celsius.com/role/MezzanineEquityDetailsNarrative", "http://celsius.com/role/NoteReceivableDetailsNarrative", "http://celsius.com/role/PropertyAndEquipmentDetails", "http://celsius.com/role/Stock-basedCompensationDetails", "http://celsius.com/role/Stock-basedCompensationDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r299", "r300", "r301", "r302", "r333", "r341", "r370", "r371", "r372", "r470", "r471", "r498", "r521", "r522", "r540", "r547", "r556", "r611", "r620", "r673", "r674", "r675", "r676", "r677" ], "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://celsius.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://celsius.com/role/IncomeTaxesDetails5", "http://celsius.com/role/MezzanineEquityDetailsNarrative", "http://celsius.com/role/NoteReceivableDetailsNarrative", "http://celsius.com/role/PropertyAndEquipmentDetails", "http://celsius.com/role/Stock-basedCompensationDetails", "http://celsius.com/role/Stock-basedCompensationDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [ "r268", "r269", "r512", "r513", "r514", "r515", "r516", "r517", "r518", "r519", "r520", "r541", "r555", "r623" ], "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails", "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1", "http://celsius.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://celsius.com/role/IncomeTaxesDetails", "http://celsius.com/role/IncomeTaxesDetails5", "http://celsius.com/role/RevenueDetails", "http://celsius.com/role/RevenueDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r268", "r269", "r506", "r512", "r513", "r514", "r515", "r516", "r517", "r518", "r519", "r520", "r541", "r555", "r623" ], "lang": { "en-us": { "role": { "label": "Geographical [Axis]" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails", "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1", "http://celsius.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://celsius.com/role/IncomeTaxesDetails", "http://celsius.com/role/IncomeTaxesDetails5", "http://celsius.com/role/RevenueDetails", "http://celsius.com/role/RevenueDetailsNarrative" ], "xbrltype": "stringItemType" }, "stpr_FL": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "FLORIDA" } } }, "localname": "FL", "nsuri": "http://xbrl.sec.gov/stpr/2022", "presentation": [ "http://celsius.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "stpr_NY": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "NEW YORK" } } }, "localname": "NY", "nsuri": "http://xbrl.sec.gov/stpr/2022", "presentation": [ "http://celsius.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": { "auth_ref": [ "r16" ], "calculation": { "http://celsius.com/role/AccountsPayableAndAccruedExpensesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://celsius.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.", "label": "Accounts payable and accrued expenses", "totalLabel": "Total" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/AccountsPayableAndAccruedExpensesDetails", "http://celsius.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.", "label": "ACCOUNTS PAYABLE AND ACCRUED EXPENSES" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/AccountsPayableAndAccruedExpenses" ], "xbrltype": "textBlockItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r14", "r554" ], "calculation": { "http://celsius.com/role/AccountsPayableAndAccruedExpensesDetails": { "order": 1.0, "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/AccountsPayableAndAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableMember": { "auth_ref": [ "r507" ], "lang": { "en-us": { "role": { "documentation": "Due from customers or clients for goods or services that have been delivered or sold.", "label": "Accounts Receivable [Member]" } } }, "localname": "AccountsReceivableMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r271", "r272" ], "calculation": { "http://celsius.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts receivable-net" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r18" ], "calculation": { "http://celsius.com/role/AccountsPayableAndAccruedExpensesDetails": { "order": 4.0, "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued expenses" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/AccountsPayableAndAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedProfessionalFeesCurrent": { "auth_ref": [ "r18" ], "calculation": { "http://celsius.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued distributor termination fees" } } }, "localname": "AccruedProfessionalFeesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedAmortizationOfOtherDeferredCosts": { "auth_ref": [ "r579" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated amortization of other deferred costs capitalized at the end of the reporting period. Does not include deferred finance costs, deferred acquisition costs of insurance companies, or deferred leasing costs for real estate operations.", "label": "Accumulated amortization of other deferred costs" } } }, "localname": "AccumulatedAmortizationOfOtherDeferredCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r86", "r176" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "negatedLabel": "Less: accumulated depreciation" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r26", "r27", "r28", "r183", "r494", "r503", "r504" ], "calculation": { "http://celsius.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "Accumulated other comprehensive (loss) income" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r25", "r28", "r124", "r457", "r499", "r500", "r587", "r588", "r589", "r597", "r598", "r599" ], "lang": { "en-us": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "AOCI Attributable to Parent [Member]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/StatementsOfChangesInStockholdersEquityAndMezzanineEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r6", "r554" ], "calculation": { "http://celsius.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r380", "r381", "r382", "r597", "r598", "r599", "r663" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/StatementsOfChangesInStockholdersEquityAndMezzanineEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentForAmortization": { "auth_ref": [ "r45", "r78" ], "calculation": { "http://celsius.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.", "label": "Amortization" } } }, "localname": "AdjustmentForAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net (loss) income to net cash (used in)/provided by operating activities:" } } }, "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AdvertisingCostsPolicyTextBlock": { "auth_ref": [ "r385" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for advertising cost.", "label": "Advertising Costs" } } }, "localname": "AdvertisingCostsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_AdvertisingExpense": { "auth_ref": [ "r386" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.", "label": "Advertising expense" } } }, "localname": "AdvertisingExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r374" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Non-cash compensation expense (in Dollars)" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/Stock-basedCompensationDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": { "auth_ref": [ "r184", "r273", "r277" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.", "label": "Allowance for doubtful accounts" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfIntangibleAssets": { "auth_ref": [ "r45", "r73", "r78" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Amortization expense" } } }, "localname": "AmortizationOfIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/GoodwillAndIntangiblesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "localname": "ArrangementsAndNonarrangementTransactionsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/RevenueDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r144", "r158", "r179", "r207", "r252", "r261", "r265", "r275", "r303", "r304", "r305", "r306", "r307", "r308", "r309", "r310", "r311", "r422", "r426", "r436", "r554", "r618", "r619", "r670" ], "calculation": { "http://celsius.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total Assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r171", "r187", "r207", "r275", "r303", "r304", "r305", "r306", "r307", "r308", "r309", "r310", "r311", "r422", "r426", "r436", "r554", "r618", "r619", "r670" ], "calculation": { "http://celsius.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AwardDateAxis": { "auth_ref": [ "r625", "r626", "r627", "r628", "r629", "r630", "r631", "r632", "r633", "r634", "r635", "r636", "r637", "r638", "r639", "r640", "r641", "r642", "r643", "r644", "r645", "r646", "r647", "r648", "r649", "r650" ], "lang": { "en-us": { "role": { "documentation": "Information by date or year award under share-based payment arrangement is granted.", "label": "Award Date [Axis]" } } }, "localname": "AwardDateAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_AwardDateDomain": { "auth_ref": [ "r625", "r626", "r627", "r628", "r629", "r630", "r631", "r632", "r633", "r634", "r635", "r636", "r637", "r638", "r639", "r640", "r641", "r642", "r643", "r644", "r645", "r646", "r647", "r648", "r649", "r650" ], "lang": { "en-us": { "role": { "documentation": "Date or year award under share-based payment arrangement is granted." } } }, "localname": "AwardDateDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r345", "r346", "r347", "r349", "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r369", "r370", "r371", "r372", "r373" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/Stock-basedCompensationDetails3", "http://celsius.com/role/Stock-basedCompensationDetails4", "http://celsius.com/role/Stock-basedCompensationDetails5", "http://celsius.com/role/Stock-basedCompensationDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by location on balance sheet (statement of financial position).", "label": "Balance Sheet Location [Axis]" } } }, "localname": "BalanceSheetLocationAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationDomain": { "auth_ref": [ "r125", "r128" ], "lang": { "en-us": { "role": { "documentation": "Location in the balance sheet (statement of financial position)." } } }, "localname": "BalanceSheetLocationDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Presentation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r53" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.", "label": "BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" } } }, "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BuildingMember": { "auth_ref": [ "r85" ], "lang": { "en-us": { "role": { "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities.", "label": "Building [Member]" } } }, "localname": "BuildingMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r419", "r545", "r546" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree." } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/OrganizationAndDescriptionOfBusinessDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r119", "r120", "r419", "r545", "r546" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/OrganizationAndDescriptionOfBusinessDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1": { "auth_ref": [ "r115", "r116", "r117" ], "lang": { "en-us": { "role": { "documentation": "Date when the acquirer obtains control of the acquiree, in YYYY-MM-DD format.", "label": "Date of Acquisition" } } }, "localname": "BusinessAcquisitionEffectiveDateOfAcquisition1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/OrganizationAndDescriptionOfBusinessDetailsNarrative" ], "xbrltype": "dateItemType" }, "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": { "auth_ref": [ "r118" ], "lang": { "en-us": { "role": { "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.", "label": "Equity acquired" } } }, "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/OrganizationAndDescriptionOfBusinessDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_BusinessCombinationContingentConsiderationLiability": { "auth_ref": [ "r121", "r122", "r420" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.", "label": "Accrued liability" } } }, "localname": "BusinessCombinationContingentConsiderationLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r47", "r174", "r526" ], "calculation": { "http://celsius.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r48" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": { "auth_ref": [ "r48", "r143" ], "lang": { "en-us": { "role": { "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.", "label": "Restricted Cash" } } }, "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r42", "r47", "r52" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "periodEndLabel": "Cash, cash equivalents and restricted cash at end of the period", "periodStartLabel": "Cash, cash equivalents and restricted cash at beginning of the period" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r42", "r136" ], "calculation": { "http://celsius.com/role/StatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net increase (decrease) in cash, cash equivalents and restricted cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashUninsuredAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of cash as of the balance sheet date that is not insured by the Federal Deposit Insurance Corporation.", "label": "Amount excess of FDIC limit" } } }, "localname": "CashUninsuredAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r180", "r181", "r182", "r207", "r226", "r227", "r230", "r232", "r240", "r241", "r275", "r303", "r305", "r306", "r307", "r310", "r311", "r314", "r315", "r318", "r322", "r328", "r436", "r523", "r577", "r594", "r600" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BalanceSheetsParenthetical", "http://celsius.com/role/FairValueMeasurementsDetails", "http://celsius.com/role/FairValueMeasurementsDetailsNarrative", "http://celsius.com/role/MezzanineEquityDetailsNarrative", "http://celsius.com/role/OrganizationAndDescriptionOfBusinessDetailsNarrative", "http://celsius.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r21", "r147", "r162" ], "calculation": { "http://celsius.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitment and contingencies (Note 19)" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r90", "r297", "r298", "r508", "r617" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "COMMITMENTS AND CONTINGENCIES" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/CommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r597", "r598", "r663" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/StatementsOfChangesInStockholdersEquityAndMezzanineEquity" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockOtherSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Total number of shares of other common stock instruments held by shareholders, such as exchangeable shares. May be all or portion of the number of common shares authorized.", "label": "Common Stock, Other Shares, Outstanding" } } }, "localname": "CommonStockOtherSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/MezzanineEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common stock, par value" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common stock, authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common stock, issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r5", "r92" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common stock, outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r5", "r554" ], "calculation": { "http://celsius.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common stock, $0.001 par value; 100,000 shares authorized, 76,382 and 74,909 shares issued and outstanding at December\u00a031, 2022 and December\u00a031, 2021, respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r29", "r189", "r191", "r197", "r490", "r495" ], "calculation": { "http://celsius.com/role/StatementsOfOperationsAndComprehensiveLossIncome": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "totalLabel": "Comprehensive (loss) income" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/StatementsOfOperationsAndComprehensiveLossIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other comprehensive income:" } } }, "localname": "ComprehensiveIncomeNetOfTaxAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/StatementsOfOperationsAndComprehensiveLossIncome" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r58", "r59", "r133", "r134", "r270", "r507" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage." } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r58", "r59", "r133", "r134", "r270", "r505", "r507" ], "lang": { "en-us": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk Benchmark [Axis]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r58", "r59", "r133", "r134", "r270", "r507", "r681" ], "lang": { "en-us": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk Type [Axis]" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskCreditRisk": { "auth_ref": [ "r155", "r245" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for credit risk.", "label": "Concentrations of Risk" } } }, "localname": "ConcentrationRiskCreditRisk", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskPercentage1": { "auth_ref": [ "r58", "r59", "r133", "r134", "r270" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Total" } } }, "localname": "ConcentrationRiskPercentage1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r58", "r59", "r133", "r134", "r270", "r507" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration." } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConsolidationPolicyTextBlock": { "auth_ref": [ "r123", "r530" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.", "label": "Consolidation Policy" } } }, "localname": "ConsolidationPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ContractWithCustomerLiability": { "auth_ref": [ "r330", "r331", "r332" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.", "label": "Contract with Customer, Liability" } } }, "localname": "ContractWithCustomerLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/RevenueDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityCurrent": { "auth_ref": [ "r330", "r331", "r332" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.", "label": "Contract with Customer, Liability, Current", "verboseLabel": "Deferred revenue-current" } } }, "localname": "ContractWithCustomerLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityNoncurrent": { "auth_ref": [ "r330", "r331", "r332" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.", "label": "Customer advances" } } }, "localname": "ContractWithCustomerLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertiblePreferredStockMember": { "auth_ref": [ "r314", "r315", "r318" ], "lang": { "en-us": { "role": { "documentation": "Preferred stock that may be exchanged into common shares or other types of securities at the owner's option.", "label": "Convertible Preferred Stock [Member]" } } }, "localname": "ConvertiblePreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/OrganizationAndDescriptionOfBusinessDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfRevenue": { "auth_ref": [ "r35", "r207", "r275", "r303", "r304", "r305", "r306", "r307", "r308", "r309", "r310", "r311", "r436", "r618" ], "calculation": { "http://celsius.com/role/StatementsOfOperationsAndComprehensiveLossIncome": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.", "label": "Cost of revenue" } } }, "localname": "CostOfRevenue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/StatementsOfOperationsAndComprehensiveLossIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfSalesPolicyTextBlock": { "auth_ref": [ "r624" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cost of product sold and service rendered.", "label": "Cost of Revenue" } } }, "localname": "CostOfSalesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit": { "auth_ref": [ "r658" ], "calculation": { "http://celsius.com/role/IncomeTaxesDetails1": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current federal, state, and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national, regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.", "label": "Current Federal, State and Local, Tax Expense (Benefit)", "totalLabel": "Current federal, state and local, tax expense" } } }, "localname": "CurrentFederalStateAndLocalTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/IncomeTaxesDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentForeignTaxExpenseBenefit": { "auth_ref": [ "r596", "r658" ], "calculation": { "http://celsius.com/role/IncomeTaxesDetails1": { "order": 3.0, "parentTag": "us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Foreign" } } }, "localname": "CurrentForeignTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/IncomeTaxesDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current:" } } }, "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/IncomeTaxesDetails1" ], "xbrltype": "stringItemType" }, "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": { "auth_ref": [ "r596", "r658", "r660" ], "calculation": { "http://celsius.com/role/IncomeTaxesDetails1": { "order": 2.0, "parentTag": "us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.", "label": "State" } } }, "localname": "CurrentStateAndLocalTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/IncomeTaxesDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateEffectivePercentage": { "auth_ref": [ "r20", "r137", "r313", "r449" ], "lang": { "en-us": { "role": { "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.", "label": "Debt discount rate" } } }, "localname": "DebtInstrumentInterestRateEffectivePercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/FairValueMeasurementsDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_DebtSecuritiesAvailableForSaleTable": { "auth_ref": [ "r274" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Debt Securities, Available-for-Sale [Table]" } } }, "localname": "DebtSecuritiesAvailableForSaleTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/MezzanineEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredCompensationPlanAssets": { "auth_ref": [ "r579" ], "calculation": { "http://celsius.com/role/IncomeTaxesDetails3": { "order": 9.0, "parentTag": "celh_DeferredTaxAssetsLiabilitiesGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of assets held under deferred compensation agreements.", "label": "Stock-based compensation" } } }, "localname": "DeferredCompensationPlanAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/IncomeTaxesDetails3" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit": { "auth_ref": [ "r652" ], "calculation": { "http://celsius.com/role/IncomeTaxesDetails1": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred federal, state, and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national, regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.", "label": "Deferred Federal, State and Local, Tax Expense (Benefit)", "totalLabel": "Deferred federal, state and local, tax expense" } } }, "localname": "DeferredFederalStateAndLocalTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/IncomeTaxesDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred" } } }, "localname": "DeferredFederalStateAndLocalTaxExpenseBenefitAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/IncomeTaxesDetails1" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredFinanceCostsNet": { "auth_ref": [ "r138", "r621" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.", "label": "Debt Issuance Costs, Net" } } }, "localname": "DeferredFinanceCostsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/MezzanineEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": { "auth_ref": [ "r114", "r596", "r659" ], "calculation": { "http://celsius.com/role/IncomeTaxesDetails1": { "order": 3.0, "parentTag": "us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Foreign Income Tax Expense (Benefit)", "verboseLabel": "Foreign" } } }, "localname": "DeferredForeignIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/IncomeTaxesDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxAssetsNet": { "auth_ref": [ "r390", "r391" ], "calculation": { "http://celsius.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.", "label": "Deferred tax asset" } } }, "localname": "DeferredIncomeTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxLiabilities": { "auth_ref": [ "r2", "r3", "r145", "r157", "r403" ], "calculation": { "http://celsius.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.", "label": "Deferred tax liability" } } }, "localname": "DeferredIncomeTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxesAndTaxCredits": { "auth_ref": [ "r46" ], "calculation": { "http://celsius.com/role/StatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income tax expense (benefit) and income tax credits.", "label": "Deferred income taxes" } } }, "localname": "DeferredIncomeTaxesAndTaxCredits", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredRevenue": { "auth_ref": [ "r581" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.", "label": "Deferred Revenue [Default Label]", "verboseLabel": "Deferred revenue" } } }, "localname": "DeferredRevenue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://celsius.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredRevenueCurrent": { "auth_ref": [ "r580" ], "calculation": { "http://celsius.com/role/BalanceSheets": { "order": 6.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.", "label": "Deferred revenue-current" } } }, "localname": "DeferredRevenueCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredRevenueNoncurrent": { "auth_ref": [ "r581" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent.", "label": "Deferred Revenue, Noncurrent" } } }, "localname": "DeferredRevenueNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredRevenueRevenueRecognized1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized that was previously reported as deferred or unearned revenue.", "label": "Deferred Revenue, Revenue Recognized", "verboseLabel": "Deferred Revenue" } } }, "localname": "DeferredRevenueRevenueRecognized1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/RevenueDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": { "auth_ref": [ "r596", "r659", "r660" ], "calculation": { "http://celsius.com/role/IncomeTaxesDetails1": { "order": 2.0, "parentTag": "us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.", "label": "State and local" } } }, "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/IncomeTaxesDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards": { "auth_ref": [ "r112", "r657" ], "calculation": { "http://celsius.com/role/IncomeTaxesDetails3": { "order": 2.0, "parentTag": "celh_DeferredTaxAssetsLiabilitiesGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible charitable contribution carryforwards.", "label": "Charitable contributions" } } }, "localname": "DeferredTaxAssetsCharitableContributionCarryforwards", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/IncomeTaxesDetails3" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets": { "auth_ref": [], "calculation": { "http://celsius.com/role/IncomeTaxesDetails3": { "order": 11.0, "parentTag": "celh_DeferredTaxAssetsLiabilitiesGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill.", "label": "Deferred Tax Assets, Goodwill and Intangible Assets", "verboseLabel": "Intangibles" } } }, "localname": "DeferredTaxAssetsGoodwillAndIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/IncomeTaxesDetails3" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsInventory": { "auth_ref": [ "r112", "r657" ], "calculation": { "http://celsius.com/role/IncomeTaxesDetails3": { "order": 10.0, "parentTag": "celh_DeferredTaxAssetsLiabilitiesGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory.", "label": "Inventory allowance" } } }, "localname": "DeferredTaxAssetsInventory", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/IncomeTaxesDetails3" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": { "auth_ref": [ "r112", "r657" ], "calculation": { "http://celsius.com/role/IncomeTaxesDetails3": { "order": 1.0, "parentTag": "celh_DeferredTaxAssetsLiabilitiesGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.", "label": "Net operating loss carryforwards" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/IncomeTaxesDetails3" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic": { "auth_ref": [ "r112", "r657" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards. Excludes state and local operating loss carryforwards.", "label": "Operating Loss Carryforwards, Federal" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwardsDomestic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign": { "auth_ref": [ "r112", "r657" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign operating loss carryforwards.", "label": "Operating Loss Carryforwards, Foreign" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwardsForeign", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal": { "auth_ref": [ "r112", "r657" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards.", "label": "Operating Loss Carryforwards, State" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r404" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.", "label": "Deferred Tax Assets, Valuation Allowance", "negatedLabel": "Valuation allowance" } } }, "localname": "DeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/IncomeTaxesDetails3" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": { "auth_ref": [ "r112", "r657" ], "calculation": { "http://celsius.com/role/IncomeTaxesDetails3": { "order": 3.0, "parentTag": "celh_DeferredTaxAssetsLiabilitiesGross", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.", "label": "Deferred Tax Liabilities, Property, Plant and Equipment", "negatedLabel": "Fixed assets" } } }, "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/IncomeTaxesDetails3" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepositsAssets": { "auth_ref": [ "r579" ], "calculation": { "http://celsius.com/role/BalanceSheets": { "order": 7.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment in the future.", "label": "Other long-term assets" } } }, "localname": "DepositsAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r45", "r84" ], "calculation": { "http://celsius.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/PropertyAndEquipmentDetailsNarrative", "http://celsius.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeContractTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset." } } }, "localname": "DerivativeContractTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/Stock-basedCompensationDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_DerivativeInstrumentRiskAxis": { "auth_ref": [ "r126", "r127", "r129", "r130", "r528" ], "lang": { "en-us": { "role": { "documentation": "Information by type of derivative contract.", "label": "Derivative Instrument [Axis]" } } }, "localname": "DerivativeInstrumentRiskAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/Stock-basedCompensationDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "auth_ref": [ "r344", "r375", "r376", "r379", "r384", "r548" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for share-based payment arrangement.", "label": "STOCK-BASED COMPENSATION" } } }, "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/Stock-basedCompensation" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement [Abstract]" } } }, "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_Dividends": { "auth_ref": [ "r93", "r154" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of paid and unpaid cash, stock, and paid-in-kind (PIK) dividends declared, for example, but not limited to, common and preferred stock.", "label": "Dividends" } } }, "localname": "Dividends", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/MezzanineEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DividendsPreferredStockCash": { "auth_ref": [ "r93", "r154" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash.", "label": "Dividends, Preferred Stock, Cash", "negatedLabel": "Dividends paid to Series A convertible preferred shares" } } }, "localname": "DividendsPreferredStockCash", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/StatementsOfChangesInStockholdersEquityAndMezzanineEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_DomesticCountryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.", "label": "Domestic Tax Authority [Member]" } } }, "localname": "DomesticCountryMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/IncomeTaxesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "(Loss) income per share:", "verboseLabel": "Earnings Per Share [Abstract]" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/StatementsOfOperationsAndComprehensiveLossIncome" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r198", "r215", "r216", "r217", "r218", "r219", "r223", "r226", "r230", "r231", "r232", "r236", "r430", "r431", "r491", "r496", "r534" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Basic" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/EarningsPerShareDetails", "http://celsius.com/role/StatementsOfOperationsAndComprehensiveLossIncome" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r198", "r215", "r216", "r217", "r218", "r219", "r226", "r230", "r231", "r232", "r236", "r430", "r431", "r491", "r496", "r534" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Dilutive" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/EarningsPerShareDetails", "http://celsius.com/role/StatementsOfOperationsAndComprehensiveLossIncome" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r54", "r56" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Earnings per Share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r233", "r234", "r235", "r237" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "EARNINGS PER SHARE" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/EarningsPerShare" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "auth_ref": [ "r667" ], "calculation": { "http://celsius.com/role/StatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Effect on exchange rate changes on cash and cash equivalents" } } }, "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "auth_ref": [ "r393" ], "lang": { "en-us": { "role": { "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Effective tax rate" } } }, "localname": "EffectiveIncomeTaxRateContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/IncomeTaxesDetails2" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r208", "r393", "r413" ], "lang": { "en-us": { "role": { "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).", "label": "U.S. Statutory federal rate" } } }, "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/IncomeTaxesDetails2" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": { "auth_ref": [ "r653", "r661" ], "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).", "label": "State taxes, net of federal benefit" } } }, "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/IncomeTaxesDetails2" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingenciesForeign": { "auth_ref": [ "r653", "r661" ], "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in foreign income tax contingency.", "label": "Change in deferred balances" } } }, "localname": "EffectiveIncomeTaxRateReconciliationTaxContingenciesForeign", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/IncomeTaxesDetails2" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingenciesOther": { "auth_ref": [ "r653", "r661" ], "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other income tax contingencies.", "label": "Other" } } }, "localname": "EffectiveIncomeTaxRateReconciliationTaxContingenciesOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/IncomeTaxesDetails2" ], "xbrltype": "percentItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "auth_ref": [ "r378" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Period unrecognized pre-tax non-cash compensation expense" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/Stock-basedCompensationDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": { "auth_ref": [ "r651" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.", "label": "Unrecognized compensation expense" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/Stock-basedCompensationDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": { "auth_ref": [ "r651" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.", "label": "Unrecognized pre-tax non-cash compensation expense (in Dollars)" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/Stock-basedCompensationDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r92", "r169", "r193", "r194", "r195", "r210", "r211", "r212", "r214", "r220", "r222", "r239", "r276", "r329", "r380", "r381", "r382", "r409", "r410", "r429", "r441", "r442", "r443", "r444", "r445", "r446", "r457", "r499", "r500", "r501" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/StatementsOfChangesInStockholdersEquityAndMezzanineEquity" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/FairValueMeasurementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [ "r432", "r433", "r435" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.", "label": "Fair Value, Recurring and Nonrecurring [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/FairValueMeasurementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r312", "r334", "r335", "r336", "r337", "r338", "r339", "r433", "r467", "r468", "r469", "r538", "r539", "r542", "r543", "r544" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/FairValueMeasurementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r434" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "FAIR VALUE MEASUREMENTS" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/FairValueMeasurements" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r312", "r334", "r339", "r433", "r467", "r542", "r543", "r544" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/FairValueMeasurementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r312", "r334", "r339", "r433", "r468", "r538", "r539", "r542", "r543", "r544" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2 [Member]" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/FairValueMeasurementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r312", "r334", "r335", "r336", "r337", "r338", "r339", "r433", "r469", "r538", "r539", "r542", "r543", "r544" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Inputs, Level 3 [Member]" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/FairValueMeasurementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r312", "r334", "r335", "r336", "r337", "r338", "r339", "r467", "r468", "r469", "r538", "r539", "r542", "r543", "r544" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value." } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/FairValueMeasurementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "auth_ref": [ "r131", "r132" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.", "label": "Fair Value of Financial Instruments" } } }, "localname": "FairValueOfFinancialInstrumentsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FinanceLeaseLiability": { "auth_ref": [ "r452", "r455" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.", "label": "Finance Lease, Liability", "verboseLabel": "Present value of lease liabilities" } } }, "localname": "FinanceLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/LeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityCurrent": { "auth_ref": [ "r452" ], "calculation": { "http://celsius.com/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.", "label": "Lease liability obligation-finance leases", "negatedLabel": "Less: current portion" } } }, "localname": "FinanceLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BalanceSheets", "http://celsius.com/role/LeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityNoncurrent": { "auth_ref": [ "r452" ], "calculation": { "http://celsius.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.", "label": "Finance Lease, Liability, Noncurrent", "terseLabel": "Long-term portion", "verboseLabel": "Lease liability obligation-finance leases" } } }, "localname": "FinanceLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BalanceSheets", "http://celsius.com/role/LeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDue": { "auth_ref": [ "r455" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease.", "label": "Finance Lease, Liability, to be Paid", "verboseLabel": "Total future minimum lease payments" } } }, "localname": "FinanceLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/LeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r455" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finance Lease, Liability, to be Paid, Year One", "verboseLabel": "2023" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/LeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [ "r455" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finance Lease, Liability, to be Paid, Year Four", "verboseLabel": "2026" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/LeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r455" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finance Lease, Liability, to be Paid, Year Three", "verboseLabel": "2025" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/LeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r455" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finance Lease, Liability, to be Paid, Year Two", "verboseLabel": "2024" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/LeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r455" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.", "label": "Finance Lease, Liability, Undiscounted Excess Amount", "negatedLabel": "Less: Amount representing interest" } } }, "localname": "FinanceLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/LeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeasePrincipalPayments": { "auth_ref": [ "r453", "r454" ], "calculation": { "http://celsius.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for principal payment on finance lease.", "label": "Finance Lease, Principal Payments", "negatedLabel": "Principal payments on finance lease obligations" } } }, "localname": "FinanceLeasePrincipalPayments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseRightOfUseAsset": { "auth_ref": [ "r451" ], "calculation": { "http://celsius.com/role/BalanceSheets": { "order": 6.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease.", "label": "Right of use assets-finance leases" } } }, "localname": "FinanceLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedCustomerRelationshipsGross": { "auth_ref": [ "r77" ], "calculation": { "http://celsius.com/role/GoodwillAndIntangiblesDetails": { "order": 1.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross carrying amount before accumulated amortization as of the balance sheet date to an asset acquired in a business combination representing a favorable existing relationship with customers having a finite beneficial life.", "label": "Customer relationships" } } }, "localname": "FiniteLivedCustomerRelationshipsGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/GoodwillAndIntangiblesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Amortized over estimated useful life" } } }, "localname": "FiniteLivedIntangibleAssetUsefulLife", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/GoodwillAndIntangiblesDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "auth_ref": [ "r178", "r288" ], "calculation": { "http://celsius.com/role/GoodwillAndIntangiblesDetails": { "order": 2.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsGross", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "negatedLabel": "Less: accumulated amortization" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/GoodwillAndIntangiblesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": { "auth_ref": [], "calculation": { "http://celsius.com/role/GoodwillAndIntangiblesDetails1": { "order": 6.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Thereafter" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/GoodwillAndIntangiblesDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "auth_ref": [ "r79" ], "calculation": { "http://celsius.com/role/GoodwillAndIntangiblesDetails1": { "order": 1.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One", "verboseLabel": "2023" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/GoodwillAndIntangiblesDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of amortization expense of assets, excluding financial assets, that lack physical substance, having a limited useful life.", "label": "Schedule of accumulated amortization of intangible assets" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/GoodwillAndIntangiblesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": { "auth_ref": [ "r79" ], "calculation": { "http://celsius.com/role/GoodwillAndIntangiblesDetails1": { "order": 5.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2027" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/GoodwillAndIntangiblesDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "auth_ref": [ "r79" ], "calculation": { "http://celsius.com/role/GoodwillAndIntangiblesDetails1": { "order": 4.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four", "verboseLabel": "2026" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/GoodwillAndIntangiblesDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "auth_ref": [ "r79" ], "calculation": { "http://celsius.com/role/GoodwillAndIntangiblesDetails1": { "order": 3.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three", "verboseLabel": "2025" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/GoodwillAndIntangiblesDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "auth_ref": [ "r79" ], "calculation": { "http://celsius.com/role/GoodwillAndIntangiblesDetails1": { "order": 2.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two", "verboseLabel": "2024" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/GoodwillAndIntangiblesDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "auth_ref": [ "r77", "r475" ], "calculation": { "http://celsius.com/role/GoodwillAndIntangiblesDetails": { "order": 1.0, "parentTag": "celh_Totalintangibles", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Gross", "totalLabel": "Definite-lived intangible assets, net" } } }, "localname": "FiniteLivedIntangibleAssetsGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/GoodwillAndIntangiblesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "auth_ref": [ "r77", "r474" ], "calculation": { "http://celsius.com/role/GoodwillAndIntangiblesDetails1": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Net", "totalLabel": "Total" } } }, "localname": "FiniteLivedIntangibleAssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/GoodwillAndIntangiblesDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCountryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.", "label": "Foreign Tax Authority [Member]" } } }, "localname": "ForeignCountryMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/IncomeTaxesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ForeignCurrencyTransactionGainBeforeTax": { "auth_ref": [ "r665", "r666" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax of foreign currency transaction realized and unrealized gain recognized in the income statement.", "label": "Foreign Currency Translation" } } }, "localname": "ForeignCurrencyTransactionGainBeforeTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": { "auth_ref": [ "r437", "r438", "r439", "r440" ], "calculation": { "http://celsius.com/role/StatementsOfOperationsAndComprehensiveLossIncome": { "order": 6.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.", "label": "Foreign exchange (loss) gain" } } }, "localname": "ForeignCurrencyTransactionGainLossBeforeTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/StatementsOfOperationsAndComprehensiveLossIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyTransactionGainLossRealized": { "auth_ref": [ "r665", "r666" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax of foreign currency transaction realized gain (loss) recognized in the income statement.", "label": "Recognized foreign currency gains" } } }, "localname": "ForeignCurrencyTransactionGainLossRealized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyTransactionGainLossUnrealized": { "auth_ref": [ "r46", "r665", "r666" ], "calculation": { "http://celsius.com/role/StatementsOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax of foreign currency transaction unrealized gain (loss) recognized in the income statement.", "label": "Foreign Currency Transaction Gain (Loss), Unrealized", "negatedLabel": "Foreign exchange loss (gain)" } } }, "localname": "ForeignCurrencyTransactionGainLossUnrealized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyTransactionLossBeforeTax": { "auth_ref": [ "r665", "r666" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before tax of foreign currency transaction realized and unrealized loss recognized in the income statement.", "label": "Foreign Currency Transaction Gain Before Tax" } } }, "localname": "ForeignCurrencyTransactionLossBeforeTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": { "auth_ref": [ "r448" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.", "label": "Foreign Currency Gain/Losses" } } }, "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_GainLossOnTerminationOfLease": { "auth_ref": [ "r450" ], "calculation": { "http://celsius.com/role/StatementsOfOperationsAndComprehensiveLossIncome": { "order": 5.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) on termination of lease before expiration of lease term.", "label": "Gain on lease cancellations" } } }, "localname": "GainLossOnTerminationOfLease", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/StatementsOfOperationsAndComprehensiveLossIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainLossRelatedToLitigationSettlement": { "auth_ref": [ "r612" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.", "label": "Gain (Loss) Related to Litigation Settlement" } } }, "localname": "GainLossRelatedToLitigationSettlement", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r36" ], "calculation": { "http://celsius.com/role/StatementsOfOperationsAndComprehensiveLossIncome": { "order": 2.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and administrative expenses" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/StatementsOfOperationsAndComprehensiveLossIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpenseMember": { "auth_ref": [ "r32" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing general and administrative expense.", "label": "General and Administrative Expense [Member]" } } }, "localname": "GeneralAndAdministrativeExpenseMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/Stock-basedCompensationDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r177", "r283", "r488", "r537", "r554", "r608", "r609" ], "calculation": { "http://celsius.com/role/BalanceSheets": { "order": 10.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": { "auth_ref": [ "r81" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for goodwill and intangible assets.", "label": "GOODWILL AND INTANGIBLES" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/GoodwillAndIntangibles" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy": { "auth_ref": [ "r286", "r287", "r537" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.", "label": "Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]", "verboseLabel": "Goodwill" } } }, "localname": "GoodwillAndIntangibleAssetsGoodwillPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": { "auth_ref": [ "r71", "r74" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.", "label": "Intangible assets" } } }, "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillImpairmentLoss": { "auth_ref": [ "r45", "r284", "r285", "r286", "r537" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill, Impairment Loss", "verboseLabel": "Goodwill" } } }, "localname": "GoodwillImpairmentLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r34", "r207", "r252", "r260", "r264", "r266", "r275", "r303", "r304", "r305", "r306", "r307", "r308", "r309", "r310", "r311", "r436", "r536", "r618" ], "calculation": { "http://celsius.com/role/StatementsOfOperationsAndComprehensiveLossIncome": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "Gross profit" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/StatementsOfOperationsAndComprehensiveLossIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairmentOfIntangibleAssetsFinitelived": { "auth_ref": [ "r592", "r610" ], "calculation": { "http://celsius.com/role/StatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.", "label": "Impairment of intangible assets" } } }, "localname": "ImpairmentOfIntangibleAssetsFinitelived", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf": { "auth_ref": [ "r45", "r83" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale.", "label": "Impairment of long lived assets" } } }, "localname": "ImpairmentOfLongLivedAssetsToBeDisposedOf", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": { "auth_ref": [ "r82", "r88" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.", "label": "Impairment of Long-Lived Assets" } } }, "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r30", "r141", "r148", "r164", "r252", "r260", "r264", "r266", "r492", "r536" ], "calculation": { "http://celsius.com/role/StatementsOfOperationsAndComprehensiveLossIncome": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income before provision for income taxes", "totalLabel": "Net (loss) income before income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/IncomeTaxesDetails", "http://celsius.com/role/StatementsOfOperationsAndComprehensiveLossIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r289", "r292" ], "lang": { "en-us": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/RevenueDetailsNarrative", "http://celsius.com/role/Stock-basedCompensationDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [ "r292" ], "lang": { "en-us": { "role": { "documentation": "Location in the income statement." } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/RevenueDetailsNarrative", "http://celsius.com/role/Stock-basedCompensationDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r208", "r394", "r401", "r407", "r411", "r414", "r416", "r417", "r418" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "INCOME TAXES" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/IncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense": { "auth_ref": [ "r654" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The sum of the amounts of estimated penalties and interest recognized in the period arising from income tax examinations.", "label": "Unrecognized tax benefits, Interest and penalties" } } }, "localname": "IncomeTaxExaminationPenaltiesAndInterestExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxExaminationPenaltiesExpense": { "auth_ref": [ "r654" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of estimated penalties recognized in the period arising from income tax examinations.", "label": "Income tax expense (benefit)" } } }, "localname": "IncomeTaxExaminationPenaltiesExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/IncomeTaxesDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r209", "r221", "r222", "r251", "r392", "r412", "r415", "r497" ], "calculation": { "http://celsius.com/role/StatementsOfOperationsAndComprehensiveLossIncome": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "negatedLabel": "Income tax (expense) benefit" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/StatementsOfOperationsAndComprehensiveLossIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r192", "r388", "r389", "r401", "r402", "r406", "r408" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r44" ], "calculation": { "http://celsius.com/role/StatementsOfCashFlows": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.", "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities", "verboseLabel": "Accounts payable and accrued expenses" } } }, "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r44" ], "calculation": { "http://celsius.com/role/StatementsOfCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Accounts receivable-net" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDeferredRevenue": { "auth_ref": [ "r529" ], "calculation": { "http://celsius.com/role/StatementsOfCashFlows": { "order": 21.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.", "label": "Deferred revenue" } } }, "localname": "IncreaseDecreaseInDeferredRevenue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r44" ], "calculation": { "http://celsius.com/role/StatementsOfCashFlows": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedLabel": "Inventory-net" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Changes in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOtherOperatingAssets": { "auth_ref": [ "r44" ], "calculation": { "http://celsius.com/role/StatementsOfCashFlows": { "order": 18.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in operating assets classified as other.", "label": "Increase (Decrease) in Other Operating Assets", "negatedLabel": "Other assets" } } }, "localname": "IncreaseDecreaseInOtherOperatingAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "auth_ref": [ "r44" ], "calculation": { "http://celsius.com/role/StatementsOfCashFlows": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "negatedLabel": "Prepaid expenses and other current assets" } } }, "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": { "auth_ref": [ "r80" ], "calculation": { "http://celsius.com/role/GoodwillAndIntangiblesDetails": { "order": 2.0, "parentTag": "celh_Totalintangibles", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.", "label": "Indefinite-Lived Intangible Assets (Excluding Goodwill)", "totalLabel": "Indefinite-lived intangible assets, net" } } }, "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/GoodwillAndIntangiblesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IndefinitelivedIntangibleAssetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit.", "label": "Indefinite-Lived Intangible Assets [Member]" } } }, "localname": "IndefinitelivedIntangibleAssetsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/FairValueMeasurementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r72", "r75" ], "calculation": { "http://celsius.com/role/BalanceSheets": { "order": 9.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Intangibles" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsNetIncludingGoodwill": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount of finite-lived intangible assets, indefinite-lived intangible assets and goodwill. Goodwill is an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Intangible assets are assets, not including financial assets, lacking physical substance.", "label": "Intangible Assets, Net (Including Goodwill)" } } }, "localname": "IntangibleAssetsNetIncludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/GoodwillAndIntangiblesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestAndDividendIncomeOperating": { "auth_ref": [ "r150" ], "calculation": { "http://celsius.com/role/StatementsOfOperationsAndComprehensiveLossIncome": { "order": 1.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the total of interest and dividend income, including any amortization and accretion (as applicable) of discounts and premiums, earned from (1) loans and leases whether held-for-sale or held-in-portfolio; (2) investment securities; (3) federal funds sold; (4) securities purchased under agreements to resell; (5) investments in banker's acceptances, commercial paper, or certificates of deposit; (6) dividend income; or (7) other investments not otherwise specified herein.", "label": "Interest income on note receivable" } } }, "localname": "InterestAndDividendIncomeOperating", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/StatementsOfOperationsAndComprehensiveLossIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseSubordinatedNotesAndDebentures": { "auth_ref": [ "r152" ], "calculation": { "http://celsius.com/role/StatementsOfOperationsAndComprehensiveLossIncome": { "order": 3.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Interest expense incurred during the reporting period on subordinated notes and debentures. Includes amortization of expenses incurred in the issuance of subordinated notes and debentures.", "label": "Interest Expense, Subordinated Notes and Debentures", "negatedLabel": "Interest expense on bonds" } } }, "localname": "InterestExpenseSubordinatedNotesAndDebentures", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/StatementsOfOperationsAndComprehensiveLossIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestIncomeExpenseNet": { "auth_ref": [ "r151" ], "calculation": { "http://celsius.com/role/StatementsOfOperationsAndComprehensiveLossIncome": { "order": 2.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net amount of operating interest income (expense).", "label": "Interest income (expense), net" } } }, "localname": "InterestIncomeExpenseNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/StatementsOfOperationsAndComprehensiveLossIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestIncomeOperating": { "auth_ref": [ "r33" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of operating interest income, including, but not limited to, amortization and accretion of premiums and discounts on securities.", "label": "Interest income" } } }, "localname": "InterestIncomeOperating", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/NoteReceivableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r200", "r203", "r204" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Inventory Disclosure [Abstract]" } } }, "localname": "InventoryDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_InventoryDisclosureTextBlock": { "auth_ref": [ "r282" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.", "label": "INVENTORIES" } } }, "localname": "InventoryDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/Inventories" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryFinishedGoods": { "auth_ref": [ "r584" ], "calculation": { "http://celsius.com/role/InventoriesDetails": { "order": 1.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.", "label": "Finished goods" } } }, "localname": "InventoryFinishedGoods", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/InventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r186", "r527", "r554" ], "calculation": { "http://celsius.com/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://celsius.com/role/InventoriesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventories-net", "totalLabel": "Inventories" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BalanceSheets", "http://celsius.com/role/InventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryPolicyTextBlock": { "auth_ref": [ "r173", "r185", "r238", "r280", "r281", "r282", "r472", "r531" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.", "label": "Inventories" } } }, "localname": "InventoryPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryRawMaterialsAndSupplies": { "auth_ref": [ "r585" ], "calculation": { "http://celsius.com/role/InventoriesDetails": { "order": 2.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed.", "label": "Raw Materials" } } }, "localname": "InventoryRawMaterialsAndSupplies", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/InventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryValuationReserves": { "auth_ref": [ "r70", "r585" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of valuation reserve for inventory.", "label": "Inventory reserve" } } }, "localname": "InventoryValuationReserves", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investments, Debt and Equity Securities [Abstract]" } } }, "localname": "InvestmentsDebtAndEquitySecuritiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": { "auth_ref": [ "r69", "r142", "r153", "r167", "r525" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for investments in certain debt and equity securities.", "label": "MEZZANINE EQUITY" } } }, "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/MezzanineEquity" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "auth_ref": [ "r455" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.", "label": "Total future minimum lease payments" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/LeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r455" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2023" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/LeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [ "r455" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2026" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/LeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r455" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2025" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/LeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r455" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2024" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/LeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r455" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.", "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "negatedLabel": "Less: Amount representing interest" } } }, "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/LeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeasesTextBlock": { "auth_ref": [ "r456" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.", "label": "LEASES" } } }, "localname": "LesseeOperatingLeasesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/Leases" ], "xbrltype": "textBlockItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r17", "r207", "r275", "r303", "r304", "r305", "r306", "r307", "r308", "r309", "r310", "r311", "r423", "r426", "r427", "r436", "r535", "r618", "r670", "r671" ], "calculation": { "http://celsius.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total Liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r10", "r146", "r160", "r554", "r595", "r607", "r664" ], "calculation": { "http://celsius.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total Liabilities, Mezzanine Equity and Stockholders\u2019 Equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r19", "r172", "r207", "r275", "r303", "r304", "r305", "r306", "r307", "r308", "r309", "r310", "r311", "r423", "r426", "r427", "r436", "r554", "r618", "r670", "r671" ], "calculation": { "http://celsius.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LongDurationContractsAssumptionsByProductAndGuaranteeVolatilityRate": { "auth_ref": [ "r156", "r165", "r166" ], "lang": { "en-us": { "role": { "documentation": "Percentage rate that is indicative of an expected degree of movement against a base line index, and which is included in determining the amount of the specified guaranteed benefit obligation as of the balance sheet date.", "label": "Volatility Rate" } } }, "localname": "LongDurationContractsAssumptionsByProductAndGuaranteeVolatilityRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/FairValueMeasurementsDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock": { "auth_ref": [ "r67" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of long-lived assets, excluding financial instruments, long-term customer relationships of a financial institution, mortgage rights, deferred policy acquisition costs, and deferred tax assets, by geographic areas located in the entity's country of domicile and foreign countries in which the entity holds assets.", "label": "Schedule of long-lived asset geographic data" } } }, "localname": "LongLivedAssetsByGeographicAreasTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LongTermDebtAverageAmountOutstanding": { "auth_ref": [ "r523", "r524" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Average amount outstanding of long-term debt.", "label": "Outstanding principal amount" } } }, "localname": "LongTermDebtAverageAmountOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/NoteReceivableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtNoncurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Long-term liabilities:" } } }, "localname": "LongTermDebtNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtWeightedAverageInterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average interest rate of long-term debt outstanding calculated at point in time.", "label": "Weighted average interest rate" } } }, "localname": "LongtermDebtWeightedAverageInterestRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/NoteReceivableDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_LossContingencyDamagesSoughtValue": { "auth_ref": [ "r612", "r613", "r615" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The value (monetary amount) of the award the plaintiff seeks in the legal matter.", "label": "Compensatory damages" } } }, "localname": "LossContingencyDamagesSoughtValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_MajorityShareholderMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Owner that controls more than 50 percent of the voting interest in the entity through direct or indirect ownership.", "label": "Majority Shareholder [Member]" } } }, "localname": "MajorityShareholderMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_NatureOfOperations": { "auth_ref": [ "r242", "r248" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.", "label": "ORGANIZATION AND DESCRIPTION OF BUSINESS" } } }, "localname": "NatureOfOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/OrganizationAndDescriptionOfBusiness" ], "xbrltype": "textBlockItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r202" ], "calculation": { "http://celsius.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from financing activities:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r202" ], "calculation": { "http://celsius.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash (used in) provided by in investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from investing activities:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r42", "r43", "r46" ], "calculation": { "http://celsius.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net cash provided by (used in) operating activities", "negatedLabel": "Net cash provided by (used in) operating activities", "totalLabel": "Net cash provided by (used in) operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://celsius.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from operating activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r31", "r46", "r149", "r163", "r170", "r188", "r190", "r195", "r207", "r213", "r215", "r216", "r217", "r218", "r221", "r222", "r228", "r252", "r260", "r264", "r266", "r275", "r303", "r304", "r305", "r306", "r307", "r308", "r309", "r310", "r311", "r431", "r436", "r536", "r618" ], "calculation": { "http://celsius.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://celsius.com/role/StatementsOfOperationsAndComprehensiveLossIncome": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net (loss) income", "totalLabel": "Net (loss) income" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/EarningsPerShareDetails", "http://celsius.com/role/StatementsOfCashFlows", "http://celsius.com/role/StatementsOfOperationsAndComprehensiveLossIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "auth_ref": [ "r215", "r216", "r217", "r218", "r223", "r224", "r229", "r232", "r252", "r260", "r264", "r266", "r536" ], "calculation": { "http://celsius.com/role/StatementsOfOperationsAndComprehensiveLossIncome": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.", "label": "Net (loss) income attributed to common shareholders", "negatedLabel": "Net (loss) income", "totalLabel": "Net (loss) income attributed to common stockholders", "verboseLabel": "Net (loss) income attributed to common stockholders" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://celsius.com/role/EarningsPerShareDetails", "http://celsius.com/role/StatementsOfOperationsAndComprehensiveLossIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "Recent Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NonUsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Countries excluding the United States of America (US).", "label": "Non-US [Member]" } } }, "localname": "NonUsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/IncomeTaxesDetails5" ], "xbrltype": "domainItemType" }, "us-gaap_NoncashOrPartNoncashAcquisitionOtherLiabilitiesAssumed1": { "auth_ref": [ "r49", "r50", "r51" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities, classified as other, assumed in acquiring a business or in consideration for an asset received in a noncash or part noncash acquisition.", "label": "Noncash or Part Noncash Acquisition, Other Liabilities Assumed", "negatedLabel": "Other liabilities" } } }, "localname": "NoncashOrPartNoncashAcquisitionOtherLiabilitiesAssumed1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r37" ], "calculation": { "http://celsius.com/role/StatementsOfOperationsAndComprehensiveLossIncome": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Nonoperating Income (Expense)", "totalLabel": "Total other income" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/StatementsOfOperationsAndComprehensiveLossIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Income/(Expense):" } } }, "localname": "NonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/StatementsOfOperationsAndComprehensiveLossIncome" ], "xbrltype": "stringItemType" }, "us-gaap_NotesAndLoansReceivableNetCurrent": { "auth_ref": [ "r271", "r272", "r489" ], "calculation": { "http://celsius.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://celsius.com/role/NoteReceivableDetails": { "order": 1.0, "parentTag": "us-gaap_NotesReceivableNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amortized cost, after allowance for credit loss, of financing receivable classified as current. Excludes net investment in lease.", "label": "Note receivable-current", "verboseLabel": "Note Receivable-current" } } }, "localname": "NotesAndLoansReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BalanceSheets", "http://celsius.com/role/NoteReceivableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesAndLoansReceivableNetNoncurrent": { "auth_ref": [], "calculation": { "http://celsius.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://celsius.com/role/NoteReceivableDetails": { "order": 2.0, "parentTag": "us-gaap_NotesReceivableNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of financing receivable, classified as noncurrent.", "label": "Note receivable", "verboseLabel": "Note Receivable-non-current" } } }, "localname": "NotesAndLoansReceivableNetNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BalanceSheets", "http://celsius.com/role/NoteReceivableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesReceivableNet": { "auth_ref": [ "r271", "r279" ], "calculation": { "http://celsius.com/role/NoteReceivableDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amortized cost, after allowance for credit loss, of financing receivable. Excludes financing receivable covered under loss sharing agreement and net investment in lease.", "label": "Financing Receivable, after Allowance for Credit Loss", "totalLabel": "Total Note Receivable" } } }, "localname": "NotesReceivableNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/NoteReceivableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OfficeEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tangible personal property used in an office setting. Examples include, but are not limited to, computers, copiers and fax machine.", "label": "Office Equipment [Member]" } } }, "localname": "OfficeEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OpenTaxYear": { "auth_ref": [ "r395" ], "lang": { "en-us": { "role": { "documentation": "Tax year that remains open to examination under enacted tax laws, in YYYY format.", "label": "Open Tax Year" } } }, "localname": "OpenTaxYear", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/IncomeTaxesDetails5" ], "xbrltype": "gYearListItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://celsius.com/role/StatementsOfOperationsAndComprehensiveLossIncome": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses [Default Label]", "totalLabel": "Total operating expense" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/StatementsOfOperationsAndComprehensiveLossIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r252", "r260", "r264", "r266", "r536" ], "calculation": { "http://celsius.com/role/StatementsOfOperationsAndComprehensiveLossIncome": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "(Loss) income from operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/StatementsOfOperationsAndComprehensiveLossIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseExpense": { "auth_ref": [ "r668" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating lease expense. Excludes sublease income.", "label": "Monthly expense" } } }, "localname": "OperatingLeaseExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r452" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Present value of lease liabilities" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/LeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r452" ], "calculation": { "http://celsius.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Lease liability obligation-operating leases", "negatedLabel": "Less: current portion" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BalanceSheets", "http://celsius.com/role/LeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r452" ], "calculation": { "http://celsius.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Long-term portion", "verboseLabel": "Lease liability obligation-operating leases" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BalanceSheets", "http://celsius.com/role/LeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r451" ], "calculation": { "http://celsius.com/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Right of use assets-operating leases" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": { "auth_ref": [ "r24" ], "calculation": { "http://celsius.com/role/StatementsOfOperationsAndComprehensiveLossIncome": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Foreign currency translation (loss) gain" } } }, "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/StatementsOfOperationsAndComprehensiveLossIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherCurrentLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of other current liabilities.", "label": "OTHER CURRENT LIABILITIES" } } }, "localname": "OtherCurrentLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/OtherCurrentLiabilities" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherLiabilitiesAndDeferredRevenueNoncurrent": { "auth_ref": [], "calculation": { "http://celsius.com/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate carrying amount, as of the balance sheet date, of noncurrent obligations and noncurrent portion of deferred revenue not separately disclosed in the balance sheet. Noncurrent liabilities are expected to be paid after one year (or the normal operating cycle, if longer). Deferred revenue is a liability related to a revenue producing activity for which revenue has not yet been recognized, and is not expected to be recognized in the next twelve months.", "label": "Deferred revenue-non-current" } } }, "localname": "OtherLiabilitiesAndDeferredRevenueNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesCurrent": { "auth_ref": [ "r18", "r554" ], "calculation": { "http://celsius.com/role/BalanceSheets": { "order": 7.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 }, "http://celsius.com/role/OtherCurrentLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other current liabilities", "totalLabel": "Total" } } }, "localname": "OtherLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BalanceSheets", "http://celsius.com/role/OtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PayablesAndAccrualsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Payables and Accruals [Abstract]" } } }, "localname": "PayablesAndAccrualsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock": { "auth_ref": [ "r41" ], "calculation": { "http://celsius.com/role/StatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow in the form of ordinary dividends to preferred shareholders of the parent entity.", "label": "Payments of Ordinary Dividends, Preferred Stock and Preference Stock", "negatedLabel": "Dividends paid on preferred shares", "negatedTerseLabel": "Less: dividends paid to Series A convertible preferred stockholders" } } }, "localname": "PaymentsOfDividendsPreferredStockAndPreferenceStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/EarningsPerShareDetails", "http://celsius.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r39" ], "calculation": { "http://celsius.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Purchase of property and equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PerformanceSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement awarded for meeting performance target.", "label": "Performance Shares [Member]" } } }, "localname": "PerformanceSharesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/Stock-basedCompensationDetails5", "http://celsius.com/role/Stock-basedCompensationDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r625", "r626", "r627", "r628", "r629", "r630", "r631", "r632", "r633", "r634", "r635", "r636", "r637", "r638", "r639", "r640", "r641", "r642", "r643", "r644", "r645", "r646", "r647", "r648", "r649", "r650" ], "lang": { "en-us": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name [Axis]" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://celsius.com/role/MezzanineEquityDetailsNarrative", "http://celsius.com/role/OrganizationAndDescriptionOfBusinessDetailsNarrative", "http://celsius.com/role/RevenueDetailsNarrative", "http://celsius.com/role/Stock-basedCompensationDetailsNarrative", "http://celsius.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [ "r625", "r626", "r627", "r628", "r629", "r630", "r631", "r632", "r633", "r634", "r635", "r636", "r637", "r638", "r639", "r640", "r641", "r642", "r643", "r644", "r645", "r646", "r647", "r648", "r649", "r650" ], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement." } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://celsius.com/role/MezzanineEquityDetailsNarrative", "http://celsius.com/role/OrganizationAndDescriptionOfBusinessDetailsNarrative", "http://celsius.com/role/RevenueDetailsNarrative", "http://celsius.com/role/Stock-basedCompensationDetailsNarrative", "http://celsius.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockConvertibleConversionRatio": { "auth_ref": [ "r316" ], "lang": { "en-us": { "role": { "documentation": "Number of common shares issuable upon conversion for each share of preferred stock to be converted.", "label": "Preferred Stock, Convertible, Conversion Ratio" } } }, "localname": "PreferredStockConvertibleConversionRatio", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/MezzanineEquityDetailsNarrative" ], "xbrltype": "pureItemType" }, "us-gaap_PreferredStockConvertibleSharesIssuable": { "auth_ref": [ "r316" ], "lang": { "en-us": { "role": { "documentation": "Number of common shares issuable upon conversion of preferred stock.", "label": "Preferred Stock, Convertible, Shares Issuable" } } }, "localname": "PreferredStockConvertibleSharesIssuable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/MezzanineEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockDividendRatePercentage": { "auth_ref": [ "r315" ], "lang": { "en-us": { "role": { "documentation": "The percentage rate used to calculate dividend payments on preferred stock.", "label": "Preferred Stock, Dividend Rate, Percentage", "verboseLabel": "Dividend rate" } } }, "localname": "PreferredStockDividendRatePercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/FairValueMeasurementsDetailsNarrative", "http://celsius.com/role/MezzanineEquityDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_PreferredStockDividendsIncomeStatementImpact": { "auth_ref": [], "calculation": { "http://celsius.com/role/StatementsOfOperationsAndComprehensiveLossIncome": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of preferred stock dividends that is an adjustment to net income apportioned to common stockholders.", "label": "Preferred Stock Dividends, Income Statement Impact", "negatedLabel": "Less: dividends on Series A convertible preferred shares" } } }, "localname": "PreferredStockDividendsIncomeStatementImpact", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/StatementsOfOperationsAndComprehensiveLossIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockDividendsPerShareDeclared": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Aggregate dividends declared during the period for each share of preferred stock outstanding.", "label": "Preferred Stock, Dividends Per Share, Declared" } } }, "localname": "PreferredStockDividendsPerShareDeclared", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/MezzanineEquityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockLiquidationPreferenceValue": { "auth_ref": [ "r205", "r318" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of the difference between preference in liquidation and the par or stated values of the preferred shares.", "label": "Preferred Stock, Liquidation Preference, Value" } } }, "localname": "PreferredStockLiquidationPreferenceValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/MezzanineEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.", "label": "Preferred Stock [Member]" } } }, "localname": "PreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/StatementsOfChangesInStockholdersEquityAndMezzanineEquity" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r4", "r314" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred stock, par value" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockRedemptionAmount": { "auth_ref": [ "r22", "r91" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The redemption (or callable) amount of currently redeemable preferred stock. Includes amounts representing dividends not currently declared or paid but which will be payable under the redemption features or for which ultimate payment is solely within the control of the issuer.", "label": "Preferred stock, redemption amount" } } }, "localname": "PreferredStockRedemptionAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BalanceSheetsParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/MezzanineEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r4", "r314" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred stock, shares issued", "terseLabel": "Preferred Stock, Shares Issued", "verboseLabel": "Preferred stock issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BalanceSheetsParenthetical", "http://celsius.com/role/FairValueMeasurementsDetailsNarrative", "http://celsius.com/role/MezzanineEquityDetailsNarrative", "http://celsius.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred stock, shares outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r4", "r554" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred stock, value, issued" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/FairValueMeasurementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r586" ], "calculation": { "http://celsius.com/role/BalanceSheets": { "order": 6.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Prepaid expenses and other current assets" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BalanceSheets", "http://celsius.com/role/PrepaidExpensesAndOtherCurrentAssetsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "auth_ref": [ "r40" ], "calculation": { "http://celsius.com/role/StatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the additional capital contribution to the entity.", "label": "Net proceeds from sale of common stock" } } }, "localname": "ProceedsFromIssuanceOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/RelatedPartyTransactionsDetailsNarrative", "http://celsius.com/role/StatementsOfCashFlows", "http://celsius.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock": { "auth_ref": [ "r40" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from issuance of preferred stocks identified as being convertible into another form of financial instrument, typically the entity's common stock.", "label": "Proceeds from issuance of convertible preferred stock" } } }, "localname": "ProceedsFromIssuanceOfConvertiblePreferredStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/OrganizationAndDescriptionOfBusinessDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock": { "auth_ref": [ "r40" ], "calculation": { "http://celsius.com/role/StatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds from issuance of capital stock which provides for a specific dividend that is paid to the shareholders before any dividends to common stockholders and which takes precedence over common stockholders in the event of liquidation.", "label": "Proceeds from issuance of Series A preferred shares, net of issuance costs" } } }, "localname": "ProceedsFromIssuanceOfPreferredStockAndPreferenceStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": { "auth_ref": [ "r590", "r591" ], "calculation": { "http://celsius.com/role/StatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.", "label": "Cash paid on taxes on restricted stock awards" } } }, "localname": "ProceedsFromPaymentsForOtherFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleOfNotesReceivable": { "auth_ref": [ "r38" ], "calculation": { "http://celsius.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the sale of a borrowing supported by a written promise to pay an obligation.", "label": "Proceeds from note receivable" } } }, "localname": "ProceedsFromSaleOfNotesReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromStockOptionsExercised": { "auth_ref": [ "r40", "r107" ], "calculation": { "http://celsius.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.", "label": "Proceeds from exercise of stock options" } } }, "localname": "ProceedsFromStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/StatementsOfCashFlows", "http://celsius.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Product Information [Line Items]" } } }, "localname": "ProductInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ProductLiabilityContingencyLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Product Liability Contingency [Line Items]" } } }, "localname": "ProductLiabilityContingencyLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ProductLiabilityContingencyTable": { "auth_ref": [ "r301", "r612", "r614", "r616" ], "lang": { "en-us": { "role": { "documentation": "Information and financial data about the reasonably possible loss or the recognized and additional reasonably possible loss from product liability related to an individual product.", "label": "Product Liability Contingency [Table]" } } }, "localname": "ProductLiabilityContingencyTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r170", "r188", "r190", "r201", "r207", "r213", "r221", "r222", "r252", "r260", "r264", "r266", "r275", "r303", "r304", "r305", "r306", "r307", "r308", "r309", "r310", "r311", "r421", "r424", "r425", "r431", "r436", "r492", "r536", "r552", "r553", "r589", "r618" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net loss" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/StatementsOfChangesInStockholdersEquityAndMezzanineEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Abstract]" } } }, "localname": "PropertyPlantAndEquipmentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r87" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Long-Lived Tangible Asset [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/PropertyAndEquipmentDetails", "http://celsius.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "auth_ref": [ "r89", "r509", "r510", "r511" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "PROPERTY AND EQUIPMENT" } } }, "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/PropertyAndEquipment" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r85", "r175" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, plant and equipment, gross" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property, Plant and Equipment [Line Items]" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://celsius.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r87", "r161", "r493", "r554" ], "calculation": { "http://celsius.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property and equipment-net", "verboseLabel": "Total" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BalanceSheets", "http://celsius.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "auth_ref": [ "r87", "r509", "r510" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property and Equipment" } } }, "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r87" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Schedule of property and equipment" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/PropertyAndEquipmentTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r85" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software." } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/PropertyAndEquipmentDetails", "http://celsius.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.", "label": "Property and equipment estimated useful life", "verboseLabel": "Property, Plant and Equipment, Useful Life" } } }, "localname": "PropertyPlantAndEquipmentUsefulLife", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://celsius.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ProvisionForDoubtfulAccounts": { "auth_ref": [ "r199", "r278" ], "calculation": { "http://celsius.com/role/StatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.", "label": "Bad debt expense" } } }, "localname": "ProvisionForDoubtfulAccounts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReceivablesPolicyTextBlock": { "auth_ref": [ "r603", "r604", "r605", "r606" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.", "label": "Accounts Receivable" } } }, "localname": "ReceivablesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r340", "r460", "r461" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Related Party Transaction [Line Items]" } } }, "localname": "RelatedPartyTransactionLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r340", "r460", "r476", "r477", "r478", "r479", "r480", "r481", "r482", "r483", "r484", "r485", "r486", "r487", "r669" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r458", "r459", "r461", "r462", "r463" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "RELATED PARTY TRANSACTIONS" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/RelatedPartyTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r108", "r168", "r678" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research and development expense" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpensePolicy": { "auth_ref": [ "r108" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.", "label": "Research and Development" } } }, "localname": "ResearchAndDevelopmentExpensePolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RestrictedCash": { "auth_ref": [ "r578", "r593", "r679", "r680" ], "calculation": { "http://celsius.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.", "label": "Restricted cash" } } }, "localname": "RestrictedCash", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BalanceSheets", "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedStockMember": { "auth_ref": [ "r54" ], "lang": { "en-us": { "role": { "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.", "label": "Restricted Stock [Member]" } } }, "localname": "RestrictedStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/Stock-basedCompensationDetails3" ], "xbrltype": "domainItemType" }, "us-gaap_RestrictedStockUnitsRSUMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.", "label": "Restricted Stock Units (RSUs) [Member]" } } }, "localname": "RestrictedStockUnitsRSUMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/Stock-basedCompensationDetails4", "http://celsius.com/role/Stock-basedCompensationDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_RestructuringCostAndReserveLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Restructuring Cost and Reserve [Line Items]" } } }, "localname": "RestructuringCostAndReserveLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/OrganizationAndDescriptionOfBusinessDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r7", "r93", "r159", "r502", "r504", "r554" ], "calculation": { "http://celsius.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Accumulated deficit", "negatedLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BalanceSheets", "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r169", "r210", "r211", "r212", "r214", "r220", "r222", "r276", "r380", "r381", "r382", "r409", "r410", "r429", "r499", "r501" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/StatementsOfChangesInStockholdersEquityAndMezzanineEquity" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueRecognitionPolicyTextBlock": { "auth_ref": [ "r532", "r533" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.", "label": "Revenue Recognition" } } }, "localname": "RevenueRecognitionPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_Revenues": { "auth_ref": [ "r196", "r207", "r249", "r250", "r259", "r262", "r263", "r267", "r268", "r270", "r275", "r303", "r304", "r305", "r306", "r307", "r308", "r309", "r310", "r311", "r436", "r492", "r618" ], "calculation": { "http://celsius.com/role/StatementsOfOperationsAndComprehensiveLossIncome": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "Revenue", "terseLabel": "Revenues", "verboseLabel": "Net sales" } } }, "localname": "Revenues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/RelatedPartyTransactionsDetailsNarrative", "http://celsius.com/role/RevenueDetails", "http://celsius.com/role/RevenueDetailsNarrative", "http://celsius.com/role/StatementsOfOperationsAndComprehensiveLossIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.", "label": "Sales of common stock" } } }, "localname": "SaleOfStockNumberOfSharesIssuedInTransaction", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_SaleOfStockPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.", "label": "Share price" } } }, "localname": "SaleOfStockPricePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_SalesRevenueNetMember": { "auth_ref": [ "r270", "r602" ], "lang": { "en-us": { "role": { "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.", "label": "Revenue Benchmark [Member]" } } }, "localname": "SalesRevenueNetMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.", "label": "Schedule of accounts payable and accrued expenses" } } }, "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/AccountsPayableAndAccruedExpensesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Securities, Available-for-Sale [Line Items]" } } }, "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/MezzanineEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": { "auth_ref": [ "r113" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.", "label": "Schedule of provision for income taxes" } } }, "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "auth_ref": [ "r111" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.", "label": "Schedule of deferred tax assets" } } }, "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r601" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of earnings per share, basic and diluted" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/EarningsPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "auth_ref": [ "r109" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.", "label": "Schedule of effective rate on income before provision (benefit) for income taxes" } } }, "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": { "auth_ref": [ "r596" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.", "label": "Schedule of domestic and foreign components" } } }, "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "auth_ref": [ "r1", "r11", "r12", "r13" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "Schedule of inventories" } } }, "localname": "ScheduleOfInventoryCurrentTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/InventoriesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock": { "auth_ref": [ "r99" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock units.", "label": "Schedule of restricted stock activity" } } }, "localname": "ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/Stock-basedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock": { "auth_ref": [ "r99" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the changes in outstanding nonvested shares.", "label": "Schedule of restricted stock unit activity" } } }, "localname": "ScheduleOfNonvestedShareActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/Stock-basedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfProductInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule detailing quantitative information concerning products or product lines by product or product line.", "label": "Schedule of Product Information [Table]" } } }, "localname": "ScheduleOfProductInformationTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r87" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://celsius.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "auth_ref": [ "r139", "r140" ], "lang": { "en-us": { "role": { "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Schedule of Related Party Transactions, by Related Party [Table]" } } }, "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": { "auth_ref": [ "r290", "r291", "r292", "r293", "r294", "r295", "r296" ], "lang": { "en-us": { "role": { "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.", "label": "Schedule of Restructuring and Related Costs [Table]" } } }, "localname": "ScheduleOfRestructuringAndRelatedCostsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/OrganizationAndDescriptionOfBusinessDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "auth_ref": [ "r64", "r65", "r66", "r71" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of net sales by reporting segment" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/RevenueTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r342", "r343", "r345", "r346", "r347", "r349", "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r369", "r370", "r371", "r372", "r373" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/Stock-basedCompensationDetails", "http://celsius.com/role/Stock-basedCompensationDetails3", "http://celsius.com/role/Stock-basedCompensationDetails4", "http://celsius.com/role/Stock-basedCompensationDetails5", "http://celsius.com/role/Stock-basedCompensationDetailsNarrative", "http://celsius.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable": { "auth_ref": [ "r106" ], "lang": { "en-us": { "role": { "documentation": "Details comprising a table providing supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices.", "label": "Share-Based Payment Arrangement, Option, Exercise Price Range [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/Stock-basedCompensationDetails2" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock": { "auth_ref": [ "r106" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.", "label": "Schedule of employee stock options outstanding" } } }, "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/Stock-basedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": { "auth_ref": [ "r104" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.", "label": "Schedule of black scholes option-pricing model valuation assumption" } } }, "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/Stock-basedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the change in stock options.", "label": "Schedule of outstanding stock options" } } }, "localname": "ScheduleOfStockOptionsRollForwardTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/Stock-basedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock": { "auth_ref": [ "r551", "r656" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the change in unrecognized tax benefits.", "label": "Schedule of reconciliation of the beginning and ending amounts of unrecognized tax benefits" } } }, "localname": "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock": { "auth_ref": [ "r55" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit).", "label": "Summary of preferred shares" } } }, "localname": "ScheduleOfWeightedAverageNumberOfSharesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/FairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": { "auth_ref": [ "r76" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.", "label": "Schedule of future estimated amortization expense" } } }, "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/GoodwillAndIntangiblesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock": { "auth_ref": [ "r57", "r58", "r59", "r60", "r133", "r135" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.", "label": "Schedule of revenue & accounts receivable with customers" } } }, "localname": "SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingPolicyPolicyTextBlock": { "auth_ref": [ "r253", "r254", "r255", "r256", "r257", "r258", "r268" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for segment reporting.", "label": "Segment Reporting" } } }, "localname": "SegmentReportingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SellingAndMarketingExpense": { "auth_ref": [], "calculation": { "http://celsius.com/role/StatementsOfOperationsAndComprehensiveLossIncome": { "order": 1.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services.", "label": "Selling and marketing expenses" } } }, "localname": "SellingAndMarketingExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/StatementsOfOperationsAndComprehensiveLossIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_SeriesAPreferredStockMember": { "auth_ref": [ "r582", "r583", "r622" ], "lang": { "en-us": { "role": { "documentation": "Series A preferred stock.", "label": "Series A Preferred Stock [Member]" } } }, "localname": "SeriesAPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BalanceSheetsParenthetical", "http://celsius.com/role/FairValueMeasurementsDetails", "http://celsius.com/role/FairValueMeasurementsDetailsNarrative", "http://celsius.com/role/MezzanineEquityDetailsNarrative", "http://celsius.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r44" ], "calculation": { "http://celsius.com/role/StatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-based payment expense" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "auth_ref": [ "r548" ], "lang": { "en-us": { "role": { "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.", "label": "Share-based compensation service or vesting period of grant" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/Stock-basedCompensationDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription": { "auth_ref": [ "r95", "r96" ], "lang": { "en-us": { "role": { "documentation": "Description of terms of share-based payment arrangement. Includes, but is not limited to, type of award or grantee and reason for issuance.", "label": "Stock incentive plan, description" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/Stock-basedCompensationDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "auth_ref": [ "r362" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.", "label": "Forfeited and cancelled", "negatedLabel": "Forfeited and cancelled" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/Stock-basedCompensationDetails3", "http://celsius.com/role/Stock-basedCompensationDetails4", "http://celsius.com/role/Stock-basedCompensationDetails5" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "auth_ref": [ "r360" ], "lang": { "en-us": { "role": { "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/Stock-basedCompensationDetails3", "http://celsius.com/role/Stock-basedCompensationDetails4", "http://celsius.com/role/Stock-basedCompensationDetails5" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue": { "auth_ref": [ "r360" ], "lang": { "en-us": { "role": { "documentation": "Per share or unit weighted-average intrinsic value of award granted under share-based payment arrangement. Excludes share and unit options.", "label": "Restricted stock granted (in Dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/Stock-basedCompensationDetails3", "http://celsius.com/role/Stock-basedCompensationDetails4", "http://celsius.com/role/Stock-basedCompensationDetails5" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "auth_ref": [ "r357", "r358" ], "lang": { "en-us": { "role": { "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number", "periodEndLabel": "Unvested at end of period", "periodStartLabel": "Unvested at beginning of period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/Stock-basedCompensationDetails3", "http://celsius.com/role/Stock-basedCompensationDetails4", "http://celsius.com/role/Stock-basedCompensationDetails5" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "auth_ref": [ "r361" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.", "label": "Vested", "negatedLabel": "Vested" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/Stock-basedCompensationDetails3", "http://celsius.com/role/Stock-basedCompensationDetails4", "http://celsius.com/role/Stock-basedCompensationDetails5" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "auth_ref": [ "r370" ], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Expected volatility" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/Stock-basedCompensationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "auth_ref": [ "r372" ], "lang": { "en-us": { "role": { "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Risk-free interest rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/Stock-basedCompensationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/Stock-basedCompensationDetails", "http://celsius.com/role/Stock-basedCompensationDetails3", "http://celsius.com/role/Stock-basedCompensationDetails4", "http://celsius.com/role/Stock-basedCompensationDetails5", "http://celsius.com/role/Stock-basedCompensationDetailsNarrative", "http://celsius.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": { "auth_ref": [ "r550" ], "lang": { "en-us": { "role": { "documentation": "Number of shares authorized for issuance under share-based payment arrangement.", "label": "Number of shares authorized" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/Stock-basedCompensationDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "auth_ref": [ "r351" ], "lang": { "en-us": { "role": { "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.", "label": "Options outstanding, Exercisable at end" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/Stock-basedCompensationDetails1" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "auth_ref": [ "r351" ], "lang": { "en-us": { "role": { "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.", "label": "Weighted Average Exercise Price, Options Exercisable" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/Stock-basedCompensationDetails1" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": { "auth_ref": [ "r364" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.", "label": "Aggregate Intrinsic Value Exercised" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/Stock-basedCompensationDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": { "auth_ref": [ "r631" ], "lang": { "en-us": { "role": { "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period", "negatedLabel": "Options outstanding, Forfeiture and cancelled" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/Stock-basedCompensationDetails1" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r631" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price of options that were either forfeited or expired.", "label": "Weighted Average Exercise Price, Forfeiture and cancelled" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/Stock-basedCompensationDetails1" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": { "auth_ref": [ "r632" ], "lang": { "en-us": { "role": { "documentation": "Net number of share options (or share units) granted during the period.", "label": "Number of option shares granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [ "r353" ], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Options outstanding, Granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/Stock-basedCompensationDetails1" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "auth_ref": [ "r106" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value", "periodEndLabel": "Aggregate Intrinsic Value Balance at end", "periodStartLabel": "Aggregate Intrinsic Value Balance at beginning" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/Stock-basedCompensationDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r349", "r350" ], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number", "periodEndLabel": "Options outstanding, Balance at end", "periodStartLabel": "Options outstanding, Balance at Beginning" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/Stock-basedCompensationDetails1" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r349", "r350" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "periodEndLabel": "Weighted Average Exercise Price, Balance at end", "periodStartLabel": "Weighted Average Exercise Price, Balance at beginning" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/Stock-basedCompensationDetails1" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost": { "auth_ref": [ "r377" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "An excess of the fair value of the modified award over the fair value of the award immediately before the modification.", "label": "Incremental compensation cost" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/Stock-basedCompensationDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r345", "r346", "r347", "r349", "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r369", "r370", "r371", "r372", "r373" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement." } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/Stock-basedCompensationDetails3", "http://celsius.com/role/Stock-basedCompensationDetails4", "http://celsius.com/role/Stock-basedCompensationDetails5", "http://celsius.com/role/Stock-basedCompensationDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r354" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.", "label": "Weighted Average Exercise Price, Exercised" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/Stock-basedCompensationDetails1" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r353" ], "lang": { "en-us": { "role": { "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.", "label": "Weighted Average Exercise Price, options granted", "verboseLabel": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/Stock-basedCompensationDetails1", "http://celsius.com/role/Stock-basedCompensationDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "auth_ref": [ "r348", "r367", "r368", "r369", "r370", "r373", "r383", "r384" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.", "label": "Share-Based Payments" } } }, "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis": { "auth_ref": [ "r103" ], "lang": { "en-us": { "role": { "documentation": "Information by range of option prices pertaining to options granted.", "label": "Exercise Price Range [Axis]" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/Stock-basedCompensationDetails2" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain": { "auth_ref": [ "r105" ], "lang": { "en-us": { "role": { "documentation": "Supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices." } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/Stock-basedCompensationDetails2" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/Stock-basedCompensationDetails2" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions": { "auth_ref": [ "r100" ], "lang": { "en-us": { "role": { "documentation": "The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.", "label": "Number vested options, exercisable" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/Stock-basedCompensationDetails2" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions": { "auth_ref": [ "r97" ], "lang": { "en-us": { "role": { "documentation": "The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.", "label": "Number outstanding options" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/Stock-basedCompensationDetails2" ], "xbrltype": "sharesItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": { "auth_ref": [ "r625" ], "lang": { "en-us": { "role": { "documentation": "Percentage of vesting of award under share-based payment arrangement.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/Stock-basedCompensationDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": { "auth_ref": [ "r549" ], "lang": { "en-us": { "role": { "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/Stock-basedCompensationDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "auth_ref": [ "r369" ], "lang": { "en-us": { "role": { "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Expected term" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/Stock-basedCompensationDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": { "auth_ref": [ "r106" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.", "label": "Aggregate Intrinsic Value Exercisable" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/Stock-basedCompensationDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": { "auth_ref": [ "r106" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Weighted Average Remaining Term, exercisable" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/Stock-basedCompensationDetails1" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1": { "auth_ref": [ "r364" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.", "label": "Fair value of shares vested" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/Stock-basedCompensationDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of options vested.", "label": "Options to purchase vested" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/Stock-basedCompensationDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1": { "auth_ref": [ "r98" ], "lang": { "en-us": { "role": { "documentation": "Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding.", "label": "Weighted average exercise price, vested options" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/Stock-basedCompensationDetails2" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r102" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term of exercisable stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Weighted average remaining life, vested options" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/Stock-basedCompensationDetails2" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1": { "auth_ref": [ "r97" ], "lang": { "en-us": { "role": { "documentation": "The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices.", "label": "Weighted average exercise price, outstanding options" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/Stock-basedCompensationDetails2" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r101" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Weighted average remaining life, outstanding options" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/Stock-basedCompensationDetails2" ], "xbrltype": "durationItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Ending Balance, shares", "periodStartLabel": "Beginning Balances, shares" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/StatementsOfChangesInStockholdersEquityAndMezzanineEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_ShippingAndHandlingCostPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the classification of shipping and handling costs, including whether the costs are included in cost of sales or included in other income statement accounts. If shipping and handling fees are significant and are not included in cost of sales, disclosure includes both the amounts of such costs and the line item on the income statement which includes such costs.", "label": "Shipping and Handling Costs" } } }, "localname": "ShippingAndHandlingCostPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]" } } }, "localname": "SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/IncomeTaxesDetails5" ], "xbrltype": "stringItemType" }, "us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable": { "auth_ref": [ "r110" ], "lang": { "en-us": { "role": { "documentation": "A summary of unrecognized tax benefits for which a material change is reasonably possible in the next twelve months, typically including the nature of the uncertainty, the event(s) that could cause a material change, and an estimate of the range of the reasonably possible change or a statement that an estimate of the range cannot be made. An unrecognized tax benefit is the difference between a tax position taken in a tax return for which the resultant tax benefit has not been recognized in the financial statements because it is more likely than not, based on the technical merits of the position, that the tax position will not be sustained upon examination.", "label": "Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Table]" } } }, "localname": "SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/IncomeTaxesDetails5" ], "xbrltype": "stringItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r180", "r181", "r182", "r207", "r226", "r227", "r230", "r232", "r240", "r241", "r275", "r303", "r305", "r306", "r307", "r310", "r311", "r314", "r315", "r318", "r322", "r328", "r436", "r523", "r577", "r594", "r600" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BalanceSheetsParenthetical", "http://celsius.com/role/FairValueMeasurementsDetails", "http://celsius.com/role/FairValueMeasurementsDetailsNarrative", "http://celsius.com/role/MezzanineEquityDetailsNarrative", "http://celsius.com/role/OrganizationAndDescriptionOfBusinessDetailsNarrative", "http://celsius.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r23", "r92", "r169", "r193", "r194", "r195", "r210", "r211", "r212", "r214", "r220", "r222", "r239", "r276", "r329", "r380", "r381", "r382", "r409", "r410", "r429", "r441", "r442", "r443", "r444", "r445", "r446", "r457", "r499", "r500", "r501" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/StatementsOfChangesInStockholdersEquityAndMezzanineEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BalanceSheetsParenthetical", "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1", "http://celsius.com/role/FairValueMeasurementsDetailsNarrative", "http://celsius.com/role/IncomeTaxesDetails", "http://celsius.com/role/NoteReceivableDetailsNarrative", "http://celsius.com/role/RevenueDetails", "http://celsius.com/role/RevenueDetailsNarrative", "http://celsius.com/role/StatementsOfChangesInStockholdersEquityAndMezzanineEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r210", "r211", "r212", "r239", "r473" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BalanceSheetsParenthetical", "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1", "http://celsius.com/role/FairValueMeasurementsDetailsNarrative", "http://celsius.com/role/IncomeTaxesDetails", "http://celsius.com/role/NoteReceivableDetailsNarrative", "http://celsius.com/role/RevenueDetails", "http://celsius.com/role/RevenueDetailsNarrative", "http://celsius.com/role/StatementsOfChangesInStockholdersEquityAndMezzanineEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r4", "r5", "r92", "r93" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Stock Issued During Period, Shares" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/OrganizationAndDescriptionOfBusinessDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r4", "r5", "r92", "r93", "r354" ], "lang": { "en-us": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Number of options exercised", "negatedLabel": "Options outstanding, Exercised" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/Stock-basedCompensationDetails1", "http://celsius.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": { "auth_ref": [ "r23", "r92", "r93" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued as a result of the exercise of stock options.", "label": "Issuance of common stock pursuant to exercise of stock options - Cash", "verboseLabel": "Stock Issued During Period, Value, Stock Options Exercised" } } }, "localname": "StockIssuedDuringPeriodValueStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/StatementsOfChangesInStockholdersEquityAndMezzanineEquity", "http://celsius.com/role/Stock-basedCompensationDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockOptionPlanExpense": { "auth_ref": [ "r45" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for option under share-based payment arrangement.", "label": "Share-based expense" } } }, "localname": "StockOptionPlanExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/StatementsOfChangesInStockholdersEquityAndMezzanineEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r5", "r8", "r9", "r68", "r554", "r595", "r607", "r664" ], "calculation": { "http://celsius.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Ending balance, value", "periodStartLabel": "Beginning balance, value", "totalLabel": "Total Stockholders\u2019 Equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BalanceSheets", "http://celsius.com/role/StatementsOfChangesInStockholdersEquityAndMezzanineEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders\u2019 Equity:" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r94", "r206", "r315", "r317", "r318", "r319", "r320", "r321", "r322", "r323", "r324", "r325", "r326", "r327", "r329", "r428" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "STOCKHOLDERS\u2019 EQUITY" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/StockholdersEquity" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r447", "r465" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r447", "r465" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r447", "r465" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r464", "r466" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "SUBSEQUENT EVENTS" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubstantialDoubtAboutGoingConcernTextBlock": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern.", "label": "Liquidity" } } }, "localname": "SubstantialDoubtAboutGoingConcernTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowElementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental disclosures:" } } }, "localname": "SupplementalCashFlowElementsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_TaxesOther": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of tax expense classified as other.", "label": "Taxes" } } }, "localname": "TaxesOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": { "auth_ref": [ "r303", "r305", "r306", "r307", "r310", "r311" ], "calculation": { "http://celsius.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.", "label": "Series A convertible preferred shares, $0.001 par value, 5% cumulative dividends; 1,467 and 0 shares issued and outstanding at December\u00a031, 2022 and December\u00a031,2021, respectively, aggregate liquidation preference of $550,000 and $0 as of December\u00a031, 2022 and December\u00a031, 2021, respectively" } } }, "localname": "TemporaryEquityCarryingAmountAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquityForeignCurrencyTranslationAdjustments": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Adjustments to temporary equity resulting from foreign currency translation adjustments.", "label": "Foreign currency translation" } } }, "localname": "TemporaryEquityForeignCurrencyTranslationAdjustments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/StatementsOfChangesInStockholdersEquityAndMezzanineEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_TypeOfArrangementAxis": { "auth_ref": [ "r662" ], "lang": { "en-us": { "role": { "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]" } } }, "localname": "TypeOfArrangementAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/RevenueDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_UnrecognizedTaxBenefits": { "auth_ref": [ "r387", "r396" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrecognized tax benefits.", "label": "Unrecognized Tax Benefits", "periodEndLabel": "Gross unrecognized tax benefit, end of period", "periodStartLabel": "Gross unrecognized tax benefit, beginning of period" } } }, "localname": "UnrecognizedTaxBenefits", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/IncomeTaxesDetails4" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": { "auth_ref": [ "r398" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.", "label": "Additions based on tax positions related to the current year" } } }, "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/IncomeTaxesDetails4" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": { "auth_ref": [ "r397" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.", "label": "Additions based on tax positions related to the prior years" } } }, "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/IncomeTaxesDetails4" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease": { "auth_ref": [ "r655" ], "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in unrecognized tax benefits attributable to uncertain tax positions taken in tax returns.", "label": "Uncertain tax positions" } } }, "localname": "UnrecognizedTaxBenefitsPeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": { "auth_ref": [ "r399" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.", "label": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations", "negatedLabel": "Reductions due to lapse in statute of limitations and settlements" } } }, "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/IncomeTaxesDetails4" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": { "auth_ref": [ "r400" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.", "label": "Unrecognized tax benefits that would impact effective tax rate" } } }, "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r61", "r62", "r63", "r243", "r244", "r246", "r247" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Significant Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": { "auth_ref": [ "r405" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.", "label": "Valuation allowance" } } }, "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_VehiclesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment used primarily for road transportation.", "label": "Vehicles [Member]" } } }, "localname": "VehiclesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r225", "r232" ], "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "verboseLabel": "Dilutive" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/EarningsPerShareDetails", "http://celsius.com/role/StatementsOfOperationsAndComprehensiveLossIncome" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted average shares outstanding:" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/StatementsOfOperationsAndComprehensiveLossIncome" ], "xbrltype": "stringItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r223", "r232" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "verboseLabel": "Basic" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://celsius.com/role/EarningsPerShareDetails", "http://celsius.com/role/StatementsOfOperationsAndComprehensiveLossIncome" ], "xbrltype": "sharesItemType" } }, "unitCount": 4 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "40", "Topic": "205", "URI": "https://asc.fasb.org/subtopic&trid=51888271", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "2A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123586518&loc=d3e845-128460", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123586518&loc=d3e848-128460", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "25", "SubTopic": "30", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126966325&loc=d3e6819-128478", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(c))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "60", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r142": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "320", "Topic": "940", "URI": "https://asc.fasb.org/subtopic&trid=2176304", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(1)(a))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a),20,24)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.1-5)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.10)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.8)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r153": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "320", "Topic": "942", "URI": "https://asc.fasb.org/subtopic&trid=2209399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "405", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126941378&loc=d3e61044-112788", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124504833&loc=d3e7104-158389", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(15)(b)(2))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=d3e14931-158439", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(c)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124508989&loc=d3e19393-158473", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r167": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "320", "Topic": "946", "URI": "https://asc.fasb.org/subtopic&trid=2324412", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(15))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(16))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(24))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(5))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(26)(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.27(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1377-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r237": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "https://asc.fasb.org/topic&trid=2144383", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "270", "URI": "https://asc.fasb.org/extlink&oid=126900757&loc=d3e543-108305", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r248": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "https://asc.fasb.org/topic&trid=2134479", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r274": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "320", "URI": "https://asc.fasb.org/topic&trid=2196928", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r282": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "330", "URI": "https://asc.fasb.org/topic&trid=2126998", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r287": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/subtopic&trid=2144439", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(b)(1))", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(b)(2))", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(d))", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(26)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(4))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1(e))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130531-203044", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130532-203044", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(l)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.2.Q6)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r384": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "https://asc.fasb.org/topic&trid=2228938", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "35", "Subparagraph": "(a)", "Topic": "720", "URI": "https://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "35", "Subparagraph": "(b)", "Topic": "720", "URI": "https://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "10B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(4)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r418": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "https://asc.fasb.org/topic&trid=2144680", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)(1)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=126980362&loc=d3e28228-110885", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123602790&loc=d3e30226-110892", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=125521441&loc=d3e30690-110894", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=124440516&loc=d3e30840-110895", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r448": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "830", "URI": "https://asc.fasb.org/topic&trid=2175825", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "40", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123386189&loc=SL77918607-209975", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r456": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/subtopic&trid=77888251", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r463": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "https://asc.fasb.org/topic&trid=2122745", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r466": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "https://asc.fasb.org/topic&trid=2122774", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "330", "Topic": "912", "URI": "https://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10)(1))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(7))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(26))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(22))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=SL120174063-112916", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column B))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column C))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column D))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column E))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column F))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column G))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column H))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r519": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column I))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r520": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r521": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r522": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r523": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r524": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(1)", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r525": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1403", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r526": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r527": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r528": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r529": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r53": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org/topic&trid=2122369", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r530": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r531": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r532": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r533": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r534": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r535": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r542": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r545": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r546": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r548": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r549": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r550": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r551": { "Name": "Accounting Standards Codification", "Paragraph": "217", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126976462&loc=d3e36027-109320", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r552": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r553": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r554": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r555": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r556": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r557": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r558": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r559": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r560": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r561": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r562": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r563": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r564": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r565": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r566": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r567": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r568": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r569": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r570": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r571": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r572": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r573": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r574": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r575": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r576": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r577": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r578": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r579": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r580": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r581": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(26)(c))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r582": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r583": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r584": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r585": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r586": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r587": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r588": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r589": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r590": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r591": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r592": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r593": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r594": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r595": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r596": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r597": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r598": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r599": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r600": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r601": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r602": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r603": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r604": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r605": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10149-111534", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r606": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10178-111534", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r607": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r608": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r609": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r610": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r611": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "410", "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r612": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r613": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r614": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r615": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r616": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r617": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org/topic&trid=2127136", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r618": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r619": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r620": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r621": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r622": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r623": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r624": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "705", "URI": "https://asc.fasb.org/topic&trid=2122478", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r625": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r626": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r627": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r628": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r629": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r630": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r631": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r632": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r633": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r634": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r635": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r636": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r637": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r638": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r639": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r640": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r641": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r642": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r643": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r644": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r645": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r646": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r647": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r648": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r649": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r650": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r651": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r652": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r653": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r654": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r655": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r656": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r657": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r658": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r659": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r660": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r661": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r662": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "808", "URI": "https://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r663": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r664": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r665": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=125521441&loc=d3e30690-110894", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r666": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=124440516&loc=d3e30840-110895", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r667": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r668": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r669": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "b", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r670": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r671": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r672": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r673": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r674": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r675": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r676": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r677": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r678": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "730", "Topic": "912", "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r679": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(1)(a))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r680": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(2))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r681": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r69": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "320", "URI": "https://asc.fasb.org/topic&trid=2196928", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.BB)", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r81": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "350", "URI": "https://asc.fasb.org/topic&trid=2144416", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2611-110228", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.CC)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r89": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "360", "URI": "https://asc.fasb.org/topic&trid=2155823", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r90": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org/topic&trid=2144648", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21564-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r94": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org/topic&trid=2208762", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)-(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" } }, "version": "2.2" } ZIP 103 0001829126-23-002816-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001829126-23-002816-xbrl.zip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end

XL%=0;>LWJHX1P/* M \K&!??A/\S8W^HW$/D*PL41> GIOV4E'DAJF*#%JTCS+J)>UE3C"A0!O(TR M&+X8UY./8S&T6UJ#1Z#8>QDKWQ_,R7J^#%PFL_P#+%'%4A)I19%&EDI,]VC4 M<_LAY"3 C53F-+)V!><<,,Z&"^!9.ALS@$XK"+U9LJ] Y[X^V2 ZVH['S3Q(PK +AG<43S6 M55YTDO9=44MP\@Q>Y#!.*NZ%:$<*Z28\!#DAL'WX%D5TY MPUGDGU_^212A\C8+T])?^)? G>!-'H^TMX4*6ZN[5;2T/1'4XNX2LL$'A2 K M:)2ROVER2RN5PC)[$D5@HJ)XW>2%"*FNZ7V^_I;1HGQFNPL1RFKBM%@4,C#W M_0[3-4L+)!FM=(I/OAE(N4P2=X22I*9P$9EKN42?QTJ7;_(4F5_R7^V=Z M]A*Q%*I\WN9IMQVXS3^4_+?AY&!Q:]A''"X3.]-0:FNHU/8 M4CS8B' U^(B&1K?@I%><5*<@^CQ1..AHGO'?:/I"VZ1QKN3Q5C),445#R;:XDE4Y'(=K] M+$E$R8 H%7>*=[Q-GJ/2;'L'':[V'U?2R.;24"L/BIVB#U\.YBYR>"K;R7"A M,*JCNZ2+RHX;*7^'0.X-7=7%+B[Q :)#B1D+4\TI.$K!$1"1+S2N"P9Y(75O MGJKN,LF!"R%?=0WGL(:/:$9+V9/YA.<5$#5.PU-Z]0H@0=B2BNR%SJWF'-$&/"R$_9:TIO.,NFPR9DC'OD)/V M-7#B_OX8[HYBFN3 !9>ONL[$^NL-&1:$:S-T!1KWQ,BPWC1^OQUOS_8KK5%! MA/BJ/K9B<7+E3FJ#R^EGX1W*0 ]E5W7@ )@4#&!-B@L6IGHL#)+G)P=PR:W[QK2=TE?J>"4R>YYFC?F6;'AM0"W<=[DQ)# MA!PB!:GU=$=4D)HYM!+%4 T$]0-L-U7#*&!:%Q2N3[@!G!I+= P2H\7&+>RXP U?$0QDLLP MN_G?_HII6?(-K#26$IQ!1@_+IAAP8>6IK;%)$6SB[$4Q$N#L3R(A/79URFSA MB7.=B7A)Z8EJ #;-@@LR;WV=;KF:4_KF0@H,&4\JN0,%%,>4)MP0V_/ Z>^4 M5FBYE%LN#!?4!_@22V2Q$ E+OFYQ4D_C(%)X&!_6:)L7%=R:#-O@(B\M'7N* M 1?6GMJ:7J<-FP5#P1FJ &)CG:6*G'9LBD=H<4$TK:BMUF';F4JB>(+7IFR_ MXC;/YJ S),<,D$/7*8PX&PZ<+J]8QH=G%J4W-QT"FE3U%* M()$3WP5$99ES$;"V_,:J9^$X#$"9T3#(3BR MXE$$M,('7:48"I0#C5O".96I):'_1BRCQ27=Y:4EF<4H-2X\?%0U7(!$E-&C M8@(G!LE%$LD6\(+TJA!90%WWH^HQ+@BLNKEN1S>2*LQR^)%!-DSM]F5;_PXH M<#6T2SUSA2OI&L?<,+6ASXLH2\K[O(ID] _4(16)(XUV=U+B:O\I-8H+*$;EK&*WK 72#-;<6W98RJ#S]N;$!=A< MMPX,'%Q[^"@\AZG&2AI4HWJ#[0F$^-S3JI$/1 MA_"7-;VE?U4RENL37P@^.[J0-SLN0!?I;NU^?'<)KO)M7NB=OL> V.R,2R*5 MC(C;"EEAO+!&/_>_:%3<4;=0&6P'9J4'9T7HKDAHM ".1, $\)N,6 88'I 59E,6PZ M:2(O(QW;\!F\Z &<4-P/S;HCA%#IP2&W[UBP]<$0/59S,,'2\.J^RZ?]%2EZ M&/IZ^O606/)@0>4VSV)_8%IJ]-@8JOK!DS5L01"ZS45Z:A"."[;I? MW3HFNRAQ(3.EIH'*,R5)2P5N0QD7H4HY@8PP,;)9R:U%'NVDX']8J,P?YN&' MFQ07,I-ZFF>[FH'$#8>J%!*J1,@VEWE5SM(T_Q8UN;9I?:9)'<-CB%]X MH9DUM\9,";@@7*J^Q6%/RR&1%@0EKH0D$D%YLT(+@RY92''!YC"7-T3W(2ZH M+)K9)Z1=N(@!I9X YKE:W*V=,UXHJ; S2ILX2]]Y[\!Q7 M,]N5,V.*@*K=080+(&I38;S00OO=:U]\H^D]>'#!X:_P$")U#M7-\?$"E5MU M:,).L8?SE%;+,Q.E_F-<@%AU&[9]+(@^J 5CD":^83&4YIK*YF8GP]7DHSK: MMM(LV^3%-M+K]E3RDT@+"+-OXQOZK&)\I_%ZR=(:JE_)C>=H*+T'$RZP9FAL M+%-;5I(HWJ:*=2J6!)7M^@_QM7$5MV,\N22*)09U^6'IRC:?>V%Y79;V4KP M]>/7]#%]LY;NZ:U:>%PO(^9(N>@KNJ"-[&Y==,TZT9Z!FE&?7#$Z9K F%:+F M'5%NV-0=TM#V*X.1J8^CA2?+UQ_10.*KJ3& 2SXB&%=M\J45:9G#=Y2)'H*S M:_CTB4!-*Y+[/>=I0HL20ESZ=P!NJJ\_H6GH$>7,,.F6]!]$$I.S2J[-18:Q M*H>\52A,_2Q+_-"9XL'9*<95'>DIHB*>) \$TN\%WT;<%?F&6>>*SF-$36_3 M:MC*@H9(HD!MVU3A5-L-ZXAO$"%J9[=N1I'!ICJH)B5_7M)-5*<5N0&A;QU: M:'S"=1;G6[&U'D6A)<.(@T4[-Q*2F+P#\O>!FE^7/U16\:5^S(L$CHEH MZ: M,')>TD<^1]6%O7O,$H (LF5ZFVZ04HKN52O2%42$)#&'M+*"G+G51;ZC4=8I M&6L>O)DT".":5,TX?C-I W4MOI7)^^."Y4!NDA@!!OXZ&KFG.QS-<*>8PHUX MH 8W"Z7'.L0B[Q1/*#SZA1ATE9A2:BIR3<&! M,>0)B:T@S>%'A-PBM=UU$V7B_$;,2O>V1A*1H@*!?)%O=P5]Y@;'7JA4[996 MZ\U@(O(@1P2ACY9F\L<.3W\%N"*<&QQS./\*UTG!O\1]"TW.9,ZWVQH\C51! MPJX'RWE4LM@&Z"P!B"!>IO<0="V%*#%$R@&LI:1NQ8L5$<)P(2U\EE0Q-9=G MUD(1^-&>U'Q/O)7\4*>R/IB:WX[G$L*MFW$D*RA7 >O+:)V;B;J_#( R(;;F M'R%'U'U\M#2]59H5RV QLQ)%4\+$=[[PJ38O7ILXNJN\4%D0LF3]6'(A%?B9 M0Q"<+>9S#CL"_/;1VMQ@S!$3ZDXV!P<2E:P[?KTOHJR,1#SC[Q'+8#'VD!4T M2H>EHY?P(\!W+[6-JULIA&@II".&@)QF-=L*"]&)095U)BZ8+\ ,(4:9JVAV M5Q:_3T40M$22"L"#8AZH'?X28PRH(;-IJG99)0V\&L#Y@[ M5.OR@6 (.FM_.-2KNP]I*""MDF""0O.H$C MY16UYBB:+P0]SCZZ>\,](@S-^"XFG<:W9,Z\;N-$@.]"A3W':SE'M[XXX4I1 MFM^G%R@JFEXO4)0?NV.^WE<6 L0/]@G3'=M;9JA+<94(]SX_B_^W9@6RCM2.@$-6.($D*TE!41)'#Z7=R_OI00GT5V#^68DR+*_;B7)+[7\D[ MD,-']/>D$45:60$SIY7K[#R'RQ!'F+B=# %B/MJY>EZ?'$'(U5W!LICMFG1[ MU@XURH D7EZ3@1;-8Q-*?7 7U/MH[ MI[]\0];"![EX)>X+5C$3MK+EC[@F1%7)=>&$:.%&U)D7*#US0FQ$A9L0&U+U%*Q;4(;*KCBB;P@)MY_X<.Y1TM6)Z8BWC(2"MB7V3"A<]117_; M;*C=3?1M-4!D9X$^W'!\Y(*E2P?IR%^1]M5$DL"H-/BQSR%U(I:-O?!ZE9J1 M)@T'Z$:DW9423WV&^XUB6%BK@,\^3;RQ-V\J8KI@X.R6BH6="0<-Q M09%WJX(2X @7P!-SFU@7=U%1J3_$L4+)1")U.#'J!AF79;VER0_6%TW7AL)3=PW^3CTK :KGYTEZS,C M0GV^SJY.+49;2P'@MM-+0>1/]=][J(EYGO(]2:C0Y,$AL0W3 0DBY%R:&0ZX M>D^H")&$AH]MR M,?BZK05,?Z[3Z*1#91?TS4#XS3+2YX):-__>S*?6*WLZ[],O01#2GCD$=0[? M"?7.GKJ+^V< '.<8[!5OTJ4=%'A/K'_V5-ZC>X(?_K;C6,H[8QOP8_;.KE BI1(I%M, .\<&9@E A/TR MO?W'X=- VAM1[,C-1@C)[.@S)2*>!^=-?DC:W%X99YH:,0X>]7#LRY'@M7#. MXKC>UBFD,K^DNX+&3 0^\W^G5%0GS!(^;!85^UM6DYP3HW@HV8@&OX-_DE%! MK'T!Z;YA19IWR+P3G;>L<$9 \J&?5;R/O%##L:SSE=T/<4R',Z4@,I<]E+=, MI%S4!R'+YF37-9RN0'S@BZHP,Z$6/*^OD_.U:AC7J.1P/.@2H%F$VO>SK MKA:!@(X!SJF@,URK)&.>CC][2$34\0[T(;.&VI5(YQ8/9\M@3D++VF+.PV"+"WI7/;(:1F_,%DD[:(J9N MU9<:1-@;6E0M$)1\$QL373B%4V\Z MXIK*E=YG*-"VWCR,W?;[,&&;;[UT'052KX2% ,@D]Q#02\!BLOWD$Y:\%!.= M=9(?9T_U5]L+W?&L'"BZ:&=$,2X%_3@0(#E341=V3DXL_?&/**W%H8>UCL0, M-@28+='6J],U_"14T0C]:5":36>9X!JJU9AUZ'20(ICX?#4<8M.E%_AH#EQ@ M?*:0%@+J3'RF99V"T_(5Y[N)=B5=;\YVNY3%D+X %MIUQ7^Z85M6F47NCO@: M1)WUF%_G;4"0Q$6]CS3O(X V$6^$Y53[3J)>"K]V7ANR#/!Y5-($2I3S79H< MZ8H"DFC"NOW\M251@1)GWZ(B6>^$VIV:NK+:L6QK[K_L^[1?QS>^F<4V[Q?[ M@U.UT*N\V%!6U1QH.#S\:\<*N9RYSF2^[F-8ZN1+$2U0W^Y;CVFY'2WDJ6ZK MAZB&*C0Y-1.&H^GJ]3HKJZ*6Q3@@[?#]+M=RZINHPJ>A6QPEA@ MA-+AZT_!33[XIULMGTQ8_KFR?&*Q?)OA:[7,5;30C(!J!'1S+E6Z/]WP?_&? M]4_\_QZY&OR7_P-02P,$% @ [J225AA5S2YJ80 .KL& !4 !C96QH M+3(P,C(Q,C,Q7W!R92YX;6SMO>MS(S>2+_K]1MS_0<<;L3'[H6VWVNW'S,X] M04E4#\]0))>D[/%\<91(D*KC8A5=#[7HO_X"]2#K!2!156"BU-R(';VG:W?__J'^[ MFE@[\M>K3\0EOA5Z_M^N?K:KN]0T)"_Y!\^*]7'[]^_Z-U M]>X=8-R?B;OV_,?YZ#CNK)[)SGIGNPRW%?DJZ\5&J>OW_J>??OHF_FO6M-+R]K=^^MW']Y_ M_1JLO\K CQ'T/8?,R>:*_9=*[_C5%7$".XKE]0W[VS>W'M5'2FC-A3O0QLIE9?77W3[+,WEL,06CP3$@:RS]43-WPFH;VR'"6::GMV0B";+F1'!P^FF^F>37&J0\' 7;-I[9-GX@;V"QE[ M03"BAF1'9&0W':]S9FZ?+7=+Z%<6H;?Z_=ESUM0Z#?^([/! J7D@?_YIN;9+ MDM^H<-5HX.[9LX+G>\?[+-5M8:=.R)KZ6\KQG[&D*0)W)%CY]I[]--W<1 '% M(I!2J3)&1Q,SL"DB,Y\$%)OLNXMHM[/\PW2SL+>NO:&SS0T'JY47N2%=0F>> M8Z]L C G[J0F1$N71, MNGW*@:D _1+]C1^1H\K*: 0/T,W"E9L] M8]MZLAT[!)@(2;>.C*5#E^TUW?>%AZ5ON8&UBC=2 M3+X?XO7HA*![R_;CH^<#-4:1G^R\9#0).W6T K+-]M)ZA:R E:;=B>H=.UC& M9P$ZG>.=$4A>_&Z=D$8'WMEAC'I\4HEW9,2%[/4 7;M!+WH*R!\1_<[P!:)2 MO/;HF^=S;**U;*;;$+2T("MT=U_05) D9/;>.N3Q4P4K@=-&S6 M812)^G2X<8<14]=6VR8>1I*\I\8-/8Q$2-_S;.YA]"H.HW.C#R,8U%G?WA%& M)*!KU_M(J,WC=-"YIX21!NI\-@_I'0DMVPDFEL]\YB]2;TN;,='W0REA.C=$ MI4^8PO+[,_#\WC2FP4JMXUM:]L) !99TTTD:&'-H_RZW[D#XZEMK( 0,EJ1; MU^<*($[\'F>[NU %LLV8&HY+0*"%G?21!485UKO#DQT0M]K&VLYV0*( 7763 MJ#!=X&-H/)("D05UUD^F=*\%ZZV?4+ :J(URGF,_4"=4Q]%Y\ >2#.NM];Y/ M?7^B-HZ.^T!5FH'=-=T7JE(+'T&?3PBHOY"^VHD$ ZLT2-?.+/!&F]=#$T'2 M)4S011-)U^HD76LFZ8,Z21\TD_2=.DG?:2;IHSI)'S63!#8.@*XZ'@*^)0CMD;=/W7>^OWK''8!$C MF_XS:9G2D5'B>*O"QQWV:,HK/4_*'J#%3Z,"LOIZZ[U\LR;V-PPC]H\8K!@H M^L-O\8<&3T'HT[-6-I)C/1$G'O\WVJ;4Y)LS4)4AL:0CUA-5;%&F*2^S@;^Z M\GQZX*%89V-9_JH@J>I;LK3%-_OX[=*[U;/M'(6\\;T=#YT4"8]#:!XH^HGS MH#F@WU\S&NX=:UL/9ZD)$,_W&(#6T"IPL0^ ^8ED+(+9($!JX;6;_B2P_)+YS@"!=:0P$^R,FV!P.D?".G+4U$/'O43<>'!Z1(%\\ M$\=AQPK+!6EY77L@[#]@PL[GTP#@XU<5=W1I@6.?ZP*$_T=3X*]PBR2!&?%M M;TV7=!^ ?:4Q$/6?,%'G<(B*]]!=0]$^-@6??_#!+K&'!/6]':PL)Z'HGOXN M$,-=TQP*.^]V$D:8QGJE1Y0Z!&/J&)F414^6>0AVIZUA.*->%RM9PX3 MYYD7A);S;WLOVTG6MX=BCGAP%3%Z;@=C(G?FM."%$I6:0/%%.:O6LG-N2)F$ M?6+QU;?8 @HHR@&TCIDSXSGVV-W'L^<*_;'55E!<44Z2/*;.;7A9''' G?JY M/X,CV%#,:IF-,\/XBV^'E (6 1ZYJ8^&X0??M4V:&(.83)FE"M]UQ'!=[:.!/-QN>Y16UAR*. M )6#LSR 4ZZN$M-8$"BW*R MJV4'R28,7U=Q.2-^]$)]2RC *"<]$7-HMG<+LKU;1=N+__0ASGGZ[WV5T0 M*_!D"!1[Q$%#.+%)\6$D:S_4+NK-!**13AS^L!Q1_Q0E', M+%K\O']+%YZM)[XS+S6$HHT8"EO+&@K(BYWE..5*KW4@EQI"04:,>:UE#07D MX8[X6VK4/OG>Y_ Y?=LI IO3 0HZ8F2KD%4<\%]/[\B3]V]"Y&M:@[,3(,+. M91(K[<:Q3@1=R=VUY7-0%[6'XH[ZL)+/Z)F1C[,FY_=/,3$C>FX3!3W(>T&E M@')B ?3.L9PWDQ%3XZ]NG<\2[@O+S2#XHMX"JUA M"P7>&\O]W8_VX>HP\[T5(>SZ)#C.-L"!"#@ 5"2(YU,E*'#:O? MXWI"P30* V80*7U"IX&P'U0TF(\X 8PC[8*"TT,OLKXYS,F&^"Q,84E>PQOZ MH=_%FR) =ZA\4#,*@6$XLYA&JXT?.[P]?Q"&)$A@XP<3B-I#!8%R()8SBG&W MXOGWMK\;<4X&I290?%'.OK7LX$#*CR@H- #G?T.$$S%^(*5@[*T$]]J51E!0 M<:Y6ZUFJ ?:_OZE0/Z:_T)5;^L9R++H8T$,%R=TO%G),7U^]NSK>0<9)IMW M<^PU6T^NTOY7Z0"MM6-C!4\Q_E'P;FM9^T1%B!,&V6].NI+^XK/"7FB)NAN(!<(_NI!8,5M6?V3L6:ZBI !=T5)]-Q 7& ETF665J ^4-KYX MBJW04H WD$0=?^B@%VMI9Z6T"VSQ90'JC)8NO(&(%-!H*[EJY23VF]_NF%_1 M)W'A)$;HK1>(!,'ZB+N@I0M7@5_.AB'3!3@QFDV![MU^399WB;)3VA,YC1.N MN13&Y(5>:#EQ2_-V A//737?#.1[XR4L5SF1JB"!/M&RHO4SQV(U8DZ5ZX6; M W$OO"3G*F*"<(XNGLQ8'VNK)JP)A2/J@Y<,744TD ^$:7S1W9 M,_]ZD# D,F7%=G@)V=7,5QUWF@\R\0DJWLO370;L(%/?!2\5.PAC.0.&Z/B( M8N9N;;KS.ZY>P]>5$[%0HT^>M_YL.W6)$HY.#$AOO$SN*O-!!0ETLO#V+:>;,<.;1(\D#__M%S;)>RH$Q[H MF2<.A'SV'(ICD/Z2?UG,AFL\&EZ>]Q:7_*TX-F2RY>@'QP.(^N!ECN]"&AZ8 M3T/$E]T"SJP#KA4JF_*57 R 2Y,@IGOK^!EO%=& M7\J+(1.EZ&S*^#M()XJL'UZR_*83!88$NL#R_B>XN,2]\++L-Q46! 5T465^ ME#EY(6Y$I$+BM<=+TM]4/&+.T043.[94=GC<#GCI_AN;.3'OZ+)1$4L;B6CS M:BA+!"2,OL4KC#UWNR3^[HX\Y>[E 6=C23^\R@4:SL<@C-!G)&=C!(D[ 73% MJY6@)@709E$8@:(VA5^(_^31H3$G<>TN"R)W:4>\X@UMI [$H] M0E!,H1=>X8@VTH8@@6^<2]LYN@Z5-M\@.ZTT"EX%BE8FNP%2Z.(%3;Y&7&F,N*NA+(5=L(KGM&]K 'H:')2EXD77]%R M6^,5W.A0&$(.#;&)2[)C^6O\0T)?]K)UL&.W5(,P].VG*&0W54MO9HG7O09# MX97]@,C&:\N>(3)6BIPXAB"TCH_04$RD>TO9@ZB(7!XPV1/\2DN\*B1P?*M+ M5QVWZ&(8K-=V\66S6D6[R&%I M<](XVQT%]9E5/GTAR9%S[ 4LF'.ZH6=/8(53FDH2C@BZ\*J\J6P],$NL-!4.G^,>G[J+ M'A\5HIK$>+4J2I@IK=+3CS/)+17N6U!(=?=!WBNNZN_%,;[KTON M.TV<+=EY%Y9(E(+H\<27?>CNYR!4Z/ MFK:&B8&G6F771PTGIW2B2-.#^&P3,\MV)S%Q#X13>"5C7-0).U,G7[?*$T3. M.OJYJD@TQTV)6/%P-ORWFVH#( ]G>2B4>7(R*F55."("]76Y?6O5;]B'^S$ MMPWG4!WC1LI&7!9&P%N3NC :G8 MI*2[0$Q[4+87L'Q7IR/*Z:[!JT/5QK+AS8EN',5PM'=N@Y/7T< MXKE))&/NKIK=4B?WU?47#M^)+AQ.G[CR-E>GCUQ1+*X*G[GZ"_O0?UVEGT+* MS\6^?:19?OO [8!U=Q_'A M\JJ<6R*X&"=25*_@B8P98MR"<;E*R1.:LT S; MB: &>BV/Z,A_\JF98)E!1($HA4;8'@$UU&OXZW$DPX(X#HO>==@$NB MDHP9B(LQ(BRP)RE:QNN!71JHK;AX&!@CI)2T1?1$H;1=YA#*"N'>']I\QX-/-G1W$*5BG[HWG MKK-$K)Q(#%A7]")"RA*&\V;(U/UDV2[;HTU=EJN"*6%,=9P]1G 6%/9"+S#4 M=&)"P$"7V+WG$WN;EKI8'9:^Y0:4)4II1OX-V= VPO=X2H.@5R1J*L\&4&D* M71M&K-*8Y6;)7.J%PYK6MD2O.M3($ J8QES-]!T&&QP"#:AGU'1V26'H\7G_ MY+RXIW EB5XBRN?I0C.Q',>T6R08OE*PDHVO6H)FK!9;S?RPH)(3[B4C/T M^E.*SL,Z)GL\$XM1J)DW+2B!,MKMA3YBM5'0:V*IB;P)1&]G(@]>+-M)TE?E M@L325^LW5F"O@%,=,A!ZA:T6Q@ .5(_-14U2F"PAC/PF"=09KS97PY@C,"#H MGA=16A^^JV'@KN.?G$0$Z_\;!6%:8ER2-$G7]]"K>ZD(O28_KC81H&N8 )A& M9L& 6F#-90T H\O+B;% M62P6WI[+#)GJ-C"664G$8],)EC>753.S=G')-*-#"X3@U70KO M Y4'0B^MIE=G9 AVK#6(#Q1OGRUW2X)1P0]T3!U92B9Y9+_P4O$C_*5B^K4K MV[W*?^\_K;T7_.TJ^4C\AO'XX?27Z#D4FV6A!W6_9%%LE46Q06[;2QI%K3+I M<1K%M#J&M]M[+C-:P%2*]=WZ*)9Z3M!3*I;(DF55Y#0W3" B92N?3NL9RCTL M0T]'(4NK6-,4^^%V$TEP.48_/7+*7,CD(NF&_Y M+6N-:%AC3EMC]@Q;;+Y3T MF6.M8OI5P*_OCYW+I84H1(!@"T9];HA&,68?UHV0NIU#W6S*IG&:9TJB*\\L MQFF/G7!%;7/&9?B<4V<6^>RWX=(;OA)_90!(J MNK>#9(;4/5[@:!Q\3 M.]-*BVFE"IR)0AVYZE92?6SL_"QG$'(92#,L:I))^B[RZ=EA%F_]XZ3L>08R MM@0!=PV&0D_AHF:(F^!DVG36-965I[&^K"V:YW'7G\*6 MJGA1&\-?986=T//$@-=3 .\&9CQCY+&+VWO/CU-.3-TY"4+?7H4I_8//EK_F MS5)P;_24,+"IJ(@&^GQ;DMW>\RW_D%QSU+T7++\0%(18-1L-/0T+>(:V04O3 M^KEX]OQP\9GMOJV#P*E:TPX]SPEL2G$Y1)\\284"<6J2?!OTO"0*A>3*G*&# MW>[R^;=K W*$M+A_9O1W MYQ,,A?KD)XU0E9R7)ZKO\%8R'6U((*LIMUIB!CZPJ@W1YJV#)O- 5?+GH85WGT\ M +",B\Q%RI:*I3$RFAEQQ(2 MN-$*K;##RP7T74S> #LN#DD%5 $&%TA8HX#*A.JL7=>]!1N M(F>PBFMGB%U.@E[8T7A(HH= J3?LD+USBQ*&BM[K M:O>%LNOYAX%#3Y7L%I7JT_!U10)6HFCZ%%#P0D)Y7$YZX@62+QVN/'3.(9.'%\*&OY9FIRE5G8#E8K==;^DM;M)[+ M>Z+'#*(=UF"8H@M?7G7IT?6)Y=A_BK;W:J.@QQPB*443K V,JV'$3MVXSMHM M6_Z<)+* MZ?@-T>/4<38/LC0Z_5&@6+E,\[N2/+?'#II\@RYFUAE#/0PR,X\ MONK(H2\=59*S8RN=/L1^$2>$@_5&CY%L(!>98/DHO;&YGYV4;'$=86$W].A* M#0I0@\L;D_S,)WO+7F>[X*Q$H9NX0Q*WIHI*P,9##]?4H"LJ2+XQ)K*=>%5MLKZ(QT.//=6XXD"0Q,QDS75MUC#$R*?;KIV79&@[ M.N.XGDVE,= #8IMK00-N^R?Y.YN]77B*Z$"YZM_!/>&_NFHT%'IDKB8] .#7 MZY3V-;"Q]?)T+E/>@M3W1P_ZU;!:B) RT!U592#;+,T)W6='Q\U2XG<+Q;N' M^EFC,*())?TZM1C*:!JXCB0% T;NG)5I6'J/\0XZ]L%-GQQ[&PO');P72N#> MZ+7ZVLE>$24#'5 E756Q[Y6NZ,7X-)AV#C[HDH2[4?DB51D#O09?ET'FBLCU MN PCAUGF3PLZ>CTB' N]2&!W[T< F*%;!4KSBI!UP'+=+2R'3#<3+R2@VP5 M5_3*@BTD4XD@A.&$+]'DG72P] :K/R+;9V%2U%*%!Y8O+Z2[#?:F=,]Y+)YQ MJS &>L7![F2LC%ROO<%PW+JP\ 84+^Q,4=21>WL;@GO;M=Q5-QL"X5CH]0N[ MVQ ,-,4N9R9MJE[X[$<0\DE!>?'#N(:OF'R!0T$E?:Y(__:25L!0Z-D?\KS6,P02,\ER2\(_2.O M/KROYKJ$9U1K]+%_X6N(S/[9Y3E[$Z]&>]J _KSPWM-V(K-/;S_HW:2EQ)M &56N3W(!G*_*YZ8#G*;)(+7%D56/;7K.9/JM=8D4\K[FJA/"FF; MO]-?*.=,&O5V$G9'^[T3(V0[,B@WE#MT%]G!ZX=*KAHNM+-BHWD MJZ_=>[[%ETJ^1 FW%U0:^BKFJ$!;4WQ%@@?ZCC:I#,-N'O@3)]\&*I#N':XJ MJ'I<^@V!?>2&A"(7,F8FM<\0CA'=I890 73OW&PN ZWFDS1,&*!1YZ\^VXYQRI8KSRO/:0\75O3-1'7,/ MQ%'+[9P)#S;3_$M3?T8/*ND/.8AB>YU[:S8(@FA'UN\%[N6F T+5HWNG7%OU M:(EAQQ>'9Z[\,O6WEINF7V6N0Q*L?'N?7)#=1('MYJMV%PK!_'#U[HIY&ATO MB'Q"?YC./PTFHW\/EJ/IY&HPN;NZ&RYNYZ-9_//T_NKF<3&:#!<+G&(P>49/ M-6L2KF;]%+!!O-?V=\6HT^3T?WH=C!97@UN;Z>/ MD^5H\NEJ-AV/;D=#I/E>91E0:D70!V=F_X\Z/\-C\_+=Y_6YX6\^'/P\ECL[G M\9BR';;(!H*BYC.0CXLR3-U9GF MZ Q*F9)*B;0*T^>Z/'WH*64V&-U=#?\U&TX6PT5\4IDN_T'W/K>/\_F0'5 6 MB^&RV>22&GX()^!506VP3E^6 KXL6T\4QS!CL6DBO\(SU"; X4] EO:B)NM% M8:I]*$^UR70YI-NHV^'HY\'-6--.JD@9>.KPNG7Z.*/P#=ETX+8V0_'%.!?> M4XC9QE?F^"$P9[WXKJS$X^%@T7"G)=7=A!"PSI:;XVR;QH0:*7),@Y40!=@X MR?J9H>;U(BEMFF 0X"MZELFF-HE-0>T_5K=)T]EPOOPUWAX-_^=Q-'N@6R.< M P>=>/+27\X?AR=W ](* MFK 69+Q9#N"J4]@)9W9"RFTH3=/& V*OI7*!EF9G2^CPIZDL-WIA MOO%H<#,:CY9H/O2W,B$Y0EG*'!Y96 ZL>^\FFQ(L^%-K3AP69LB"&_.U4SES MJQ) ,!^.!TNZQLT&[,"XG \FB\$MBP)"FEP\=N0S3-X39YKQZ%):ZY0&09YR M4!&6YET#G/!GWP/Y\T_+M5W"#K;AH7;275?"$QZ&__[W8#*:#&/OS/)7O+O@ MM,[O'7G*3N?A84%6D0],#ZLR!MY-<4HAJ_00T_A@^;^3D!GT"K7N^I;XH66[ M5 77QT(_RK?,>KYHP VUFL+47%CKE 6^/8@3$CU[#I5#(#()E+4<_ LO(C&E62TB4= )K>Q:F2307E'4"WV_)Q5-M;::% 3\:1*O MC>^>K("L;[T=NR>(1ZV?,I6@DGBG]NYFL!C>7=')PZX&XF=3.-/G1%J<$_/( M3'J:OO6",(AC^F-VLP2Z\AG6=ER<20BF^B9/-6">MAX8>2IWHR:EV=X1VO@& M@263M9-S*3MTQLD5M\3E/J2\KH3<4$/P,%K&>\[XZO!V&C^2'$[P7D@*F%)9 M:A6'04JC!B$2,,U5QT&>U8U$7,Z:U@@Z_#F[B)X"\D=$1QN^\ ^*E>B/- M8O@_C^PBD;T1PSHBEJF'9&;C]<#*,U>D!^)BX7=!GD@R<51RR4EXQY\>;9(' M"),(7%=B9[I((G#UE^RC_W7))] ZGT")L$/RO_#, =+^/P=L#NXC*8ITE*"!5V(=*:O*+5) J:Y'?Q^ZY.U';)_":T=OQ,X M%[\I @- @"^F)(5VN0H >'F"=0>*3ENQ,G71J=)KN5&5+714H,BU ME2+K2.1J(*)KPNF9+WP.B_H I:@MW:^R%.4 H,OHF.$#+"%^#Z!\M!4+4Y:/ MC'ETZ7 ?-X*E!1\!*#UM-;&4I:<*#KHT3^FCIWY6.'_]$O*UO[9_MU9T56G+YL2&41H#*S #/BC)O MADQ-P>O4[$^R':K"$%"!FN.<4<:GUTGQ!=R"S;/*&%!],,?]HXX0^A1/LSS2 M/;FW=6TEOS>@*U2$YCB$P'AH6D3O4JN0T@%;-V6=H&(PP+D#84>K -(7WG1/ M%?KV4T2[+8F_L]T8K'L".;2S<=2'@0K) '=,,P:UBNTV"D)O1_S!^H45*H=D M;8]K1DF[0<5B@'\%QI A"P\ED!Y3[8#R%0HQ,SQN "Q0)?9G )) M/_\<5[1Y(8X7.Q;2E"^RDP"H,U1VYOA;%#!!E]^]YQ-[ZR9)%E;%1^+N.O[1 M2:JQ@&=CBR'!=_'&R+HU?O@:D#VHRA7M&;F4Z6@'N6\"=H=*U@#7C!ICADCQ M^-Q'X7J"UP,J*W.\+C+NT<53+NL!EI*T(U18YKA$@%B@R^ST7B;_HF:Z3P-X M1W&8B/U"V+6*U$PV&@PJ6W-\)2TP0YU -.D+]?ED6)]'DO"O34ISVZB_))R^O MRMK,X]4S64<41?;,/Q>G/MVP^/2; _O?>TH?NWJ13^@F@_7MO5D+Q-"M=BEV MZ^9PBA$:^,0"YP=6':=W#]2: 85OP"O57@5&&5!P&-G$]K_R<&8LIILR96RI M7;$+'=N)0K*&SKS& V(G-E2K6MP2-_R)F%6VY<^_#[S*QNTFG:$ECCN<2>4' MD"-WX_F[6&@WA_2/2C-)<4 S"J))JBNW9=*4>92KPRR:2Z)JS,B+V%LIRWQ2 MI2-Q:24%];5+-@)Z&5Q(]B3U&C1E M=PW0SF8L-_ RLVJ@X$^$M$JH8 )4,NLFM6NWU1%6[; MO&DV8 ["<:_=P<%AP9]L]35L1=.MDM265\D6><)]225MJ8FW0Q)[FP+WFZ4!X= MN..O%])*RJ*EHY)F&51/&7OC]D;JN)X."I ZP>J.N":C8F_PE*N^=@$B_B06 MU:[E3-U*.F=NM>7+= 6Y/YJ652Z>^=]<=>5&[)DRKVI+TXEF5268C5.@#GE. MO9U*=2?5^H78V^>0K V9!+MGH@_W<2! 0U6/Z7A^E?9KA5N^!,S5_%. M-!TK84SYNG?H=[]OHP!>_GJ3$7=#-IY/3H32_P1A'):3/E]N*)\I"?+&^*2C=T@0J#!H-C^AS:ZT!A#@_1@N-F0 M%7N+>61@;L47P)Z[HGO 6 X-PAP;C(I=@:&-)C1'T2!5R+)K4>I3SZO;SD^A M."!V484NL5S#W'H2O:9\MO$.NL/B9VE8@V&M 4 M04UOJ8_/OY;/Y)YJH;O]/Y%O!VO[F)5F2M] "*MN&SDL]XMJ9$"[ MP;'/Q=VJ09?(F'*(GOI;RTUC!N-DSL'*M_=)]I";*+!=$@1W)+1L)YA8/GL, M\D+JS]:5!Z_3^:?!9/3O4R*=N^'B=CZ:Q3]/[Z]N'A>CR7"QN/I+^H&KXQ>0 MCMUY, H%H2DR^0Q$N72Y"_H; CQ]=S0\]DH2+X/1BKT2BA\&Y2=3K.:0900P MB,QX5*:0%A/2J4YP%Q0 '/EJ;&B)\$]$,M)B0@/BOQ!JA>M_[D>]'^@;#@-S MK/YO3"#7H&7,R#IB6S:^CE7*3H @0#=S-1O#8_CG'=5$]F#Q^)?W2N<-X3C( MH1(JG@WY$02 F(F"GA&?Y8ZVMI3FG[TD(V-(J"#"(#T05 M($37@-C\))<6=S'WE'C;2VZT@@GY'/])N+V!]<>..6@A836(T"4Z\[T5(>O@ MGD+ 2&/INN*4\/5+C^!HICH0]CK<0L8-0=-TJYNK)IUEPHAK55%^'BS_=\), M"N\ ".J*?3'?1%)P[DRY56U3M22]#*V_9*UD/NVF;$GZS4O=DDXN2*E)65,5 MS^6S!E^+/%^ M*RWR,"'\VXA,B>N;8Q_XH0I87LA$S*.?_+(L8J?H8;>NQY64-_.LT8^L/I>OQ4 ME=!R.):-MA%KC(UG+GB8L9]&38[^*362A M"?CF&!W'.M;,.V^>HA,$D3OB7M@9H.6>>MGAI0:$-W%?>.*F<&%8J137Z87A MU?O+E6$70<6R^\%2.S/.2.J7@24V\&_^CA15S(A "&/C[OEJU8@'_EC[7=Z7 MYBL0P@]R#'1\'W=Q#)S9,5 00T!67V^]EV]BZ^@?$DFD/YP$D?[BM\=%W5XX M^2/[6S]\!"=Z-6Q^U0!=#/F LK^AQ2HV /3$"R*@]R,^H.QO:$E>&@!ZXD73 M(5?N+6CB*L#WN9S/31!?:8P]=^NP2G=)PFD.E/5-D<^H_#UE(9Y5P*4F8$M? M2]_X+;VTJD-:Z]ES>6@K],>^7H/)0!F0-^$HD*1QJI3![M9A@)WBZ8TX#O+7 MDYPBT0HAQ\(1S#ADM8L\%C*([X;@4@AP2T#ZFB%"5:6%ED-'=VC$R6+Y#HS< MG_LMB"(O**Z+^/O<[75&('1WK=\]45&-,I89J5J">R5@/MBNO8MV(CA+33#/ MSC6BSX%9RPM**-2#]2I%M=@$,WI!@FH=+_@7FU;P_.C:+MN@K@<[MB\0W&?6 M-<:_Q@2N]^7;3#[GZ%(Y9<=F5/(%4FZ'?59L+(QZAM'E,' <[S-[Q4R/L7=> M]!1N(J<:&Y]60Q8<>M2&P7[EWUB*C>!"%_+(?:'D>/[A6&,E?40M."F(^F _ MX&\L/CD0Z++B\O88$*IL8WLC.*>#.F,_ZF\L/05HT,4XVNTMVV?$33?,0Z7W@TK@KWW K*>;@0S$#X$=N;\YA-2%29TP6;E+=/7?7SQ51H"A:3MI5QC M(7%8SHEBGV4]&2)G0%F+512YKD]^)RC M"X7Y7^CGG^-J8B_$\6*&I/*1=(.*RCP?!P@/3:O8\'7US"YXQAX]@//BNLJ- MH% ;Y'NH8\.0Z9 &DR5;]]4AKG1 32S%\I-ENXS8.;$<5I>6/S=4QD!/W]-X MHJ@C9;!P&;DW9$/_OK1>FTBV- !4K.8Y)!0Q,EBF3 U;R;0T %2FYGDI%#'2 MM+K=,R*>!5N+N&I5J1$4=,.\#/6\HD^6.0OK=['79'US M> S(>I2]L7"W:0UU6Q3 H#(&5#O,<\*H(X6^"F 9@=^NX8(VSX?3@%ESY'W& MR:PB9?/I"T#':1-37&4LZL0WPQ-MWK2C&%H"UM9I+NM+BAC"9?Y@R1$O.=H(R*+ZM#)%$ M!3C-L0.]%04M9!K=NE=V.K83A:*+'&X'[ CNEF(I,8XNF%]B9RE9#^C$M;9D M$K'W:]--4KAQ&H5!:+EKRH!D#BD.@QVSK2C$1B#UVH1R.$ZUM\*XLF+P!\*. M%.]&-61 =:P<9IQ;)?E2OE>W/)"&PP_)>,P%]:1F"H&":>'SX/=L2GA(CRQ]2U MZT6>8 [M.KT&$LB'$;O8$X%=;-&+2D,5JA$!'@2V4)?S?^]%-MP2S=U >]9L MP@84'M*03KB#6,9XRRK8\)U:&)]CN$+Q6_#0% ^;$L?,C[)39UMOS.7\>3E_ M7LZ?O3A_*@@@N5<^T<8^PK 35ND6=NJ12(1\Z#F9MA>-K"BWI)L9X@&H'4Q6 M>DO=I@]_LFV%<&O*:8M]U0W2HL+3&Q'/*&>JB[^LXB^[OOC+WHZ_#*7@$W*- M':T%GYJLMDLZ]G0SH$!P,CYB 7$8>4Y>1$43!PUQ//M4Z_ MR3V]Y:_&Z4C* YDA/*$BEO.BJ+*H9YLT(_O 7GETJR$N=UUIAIZ>JZ&R%0(8 M.,QK\I&.[15[$GU,0B5$G-<8/>=)![B+@4!?3]C+J8FUXQ5*R>+_"ZW,,$"@ MU:-(>.X0@XNV['!<;F<&XG6ZPL%;[WDWGGEV(6CI\N'TZT9JFC!W.RCF+C-]WP7:F';%V>B$JKI2SJ>H2HTP7[^I5 SM<26+HN4?"4I %+[HB>> ME^56V*^K@.:DGCG]Z8K3[$7!PG((V^4^6/[O).3'=L.Z8CN4@#% <2^IJGVN*=TNR',>/$:8S]5@DTG,:N:\!WM]JSV;"A> M6BNML&M)P!#E,*<)RCG91.Y:9!=8LTHK[+H.,"@YS*'OQDNU08[_67E;E^55 M?<\WSX"NV.4;P"8:#(.!!3:&KRL2!/>6[;."9V1*OS0*@HB=".DI<47(6I#F M6=X3W?\,FV **&BR7\DR+SC>LE;E1N@N(!BZ];SAOS7,:OW9)!"^-_RI'/DY MFOP\G"RG\]%P@9U,ZEBO\$2@_!&NL!-6+%9*TKWMVL$S67_RO%K34V:AU![9 M_P80!Z_@9"WCZ$O\D;RY]?F!3G;?MAQVQEQ$>[J] Y4'Y?;$=M"U$)8$#5U7 MDW21.I*0+S2;K%^4D.E30-D/V:K%?+B\A:3)0-@^/05I-66QZ2[-H+RX1Y8G M!+( Q*VPO8PMYF&.R^9><^8&QGV(,O/)WK+7F2./*2=[T)36YTNJG8)>J7S\ MMKQ7F\<" MX1;\R$5M,*3+\P*-&8D);=("E:#.6-N>-K*HG=D*4.$?("9>2$XUW45GB(_O MR_-R,ET.K^;#V^'HY\'-6'ONDB*IX-G%ZX:4SY)2P[1J[%EN<"*+I426S2) M5S/FD%A0Y;R54$!Z?0/$YQ)29Q'6&^TLHD7ZPMJ*/56 H,2<9?:HAU=V@JW MEN<^;W1K5TS)EO8:NG1JW[B^B47T33S'5II*EU?9FKW_AKS*ECRRF[/P=_ZK MQMR?^P!OD6*4+%_Q]T6Y> H-\%\F5A2@C&5'CW@:@?E@O=J[:">"L]0$;5=3 MAJL"9BTO*"^;'VQ7BFJQ"9HS5(YJ'2^:;AK*^[1@Y=M[!@%GLR-HWXN(>"F_ MZ!=Q8\_=AL3?W9&GL)1.>^32/Y" JD\HV,^!!\"^E@/'W2A"8H0(ERF]*9V# M'7NG# M8?3=>@XK;NM;3I*MG+/PB#KT(Y!?SC+^1<>86($X2.KCA[*79CP<+%K'1TE= M,@EE8%=,N3G20D""@)SF5$S4,;HWJUAV%Y$)E=+R,W%>R(/GAL\")T'S$:N/9,@%!TC037$R,+XZ?F/81N#'AXK=RUKW M?8=8UDT8PQ?SV6S_K\3REY^]]B;_.!#:UE.CJ2^A9+R%ETH5/ #:YE:#/>=+ ML1]FG"]5N9%3%6CW+U*[-=H&R?*\MII^4^1]4Q\*[>&L;GN=1ZH?%ELL6X4A MT)[NZK+:'%GVR&YS9 NT=$IB[?X9L0;;;8I$SVJ][[U(D.A2?22TM\N:;7<> MIUZ8;K%@X2/@/6369+DYDNR/X>9(%F;EU(2*ZQ13X0A?GFPNRN+;$,LEX_+Z^U9.I*HC@,5#F,<(4U@@A3*>"67T'0'./9 M7L:XKC%EM@S9BG%L%7^&V!)_)#S$&=\L:)@89XY>39B0%>D+!VK9[*.'#+=<$F4 MY5 !CV!&R@FP%,M)/L!\XN=>X5(XEN=B@?0U0Y*JNEM)PRAG])+%1:<@+OE= MWEA^%UV92+KW+^%D(KEDS3E?UIPNELN;PY)^5E)]&=*YWW9:A=.<;ADF3$:C MM+0SI+,9PE106J@<\TSJJ0W]0/S5,TM\$MCN]OC=6X]R[0?"*M&@GMAI?11T M+^\34$ %W59.-QM[18Y$51SS&Z(+@,/09D$SEC>R-PJ8 Z(^><@[L8H*M/%9E>W\ES^?SD>T&3 M_63:S]@UKK'@"X"@S]S!:A7M(I:D:GU'*+@K.X:6_MLA,<;N>K#S_-#^,_X] MERN^A+O[ G8FO,:ZT#7(O8[JX'(G+ (@[H6=@Z][*]%%=0#3K\_C,;C>.*,)LO!Y-/H9HQ?ZK:6M[0VGD+Q6\5AT*)X[)",J75: MWT9!Z.V(/R=.K"'!L[T/)/MD8'?DJ==(H-4X'SA0Z/OG'+5ECG.[OOSN#B1C M\%C8YZ..):Z(8:\WP@*VX<: TQ/[J*19+7@VH'WUK"[<_C>^Y:Z#./3MEFY) M#[:[%;ZJ$[3'/MBTDJ.$MVXL.#?M^)IL^ HTVNTMV^TN1_-)T2)HTN-F ;_RP#D'S"],D:0[31N/UVEG0DO=J%$\7J_]&2UY-\2_H4;^8!,2OVM]* WZ%KP>':!JLF8(XV=D_7KM M#P'R^,8=)))PFA_5'278 35?DL.D1F-'KH(;&]+[#3@_5& RV%A#XN)AO=^V M$T(8)8\4,9W;*DPW99[YXI3U>PM> !@V^$%U@U6SM]G"P75[/!KP.ZA,8K*OWE_'%X=S7\UVPX:5\WN7UT M:L)KD#%K.:(BRUDLI:@3VHN%O.RD^0!Y[;&C5.7BJ+XB$#"N*8[B+B)+;T;V M@PM:+*@2C/CN0IN$S\5-^[DZ7_QC.KVX?YW/V_&H\ M&MR,QJ/EZ++%%9O$GRTG(H,UE=72>DUK#G&L8GW3_NQ8^3QH7706% MR0UZ( M;VW)K4>AL5WBWY&]%]@\J"5]>K:E!2& OC#%5DAE$>)VZ-$F6<9*_Q>7^)D6 MW0A9?GA8^I8;4!38JRW0_<3W[\O+S'PX'BR'=U>S 7OSNYP/)HO![7(TG1AT M0\%C6;[LR'MBI\CE47AS*/P%FB]7:3@SDHY!I3T[>AN&7)'^O:FB$^=:45 MR$QOAL?8>[SR1NY*F,ZQV@S[7,'7E/QQ@L<>^@GBP?J_GF^'A\4S9?;9IR.1$PBYY+ M.$^2;/6H:VN(M&0:6))('2=:TLFKS"+BVR08S#(/0$ROH1N[&&8?8&!*+1Q_!Z&3)H.31R?U]SUJ#F"DUDZ41\SA"=3 M1X!\].Z2F2.:^4N2,+#4XRG<, M[ &U9]W7% 0!6]] YC5=AQ2_//%<=>2K MG8#@=U\LO /P>1"@+RA?7DF.]LN,2GV.[R[U.;[H^ASM-PX19=YVM[(]>+D= MMF>A>:6!>HX[M90!67V]]5Z^61,[D0']QPEZ^L-O8[*UG*$;VEP?-6U5:63& MC.C$UM6QEPNB.H<,DD]S315M4FR!C'X=8A5,BQ1KVO3>)16+;Z[: MIFBVHP)0S;Y*P)P!NZF\[R#VE0:C((A.<0QU2RV_#W+<%?16MK*NRE# S); MO4_Q5PS:;?&G$RC, A9^2AWR[UM41L$VS>F*N F/&H]:$[HVV%[BGU.<)YJ +Z8C];J$)[G! -$FD M,*VLX%D4 M\B*,/,I:8*:GMA>^C;VCP! M%)H6F^'KBK +TM32!L#%7]X-VU_?1!10,'3ECJ>G)';'P I'Y\]0]Y;MQZ]: M.,( ],/V!S:1!A@.]&W!S/=6A*QC?3E1G3L2"5WMLJ[@8Z(IPH.SIG4Z97N7 MPEWWUM)*AY6<;1(T:T7<&>QK@GFC!IB'2G>\(>*[K;,;$"DJ::XLN1TQPJ,=-<&$+N\5."/9 _ M_[1KU^4WJP_#?_][,!E-AG%]VN6OYKQ4';DO) CCX]0=>0I%D8X.SAML>^J8)-!R*@F<)?$!4);VQ+[Y@D&K(!)7;#&U?B@ MR'(:8U\D <$5LHINLEE4_,3:R=[7%%J9L8%IOKDL>4-09FKZAF!4)W6C'01KWHL,U*UO'R3 M@/E@N_8NVHG@+#7!BXTHXU5!LY89%$OP8+U*82TVP8MND,-:QPS^CJ[FTW>=5FNCEXRZHJKSS_/BPD6+D+E!WV5 M'MAOB-I//#D>NI+@6 '+ A/8ZSC\Q'.7'B"N7MH+^QU1:XD <7FS(?;:G@JU MEDR3>'N#WF_'TYLRO]WZ9$OUZ4AVGA_6AF\(%8; OKWIPC(J(X:^2\GB*Y,D M$"0.LQ26'^=VP+XDZF)_(D$#75KYG L.C;908GS*&37//*NV#=174@0C!"Z M+(M+PMC^([+7,=3)'PC5/][Z6;N;%HV _N"I^\.#'#!]Z1U85;D[^X5NN%S> M(:#2"OUY4^OUC<,X^D3*"!)<_.::H+]/ZF2=*K.,+H3BY#S2E^V)[LC*H?\! MNSX$ Z"_6^K>EDGATN50S)WE?_;8BXYY')Q4( [@Y1#T17^5U*G#0PJ2H?-P M3L\B)SY4)V&Y-_J[)7TSL!XHPZ2:BZ--_AE0X.<,?JAD12- I6NFVT697=,E M?'*2BY\\@0> RM=,1XLJMUSQGOE18DQG4NH *?Q'DOV-5M8]D[\#/'F9^2R4Q7=E+!O7G_[_J,X MG%W8!3M^#!#)#F#Y4H(!W^X(RC)T\Y3F4I9!7RVRW=YR#Y(:6(4V:#$&D$(, M=>QH8D")MY018DW&0O]/8$V@] 86'R=L.+],J-Q$K%5+]T\ MIQ'W(S>7\D^@#4JCH#]2T*8'#< T20-FOKTB67@!2-JE'N@/%\X@V5J0=,5> M1$^.O9IN-B2V*NS+O$B+NI;HKQ8Z%P>75:UB&*S7-J/<AH/%XWSX,)PL%\?;7O%O7!FX9&F)"O^ MP%UG17=L$J1R6T_=.0ON8&:=-IAXKI_]2-77#B3WYQU^P@Q_-D3ZI5G;(0;X MM^E=,%,QK/AS%Y(8[X(A[: M_PM3#PD:Z)?WM7N'*LFRNWW%80Q3 I#*\R0,XUA+7JLFR]+U M"CMA.[0;:2Y/B'Q4T,]O=31>-Y'2^]!$RY MV[LH2?A[Z[GQEB:@AXMHE\0CWQQFOK>.5JRB\*?(8N\2"/G9N@XL$0W M?/EW,CCV+ 9K2H=0:HI2G-O![QN?$)M^F:)(*:R5'FM;WQ3[7D0N"S[M1MI1 MU,Q:^L+GFQE7.F&GBY-.?:H I'#QT1GH%-+OHY-4X3M2\HEX6]_: M/]LKBQ?*2=L+FOOQQ,@&0;9D:KBN.D<]OCBP ,;95.? 9P7;&43KH M]L%>W7H1/BJ_>78U&[*\+(]^,S M=4K9\)6]HB4WQ"4;.ZQ30CF;;<9$GJSJYZSV &KRAZ>$94M_A32>3T_:#?O. MH@/$/15^#5F84T+CY82%QM&/.!"A%E&3=<>^!.E.N&I\FR7D=(>H+EY^1^QK M$UV"E4%EC$@)*SWKM)R^P%&PKV*T"5L%Q,9W:J$76@YJX,*QQB:$7_F&K.%P MV/=#ZINQ5KAIVH=E-&4[#,ZDX&S'P+VQLRNU@]YKP#'^S7EG\[R %EQ!2M## M1L%.V=2)HC3BW) -P1& 9.?26-RR_FA9IS4*&H;9F[ )+3>,BL, E45;76LM MRO*%[!9SL\':V6Y2[YFXEL/>S:7< IR2PMY@IX\YFT$56$QTC%_7.\9_A#G& MKR^.\7;U^;+(LB-M+-YL3E:>N[(=.U'\_($THC0<"HWY_'8R>.]HA:K?'X@Z*[677L\62 M8-A+/9B&SZ(HTA9#8CO0SZ,#!?P,U8"ZBV15D=>/@>T[[TK&(H1,]'E]J/=Y M_03S>7VX^+PZN7J@1"4IV%*E<;9[5%O# RNUSA)U M#/^([/VNWD-510$V4(\<44U9;'IA^%.RZKED2U?FM8:4#165K?6;22*-9)U[ MYI%2PT1S#-B1B+F]?:8'[\> 9"IW@(JEMFO/'$TJ>/1AGIW(CW]6%V7:K6^7Z4>=,JIT=W15=2RV8^AID7 MV (G>WW3'GE<^$P8MC/,>_'9'B?1$?E&D->O?QX3&!+&".PXCT?N"X7#\^MV M#+RS2ZX/=J1?!R>Q"@+F">F3YZT_VXY#3P[EL@$*8A..TL.0O"8P&9@:K\)& M[MSXR?<"\':CV@\J5!,<)4"66HH1/[ZVPF/U2E5A3M=UADK=3*^)#!0#3W 3 M$M:[?;@FFG63]H+*T13G"! &$V^*OJN]*?KA6]A-T7>7FZ)6?#RRLCO>UK7_ MC#4G?4LAV-IP._3N!DC">N-U;D]\VV,OV?P0=;7C\$>!\HD5D&!.@LAA%UYQ MEJ+D7?8LICUWW%77!.7Q^W>CU"VRZ&<>)79FE U?FYIP1^_?;527J)JJ(G/" M*@4P2@O$=MF^;:IL&VI3W# ++^@'3PK=@8 W+(=_4!,Q2E MPPG5J4*-L5/-5CF9&J M)5N]!,P'V[5WT4X$9ZD)9C;Z&M'GP*SE1<_)5(:J]2I%M=@$S7T@1[6.%Q14 MWUR%$2WF65Z6Y/I2EN3++DLR\=S'0%;]HM"H3R5(:KC3%6ZX2%/(<+&,@_3* MK= \?2I@UE*N&U&;14"_(<[TZ9ZPB-)?B26P#X5&V)5/NCWA MEPQ*#1PFQBE,+)^]#WPY;0H*WLAKF#?R.,K%*WFN%ZY9_F&%T"[(8+V+=V@! M&;K)5*"]8/D[D7EIQ/[%*[1%3]..9/K9)7[P;.^3186S%ZFTZE$H0"W]>G=Y M=%VV'+8J3TC(%?-=1)8>#/XV _;HSKTMJUJ%.B<[[X6LV37_\ID,7NA.@GDG M)IZ3)XS.VL> _JX\VSF";3MHCZ[.NV"W?PNA-(%6D[%Z]+"U!9>&"+L:B5]F M)CN.#7:L!BE?U.HC]>B1;&,>#1$SYRR]?+;"7[S(68]V>\KU,2_44I:4NNEX M/7J=VY)3LP6?Q(%F@:)W)/FOLKQYP_3O@6\CG-"E*RQ;D+R3C&OZMBOL4#=0 M_UX&-\0*WT\89]-]5TFGF[K[ZEV%'\JNPL5R>OO/=S>#Q?#NZG;Z,!M.%H/E M:#HYN@V1G(4G(J>;/'=SXK HX%LO"(/%,]6(F/^9=6 >>D!=X;;C(L6YK9[) M.G(HS3%ME038 ]]GVXN8UIO#J4U*_X!M,67AD-U]PHP[^&XTJ!SFUAU*!D1/ MREC@<5"Y5JE1IP[&-D./.I][997J *E+T"2J)"^ADY?0R4OHY"5T$OO8UW@I MN;=LG_FP6-J<:+>/'^RQ\\Z*;I1^]NA^*V8NMH$J$O. M#"VM'%NKO#ZI\,JR$=853I52JZ#,T,6NYMW<#GZ_]PG)/$9G MM)?UG\8.5^B'N12)3=.M>J?TWWO^AMAAY!-!T2JM7\0.MNA>S[1#U@\G\LE0 M%[S(WRE[D:_>7_S()OB1FZKT--'B:10&H>6RNF^32/S(1,.GD#?_>AS*NB32 M^QQB'2+S"V$YY( M519R WL5;T+.HN#E3V*?/$Q7Z7H182NQZ+32Q \@G/CVA[GY1D$0D?5=1'>>VT0!8[:#^(_3[)HFT<$ZN6>3H,%8 MV/']>JQ!8U![G02WM1',X,!>SA3IP'Z\8.:*UDB8:(N:R+S!++NZ4=/VU@%C M81.9,D/-D:H"+UFQJ'/YT&!?1R_39N2!3T5RO5?3TP4R>Y0T?-W;?CS"D7E] M.@KX-'K).2,5%"RSM[T?;(L2SO5=2[+0R_'U(KO&8810*I4?TE1@T M4C=KH>KD8JY:V*2W^FIT*(6*;G]9=R,* %XTWK!H"A6M?F/7*6T@N^CQZ8@< MIQO3O-.H^114:WMR]:,/J#>RK\UQAK-/ !, U74B=5WYFZ&N+**8!HF28Z31+4,HO#9\UDRQ$>J2'XNR&7F6&YP25 F&?F&X* MGWTOK.4G[(']ZEGC7"D4_Y"CIJMT2\V7KY7E=8U>VQ)?7M=H\OJ@+*\/BO+2 M=F.(**\/:/+Z3EE>WRG*2]N-!**\OD.3UT=E>7U4E)BO#ZBR>M[97E] MK[K?>(L;CN_1!/:#LL!^4!786]QQ_-"+S,(-H4BB'J:;7/A.>E]RIL.FB C M,PQWY?'4>?B42]4,+:Y<:#7DM\HG\(JO+K>-\+X1@< W=3@'30,34/\BITFA MRPW9VBX#Y\9R6!E%Y3 '+"JQ$YZ]X0D#4Q S9DW7BVDN@ 1GBU1'P)OR!*+L MD?AB-4.-NYK;53Y%<_MU!C.BE#*TAD9^7,K1M7T2-^Q:\^8;+T"KH4L(F M_8 XFK+4[,N0<(EI0X,5(5R>.''7;',UL78-HQ7;?LT,S:G5^LX2/8KXUU*= M5T&'YH2NDS:K*QCO1+F7S6E[3G,S;SNZF0DE-1 "9L:QN\DB-/PCLL/#R*7, M13%@T_"9^,MGRTV/5A//?:&LD[6V- CJ)!AYU8Q9G;&I%$VNF]()#H\IVR4' M034]*R?.!H42XZWJ>:M"MA>JH6J^I 0'E)I@Z956ET?7#NMVX:R;M)>9-ZIM MU0<(EJX(O>(G)<38[IWG.)8?S(@?L\J+XFL[JID7BFU%W1'8;WA35JR&@K$G M*U-@YDV?T7NR>B%^,5JK/3U@2WK,O)_KD4:_M7SR4O9_CG>EF%:Y3 %V!:D> MZG"]$#5M*SMCXV;>C:#H)!36%NRP=Y;U399AM]" M_0XI7&FU!US%KR'"S*>[1FL^5Y28J@_SC1)0P&C)WG?7<+2+V'IE[#T2UCZ)2S]$I9^"4N_A*5?PM(O8>G5L/0X MP&>^>%0,3R]W,SZ@4EN8>CV %V_2)5R]3YXDP^-XOVA/4@^L:U_<2(:K^25< M_1*N?@E7E][L7<+5+^'J;W%/=@E7OX2KOV6-OH2KGUVC+^'J^L/538DMNX2Z M7T+=+Z'N;SCH]Q+N?@GZU1WTVZ/ \DO,;Z]N:50"(GL4>7Z)^;W8WTO,[R7F]Q+S>XGYO<3\7F)^ MJ0[-B+_Q_!WSA\3$![)H7VX'XR/1NHOSE8!V\1U=(GS[Y#>QLKV*, Y4NLX"56$*#1/8K#OL0*7F(%+Q'SH.A+O%]O?+:7/-Z7<+^W[;95T/">A55?HOVT M1?M-+(IB:+^<%J5"U-]/ZE%_QQ$OT7^7Z+]+]-\E^N\2_7>)_A-% Z71+^+@ MOV*K+T.^19[10_^@07MFAMO5J1D'[X[BY'AG%+8?&[DK2C+=)+%O# M]"'.1G2GT[RHS_\-F=& MA&,LZ=]S?S9C\F@SBT5F1;SJL][<>-0;'DW7SB33^9[U(*9NA5 M$ZB2&-%T Q8,HO#9\^T_B8ZW"OQ/85^+FA?D*Q-+?Q7NC@0KWXXCE37H6&'T MRZ-P /B:+O1GOO=B!RP^6F R2<.:[.L+C^^+>R\-!RWAU][VZUQ-PL'7O#B8+P@B MLKZ+_./4B-\EQ7]+F1B^$G]E!\+SE?I0;^^E;G,L*@JA]@+LA?A/7D#,3MS% M]9?5)L(I/9S+L)KY]JI-WJ,NB?AR7_EV+TI,U><\<[$+(@_HN=NM4K(!S?G">'S:476D[^[^P!WL0+?R7AG*R\ MK>GOV+M!,?0<]/Q!HL&(2%IB")W M!W9[R!XJ6UN9QZC[SYD?OG;VS0-$/F9H M7Q/8XJ0#WMK>V,D;T)&[\N,.U<5&PS6@TM>ANMG3VYHS2:]&5<^<<(U2MK/# MV.BS-*">RV86<51V M-%R8DWE-Q/B1'7FB-<5AD"*J?6\=K<*Q;3W9#EWI3V0>).G2Y#W->!712)KE M"&HIK_BYS 0T5NR:DC3'IN4C@^HL7(AC[8G$)(^/A%OZUO[9[I0./P< M"8+F_121F"<]*<-D(B';,C7TL"I5 M!$]MY0<_4=:1']MBWTM ,,=2J$ ]SO?D))MY+ M_!9P^9F2?5C2MF3YV5L^>Q'%)4A^.W7Y&8+8((IC8#] X6A/WEO:"!5TR]3? M!+1--_1U>64[SI_5 /]+7ME6)NDN9/-M-[97=*Y1+?CD>]%>:("$/;!#Q^4Y M3P$,H]N61?04D#\BRN[PA?Z//+4*MX,AVM[,XG"Y0L_T5$.9-!4*OXL90I(H MG5PVIJ0G*9$F2UK!:8[^H$&F8F*!&)!*L&^91QMXT:H)13O.['1)*/H&4E]V M_QK I,R76&E:-<3!X^1IY:4O.,933#?WA,S)BM@O_.0$O-;("714[LD*N07$ MW*-OT3_1E7CL!4%:W6GIC>W0WL:H+D@8.K'_G[_I ';'SDK31'IJ'&J=0@O+ M(90 NA^*R TE^OG!\G]/58G[M#H.X -TQ/:L-9U9<%#0)QG3GQQ;=]:.VH-@ MX47;YY!71C/M"^B*G92EQ>0" Z-I8LT)I9Q^//7NQE\7U345M,=.C=)T&DDA MT+4M\(+P_T3K^#IOY(:$PL4+\*YOBIU/I/&.0, XNJ6ZB0)*.YN4NR?;3<,+ M4[Y"^J_ IJ"F88(IWWS;U6@P=,]K;>DMGVU_/;/\T.9N M'" =L3U+32<@'!2E:-KT+^Q_6)0Y_R]^W/:R+8H_+NK M_#_H^MQ]*JD/',"O.,GV+>)'QGLH"P 0LL<)][]\2 'FMUKW>OQZ?_\]!WC3L6<,?W_KE5WZYM&'@P[MW]_?WV_<[VW[0?5<_/#Q\]X#7 M;(F+/CSD7M>HU>KO_O/UHF7U6-^L.AX/3<]B\4VNX_V:_'S\-;ZT';A.YE+\ M1KUDY]W8H^%7.[DA??'^._%CYM(P]](]<6FH+G6XO]NH'SP&A[@BON%ATK5U MA!DP9/_Y?'.17![F7Y]<^BX,3(]W_*!OAK"'^*2]:JU1;>RG'E+ES,H\"#YO M=_V[)Y_SOKI35\\9VYPLIOASV^3QBMML9+G5.^$'N*/14!<&K#/QL?OOX%=U M8<2K7=,./$^O(;N_6M'W\C M=\'S M]E//=-]$L&1#L,JN%PP'@^^O#S._P9[ZE5:_5J(]X*RX^\,!CFKZ_\ M,?,J'@Z"_*OQE^RE03Z^F8LLYO;BJ^ #=R*^;?E]NJC> *(AH<%,&_XU\/\^ MA4[HLJ-/[\2_\&N?A::!CZBROR+G[I];Q[X7PFI7;P'I+<,2G_ZY%;*'\)V0 M+>_POG?RL9_^5[5JG#G,M3\8+19^-"[-/OM@/-@/'XWS$_KC1ZVQ\^-;ZQ^- MDR_-YC7\@^#]0)2-:G7:1^P<_$!T?Z30_*'0G.$QN^_IKEJ]5I_G]KV3'PPX M!W" _W_JP2H.CV%Y M,]]VSV\#L;_JB!=-W9K1_L[\_RW+W45(S]:03WXKH00ZW3/>:!8YOG\%W_,?9G[,\LS;QF7\R,Q!/Q-6< MX9G[GX$D3G[4?TC9+!X.7\WRC,:/5L\,&+S\!ZDB\1!.W\WRG!.$Y5H^:V<, MI.<]_/#'=12P'[OIIPS@&_F,MF\/\5_;N3-X.'39/[=LAP]<<_C!\'R/$0\[ M#Q^0WUB C$R?'-MF'K$U?H0++V%7 L<2'/L0WJ \/PO\/NX+RJU:/?3I[WJ# MU(D'L,*KF/,AEXZWCA)"_O0N\XIBWIJA\JTC)/.%O&_]EA%YCK@6I!Q8%?R#Y[B@ZX$7MXX4,.K-CT"#FOG#">LP0,5& P)_ M/O9YR!5VLP!VL+,8P*["'@L(JDO?FP>PPX/" %/[U[0LN-6^#OP.X^C^F>X9 M8_,L6[U>W'XJZ-3*W; [YD5L'JAV:H5#1?MXX9AMQW5"A_&F9X\ "OMKS0'K M7KUP6&]9'^0-B+U3L*Y!")E!, 3AT^RC>] ,@7?;46BV77;K7YLS [Q?'*9]]S^;7YA )8_XUWB\)L%.L:_&"]8OI M>!<^YU?>+0OZ2 <$]@6CX,B<2WI0O#";&%[>QU(J%JA;_TZ<>X<\-EL?NY9?I^A_4EQK?/^ .Z> M$^K#$D)=BZ&NY4.]4RN>CPC8GN^"C\R%KLW3I/5# =$/>=N/++)?6;\-WM$H MN+O%BR<1:[B*0@R08YR_.&CWTHLKWO-<+D.O$>/X5YUCO]_W/7H][O9UX-P! M05R[ID54,1T]Q/B ]1OU(Q=UM#3.^X. ]4!_@W,D"&X2DKO%RI%%87C#0A#P MS#XU P]VF4]"9V\UT)F. !? +OBZJP'^ J![TL:;$?C44DR ?+]X!Z 0R.?G MDP5X"(5@-"5?[!?'YH6"/Q4?%&V YS+U=13@M^&M?_K LOA\',*18YA(9?Q M?(]G$117H(V\=*RGI,JB#>PEH#B.0W$>^-*W:2KN*S"*F!$=%$&W3Z( "$2< M)GPWW8BET5+(VLMCNN+=@$4C.R6OO5^0J[! S*8BS_<%\Q^RTK7IV&=^ #XP MN!9>E=.>-IG>%ZSD%H/'_)SUON" Q6+PFXKD#A<>W@:DF-.5 M9RO6\!:3F5R*:#7MGQ$/T>,HG@0/BY?T2\"K:=M.2 <^2 [GWK$Y<$+3G81C M\8;P$G"<4L8?%B=#EHC<=#Q7L/AH]?P@;-VCTC*'(C5'-#.Y,> MV*T5?\@_/^3S<^8B3BWFQ&(J\JX7?UX]W8'%G. NP!V4<6$QW MQ%8 >3>6$R:.["Y*/SXYI+X)@]\H:P'\VG2X@77C1F$U%GGLECJ<^Q]!:0%[*$O": M32D66-2Q1!RG9+C]XD7)$I";BN<6D!#_1$3D.9RT@+2"\I/>#I^-A>X!\6O[W3QL_F@?5]D_&P.E[41$T=C9E&RJ/R. MYT(^/W,6F-E1*$93*MGW+YHQ.AG\J5CA_3(BK\]R'9_%*Z6/[3S"3S.IZ:*S M;I:*Z?R2HS@MN72LIY0NAZ4/VDU1Q;9;8";5TC=J*CEZN" =]NS0QB+8KL < MG64A.RVWE34M^'GDN5=;&/^U !O&CWWOC@6ATW99 @\9UI3DM^K+>RL>?&(SBML]@I,/5HVTM,)G;T"4Y06BN%C&GYO 1E* M<25U5L2-]^TI0(;4BP_0%0?^E'14+W&X_CE[TRAQ&GY1HKU1O/VX!!RG),Q& MB7/QGVE8%9C^-65@^5FQ5Q8QBG/Z<< 7L!!SW, ?K*L>*_ 3DYY3:?& M.OG-N:X'!;G'LZC@?L>X7 M:$P5"_J39+'?6$2#PE'HBE5W2GX'$;6W?%B&CON%YC#,BMX3V_S8E)3+,9L3OVK)*S@ M(1$;@<4"Z@'9".Z\HW:P+3Q80*SLB^_;]X[K)K&0IR).CT)8 M8,W='! ^37 +,+TO?<\R>>\JN#:#4'YH6G]%#J&;Y(=B#3-]!'(ST$@LQN1O$$A=B MIP0+\6AQ K;WA[6PF'.'#N$"U^*PP+4@8^C"][H4QA;1E1M&QQNWOCQ8D\&7 ML7CB2!:^!)\D03[D[_<6X+HLR_0_++ 'Z-)-_\,%]/>\8$ M+([,4?19:8"A MPNPD8F*D5Q3D$D^^!JO7=XM.B_%LUJ'SF@LD]-&CG,1P>(S$1Z%L%%U>#JMU MZQ/_SP3&^X+!H/3$IFW3@(C<-EB/ [2(B059OB ('R.H6#*?P;[2U>?>( KY M!2@KMRX%;JS&*%.J.<6A:'T1Y;Y%HK;S'-06$=%;W*XE+.WFL?0D)!<] N1Y M2#8*07(!G?D7L)/C8!<*[ODX%YA/ MJ?QZD6G?L<4L(*6Q-F":7/B6Z18&;O&G]Q)<:<9.!^C3[G6]\*QD=0ZG*"#. M-BAD81>007D2RX(4(10,]>*2.20]% SO E*@%;S,!AO;70C7%9CC)4Y'6= W M/91F3D>Z+;#.;F33#%G0')_!2[ Q:0Y@)Z=RWBA7?6^O:#^X*."?5B&9@4Q+ M ;T]"OJ)(&+.5< +Z #N(%)*YEX M;N+)V!HEQ>/IW<@D$+X@%O,?IM3W,O-ABN"%U'1#827G9VJ-)VH][M7N%5@? M2'!^ R8-,(<>O6Q?Q-%G"9+L+\#"^^8%L-%=S_F;UD\J%ZYRA_@-XY&+^TZG MIL*^$C6-*23F/1NJ[^\6K_47B-&3K +'"F;ZV(Q9# M)@I^'B:7R$@;C321=<%?X$+<6[&%7X+YSUWK!YDV/<4UOGD*0SX3BG^ ,NR% MS&[>@2'+LE/HL-IE+\FY!RAZW+%RHH=%+5!C+>GFL5Z04RW+[IK3S;,7 M:'_UZ.8[8(8G HN4-X7VRI/S=0I:#X'^B+U A',"[FI\[+"0=1EMIKX*Y'*) MC2!PR2XC@=,4AS?3K<9>H=*E6"KAWR36,Q+*\Q9D!:7)-.0Q/J)KW#Z\:7V; ML"K[)18FSR23YRW,Z SH57!/GD)IS=R4I]!=07=E'H:'Q>SX>-!@,8%A[GK MC8>OAM6G79*=^NJ1R!06YB.=KJ=81 &>N-<7.$ZWJ\/W.JQO@EO,![HMHUJM5M_9 MK1_L[W]Z-WIS\KIWN>^3;QL0.8]#P4,S(%5PE*"CGI3\-G8;\^SD)L([>;V= MN45]GP% ?2F7=/(ZQTYL;;^Z4UNQM74\G/T0'B4(Q*^0OQ2Z2#O5&NS%[NHN MDD1@H8NTFER:H:0,NRUDD>JKODCU)2S2J%WT6)W"2RUD(N99%PV>U _R)QN M>.XDLF8R_@&WM1&LAW M^5"N$K-H.B@Q'2Q4'DS,SEDM\9FQ!.OS6(+U15J"$Y,Q5WB5:_.L\ZPT&\/[Y628VI-%ZK*Q?7^\R?'KH(%'U^"UTF$W6VD=\G$G*Y2 N8_?'SMVU M4?WB^S[J3"UEW[5175JC^F7H01O5JV94OPB=:*.Z1$;U,BE@98WJ%V$3;527 MQ*A>RNZ/GKYIH_KE]WT9I^]C[6NU45U:H_I%Z$$;U2MG5+\$G6BCNDQ&]4M0 M@+87RV(O+B-+9_(D &TYOA %E#PEYDG"T:9GR4S/E2!<$J;[?_(N#)M=)?8Z%Y%@M)&]PH:W2M( M:-KH+I?1O8(DI(WN\AC=I26?R1U\M-%=!L(I7[.5)PE'&]UE-KI7D:"TT;V" M1O<*$IHVNLME=*\@"6FCNSQ&=_G(9T)3*&UJOWQ:T3*:0&E+N>26\DO3@S9T M5\/0?6$ZT7;JB]NI+TP!VLPL2SKR0G=_HKMA13ST^S_.(L\Z\VE@9C18#RKX M'''@;LZ;%E"!&.,J]I_ZE^<@K%V,QP2&)I07(Y3E"XF#:N-0_/4>B%+M/4T0 M$NO3#1A)6(%YRO_T[E@0.FV7K:-BN79-[]+LLQ1Y3%R3IXED+I4VN17N$VO_ MTM(-26I6Z4;4M^3XVU.TKFGXU6K$)V.V+=/%*;K071C.'\>?F:>U>N;P6A#[[PE+%:6 MY@!S.QRD&6*:K2H&)AZ$B6S_POQN8 YZCF6Z*6A&B4%SY6SI2YHK-5>N.5>6 M-BML^>HY,$X*V7%_(QUS8^:'S.DH*W5E[)6-4=JCBP=1[YJBU5SI.;(TG'D:[1: M->^M(.]I.U'S@.8!;9EI'M \H&VA5#L-/_)"V%N+.7=FVV7S.RBO-UUYTBJN M)H<4Y:64*F-Y!6TTS9N:-U\%;Y;6=ER.WGR=1]&:+TM]&OW*]:7F2/) M5ZXGKZ.VZSQHGM0\"?9KBA:TGGQ!OU+SI.;)LO'D*]>3KS511'-ER7-%7KFN MU'RI^;*4?/E*]:7FP-7D0*VA-"=H3E@P)ZR03@!M^^.KXSG]J+_:Y(QFPXWI M=26AX,<,7EHTSD 0YL-Z$D0:+TT0C\YU0$D?#']\:ZWR_C_F1P@$/WQK+9L0 MECS:IZYW=(D[6E_"CH[R:.MTS7>T=?K*>%3OZ+KQZ-GYFN_HV?DKXU&]HVO# MHR+8LP;G"]/$SE\PWO=2M,QT^.JTPP"/+C%YY2U[+I\HZOS@UJ:0-8OO/54^$/ON;8R MIR25"\>"U69K-LS^,8+)QUB3S4Q1,DTV)2";57)@--F4AFS*[.3DY*)>^D'8 M:_;AP9:YVO3RA ^,/X\CJQ73=(I)DXI61E,J(TTJ6@'-H(!.H\ ?L+4GDC2: M6NE,KW0T>6A%\XBBT>2AEK;#':][^E?D#!#=8]]W6;#BI2K/)X)IWJ).^Z\QT!6$PVL7MK/I MV?%:CK4IFV+)M>$Z9U.J5TK6L^DJ3=;E(.O\S.PU)MVU(*J7;5:@J6-EJ.-E M6AV,6WJJJ>U5I^-8+%ZFU2:6$AIWZN+<==:J;UZ+[M60[PL;<9I\Y[; M]Y??]^5T%WVT4T=,#RUX">/-ZX!U6! PNQ7ZUJ_U((X;YH(8M:]!! ]O ]/C MIH7-P_CG8?J79U7SSP).G ]P[)H<-HE6.DNACVS&BXJI3-^0E^TFL=LX>/^^ ML5O;U]2I[9S9&]!(\FG4-?FLJ=TSJT#1FE!KPE66>[/V:),2\/VN)NH7)J22 M=7";E9"TX-2" MK^U'5J18.E]YT5Y:&V$:4K_T/4WMH]0^NBB:X%>2X)7-\CER8+6\[H@I\]7\ MZ0>P#*V>&;">[]JJ0B?FE),SQP.J<4SWXN)X/?A@IB!Z=N%>C@O4/1-WK!C0 M;.9\N&!=TSVE/4V+AQQ*T%PX14A.6J@@7N^ ZIRVR];1@U)F5-2$L,0)PZW5YXS0(+L#:[*]ZP;EH3,!=I33@S$2@K(EF M-J*Y9^X=>W5TDXNU)IV96I6LL^6SW&+'U;*O7K)53FZ=XBNAO\55*VKZFRO* M@4MP[J$*<4"9@+O?J-7W5ION'@M>/(*NUIPSM7W4E%,.REF]?I":5K M%)G(G'TE<_"OPQ>CBF+X;:9LKN,HNT$,-IA!3K+Y=E_:*D M6-]=)L/7=Y-$MO[ ](:KK1L>R3E)H_?25L1JD$;J?-9U':]+VE7D":UX#?1D M,IF(ZJJ2S%+-AT2::))979)9D)09J:Y?XVC<&L3)EE*V/E(LI2FB9!11\BJD M">UYSDPG^&ZZ$3OW!E'(+]@=<^OK?P2@Z"=&__,P_O,W>(\96+TA+4:6WAY9 M+GUJL/13J\>(N*&)>!8B;F@B+B$1[V@BGH6(=S01EY"(1\V)<\]F'<=S0N8Z M=\P^]P"L+A:FB )(3R93 M1)/J#,;%VA-%0Q/%S(IY[8EB1Q/%S$IM-8GBR=K3$[_/>.A8QW[DA<&*YWP\ M,3!:T4$NSB]]HK(JBX7_K>MQ6/(B^GIGU**DVMIU:%SQW4 MNZ;$67S!NR;.Y4E.63CPK77&;!:8[OK1Y]*%)Y4GC"RH)M!G$RBM>-.SL?&Y M)M/"R#1G636QSJOJUU^:+EW;:VFZ$ )=ETQ%H[4,0J_JJ_G]P[ M9;6I+H1B1;%'?J]9VJSNU%6M/D20?* 06F7P@WH%L MI=ZF6Q*5JB61VJ"9V&N46AZ@59KVGUP4W@8F+BJIP\#V(DUZ44+ MM.+W6:S@L].UU$53K836][.=&6KR6AWR6L&S14U>JT->*W0&*$_*;U;3TH MIGEO!O;XQ,5'<5XVV90F^_N:!1T_Z(L!KF; 5OPH^ D:F("M%AK3" U-*NLO M*,8=HK&SSU7=[^QOGLT"\CFO!O@[GOOPS\/,@J2HC$(:CRS:FEN@$X-:FHY6FXY6R^E]A.C6 MI*'&FHY6EX[61GBM25KS!)KK9B>Y "R]-1ZM+1ZLAO$:KSD9RU->#WJ;+QW]Q<5-?I+B1^SU: M!J;W^^7VN_8BZD7O?$GF%Y=,(3Q9D*P)YB4)IGSIV--5]FDR61>'93J+45=R MOFX+4N^_MB@U)93 8%A]"U,3D+8XI[% =%GXZ[,Z])ZOOZ4Q65'HW=?*80+1 M &$FQ<#UU6N,.E)A6Y^KPK:^^*Z8]5KL!* L^,'#0?#C\D]U>GGIWQ$UWMX# M^L/;7L#8[;U_V_,C#E0OOKWR5KS-W!.]KW%)/ES^^32?SBPC<$-3IYXS+?8+ M.R5$-S,[)4ABRR7H518;)5[EL5;\6FQHL;'2L8P]9:+B7[N"H,\N%$&?A+BL M_0O'PAWQNE\"/QJL/_F>711+OCFMS!]9V9>VC/?FL(R)>A9*JSNQ\-V1HR64 M.]6*VIS]%0'2IW?PG]4FSSC)+(O4N%N5B_6+DL[./&)N9Y$S)A+2:<2D W)U M1Y-.^4BG,0_IX&861SJ1YPBZ^=8Z&2."/C-Y%+ CA_N[C?K!![A&/4S]E'T% M/FW"\T4<9.(KY"+017._ ^"[GO >V[D#ZAM?6[SW,NJSP S]'%4WPQJ,PICW MU-1+3YCG]QWOJ=<^O2ZC[\U[L/H]LPI3+.@UO.:)+1O GU-NV*=WSL,'P,./ M HMQ_(J^Z3'3)J;[] [@@W_Q_WT:&#P.D"V'XQZ;1 :M\#XW+AD]\:- MWS>]BOBB8K2 W#L?C;X9=!VO&OJ##P9<'G_1]D,P[++?N:P#3ZU]-) EJJ;K M=+T/QD^P )W.<.OH$Q^87AJ :L?L.^[PPU,@T+7<^9L)B+>._ON_ZONUCY_> MX0.//KT;2/0 P?]5K1IG#G/M#\9-Y++JM=EE1K5Z] D60;WZWK'#'CZJ]H^M MS ]M/X U$ZA^=DWKE]& ]>&^Z]@?#?FC0EO\7D]^3P.9AA%77_XW!=R[#'1K MOS<+0RZ-#$[S0:5;'"Z?VD??+L]O3T\V-UJWS=O3UJ=W[:.U0:UU>OSMYOSV M_+2UN=&\/#%._W/\6_/RRZEQ?/7UZWFK=7YUN5;X_F'R'CA(H>]5-C=.MH^W MC49M;_?PI7%4##.C%,NPM1F%?OS&P.GVXN^DL&OL/2GK5D&6+99&)JN5E<-G M5]+\V=7-5XD6/1;MCP?[X<=AK?&#VJ__X@7_5 M&SOU'W_SORY^_^TKOZA_-N&98%MXOD=VF&,9TOR]89W1X&;H)[&G+<,ST:F! M%WY(OV_KJ%ZK_OZN219+\M2$'==(^KQI M8V8KZY<>EO&_6W+XV>%CQE(8]" M!<\XJ%/A6#2Y?S6#7YL;5QXKBL[+@->(##T=D:%-SXM,]X8-_"#,EZ7?K]G> MKY\AWXOVYI:EE 01_G/+>0@_M'W?9:87!A'+$[)I@)#,#@]V]S].E+;TCU$H M&30O+[\U+XR;T^NKFUOC^MM-ZUOS\M:XO3+ ^KP%"U.0?GW'N+HQZGMO[+?& MU9EQ^]NID5BGB6':/+[%G^N'.[M&#E6]J/Q<4=&#-H(?;&Z$/69T'&Z9KC%D M9F" KF*V,4KPS1&"OZ:0V*D(F.53_'W[/\V'X[_W_J?)"J%X&T];0X1 M4N;E$7X&L''&/9-X'$S8 M\)A!\#.,?EWV/O_YT#DHTB#HF"[/M0A&H9)6P>Y2K8+;F^9EZQS5O[8,RBR- MSE *2[,%VHWNY]_?GGH_8G7G?1UC MMR]NY92!_G3LYMD[-!X,6TW&5H'?40;>S3#P#>O2?&\OQ&RR?":.[GO_\_OE MY<[O?;@U%\B@^93 M&,S^@CL6A)BHJQ9-K*Y*R?D4VB/T\6C.QTPX[1[^8PE&W:CL_YR1_>>>Y0?@ M^HEF@YC ?.Q'7A@,CWU[4N#K_=4O]O7XWY^CGT4XJ57.+$S-"]D@\.]05&6C M7U/ N75TR>Y,VYQ&583V^,Y* HVWMIXOF!+1\8^$$?*>MR:4^>?PW_?'!]_;A9D+$P#8.FK4JHV#W;V#P]J4! #_"98@,)X3 MP()56SEK)C[M(_[-<_G/A>*R>K\&NONS4 M__!_NW,W\%7NS>&D\SS%6:-HUIY MLS%!4;/+N\OA573]G_T%HMG8.FI%3LB,1NW]Q(/*M,P8Q:Z>A]TQ_'D5W/KW M7CYN>^Y#T#GO77TV;=,X\8,?6\R:M/0)&G-J^ :K&!0*1., M[XO=H7GREQVXW?EQFMGXS@=PZ^C,]0-GX6;WLFSMI4NF]WE4<.W#=KC_XPPF M.V#G?W\-CJ_^<]CX\JMHNLZ\?>MH9V=W8F;!2NKP@I,XQ:()&/V.,0B +YP! M"''VP*PH=.XP[ :6#^-C)L]:F8! , (^))M'K+MW%"0Z>NEPV+J-^L%'(,60N6S0\SUF>.0>5PR@23="06N8 3-!0MCPC$GF RJV)EPV6?HP M?A.<[[2^L,]%2)_T^[:.WNSM8R9TKKP9 WE/@GP!^M>]1I0?BTA8O2]?_W7Z MW?SKMR(B$J/O!#/N8+_::.SH0T@=M%^='5H?%%N@;P,G=!B(P(#$(@N8;0RB M@$=XWA7Z<"L%H&0F4>--^RWJ;$QU;5KAA]?$G&MS5@-+_72PHOWL\/O.^V6$ MWV^=T&6Q+[U'2^0D3"=)&.G!ZN$ -,/WC/N> UR5Z(=B?=@VK$XW\"//1JGG M!Q^,H-M^TZCM5AH[[RN-O;VWS_)G\UWDA2_GA$I1J7"']4:;!%>^U=TZJ_W[ M\O.O!^_VL "K>_2=6Y2QB(3V5>!+?F M:JFE\NVJ$97R/J5P%6(UGZ+\;K_QKXOS^^]W102L,R^D#+3?-+V4GU[V1H30 MJ93QD_,7:U]N3>?,,J^L^?,71^/FJ%G&0^9Y,&V!2N*V^=>DT,:Q.7!"TS6P M3):%8L/&MTW'T19!6W-XCMV,YVB@Q>%[[+6%>-8%N7//QMP$L!C;0\/J,3!Q M 8)?AB.V.)4TZW##-.[!2Z[^\OQ[>#LS.6R\#3_P"$.M)C=LUG'H*X]B7F+E M=FM[BF(2=TYLFE).?[9W^4>=__!S^'%D? M%%=5YZ':(BZW#:"V#/F,T].*[[T9>: 94!!3P?%XXO.JU&K^9];_>FS/P0@,4]=4CK+"FQ/ J*?V^ MQR@Y,4ON'XPW];=&#P0Y$KEMF*X;4WJ:!=I,7@ /?8KJ4R)?&86;&\ *^#O5 MJ-KPL]>E:P"#8G@:/K)[!>S[6:!BB_RC<8X:C''MO M\G%VI9LE)F]!4WFV\:;Q=G,#46V#"0L7M'\"(G@#70MW(1CR05@MS D*@M+D MH7%8,VQSR,=56#85278O$ 7&Z&N%9AA-X-J?E]9O_^9?+^\P,6IJKMW1&DSS M]1-\32P-)-YWPA"X@KE ZH'OH2OK#@T&;NW0.$?7PK0H;>/$#$WC3.BY#-%#] M$1Z!';,Z(C?GW\C>D4@5>3'; NR$VC)8(1#]\%$)EA6A9H MBOFO,#!QZ!/Z35A0+=\ON V+!"52+P-#"K<#6Z1C?P M[\.>^GT;T&$$&D43J$$+1YV!:5Z-VL=) -+/]8_JLB@*PZLI,P*/>:%<;ROY51B^Y?VM*9Z\QSV*^4P^Y^,FA]FZAI]J/5PY0R. 8 M.*+K!\-\6Z;MM_9K?_&??X?%E;>*&1;$@Y9\>5Z>?0:ZK:.+?#9?W@'5Z%;M M[!2<@) -JBP.<)$V6!C@S?$M63@*]??%K_WNA..EDHJ,(O&_S%/9B]O&!6]= M>8%M3;*!5@/\QT]G"+G/$7<\QB=$M';/_^-]_W[P]8_WQ30\G=31+P>@*9OY MO3[>/\TW9%>3(@\S%*E0^T*8'0O$\BDSN-WY]_NV'=U?+[;7Y". S4*AY=V1 M0O-KE@[K:TTJ678P?>#>\U/$# 1^U\YW"R@CS3LQS31:\#^^L@ MJ#PT/=L,;&Y@C;!C/YH*O%BGP^AXPJ,: M7/@6;W4PQ.P!!:,."WS7\,$Z21%V8HA&P"M!EGQW:[NILJ"6&;1->'CUZL%E M0Z1BXTU]S_BVW<)Q40>-?:PA>HL"H#?$=Y0S;!;4:V$TKHLG2T\%3NA#\Y7S>O3L? M]O^]4Z3E,#JV8C)84PZO6"\.7&OQ(A0D3Q(E@$.,>>KX)FK2M%A*I %7([NY M>D8BLK M)E9.BV0^<9\A6'P1,=;:BF'X08):$CXQ^Y_@1=X>* MS_/>NVUHG;BRR#VE ]'$(KKRP403A)'0BR+R% V2@HB/[5%16CZE)H ^=(?< M(2K%WBL>ZKUJVT2C#>TZYG%3M!_#Y 'XC1*3XM>GR3K6J*,]*@*>SD((P,B\ M0XZ+89"F9)H595+#;FV[7CNIUH$5M9VWZLC-F%=#)Z:\QUQ7.3/&FTEIT!-/ M!=_.DQ6:;4_90A >#7C\];Y3__I'LW?SE[.,4%P*'I%5FFNJZ/32%4?NM@>< M8G:[(Z.A3!8^H/%24;E&1(KS-!UX"LB#93#D#'4RRA-MBZV,DB],<@,O] MX #),; B'N_B?DT^QYGKF^$/Y_S'P-OQ=B0C[._4?OS]^:?[U\[#;Z>M_:1P M[HP2O "V4>I-/6PKPQQ-?M41S+%?W:EE&<*+^K8?VLP"@-TM0_[!_[E5W=DR M<'85O +^PF'E]*QOK9.MH]W*XI5Z'_^W'S5,47'&!E$DK]*_(DY)DIU;9 MW$ X*G%.ZG&2CD#J+;/J^ >FON&0+?R -XB2K)':JVWC#)X'.FX *CO>%LPP MZOKJ]"(2GD@%DX,W-\;5:,6P'=3Q/OZ)'FZ]]@^C#6XJ_(S&GW_OH;(=WW*T M!VP&MH!*-DP(Y'7E3:P);-UC2(.F:J8&[U@ SX5112W UH M#KD9^7BGUJCO_OC[[O/_]+]9WL' =)_FX\>>F\O8.]4:*+O=*1G[_/(LQ<_B M#5M'!_N5@]I^Y?W![D1^YG0ILD"631/H),N?L780F<%0&A"[-,]N1W-#$<@M MO _#R=7QMZ^GE[>MS8WSR^.KF^NKF^;MZ8GQ^4_CYO3L].;T\OA45TW.F1X(4R&[-U>BPS+]]F*Q&2NH/Z;A/] M+U@V3T:HXK?EH(-RU1 C@HVOC%'4&@ DW='S71M-%A/5F9-:/;1D [5^&'OW MC6LS"(WS\_.XQD%4_FP;+33 'EFT>P=\R'C9DH4Y/09CV0"JUDLY;-'3_UQ?-"^;MUGTI[K0FZUT;]>P)F4^ ,T$[(-\UN=[_T3@X^7W8N.EOB MB<_MOI3W[G$)L\Q=D%\Z'LXL@8NV]QROV(B S9EC#<.0S'J&) Z S$J?=Q: M]?=W32P8)3MOY-K8YG.P;%MD%K@B7F3BE<8Q<[D3<>,W,-G@9X %K-WMV 1Z M$_I=BN/+)"!,/8"-(PU !AV:JX[MF(&#>*0,SN-,N<];92K>Q+D<613BN-P4 M1I<(Y<4H7P4.[!/<F36;X^JL96#T)L @K@(6= M#P*6 S-U[[9Q"R^'%6,J3AB;NJ,;"U_%&W/ZT'/:N-P[]>T&P;K3@#_@]^0X MV0R-?YE!X-N;&Q> !6#"*0Y,\PSH CSI"OA+11D,6_X9./PXXCT*/+X/W MR*-';(UG=@-ST#-VWUCQX;F%2;QJ2H\X: R!5L5K3^,@IWJMS.7A"B]$JTYO MF@1HWAT-Y1,E(&>H2*RU!!PS:T:@Q(CIZ'-IA6%'Q]8Y;XO*%$E:M/ I7:QU MT0B?@\^,=78B6I\Z)$#&3-KB4W9'#O>:AB6*WMVA(80C2DJ5+'(:>#PT_MOL M#SX:?_H1/.?BXIKHKC.$ M%!4)=S1V)#_!'PUQCI#NZP&.=_9@M;XG,]HFM!PQ1,>1S0UL.4*MJD@NP:/2 M887TU8G@S3M?F3SL(B!@D]^3M)?X=XPCB&Q2W #,0AU;ZBRCQWBG8QT9U' U MN,I"-:OU7\);))]D( M:.$(*9.6DYBUBX"29 G-7\PC4G>\V*ZI@,4X&+@BA =P"EPPV1VDK"=.D= ( M0^_ 5"DA>0# [LH0T1:+ST?'I&*GK([D2_7M, >0+GA#B>L+^_Y$9ZR,TR' M,FT9!/T9>2-1T%&1)EH>8?JQS;(!R/$@KFR/E+^:F:$KWA!6(X:0;D>;4;XL M+1E&PX[$.#+^L-XL-%>8:^>C<44^(_^ KY)R_*/Q'9,OUJ\A2GHIU")\-&Z' M \#UPK]G ;WNHX$-9\5B7?JX!$XF;*7NI#!N>2-JKX[85S>R=MO\?'&ZN7%U M9AQ?7=[B<>]K"ZV5L-='3DENWH "L&-#EE.KFWN[!&5T%CDN_>.CZA0.3XQ- MSWUIAA6KM>UZ [CQHZ%F1\I]5U_+-[T?'052&(Q/3<28U!]]PMK%#-D^0NDG M&&="/?:46SK%S(G)"YU9+AQ9:1J] .Z_V7^J-7J6T?B=/?3._,HAC5^_*(W M=[H-G0F*O/;U-'=LZZC^W(WX8Q;>6@!NI5_A)\98+Y_>,\3>V#HZ!^=+1A2V M!-$NX*0#AC<-_&6!WX WP1 M*_6V+(J1]M,[M%/"'0( +UC7=#&5SV+4L[C4&U4H_QRD=V>WA+L# 'X%Z\!H MF1T6#HV3)(!R74 M P"@J&VDTL:;\;1X421FG/X5.>&P E>X= *?ROPWOF*3GD"D6(D15,9U%%@] M4Q9)BGM3:0<+5#$E8KC,0M=K:4K8+Q\E((#_]X9Q%H#;\_\6MT,[SW9-BV30 M>CV]+0U_";00 $V9L)8U\<#M;<5Z,&0QIH%"9]VU1K)B)!AZ6 M< L!P&/*NJ*\*MPXX#VS&S"YE90'U!2=_$S*_?341Y5;G9! PK8+W.N#4O%H M)HYX6$99NX=SXJD9I&!,BE;9BPV$/'^3%L60F:CB80G#\PCA%24_GB?Y@PO< MJ5*%%>N9L.+A<0FW!R!,Q!SZDR9E8Z)WR> FXU_@ G+;D3WNJ*CE.J#D3=A0 M/I#-[\J\H3HBLVH1F9$89#V)0;Z*(.1.B6(BFN1?0&MD@I#U6@FUQB%JC;@K MVE@]H;#,CE5C$>,+]AQ%JWJ1AG2)N":S6(U,)+%>PN0CA##9P^-4!]HR;U>1 M+-?(A!7K)4R@0 AE0'YH7%'/P9XSP.#@,=;R@+/[.>E)*'XG)DQBD3*H./$X MH,Q[O2C6S*8%EC K R%4&TQ[A]8V;#S/[.8MC@@13?EDDTHEG<%(M]D *T-+ M+GP+Y>9L9F$)TSD0PNNXI#:)1QEG3+8^:+'@#E3I*^%*;6:^B&?5V%6>U??7 MX%CMEBC+5E/\"^B%3'2[7L+T#H0P[CF0/8Q(6BNVL,<$]D=8G&XH$Z=D%R@3 M\*Z7,"\#(1QIGM2*^GTS&"YPNUZZL$-+LY?EB@-P#N%',YSC'&STV;/N0P[ M"U;C.R/;$,^Z3%DD 7]^.94CY&*?,3FAFJG)_KT MJ>_5+?=L])N(JR]0N\LO_2A0WU+[9>HSE]_ZCVY#XR#=V:],_8A6M[7"LFF9 M;6[TS#N&3)H8E[:U2,_A$=S%S,'"!X$%Z8B?PD+G8NA#Y:2!JM8:&:][S;:/E MNSBS1@R>]>Z8YV \23))#&G%X")J8#9 P#F@>&?Q-C[_]:O!AO^V[\-(V7$GC M8>)6YJ*S('8^0AS%4%T_YO6*R!0:&OBOF\X=@ZXH)5:"/D7LK&F>J3Z#"4OA[6R^.^8'KXC>>NZ.:&H(61M7Q5 MG/]4!Z%=W2QHM%F0[A94-B)^;BO[V>BFR,Y V&9[<^/F]$OSYN3\\HMQ=G7S M!_Q9O;BZ^AT_MVZ;MZ=?"^P8E+,]Y>S@ORX$*SH.2E4L6_R!I3DRT11UJ9A5 M*D>OR6:?H!$Q'2SI.(Q*4+4>1+W53QU%4A)\)T)_5;8")"TONPGVF>G1:'L< M69)NZ-DX:,8-/9.FJ+*99_UP9R?="K4B#U+2]]=/<^X?::IJC/94SF\&=M7U_5^87Y=:566<=",3*[F8*,*2 MBP-6&*5->A:U841#\ X['8!!P:4]$'F6."$,J5J/C?]"W(C@6.1OF<: M !*+1?=QS(M1%@5YHW#0#_Y' HE5@MAT7U(\ $EWQONHY#,KKG8^: MQ2'K _N.TR@R"UP2CH]-6O&&O<"/NNCFVY%,3Z<;_+Z/GT#S@6;R[U&U\)/Z19G_-_NO/_FE'04 :4&J;Z!L.OYHT9D%,(%0C'X"?N\RG22>. M)2=S)S"[,; M]#4>$40>A9!QC!J.N#'PS!KGFL'_\'X+Z\A",1W-'LKP4S_73!H!F<FX\K8&0H"E:G!I4O>#9CM:)=<\[;F[57A;?Q=ZO-NX-^'/8R04P,V M'KO<_%Z-/>I@B:^08L&+1JT:"B# M:$#+?N!CN0FH<&G<>UT?I8(P^%'%>_"XXZOOYR?5^B$E4JKVMA$'SQV[P>"$ M;3]0UGWLS6/I"7Q-_KX#(D'SO>9[S?=EX'MA#C [":7[GH!6IELSH\V DE#1 M.YX- 3#3((M,FLN+X&>_SN#YNT\RLF;D4S$R5\DZ?JMID=)Z*Q)G%G$$H0_"6 MW_7$ "#X66;'2>^>6N@/S*'6T9JM-5N7AJWS=;0H;\7?4FT\DM8-G%D!TURL MN5AS<9FY.&MI6X$/^MGS^XZ%*6^B*$7SL.9AS<.EX.$NAK,PJB695&IB4+HJ MCR7%ME0I:B)51:X9J. 9M4]0E65^D*XWP\Y9HKDZ-^Z!8?#?3%B>>F.9!@?T MG X0*_;#R$#"7?_>]N\]*F[O=D2N#;XEEBKH"]"(4"U4M%#10J4,0F7@NPY1 MB1%Y >-A(E3Z>-*.+?O,I/:\(V>F43=_(4T2(>,.1>>WH$\!?:_C.A8VI#.^ M_0I,D$\BA,>Y;SDTTP&$3_)V$#*#%/ MO]_W;4IE8M6+EJY3 #6=?Z*'!LS4$&!"# M M'<<[5E&U8'X@DL/@-V!@L/Q< MEZ'QI[E8<['FXC)PL>B5#-ZIX=B$& L](QPN7@?5S>B:+4R":9&2"PL=)TJ+G MOCS_P;,IZM^/(P'3/9SB?LD8Q$V:-SD:B;Z-JR:SZ-<-* @.*"#&&ARMR7D''O/,#8MBNZ[=!-/F!/&%/'>"GCNO3 MX,<_JP/UV/2)S\^W2RVX]!R!J9"[Q5%8CTX2$,W&AB(W.C4_)!DGAJ,%>-3& M<13$)X87]=M [)A=C>,S*MG9&>H(-NH/1LEN64B!."%L M",OUB\EN"Z!24:\:IO57!.PB$L=&SE;Q48G:1@@'4=L%,N\QTPU[>&8C3GQS MZSP_RJD?F7DAZ,B[CH(OKRT$Y;WAN3 +++@5! ?>*YD45)T[Q"67K9Y0M 0F MF @@/4"FZ.$<*X@<,!6Q%!/5PZ[#R4%,A@C*R2NIF@,Q9\9FP"3H.(K*0W@+ MC:O#?QU/5C+@,Y1_B;$6>RA9R+*=VP;;HOG M[8@!]14C-?:Y:52-&X#+.!/@QE,V11)6W\)T3\\-3QG M6X$X^T%? O MR H39PW*N43C>T'#?"P_'85SC4 MV']]&+&<(1 *BQY@!Q$ZK$NA?F%V"(#(C8Y:%*9 MV&VJ"@=3!]-CI< 0"6@X$ CV '85Q\ZP..J-WJT> M)'I/ AQIZ2/D;=KV$Y-AL_;>2+H=_"A7(J4ZMCLGT_GB,7\IVUG(?:$* MQ=_36-"O2N8_E5"TKQ.*1A.*[G0^4&'(C1-7P?-IQ<,<^Y];YH]:K;ZE M1M!>-V]N-S?."QI*JS=RRLY8^QP8%[S15W#RP7D>9VX)NV$8A8%]RM#EHX F9(IUA8VO&+I#NHMY$GO/OR._#AVQ/GA G%PKLMU5 MR W7P"773T9\8J HYB7ZB86PC 0CA7(R@%)3\(!>!\B'(67]W[$QA/'QX/P M&>*CDZ.;CA.B@,9M"7L@K8$^7I>'L"[(T8QG"Z.L1).PMSSV30+:@%>@XQ1-HVD4VN,"3IFEW>NZ[C ("KEBX BAKS#WI&,>G%ZWS;ZU/L M(_ >[2/P1TGT; MWLXQA:):WZV!+'>%)'_3'JJ#8NI@%DNC.(:"%92;(L&(/Y\/*!FS.C!>FC!LXK(B>'R3PB% M"49$T3(!"'L*H6 L6"9L;LPD%(Q%R020-C,(!6-A,F%S8Q:A8&B9L/+(966" MR3D#ZWX2X57(=/6R\@*(Q>IA/2MS,>K.>):Z;$FM,9725[X-1(36>Y;2T+C% M1R/+.#PSFQI](.G!W/N8^,=E2Q$@:M,>PJI6!3PIH46Y''*F!W@AL/0]5NWZ M8%S=VXR.;/N)L2XA/HO7$N7;B* M<>>$0$= 60.&1RPR\85559:+9O$51.X*B*@9=>'!,MQ7,1JU1J.2/L6B?;YF M ^X<^Z!#K6WCC4H@P2_E,=I;;'T12LK$OE[8J0*8S3"[H 7D:65"CV8Z?^4Z M E5H8E):4UV2^CD%3_)2P?7'@MF,6[!]1.*9,0Y[WH_J0:3YC7'L\K 2#L>CF&%Z M&NIAH7?CO8NUN\-YA*EK9-Q7=O?W*_O[^P;O@6RAH 42"/S51#.%,JU%V=B4!C$4XX$F#+42DB]_) MR)J(T\2/(I$I5S0>\):AG( V@'P?>I8 )DT]*7!$HHZP6<6;VY@=J.S4T+ZR,I*1*]L(24K47]4UO!%CLTR62&GB< MX3F^1B.O[(/[BU4;1FC^8IY(W (G0%9FBB_C9("\4 BD1NJ!A(),!Q/?8X3XE/C1U7/,Y4:E=ZK&+<*91RCCT+O-).8:<=W M73J"^K"F?)=!*EJJ5L4CMA(FB+UF8.NW_H:]NNLF9 M9-H\5('3C(49!Q#B-$4A\$5 =ZPT9GLV<)HD:D!^22]D?*1:.A,?,_IA(<,( MW^Z" X$%:9GJ"8:0BQ:1E=D@$5$I\;9.%-#CI'A4AZL&]I;W[&WC/ _0=!.W M5,W=;%#D5./%"EPD 'O4G+(SK&32BT=*FVB+TYZUCU&[60!!+:*B:>JT&Q[N MFI%G]81RQY5JDV["^D1I;0BM2>6,5!?"<6(6&R\13,H#EVMOEM*^? 8RF$69 M*)^TLAE51L]3/E.IXDH4Z"@NB?+0?50'S<(5$O$[6ZEKZH7.9I3& MHJU;NDZ M*0*/-8*P#I)W#D0P4_0[O<<#$[&+(A-*AB.RY?8S[,U A4K3MDQ%5/^!>4+% M]Q2E(\TM:@U35X(J!Q?2COMT")\*CUK!N9L-&+/OBQ,5F>*5K12A*D61ER;R MN.#[F*909]*)$H'+1H"=#8P8LYRB_.?JW#G<,9)\Y:P/ :J[$F4S'_!5+49F MXZLL&FF"I>I8XP4C]==2+U)>:[(DMEUQ(88GK41MV:V 94?1YUGTDN7Z(LCJ M=RHJQ!B[Z@8J7]^K#@(PKSS9C(&9TQ=.FX;NP8 MBY0&.ET*HH$,TPK' D3I )-:U9D<.AC"BTW@L,43U)G8C X9G97%)U'H^/ ! M9MM-%J_D#6(.BBOZJ(G =!!##)XOB(19/4/4#8@I=3"[$X=TPJL+,SJ%?I(B M7BH"\)>5KVY/=!MG@R:5MP$5'*WB4+>]XR C#P2WR,-N&;E'',0JM@*Y?U0 M?R3,&(<-IY. YS+7C+HXPQBX_7(Y)@1_4D%V 9O(FJH8=[X+_C\F4]Z+H_09 MX<#,:N#F)+BECF+C>+L*^6,C(WD2HXT';3QHXV&UC(?4H5JB?D>.[-+=#ATO M)!7"TD=S(KPK4Q)EC'M>K8"%-^90A+'?86.W$9?G$7E(ZH$LB02K&15"8H&@ MCDDT$@$EHMUT]*@LB<2)$]".*R?,))[12>51IX,3N< TRYR!4Z ]92^E :A, MF3TSH[NLI'VR"UK8:V&OA7TIA'W+[\\H6911GY_])^WQ. $0#X2P@UA M3?8 M*1:[,L@(6D6)'LK_5H=Q,XI;T7 !9:R:IIKJACL2%TMWSIW@QLGR*Y):LT&2 M>%UF"B(4X-D6O5KJ::FGI=Z+2KT_9I1Y(U*,+#D2-9@TX-REJVD"\]Y0W7/' MY ]Z]P-QB$]/F".'HR*/YT78!QN7=S'U7![\@Y?-S0Z6?0?LK\@)9&,9; W, MA=4KVIM'8<\/I)VNI/&L:H 2+RS,$.'"]@_IX;P21[Q&NX;+4DJ,!5 I$O4K M%OD*@JLR1RFSZP$58:/0WG3G5W2&:8;]1TOZF-\'RS$ MW_Q[?&,%7?4DZ)!UUT$D@P3&X0UD*8OZ'[I8=*R/89O1KX=-65(8\X=H @8!@ZWY[()T6Q7B@2-56$&D]\O\X]# M\T&$JD4=H?ALQ&,\XH\!N\-L'FH5.<"]M+D2U3;\6L+/0C0JY. NY?*)Y?[D"[N%(M%W74R>=FHZSP6IE/)U6;/7DD6)WF+ M+1][D8J1QUG>':!/.STB268\Q\>I6I-I3:8UV=I,A4YL,2S1 D+(F-TH M_9Q M!?N8<&ZF"!'<,^JM8$+"DS;"- M(!7]-BRHM%?A.F$44^:H-?/9)@#BNYA)B<_ >824*-$VO5]XFF<-*YG:>K$, M$9?Q*C3\4FK"]:F+"IJ&B:B>$9PD03\W$6-25$?+8BV+M2Q^45GH<+) M38P\H5^DMX0=^H01<;* M 4ZWU(S;_YF4"3X4F?2A%-2SUEN93C_.CG/AY:YJJ"@./S,R6?CQ&4F<2,AD M7%TPLY("_$$0TRSR&?+K95CB9Q0,529(P :1"""])CF])CVSFM@!35H[(QUK M)OM;Z5Q8,4DWF>YKMOT[9%Q7FE,4B^JW@63I?(;,'S&GO$)L2(QOQBD&FQO9 M4Z#Q0Z"$W.(#(0!#V1.2J_*,"*,I6D^(P<>CR&9 QH:E$V 6;,D>3(L%;8S^ MJHX6<2^!>.*Q&'P):R(&'E?4B.$T?Z<&$Z>B^Z)UNM 4WJ@W&HBAW'#>Q:(%C1R8VT5[J)VPS0;@]V9MHD" MMSD('%>L2&,?.XS7]D1CS]%.M:;GB?GKE(4%=YX!JXW.HN,X%@Z?//#ON#RUTC[H+C^O)@I1I6NCM MXD +3-3JB4:-)TJ]*C3S=F>:];D*3:D+3>"U-:%:&@M<% M.1R!BF5[U]+MU);':B*'E@=G[!<-WR27"CPO-8,+D[O%U#'A8O5-#)R#=.C' M&9 T;S#BJNAR$/A@FK 0ARV@/];WNPQ4K_%&3B2JXGPBN/BM\14NNG8CGII[ MA%W6\),<"RI<*C&TJ.-S5.DR+:7KBW%@HNFZ([H1!$.;@D9@4HA&-PB9F)4& MEH(G!O.0T>!S3M,X5!]N?"1801B](0>7&KT'8D8I^M@AP^2@2&0+D3>9&0R) M"I[[MLFWN<43DJ] J-H&+0"X8W/ZCE@%'0"X"H?)[B M)0!;/0RB@>H:C[@:KG]/#8E]VXGZC[PYPC,!/!ZNPK)6AWX$=W4Q/9*I%A+I M@;"J,2,.V@#KDYG&F],OQU_>@I^+;08P!17 M^"5\ ?8+WWZZ[.:920>J 8; M'>>!):>J 1K\GC%86FF.X:MA@P#E"G78[YI!%10UK(\=7QG(^6T.3_:C!;![ MMIDS/DMX\1BFY$2;DP9[XE)6)7W*!7%$D+_CIP?/BH-Q@HS.V'\)VU!5$#![ MVS@UX8WU!KP.>08-OMS)Q)&O*9:8<587? ZES/5-J%9$;)R E*4>DZF02)^>R MXP0\3(KA;=5$1!2_#\ 2IMQH\B;7="G7FDZ:%J8.4;O@]+PP-2G44#,Q[VFH MN&F*D9?5'MD6 M@+9OC[2=#<>G?6(:IT6>,[G=Q $2CLEC/\%Z'=4@:-+BY"AQNL\>L)",#!W* M\NW3U%7 &5;G5%LY+;&+RZ(2K MP 'FH4)KD-S?G;;(OW>P^9G($HAGZ-+\WKPIL_&LF(Z+@TYF3=F(.]Z!ZFF# M,%&SRCS?JR9?O::3?IV1I25.>27.;.R-<[#!2MY]W_A82;MJY)?5W]/00(,Z M#:2LZ6Z IVH3S(MMX[F T$MQQ@*VF1&QO=3<;S*R*X5)9M?G40>()O8_DB]H5&JU6I_\FXNJY81!Y-)4=P1L M1_VB0DR59-@[$U72L1*9<8>$.OM@-)$VC'^98D@Q4*B-.X.EU]P!#Z>"9Z4L M\'SC&KO258QC(!&@E L'AZ]\=B/6IL_7 !90-D(RXZ*T@$'NQ4-.P+'TO4X0 M.2$P+,(0X$I\""C@EHMTW,P 4#W.- 224ND=9!(K6SR1RMD M=XXII)-*U2%[!7#!F29;8)-ACO.9 M,2/'>9BUSHM2ENC\7KG0=.QI8%;0+YIX4L48C_18,1W;BOK@W^*L&"K5H[9F M@\1?EN5Q\(P9%R430X:W#F /3'+G+=_RO0A>?H_)U7WF^IC-C"XVI:.$J)RT_'0VG6KZG5Q@M)KTD]K)2:!)2'2.[1_ M4.MA_1G>VN:"M@9F"&PE.@J($3J4KX"5"UT<[\=[S.W(4CCA*&)G2 *%^V[F M6$F ABR!,WGD4 B&]:DBY0<#H@Y680B> G$2.%PD%U)KA;X/.MHS7-__AS=2DP-\L$B"P^(-,<+!EW%70RU9-;-D@I6IML&K?OEZ53%^^;PGYQG? ML:XIFK Y'4>>97%?B)6N&U'R);Q(9T*L(')GP B;&V>^;QM? C\:&%?#GQ4J M&!=5VYDZ%TQ)"N2XDGO*D#ES/)QK9;S!.'*C]A$?9^#3Z'/]XUL*9YB6[)X$ M/'!EA7X;3T:H-(H"/:F.V%ADE5R>;N3**Z(='3RB;6(5:3HI5B;)LJ #K^8R M74Y2:CR*0+Q?0EQ!6\%6T\(N_>#>%.$=SF(Q GPEIK7$]R<+<-9LW5;@8>&9 M&?3I&<>@?K\[8HJ9@"@Y"/;O/5$F%*_/JV*6ITJ"#G5)4*HD:$>7!)6,?I=I M%8YB7'15LDPUW=QHB8S,@LJ"RHCN6BONFRY.AFYR.8..)+A@/^$(SNPC# MQVM<*&U"OI?*=CJP!9-?BVN,I4+Q*[!,R QP=)NG@K21*%$2"PWV/?@%VP9. M59IXY)0M\I'&E\/D^VR<6.N)B4AR5]N@ &50Q0GB=C@!B^N0\4<'K)4!@__@ MO%!U)W:WB*@S)+8%&>_7-A)=QJ\D*MO&'TS0&O8C0L"<$%$&W/%='^3)A=E&9PT' M7DB&_N8YV U(S-O9W+CZY9H]V$CB9KE%V!9"7JV@P76480C[D86;)"<[?I!^ M7&H^AB=D[>8&:B[1S=M'=XX] #(4GO%Q3"66\_E8K0H.*#6$YZ%O_<*^#OB+ M(T(S'NX0=?UQ7,>,-0YSJ).YQ"B\]_-IA0L'#>LWU:*G05Y3]EQKV4/M3BPXC&S$?&]AOQ(='*.+JX@.PW0AQ.'#:\QY/)RUTSHI=L!R8[JT"5@LGD_#A)OL_ >*X=5BF,E*2:OY"2/"DD@;#AU M5(!EB&V_BL6Q@>^Z6*5F^U';9=4V <"/O YKZ*VE[L@*F.5,$ZUHIXH6%3S M0/DN- ]40JA%C?\!EGL ;UA%]L;2;)H;@?"2',4@C-_'CF \":LZ-)?,,#C$!.NC4O6,C .;*88$B?J]4V)!U"X36W3,/+0-EV3!AB)B/&V<1-?(X=$ MD&VFWB#6@U.3'9%/(/0C46N\3E2/R#R<_"!NQ\6W':J(P QBC'<+[ W^IWIPL]@:J>!I%*\!*0DN4 D+GA,0F$#&+\$K:8V//$":+TQE$?7 M3=PH>0_'\10VWB14K9AK(=_D"+KR!P,?V_GD (Q\M[DA%A>)KN?+,D4'MT50 MDB1]Y1*)0762KK>E5X15D.+5]_ [KXB60"B0;,0&F^TPV(!*-@*EE7M+)#OYGNF ,:/6UBLA]52(.9#;*F3=T>JUFGHCD=:#( M8%A18UID'R]J#DMEJ1@&#'O(7YA.CY(K"D4NN;R9!6^ENTD'6]BW[,&QA?%, M[\.9!8XP(3,HJ+N M8JEB!A0CQ+24!!#*0P(ZZ?!M,5(4SP^$.2TUK@I3D'.O0.1"FTH1)/;7$A4- MI" 3,31./]0B!!NX8$4V,V6)B"O&E@H;F?=54D#2K\()TM.9B:HP$P&DI8-$ M!-+TG,0D+AI *4%3!*P :C/1)9V6;A1L>;L SA9O-M/43NW.'X9=H*IH@(2_ M#:];*.]EW#/J>*>&^2>U,[#!XF#8%TZHA:LFZ%# 1>NL2&76%[% M!&-++2KO1-4NWXA4B*"+5@-(0^*MLL,=Z3$R!7!LE(@,"D),Q,(;3(&.V\T0 M%+VA+21&@-4S;Q$A@;^B;[1!X$-G$=Z%L9IEY1\# %-J-VXG@[N#0"WIV\LBT15\1RC>W7\BM @_O[> @ M)6ER/Z:O/*0Q&M_[Q\CV,"KO3QDA>ZY64 M,^RGGZJR#Y29D^-HI;9 "\L51(Z$)6CCP%;%.F*"13Q,&=EMC%A M [X!9G-0Z&*VG1>17_)VV_B#>@R.A;,3% 42Z-X+'-/ 521',C%H4YB&-"Z- MV=(.$L>':-W%'G3A:)5#5/>S";&SL'L5&\#4SX])D(.2@JYR;V4S[(LZJZ:@IH9]R5Q]R2 M 29X@,H56;7B,8V)C\%J$4Q.48W_J;1&HNV:;8:.FS*Y58;1MO$9CTFD1Q6[ M7VH8 _AMN+!<=EN5/3U,%O@@GX3F$RTTJ$$+P%$!TG)=_UZ9^,T^$!Q&28YQ M.X1VE$=S7_&(#8,_W0C II9PM'#R261'#' JN!]QU-"87HRG:9B>+_1S3A13 M)&W-Z,&HU9[0^3#5R] 0&AWG ]GF()Y13G/'Y3$D5@F-J/^*;)I83<6"1[HE MVE% [Z"<:U ^\#?8'Z,^)RR'Z_3%P64'[4@:SI4^_)H+<1<[O.3XH]C2I6]* M&+MBOD/.9;*JGZY$-PUM\@E.<=KKHS!6XR. >KBS?0!>8Y>J0 (:ZXC4I]I% M[M62WZAU)#:E3MY946.!R?I+>;] *!CE'?&!9W'5L\C*#IAV,M-=A&P?VUER MV=4,%:$BC<9 KH"G,)/4"'9FUT6'K,#"I$Z&PO;DQM4I5\;Y$MN,O*547 MFL(5C<_5XR[0:6L!0^FJ WYL06QN8/Y )NZ8T:_TH(K*@8I#A),S["HHP^F( M'158O284J!!+,20Y^A8'W20*UWAI?8N!5[6?2M]>^H8X#I';1:.-A&IR DIV M68Q.%MD4!;4CSE7AQA,:/*6+DSCCH\IX7H1GT,6P18\K8]6)+3[_BE$4@P43 M#;R[GZM^*\#BL^A><; L!,>+ZM[-#87;3LJPR#6SY"R&5/Q'OBN>Z>4Z X?" M=#A*B\>K)L2@U0,9C9TZ?#<>54K [<$%FQOUG7\(H6K:QL7)1>;R>H."V>__ ML9TDL8F-Z9G8W30U;[+M8D6A ,0%T]U]76&B=4%.G.XY#^MJ$.Q,, BRFG_< ME\;\G*5K?F-4\2O_:=F:WQA1_&K4:XD\[9?2_%EO?'/C)31_*Z.(I"[!C$8E M[*6K&FMGF1V%(5!ZFO)CU1D-W?']"E!N'S40V_:1/,9HRZQ$62@4J\LL_3]R M!$LQW@2?S#ER]B%I3WSDMFT0,Z!M[DV1&2F& &,RCBIV%!5I@2A+Z#$@8AS M'##/="MX_I39%\*\WX^\I%R+2M3CY!^2>YCL1FN'F6I"V]W[P2]XZ!WL*R-U MF!W#K#7@*B)'(_2HA&FR#OSJP,.33/]S#Z (HU".Z@&Y2KG+K.][(K5*$#/# M,A?3DMUYS X+XY(=T?TM#LB@="('E%2ALE9!E(I\,CF%-H8%"K9!$LAV:51%88,4. M@BSC(JR_*)I8<3[221X-'!:7E@,N&*H1>*@_JP$D2EUE*? M%&J,$FP;WT+'=?X6D_ 4%$K$14D>,OGRLO&DZUOJ-$-(U:ZTL&5FKYS=K*9' M4O$,=O#] Y8E C&-Z>)]C%WDU#VK4=E)GR8UKUI:QQ)*L)0L$2D'4XKUVX"G MR*Q)&E%A.11-SB9$3(/ZFPUE8J\X$$3YCJVC7*?#GK PY5-1"PR8);LQ<:.^ M)QQS0 C4U.N2WT]F9-1U1D8J(V-/9V3,2L )L"\/2W',U(K[@K@NG3S&)>"! M>9_(.U$J$#>"$+G-Y!*18"49& @:)P+7%*&+4!? '7I82]P[V ML:.@=1+EI"Q%(>FDM-\VOJ#>0Z K.";1;^. UC$)KJ#.@$+%)#:.T@#_3RA+ M1YG9'/M5I)X@>QAPTHY8;.LZU#XTODM([I%N&9,;C7B6&]EL?&JOT:6AO<:; M>"9LX/OAVTHR_&-S(QG>6TDF]V)K5=3&#!X1F=A4-#WO-QX!W'4C*PI\SP>I M%OIX=6J*KVJ.*9N:BB%5JC^G+TJ(.:E,7(S-#0\]C)\X3%D8EA2#,ZG(E!JO M>$.U_:EE.D/-SX)0!./CY:+41FPO __#8PETBU)WG7ND'RE-1+U.S?%UL.3( MIQ&_+ BB 7DVHE+(BWTH@9-0P!*5Y/E$.B(/E+89(T-4&@Q78X8_\)JLW4S? M(J<58YHIQ]R_ MQ>(V.=\\(N)6B&5UZ93EV,1V/#NBX#AV$,)*OX Z $CI UY^$%(3)3HJ0LLV MU1DQ3D>^^GY^4JT?8G==&V>5$RT3%;=1MJCYTYQ96%ELVEBR$C+%0U3-CQ=C MI"P#0NI :21P!5X'XDVE8#&0FL17$#GLS9/IX)32P:3* TH)SS351*I1E&ZF M*0H].:%?&<>##$RGUV2QBLBEFL!R4,6N&;A"1F&0$#N=BK08<:ZDK*DD)"#L MNE2WL52 P4GDXR7F(UC2$]<==E83N4_MHQ/5$!=,GH)BB67$=+VWT3DZD8[0 MIW>.WL(51.[<$PT@,F:G.$)V.;LGYPHD+TA=<,WD87OET5:8U*;>I.Y-*-W1 MX0*OS053LDL6 ;F\P]B7I8;;=+(*WASE(MPQ3[2TXB%VQ:H8=A!UXP]QGRG1 MS8V^H^:B> X-\.&!?2C<3->)\V^^;=L)?J'Z0(2(77U6]-56VN2 #OGF@VX ML[VYD39;C28&8E&I:>MG-9&[ NNG&77AP0+->L5HU!H-"H;1&5KZXY]&7Y'%FBT[RY@IL +@^@B<*.*G6+A0MBZ29I#&"#@. M@_<2O '>L%')C&PY <>9K=9CC^'X8B5CLR58RU#V@6"WNU D#F408[Q77H4K M;+./'K^O[WVO%*SRI5=^_N/'[R=>[GV0IWCO\0?OZQ>4S4=K0<4:4Q&_]@GW M]*?RW[!?7KVOJ$N 3;AEE=COO<=/WC?4@VW'V:V\!:"3ZV9/*(J\KMQ.*.(# MCP*:C:4]MUF )LTM>AR608PCTIS%3+&?K$$Z?L-7O>T>SCXGTXGNIKZH.R/[ MBKP"0%#3UX9;"LQMP>60P'3KEW"; .BOK%J]0;]3?'MVSR+'BMA;GE[,9P?G M! ?'#@U?++0> P4Y72N%F6'"LEKN@#607;H:"&X=+KIZ3Q)*N=![Y?MYIG>> MFV\4@F'5DUY66<=U620NFICQO<=BQ,7?*^7FK[B?<\";U?OL^^JYH<>(6Q2ZN4B>Z:B&SI-#H1 9;;YA*0_EESDK,]LZ8FCR.X, U5L,XV]UU;(5DIU+ M!2&.Z>_G@^($H=%(%\LKK8-"55YG"_*MF6UOY%/,$JW$_CQ3DSO[29:0MA_E MAC!Y:VY9#B*G??IB%F=%KW]@@'B&Q6 I!BO8]AKC/] W]]M@KT_.L-<,]OK) MNP)[/9D%_% .C3^48EI-$0]NP3FA>)J#>U79*9/NABF ,(BXJ_2UW'_4GXO* M?%8VFSQRZ/+P'$-ZH7:0ZZ$<\E ".0H&JXRW86BFK@> *O"YK,>JF,P0B)V* M7R,DCV:YD(QK;FL3,#[[>";^ZBL+A^IV4>%;T["T2DZ7V*$BD!QEZ+FQ]Z QYK;S$B=]F-4AZOH[) M5WO1M%OWLS@SV>"HG,41ZW/.#1J+WOP_%75?(&<>RQ#0-+\-"E?O#2!'J#CG M9[AY/=Y'9A?'B.IV&F]\%)R*TVZMNUJZ"%W4B(C9!-=!-!S^L2'G=5*^8'1V MW+F^!H@9ZQMY?,U$#]^YSD!>&CA8'+X$V"IM10%--:&DT6'6[#N7%^;5LWDY M2S/9*E5KF@;WVIZ*:@_)U\!%4NSDZ[]" M$ .TS/_[DZO/ 3*IV%Y@$8S)TF((2!QW@XRW_3N;AQ3?6(*BF-TT5;\-CU0+ M,WN">98$UPA<#I&RRF:8"-V46.ABGE=5-[1, -X#?3698!F(OILM>#D.7Q&F MA6]?036<=UV%O@(Z6)45^Q9?T>!B2U'7^,C(8%\YX8:M,^^GP!(AM9&JAT"! MJ$#N'A]=AO(FX>YMZR&/!;ILRS,M8M?IBIG,6;E^U92E6@JEB7S^SL?="0[N M9S%'VF];RW<.3#63 EFG#[H=%.S3L]U8FS,TL='==?NP51]IM@)A5;/3_B+W MZ_%U[&4X7!4:F9&.T\2SUK#.+M,I#D["MV=63$<=I48F0CL;1,5!O@.H:LZ_D MY-K&J.[#QW)F*3A%_ON8/HW\XX-_>Z O8'IUZ7O V;M##:6^_O???? [_BR? M6_K/]YX RV(NY7T7NTZ>P?_U!30N]AMA?IO8A?;_Q3+C9^)^5-_N5M>?)']WKL5][AA)[]'UK]/V_*??CO.FZ>-=U^V?A M7SF_;SJI$S/Y^).K3U_UL=&B_2][C"=OQ6,\N?K\C9_B!.SHX;-KD\1_]31^ M=O796_ R'\L\O V/\?$]'N-4S-,1EPAGGQZZ,N_"N#][#U:X07?L/G/=@PY^D\3^?; M-IW1K/V>:<"W(-WY,$D=7Y/[]F[!O+0ZS(._+NT]<85N,@=^>7&0!&>#IF>_ M'Y^SW^?L]VGD2L_9[X>9%/[TD[<_*?S1IU>?O&M)X5/)7/QWY< >/WXKDF!/ M[I-8/0$K,+'SQ54N?_TO?YU7'[T%;_/Q!X>IJ7,N\2W.+7WX^;N94_ODTW-. M[9Q3.R>!3G\ZSTF@_S:*WA=*!H5S]:K8[4)141K! M>4'*6MN?V)JA#85^VPZD2WO3M;I1/8/(KTE^5VBWR@0<2&5E,C+HZ9+_7C?D M!BNZDI] UPCU=W?0'<&I.V>^D;P8F0#B-@UWIJTTY=]Z4]NJBH43B5VWQ6Y3 M+E65;)OIEPQ8)-NP;@.%TPYHPRBNOBU^+;?63U"VF+5R8;)@M:O_.OF&#>!& M6Z?NG,+$1,M*+!EEQK7N&"9H9;+[H"REX::HE'T_>Q1Y"OG'N?_@! ?WLRYG M=I[M6K#]L&/%FRICEV7>H#E'[U(BK$5760>2'WXP-7!9:^$[M2Q>2XOQX9D6 M(Z/%^/1=H<4XF07\4 8')U19R' 0LKN63NG9"SW-P3T%NY^<-7<["JJ;HWE$ MC78D1NMN*,G(E'A=EL/ Q>ILK6R;ZUA MWM1G019G9+<0H%F7'1[V;[V&MU-L9+PGS89@H%-7=UE#W]Y\4H-\OE,XA4*:2^A MSTUJ;,Q")<]1KCRL3M(RQZ9EGL\)[G%X >>]T=G&T4'N4]MX-T$Y2EVY9M#8 M3QE4^]> Q2DGF7&9V&$8YOKA\H:V)I%Z+;XQ;/FZK(L:G"6@,JF+Z_3PFBN1 M!S=-/<*K>IF![WOG)HU/;FP\]SAJ;1J<4338.VA5\-&%5N78^XETC,OBT;.F M*A*7Z%?M%2@1=O*(+^H"EYW]L6WZW5QV2[>O_O5_/?GPPR_FLY\QR&XL+O2\ M7E[-9]\6=2='W7^JD"RZZMN=_/JOY5Z>_8>-'+7%,O1,WG3\SGSV75.3!OUK MCDQ?UH_RG%_V574^]DYP<'+L_<"$1H!"T^7%CV3Y.1]_ISDX''_T86$?.Q77 M>"6A%@L/\NI_J/KN\*_[ME@%&*HN>?M#%;,?BKV;RY_\P[/OU^)90P\[8[(K M9G4/D"FQJ8F:.=WA;#U.<'!QO9')&FQ/>1)\CQQ_EC"=;24\ZIDT=P6G(97: MF,DZ8U.+^567,I^Y'+WZ"RY7#JV(* 3.E+]/%4V+IBO--!('\4CVYR6K?07H M$->A1:5='H3Z!Y9UV1L%N.LWY[?9T? :"_]VMJ5LA F06'E+7.!EU6##B;$&G%24T/I \ J[=]'OUKGA5+:Y:#5V*H2*"ZU_)CI$<5Q5HAI#.V^@$QP<-A#5*\!EB%>>N0U, M\>4[PI@ P2%O7V'#!8JE>HJ46\3*%#J0C[+@W7<(KV4S_6R:Y.W,W9[T$'I"M26"'1Y4ENBK&Q/@T(?*=BEV!X^H[!X\WGB5%.GAV#BO MV1,,U>%.M@,!6[B-\O$IZ' M^J9L&RYH)',Z&4OO0M/^&4UIK74HXH7O7;3(5'7R[[1Q3W1PXJMR24MM,Y)/ M-;ES:;7U9\PT_HM'1A2X(O 6[L-<,3VET54GMYWI1EIR6L0OJ,M" MOG7KSHTK!,XB9_MMT9*TE]BG5@%)=]$WXZ<1-(A/ J0=?8ZFUJQM9TG9[%8% MSPO5.0SPO7JM/JGZ'EEI6_@VBQ(9M55 LK=SO-(MR$>;#C,HA\4:M-H8YT@Q M47PAPI$XCTT704@R!7;K3!C,1N=0K3);O(N@#[6W>XM+V5S7LBDZ'&VQ )>_ MO;]!%ZO$B^)1AZQL4ZVHC%DUMY:*+N*4EAVSD2YL)^]$5@/!!WL(;9'&%]&8 M+**MMILR:\QIC?-,+E^;F%G!['@NW9@6%-[HGA5HO[\BP*YF/_B'[47R;WH; MV:D=W05;&"PV:D3'P=L.]^7 !EA3F&0H216!U6A9 T,24+IJ4Z9DZ;45&2;P:TE 4.S7KBKNXON_ MO'"-2WDI\K99KY2)Q?O981?)4]]N@FI?U=&-VF?KG83AA\@YC1T6KKCI]-#9 M[@-D2>?Q\L*_4DGLM4.^C,U O ^I]=@;J MO64+^*$,S@ J:N9,(_3KW.>?_5E,W3E^/3H:J/)+2 M.7@TLAL$ASP3QX?A?!:E3?U0I':-RZ%(X!&V96=JI'@2A![TU?<#F(1>=WD' MH,NU@B6:76CCD>OZJDEK>#@&.^#C6#24E8!21V(P"@DY/3:>&HTZ^=:SD7D# MZ-M@7B])PD(:$_D]R%D.9BES*N0-KC#?-:L#DI*%:ESR M>X;%X]8%"A54&L%-\<=30SX'<)5!$M]E2 #K#]"0DTP/=O _:,D%X0Z-N*&]\%?@RN[/HQFD.[CLK MP5O=GCFN4!=,R63JB;2U>A+1X.II0Z.:BHQ,PZUT0<#.+CZ[.^AZ'FB&:TI.[E&8+_=,Q+P?G&_=*W98>L!@VKRH'1%N)S"=6R M+$S1&Z_7,A4^"\NB732J_X5/4#H\_2H&F @N_8BR8^^ M_"&IRCP98;%CWKBI42@W*P";%Y#IYIRL?26^>JIVS0B7'>>_<_>C^_SD /'3SZRFX20 M\7\]E'G],4IB2MQ#[RBZ][L576 M.O#Q0!7W;%U.<' 2<7SM;_\<9YSFX/)&++,1A=53V(R3ZI-%UX5]=%@ VKAA M0J+8*\Y7,SOT?= N],A2(TJ;7'E/DLK7(NG0A@WT9 V4G*4A@%*3'^HN 3@7 MH9;8!%D9[_=TLR-^C,,*T$VD0J,JAZLZS.MFV;,HOTF@#H#='RT"@0Z#L5@' MF%8N!Y:M(#P>H88WD9;BG*$7[&RZ3G!P^;)WF&%AZS2LT(@F*S'&@2L4R_G3 M/A1;VP--^Y)Q+/O35.';M+@54Q,;R61!87EE24M&WEA1N!S Q#C)SPOI% =' M !G2KR4Q5%__K<<_^.Z?ZWHX"]^>ZN!R(U',EGW%P%J!:J$*BY81_JK4[+L: M#SC0\IMRU8/4@3TROAZ21[V3(TS/$;!VS7&8-;=(>*4C1[ML#/9T>5'+0\O5 M"LOM9>=4[.19&0&7*A48_OIJ]G,C%F<^DR.ZM*I,V&_J"EL>NJ M6^(JM0Z':=9E/A,O.541CT:"V#'\+GE/N M#1D#(4H.=X!< H::C-^<-FUN[I18->!;?\H>A0%+J)=B;(IK+RYL'0%=MNE) M68+]6R_CT^KX6JX%AF*M@P(Q7*/,X9#)>$U+N[9S>OSCN5'#A]1';N-L,F4J MC8U&3*N9PGUS*^&(6,JL7;(+==FT/H^;VD2R* MA2.)Q%RA/+K+G:;D7L6^_NYE*8:#W2MWLUH,&)H!D-G=$E6"U$@\F#TG R\4 M_#0_A]BNL%97FE=8^7&.Q-S0IN]@Z,1B M6T%:'-YK>59OBM#'1TL#$D%-O[??+^4>3F;;P$\6YQ-%[J#]%OY$J4U$#X?8 M49C/^#[?=5E*:';=D"'%\TTI [5LBN7&OX&/-FT^#T.G.]U*W6G/1&5W>J>, M]VN1QQ^?D<<9\OCS,_+X+5O #V5P1("ES+F&:5]:ZOSLP?BYH ]@@S=1M<+Q;\=9*Q__ZOSY[\OC3+[J41B+N MV0O+60,CRLA9W8@UHZI\B402XR]65F[M_+_31+OAMIRNK9$3-[@? (_&@%_R MJ;W,39Y')S6[!8'VR-IHN0Y$/)M'LY/C6?TP%FAFS^N4,5NSDXUU'_#71O]RO'*: .=\:468'T-7(=Z52C5(5@[F&>&9PT. MR+M91MZ%=E1NN )_1LI&/.7:V&D687\;0JU][]&#)I+,,K794M=UCKU5*'P3 M1, ]J[PUEJ?\6BT,>MV+ZJ[3CQI MU35S*#,D"V3B9*[K0J-!9TF MB1$-UK6FV3R$W+*A<\1Y%-([BEG^Z2>QYS0%Y(PV;#A0>\BY/R%#*RNK#I?; MV:J=X.!HU>+^YGTLG1D#8F\G 8\(^?"%:/#WQP#6)L#>_V M;^ESJ@["CIR4*MD2)%"9H(^V)I78YP7'J0T_^6\2"D6>APCC[&I+"(4/J6CI MSZQ#?@D8&??OVKV:&[&2FE0BI\=R2?.:?VD)$TK.^:JJ5>0H_DWVJH'Z9QTI M+CHHZ> -[MJP*TID^J_!0!+:FW*)2598S=W$$+SZR1-GO<]F;9YU4"'%WIE! M%WM;=B0"OBF6;G7DY6^0!I W,6EO9P5O/'>O='#"SI,O+,^AGU2W3A9L.?"% MSU;H! ='*Y0'O8A@>,B'=$XUQ&> /,/(\,@6(&MJF?IFZ$SAQ[R9TDOZ>7*1 MR4.M@V:MF(8"T$T7':.58X+ MI/[:1.1UO"LE6.\Z9K=)G)@Y^E,P;"#T]QV=3X+R2T=T AEY:D(&-:@R@EB$^SX\+G$F: 3%6(P MZ;>/*5KS7?),K5,I'M[W@2[D![U+)]G^N38+.:#A%*-)P?M5L_ 9W;'68P/O M=.NG:A8>Z8[$![>@+R0Q/WQEY2MXLXUFP81"Q:/B M-#[YIZ)MF]7LST5]O>&!1YV131G6LV^B"VHK!@%#$WEV:]"*'33(^$?0LE]D M%+M,=C3B7>('U9QHSHC>DQR6W#:]:13B=GN[: MLM))0E?6U>R[]BJN0<9.0&MV1R]A2US;I0HKY#SOVB)4SM$!B&>XWCHEXP]M MN6U41&0&>9"FM2CZ&W15_ZFO[OQQ'C_QXOOLNR+^]LD'B.1XC&Y"E8@HTP:( MP;Q2VL@HC]PS!T1)^(FHFXT6&O(9>3"3YNQGC=25H/@=SI2GQ64VZ0.F?2ZN M;A1DZ8B2P(2HYBQTQ=)]Y;;MMHL\]L^^?/[_8=SRR-_*EH;7\=WRF?BBL_>^ M^_:[]Y4J=!/:]F[V97A9A'9_-?LVJ!%Z!G;,=2FO[H=^49%*E'@VY8FJ=6PV"./YT\SYK:GDR5HKJ^TH/E^T@)A:7'VS[^(M9GT2O MW-Q^8-+(-A !:.(K86KNFM[+T ![K7MJ3D9">E(71*^OE35OZ0[^&:@XY<0=L!:/98QX7/MM"2QV47=,+WZ(,LPRRSU+"^>@]C<2U(Z_N M[&4-(*^\RKZ;1\):L+WV;:N?Z)@LGI5;YVJ:\TF8JO%?@5IJ1#*E$ICNX0ZS MI;6G7)(CT-KKLAR.=BD"[_%.'0ROA:%]3 DSEQ M6=N\)2,NV[1.#TIWUIRA]]<*7?+0%%QCOJO6-88/Z\H,J&_(?I!U?GEQL-#' MMXQ\>M#JJZ.S:3M(?SGD_Y(M=!V5<[IY')AB6E/F&\KP9 MRVT2WC4H@)=;V^[]&![8.Y,'K62ML9A(P5R%&\E[+E8V!;.T.GP*U%767&KE MU=3XH^L.9'[R<4N3!4]S8E10->"3%*E\&8./?WN@&W#:NBA&>"EK;8?HM+[^ M]]]]\#O^+)];^L_WGH#;X_,.#5_6\S\6;B$#^X^KBLD;O9K_[CO^#B3_3J_\15\/DGGWZ> MEL$_\:G_F8_Y%63HB@Y AMD]_@?BQ4Q^9" @Y3GM@>*4G!UU':H,J9T[(0=V M^>I^C_.4]DA,'R(K>:1#.[^TA$A/2M72J1=(&OERU=S6N:F5B\F3*\'I_'Y/ MHE@XO=NZ;S7OI#;4^59GT.&K5U>SYU,/JL:U8J:GK]?%36-2F/=YBOP4U#Q& M;!Q49"N$1.I.UI+:Y#I<%ZP^))D9'E!XQ7E&C"V ]WD0'#G.[UG6=7.CV;>J MZ.OE)G3._JWTFD#9F:.B!R[;R[= Z'5H6L^X,;&;?K]O\1_,SF\^/R9MPIN9 MT?-Y<3XOWL7S MG41C.B_[A1RH.2W+L?IH/E4-EF2EU:>[0 8+;J[VD<7=#+ M3:],C5CD:K7+%-?:TBCO'KX( KY6?=]5O*1JA$.,"^*-[:'-_O63IQR/4,9*G8P(/1 M.ILB0[SGKF_E.._8N0T^)7^+_&NL)ALX^M[OQJX^U)KB,=6&!?#/\@LB07F* M1@1CTDD< "8M-#+6D?L]C+*QQ($!S5ZT,9Q#[<)T>]F @=_'-16K#WS<,'K8 M^SW&H;+;^?0[GW[GT^]_X/0C9NX^>]<$YQ$GS3UO$D.+&[Y M+'G&Z&S3SC;M;-/^1VW:]_?U1P;ZU5L7+47G6H.^4P [Q)7> ;*2L??4*_G) MP"J@P-120%3WH'6\9ZH%K8X>/,!S7 0FTMM^9VDE=;Y6(T8H.&'JZ:?G6.D5 MME$-Z#X/HF6!-TBZ#[,\U,ZN')?9K']/YUN?&(Q5RWM[SS@;#*M(+6J55V,H M-3A3;D(R\7802$SA\/?;:J#1; MM.RQNI7/$J=SO\<8+K&8<#?>BK(*5,5=YKJPPD\#GE>80]Y/-"32*.ZYX&0/!!2U/B)-->GTI0@ M:R7N2J0H3A_W\'0*2U*+W.P4[(FF?M9R OV,<4VMQ-#_GX MO&)Q3WO+[C :V:B^G7"2H\08C*^GO8[$<:;41JMUOR=)85>1/9'30)P39&>K M=[9Z;XG5^_F>-F]DQ>C)T=2@LEJ2.MQ]U[:XC?U)!_8'X?U.*YV\PF\H=,^M MAJEY'W037P-FFQJP(*"UOSLJ,LV>KJ+?;TS!9AZM\7V/@;EI/URK* 125;AX M-X\IK^*F*"OW_%E7W6Y#RV3 OBUJ)K8*+>KJKAK44NY_#GB*385X0&5^+K&> MK>W9VOY/ XQ^ YPGX74LGE)I43VE!4UCM7 <+ISB&=J?LT=X4&G181KS=8@N4 F MX)Z/85,)@D'.Q6'6HEC*-,CX9>B[%@2/>WQ66XNWI)1CNCP,FR_>(7-]-MEG MD_VVFNP_QOZGXIZXE,RUA$=(6?.K%U>S=5BA(#17A@//=5(,K-P51G!KK4K1 MF4:KM Q11MB6W>HW^85&0\O#! ZKNL*,_0VHN2]^U7RU=DCIS_BHN=C^8QMN M .D!SK[= =CS&YY&SI+P:ZG21W+A6=LGX UTTK*L!?0CF7@ULVT8Q673:3Y6 M+K+MJYZ/)H.\?WW;QI?ZX] _V.PQ!;MFEQXFM>"ATH[S8IA&R1/I]X1!IJQ[ MG0%O[3WD;6LZ610-'0!8<=[589]C;OUEW[_]):)A]94?W,CSY!$.NY;UN?+X M1E\BZQJQIOJJT^SAG66O8I#X],P@D3-(/'Y7&"3>VA5[]KS.GM?;Z'G]EM3D M(GBZSZ10EK(0!J$B3NNR)51/HJX6_/P4')!S?\?CM9E=-\V*^#LX2:#F(\G[ M/9V_KD/_SNT&+A8D.F8@U0Z1KV("\>.E^!C$KJ*0"4[)JJF\]X3I4D%L!U+)H;;-S*W"GF3K<+5XNA^\/D%B[3K;T;G7- T$*JCU20 M*B;KO%Z[%K*#5V#"J"7O;)?Y&&]U@>] M9M7>(:W=XETV5!? ZJ2/G;4*H%F[J'L3=:0=NZWE8[J$)T7G>8M'4&2K/D<_[IS28Q\M6*$]V]L3 M'AQ6[:HA8B_2YQY;+. )IECPGC0!_5Y#+VVS2U\R+O=( H.2S>1^<(EE_O41 M_PJ7==!98[HF=D9+49R#G++O0)6K&ZY)]*5H*,ER%L2*_1';0 MP"9EI"CN>$+(Z(*W%8K/HD%\)W:_.G@4]#'*H]AH77]Z=$U+?:)A9B\O0JZR M*"@2WP(Z) ?PY^ M B;;AF0!C^SL._@"=;F*)1[:$%;IF(4PBP3V3:WLHOI:O:E4A<>*](D[!7%R MYL%U5S;*C8<9YIHE1+\T:1WKX<0JJ.[X6OB99=&%^2AXFPA4E"![.A]\^R;] MH0_+K#QHFWEXW@_"%Y" ^,^C7661S5S/*V\9U__^<7SO[SX0]?O,.Y//\*XY=_'5Z&<*,2% MJ8X8$.[7;; &*RXI=1%DU(\@T,@V,<@6W@TWP*:X(<]J[@$,"%A+$,8M^1W&;7KL#M86<+E^"(M#6]C"6X_:7E6X,C*S01/]MCF,2 & M96X.YU!G;*_1GE"U?1^2ZQ8W?KH I";2M <@.GE"J8[8P;,C&49OHD[\N(L:4U#*PIYE\X^4[^+?E&*(?$6\TY41< M7IR]B),?W%_J$D(.+1*>J;@=+9A6P>5H'5OC.8C4EG &Q)THE8B[EJ!6&\K] M=ZNVOY[1>9 ?ZG[?JNGTWVP+64L(]C:J\K.L^H4<$+)B-TWOP!T]*].25X<[ MDBHNB[:]HXNA4,_LI(X&GJD N8RZ%ND;>WX: >,$J&BHO*DY8UON#W(E_+8^ MB,_.?1!Y'\23=Z4/XF16\$,9G![_SU,S&$$*'5&2L1$0<'*8U#6: MVY&=%H^Q7@WD!P>T 4I5H$7XA!!A[-XO?K$FC'4E!W!O4?[EQ<_NCGI#K">Y MAY?*T"F$YL1S7:6O#A>X/S-A>?U>PO&_!R5?;K7%-6N2T-RMW_C6/I>E^G<% MR0+Y"$:=Z!LHT5]%?X2Y"PM-4;G>A!4I<[/D YX^2WNCI-+V_-/EA6;EO?IL M8N-=URRSA +3[[AF1H*8C[D9S#E[_$1^ MH!>'=<8,1ZP.LEVV4!9I>3Q9"PN91$Z4T:==S9YV@^$:8B]^Z&Y0Z?$K$VC$ MO$UHO1ABK\V^Y6]C^/J5>2&KM-.,]=T[Y:4]E,']O"E1Z-&]6B\MS1?JT%[? M22Q1UB]IH[@@E*?=4$.1I_TX1PK/O&*:0F\"+/@L5%W9=ZI0^P9T*+"&37^] M20 29'WVLXVL3VH@=?NKV4\-MF7+<"*#/#VZ12W1G_2 GP45.3S'C:?K2+Y. MT>289 2&L6V*E5MA;T93+2J\1)[^3SYX\IA3*/]X0LOUAAPGBG_I]O)R6IX* MNN_"#5HU$&BQ[8[M%5>S%VHTIP9WZ*'DN,S1L$VBD!WZ*.HA<8?_!]8QE[>5 MUU[+9V$Z6+_,(CG:$R3^8FJ6F5@RUV9#I(UVLBB6R,D MD75W-CPG.+@LMX;<-(O=@]T 2C@LV:,0\[$8S00P=M0I9+GC<_;LA >'&IQ[ M,\NFM;+,L<42TZICAFQT^:42SO=#>O'7+KV2?(@MDG=A+K:H0#M3KZ4T:XJ& M*!RNE=]HGJF8:@W'KC%;J;>I& JSV+MR9=()N<%F(\KMN'2=O+'+BUX.U/:U M0X"'/$$1?L3AG7O$,A^>&+D\;G[$R*:.Q2WW''C/G *SQ)UD0Y;A$&S'LZEM M@?DT"?4T!3GC;SKDVIDX!WR#9=?UP=S0_00K_1('G^K M"**KV7=-&QIRM+WB8/4S+ \.Z#]"6_;E6JFW!9IY (A# MG@J7C'!C[;7X;0BFG>>A UXRX0@XHQK7^3?&AF43JM54->U@KG"H[YN&X>-< M2U=<,UB,NZI 4RG&J\(7J>\A/027_>M&"5-Y).0LV8V^@68.,4,_QDXO]R8$M:/U'9%+7 K--#S[:VE M-[(R>R]Y M&I7^O2=@P:@ %3P0\ZU-[O!9!D5;[$'F K@#<(#(ZZ6D;9M"^[ MH704 9(F)BC/=R,C>505"\ T(2W833;B'M!/*69!GG9=[BV$'!4#")U@JDPM M/OFL#)#!& Q!GH,C+.Z3\R)H6)J_>VJ'3RX 0/53O(@7IB?,?M,R11H>&<8_ MY,Y!]MO;L.CDC>+5- LPP,2_%*@R+%/0@5H3NKBU8.#-"7;XZ8O)94S$55GO M(=-XIV]_M[GK0/T1;5SRG @SN99I3 N1I0WQ%19]6:G3E3TSN/H7UL8PURC8 MJQRR4*-#HF]8(V_S-%(KXI1+%9,&FHB\G9P]?K3I,QYNY7U8!<0MC8XIQCD3 M=X&=3P8]G?CC"4I3\=JFRH&2)!=$=1<5)0%A'YX\P_[\,!LOH?@R;/"F] AM M1Y:&%'%\(/+X.MW&RXLCPHW#;9/AZF12=TR!(QRF+&@]5H1[+<@N.U93(?'R MXJ?LY!TQ.^$.4]\:Q*GUD?@TC?U=352_%L?T^1G'E..8/CSCF-ZR%?Q0!J=Q MR(O4WP_VE-BW3Y?'G"YQ'VN-.C/E'X3\ !_8*=UH&#-PUG 4'$3>2IN^*1?E MWC,+Z^2WQ!#^')V<[N#^6HBK@Y+]@%T_.?^HZ*T:6.R!YDA<>YZK^V>MP8F\ M\A!Z< M8\JB*J'X#$^%5B)2*AQ]DBLQ/^TTH*KB*2CGK>2B$'V+E.V-CR0:@ M- #N3'N'\Z'#$6_'*LZ,-03C9=3,4:AORK8Q707\WIZD*FY-8B"* ,Q9L[^; MWHB#/J=WRC%Y*(/[!IWKX==BNP.62]<+5A3?K"P'>,O/Y/;B&M1E,9^]K)O; M&AOB!PGE&VO+_N1CB0(T(Z"J&@#?,(;9DJJ"^Z!@S+N]% MX%_B$V'HE>%[,!\[2M'-UK*;?1?)@PU;)=<89[L@KQXT0_@P6L8,OX:M8>&Z M;+MZ]'6+*E?.E"W6;#2A/FA8@=K$FA>6Q9[8\1FT*FY^_8=-$P_7T;O41*)7 M":/JA#B#2U<,Q4?2D[!W3^(<$')'(Y:(#(\D-Y(,Q4Q6^F;X%-Y3;1H@5I!^ MH)OM05N2O,^M<6YD]@!WK-OV^PZ%;\L<#E)_<8NS0%&@&#;HWWX M9U?P= ?WLP,FHX>1D3)D+UO3R069M8.RIMCKUW(8NL74Z:GN[MV2CG2A)F0M M'07*I7VXOK-,%U+0?6MV'M>C[WAPR=2%7$ZDW&(?7'JJ89\][7K>[&S[YV#S M:)++'A4/^LH^YMG3R@"OMRHA51M3# K;GN<]TFG/ZM/DIDL*A(XP!SJJR1*2 M&62GM%YY]Q_S-U?NO?2M#"]&01.[Q36I?OQ!B%M9%Y:89^DUGVG^Q0[]/7.* MD\!]E_L:O!%FK2="U#F>QC.@)E"UC,":!IEE)&(!BO%4HSS]C08]TZ/X8@C2 MR03(=%4OH0)LJH5DU_EB)%A+H@8KSFL:4]>_GOB[0CY:^#+S2VOUH?./C=98 M!IQR!T#5J3)>GXVX7]P+B56>CX*7G=]5'I<5()F"]3I>03;9*@S&X$B/\04.'\ H$O*^W1L=?UF@-$\!QV_ 14!MFG7S(\O MP .S,'FLCIIZ=!Y]/;"'17Q3<3OQ7EBL$4>5_KG2;I M.M.$ S)B*.=S'ID-_U6UR7$()U16T93#%KFB_3+LGFINQ&32L#Y&I.1\B5&K8+&6NCWI1?-B@0 MN&;SU'QV'052S9B)]>(!\O5-J&?)U2-H$4#QHH]U <^P[@\%%I]2N.A]<=I*I@IY(PPZF_#9V70#Y M=B7.=LM"QK$IF])@PE'0Y7EU4S95='UTEG\=[7$]0=(XL@,_$KGG1X/#XB\O M,I<_6I/T@H@O[%S' 2=:$".Q]V$E\G6Q',B'*2$C/@+AUR M\I^/OWA?UTB&$1V>1*3X(L8E=@]FCB&3GKA:EF7A>0A$.)CM%YK$OB7_-UQ?8JGIE3J73/'^U2U,1!QS9J..;=5LECS=#/QYS-PTZL@:*-XY0 \K"'46?SA80PNQQ,? M^KMY^2^Y..E$U..J8L($*W2N +W(G!IJV2I++4?@*%TVNS"0'!_<8#G"-A_Q M;N NJ'-C'H"Z#;* $'W>_MB-D.A;[6'2R=,$4'N%X M!FQ*V"AO!]19QG0](:/FFK*##<6W?7MD>7A?#\YNGLBO918 MWM*BL5A'UU7F8ZB+LW1, 8^Z&"@X6=WP8EC2< 4J2U9B[]+-&:,F4P:P-^<_ MZP;/_>;L[+7Z !>VH2(RKWH^"@OF(^LW/KG5"B:W@Y=ZQLW;C:R=:3K1\^D[ M[P.3$%,>L[D+P2CK4HY:3W<<\W[DQ\"!><7@#$!RU3U23QJR@=;;ER<'1M-!)>V0_R)2&NM/V6?>ABI$GB4 M:,S>BL[C;8C8_,,21G3I#@(F"X!M;MXI,_4ZG*Q$"V><;(:3_>B,DWW+5O!# M&9SFG+_1\X?6=-!=P=,(R6*JEK QWLK+XF%3Z<)/Q64ZX*:#M'-6^70'I[(4 MU]8:)ZYZ*5^E2RX'ZEHL;@,?W=^TG? !35\XC&. ($?IW_I2HQRYVR^-! @S MN/W:Y#8L'T:^!OR!F4C]F#ICZGM-KT7UJ;R/)E+2Y1\Y: ,*,.*^W#T(VQQ9 M[?0#+B]^"+NNG ,SI[TZN$*_(PAPBVI@8YR#*ET[JL*(;29]H';W5VCXVYM8 MC\5 ZCZ(1]FW>.!%J ,JWG/EX^RHAZ"13G<'[C)F9H?0WR)_ZKFKV9#P,/(+ MK)0N8-T66Q4?5@VA+RQL7H9R9QKQF,X"5,S()AN3S5:LQ TM>6<2 M!?8[32#$'*/YH^Q84B1A6&[JIFJN)5Z_Z_9A.^!J4=EC*BUD9"Y=V!7VY)K@ M9_19APH+=G@KOZ8BQNJ0UM1@I7^19;7B\*IR[8OXP2E_&7X-2Q[S)(^*#K!HI__!1X6S]##:KV+9"?'XH"$N?ROH$*T(6U4 GAEN])F37+9)I*6LO\@$O1!.260=)-+T%D%F9OIPL)?C;17EA(NF&^:#VZ20 M-QT2F<9YRC4O8WJHV99=9Y K5GHQ0_$0] M(\G*%UD.H*]S$RB+3N*YK35=9$EH*W4X2/0:E\X^P LFM?.KV8MI Z>0EBKY&*M#);#?+?&I.BNS'RT[._NEKV"US6JDL7#+PJH1ZA9UKX\@ 9U M8VS0.Q6G/I3!&:OW4!;'/9 A/(TV.OD_^29Q#R2B^.-:SUC+=,V9:S2M6YLZ MHB>5:\YAPJD.+N*A"\+AE%DNK9*A?S^Y9-Y<1?E FS);=W2*RW5LN#$@/B4< M9U,[P#0]AANA:*,W'E?^K7OF1F@'DK@TP/QYYIHFG>R)/TLW/;#!J7W]8]4L M$'YH1Z(F>L4E+V2!-+N-K ^6N"*!8 (_9)4QNH^3L#U YL"FA7KIB*!J!U?0XMI M/U%WB^[]MOBEB>0^)4WO*BN?W6["2#!8(F>0'D9<_$KK=4V_9VJ;W*IXSHB0 M*]JM7%(>;#]VX/G%'WN)*0I&W>NJU.H.G_\ M7'4;"BO\I?GUNVQ ."7'!_$K9;5:E\QL211>%ZL&_PQRK&S^UAR\=U0"S_OI&6_A;KDX6)C ['J;+= M$'G\R@TG08J0& M ?6/;D E%#E>L<>C","DK(6W'$4IB[D-YA5GAKVNF%R*WST@Q=,/:C]8WJ Q ME.K -0;+P;3!W?+D)UC"#&L6ZVZ(S++#*K;C[GKHK'7:>G,;6MT[,>D! .#C M3[_(#S;[QE@6'DL@+)!MEE]0;7B:U9DNX\2;MR%I8(T2[="G/#A.)Q0;.C9G M):7.PZZU55B"5"YNG-=J>2+Y=A;S?/CGN_%@5B0DO[RP[C>2JXU/%P6*'!;, MSO[="0_N)UBORXN2- YR.M3.*G'=%JN>#99&4@S^-K6ZA>DT[\.6A@$Y\-E* M\W.),7()$@S:_HI,N9311,*NI:#F[=ATVIG#VVZ;;Z?-DPI.#8-= C?B* MNS>[8H]\/HRIN&@*4L2#!D,4#4; *E:KN(0[:P^1T93:['RPY*\N+YX91=_A M_?09)_&)URWK+;R8^R$WUJ+JB$ ]N+I,X#GSI:+_Y$XI".)9(8@$^CS;L"5Y M4/OIK:>573*.7/&?W?X8*SX5T"SU/D'[;DX8\>Q&>@L)+ITT,! Z(77V"FZ; MMB)MH$]*FG9X8GT;G>'C_JH?W8[!+]N!5S?DF'378.P7QLG001P[G1_H_OYM ML*;'9UA3#FOZ^ QK>LM6\$,9W'_JB<. V;RL?S"$/Q*WJ^,_=<+D$;H<=PLJ+#$Z@L3B44K@>3Y4!Y-Z:UP_ZR8^0]M\[8AO%F,JS9-ER M>X8UXTH[9[2#8NBTS(*7?0^\@.0 J5#?7$N:*%<5B9T@"].UH)[DAXP*P$A[ MMF@PS14-M-LQ$@5(W)>7>/'='?YX-7N67*4#)/ .@U$]*IHM3*^BVUQWHG" M&'1Z\)176K[4\CF909BDZ("/9@">B:66S1LC1ERZ4V/83[J\>:TIC YH^&8 MRC ,==*/QM?'""I>.$// 5VG$8PCS5;U*NF(DA.2/P;)DFD]-!BQ_\?)-B@S M:]UV>F=C,]]ORG;U"#FJ.U=Z@CTBLV(F;0JP3>X[QLM']45__*J4U9CK4^:4 M%$3,W*[H4"_Y8!%[(+^496)2AP-?&KYFL[*&R^1:9CX=W=/!7:;=\O@HQ_QR MSZC1CQWG7)9'@X)LQ6A&)G/1&>3D;KJ":"9\=#7)1T8^Z9C/[NF7_SRQ4)2+ MTE97RI1ELSM2A6Z[O\A8CEG^RONNJ"F!O8D@M M2VGO7W8][&55E%NS(YY(E?4,7";V*I]&X4?ZK;7N5#.O4YCPG,/(VQ[/Z:X3 M'AQY%$?*!7,2+J%"0RS%?(+R*E^)3OM+FVB2NPHLM*6=CAY*7*Q#1HUWL(0O M+W0UDC] O'E30R1-*A=RMG57?^5F* M_#0']_T!G]@V5]ON.R=KS$V[Q!OURDK#T5]T]CG[(SDE6=PTN9SD@Z;B(2JM M<#=0TU_[:HYZ1[5_P6+RPE=K"6\1SQ/<]$RAZJZFWI$7L,CNVMZ'D83^RS? MIZERGO?.<#NU86M\8;[QQRGZ1&@O&F]ZA"&S7V1#=4[&%G/JC=P.O4=S* MHH8>[P$IUW"WQP<[;^$3'%R*?$@L9@T+A<* M2EF'IU(JT?UNVL>!NH:OJJI M:Z2OS5V">,98Y6(_DV6.^1UDD@ M6LAYWBVI-_/FK#V:9:,3\04%JEKDYH&E-QD-5[&4>A&4CZIZ!1 MRR8&T3\@:OU2Q=MO,TA[3M26M:,G=_]LN/GAFNKNGST;6H5BOQ=' MF1GYC7K,\\2'8JEY19K*8!XI'+%IKXO:J4CHCH2;IKKQ&H#UR&(^4BN9@0G1 M%(85ATY)T'1WS7I_B\^\)[_#/^8SO(IFRU_B:C=E"TV3]^6%;.2P]9NPZ,U21Z9A%#QE-?H>&,L%5_[XPI>Y#+5GDY\+1Z[QDF4TW?K+D][ MV!RK.Q.#@(44U@,1=%OR%V@*=-H4@:\R9 $ M5>!Z\L)-;'7 ]-.%HEUNK$S"/[//2DIT>) $S#VJK.%A M1&\;TXISY8YPS/VR:GIU$V:0#B^N<[AK><1I-UYRSPNT>>TX^G'QW'8>@?F@ M#KONZT1%0#TR)SLOZT@@/H^=+NB\GC1DHH^E5L6F.>LAX M >7MI BI3\R/L>$)KMI"IO$1^8S),[Y3$KS,[>DCY^Z(4[F3ZU9%&RD$O DW MEV,9.K]S%9"7\"4=[/,\)X3>,1.U,(;2Z",E^(K[=EZ?1,%F RUV5^A)="!4 MPJX0:ND;J2Q>M\RRHF6."(]G;T0FYA4K9&)AI$"+#S1@-Y'OE-F7AA2G2D@Z MP3029P*QE>."AMPG7O=W&$,W[*6?J]S)?,@JR&'X(YAH6"FYG[R7Z/1Z(&WA1\K.C@E^#).OJR>.5O.U^IJ6 M;-O G+O3IB09G ,D(PVM9^ :\9??*6_LH0SNH$;@9H<2OF$U(!7=RD8T0^2+ M$K%X%H>KP.UUPY; X99BAV&! *-+9/193R\SFPS4XFT 4U1JF9Q#32VT5>2R M<\];T#(;9!P%@3T:4YG0B/W+PMJKV;?-+4H38IU0#E!L1U_O$&PMHRB8E_R0 MTY"3ART>:NI(PYQ1;K]&9TB*!:.VFL1([A7P--J;@7)) M5"W_IVZ'Q5#(M".<)F^$&=9WG#@BUG8:N#[;L+KCX.V!V$[#^D,Q?NL:"Q,@ MP.H/6BUH*?4@\P3)@8&R ^)L4TYP<-])[-3H_G':8BQ)3;\R#^!),',K\B3M MLF&^7SX8L6T&=V; LNKWE M6Q46,.C/Q>>2(W5(D3V50$K8'K8YA15.AN@^Z!VP2T4%=&!VG1@.&([8UG BFC?/2![L6!^VQ0 M_=7X;96U%7M-?$VM2G+TBE41#1 MQQT!CW]RU73:&YVW% [;"<70UN6>^>^D9I*ZN8T"_-@862K?@FG"?'T<@L@ MR[7(95IT^4F/;KQV'-P]4&OUH$WQ).]9;CXL":UQ;$)TH%=U(CU]M-!U("Z> MJU'D^B+*!6K-/.3",*\E<0CF+:B9[$W6FI,8"U*\EUF GN;5ED'<> MSW[K=&(S,KQ5. 8#9W&0H_$N9)9TUJ727_A/-)>E'%$2E_=@,GG/M+D&R]Y% MN@92P0-XKMP:V32OR\V]644#>E($]ZT6FI(DUM/4ZS'W]%*VAUQBF%H4Z[ * MK1UVK(Z:GI-)=DT>]?DT#,;C*1#]UO"NV@.ER0EPM0[W?Q6NR\X.-\=RA;JP MHIB%!P,U6;(GRQF((YT=<9B6KWN4GF6)_*7F!L?O_H@V-KG/5[C/#\G._!A' M-!!/^^-7/_P8Q=,6XBEM\2CN1>%AOBON=&L\^>#Q9TI])Z[/-K"_B'-HQ-BX ME%>3NV&^*%?+93Z4U;2276M8E*[XDVKX/E^(SF0@I(OM+'=D(>)P]!E%JX6G M31=C[Y:BCS=8!ZJ9KF$2'2\VJ_M3#XCZHB[A&C6]NJE3IDU67>SQ UR#)4+9 MOO+)NBQFS[P7YP<[ IXJ22VG,)_^9YEVG1OH6Z0OTV+X4U^'] *,]D9>DRJ_ MI8Z=/Q5U+UM$/_IX+O=Z\L'<.Y8"(\= MI?.LHH_G^_+)ETR %,1 +Y#FYNTL%M)VTK3D. >;HE785IX^!?3EUNBIC8Z9 M&04#&;PI.?*SXOF2Z2&8L+(*#RP3G5&?-8?1F/CUR@UT8U#-,$\IZA'.EM%=ZEO&"N:Z;Y]!,5W'ZP-&C M*[MA6GISY]J[RWJ1C8V+1;9^W'8;#\:$I&"W"?4,+B^&@@:I>]JXRS4RW:FX MTKCM&A_1'G5_T&%P/]C(,8*+)2-G@6?))%:$-.]GW]33C7'R#H3MJ2*0>G42 ML=>D"U&PR78? &ER4\%1&1#KB[QA]#>?7;Q9F+G/JL4PT6'QU*I9.7Z4A5DJ8^C(?44,:2WTVH5Y&G MG,%- JRG?$9\6;-C[PK^7[FU)E>=BEP!,$FW)K,/>GD'9L7'CA[>5\-C3WEI MQM>8O_(B XR2.R_8[?.XU2.GD+4X'M_4'MHM717U -GDF)]V:T5++^3-C9\I M@\FKD^)0+3""^DY5:.ITL!DQ= DV1T)BPOZL:KHJZ$D T66NI(N%,$WMV*W# M,#42?O8#TJ3L*[%B,1(2F">^ ""?R!+@E/IW]&7$VBA^WQV7Z]# U/ZDN!95 M>Q%?B9):=&KN@H2PD"Y;S;X*2^:*=!8_U,S$$V;JKEMY3&9KGCSYF+'\AY]^ MEJ?_W/.WG)K=";^2O_CI*P%V@FN!,X=Z2H:N80P^[4$G=%4;M8BTLSX7L,%( MX2.773YHS1_EV2)E76'.(_-B#\ 31!_D32[,7]Z&V?B><^Y;MJ>Y0&(V\7F= M4]6_DY!%)G8V=YAXG* HU^4LUQE3$)(KV>3?HN 'EIFD$I4T*Q3*0-!4I#]R M"3,EP0FC;J*L3<@&,2HH#V%FW< L,22:22#C&)$#YLNL[>F0L5OM6-"A+CK_RGQXT7RU>4]6OKZ4 M3=UU1=XI#_:A#"[K<2VL=IZZ<[2"/J;)L@V%I#Q6;,:/D@(IG/57Y\/^- ?G MJV$1^$)1M%L;$ .Y@-AZ9?P% R/+Y &RA;_T+1I4J\H/SQ6XR8B(8S'%;I#C MX6Q!=:9\T S82?01[IPG@QE[[*#V$.F! J;IN*.&_,&(J6HR!'+""$E["X* MSX06/ .=(T =YESL<_1)-R@Y6F(Q_+JL^BZ>/W@=6F*(QYVE!,]F_00'E\RZ MP^*;?I XW8=BFX%,0?\84['G2.V$!Y<1]1DQ7O=2K##*GC%TFP^;5.:Q+ -G M;Y7:C8P7-(D)CZB-\F!PM+:N+B\&A+PCZK7<74VIT.N&.CTX'HS%;8*US>2# MK8PP-_-)FT;/GZB3#&4B3T(4-MA;K-?#RF2QZ"SO:^/RU!J+[5%<]L,MUK&( M=BTJI/M6^:QDL4(%/,%@TI@^+LJ*D:MI\^8/G16R#J^=84,UCQV56 ^T=S)$ MJ)]5IE,]!1 U'?-W.@O]4 ;WO%81*O#*%NW1?86-F0II&<4<2#I$$G-@ MM0H2D7S3M]C*6^>12NY+8KTR/I).; 9_9=T/"6:4N;&#<:$M$LP+-^3+RA( M#1,$^CD=0Y-WR&37E]"[-N5/_3)@OW,GK1O03!_9QQ*/I1S10.DLX^I2->UA M:BNIOL\'.J#^K=F_%MO=%V_DAC[0;?.@;8(Z@#\A8B"D\1L02>,5?]7VU[.G M*[*SB &OVS5<1:B;13QG_6"1)XA"Q%)X*MY2M#> M9PST(ZF6L]-YJH-S.DYT-S/16.M!PT:62I;:D@Q2XCD:GDW,:6 C+-X]2@D9 M>I:9A@)RB>'1HO<^V55<.%$:?KC\YLXM!0M&CA>%V@QNJX<#R447$C'[.F1J MOPRW"66 MBET;Q]X"L$RJM\@]S!&^O-#%>3ZL'^Z2(^OW8,7$4&'[;G9M+2D\ITU72%9>#6N( MSAR52'*TL(I=*4Z/W3.]1$:61DD")EF.)RM3=9I5B1Q_K>LOQ8NGV^?"XHY) MEJE(D$HA63"K'KZT5_&,B0P]TM3[HK4B[WVW*M>7@#'8-[M>; MLFT44^O$?EB"WJ8V[/J*XD]%FU$#RV<1^:4H8:>9"BLN41/,UD( ,<4XIY!II"21%) M@F[P9[(,#=I;CLEMKU4)R:2TAD!JDHF/&O558CS!H5-7MUD_Y32=XKU:BJVL MC #2<<#> ^:,D;IYG556PF&9N8HO4W'-!NLQ#/Q810G%4V?*(GC#\[EXG%5; MW!9(YVLADD/I0OEWI6V*E/*OR2QE"3\G%A[:GB/$ IHV/AN@UP*8/SH#F', M\V=G /-;MH(?RN D@/JQ[%Y*^&3*?#]FJ204)IY;]>XN])R5 MVXJ; Y2R:>Z,*GK+ NQ0U[457!/D+HJ1\D0-F6.@",_D"::YT7(4=$2<"1GLV/4#H8"<60;T"LI M@[[+%[U3[N1#&=SS+16QP33D0KD:=#AB:$AHSV4[ZDH@Q8;!#SK3$='],%'P M8=K)P$O:I2I_1/<"XRCVIVC$DKA*#O<>Q I*<4@E3MOC01^%U77([F*8G=(" MX<0@DC:]XOM# D*/$[)F**XN+UZQ=:O*Q97;L):-LDF,#OQ *K3*-B4D"'NW M':5SE=1RG_:D"6-'W;&L'9>!>7;5F&Q3:9#(.V?T;_%WJE)G-J7MDGS]3TR3 M+<%M4A5)#N&K]FKV0]BA'_I%C5@\S/X(&9*YK*UN7_WK_WKRX8=?B.G\&:9$ M%IPLHLWLJ3R+G.YS2$)?S6??%G47:@DM5#KY6=/NY+=_I;SW#VBT*)9!C,R2 MP;%^Y3O0",H]O];# "/Y46;C2UEJ"8@\> 4*Z07=OU3:B) MN#,F)O_+"F7]X:^V1=?-H!FQ*7P9R8M?S,"E2-EW.4BPM7/-T+SC0P[+%N1$ MAL>^O- S8(]%MX^RC6;MO1S;Y7046%Z;4%36'H9?JUR)[)Q@[5(Y2T,&AJMYZ3\['Z@IO5!GQOTW@;MA.@T(JK)LY_AD2F@!(6H54KE MDWY[&Q9=N0_T618@H8Q_&:CENK%5:;,"M+%'V M'^XV=QVA#/H$>1*2XCS7-$;F\ADID'S6"55 C+;=]567B#$3ADU3A4DO9ST; MT C1,)G'R7W *Q?5H[W,[&Q1=&5G>JW^&!DY\Z['_D^;:R>#I!:Q7$8I' ;9 MW:B-S7O)F?6";T+^>@T&39H7[ELG-7: '^P6B2]N#%Y',0,Q=B.UL<3XRDVV=KHE 6BF[7:,_HX+7%US6X#LI& Y.,B\;%R1,F85VPKB-N.JU: M7>1R57UY3[?%WZW*4P6RGB99 2XY%P;(KG%YL1-OGII2\'F,)0=$+9[J9X+Y MMDXLKOZ%Q+:=]08F7M.!:U:LBMT^2B%AKSJACD[7GACG"J?:LM@%32$K3S^8 MA!2*?--4,G5YS[ W/J9DLV>78UMYQJB1-9,_2$/XH*W\5WTP*K9_/%EC?"O' MV8^\AY44U_42/53@H"YAB7H6:[A]\[[E7 ?>5:X\FO65W**0]0_FF;R&Y?= MPP90@(9Q)$,OV:]Y8-IL6H MBI.3)^XC/ZM\JCA",B[1W&MU'@O71DV;DUF"P;/DS1E#DY^W:KS>YI]-_@,; MG)K\C/YSD-C4S"+Y9YO=3@EH4]2DL0\2 G3%NFPS =8V5:XW@)S_"7,F!$]%W3A1:=A[E,P6.G&../C8)-"Y1S1#. M4WIP@.?D[:&3E]!1D11>+](A:7-=M*L$E5\BU 5^68(":$HC-V$J;_+!1]UM MD+,/%#E6'8O4H8BGY71:$>/:E6VF-X4&2V,TDAM!CDH!:7G65PXUI3$B/86= MK=D7D7@)[0VCVII0-'A/)^M@3)C6KEI(>K4]CM-OW0S>6_(8=\RS]:LRGZK MQR>SJ4=OA1@E8X"Q514GTW7T))Z7N\YG!50@,=_R]CBI_M'6*"JZ-/@7LF;K M57%PSY39>1E4A=!*)&F9=QC((^N1R#(:4^M6NU/'>3W%R >Z+[?D*=8U62+K M;W+; WVV9H'7Z!VMA:;Q7QN29O%E1FPRY,\!S2CCUIB1TS8/CTN1%:H4_4PC M[_N-I$XL.1C%,6C&TS$P+EJQ:U2LBG&TD]OUNL]X1\IC!PJ!@=/F1\=R^'[F M SRB73(/@%5^9S(D.4,-7PLU_/@,-+JT520UY7O^9#Y MD^%/BS!(4T0GRR!:WMB)#E 2.:1#])Q&/!,K%_Y%2>VQ4SYY#9B,#/_]O" M3Q6F 7TBD]Y>0AJV?,8J#R,'O.,:BE;;-8KV MCAKM>^5;7]L&VAU,1]1Q?I6?14Q%'+\I'9 UCMT7]''ESVLE!%&YO5[K=0?2 M?I[,&A:NO"B=!^4Q$>7=8_#QXT6]5)JN[(A S=4:BN+J\F(H&03?,D;[!5 ] MUO&R" RLLLHK-6&M^ O)"..E-UR+K\RPE17"_N%X7?DN7&&@BK1R+CN4&NYY MX7P^68'7[7]8A&>A)%4EIT03B]6J-6K C#FD M1M%&V=1Q">$;J!7'QSFHO\S>O/SRBOZ7E^4:SG8PC 9Q\J*\ABOR/':OWO]TJG7?U M"0[N)R6ICJ6?U%DT]':R[+='HHGINMN$:JTP\7PW,RAH%/E+Y7="(HEZ-T#J MZ#C1E$06PX/-0WFN+;M^"%+TY:H1&;D=!S37FD). H@ W.>T>,84J1%?)+)4*1*-#"(,<6I-,U@]_GP'Z9 ME(H*J65GO2JI!.%DYMD1S)FX8@/'V$'][?OY\#8197=YH:IS>L*'MND,]X"9 MJH#V'266)H@.[L?%?F92>5"#2\%:AFPJZL3=[!5'KOY'R!0LL9O0WJ*_.VQ& M9&UON0R[?9X1'!0_ERA2+S5/RGVCV5M-$^0-RL.>R,$63S#GL H#!)7N)-5= MT6?,'N\H!2^X+7GK/[>3(ZRAHOM$DB^(&%C/2HP].>[3532 V-E_ <]@WP)-J0]F8[ M..]0>X50KD[,T:A@(..4,RY)3"T'4Z<-M7<9 F#XGHZ^H\@U7^5O'U&'4\D; MW=+11^,4LHJ1_*8V=O$,5F(\I[.&]]DM39S-[^N/Z=^:@3T?W"*";,89V&KS^FNS\^20]U<%Y4]$1%'M=[#,+=UTU"UD3;QBY M=&&IP=QM<'U);X97I'M>U8Z5[,N+ SX/"KB'=&K%/Y*PCJWZ8@Z7J4R7@[MR M2#NNG"Z8""US2'MA(3>S1\;"D,>C:!BU?I$,HYX?F@-"A63@Q'U9:H03"(YYBWGQG.P!3T$?2EA M%<6\O N!)W*G-W,=*YSJP/]CCI;%#F52:N(TK+IH0=(;9#-N0*<>5\9#8X_. M5 ]U:97MB@B-=RUK]9 &F/5;I21T7F#O5,@#N:3SD7'"@WN*U@HQOG>[TD@\ M,H+MK-GY83155CE43%*Y0WMX4U\W M,(EBJEK8-[1%QQ\,=:(H]\K. I8)>&,-Y7#XA>[XE@L*!L)7IW,0GH(1SZ?)ROT3_G\G#P6$6T<,) M_&0L*=D>@Q=8F#J7.?R\4E-APL ZHJ2IR+0 T%E9?,Q%2+G M:<-Z%(=0N><,0'8;_QH(\B=G"'(&07[RP1F"_):MX8[+WY@U"5(II?>M>7R1247 M=BKZM6I S,5K!L.\5G3)CN;47^*#+$O/SAY_R@P4/62;PP(O99**MKH;-#&F M):T$>I'D'3PTMV##F7QX^D#HBX.EE=E'E HT_8:)&3]+ON MPQW232O'S:>P%<@LQ5EXQBIQN2/D;?M:<>3[V9!77T>C%4X5L3I"5@^2^=5\ M=%DGLI?5NL-?]YN^.^RN+1LMK]*!W(+/.@K7DH!WE\\VRR-1GS?J\[35/ M/B\K Y/X.'^G5[.$&G.8Y*<9<'BQC6.\%3TV%C['Z7 M%VUYW9 T-\EN'UP$M?T5.LL]O9)*"F,UFX3?4D )G!HC+=R&L,\:W%>AVY6J MW +G2ZSW-5'1Y3ZJ$A]](AY2EI!)]W#]Y**23?V*-_PY:(LODX7YBVS7G]P4M3N63L(H35]:7:H MD3@"JD)[%9PL5CT2DH6EH.%I;4,Q] +M:/>2E,XA [SXU"86E$RCW2[S@A(J MV?=,!CX\--M#'/]K+.V#-$+OCH5EEG;(FI4;5O*,#B K7-_Y6>VYWX,2Z/Q0 M_4"_)\,+-5"@<=%FB-VI8_^UR!L^=8+MC /FR!RO*NG7;6%KWYM-U*QJ,^\K M[.JFWP*\5%YOO/J;>]:.Y_/IHV]/GYKMF^"<"0DB6P_.'$<_&1PG>4'-$9(> M_,TKR<]T,R>FG.$8!FW2OR>ZQSEN:)-(]2;SB363M'-;!-K+E]J0*U;X/5 2 MTPANT0HK+MS<6$\JQL$^G;=-^U*6Q-):+H$Q0-&>24/& MHR2:4Z9(5)QZ;4!KM/W69*!!F*R&;%^T==FIV)Y.< YQ<_28NY9#BN9-(Q'B MY84ZNLE1>&T=Q+SP'VU& M/Z1K+?-OAJH*A28JR#8=^9"(2MT;J+:OQ6%'[6P^*SGO%9_(]/#VK)#)9W ' MZM9M9[Y'R30V!>C+,(XZ$"J)4Z*K[(4[QS%&.'P5D%0 MKD2 (M9 4="W$"/6M*E19BO[KIB]IVFPP/$&6:_,3/RE, Y/#"5=B-;298=]#N^[Y=PUG?HK ML.:R(LK.]!>'R29'8T-XP!V*A@="QX7"/G+D4]#8QT5CD\$K[V$VN$R\R[Q8 M0)TQUV95&6-5D\PW;MK[LD)1":7D(:J5<&<(!.?;N[S0.=V'B8R6D3QD,:E* MSL>LU=!6V"JS1[N:?1DS]O621)-9(J;LFLI]/G'6^K:E0(=FH#P\9KL:)Y.Y MJMZ0;V]@#")O^%P'$>3E)O,%@6B0=,!W&!@?A>!>7N@.N$&)3RF0#=0+N*P\ M%41(%LW=4OR5(Y56N;+A/J,GFL,I,5$,AW=5)[PD*F6F6:_P5H)(>*D MN]LX[T4^P4.T@I.T<<#U!UUL6P1PO MC0V!H9>K5T6WT0&)86SH_UU#PZ=SP#^WM]+XT+]L2AZ^EQ?4H4^ BTQAPRRL M;I0![% VQ])I>WW[^''KIF90@V#,#=="IG!3[DSB3'[>0/[!;+L/244O)G*1 M8F *?T B[-&AK!H4,B1R1Y&BTA&B7Z>NO)HP%%8R*)>_JOZ\U/TE4*0/ Y[FGSQ=.RBPM:' M>>11=)YD\_:B'-4@?(KTD/C+7VIVB?ZG>?GR(YY-'ORKL)1%$$_@;WF%'WF% M+[)7F/PV[WNP[I;!B4G'*:NN1R?Z>&JH$C>DG9SMF98A,\K2#4)E_8+^39V$ MLIUZ4'![]1JHR+HS;W5;7B,]SGO)T9E.LBX#5\3"+JSA"816WL'LA]JU,R=LF"XBP(B(Z<@<]H]564$ MX,-VT0E_9"KF'O;:I#Z:M^H82XB?-T)M?7I&;>6HK<=GU-;9*?POK)3^.7KV M:%*&"6+W03!O),<(C_L9IFEXSWSN#V!P/SL,G"IA;"W%^4B_XVXZ@F@B]BH% MBWFQAADYK(YE"/ !<@]D/EOT>SI>B?]Q3L15!<4U9NR0SPEZ]S$AQ?RP3 3Q M4R23E.*C9D-/_C1TJ-!N;("3VZXOQ3-*8UZ7%<@_0,W1T37GE\TA1,+%Z#8( M+]M:!+^*U!?^=(DB%.EK:]0AON4P)P'U.!_< 1M'CGK!3)D.PQ"=M6Z:52K\ MD2Z^-=B;#/%J]@-]$602*LAP6I/3OCU5KHZ@'\$=;C>\.II9Z='Z7_-K>M:OINB[L88P0X R\)I_V M(L[RP0QG.#!KEXB3IV1DM[EXWBJL0ZW+EW\[8%>]L1H\>^?Q6]OLJS++7Y;2Y$N.7 MV*+U]7[#[)G%CJNR:WOGFF]F6"0Q?'^@IN]!V_6GM:IXDBE'?$-M[]F2PC4% MFGE-0*GN-JA;>$%M;C6J6"FP3,F>^5>*T"L%@S3NIX^>X'58JS(U^Q>':U*HF#^VREL-UCSI] M!KFS,LQ$K936;Y$CU;%B!TM5ERCIPJY,=5Z/?QE='EM^1/62D0\,->)#!!0BC(J$!7%Y 8]DA MP@CFQ[X*.N>//RP>/?[XO?7[%K9@; M>2Y^^:[? 9O1T0N!7T,6A18UV1V\AE_#LJ+9DQSK\-CX5P99[,D_I$NCM];MG[")!]8=SGG4X%4> M6+ W-DGU[,D'3Q[S&>0?3\02'MY)#1?LHT8KM%<%/."%H0558\W^;L0U]WB, MN68@F%#8NV1,D9L:V?)=Z2A:;1V<]!E&@52:DJ*NK6+(IRJWT[8FRJ O:)MN M4$AAL+,*>S6C9 U">@3%_Z(KSQF'4QP<&X+=#4YB 'XXRRIRS]4/M8G]QV-D M8K6E[S8,'8A75/D>H/RY2_;6_I"<8(@-36[Q-]_-9(('Z$(C9R1.E ><=B95W#8WZC;0OLL#<#%[F?X]@=XM$&O1)H38^$Z(&B? M&DLZKJ?%9X8XN$%: .! 0'RC_9<^>-_SB"/2B\$A11-1D+>/7 D3R;_TJVOK3-T4[9;/FL,J\XR\ MIC *STWH:M+P,FOH>JM MN\S]\&RCV!_:7(.LKU_6S>V91OF4!_>]>&1_*L0+:N]TG)_-Z?NQ.\ZPO&)@ M9Y62+.;+9_95J?$HUL?7-4%(QOJHLHYV=CJK KS!9MG')(YC\4!O6X*ZN$!- MZY%!+,&[^ BL$.J0PIK>>;2*FS.W*H^TQ=)U@/=-V63\&CS=E%L#=%U]JZEE ME+1,A'C)Q;RZFGU?SY[VUS*].@E//I#P5J?![T=0'V9"C/&N$=O+_?+FPW/; M+H\,['YI+,UA-C7[O*-..0@?](.C!]0/QJ=A3V-TEGF!#14,6+=F2K"8 OH# MYX_>"'Y:YT_SAQ-3IZ0@L7$74A([ZZP\*"KJL69_3S. YY)S?KWV--[ /&F5 M$3006JC?>*/N+;O2X(+OT%.%;GG6$%D$E -R*3>:)QAX?/U#XV<3J?$TLY$L MJTQ_]DQ>]K &AP,QUY',&G?7VJ^4:HKAU]CRULV'"Z.;#VI8S(RA,MWEQBE> M*+84&5\X(EIPVHSNYSHHT456^E5/Y[%5AA:U&66>[N7*OE/+]K78S<_.V,T< MN_GDC-U\RU;P0QF>ISHXK^]F;IA*)V;%1EDQFNR4!]7P MX2]7+ZX4C&.05B<@_$5"E Z!@5+KDKG#K1P8.KSL" \:XEQA[*X,C&\N2#QY_';F.&SUQ/'NC:^J.=HM#! 9UG M%A>XN__\QQ>*C;/L]>NN<7F17V1M(:D\V6?#)XOK\;S<3G!P3_1F?X.">9?RJ-)5XI2H]_:A8=0%FQK.'V/NO"SJRV1ANZ0^W:F7$"XF\X:IY+^C1-!QP$[AR^?E> %=Z," MR)N&_4Y)KKZF.8H$9&DMM,%@';LV&#(B:#U@=6P"?\/HOVDT,2?NFJ;EO\\X M ?@&OI;+--MRB2)^_"9?^U>9.--[IE/R_=?/OC*!DO>9_88T*-ASD"WW08/D M 'W*[!63=?F('4OZ6C..;;5U$4KF1[FB9!>@",H4>0UQI+(G8U>_BK$T;;6",GNT,6BNHL2U*63QK)UU MR[:7MW1GI&AKO%%L$T5S>:00"="OXBK45]U4IF^;U)\UU$EORC6#;U%I*Y-[BJ[?*$^PK=P[F K.$O9G9XR:FHHWH'OS?+]U_\-TL$[OK]W@0 MSBR82$!3FEG.LK:&EJKW6V=>"9=0G6A6\N9*8V@#MXE6$1LJ[@!T8--CJ\PN MLY1I+ZHN+MU_JB5]H,?U@_9%_K"()9P<0S1 ,2FB"/!?%&HSQU>L)WB-$<+9 M">2O&*IX6YGJ8\3'=Q?@*._O# "G!=[TC;] M,0+#GSHP_&D"AO^03G,_G^E2_?'ITQ_\D([9I3&D#>:XGUI0:[3PZ'*B,W*[ MD?C00JJFS7VM9=DN^VU'QI2./$E@=3:T6=O>X1D5/>ZZQ0>Z M+Q[TIO^G'A>K/O;0BA]1-JN!;Y:@2)$H.>T,L"YR:Z1V_'B@1%2 W_/V.&O8 MD;CH*7_S55@&B-;J&_WP,?%!3^:#,PXM.[+ZD2[:R;[YM0365.[QOQ]_>/7I M3":Y\@CE<%L?^^:3JP_]F^=-\M\W.%3('\CTBF-W4#F,NE($FX+_SD.RG-B0@.6H5T\/26SI['/VV>_]VW7.JEP,N*D:R;0UV9I) MG$X0,L0365;73H8OH@@CX0'/7O2(V*(8( M*X$=*)CKX%A=+L-M,X]#:LLTE-MJU@.Z)A-L',W5XGKRU(\S 0+:BQ)LA7FT MNT.X%SH4Q2K>]_"OJ!8?#KI'6C^QN4SC'_ES7>\5#C:), $7NH\VS^,*-V? M07F0#_]YSJ$O:0"@*4=A!D8Q@7K YF*(;:)T%ZY ?/ $HM)K,/.F/YTYL!B4 MKG6'&B/"BAE1]ZA,8RVT,^;D UU8XL"M&N/[7AE0VT(KAF/&M$W8G='%W4:4*(2_HODDJZ!@>DOA8'I2N)I&5(1 M!Y+ENSS[:.Y@R*S0._8U@$5U%PQ!"%K$HD82!V+_=UL[9.K++%]P+LW!IC8E M&8XYI@>K*5T-0U.O=#&,82TVW6*#=3KS_R)A+M4T)LFB,1C-5)%K##N=M.LX M<]ZOZ2%I17X3B?M;E S1*S;\9>O=!&I*F]18\(:)M'C,Y4^(F2O?$N/DAL!G M1S.79B?X&DE:'J;&<)@^U@D.L:EWC%X-(781"D*8.X54- 229^?!DO"](S]C M'P,KJ-G!8B?-\BY-+S)>SS4#6IW= *\O!:7EX%=1S;D4CW%*_TJ2C4-G&$VD M:C^BXJF4"KKW5@N"5$7JPF?$] *CU*5"U87>?79A"J<\,T.O1( !71AO*QLL M6'M6;N/G55:=5#.IDL!QK,Z3\75U8A(WK MFP-U=K[XMK_U>RY/EL%A0Q'#ACJ"W*Y%+U+_ >O@11D#A^[D[$-%6I M6$)2KM"XAD0-XT3HEI0UG]!MKITK[[B39FB0=CS!PH(59#PL[1*S(AKXEKZ! MOU\V\0-]?0+&L K.8(Q3H@.+?3&I7]E@=S*4PS'_A)^#9&9J63$-%:3^)4)P M:LP4PP'P'4:8*&%_'/09=*3G[3&,- VL&ZM4#%I@1ETGG*HO86XJA6W9I2V4 M=((-N0\2=(QG-$.KE6^=!K72@Z5XRB.:<^AI71",BFX362H6+9=HR] W5:%8 MH@STFM+1%UB/FTWAG&0@F8TP=%R[048#$)=C[:>1R9P# M0WPUMP97U_Z49-?B(SIUA\1SHK&LB7)7W.4E&*IZHFQKY3:0.+!R_\=P.:&V MNJ$%U"<&]XTQ\VG$8!&S(FZMQF821VV@[D$CI*B3BW>MN+$O0,A6S-$WITD4 MJ%*S7LEK-HB%C"F4EQ"BL$Y?JZ#='1X2HR?Y.5.A.XON4[T@TV:H,6X['D+5 MS(R0DG8*^K#T8G'(;,9SZ6R3.Y-C)A:<19 ;JJO$T$RQ"IFJ@UA7N<&4GA0AHS@G);L87#=J^*"A#S=, M9>(POTXJ2$6$G< T"[]TG(HAG70@FQ''ANLH_A\&:K_@2@/KC(; M"\?O.8,D,&QBBC^TO6\ZVV@WV+B,98AEDH-A*B5(YM&:=##?3/A\#B#D-_:)) MNOBV:J\?5YS25E\X2LMT_I%8X'761.9L[Q=??WBHL=,<7+SRG"W;NF,'RW2] ME[8*=AQFZ#5@A0_XG==6^.#'T0NO&3T!OG*&5:2#[N#0V(I1BW MYE4#B0/SBG2M538+8 I8KIS36##?*/P7: .)$' ?NO/DUAQK M*'&(/KI,:-#XNL![>'PTZ#XU=7KHCF);*6' X#\PXP.>)[&!=V:5VP*35-E/ M6U@C#$KEX/0:'NMHB6H2EQC[,"6FIOB &7AA4CE%H(V)A5[#.(&UVQB5T\-8 MF4I%%H[N>%S(S-A+T +\W5RF>-!KRQ3=,L7#MDQQPSAX6XB[#N /Q=H913.] M<[3Z6DW=3.(LJ+SD6)-?X/+K@]X#^AD^-](_K[T!($SR M*7ZT]].J]GN>KO\:&D$_\B.];?"*9YZX,"-L0)QG0+_^UX/G2'"P_FMJ3L:0 MV.L>A3$V'^?!\SMX^("??HM<\/3XY*EE@UM<]6TN,\>I8]X:_\%>"E\L+ SN M8P@$E(@3RIT7*7Z$ZXVTO45='>$%AC$2A&$"AB_OS>,\Q?_!6_+5TJ#VA%>[ M%.WM;V___;O]!L9Q+0D0E^.267N1VXO<7N0?>Y&E?(-:0-:YS&X-J5ML@G$6 MK#TTM1A.@4BUEH2PM' ^.#H*^&^;GEYO,520X3.>U@CLBDQ7A!)*KYJ '8'% M(-AE. WG\/N_DA!3X+!&:J(AV$_VP-%/"3GWTHJG5CRUXNF'BB>"?A> I35- M#0L1OX"NU%[L]F*W%WL#'(BU+[4M'["5?,-2$$%7-K9WO+WC[1UO5H@P4/-\ M*J IY_7V_,WOY[]DQ1RY M_^00R89_VSD.13R2EDP7^8>KUXOY/.)![M)('ZX;GC300L_PB:U0:85**U1^ MI%"1^[C>)2YUGG$!@>GCMAUHW7MTN[>D.()+^:@Z:YCX:<"@"X@3AX'E*7=Y MF1E*5QVJ;,(.<;?[D6#@+_R(YE$1N!^B.TBS.I>F\) GE0Z,R9*0\MA.EN@]@SPB[NJBR0W6 #<_JC2N<(B+R6M:R5 M)^QH^D,)<$21Z]%>NSO9U$^YLZV6J#2<3'/=7XE_5S0U S0G]FFEC-*' ZIJ M"K?:DL8&$T>7YA2U9,3L\29V9NIY8/(DEXPP4G.SS$6YGKOPIF')(? RS38< M%REC+(WTV-G$-#'+9>$!M*M<9D)1#[\0Z[HS*Q3/[,)*W27,O;A:;)A$W!NW M8[)F#0+4Q"OX-[_,K6#Q,7$5UN\'-X;2 R:IU+-H 4$(:_KSNSNT;%UQ+J"A MQ9PZ&=$!]KF1DBC5GX05*H8PQ'YCI->_DF0;]3N8/W#O4("3*L-A(766U-0H M:X&E\QW7S>7:T#;OXBT.U&SN(F0P)Z ,G2@Z9!(O/M(U"XL9=BH;>5+]?HU@ MV!&.$/[Q3%W[@>WOX2\&0J7N41I2A"N4E;S,7.?/ZG^N?,B.U?*Q0WJLAS->8N.X( B3BPK7#B_%!S7/0NZY M]E/=V8SH@Z#ER9FA^37<09K*5HSQQMOU.OMLL'O<6]7!=/?N#J,>/NQU>[T^ M&A7\A Y%T90/2Z2?K]L :AI_SV(+ ML5:IAYR+$42FZW( %HSE+4=T "QYCQ!)"VL6J(@=1['"=DA'@/N*O'8+=W?. M^:B0+%@9+.VO(A;!>1>KDEV4K=(+VMU9./+?YTDLRCPJ8KZ:U!UJ?BR=GG-< M^#DY3%!C>H%@_/IA6F5<;P^Q+]07*1SAR>-Z./)8F[QPJXA3Q52^[J[JZ>*( M/)]'>JH=*TMLZ9DA/*.]!O7/DE/!ZE0R\VG%;RVY\DE%.!X^@J2.P]C".]4) MGZ[W=ZMP5Y Y//.J0LBHF!5BZAC]KO$X-.%P&2B28S/?B&L!3Z9I)J$@FU$# M,E;L[ -7!(2;A\C%LZ%,7&8PLF3<]5[J%^'H6\*X&*4% 9NL)CRJ0NP(Y-!/ M= XK1WL!*>OV0]0N=%=AEW-.-0/=Z>TKZ!URAOKP$T01 4";UCJ&88K=3>, M/K'"&1 VKK/]#/M%4_X(-]':6',_#%P#SQA5MV??;*()\'7-S?VVN=EM;CZZ M+\W-C>'@;7$_G&B9S'?75H.64XAHI+Z ,"V! IEF+-V?N&A1<># :/4V,M1@ MXI8S"*)E996QF8/#G\P 7>O6."'(LN:CL<0I_CZZZ@@LKU@J&E/*P,]'A NE M>8]@."-E\.=,6*;C8KF1MT5&#:PO1YYF(/TJY)T.^K(OHSL0,DU*_?W@&:SN MY/=\X $V M9F53'N;Y@1KQ>/HVSM) XBQ\09!0$H+1&]D@O6(D(6N):A!IM]'6 0G.E*)K MQW ]6FJW?-% XI C*/T3(P(YNR W,X/ 57X=(_D M2FR&!+A^-DLKBE',Z1<4[7: ,C7L9,<$.V0\BG2:N)"E]O=6]L%27-2#)>%] M4D1ZJGS7.P\)7\%LCYWICE209KMQBQ#'$2@@A.RKI(PB!^XVPHI05A)>S+2C M3X-JE8(M!OS:?K2,DUB:8')O(^@W>IB#UL-T/#R)8_:Q,.PMZ9LYO-:7>@GTXS",S"LQ MN)HZ$$V%9ID>%V)F2J;@T88\G9V3_;8X"$T>2I\CQG,;3VDP<;?(O)0>=J&] MP3K%1\?)96E@(*;9JR_(',X]=UNC OL.A#<,,YHF5$IROSHS$UI-SIN>.PW3&E4.8];L(X;V D85T>KY=E":XJ4U%E/325Q8<]SPRL^4UR18N2*? Q M V3Q1J&L4'1Z?L086YS9TLWT G>(H38[N$L&6>&14&8.:"9_;J@8Q%H[3GH\ M RY0T+CHM,'4)%9U8U8:!%_%$[3@!$B?P17A=''BCYF$)839Q>WNF&JNP"LM MB>LHHTB@ASV>#&5QARFMS E=7!%^)2&$ M;1DNV1'\,Z68V9!_ILH/2A> IUN4E8.,T#23R7CF1*IPR'2D%F9]RE!LG"\ M^BZ%_2B/TZQ,/= (SF8T)L_#[&A7UA;&15@G6AY>6QI.;1<2QH3FQZ4"FC=* MH(5U3BU[P=KWI2B' $[@H"@1/[.Z MCA3(HAZ2$2I(77VI8"*L7.WZWMXAJ ^,E,R="9"I$N,$]ETA#-@\E+$W(=0P>KKWQ2RV2\A?.ZH&?ZT"FG[U]W RO?2O.MX+^)CWT<\QN/ Z2M(P\,$V.SSH T.] MIU>H&AQ$7KL54:S#H#0Z17EVID7B7L 9\O**HC &WQVB0 MS$!?G.5.Y6X8$DGUEO'D2 Z6I0$5IE\9_$O[#N?)K=AL('&42< )"3RR@SF7 M+X>'J!P4E+^SV.UDU*>86N]Q'[J?#7[Q 0H/]4Q\SP1QUG!0L)-I0XX+8/.A"K6:H]RV82MSB\V(XLOG;@L"VNRJYFPR32Y<# M'&>OWOZ=.D6E+M@[)0'P6@W3 AQ82< >$@3808?K10C[:G?GL.?"HJ0*V\%K MQP(+LI/Z,L*B1(2*Z?1Z/1=P,[F,Y3&+;8V?RIAV\AY)1' !C"I##WJ7!'0I M0# 8!YF"U>-\>8A%P81M-4R3SZK47.W6-L()YD7>-E@WE#A@;Z,O6YG73.)^ M"9\3HAY7:&XEB5M]?BN!20K>2!UV8SVZGN!X6;A%#@\+IE?&ORT#JSFH7OKC M?GK;J&H=#8I6!=;1P!Z[.WNB>S\*?)DASH@J@WCI+?],/5K;6E!ME/;[6JRV M*@;>]5!MR^GHN+C6YL^4&I7#=#!M*SAM5(%0@6I;BFODF"/2YI/M"R(G=MY0 ML\_NSLN"\&7P$5? 9CMA[^^5".%?3*2*:MEX4"-@$(!S:&E8 ;VR(-;$^&F MP'*OV07-D-3S(M6[#T^Z3XYO C1T<#S%+L-:! =.$$T_65E0]1VO8Y<%FG=W MD.A*=B4OO=:^0"ZTI'468-3-S;[B:W;-+M-^PC_ZK0760.+^ %*'8)D_)=@ MIJ^1;1IT4R*O3)[L[ZV"?>[4.?@ _W5=@GWOK0)UO*5MM>$OU1 MC:@NY]P72'\L?C;=L38JUU8^-Y-_WR4QUB&P3$1UB$V/@;2$.$PDJI6YO:J;_6^K/IVU4K9G$?<+9K>,$ M1P.AOSO!LP0W$P<%^32-8I_<7X(F3<.,K7;'J\P3-E\1$2_K_M>6[M)6%12$ MLXF7I:-?'\ __NSU^MV_YI,'GA_EOSXPTQ^G"B=X@%9]\F3^Q8PH/.[UYE\> M>(_OUTV_H[&9*VV ,UOS@3LVLW889JWUONJ$S-(4RO*S MHHX%G)]E!7Z9_.>'L+O>I8\%Q0A^PBG4NAA4_\3ML\=Z8XW[60H <(2@&GC, M5#3>9UAG#.O-%;CQDS0IYIBZ1?$*TI5:/W[V?@.G'2Z]]P+#'#YA.)DI;AVP M] 1]K/3G#E:'S!+O#Q^_R;_YIP+O<.*]3#%^,D<<'(JCG"4,T$+[<9:,_/VS M)/+U@KO>V1+I3@U5&O&'<*IUTM6,17&HHD#-4*G8NR198C/3C,(DP1]Z X)P M4WI:PB'AOSF6;N87C61M+N, ]_[(@9ZMR_OUYB,7&NWN7%]IU)J4S20.8QKW M*C2Q+<15ZQ'[O9IZQ./N[LY'E:GT0@7WKA;PQB#4<1N$W MQ4A:D%;]&FEU0M73,9PNFNG&&,=FK()!4=$2/@5S^DJ,4MN=>*;'R--G/@IF M(GSDO<&";!%G&GHS?@F?_V]28,F)@#?[@>1[=20LL"S"8-%_%3%/Y+%SWQ%V MM 2"Z2"K67C4% <%)3PX*::V6.,VJ2A3EU.JH24/BKI:#8ZF?1RZE/ W-)TM M:R/O:0 WQ8&KF$( 4IC\65Z4M8L#OS TR+S=/D M+_*7:2XIPO995_,Z>C\P]DBJ>Y-MD;,#)77:]:IH\KKRF9%#+ <08"R^M$(X M[H: SF) 82[XL%F6 #?@LAW(8V=];05C,R4BWL$[52!P"#E/3USDKUTAY()AFS)H8OXZ[,+EM\<%\_N,WNG!-75XS=T>TYY&B(HK8\:1UL8L#4GFTDA2,:"X"SVM'/#APLDT*1"21_ E,#+"RQ+HS;Q>9,H&2)4&[WTBKYF#5R.TXM).2UF?EQ9(3Q1O'R4IESQN;@QE5?. MP%Q#8 PO]S\KPEPA92$@R/Q+;?9Q">7PRIL@F'XL%9.:,'C&GDW1..*90?9Q M3[("$1P4#AD-L&$V'!8\&SZ;(O0@82S%P MS"S,O1CXY@*4H1\;C'U=$\K+"&-3(PI6+>*Y+8#UIU8CV;/J @.:"1ZLD[J> M:])Z^R6;UK3RO0$VGX=<\I]3&HP/61^(+:T%;OI,]=H31?3SK%)8G0+S.[E2 MZJ9M,]N[R*-H]:LHO*!F QGB)WUXI 3AB&.5\UC45NDUD#C=HK6[\\G.#I%N M=6$9_,7I)%5DL]V2([2)6['5Y_RMK5QQ$N]?)&0!U72>9*6.KJ[W?DF7#DLR M\P#J[ 6]P!U?,C&(D]9E0,0GW:.?EAGO[I!K04\XYSDEL+53G<$.I'M*CWQF MJ<[-+/7-*^!615E"NM8&8!@R[9"W3>="[>W 8BPR'*2'#=NV,)/.T M9T_#>;DSH3(/6]1^M0*"&Y36ZZSR91D6.18K-8ADBK#8 T*MP/TJUD#R MC3"AP05>T]4Y N6;,? !/(7&#$_].%91MOCH&=A=B,!:!Q/